[{"sessionId":"11045","sessionTitle":"Bone Marrow Failure: Inherited","firstName":"Blanche ","lastName":"Alter","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inherited Bone Marrow Failure Syndromes: Considerations Pre- and Post-Transplant","keywords":"Diseases, Diseases - Bone Marrow Failure, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation","combinedName":"doctor blanche alter"},{"sessionId":"11045","sessionTitle":"Bone Marrow Failure: Inherited","firstName":"Jane ","lastName":"Churpek ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Old and New Tools in the Clinical Diagnosis of Inherited Bone Marrow Failure Syndromes","keywords":"Diseases, Diseases - Bone Marrow Failure, Mechanisms, Mechanisms - Genomics, Study Population, Study Population - Adults, Study Population - Children","combinedName":"doctor jane churpek"},{"sessionId":"11045","sessionTitle":"Bone Marrow Failure: Inherited","firstName":"Rodrigo ","lastName":"Calado","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment of Inherited Bone Marrow Failure Syndromes Beyond Transplant","keywords":"Diseases, Diseases - Bone Marrow Failure, Mechanisms, Mechanisms - Molecular Interactions, Mechanisms - Proteomics, Therapies, Therapies - Biological","combinedName":"doctor rodrigo calado"},{"sessionId":"11045","sessionTitle":"Bone Marrow Failure: Inherited","firstName":"Blanche ","lastName":"Alter","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inherited Bone Marrow Failure Syndromes: Considerations Pre- and Post-Transplant","keywords":"Diseases, Diseases - Bone Marrow Failure, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation","combinedName":"doctor blanche alter"},{"sessionId":"11045","sessionTitle":"Bone Marrow Failure: Inherited","firstName":"Jane ","lastName":"Churpek ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Old and New Tools in the Clinical Diagnosis of Inherited Bone Marrow Failure Syndromes","keywords":"Diseases, Diseases - Bone Marrow Failure, Mechanisms, Mechanisms - Genomics, Study Population, Study Population - Adults, Study Population - Children","combinedName":"doctor jane churpek"},{"sessionId":"11045","sessionTitle":"Bone Marrow Failure: Inherited","firstName":"Rodrigo ","lastName":"Calado","credentials":"MD, PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"12:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment of Inherited Bone Marrow Failure Syndromes Beyond Transplant","keywords":"Diseases, Diseases - Bone Marrow Failure, Mechanisms, Mechanisms - Molecular Interactions, Mechanisms - Proteomics, Therapies, Therapies - Biological","combinedName":"doctor rodrigo calado"},{"sessionId":"11046","sessionTitle":"Bone Marrow Failure: Acquired","firstName":"Adrianna","lastName":"Vlachos","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acquired Ribosomopathies, Red Cell Failure, and Myelodysplastic Syndromes","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Hematopoiesis, Study Population, Study Population - Adults","combinedName":"doctor adrianna vlachos"},{"sessionId":"11046","sessionTitle":"Bone Marrow Failure: Acquired","firstName":"Jaroslaw ","lastName":"Maciejewski ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Implications of Somatic Mutations in Aplastic Anemia and Myelodysplastic Syndromes in the Genomics Age","keywords":"Diseases, Diseases - Anemias, Diseases - Anemias - Aplastic Anemias, Diseases - Bone Marrow Failure, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Genomics, Mechanisms - Pathogenesis, Study Population, Study Population - Adults","combinedName":"doctor jaroslaw maciejewski"},{"sessionId":"11046","sessionTitle":"Bone Marrow Failure: Acquired","firstName":"Christopher ","lastName":"Park","credentials":"MD, PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoiesis, Aging, and Bone Marrow Failure","keywords":"Diseases, Diseases - Bone Marrow Failure, Mechanisms, Mechanisms - Hematopoiesis, Study Population, Study Population - Adults","combinedName":"doctor christopher park"},{"sessionId":"11046","sessionTitle":"Bone Marrow Failure: Acquired","firstName":"Adrianna","lastName":"Vlachos","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acquired Ribosomopathies, Red Cell Failure, and Myelodysplastic Syndromes","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Hematopoiesis, Study Population, Study Population - Adults","combinedName":"doctor adrianna vlachos"},{"sessionId":"11046","sessionTitle":"Bone Marrow Failure: Acquired","firstName":"Jaroslaw ","lastName":"Maciejewski ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Implications of Somatic Mutations in Aplastic Anemia and Myelodysplastic Syndromes in the Genomics Age","keywords":"Diseases, Diseases - Anemias, Diseases - Anemias - Aplastic Anemias, Diseases - Bone Marrow Failure, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Genomics, Mechanisms - Pathogenesis, Study Population, Study Population - Adults","combinedName":"doctor jaroslaw maciejewski"},{"sessionId":"11046","sessionTitle":"Bone Marrow Failure: Acquired","firstName":"Christopher ","lastName":"Park","credentials":"MD, PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoiesis, Aging, and Bone Marrow Failure","keywords":"Diseases, Diseases - Bone Marrow Failure, Mechanisms, Mechanisms - Hematopoiesis, Study Population, Study Population - Adults","combinedName":"doctor christopher park"},{"sessionId":"11047","sessionTitle":"Management of Sickle Cell Disease: Present and Future","firstName":"Elliott ","lastName":"Vichinsky ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chronic Organ Failure in Adult SCD","keywords":"","combinedName":"doctor elliott vichinsky"},{"sessionId":"11047","sessionTitle":"Management of Sickle Cell Disease: Present and Future","firstName":"Mark","lastName":"Gladwin","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Emerging Cardiovascular Complications of SCD","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease, Mechanisms, Mechanisms - Multi-Systemic Interactions","combinedName":"doctor mark gladwin"},{"sessionId":"11047","sessionTitle":"Management of Sickle Cell Disease: Present and Future","firstName":"Angela ","lastName":"Rivers ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evolving Treatment Paradigms in SCD","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease, Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Gene Editing, Therapies, Therapies - Biological, Therapies - Biological - Gene Therapy, Therapies - Biological - Transfusion, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor angela rivers"},{"sessionId":"11047","sessionTitle":"Management of Sickle Cell Disease: Present and Future","firstName":"Elliott ","lastName":"Vichinsky ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chronic Organ Failure in Adult SCD","keywords":"","combinedName":"doctor elliott vichinsky"},{"sessionId":"11047","sessionTitle":"Management of Sickle Cell Disease: Present and Future","firstName":"Mark","lastName":"Gladwin","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Emerging Cardiovascular Complications of SCD","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease, Mechanisms, Mechanisms - Multi-Systemic Interactions","combinedName":"doctor mark gladwin"},{"sessionId":"11047","sessionTitle":"Management of Sickle Cell Disease: Present and Future","firstName":"Angela ","lastName":"Rivers ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evolving Treatment Paradigms in SCD","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease, Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Gene Editing, Therapies, Therapies - Biological, Therapies - Biological - Gene Therapy, Therapies - Biological - Transfusion, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor angela rivers"},{"sessionId":"11048","sessionTitle":"Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease","firstName":"Paul ","lastName":"Telfer ","credentials":"FRCPath, MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimizing the Care Model for an Uncomplicated Acute Pain Event in SCD","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor paul telfer"},{"sessionId":"11048","sessionTitle":"Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease","firstName":"Amanda ","lastName":"Brandow","credentials":"DO, MS","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pain Measurement Tools in SCD: Where Are We Now?","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease","combinedName":"doctor amanda brandow"},{"sessionId":"11048","sessionTitle":"Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease","firstName":"Kalpna ","lastName":"Gupta ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Novel Mechanisms of Pain in SCD","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease, Mechanisms, Mechanisms - Pathogenesis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor kalpna gupta"},{"sessionId":"11048","sessionTitle":"Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease","firstName":"Paul ","lastName":"Telfer ","credentials":"FRCPath, MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimizing the Care Model for an Uncomplicated Acute Pain Event in SCD","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor paul telfer"},{"sessionId":"11048","sessionTitle":"Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease","firstName":"Amanda ","lastName":"Brandow","credentials":"DO, MS","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:45:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pain Measurement Tools in SCD: Where Are We Now?","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease","combinedName":"doctor amanda brandow"},{"sessionId":"11048","sessionTitle":"Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease","firstName":"Kalpna ","lastName":"Gupta ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Novel Mechanisms of Pain in SCD","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease, Mechanisms, Mechanisms - Pathogenesis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor kalpna gupta"},{"sessionId":"11049","sessionTitle":"Emerging Issues in Clinical Care in Thalassemia","firstName":"Ali ","lastName":"Taher ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Iron Overload in Thalassemia: Different Organs at Different Rates","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Thalassemia, Mechanisms, Mechanisms - Iron Metabolism, Mechanisms - Multi-Systemic Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor ali taher"},{"sessionId":"11049","sessionTitle":"Emerging Issues in Clinical Care in Thalassemia","firstName":"Maria Domenica","lastName":"Cappellini","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Therapeutic Targets in Transfusion-Dependent and Non-Transfusion-Dependent Thalassemia","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Thalassemia, Mechanisms, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Genome Editing, Therapies, Therapies - Biological, Therapies - Biological - Gene Therapy, Therapies - Biological - Transfusion","combinedName":"doctor maria domenica cappellini"},{"sessionId":"11049","sessionTitle":"Emerging Issues in Clinical Care in Thalassemia","firstName":"Antonio ","lastName":"Piga ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Bone Disease and Pain in Thalassemia","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Thalassemia, Mechanisms, Mechanisms - Iron Metabolism, Mechanisms - Multi-Systemic Interactions","combinedName":"doctor antonio piga"},{"sessionId":"11049","sessionTitle":"Emerging Issues in Clinical Care in Thalassemia","firstName":"Ali ","lastName":"Taher ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Iron Overload in Thalassemia: Different Organs at Different Rates","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Thalassemia, Mechanisms, Mechanisms - Iron Metabolism, Mechanisms - Multi-Systemic Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor ali taher"},{"sessionId":"11049","sessionTitle":"Emerging Issues in Clinical Care in Thalassemia","firstName":"Maria Domenica","lastName":"Cappellini","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Therapeutic Targets in Transfusion-Dependent and Non-Transfusion-Dependent Thalassemia","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Thalassemia, Mechanisms, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Genome Editing, Therapies, Therapies - Biological, Therapies - Biological - Gene Therapy, Therapies - Biological - Transfusion","combinedName":"doctor maria domenica cappellini"},{"sessionId":"11049","sessionTitle":"Emerging Issues in Clinical Care in Thalassemia","firstName":"Antonio ","lastName":"Piga ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Bone Disease and Pain in Thalassemia","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Thalassemia, Mechanisms, Mechanisms - Iron Metabolism, Mechanisms - Multi-Systemic Interactions","combinedName":"doctor antonio piga"},{"sessionId":"11050","sessionTitle":"Congenital and Acquired Neutropenia","firstName":"Thomas ","lastName":"Loughran Jr.","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chronic Neutropenia in Large Granular Lymphocytic Leukemia and Rheumatoid Arthritis","keywords":"","combinedName":"doctor thomas loughran jr "},{"sessionId":"11050","sessionTitle":"Congenital and Acquired Neutropenia","firstName":"Brian ","lastName":"Curtis ","credentials":"PhD D(ABMLI)","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Drug-Induced Neutropenia","keywords":"Diseases, Diseases - Immune Disorders, Diseases - Immune Disorders - Neutropenia, Diseases - Immune Disorders - White Blood Cell Disorders, Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological","combinedName":"doctor brian curtis"},{"sessionId":"11050","sessionTitle":"Congenital and Acquired Neutropenia","firstName":"Seth","lastName":"Corey","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Diseases, New Mechanisms, and New Therapies in Congenital Neutropenia","keywords":"Diseases, Diseases - Immune Disorders, Diseases - Immune Disorders - Neutropenia, Mechanisms","combinedName":"doctor seth corey"},{"sessionId":"11050","sessionTitle":"Congenital and Acquired Neutropenia","firstName":"Thomas ","lastName":"Loughran Jr.","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chronic Neutropenia in Large Granular Lymphocytic Leukemia and Rheumatoid Arthritis","keywords":"","combinedName":"doctor thomas loughran jr "},{"sessionId":"11050","sessionTitle":"Congenital and Acquired Neutropenia","firstName":"Brian ","lastName":"Curtis ","credentials":"PhD D(ABMLI)","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Drug-Induced Neutropenia","keywords":"Diseases, Diseases - Immune Disorders, Diseases - Immune Disorders - Neutropenia, Diseases - Immune Disorders - White Blood Cell Disorders, Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological","combinedName":"doctor brian curtis"},{"sessionId":"11050","sessionTitle":"Congenital and Acquired Neutropenia","firstName":"Seth","lastName":"Corey","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:30:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Diseases, New Mechanisms, and New Therapies in Congenital Neutropenia","keywords":"Diseases, Diseases - Immune Disorders, Diseases - Immune Disorders - Neutropenia, Mechanisms","combinedName":"doctor seth corey"},{"sessionId":"11051","sessionTitle":"Therapeutic Apheresis as an Immunomodulatory Tool","firstName":"Douglas ","lastName":"Gladstone ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Desensitization of Human Leukocyte Antigen Alloimmunized Recipients of Allogeneic Transplant","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Technology and Procedures, Technology and Procedures - Apheresis, Therapies, Therapies - Biological, Therapies - Biological - Transfusion, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor douglas gladstone"},{"sessionId":"11051","sessionTitle":"Therapeutic Apheresis as an Immunomodulatory Tool","firstName":"Jennifer ","lastName":"Schneiderman ","credentials":"MD, MS","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Extracorporeal Photopheresis for Graft Versus Host Disease","keywords":"Diseases, Diseases - Immune Disorders, Diseases - Immune Disorders - GVHD, Technology and Procedures, Technology and Procedures - Apheresis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor jennifer schneiderman"},{"sessionId":"11051","sessionTitle":"Therapeutic Apheresis as an Immunomodulatory Tool","firstName":"Jeffrey ","lastName":"Winters","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasma Exchange for Thrombotic Microangiopathies Other Than Thrombotic Thrombocytopenic Purpura","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - Vascular Wall, Technology and Procedures, Technology and Procedures - Apheresis, Therapies, Therapies - Biological","combinedName":"doctor jeffrey winters"},{"sessionId":"11051","sessionTitle":"Therapeutic Apheresis as an Immunomodulatory Tool","firstName":"Douglas ","lastName":"Gladstone ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Desensitization of Human Leukocyte Antigen Alloimmunized Recipients of Allogeneic Transplant","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Technology and Procedures, Technology and Procedures - Apheresis, Therapies, Therapies - Biological, Therapies - Biological - Transfusion, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor douglas gladstone"},{"sessionId":"11051","sessionTitle":"Therapeutic Apheresis as an Immunomodulatory Tool","firstName":"Jennifer ","lastName":"Schneiderman ","credentials":"MD, MS","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Extracorporeal Photopheresis for Graft Versus Host Disease","keywords":"Diseases, Diseases - Immune Disorders, Diseases - Immune Disorders - GVHD, Technology and Procedures, Technology and Procedures - Apheresis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor jennifer schneiderman"},{"sessionId":"11051","sessionTitle":"Therapeutic Apheresis as an Immunomodulatory Tool","firstName":"Jeffrey ","lastName":"Winters","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasma Exchange for Thrombotic Microangiopathies Other Than Thrombotic Thrombocytopenic Purpura","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - Vascular Wall, Technology and Procedures, Technology and Procedures - Apheresis, Therapies, Therapies - Biological","combinedName":"doctor jeffrey winters"},{"sessionId":"11052","sessionTitle":"The Changing Landscape of Hemophilia Therapy","firstName":"Lindsey ","lastName":"George ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gene Therapy Comes of Age","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Hemophilia, Mechanisms, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Gene Therapy","combinedName":"doctor lindsey george"},{"sessionId":"11052","sessionTitle":"The Changing Landscape of Hemophilia Therapy","firstName":"Margaret ","lastName":"Ragni","credentials":"MD, MPH","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hemostatic Therapy for Patients With Inhibitors: Beyond Bypassing Agents","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Hemophilia, Diseases - Bleeding and Clotting - Hemostasis, Mechanisms, Mechanisms - Proteomics, Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor margaret ragni"},{"sessionId":"11052","sessionTitle":"The Changing Landscape of Hemophilia Therapy","firstName":"Alfonso ","lastName":"Iorio ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Using Pharmacokinetic Data to Individualize Therapy","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Hemophilia, Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor alfonso iorio"},{"sessionId":"11052","sessionTitle":"The Changing Landscape of Hemophilia Therapy","firstName":"Lindsey ","lastName":"George ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gene Therapy Comes of Age","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Hemophilia, Mechanisms, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Gene Therapy","combinedName":"doctor lindsey george"},{"sessionId":"11052","sessionTitle":"The Changing Landscape of Hemophilia Therapy","firstName":"Margaret ","lastName":"Ragni","credentials":"MD, MPH","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"12:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hemostatic Therapy for Patients With Inhibitors: Beyond Bypassing Agents","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Hemophilia, Diseases - Bleeding and Clotting - Hemostasis, Mechanisms, Mechanisms - Proteomics, Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor margaret ragni"},{"sessionId":"11052","sessionTitle":"The Changing Landscape of Hemophilia Therapy","firstName":"Alfonso ","lastName":"Iorio ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Using Pharmacokinetic Data to Individualize Therapy","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Hemophilia, Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor alfonso iorio"},{"sessionId":"11053","sessionTitle":"Controversies in Venous Thromboembolism: To Treat or Not to Treat","firstName":"Marc ","lastName":"Righini ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Distal Deep Vein Thrombosis","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Anticoagulant Drugs, Therapies - Non-Biological - Pharmacology","combinedName":"doctor marc righini"},{"sessionId":"11053","sessionTitle":"Controversies in Venous Thromboembolism: To Treat or Not to Treat","firstName":"Marc","lastName":"Carrier","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Subsegmental Pulmonary Embolism","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE, Mechanisms, Technology and Procedures, Technology and Procedures - Imaging","combinedName":"doctor marc carrier"},{"sessionId":"11053","sessionTitle":"Controversies in Venous Thromboembolism: To Treat or Not to Treat","firstName":"Jan ","lastName":"Beyer-Westendorf ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Superficial Vein Thrombosis","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE","combinedName":"doctor jan beyer-westendorf"},{"sessionId":"11053","sessionTitle":"Controversies in Venous Thromboembolism: To Treat or Not to Treat","firstName":"Marc ","lastName":"Righini ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:45:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Distal Deep Vein Thrombosis","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Anticoagulant Drugs, Therapies - Non-Biological - Pharmacology","combinedName":"doctor marc righini"},{"sessionId":"11053","sessionTitle":"Controversies in Venous Thromboembolism: To Treat or Not to Treat","firstName":"Marc","lastName":"Carrier","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Subsegmental Pulmonary Embolism","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE, Mechanisms, Technology and Procedures, Technology and Procedures - Imaging","combinedName":"doctor marc carrier"},{"sessionId":"11053","sessionTitle":"Controversies in Venous Thromboembolism: To Treat or Not to Treat","firstName":"Jan ","lastName":"Beyer-Westendorf ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Superficial Vein Thrombosis","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE","combinedName":"doctor jan beyer-westendorf"},{"sessionId":"11054","sessionTitle":"Common Clinical Questions in Cancer-Associated Venous Thromboembolism","firstName":"Ingrid","lastName":"Pabinger","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Direct Oral Anticoagulants: Now Also for Prevention and Treatment of Cancer-Associated VTE?","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Anticoagulant Drugs, Therapies - Non-Biological - Pharmacology","combinedName":"doctor ingrid pabinger"},{"sessionId":"11054","sessionTitle":"Common Clinical Questions in Cancer-Associated Venous Thromboembolism","firstName":"Marcello ","lastName":"Di Nisio ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidental VTE: Is Anticoagulation Indicated?","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Multi-Systemic","combinedName":"doctor marcello di nisio"},{"sessionId":"11054","sessionTitle":"Common Clinical Questions in Cancer-Associated Venous Thromboembolism","firstName":"Agnes ","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"When Can We Stop Anticoagulation in Patients With Cancer-Associated Thrombosis?","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Anticoagulant Drugs, Therapies - Non-Biological - Pharmacology","combinedName":"doctor agnes lee"},{"sessionId":"11054","sessionTitle":"Common Clinical Questions in Cancer-Associated Venous Thromboembolism","firstName":"Ingrid","lastName":"Pabinger","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Direct Oral Anticoagulants: Now Also for Prevention and Treatment of Cancer-Associated VTE?","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Anticoagulant Drugs, Therapies - Non-Biological - Pharmacology","combinedName":"doctor ingrid pabinger"},{"sessionId":"11054","sessionTitle":"Common Clinical Questions in Cancer-Associated Venous Thromboembolism","firstName":"Marcello ","lastName":"Di Nisio ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidental VTE: Is Anticoagulation Indicated?","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Multi-Systemic","combinedName":"doctor marcello di nisio"},{"sessionId":"11054","sessionTitle":"Common Clinical Questions in Cancer-Associated Venous Thromboembolism","firstName":"Agnes ","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"When Can We Stop Anticoagulation in Patients With Cancer-Associated Thrombosis?","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Anticoagulant Drugs, Therapies - Non-Biological - Pharmacology","combinedName":"doctor agnes lee"},{"sessionId":"11055","sessionTitle":"Common Hematologic Consults in Pregnancy","firstName":"Christian ","lastName":"Breymann ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Iron-Deficiency in Pregnancy: Clinical Implications and Management","keywords":"Diseases, Diseases - Anemias, Mechanisms, Mechanisms - Iron Metabolism, Study Population, Study Population - Pregnancy, Therapies, Therapies - Non-Biological","combinedName":"doctor christian breymann"},{"sessionId":"11055","sessionTitle":"Common Hematologic Consults in Pregnancy","firstName":"Leslie ","lastName":"Skeith ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preventing Venous Thromboembolism during Pregnancy and Postpartum: Crossing the Threshold","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE, Study Population, Study Population - Pregnancy, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Anticoagulation, Therapies - Non-Biological - Pharmacology","combinedName":"doctor leslie skeith"},{"sessionId":"11055","sessionTitle":"Common Hematologic Consults in Pregnancy","firstName":"Douglas ","lastName":"Cines","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombocytopenia in Pregnancy: Evaluation and Management","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - ITP, Diseases - Bleeding and Clotting - Thrombocytopenias, Diseases - Bleeding and Clotting - Thrombosis, Mechanisms, Mechanisms - Immune Mechanisms, Study Population, Study Population - Pregnancy, Therapies, Therapies - Non-Biological, Therapies - Non Biological Therapies - Non-Biological - Pharmacology","combinedName":"doctor douglas cines"},{"sessionId":"11055","sessionTitle":"Common Hematologic Consults in Pregnancy","firstName":"Christian ","lastName":"Breymann ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Iron-Deficiency in Pregnancy: Clinical Implications and Management","keywords":"Diseases, Diseases - Anemias, Mechanisms, Mechanisms - Iron Metabolism, Study Population, Study Population - Pregnancy, Therapies, Therapies - Non-Biological","combinedName":"doctor christian breymann"},{"sessionId":"11055","sessionTitle":"Common Hematologic Consults in Pregnancy","firstName":"Leslie ","lastName":"Skeith ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preventing Venous Thromboembolism during Pregnancy and Postpartum: Crossing the Threshold","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - VTE, Study Population, Study Population - Pregnancy, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Anticoagulation, Therapies - Non-Biological - Pharmacology","combinedName":"doctor leslie skeith"},{"sessionId":"11055","sessionTitle":"Common Hematologic Consults in Pregnancy","firstName":"Douglas ","lastName":"Cines","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombocytopenia in Pregnancy: Evaluation and Management","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - ITP, Diseases - Bleeding and Clotting - Thrombocytopenias, Diseases - Bleeding and Clotting - Thrombosis, Mechanisms, Mechanisms - Immune Mechanisms, Study Population, Study Population - Pregnancy, Therapies, Therapies - Non-Biological, Therapies - Non Biological Therapies - Non-Biological - Pharmacology","combinedName":"doctor douglas cines"},{"sessionId":"11056","sessionTitle":"Thrombocytopenia in Hospitalized Patients","firstName":"Marie","lastName":"Scully","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Approach to the Patient With Thrombotic Microangiopathy","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - Vascular Wall, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor marie scully"},{"sessionId":"11056","sessionTitle":"Thrombocytopenia in Hospitalized Patients","firstName":"Ryan ","lastName":"Zarychanski ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessing Thrombocytopenia in the Intensive Care Unit: The Past, Present, and Future","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombocytopenias, Therapies, Therapies - Biological, Therapies - Biological - Transfusion","combinedName":"doctor ryan zarychanski"},{"sessionId":"11056","sessionTitle":"Thrombocytopenia in Hospitalized Patients","firstName":"Lawrence","lastName":"Rice","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HITs and Misses of 100 Years of Heparin","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - HIT, Diseases - Bleeding and Clotting - Thrombocytopenias, Technology and Procedures, Technology and Procedures - Serologic Tests","combinedName":"doctor lawrence rice"},{"sessionId":"11056","sessionTitle":"Thrombocytopenia in Hospitalized Patients","firstName":"Marie","lastName":"Scully","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Approach to the Patient With Thrombotic Microangiopathy","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - Vascular Wall, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor marie scully"},{"sessionId":"11056","sessionTitle":"Thrombocytopenia in Hospitalized Patients","firstName":"Ryan ","lastName":"Zarychanski ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessing Thrombocytopenia in the Intensive Care Unit: The Past, Present, and Future","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombocytopenias, Therapies, Therapies - Biological, Therapies - Biological - Transfusion","combinedName":"doctor ryan zarychanski"},{"sessionId":"11056","sessionTitle":"Thrombocytopenia in Hospitalized Patients","firstName":"Lawrence","lastName":"Rice","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"12:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HITs and Misses of 100 Years of Heparin","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - HIT, Diseases - Bleeding and Clotting - Thrombocytopenias, Technology and Procedures, Technology and Procedures - Serologic Tests","combinedName":"doctor lawrence rice"},{"sessionId":"11057","sessionTitle":"Thrombosis, Devices, and Interventions","firstName":"Leslie ","lastName":"Raffini","credentials":"MD, MSCE","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anticoagulation With Ventricular Assist Devices and Extracorporeal Membrane Oxygenation: Walking the Tightrope","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Study Population, Study Population - Pediatrics, Adult, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Anticoagulant Drugs, Therapies - Non-Biological - Device","combinedName":"doctor leslie raffini"},{"sessionId":"11057","sessionTitle":"Thrombosis, Devices, and Interventions","firstName":"William ","lastName":"Geerts ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inferior Vena Cava Filters","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - Vascular Wall, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Device","combinedName":"doctor william geerts"},{"sessionId":"11057","sessionTitle":"Thrombosis, Devices, and Interventions","firstName":"Suresh ","lastName":"Vedantham ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombectomy and Thrombolysis for the Prevention and Treatment of Post-Thrombotic Syndrome","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Anticoagulant Drugs, Therapies - Non-Biological - Device","combinedName":"doctor suresh vedantham"},{"sessionId":"11057","sessionTitle":"Thrombosis, Devices, and Interventions","firstName":"Leslie ","lastName":"Raffini","credentials":"MD, MSCE","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anticoagulation With Ventricular Assist Devices and Extracorporeal Membrane Oxygenation: Walking the Tightrope","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Study Population, Study Population - Pediatrics, Adult, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Anticoagulant Drugs, Therapies - Non-Biological - Device","combinedName":"doctor leslie raffini"},{"sessionId":"11057","sessionTitle":"Thrombosis, Devices, and Interventions","firstName":"William ","lastName":"Geerts ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inferior Vena Cava Filters","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Diseases - Bleeding and Clotting - Vascular Wall, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Device","combinedName":"doctor william geerts"},{"sessionId":"11057","sessionTitle":"Thrombosis, Devices, and Interventions","firstName":"Suresh ","lastName":"Vedantham ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombectomy and Thrombolysis for the Prevention and Treatment of Post-Thrombotic Syndrome","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Anticoagulant Drugs, Therapies - Non-Biological - Device","combinedName":"doctor suresh vedantham"},{"sessionId":"11058","sessionTitle":"It All Starts Here: Disorders of Primary Hemostasis","firstName":"Veronica ","lastName":"Flood ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Advances in the Diagnosis and Treatment of von Willebrand Disease","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Hemostasis, Diseases - Bleeding and Clotting - VWD","combinedName":"doctor veronica flood"},{"sessionId":"11058","sessionTitle":"It All Starts Here: Disorders of Primary Hemostasis","firstName":"Patrizia ","lastName":"Noris ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hereditary Thrombocytopenias: A Growing List of Disorders","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombocytopenias, Mechanisms, Mechanisms - Genomics, Mechanisms - Molecular Testing, Technology and Procedures, Technology and Procedures - NGS","combinedName":"doctor patrizia noris"},{"sessionId":"11058","sessionTitle":"It All Starts Here: Disorders of Primary Hemostasis","firstName":"Cindy","lastName":"Neunert","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Newly Diagnosed Immune Thrombocytopenia: Can We Change Outcomes?","keywords":"","combinedName":"doctor cindy neunert"},{"sessionId":"11058","sessionTitle":"It All Starts Here: Disorders of Primary Hemostasis","firstName":"Veronica ","lastName":"Flood ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Advances in the Diagnosis and Treatment of von Willebrand Disease","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Hemostasis, Diseases - Bleeding and Clotting - VWD","combinedName":"doctor veronica flood"},{"sessionId":"11058","sessionTitle":"It All Starts Here: Disorders of Primary Hemostasis","firstName":"Patrizia ","lastName":"Noris ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:45:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hereditary Thrombocytopenias: A Growing List of Disorders","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombocytopenias, Mechanisms, Mechanisms - Genomics, Mechanisms - Molecular Testing, Technology and Procedures, Technology and Procedures - NGS","combinedName":"doctor patrizia noris"},{"sessionId":"11058","sessionTitle":"It All Starts Here: Disorders of Primary Hemostasis","firstName":"Cindy","lastName":"Neunert","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Newly Diagnosed Immune Thrombocytopenia: Can We Change Outcomes?","keywords":"","combinedName":"doctor cindy neunert"},{"sessionId":"11059","sessionTitle":"Lessons Learned From Quality Improvement Initiatives in Sickle Cell Disease","firstName":"Jeffrey ","lastName":"Glassberg ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improving Care in the Emergency Department for Patients With SCD","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease","combinedName":"doctor jeffrey glassberg"},{"sessionId":"11059","sessionTitle":"Lessons Learned From Quality Improvement Initiatives in Sickle Cell Disease","firstName":"Joshua ","lastName":"Field","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lifespan Approaches to Care and Transition in SCD","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor joshua field"},{"sessionId":"11059","sessionTitle":"Lessons Learned From Quality Improvement Initiatives in Sickle Cell Disease","firstName":"John ","lastName":"Strouse ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rigorous and Practical Quality Indicators in SCD Care","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease","combinedName":"doctor john strouse"},{"sessionId":"11059","sessionTitle":"Lessons Learned From Quality Improvement Initiatives in Sickle Cell Disease","firstName":"Jeffrey ","lastName":"Glassberg ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improving Care in the Emergency Department for Patients With SCD","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease","combinedName":"doctor jeffrey glassberg"},{"sessionId":"11059","sessionTitle":"Lessons Learned From Quality Improvement Initiatives in Sickle Cell Disease","firstName":"Joshua ","lastName":"Field","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lifespan Approaches to Care and Transition in SCD","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor joshua field"},{"sessionId":"11059","sessionTitle":"Lessons Learned From Quality Improvement Initiatives in Sickle Cell Disease","firstName":"John ","lastName":"Strouse ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"12:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rigorous and Practical Quality Indicators in SCD Care","keywords":"Diseases, Diseases - Hemoglobinopathies, Diseases - Hemoglobinopathies - Sickle Cell Disease","combinedName":"doctor john strouse"},{"sessionId":"11060","sessionTitle":"Emerging Pathogens from A to Zika and Their Impact on Transfusion Safety","firstName":"Lyle ","lastName":"Petersen ","credentials":"MD, MPH","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Emerging Infectious Diseases: Clinical Significance and Implications for Transfusion","keywords":"Diseases, Diseases - Infectious Diseases, Diseases - Infectious Diseases - Viral Infections, Mechanisms, Mechanisms - Immune Mechanisms, Technology and Procedures, Technology and Procedures - Screening Assays, Technology and Procedures - Serologic Tests, Therapies, Therapies - Biological, Therapies - Biological - Transfusion","combinedName":"doctor lyle petersen"},{"sessionId":"11060","sessionTitle":"Emerging Pathogens from A to Zika and Their Impact on Transfusion Safety","firstName":"Susan ","lastName":"Stramer ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevention of Pathogen Transmission via Blood Transfusion","keywords":"Diseases, Diseases - Infectious Diseases, Diseases - Infectious Diseases - Viral Infections, Mechanisms, Mechanisms - Immune Mechanisms, Technology and Procedures, Technology and Procedures - Screening Assays, Technology and Procedures - Serologic Tests, Therapies, Therapies - Biological, Therapies - Biological - Transfusion","combinedName":"doctor susan stramer"},{"sessionId":"11061","sessionTitle":"A Sticky Business: New Insights Into Neutrophil Extracellular Traps (NETs) in Physiology and Disease","firstName":"Christian ","lastName":"Yost ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NETs as Friends or Foes: Lessons From Human Neonates and Translational Models","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Proteomics, Study Population, Study Population - Pediatrics, Therapies, Therapies - Biological, Therapies - Biological - ","combinedName":"doctor christian yost"},{"sessionId":"11061","sessionTitle":"A Sticky Business: New Insights Into Neutrophil Extracellular Traps (NETs) in Physiology and Disease","firstName":"Denisa ","lastName":"Wagner ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NETs: \"Nuclear\" Weapons of Inflammation","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Multi-Systemic Interactions, Mechanisms - Proteomics, Study Population, Study Population - Animal Models, Therapies, Therapies - Non-Biological","combinedName":"doctor denisa wagner"},{"sessionId":"11062","sessionTitle":"Debate: Patients With Acquired TTP in Remission Should Be Treated to Prevent Relapse","firstName":"James ","lastName":"George ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Case Against","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - TTP, Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Proteomics, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - ","combinedName":"doctor james george"},{"sessionId":"11062","sessionTitle":"Debate: Patients With Acquired TTP in Remission Should Be Treated to Prevent Relapse","firstName":"Paul ","lastName":"Coppo ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Case For","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - TTP, Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Proteomics, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - ","combinedName":"doctor paul coppo"},{"sessionId":"11063","sessionTitle":"Getting Patients to Transplant: Myths and Reality","firstName":"Navneet ","lastName":"Majhail","credentials":"MD, MS","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Getting Patients to Transplant: Barriers and Bridges","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Transplantation","combinedName":"doctor navneet majhail"},{"sessionId":"11063","sessionTitle":"Getting Patients to Transplant: Myths and Reality","firstName":"Daniel ","lastName":"Weisdorf ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Too Many Donors to Choose From: Which Way Do We Turn?","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Transplantation","combinedName":"doctor daniel weisdorf"},{"sessionId":"11064","sessionTitle":"Novel Epigenetic Modifications in Cancer and Development","firstName":"Anjana","lastName":"Rao","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Beyond Cytosine Methylation: Ten-Eleven Translocation Proteins, Oxidized Methylcytosines, and Cancer","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Myeloid Malignancies, Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Mechanisms - Proteomics, Study Population, Study Population - Animal Models","combinedName":"doctor anjana rao"},{"sessionId":"11064","sessionTitle":"Novel Epigenetic Modifications in Cancer and Development","firstName":"Maria ","lastName":"Figueroa","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"DNA Methylation in Cancer and Development: An Evolving Paradigm","keywords":"Diseases, Diseases - Lymphoid Malignancies, Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Mechanisms - Proteomics","combinedName":"doctor maria figueroa"},{"sessionId":"11064","sessionTitle":"Novel Epigenetic Modifications in Cancer and Development","firstName":"Frank","lastName":"Lyko","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNA Methylation and Its Role in the Hematopoietic System","keywords":"Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Mechanisms - Proteomics, Study Population, Study Population - Animal Models","combinedName":"doctor frank lyko"},{"sessionId":"11064","sessionTitle":"Novel Epigenetic Modifications in Cancer and Development","firstName":"Anjana","lastName":"Rao","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Beyond Cytosine Methylation: Ten-Eleven Translocation Proteins, Oxidized Methylcytosines, and Cancer","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Myeloid Malignancies, Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Mechanisms - Proteomics, Study Population, Study Population - Animal Models","combinedName":"doctor anjana rao"},{"sessionId":"11064","sessionTitle":"Novel Epigenetic Modifications in Cancer and Development","firstName":"Maria ","lastName":"Figueroa","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"DNA Methylation in Cancer and Development: An Evolving Paradigm","keywords":"Diseases, Diseases - Lymphoid Malignancies, Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Mechanisms - Proteomics","combinedName":"doctor maria figueroa"},{"sessionId":"11064","sessionTitle":"Novel Epigenetic Modifications in Cancer and Development","firstName":"Frank","lastName":"Lyko","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNA Methylation and Its Role in the Hematopoietic System","keywords":"Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Mechanisms - Proteomics, Study Population, Study Population - Animal Models","combinedName":"doctor frank lyko"},{"sessionId":"11065","sessionTitle":"Primary Immunodeficiencies From Childhood to Adulthood","firstName":"Jennifer","lastName":"Puck","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diagnostic Challenges in the Era of Genomic Sequencing and Newborn Screening","keywords":"Diseases, Diseases - Immune Disorders, Diseases - Immune Disorders - White Blood Cell Disorders, Mechanisms, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Study Population, Study Population - Pediatrics, Technology and Procedures, Technology and Procedures - Newborn Screening, Technology and Procedures - WGS","combinedName":"doctor jennifer puck"},{"sessionId":"11065","sessionTitle":"Primary Immunodeficiencies From Childhood to Adulthood","firstName":"Troy ","lastName":"Torgerson ","credentials":"MD PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Disorders of Immune Tolerance: The Flip Side of Immune Deficiency Where Autoimmunity Trumps Infection","keywords":"Mechanisms, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Mechanisms - Pathogenesis","combinedName":"doctor troy torgerson"},{"sessionId":"11065","sessionTitle":"Primary Immunodeficiencies From Childhood to Adulthood","firstName":"Anne ","lastName":"Durandy ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Primary Antibody Deficiencies: Scientific Discoveries Leading to Challenging Paradigms in a Complex Disease Landscape","keywords":"Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Mechanisms - Proteomics","combinedName":"doctor anne durandy"},{"sessionId":"11065","sessionTitle":"Primary Immunodeficiencies From Childhood to Adulthood","firstName":"Jennifer","lastName":"Puck","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diagnostic Challenges in the Era of Genomic Sequencing and Newborn Screening","keywords":"Diseases, Diseases - Immune Disorders, Diseases - Immune Disorders - White Blood Cell Disorders, Mechanisms, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Study Population, Study Population - Pediatrics, Technology and Procedures, Technology and Procedures - Newborn Screening, Technology and Procedures - WGS","combinedName":"doctor jennifer puck"},{"sessionId":"11065","sessionTitle":"Primary Immunodeficiencies From Childhood to Adulthood","firstName":"Troy ","lastName":"Torgerson ","credentials":"MD PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Disorders of Immune Tolerance: The Flip Side of Immune Deficiency Where Autoimmunity Trumps Infection","keywords":"Mechanisms, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Mechanisms - Pathogenesis","combinedName":"doctor troy torgerson"},{"sessionId":"11065","sessionTitle":"Primary Immunodeficiencies From Childhood to Adulthood","firstName":"Anne ","lastName":"Durandy ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Primary Antibody Deficiencies: Scientific Discoveries Leading to Challenging Paradigms in a Complex Disease Landscape","keywords":"Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Mechanisms - Proteomics","combinedName":"doctor anne durandy"},{"sessionId":"11066","sessionTitle":"Genetic Pathways That Disrupt Hematopoietic Stem Cell Function in Inherited Bone Marrow Failure","firstName":"Marc Hermanus Gerardus Petrus","lastName":"Raaijmakers ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deconstructing Niche Contributions to Bone Marrow Failure and Leukemogenesis in Shwachman-Diamond Syndrome","keywords":"Diseases, Diseases - Bone Marrow Failure, Diseases - Lymphoid Malignancies, Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Mechanisms - Pathogenesis, Study Population, Study Population - Animal Models, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells","combinedName":"doctor marc hermanus gerardus petrus raaijmakers"},{"sessionId":"11066","sessionTitle":"Genetic Pathways That Disrupt Hematopoietic Stem Cell Function in Inherited Bone Marrow Failure","firstName":"Steven ","lastName":"Holland","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"GATA2 in Bone Marrow Failure","keywords":"Diseases, Diseases - Bone Marrow Failure, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Mechanisms - Immune Interactions","combinedName":"doctor steven holland"},{"sessionId":"11066","sessionTitle":"Genetic Pathways That Disrupt Hematopoietic Stem Cell Function in Inherited Bone Marrow Failure","firstName":"Inderjeet ","lastName":"Dokal ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Bone Marrow Failure Genes: DNAJC21 and ERCC6L2","keywords":"Diseases, Diseases - Bone Marrow Failure, Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis","combinedName":"doctor inderjeet dokal"},{"sessionId":"11066","sessionTitle":"Genetic Pathways That Disrupt Hematopoietic Stem Cell Function in Inherited Bone Marrow Failure","firstName":"Marc Hermanus Gerardus Petrus","lastName":"Raaijmakers ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deconstructing Niche Contributions to Bone Marrow Failure and Leukemogenesis in Shwachman-Diamond Syndrome","keywords":"Diseases, Diseases - Bone Marrow Failure, Diseases - Lymphoid Malignancies, Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Mechanisms - Pathogenesis, Study Population, Study Population - Animal Models, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells","combinedName":"doctor marc hermanus gerardus petrus raaijmakers"},{"sessionId":"11066","sessionTitle":"Genetic Pathways That Disrupt Hematopoietic Stem Cell Function in Inherited Bone Marrow Failure","firstName":"Steven ","lastName":"Holland","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"15:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"GATA2 in Bone Marrow Failure","keywords":"Diseases, Diseases - Bone Marrow Failure, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Mechanisms - Immune Interactions","combinedName":"doctor steven holland"},{"sessionId":"11066","sessionTitle":"Genetic Pathways That Disrupt Hematopoietic Stem Cell Function in Inherited Bone Marrow Failure","firstName":"Inderjeet ","lastName":"Dokal ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Bone Marrow Failure Genes: DNAJC21 and ERCC6L2","keywords":"Diseases, Diseases - Bone Marrow Failure, Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis","combinedName":"doctor inderjeet dokal"},{"sessionId":"11067","sessionTitle":"Next-Generation Sequencing in Routine Diagnostics: Are We There Yet?","firstName":"Kojo ","lastName":"Elenitoba-Johnson ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NGS-Based Diagnostics in Hematopathology: Strategies for Implementation in a Clinical Environment","keywords":"Mechanisms, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Genetic Testing, Technology and Procedures - NGS","combinedName":"doctor kojo elenitoba-johnson"},{"sessionId":"11067","sessionTitle":"Next-Generation Sequencing in Routine Diagnostics: Are We There Yet?","firstName":"Elaine ","lastName":"Lyon ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Understanding  the Genome: Professional Guidelines in Clinical Genomic Testing and Interpretation","keywords":"Mechanisms, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Genetic Testing, Technology and Procedures - NGS","combinedName":"doctor elaine lyon"},{"sessionId":"11067","sessionTitle":"Next-Generation Sequencing in Routine Diagnostics: Are We There Yet?","firstName":"Torsten","lastName":"Haferlach","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whole Exome Sequencing in Patients With Hematologic Malignancies: Ready for Real-Time Precision Medicine?","keywords":"Mechanisms, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Genetic Testing, Technology and Procedures - NGS, Technology and Procedures - WGS","combinedName":"doctor torsten haferlach"},{"sessionId":"11067","sessionTitle":"Next-Generation Sequencing in Routine Diagnostics: Are We There Yet?","firstName":"Kojo ","lastName":"Elenitoba-Johnson ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NGS-Based Diagnostics in Hematopathology: Strategies for Implementation in a Clinical Environment","keywords":"Mechanisms, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Genetic Testing, Technology and Procedures - NGS","combinedName":"doctor kojo elenitoba-johnson"},{"sessionId":"11067","sessionTitle":"Next-Generation Sequencing in Routine Diagnostics: Are We There Yet?","firstName":"Elaine ","lastName":"Lyon ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Understanding  the Genome: Professional Guidelines in Clinical Genomic Testing and Interpretation","keywords":"Mechanisms, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Genetic Testing, Technology and Procedures - NGS","combinedName":"doctor elaine lyon"},{"sessionId":"11067","sessionTitle":"Next-Generation Sequencing in Routine Diagnostics: Are We There Yet?","firstName":"Torsten","lastName":"Haferlach","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whole Exome Sequencing in Patients With Hematologic Malignancies: Ready for Real-Time Precision Medicine?","keywords":"Mechanisms, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Genetic Testing, Technology and Procedures - NGS, Technology and Procedures - WGS","combinedName":"doctor torsten haferlach"},{"sessionId":"11068","sessionTitle":"Hematopoietic Stem Cell Generation: Reprogramming and Expansion","firstName":"Kristin ","lastName":"Hope ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enforcing Post-Transcriptional Circuitries to Achieve Human Hematopoietic Stem Cell Expansion","keywords":"Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Mechanisms - Proteomics, Technology and Procedures, Technology and Procedures - Cell Expansion","combinedName":"doctor kristin hope"},{"sessionId":"11068","sessionTitle":"Hematopoietic Stem Cell Generation: Reprogramming and Expansion","firstName":"Kateri ","lastName":"Moore","credentials":"DVM","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:30:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vitro Hematopoietic Reprogramming and Generation of Hematopoietic Stem Cells","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Epigenetics, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Study Population, Study Population - Animal Models","combinedName":"doctor kateri moore"},{"sessionId":"11068","sessionTitle":"Hematopoietic Stem Cell Generation: Reprogramming and Expansion","firstName":"Jonas ","lastName":"Larsson ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNAi Screens for Maintenance of Hematopoietic Stem Cell Phenotype During Culture","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Study Population, Study Population - Xenograft Models, Technology and Procedures, Technology and Procedures - Cell Expansion","combinedName":"doctor jonas larsson"},{"sessionId":"11068","sessionTitle":"Hematopoietic Stem Cell Generation: Reprogramming and Expansion","firstName":"Kristin ","lastName":"Hope ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enforcing Post-Transcriptional Circuitries to Achieve Human Hematopoietic Stem Cell Expansion","keywords":"Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Mechanisms - Proteomics, Technology and Procedures, Technology and Procedures - Cell Expansion","combinedName":"doctor kristin hope"},{"sessionId":"11068","sessionTitle":"Hematopoietic Stem Cell Generation: Reprogramming and Expansion","firstName":"Kateri ","lastName":"Moore","credentials":"DVM","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vitro Hematopoietic Reprogramming and Generation of Hematopoietic Stem Cells","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Epigenetics, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Study Population, Study Population - Animal Models","combinedName":"doctor kateri moore"},{"sessionId":"11068","sessionTitle":"Hematopoietic Stem Cell Generation: Reprogramming and Expansion","firstName":"Jonas ","lastName":"Larsson ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNAi Screens for Maintenance of Hematopoietic Stem Cell Phenotype During Culture","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Study Population, Study Population - Xenograft Models, Technology and Procedures, Technology and Procedures - Cell Expansion","combinedName":"doctor jonas larsson"},{"sessionId":"11069","sessionTitle":"Impact of the Contact Pathway on Disease States: Molecular Mechanisms","firstName":"Sidney ","lastName":"Strickland ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of the Coagulation System on the Pathogenesis of Alzheimer's Disease","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Inflammation, Mechanisms - Multi-Systemic Interactions, Mechanisms - Proteomics, Study Population, Study Population - Animal Models","combinedName":"doctor sidney strickland"},{"sessionId":"11069","sessionTitle":"Impact of the Contact Pathway on Disease States: Molecular Mechanisms","firstName":"Patricia ","lastName":"Liaw ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mediators of Disseminated Intravascular Coagulation: Molecular Mechanisms","keywords":"Mechanisms, Mechanisms - Genomics, Mechanisms - Inflammation, Mechanisms - Proteomics, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Coagulant Drugs","combinedName":"doctor patricia liaw"},{"sessionId":"11069","sessionTitle":"Impact of the Contact Pathway on Disease States: Molecular Mechanisms","firstName":"James ","lastName":"Morrissey","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Poly-P as Modulator of Hemostasis, Thrombosis, and Inflammation","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Hemostasis, Diseases - Bleeding and Clotting - Thrombosis, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Inflammation, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Coagulant Drugs, Therapies - Non-Biological - Pharmacology","combinedName":"doctor james morrissey"},{"sessionId":"11069","sessionTitle":"Impact of the Contact Pathway on Disease States: Molecular Mechanisms","firstName":"Sidney ","lastName":"Strickland ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of the Coagulation System on the Pathogenesis of Alzheimer's Disease","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Inflammation, Mechanisms - Multi-Systemic Interactions, Mechanisms - Proteomics, Study Population, Study Population - Animal Models","combinedName":"doctor sidney strickland"},{"sessionId":"11069","sessionTitle":"Impact of the Contact Pathway on Disease States: Molecular Mechanisms","firstName":"Patricia ","lastName":"Liaw ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mediators of Disseminated Intravascular Coagulation: Molecular Mechanisms","keywords":"Mechanisms, Mechanisms - Genomics, Mechanisms - Inflammation, Mechanisms - Proteomics, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Coagulant Drugs","combinedName":"doctor patricia liaw"},{"sessionId":"11069","sessionTitle":"Impact of the Contact Pathway on Disease States: Molecular Mechanisms","firstName":"James ","lastName":"Morrissey","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Poly-P as Modulator of Hemostasis, Thrombosis, and Inflammation","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Hemostasis, Diseases - Bleeding and Clotting - Thrombosis, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Inflammation, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Coagulant Drugs, Therapies - Non-Biological - Pharmacology","combinedName":"doctor james morrissey"},{"sessionId":"11070","sessionTitle":"New Approaches to Understanding Microbial Immune System Interactions","firstName":"Antonio ","lastName":"Lanzavecchia ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dissecting Human Antibody Responses: Useful, Basic, and Surprising Findings","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Immune Mechanisms, Mechanisms - Proteomics, Technology and Procedures, Technology and Procedures - Cell Expansion, Therapies, Therapies - Biological, Therapies - Biological - Antibodies, Therapies - Biological - Vaccines","combinedName":"doctor antonio lanzavecchia"},{"sessionId":"11070","sessionTitle":"New Approaches to Understanding Microbial Immune System Interactions","firstName":"Sarah ","lastName":"Gaffen ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IL-17-Driven Immune Signaling in Autoimmunity and Fungal Infections","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Signal Transduction","combinedName":"doctor sarah gaffen"},{"sessionId":"11070","sessionTitle":"New Approaches to Understanding Microbial Immune System Interactions","firstName":"Mark","lastName":"Davis","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Approaches to Human Immunology","keywords":"Mechanisms, Mechanisms - Immune Mechanisms","combinedName":"doctor mark davis"},{"sessionId":"11070","sessionTitle":"New Approaches to Understanding Microbial Immune System Interactions","firstName":"Antonio ","lastName":"Lanzavecchia ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dissecting Human Antibody Responses: Useful, Basic, and Surprising Findings","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Immune Mechanisms, Mechanisms - Proteomics, Technology and Procedures, Technology and Procedures - Cell Expansion, Therapies, Therapies - Biological, Therapies - Biological - Antibodies, Therapies - Biological - Vaccines","combinedName":"doctor antonio lanzavecchia"},{"sessionId":"11070","sessionTitle":"New Approaches to Understanding Microbial Immune System Interactions","firstName":"Sarah ","lastName":"Gaffen ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IL-17-Driven Immune Signaling in Autoimmunity and Fungal Infections","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Signal Transduction","combinedName":"doctor sarah gaffen"},{"sessionId":"11070","sessionTitle":"New Approaches to Understanding Microbial Immune System Interactions","firstName":"Mark","lastName":"Davis","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Approaches to Human Immunology","keywords":"Mechanisms, Mechanisms - Immune Mechanisms","combinedName":"doctor mark davis"},{"sessionId":"11071","sessionTitle":"Iron Trafficking: Ins and Outs in Organelles, Organs, and Organisms","firstName":"Mark ","lastName":"Fleming ","credentials":"MD, DPhil","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:30:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Congenital Sideroblastic Anemias: Iron and Heme Lost in Mitochondrial Translation","keywords":"Diseases, Diseases - Anemias, Mechanisms, Mechanisms - Erythropoiesis, Mechanisms - Genomics, Mechanisms - Iron Metabolism","combinedName":"doctor mark fleming"},{"sessionId":"11071","sessionTitle":"Iron Trafficking: Ins and Outs in Organelles, Organs, and Organisms","firstName":"Iain ","lastName":"Macdougall ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:30:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Iron Supplementation: What's New?","keywords":"Mechanisms, Mechanisms - Erythropoiesis, Mechanisms - Iron Metabolism, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor iain macdougall"},{"sessionId":"11071","sessionTitle":"Iron Trafficking: Ins and Outs in Organelles, Organs, and Organisms","firstName":"Nancy ","lastName":"Andrews ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Understanding the Transferrin Receptor and Cellular Iron Deficiency Outside the Erythron","keywords":"Mechanisms, Mechanisms - Iron Metabolism, Mechanisms - Multi-Systemic Interactions","combinedName":"doctor nancy andrews"},{"sessionId":"11071","sessionTitle":"Iron Trafficking: Ins and Outs in Organelles, Organs, and Organisms","firstName":"Mark ","lastName":"Fleming ","credentials":"MD, DPhil","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Congenital Sideroblastic Anemias: Iron and Heme Lost in Mitochondrial Translation","keywords":"Diseases, Diseases - Anemias, Mechanisms, Mechanisms - Erythropoiesis, Mechanisms - Genomics, Mechanisms - Iron Metabolism","combinedName":"doctor mark fleming"},{"sessionId":"11071","sessionTitle":"Iron Trafficking: Ins and Outs in Organelles, Organs, and Organisms","firstName":"Iain ","lastName":"Macdougall ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Iron Supplementation: What's New?","keywords":"Mechanisms, Mechanisms - Erythropoiesis, Mechanisms - Iron Metabolism, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor iain macdougall"},{"sessionId":"11071","sessionTitle":"Iron Trafficking: Ins and Outs in Organelles, Organs, and Organisms","firstName":"Nancy ","lastName":"Andrews ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Understanding the Transferrin Receptor and Cellular Iron Deficiency Outside the Erythron","keywords":"Mechanisms, Mechanisms - Iron Metabolism, Mechanisms - Multi-Systemic Interactions","combinedName":"doctor nancy andrews"},{"sessionId":"11072","sessionTitle":"Advances in Cellular Immunotherapy for Lymphoid Malignancies","firstName":"Gianpietro","lastName":"Dotti","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Emerging T Cell Engineering Approaches: New Targets and New Cell Sources","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - B-Cell Lymphoma, Diseases - Lymphoid Malignancies - Hodgkin Lymphoma, Diseases - Lymphoid Malignancies - NHL, Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - CAR-Ts, Therapies - Biological - NK Cells","combinedName":"doctor gianpietro dotti"},{"sessionId":"11072","sessionTitle":"Advances in Cellular Immunotherapy for Lymphoid Malignancies","firstName":"Crystal ","lastName":"Mackall","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enhancing the Efficacy of CAR T Cells","keywords":"Diseases, Diseases - Lymphoid Malignancies, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological, Therapies - Biological - CAR-Ts","combinedName":"doctor crystal mackall"},{"sessionId":"11072","sessionTitle":"Advances in Cellular Immunotherapy for Lymphoid Malignancies","firstName":"Cameron ","lastName":"Turtle","credentials":"MBBS, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Understanding Outcomes of CD19-Targeted CAR T Cell Immunotherapy","keywords":"Diseases, Diseases - Lymphoid Malignancies, Mechanisms, Mechanisms - Immune Interactions, Mechanisms - Molecular Interactions, Therapies, Therapies - Biological, Therapies - Biological, Therapies - Biological - CAR-Ts","combinedName":"doctor cameron turtle"},{"sessionId":"11072","sessionTitle":"Advances in Cellular Immunotherapy for Lymphoid Malignancies","firstName":"Gianpietro","lastName":"Dotti","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Emerging T Cell Engineering Approaches: New Targets and New Cell Sources","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - B-Cell Lymphoma, Diseases - Lymphoid Malignancies - Hodgkin Lymphoma, Diseases - Lymphoid Malignancies - NHL, Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - CAR-Ts, Therapies - Biological - NK Cells","combinedName":"doctor gianpietro dotti"},{"sessionId":"11072","sessionTitle":"Advances in Cellular Immunotherapy for Lymphoid Malignancies","firstName":"Crystal ","lastName":"Mackall","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enhancing the Efficacy of CAR T Cells","keywords":"Diseases, Diseases - Lymphoid Malignancies, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological, Therapies - Biological - CAR-Ts","combinedName":"doctor crystal mackall"},{"sessionId":"11072","sessionTitle":"Advances in Cellular Immunotherapy for Lymphoid Malignancies","firstName":"Cameron ","lastName":"Turtle","credentials":"MBBS, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Understanding Outcomes of CD19-Targeted CAR T Cell Immunotherapy","keywords":"Diseases, Diseases - Lymphoid Malignancies, Mechanisms, Mechanisms - Immune Interactions, Mechanisms - Molecular Interactions, Therapies, Therapies - Biological, Therapies - Biological, Therapies - Biological - CAR-Ts","combinedName":"doctor cameron turtle"},{"sessionId":"11073","sessionTitle":"New Innovations in Platelet Regulation of Tumor Growth and Metastasis","firstName":"Elisabeth ","lastName":"Battinelli","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet and Megakaryocytic Regulation of Tumor Progression","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Pathogenesis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor elisabeth battinelli"},{"sessionId":"11073","sessionTitle":"New Innovations in Platelet Regulation of Tumor Growth and Metastasis","firstName":"Tatiana ","lastName":"Byzova","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reciprocal Interactions Between Platelets and Metastatic Tumors","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Pathogenesis","combinedName":"doctor tatiana byzova"},{"sessionId":"11073","sessionTitle":"New Innovations in Platelet Regulation of Tumor Growth and Metastasis","firstName":"Anil","lastName":"Sood","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Platelets in Adaptive Changes to Anti-Angiogenesis Therapy","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Pathogenesis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor anil sood"},{"sessionId":"11073","sessionTitle":"New Innovations in Platelet Regulation of Tumor Growth and Metastasis","firstName":"Elisabeth ","lastName":"Battinelli","credentials":"MD, PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet and Megakaryocytic Regulation of Tumor Progression","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Pathogenesis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor elisabeth battinelli"},{"sessionId":"11073","sessionTitle":"New Innovations in Platelet Regulation of Tumor Growth and Metastasis","firstName":"Tatiana ","lastName":"Byzova","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reciprocal Interactions Between Platelets and Metastatic Tumors","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Pathogenesis","combinedName":"doctor tatiana byzova"},{"sessionId":"11073","sessionTitle":"New Innovations in Platelet Regulation of Tumor Growth and Metastasis","firstName":"Anil","lastName":"Sood","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Platelets in Adaptive Changes to Anti-Angiogenesis Therapy","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Pathogenesis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor anil sood"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","firstName":"Timothy ","lastName":"Ley","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:30:00Z","startTime":"11:00:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Evolution and Relapse in Adult De Novo Acute Myeloid Leukemia","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - AML, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Molecular Interactions","combinedName":"doctor timothy ley"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","firstName":"Daniel ","lastName":"Link","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:30:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Evolution During Stress Hematopoiesis","keywords":"Diseases, Diseases - Myeloid Malignancies, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy","combinedName":"doctor daniel link"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","firstName":"Anna ","lastName":"Brown","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:30:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Evolution in the Setting of Germline Predisposition","keywords":"Diseases, Diseases - Myeloid Malignancies, Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Mechanisms - Immune Interactions, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation","combinedName":"doctor anna brown"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","firstName":"Christina","lastName":"Curtis","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:30:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Population Genetics Approaches to Quantify Clonal Evolution","keywords":"Diseases, Diseases - Myeloid Malignancies, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics","combinedName":"doctor christina curtis"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","firstName":"Timothy ","lastName":"Ley","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:30:00Z","startTime":"11:00:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Evolution and Relapse in Adult De Novo Acute Myeloid Leukemia","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - AML, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Molecular Interactions","combinedName":"doctor timothy ley"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","firstName":"Daniel ","lastName":"Link","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:30:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Evolution During Stress Hematopoiesis","keywords":"Diseases, Diseases - Myeloid Malignancies, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy","combinedName":"doctor daniel link"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","firstName":"Anna ","lastName":"Brown","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:30:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Evolution in the Setting of Germline Predisposition","keywords":"Diseases, Diseases - Myeloid Malignancies, Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Mechanisms - Immune Interactions, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation","combinedName":"doctor anna brown"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","firstName":"Christina","lastName":"Curtis","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:30:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Population Genetics Approaches to Quantify Clonal Evolution","keywords":"Diseases, Diseases - Myeloid Malignancies, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics","combinedName":"doctor christina curtis"},{"sessionId":"11075","sessionTitle":"The Yin and Yang of Myeloma: Understanding and Harnessing Normal Plasma Cell Biology to Better Treat Myeloma","firstName":"Florian ","lastName":"Bassermann ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cereblon and Redox in Plasma Cells","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Myeloma, Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Metabolomics, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy","combinedName":"doctor florian bassermann"},{"sessionId":"11075","sessionTitle":"The Yin and Yang of Myeloma: Understanding and Harnessing Normal Plasma Cell Biology to Better Treat Myeloma","firstName":"Katia ","lastName":"Georgopoulos ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Normal Plasma Cell Biology: Natural Achilles Heels as Targets in Myeloma","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Myeloma, Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor katia georgopoulos"},{"sessionId":"11075","sessionTitle":"The Yin and Yang of Myeloma: Understanding and Harnessing Normal Plasma Cell Biology to Better Treat Myeloma","firstName":"Lawrence ","lastName":"Boise","credentials":"PhD ","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Protein Homeostasis: A Key Target in Myeloma","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Myeloma, Mechanisms, Mechanisms - Genomics, Mechanisms - Proteomics, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor lawrence boise"},{"sessionId":"11075","sessionTitle":"The Yin and Yang of Myeloma: Understanding and Harnessing Normal Plasma Cell Biology to Better Treat Myeloma","firstName":"Florian ","lastName":"Bassermann ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cereblon and Redox in Plasma Cells","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Myeloma, Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Metabolomics, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy","combinedName":"doctor florian bassermann"},{"sessionId":"11075","sessionTitle":"The Yin and Yang of Myeloma: Understanding and Harnessing Normal Plasma Cell Biology to Better Treat Myeloma","firstName":"Katia ","lastName":"Georgopoulos ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Normal Plasma Cell Biology: Natural Achilles Heels as Targets in Myeloma","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Myeloma, Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor katia georgopoulos"},{"sessionId":"11075","sessionTitle":"The Yin and Yang of Myeloma: Understanding and Harnessing Normal Plasma Cell Biology to Better Treat Myeloma","firstName":"Lawrence ","lastName":"Boise","credentials":"PhD ","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Protein Homeostasis: A Key Target in Myeloma","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Myeloma, Mechanisms, Mechanisms - Genomics, Mechanisms - Proteomics, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor lawrence boise"},{"sessionId":"11076","sessionTitle":"Ham-Wasserman Lecture","firstName":"Giampaolo ","lastName":"Merlini ","credentials":"MD","sessionStartTime":"2017-12-09T12:30:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AL Amyloidosis","keywords":"","combinedName":"doctor giampaolo merlini"},{"sessionId":"11077","sessionTitle":"Presidential Symposium","firstName":"Richard ","lastName":"Young ","credentials":"PhD","sessionStartTime":"2017-12-12T09:45:00Z","sessionEndTime":"2017-12-12T11:15:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/12/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chromosome Structure and Function in Health and Disease","keywords":"","combinedName":"doctor richard young"},{"sessionId":"11077","sessionTitle":"Presidential Symposium","firstName":"Margaret ","lastName":"Goodell ","credentials":"PhD","sessionStartTime":"2017-12-12T09:45:00Z","sessionEndTime":"2017-12-12T11:15:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/12/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epigenetic Regulation in Normal and Malignant Hematopoiesis","keywords":"","combinedName":"doctor margaret goodell"},{"sessionId":"11077","sessionTitle":"Presidential Symposium","firstName":"James ","lastName":"Bradner ","credentials":"MD","sessionStartTime":"2017-12-12T09:45:00Z","sessionEndTime":"2017-12-12T11:15:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/12/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapeutic Targeting of Chromatin","keywords":"","combinedName":"doctor james bradner"},{"sessionId":"11078","sessionTitle":"ASH-EHA Joint Symposium","firstName":"George ","lastName":"Vassiliou ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T12:30:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"European Perspective","keywords":"","combinedName":"doctor george vassiliou"},{"sessionId":"11078","sessionTitle":"ASH-EHA Joint Symposium","firstName":"Benjamin ","lastName":"Ebert","credentials":"MD, PhD","sessionStartTime":"2017-12-10T12:30:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"North American Perspective","keywords":"","combinedName":"doctor benjamin ebert"},{"sessionId":"11079","sessionTitle":"Ernest Beutler Lecture and Prize","firstName":"Luigi ","lastName":"Naldini ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T13:30:00Z","sessionEndTime":"2017-12-11T14:30:00Z","startTime":"13:30:00","endTime":"13:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Basic Science","keywords":"","combinedName":"doctor luigi naldini"},{"sessionId":"11079","sessionTitle":"Ernest Beutler Lecture and Prize","firstName":"Marina","lastName":"Cavazzana","credentials":"MD, PhD","sessionStartTime":"2017-12-11T13:30:00Z","sessionEndTime":"2017-12-11T14:30:00Z","startTime":"13:45:00","endTime":"14:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Science/Translational Resarch","keywords":"","combinedName":"doctor marina cavazzana"},{"sessionId":"11080","sessionTitle":"E. Donnall Thomas Lecture and Prize","firstName":"James ","lastName":"Downing ","credentials":"MD","sessionStartTime":"2017-12-11T09:00:00Z","sessionEndTime":"2017-12-11T10:00:00Z","startTime":"09:00:00","endTime":"09:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Molecular Pathology of Pediatric Acute Leukemia","keywords":"","combinedName":"doctor james downing"},{"sessionId":"11081","sessionTitle":"ASH Practice Partnership Lunch","firstName":"Beth ","lastName":"Lown ","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:30:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Int'l Blrm- No. Twr- M2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Physician Stress and Burnout","keywords":"","combinedName":"doctor beth lown"},{"sessionId":"11081","sessionTitle":"ASH Practice Partnership Lunch","firstName":"Linda ","lastName":"Burns","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:30:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Int'l Blrm- No. Twr- M2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Physician Stress and Burnout","keywords":"","combinedName":"doctor linda burns"},{"sessionId":"11081","sessionTitle":"ASH Practice Partnership Lunch","firstName":"Tait ","lastName":"Shanafelt ","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:30:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Int'l Blrm- No. Twr- M2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Physician Stress and Burnout","keywords":"","combinedName":"doctor tait shanafelt"},{"sessionId":"11083","sessionTitle":"Special Symposium on Quality","firstName":"Craig ","lastName":"Robbins ","credentials":"MD, MPH","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:15:00","endTime":"14:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Health Care Quality: Overcoming Barriers to Evidence-Based Care","keywords":"","combinedName":"doctor craig robbins"},{"sessionId":"11083","sessionTitle":"Special Symposium on Quality","firstName":"Derek ","lastName":"Raghavan ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"14:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Implementation Is Practical:Examples of Successful, Large-Scale Guideline Implementations","keywords":"","combinedName":"doctor derek raghavan"},{"sessionId":"11083","sessionTitle":"Special Symposium on Quality","firstName":"Anna ","lastName":"Gagliardi ","credentials":"PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Implementation Science Research for Effective Guideline Implementation","keywords":"","combinedName":"doctor anna gagliardi"},{"sessionId":"11084","sessionTitle":"ASH Choosing Wisely Campaign: 2017 ASH Choosing Wisely Champions","firstName":"Marc Stuart","lastName":"Zumberg ","credentials":"MD","sessionStartTime":"2017-12-11T12:15:00Z","sessionEndTime":"2017-12-11T13:15:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improvement of compliance and utilization of recombinant VIIa, prothrombin complex concentrates (PCCs), and blood products","keywords":"","combinedName":"doctor marc stuart zumberg"},{"sessionId":"11084","sessionTitle":"ASH Choosing Wisely Campaign: 2017 ASH Choosing Wisely Champions","firstName":"Matthew ","lastName":"Schefft ","credentials":"DO, MSHA","sessionStartTime":"2017-12-11T12:15:00Z","sessionEndTime":"2017-12-11T13:15:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduction in admission rate for children with SCD presenting with vaso-occlusive crisis (VOC) via initiation of individualized pain plans (IPPs)","keywords":"","combinedName":"doctor matthew schefft"},{"sessionId":"11084","sessionTitle":"ASH Choosing Wisely Campaign: 2017 ASH Choosing Wisely Champions","firstName":"Yulia ","lastName":"Lin ","credentials":"MD","sessionStartTime":"2017-12-11T12:15:00Z","sessionEndTime":"2017-12-11T13:15:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduction of inappropriate transfusions for patients with iron deficiency anemia (IDA) in the Emergency Department (ED) via guidelines and physician education","keywords":"","combinedName":"doctor yulia lin"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","firstName":"Adam","lastName":"Cuker","credentials":"MD, MS","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:40:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Introduction to ASH Guideline Initiatives","keywords":"","combinedName":"doctor adam cuker"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","firstName":"Holger","lastName":"Schnemann","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:40:00","endTime":"07:50:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Introduction to ASH VTE Guidelines","keywords":"","combinedName":"doctor holger schnemann"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","firstName":"Wendy ","lastName":"Lim ","credentials":"MD, MSc","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:05:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel on Diagnosis of VTE","keywords":"","combinedName":"doctor wendy lim"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","firstName":"Adam","lastName":"Cuker","credentials":"MD, MS","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:35:00","endTime":"08:40:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel on Heparin-Induced Thrombocytopenia","keywords":"","combinedName":"doctor adam cuker"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","firstName":"Daniel ","lastName":"Witt ","credentials":"PharmD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:20:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel on Optimal Management of Anticoagulation Therapy","keywords":"","combinedName":"doctor daniel witt"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","firstName":"Gary ","lastName":"Lyman ","credentials":"MD, MPH","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:20:00","endTime":"08:25:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel on Prevention and Treatment of VTE in Patients With Cancer","keywords":"","combinedName":"doctor gary lyman"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","firstName":"Mary ","lastName":"Cushman ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:55:00","endTime":"08:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel on Prevention of VTE in Nonsurgical Patients","keywords":"","combinedName":"doctor mary cushman"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","firstName":"David ","lastName":"Anderson ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:50:00","endTime":"07:55:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel on Prevention of VTE in Surgical Hospitalized Patients","keywords":"","combinedName":"doctor david anderson"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","firstName":"Saskia ","lastName":"Middeldorp ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:05:00","endTime":"08:10:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel on Thrombophilia","keywords":"","combinedName":"doctor saskia middeldorp"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","firstName":"Thomas ","lastName":"Ortel ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:10:00","endTime":"08:15:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel on Treatment of VTE","keywords":"","combinedName":"doctor thomas ortel"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","firstName":"Sarah ","lastName":"O'Brien ","credentials":"MD, MSc","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:35:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel on VTE in Pediatric Populations","keywords":"","combinedName":"doctor sarah o'brien"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","firstName":"Shannon Marie","lastName":"Bates","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:25:00","endTime":"08:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel on VTE in the Context of Pregnancy","keywords":"","combinedName":"doctor shannon marie bates"},{"sessionId":"11086","sessionTitle":"Quality Conversations on Social Media: Achieving Credibility and Efficiency Together","firstName":"Elaine ","lastName":"Schattner ","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel Discussion","keywords":"","combinedName":"doctor elaine schattner"},{"sessionId":"11086","sessionTitle":"Quality Conversations on Social Media: Achieving Credibility and Efficiency Together","firstName":"John ","lastName":"Leonard ","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel Discussion","keywords":"","combinedName":"doctor john leonard"},{"sessionId":"11086","sessionTitle":"Quality Conversations on Social Media: Achieving Credibility and Efficiency Together","firstName":"Mohamad","lastName":"Mohty","credentials":"MD, PhD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel Discussion","keywords":"","combinedName":"doctor mohamad mohty"},{"sessionId":"11087","sessionTitle":"AML MATTERS: A Multidisciplinary Approach To Testing and Diagnosis, Evaluation of Risk, and Personalized Treatment Selection","firstName":"Jessica ","lastName":"Altman","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:15:00","endTime":"16:30:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Has Our Approach to Treatment Changed in the Era of Recently Approved Therapies?","keywords":"","combinedName":"doctor jessica altman"},{"sessionId":"11087","sessionTitle":"AML MATTERS: A Multidisciplinary Approach To Testing and Diagnosis, Evaluation of Risk, and Personalized Treatment Selection","firstName":"Linda ","lastName":"Burns","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How Do We Approach Transplant in the Era of Targeted Therapies?","keywords":"","combinedName":"doctor linda burns"},{"sessionId":"11087","sessionTitle":"AML MATTERS: A Multidisciplinary Approach To Testing and Diagnosis, Evaluation of Risk, and Personalized Treatment Selection","firstName":"Robert ","lastName":"Hasserjian ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"What is Therapy-Related Myeloid Neoplasm (t-MN)? A Look at History, Morphology, Cytogenetics, and Molecular Studies","keywords":"","combinedName":"doctor robert hasserjian"},{"sessionId":"11087","sessionTitle":"AML MATTERS: A Multidisciplinary Approach To Testing and Diagnosis, Evaluation of Risk, and Personalized Treatment Selection","firstName":"Kathleen ","lastName":"Wiley ","credentials":"RN, MSN, AOCNS","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"What Tools Can We Use to Counsel Our Patients in the Setting of Novel Therapies?","keywords":"","combinedName":"doctor kathleen wiley"},{"sessionId":"11088","sessionTitle":"Global Hematology Symposium","firstName":"Kwaku ","lastName":"Ohene-Frempong ","credentials":"MD","sessionStartTime":"2017-12-11T12:15:00Z","sessionEndTime":"2017-12-11T13:15:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multifaceted Strategy to Treat Sickle Cell Disease in Ghanaian Children","keywords":"","combinedName":"doctor kwaku ohene-frempong"},{"sessionId":"11089","sessionTitle":"Blood and Beyond: The Art of Perception","firstName":"Amy ","lastName":"Herman ","credentials":"JD, MA","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Art of Perception","keywords":"","combinedName":"doctor amy herman"},{"sessionId":"11090","sessionTitle":"When Graft Versus Tumor Fails: The Biology and Treatment of Relapse After Allogeneic Stem Cell Transplantation","firstName":"Alan ","lastName":"Wayne ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cells to Prevent and Treat Relapse Following Allogeneic Stem Cell Transplantation","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation","combinedName":"doctor alan wayne"},{"sessionId":"11090","sessionTitle":"When Graft Versus Tumor Fails: The Biology and Treatment of Relapse After Allogeneic Stem Cell Transplantation","firstName":"Robert ","lastName":"Soiffer ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Drugs to Prevent and Treat Relapse Following Allogeneic Stem Cell Transplantation","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor robert soiffer"},{"sessionId":"11090","sessionTitle":"When Graft Versus Tumor Fails: The Biology and Treatment of Relapse After Allogeneic Stem Cell Transplantation","firstName":"J.H. ","lastName":"Falkenburg ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:30:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Graft Versus Tumor Effects and Why People Relapse","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Biological, Therapies - Biological - Hematopoietic Stem Cells","combinedName":"doctor j h falkenburg"},{"sessionId":"11090","sessionTitle":"When Graft Versus Tumor Fails: The Biology and Treatment of Relapse After Allogeneic Stem Cell Transplantation","firstName":"Alan ","lastName":"Wayne ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cells to Prevent and Treat Relapse Following Allogeneic Stem Cell Transplantation","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation","combinedName":"doctor alan wayne"},{"sessionId":"11090","sessionTitle":"When Graft Versus Tumor Fails: The Biology and Treatment of Relapse After Allogeneic Stem Cell Transplantation","firstName":"Robert ","lastName":"Soiffer ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:45:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Drugs to Prevent and Treat Relapse Following Allogeneic Stem Cell Transplantation","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor robert soiffer"},{"sessionId":"11090","sessionTitle":"When Graft Versus Tumor Fails: The Biology and Treatment of Relapse After Allogeneic Stem Cell Transplantation","firstName":"J.H. ","lastName":"Falkenburg ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:15:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Graft Versus Tumor Effects and Why People Relapse","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Biological, Therapies - Biological - Hematopoietic Stem Cells","combinedName":"doctor j h falkenburg"},{"sessionId":"11091","sessionTitle":"Dilemmas in Pediatric Hematologic Malignancy","firstName":"Rachael ","lastName":"Hough ","credentials":"MD, BMBS, FRCPath","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Crisis Management in the Treatment of Childhood Acute Lymphocytic Leukemia: Putting Right What Can Go Wrong (Emergency Complications of Disease and Treatment)","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - ALL, Mechanisms, Mechanisms - Pathogenesis, Study Population, Study Population - Pediatrics","combinedName":"doctor rachael hough"},{"sessionId":"11091","sessionTitle":"Dilemmas in Pediatric Hematologic Malignancy","firstName":"Lewis ","lastName":"Silverman","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incorporation of Non-Chemotherapeutic Agents in Pediatric Acute Lymphocytic Leukemia","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - ALL, Mechanisms, Mechanisms - Immune Mechanisms, Study Population, Study Population - Pediatrics, Study Population - Young Adults, Therapies, Therapies - Biological, Therapies - Biological - CAR-Ts, Therapies - Non-Biological","combinedName":"doctor lewis silverman"},{"sessionId":"11091","sessionTitle":"Dilemmas in Pediatric Hematologic Malignancy","firstName":"Sharon ","lastName":"Savage ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Premalignant Pediatric Hematologic Disorders: When to Treat and How","keywords":"Diseases, Diseases - Lymphoid Malignancies, Study Population, Study Population - Pediatrics, Therapies, Therapies - Biological, Therapies - Biological - Hematopoietic Stem Cells, Therapies - Non-Biological","combinedName":"doctor sharon savage"},{"sessionId":"11091","sessionTitle":"Dilemmas in Pediatric Hematologic Malignancy","firstName":"Rachael ","lastName":"Hough ","credentials":"MD, BMBS, FRCPath","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Crisis Management in the Treatment of Childhood Acute Lymphocytic Leukemia: Putting Right What Can Go Wrong (Emergency Complications of Disease and Treatment)","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - ALL, Mechanisms, Mechanisms - Pathogenesis, Study Population, Study Population - Pediatrics","combinedName":"doctor rachael hough"},{"sessionId":"11091","sessionTitle":"Dilemmas in Pediatric Hematologic Malignancy","firstName":"Lewis ","lastName":"Silverman","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incorporation of Non-Chemotherapeutic Agents in Pediatric Acute Lymphocytic Leukemia","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - ALL, Mechanisms, Mechanisms - Immune Mechanisms, Study Population, Study Population - Pediatrics, Study Population - Young Adults, Therapies, Therapies - Biological, Therapies - Biological - CAR-Ts, Therapies - Non-Biological","combinedName":"doctor lewis silverman"},{"sessionId":"11091","sessionTitle":"Dilemmas in Pediatric Hematologic Malignancy","firstName":"Sharon ","lastName":"Savage ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Premalignant Pediatric Hematologic Disorders: When to Treat and How","keywords":"Diseases, Diseases - Lymphoid Malignancies, Study Population, Study Population - Pediatrics, Therapies, Therapies - Biological, Therapies - Biological - Hematopoietic Stem Cells, Therapies - Non-Biological","combinedName":"doctor sharon savage"},{"sessionId":"11092","sessionTitle":"Novel Therapeutics in Myeloma","firstName":"Shaji ","lastName":"Kumar","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Emerging Options in Multiple Myeloma: Targeted, Immune, and Epigenetic Therapies","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Plasma Cell Disorders, Diseases - Lymphoid Malignancies - Plasma Cell Disorders - Multiple Myeloma, Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Antibodies, Therapies - Biological - CAR-Ts","combinedName":"doctor shaji kumar"},{"sessionId":"11092","sessionTitle":"Novel Therapeutics in Myeloma","firstName":"Maria-Victoria","lastName":"Mateos","credentials":"","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Multiple Myeloma in the Newly Diagnosed Patient","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Plasma Cell Disorders, Diseases - Lymphoid Malignancies - Plasma Cell Disorders - Multiple Myeloma, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy","combinedName":"doctor maria-victoria mateos"},{"sessionId":"11092","sessionTitle":"Novel Therapeutics in Myeloma","firstName":"Pieter","lastName":"Sonneveld","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Multiple Myeloma in the Relapsed/Refractory Patient","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Plasma Cell Disorders, Diseases - Lymphoid Malignancies - Plasma Cell Disorders - Multiple Myeloma, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor pieter sonneveld"},{"sessionId":"11092","sessionTitle":"Novel Therapeutics in Myeloma","firstName":"Shaji ","lastName":"Kumar","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Emerging Options in Multiple Myeloma: Targeted, Immune, and Epigenetic Therapies","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Plasma Cell Disorders, Diseases - Lymphoid Malignancies - Plasma Cell Disorders - Multiple Myeloma, Mechanisms, Mechanisms - Epigenetics, Mechanisms - Genomics, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Antibodies, Therapies - Biological - CAR-Ts","combinedName":"doctor shaji kumar"},{"sessionId":"11092","sessionTitle":"Novel Therapeutics in Myeloma","firstName":"Maria-Victoria","lastName":"Mateos","credentials":"","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Multiple Myeloma in the Newly Diagnosed Patient","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Plasma Cell Disorders, Diseases - Lymphoid Malignancies - Plasma Cell Disorders - Multiple Myeloma, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy","combinedName":"doctor maria-victoria mateos"},{"sessionId":"11092","sessionTitle":"Novel Therapeutics in Myeloma","firstName":"Pieter","lastName":"Sonneveld","credentials":"MD, PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Multiple Myeloma in the Relapsed/Refractory Patient","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Plasma Cell Disorders, Diseases - Lymphoid Malignancies - Plasma Cell Disorders - Multiple Myeloma, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor pieter sonneveld"},{"sessionId":"11093","sessionTitle":"Controversies in Myeloma","firstName":"Heinz","lastName":"Ludwig","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Continuous Versus Fixed Duration Therapy in Multiple Myeloma","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Multiple Myeloma, Study Population, Study Population - Adults, Study Population - Elderly, Therapies, Therapies - Biological, Therapies - Biological - Immunotherapy, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy","combinedName":"doctor heinz ludwig"},{"sessionId":"11093","sessionTitle":"Controversies in Myeloma","firstName":"Faith ","lastName":"Davies ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Is Molecular Remission the Goal of Multiple Myeloma Therapy?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Plasma Cell Disorders, Diseases - Lymphoid Malignancies - Plasma Cell Disorders - Multiple Myeloma, Study Population, Study Population - Adults, Study Population - Elderly, Technology and Procedures, Technology and Procedures - Flow Cytometry, Technology and Procedures - Molecular Testing, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor faith davies"},{"sessionId":"11093","sessionTitle":"Controversies in Myeloma","firstName":"Ola","lastName":"Landgren","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Should Smoldering Myeloma Be Treated?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Plasma Cell Disorders, Diseases - Lymphoid Malignancies - Plasma Cell Disorders - Multiple Myeloma, Diseases - Lymphoid Malignancies - Plasma Cell Disorders - Smoldering Myeloma, Study Population, Study Population - Adults, Study Population - Elderly, Therapies, Therapies - Biological, Therapies - Biological - Immunotherapy, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor ola landgren"},{"sessionId":"11093","sessionTitle":"Controversies in Myeloma","firstName":"Heinz","lastName":"Ludwig","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"12:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Continuous Versus Fixed Duration Therapy in Multiple Myeloma","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Multiple Myeloma, Study Population, Study Population - Adults, Study Population - Elderly, Therapies, Therapies - Biological, Therapies - Biological - Immunotherapy, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy","combinedName":"doctor heinz ludwig"},{"sessionId":"11093","sessionTitle":"Controversies in Myeloma","firstName":"Faith ","lastName":"Davies ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Is Molecular Remission the Goal of Multiple Myeloma Therapy?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Plasma Cell Disorders, Diseases - Lymphoid Malignancies - Plasma Cell Disorders - Multiple Myeloma, Study Population, Study Population - Adults, Study Population - Elderly, Technology and Procedures, Technology and Procedures - Flow Cytometry, Technology and Procedures - Molecular Testing, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor faith davies"},{"sessionId":"11093","sessionTitle":"Controversies in Myeloma","firstName":"Ola","lastName":"Landgren","credentials":"MD, PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Should Smoldering Myeloma Be Treated?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Plasma Cell Disorders, Diseases - Lymphoid Malignancies - Plasma Cell Disorders - Multiple Myeloma, Diseases - Lymphoid Malignancies - Plasma Cell Disorders - Smoldering Myeloma, Study Population, Study Population - Adults, Study Population - Elderly, Therapies, Therapies - Biological, Therapies - Biological - Immunotherapy, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor ola landgren"},{"sessionId":"11094","sessionTitle":"Myelodysplastic Syndromes: Understanding the Current Treatment Landscape","firstName":"Aristoteles ","lastName":"Giagounidis ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Current Treatment Algorithm for the Management of MDS","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - Anemias, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Molecular Interactions, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor aristoteles giagounidis"},{"sessionId":"11094","sessionTitle":"Myelodysplastic Syndromes: Understanding the Current Treatment Landscape","firstName":"Olatoyosi","lastName":"Odenike","credentials":"MBBS","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incorporating Novel Approaches in the Management of MDS Beyond Hypomethylating Agents","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Epigenetics, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor olatoyosi odenike"},{"sessionId":"11094","sessionTitle":"Myelodysplastic Syndromes: Understanding the Current Treatment Landscape","firstName":"R. ","lastName":"Lindsley","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Uncoding the Genetic Heterogeneity of MDS","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Genomics, Mechanisms - Pathogenesis, Study Population, Study Population - Adults, Technology and Procedures, Technology and Procedures - Molecular Testing","combinedName":"doctor r lindsley"},{"sessionId":"11094","sessionTitle":"Myelodysplastic Syndromes: Understanding the Current Treatment Landscape","firstName":"Aristoteles ","lastName":"Giagounidis ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Current Treatment Algorithm for the Management of MDS","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - Anemias, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Molecular Interactions, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor aristoteles giagounidis"},{"sessionId":"11094","sessionTitle":"Myelodysplastic Syndromes: Understanding the Current Treatment Landscape","firstName":"Olatoyosi","lastName":"Odenike","credentials":"MBBS","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"12:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incorporating Novel Approaches in the Management of MDS Beyond Hypomethylating Agents","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Epigenetics, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor olatoyosi odenike"},{"sessionId":"11094","sessionTitle":"Myelodysplastic Syndromes: Understanding the Current Treatment Landscape","firstName":"R. ","lastName":"Lindsley","credentials":"MD, PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Uncoding the Genetic Heterogeneity of MDS","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Genomics, Mechanisms - Pathogenesis, Study Population, Study Population - Adults, Technology and Procedures, Technology and Procedures - Molecular Testing","combinedName":"doctor r lindsley"},{"sessionId":"11095","sessionTitle":"Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm","firstName":"Claire ","lastName":"Harrison ","credentials":"BMBCh, DM","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Current Treatment Algorithm for the Management of Patients With Myelofibrosis, JAK Inhibitors, and Beyond","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MPN, Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor claire harrison"},{"sessionId":"11095","sessionTitle":"Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm","firstName":"Alessandro ","lastName":"Vannucchi","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"What Are the Current Treatment Approaches for Patients With Polycythemia Vera and Essential Thrombocythemia?","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - Bleeding and Clotting, Diseases - Myeloid Malignancies - Bleeding and Clotting - Thrombosis, Diseases - Myeloid Malignancies - MPN, Diseases - Myeloid Malignancies - Polycythemia Vera, Diseases - Myeloid Malignancies - Thrombocythemia, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor alessandro vannucchi"},{"sessionId":"11095","sessionTitle":"Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm","firstName":"Anthony ","lastName":"Green ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Where Did It Start? Mutation Order and What It Means in MPN","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MPN, Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Mechanisms - Molecular Interactions","combinedName":"doctor anthony green"},{"sessionId":"11095","sessionTitle":"Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm","firstName":"Claire ","lastName":"Harrison ","credentials":"BMBCh, DM","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Current Treatment Algorithm for the Management of Patients With Myelofibrosis, JAK Inhibitors, and Beyond","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MPN, Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor claire harrison"},{"sessionId":"11095","sessionTitle":"Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm","firstName":"Alessandro ","lastName":"Vannucchi","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"What Are the Current Treatment Approaches for Patients With Polycythemia Vera and Essential Thrombocythemia?","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - Bleeding and Clotting, Diseases - Myeloid Malignancies - Bleeding and Clotting - Thrombosis, Diseases - Myeloid Malignancies - MPN, Diseases - Myeloid Malignancies - Polycythemia Vera, Diseases - Myeloid Malignancies - Thrombocythemia, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor alessandro vannucchi"},{"sessionId":"11095","sessionTitle":"Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm","firstName":"Anthony ","lastName":"Green ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Where Did It Start? Mutation Order and What It Means in MPN","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MPN, Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Mechanisms - Molecular Interactions","combinedName":"doctor anthony green"},{"sessionId":"11096","sessionTitle":"Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?","firstName":"Ravi ","lastName":"Bhatia ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Approaches to Therapy in CML","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - CML, Mechanisms, Mechanisms - Molecular Interactions, Mechanisms - Proteomics, Study Population, Study Population - Adults, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor ravi bhatia"},{"sessionId":"11096","sessionTitle":"Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?","firstName":"Javid ","lastName":"Moslehi ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TKI-Associated Cardiovascular Toxicity: What to Consider","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - CML, Mechanisms, Mechanisms - Multi-Systemic Interactions, Mechanisms - Proteomics, Study Population, Study Population - Adults, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor javid moslehi"},{"sessionId":"11096","sessionTitle":"Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?","firstName":"Francois-Xavier","lastName":"Mahon","credentials":"MD, PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment-Free Remission: Who, How, and Why?","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - CML, Mechanisms, Mechanisms - Molecular Interactions, Mechanisms - Proteomics, Study Population, Study Population - Adults, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor francois-xavier mahon"},{"sessionId":"11096","sessionTitle":"Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?","firstName":"Ravi ","lastName":"Bhatia ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Approaches to Therapy in CML","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - CML, Mechanisms, Mechanisms - Molecular Interactions, Mechanisms - Proteomics, Study Population, Study Population - Adults, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor ravi bhatia"},{"sessionId":"11096","sessionTitle":"Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?","firstName":"Javid ","lastName":"Moslehi ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TKI-Associated Cardiovascular Toxicity: What to Consider","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - CML, Mechanisms, Mechanisms - Multi-Systemic Interactions, Mechanisms - Proteomics, Study Population, Study Population - Adults, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor javid moslehi"},{"sessionId":"11096","sessionTitle":"Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?","firstName":"Francois-Xavier","lastName":"Mahon","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment-Free Remission: Who, How, and Why?","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - CML, Mechanisms, Mechanisms - Molecular Interactions, Mechanisms - Proteomics, Study Population, Study Population - Adults, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor francois-xavier mahon"},{"sessionId":"11097","sessionTitle":"Acute Lymphocytic Leukemia: New Approaches in Management","firstName":"Farhad","lastName":"Ravandi","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Current Management of Philadelphia Chromosome Positive ALL and the Role of Stem Cell Transplantation","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - ALL, Mechanisms, Mechanisms - Proteomics, Study Population, Study Population - Adults, Study Population - Children, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - TKI, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor farhad ravandi"},{"sessionId":"11097","sessionTitle":"Acute Lymphocytic Leukemia: New Approaches in Management","firstName":"Wendy","lastName":"Stock","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How Should We Incorporate Novel Therapies Into the Management of ALL?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - ALL, Mechanisms, Mechanisms - Proteomics, Study Population, Study Population - Adults, Study Population - Children, Therapies, Therapies - Biological, Therapies - Biological - Antibodies, Therapies - Biological - CAR-Ts, Therapies - Biological - Immunotherapy, Therapies - Biological - TKI, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor wendy stock"},{"sessionId":"11097","sessionTitle":"Acute Lymphocytic Leukemia: New Approaches in Management","firstName":"Monika ","lastName":"Brggemann ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Implications of Minimal Residual Disease in Adult ALL","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - ALL, Study Population, Study Population - Adults, Technology and Procedures, Technology and Procedures - Flow Cytometry, Technology and Procedures - MRD Testing, Technology and Procedures - NGS, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor monika brggemann"},{"sessionId":"11097","sessionTitle":"Acute Lymphocytic Leukemia: New Approaches in Management","firstName":"Farhad","lastName":"Ravandi","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Current Management of Philadelphia Chromosome Positive ALL and the Role of Stem Cell Transplantation","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - ALL, Mechanisms, Mechanisms - Proteomics, Study Population, Study Population - Adults, Study Population - Children, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - TKI, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor farhad ravandi"},{"sessionId":"11097","sessionTitle":"Acute Lymphocytic Leukemia: New Approaches in Management","firstName":"Wendy","lastName":"Stock","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"12:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How Should We Incorporate Novel Therapies Into the Management of ALL?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - ALL, Mechanisms, Mechanisms - Proteomics, Study Population, Study Population - Adults, Study Population - Children, Therapies, Therapies - Biological, Therapies - Biological - Antibodies, Therapies - Biological - CAR-Ts, Therapies - Biological - Immunotherapy, Therapies - Biological - TKI, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor wendy stock"},{"sessionId":"11097","sessionTitle":"Acute Lymphocytic Leukemia: New Approaches in Management","firstName":"Monika ","lastName":"Brggemann ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Implications of Minimal Residual Disease in Adult ALL","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - ALL, Study Population, Study Population - Adults, Technology and Procedures, Technology and Procedures - Flow Cytometry, Technology and Procedures - MRD Testing, Technology and Procedures - NGS, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor monika brggemann"},{"sessionId":"11098","sessionTitle":"Acute Myeloid Leukemia: How Can We Improve Upon Standard Therapy?","firstName":"Elli ","lastName":"Papaemmanuil ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Classification and Risk Assessment in AML: Integrating Cytogenetics and Molecular Profiling","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - AML, Mechanisms, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Cytogenetics, Technology and Procedures - Molecular Testing","combinedName":"doctor elli papaemmanuil"},{"sessionId":"11098","sessionTitle":"Acute Myeloid Leukemia: How Can We Improve Upon Standard Therapy?","firstName":"Herve ","lastName":"Dombret ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How and When to Decide Between Epigenetic Therapy and Chemotherapy in Patients With AML","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - AML, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Epigenetics, Study Population, Study Population - Adults, Study Population - Elderly, Therapies, Therapies - Biological, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor herve dombret"},{"sessionId":"11098","sessionTitle":"Acute Myeloid Leukemia: How Can We Improve Upon Standard Therapy?","firstName":"Alexander ","lastName":"Perl","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Targeted Therapy in the Management of Patients With AML","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - AML, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor alexander perl"},{"sessionId":"11098","sessionTitle":"Acute Myeloid Leukemia: How Can We Improve Upon Standard Therapy?","firstName":"Elli ","lastName":"Papaemmanuil ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Classification and Risk Assessment in AML: Integrating Cytogenetics and Molecular Profiling","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - AML, Mechanisms, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Cytogenetics, Technology and Procedures - Molecular Testing","combinedName":"doctor elli papaemmanuil"},{"sessionId":"11098","sessionTitle":"Acute Myeloid Leukemia: How Can We Improve Upon Standard Therapy?","firstName":"Herve ","lastName":"Dombret ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How and When to Decide Between Epigenetic Therapy and Chemotherapy in Patients With AML","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - AML, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Epigenetics, Study Population, Study Population - Adults, Study Population - Elderly, Therapies, Therapies - Biological, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor herve dombret"},{"sessionId":"11098","sessionTitle":"Acute Myeloid Leukemia: How Can We Improve Upon Standard Therapy?","firstName":"Alexander ","lastName":"Perl","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Targeted Therapy in the Management of Patients With AML","keywords":"Diseases, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - AML, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Chemotherapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor alexander perl"},{"sessionId":"11099","sessionTitle":"Individualizing Therapy in Chronic Lymphocytic Leukemia","firstName":"Matthew ","lastName":"Davids","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How Should We Sequence and Combine Novel Therapies in CLL?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - CLL, Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor matthew davids"},{"sessionId":"11099","sessionTitle":"Individualizing Therapy in Chronic Lymphocytic Leukemia","firstName":"Kirsten ","lastName":"Fischer ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimizing Frontline Therapy of CLL Based on Clinical and Biological Factors","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - CLL, Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor kirsten fischer"},{"sessionId":"11099","sessionTitle":"Individualizing Therapy in Chronic Lymphocytic Leukemia","firstName":"Gianluca ","lastName":"Gaidano ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Mutational Landscape of CLL and Its Impact on Prognosis and Treatment","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - CLL, Mechanisms, Mechanisms - Genomics, Mechanisms - Proteomics, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor gianluca gaidano"},{"sessionId":"11099","sessionTitle":"Individualizing Therapy in Chronic Lymphocytic Leukemia","firstName":"Matthew ","lastName":"Davids","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How Should We Sequence and Combine Novel Therapies in CLL?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - CLL, Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor matthew davids"},{"sessionId":"11099","sessionTitle":"Individualizing Therapy in Chronic Lymphocytic Leukemia","firstName":"Kirsten ","lastName":"Fischer ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimizing Frontline Therapy of CLL Based on Clinical and Biological Factors","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - CLL, Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor kirsten fischer"},{"sessionId":"11099","sessionTitle":"Individualizing Therapy in Chronic Lymphocytic Leukemia","firstName":"Gianluca ","lastName":"Gaidano ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Mutational Landscape of CLL and Its Impact on Prognosis and Treatment","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - CLL, Mechanisms, Mechanisms - Genomics, Mechanisms - Proteomics, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor gianluca gaidano"},{"sessionId":"11100","sessionTitle":"The Challenge of Primary and Secondary Central Nervous System Lymphoma","firstName":"James ","lastName":"Rubenstein","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biology of CNS Lymphoma and the Potential of Novel Agents","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - CNS Lymphoma, Mechanisms, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor james rubenstein"},{"sessionId":"11100","sessionTitle":"The Challenge of Primary and Secondary Central Nervous System Lymphoma","firstName":"Kerry ","lastName":"Savage ","credentials":"MD, MSc","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CNS Prophylaxis for Lymphoma: Who, What, and When?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - CNS Lymphoma, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor kerry savage"},{"sessionId":"11100","sessionTitle":"The Challenge of Primary and Secondary Central Nervous System Lymphoma","firstName":"Andres ","lastName":"Ferreri ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapy of Primary CNS Lymphoma: Role of Intensity, Radiation, and Novel Agents","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - CNS Lymphoma, Technology and Procedures, Technology and Procedures - Radiation, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor andres ferreri"},{"sessionId":"11100","sessionTitle":"The Challenge of Primary and Secondary Central Nervous System Lymphoma","firstName":"James ","lastName":"Rubenstein","credentials":"MD, PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biology of CNS Lymphoma and the Potential of Novel Agents","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - CNS Lymphoma, Mechanisms, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor james rubenstein"},{"sessionId":"11100","sessionTitle":"The Challenge of Primary and Secondary Central Nervous System Lymphoma","firstName":"Kerry ","lastName":"Savage ","credentials":"MD, MSc","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"12:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CNS Prophylaxis for Lymphoma: Who, What, and When?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - CNS Lymphoma, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor kerry savage"},{"sessionId":"11100","sessionTitle":"The Challenge of Primary and Secondary Central Nervous System Lymphoma","firstName":"Andres ","lastName":"Ferreri ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapy of Primary CNS Lymphoma: Role of Intensity, Radiation, and Novel Agents","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - CNS Lymphoma, Technology and Procedures, Technology and Procedures - Radiation, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor andres ferreri"},{"sessionId":"11101","sessionTitle":"The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma","firstName":"Catherine ","lastName":"Bollard ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cellular Immunotherapy for NHL","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma, Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - CAR-Ts","combinedName":"doctor catherine bollard"},{"sessionId":"11101","sessionTitle":"The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma","firstName":"Stephen ","lastName":"Ansell","credentials":"MD, PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Harnessing the Power of the Immune System in NHL: Immunomodulators, Checkpoint Inhibitors, and Beyond","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma, Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Antibodies, Therapies - Biological - Checkpoint Inhibitors","combinedName":"doctor stephen ansell"},{"sessionId":"11101","sessionTitle":"The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma","firstName":"Karin ","lastName":"Tarte ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of the Microenvironment Across Histological Subtypes of NHL","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - B-Cell Lymphoma, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma, Mechanisms, Mechanisms - Immune Mechanisms","combinedName":"doctor karin tarte"},{"sessionId":"11101","sessionTitle":"The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma","firstName":"Catherine ","lastName":"Bollard ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cellular Immunotherapy for NHL","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma, Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - CAR-Ts","combinedName":"doctor catherine bollard"},{"sessionId":"11101","sessionTitle":"The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma","firstName":"Stephen ","lastName":"Ansell","credentials":"MD, PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Harnessing the Power of the Immune System in NHL: Immunomodulators, Checkpoint Inhibitors, and Beyond","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma, Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Antibodies, Therapies - Biological - Checkpoint Inhibitors","combinedName":"doctor stephen ansell"},{"sessionId":"11101","sessionTitle":"The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma","firstName":"Karin ","lastName":"Tarte ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of the Microenvironment Across Histological Subtypes of NHL","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - B-Cell Lymphoma, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma, Mechanisms, Mechanisms - Immune Mechanisms","combinedName":"doctor karin tarte"},{"sessionId":"11102","sessionTitle":"Evolving Strategies in Aggressive B-Cell Lymphoma","firstName":"Peter ","lastName":"Martin ","credentials":"FRCPC, MD, MS","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimizing Therapy in Mantle Cell Lymphoma","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - B-Cell Lymphoma, Diseases - Lymphoid Malignancies - Iv. Non-Hodgkin Lymphoma, Diseases - Lymphoid Malignancies - Iv. Non-Hodgkin Lymphoma - Mantle Cell Lymphoma, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor peter martin"},{"sessionId":"11102","sessionTitle":"Evolving Strategies in Aggressive B-Cell Lymphoma","firstName":"Kieron","lastName":"Dunleavy","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Primary Mediastinal B Cell Lymphoma: Biology and Evolving Therapeutic Strategies","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - B-Cell Lymphoma, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - DLBCL, Mechanisms, Mechanisms - Molecular Interactions, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor kieron dunleavy"},{"sessionId":"11102","sessionTitle":"Evolving Strategies in Aggressive B-Cell Lymphoma","firstName":"Andrew ","lastName":"Davies ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tailoring Frontline Therapy in Diffuse Large B-Cell Lymphoma: Who Should We Treat Differently?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - B-Cell Lymphoma, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - DLBCL, Mechanisms, Mechanisms - Cellular Interactions, Study Population, Study Population - Adults, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor andrew davies"},{"sessionId":"11102","sessionTitle":"Evolving Strategies in Aggressive B-Cell Lymphoma","firstName":"Peter ","lastName":"Martin ","credentials":"FRCPC, MD, MS","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimizing Therapy in Mantle Cell Lymphoma","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - B-Cell Lymphoma, Diseases - Lymphoid Malignancies - Iv. Non-Hodgkin Lymphoma, Diseases - Lymphoid Malignancies - Iv. Non-Hodgkin Lymphoma - Mantle Cell Lymphoma, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor peter martin"},{"sessionId":"11102","sessionTitle":"Evolving Strategies in Aggressive B-Cell Lymphoma","firstName":"Kieron","lastName":"Dunleavy","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Primary Mediastinal B Cell Lymphoma: Biology and Evolving Therapeutic Strategies","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - B-Cell Lymphoma, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - DLBCL, Mechanisms, Mechanisms - Molecular Interactions, Study Population, Study Population - Adults, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor kieron dunleavy"},{"sessionId":"11102","sessionTitle":"Evolving Strategies in Aggressive B-Cell Lymphoma","firstName":"Andrew ","lastName":"Davies ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tailoring Frontline Therapy in Diffuse Large B-Cell Lymphoma: Who Should We Treat Differently?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - B-Cell Lymphoma, Diseases - Lymphoid Malignancies - Leukemia, Diseases - Lymphoid Malignancies - Leukemia - DLBCL, Mechanisms, Mechanisms - Cellular Interactions, Study Population, Study Population - Adults, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor andrew davies"},{"sessionId":"11103","sessionTitle":"Hodgkin Lymphoma: New Insights and New Approaches","firstName":"Nancy ","lastName":"Bartlett","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Emerging Role of Novel Therapies in Hodgkin Lymphoma: Proceed With Caution","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Hodgkin Lymphoma, Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Antibodies, Therapies - Biological - CAR-Ts, Therapies - Biological - Checkpoint Inhibitors, Therapies - Non-Biological, Therapies - Non Biological Therapies - Non-Biological - Pharmacology","combinedName":"doctor nancy bartlett"},{"sessionId":"11103","sessionTitle":"Hodgkin Lymphoma: New Insights and New Approaches","firstName":"Margaret ","lastName":"Shipp ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Insights Into Hodgkin Lymphoma Biology: Implications for Prognosis and Novel Therapeutics","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Hodgkin Lymphoma, Mechanisms, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Checkpoint Inhibitors","combinedName":"doctor margaret shipp"},{"sessionId":"11103","sessionTitle":"Hodgkin Lymphoma: New Insights and New Approaches","firstName":"Dennis ","lastName":"Eichenauer ","credentials":"","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Unique Disease Deserving Unique Management","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Hodgkin Lymphoma, Mechanisms, Mechanisms - Molecular Interactions","combinedName":"doctor dennis eichenauer"},{"sessionId":"11103","sessionTitle":"Hodgkin Lymphoma: New Insights and New Approaches","firstName":"Nancy ","lastName":"Bartlett","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Emerging Role of Novel Therapies in Hodgkin Lymphoma: Proceed With Caution","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Hodgkin Lymphoma, Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Antibodies, Therapies - Biological - CAR-Ts, Therapies - Biological - Checkpoint Inhibitors, Therapies - Non-Biological, Therapies - Non Biological Therapies - Non-Biological - Pharmacology","combinedName":"doctor nancy bartlett"},{"sessionId":"11103","sessionTitle":"Hodgkin Lymphoma: New Insights and New Approaches","firstName":"Margaret ","lastName":"Shipp ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Insights Into Hodgkin Lymphoma Biology: Implications for Prognosis and Novel Therapeutics","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Hodgkin Lymphoma, Mechanisms, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Checkpoint Inhibitors","combinedName":"doctor margaret shipp"},{"sessionId":"11103","sessionTitle":"Hodgkin Lymphoma: New Insights and New Approaches","firstName":"Dennis ","lastName":"Eichenauer ","credentials":"","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"12:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"B","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Unique Disease Deserving Unique Management","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Hodgkin Lymphoma, Mechanisms, Mechanisms - Molecular Interactions","combinedName":"doctor dennis eichenauer"},{"sessionId":"11104","sessionTitle":"Indolent Lymphoma: How Understanding Disease Biology Is Influencing Clinical Decision-Making","firstName":"Jorge ","lastName":"Castillo ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biology and Management of Lymphoplasmacytic Lymphoma","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma, Mechanisms, Mechanisms - Genomics, Mechanisms - Pathogenesis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor jorge castillo"},{"sessionId":"11104","sessionTitle":"Indolent Lymphoma: How Understanding Disease Biology Is Influencing Clinical Decision-Making","firstName":"Brad ","lastName":"Kahl","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Follicular Lymphoma: Are We Ready for a Risk-Adapted Approach?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma - Follicular Lymphoma, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor brad kahl"},{"sessionId":"11104","sessionTitle":"Indolent Lymphoma: How Understanding Disease Biology Is Influencing Clinical Decision-Making","firstName":"Catherine ","lastName":"Thieblemont ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Update on Nodal and Primary Splenic Marginal Zone Lymphoma","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma - Marginal Zone Lymphoma, Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor catherine thieblemont"},{"sessionId":"11104","sessionTitle":"Indolent Lymphoma: How Understanding Disease Biology Is Influencing Clinical Decision-Making","firstName":"Jorge ","lastName":"Castillo ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biology and Management of Lymphoplasmacytic Lymphoma","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma, Mechanisms, Mechanisms - Genomics, Mechanisms - Pathogenesis, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor jorge castillo"},{"sessionId":"11104","sessionTitle":"Indolent Lymphoma: How Understanding Disease Biology Is Influencing Clinical Decision-Making","firstName":"Brad ","lastName":"Kahl","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Follicular Lymphoma: Are We Ready for a Risk-Adapted Approach?","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma - Follicular Lymphoma, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells, Therapies - Biological - Transplantation, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor brad kahl"},{"sessionId":"11104","sessionTitle":"Indolent Lymphoma: How Understanding Disease Biology Is Influencing Clinical Decision-Making","firstName":"Catherine ","lastName":"Thieblemont ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Update on Nodal and Primary Splenic Marginal Zone Lymphoma","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma, Diseases - Lymphoid Malignancies - Non-Hodgkin Lymphoma - Marginal Zone Lymphoma, Mechanisms, Mechanisms - Molecular Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Pharmacology","combinedName":"doctor catherine thieblemont"},{"sessionId":"11105","sessionTitle":"Identification and Management of Toxicities Induced by Immunotherapies","firstName":"Suzanne ","lastName":"Topalian ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Toxicities of Checkpoint Inhibitors","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Multi-Systemic Interactions, Mechanisms - Signal Transduction, Therapies, Therapies - Biological, Therapies - Biological - Checkpoint Inhibitors","combinedName":"doctor suzanne topalian"},{"sessionId":"11105","sessionTitle":"Identification and Management of Toxicities Induced by Immunotherapies","firstName":"Daniel ","lastName":"Lee III","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Toxicities of Chimeric Antigen Receptor T Cells","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Multi-Systemic Interactions, Therapies, Therapies - Biological, Therapies - Biological - CAR-Ts","combinedName":"doctor daniel lee iii"},{"sessionId":"11106","sessionTitle":"Editing and Enhancing Erythropoiesis","firstName":"Janis ","lastName":"Abkowitz","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Delayed Globin Synthesis Leads to Excessive Heme and the Macrocytic Anemia of Diamond Blackfan Anemia and del(5q) Myelodysplastic Syndrome","keywords":"Diseases, Diseases - Anemias, Diseases - Anemias - Diamond Blackfan Anemias, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Erythropoiesis, Mechanisms - Genome Editing, Mechanisms - Genomics","combinedName":"doctor janis abkowitz"},{"sessionId":"11106","sessionTitle":"Editing and Enhancing Erythropoiesis","firstName":"Mitchell ","lastName":"Weiss","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genome Editing Strategies to Treat Beta-Hemoglobinopathies","keywords":"Diseases, Diseases - Hemoglobinopathies, Mechanisms, Mechanisms - Erythropoiesis, Mechanisms - Genome Editing, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Gene Editing","combinedName":"doctor mitchell weiss"},{"sessionId":"11106","sessionTitle":"Editing and Enhancing Erythropoiesis","firstName":"Jian ","lastName":"Xu ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Situ Capture of the Molecular Composition of Erythroid Transcriptional Enhancers","keywords":"Mechanisms, Mechanisms - Erythropoiesis, Mechanisms - Genome Editing, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Gene Editing","combinedName":"doctor jian xu"},{"sessionId":"11106","sessionTitle":"Editing and Enhancing Erythropoiesis","firstName":"Janis ","lastName":"Abkowitz","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Delayed Globin Synthesis Leads to Excessive Heme and the Macrocytic Anemia of Diamond Blackfan Anemia and del(5q) Myelodysplastic Syndrome","keywords":"Diseases, Diseases - Anemias, Diseases - Anemias - Diamond Blackfan Anemias, Diseases - Myeloid Malignancies, Diseases - Myeloid Malignancies - MDS, Mechanisms, Mechanisms - Erythropoiesis, Mechanisms - Genome Editing, Mechanisms - Genomics","combinedName":"doctor janis abkowitz"},{"sessionId":"11106","sessionTitle":"Editing and Enhancing Erythropoiesis","firstName":"Mitchell ","lastName":"Weiss","credentials":"MD, PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genome Editing Strategies to Treat Beta-Hemoglobinopathies","keywords":"Diseases, Diseases - Hemoglobinopathies, Mechanisms, Mechanisms - Erythropoiesis, Mechanisms - Genome Editing, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Gene Editing","combinedName":"doctor mitchell weiss"},{"sessionId":"11106","sessionTitle":"Editing and Enhancing Erythropoiesis","firstName":"Jian ","lastName":"Xu ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Situ Capture of the Molecular Composition of Erythroid Transcriptional Enhancers","keywords":"Mechanisms, Mechanisms - Erythropoiesis, Mechanisms - Genome Editing, Mechanisms - Genomics, Technology and Procedures, Technology and Procedures - Gene Editing","combinedName":"doctor jian xu"},{"sessionId":"11107","sessionTitle":"Evolving Approaches to Gene Therapy for Blood Diseases","firstName":"Philip ","lastName":"Gregory ","credentials":"DPhil","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gene Therapy: Where We Started and Where the Field is Going","keywords":"Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Technology and Procedures, Technology and Procedures - Gene Editing, Therapies, Therapies - Biological, Therapies - Biological - Gene Therapy, Therapies - Biological - Stem Cells","combinedName":"doctor philip gregory"},{"sessionId":"11107","sessionTitle":"Evolving Approaches to Gene Therapy for Blood Diseases","firstName":"Judith ","lastName":"Shizuru ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Conditioning Regimens for Blood Stem Cell Transplantation","keywords":"Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Mechanisms - Proteomics, Therapies, Therapies - Biological, Therapies - Biological - Antibodies, Therapies - Biological - Gene Therapy, Therapies - Biological - Stem Cells, Therapies - Non-Biological, Therapies - Non-Biological - Gene Therapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor judith shizuru"},{"sessionId":"11107","sessionTitle":"Evolving Approaches to Gene Therapy for Blood Diseases","firstName":"Hiromitsu ","lastName":"Nakauchi ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Valine as a Key Metabolic Regulator of Hematopoietic Stem Cell Maintenance","keywords":"Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Mechanisms - Proteomics, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells","combinedName":"doctor hiromitsu nakauchi"},{"sessionId":"11107","sessionTitle":"Evolving Approaches to Gene Therapy for Blood Diseases","firstName":"Philip ","lastName":"Gregory ","credentials":"DPhil","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gene Therapy: Where We Started and Where the Field is Going","keywords":"Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Technology and Procedures, Technology and Procedures - Gene Editing, Therapies, Therapies - Biological, Therapies - Biological - Gene Therapy, Therapies - Biological - Stem Cells","combinedName":"doctor philip gregory"},{"sessionId":"11107","sessionTitle":"Evolving Approaches to Gene Therapy for Blood Diseases","firstName":"Judith ","lastName":"Shizuru ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Conditioning Regimens for Blood Stem Cell Transplantation","keywords":"Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Mechanisms - Proteomics, Therapies, Therapies - Biological, Therapies - Biological - Antibodies, Therapies - Biological - Gene Therapy, Therapies - Biological - Stem Cells, Therapies - Non-Biological, Therapies - Non-Biological - Gene Therapy, Therapies - Non-Biological - Pharmacology","combinedName":"doctor judith shizuru"},{"sessionId":"11107","sessionTitle":"Evolving Approaches to Gene Therapy for Blood Diseases","firstName":"Hiromitsu ","lastName":"Nakauchi ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Valine as a Key Metabolic Regulator of Hematopoietic Stem Cell Maintenance","keywords":"Mechanisms, Mechanisms - Genomics, Mechanisms - Hematopoiesis, Mechanisms - Proteomics, Therapies, Therapies - Biological, Therapies - Biological - Stem Cells","combinedName":"doctor hiromitsu nakauchi"},{"sessionId":"11108","sessionTitle":"Thrombosis: A View From the World of Bioengineering","firstName":"Jeffrey ","lastName":"Lawson ","credentials":"PhD, MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Engineered Blood Vessels","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Mechanisms, Technology and Procedures, Technology and Procedures - Bioengineering","combinedName":"doctor jeffrey lawson"},{"sessionId":"11108","sessionTitle":"Thrombosis: A View From the World of Bioengineering","firstName":"Keith ","lastName":"Neeves ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Magnetically Powered Microbots: A Novel Approach to Thrombolysis?","keywords":"","combinedName":"doctor keith neeves"},{"sessionId":"11108","sessionTitle":"Thrombosis: A View From the World of Bioengineering","firstName":"Wilbur ","lastName":"Lam","credentials":"MD,PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombosis-on-a-Chip: A New Way to Model a Complex Process","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Mechanisms, Mechanisms - Cellular Interactions, Technology and Procedures, Technology and Procedures - Bioengineering, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Device","combinedName":"doctor wilbur lam"},{"sessionId":"11108","sessionTitle":"Thrombosis: A View From the World of Bioengineering","firstName":"Jeffrey ","lastName":"Lawson ","credentials":"PhD, MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Engineered Blood Vessels","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Mechanisms, Technology and Procedures, Technology and Procedures - Bioengineering","combinedName":"doctor jeffrey lawson"},{"sessionId":"11108","sessionTitle":"Thrombosis: A View From the World of Bioengineering","firstName":"Keith ","lastName":"Neeves ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Magnetically Powered Microbots: A Novel Approach to Thrombolysis?","keywords":"","combinedName":"doctor keith neeves"},{"sessionId":"11108","sessionTitle":"Thrombosis: A View From the World of Bioengineering","firstName":"Wilbur ","lastName":"Lam","credentials":"MD,PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombosis-on-a-Chip: A New Way to Model a Complex Process","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombosis, Mechanisms, Mechanisms - Cellular Interactions, Technology and Procedures, Technology and Procedures - Bioengineering, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Device","combinedName":"doctor wilbur lam"},{"sessionId":"11109","sessionTitle":"Targeted for Destruction: Clearance and Hemostatic Activity of Endogenous and Transfused Platelets","firstName":"Karin ","lastName":"Hoffmeister","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Glycan Dependent Platelet Clearance Mechanisms","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Proteomics","combinedName":"doctor karin hoffmeister"},{"sessionId":"11109","sessionTitle":"Targeted for Destruction: Clearance and Hemostatic Activity of Endogenous and Transfused Platelets","firstName":"John ","lastName":"Semple ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Splenic Mechanisms of Thrombocytopenia","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombocytopenias, Mechanisms, Mechanisms - Multi-Systemic Interactions","combinedName":"doctor john semple"},{"sessionId":"11109","sessionTitle":"Targeted for Destruction: Clearance and Hemostatic Activity of Endogenous and Transfused Platelets","firstName":"Andrew ","lastName":"Cap ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Hemorrhage: Alternative Storage of Platelets for Hemostatic Transfusion","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombocytopenias, Technology and Procedures, Technology and Procedures - Blood Product Storage","combinedName":"doctor andrew cap"},{"sessionId":"11109","sessionTitle":"Targeted for Destruction: Clearance and Hemostatic Activity of Endogenous and Transfused Platelets","firstName":"Karin ","lastName":"Hoffmeister","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Glycan Dependent Platelet Clearance Mechanisms","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Proteomics","combinedName":"doctor karin hoffmeister"},{"sessionId":"11109","sessionTitle":"Targeted for Destruction: Clearance and Hemostatic Activity of Endogenous and Transfused Platelets","firstName":"John ","lastName":"Semple ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Splenic Mechanisms of Thrombocytopenia","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombocytopenias, Mechanisms, Mechanisms - Multi-Systemic Interactions","combinedName":"doctor john semple"},{"sessionId":"11109","sessionTitle":"Targeted for Destruction: Clearance and Hemostatic Activity of Endogenous and Transfused Platelets","firstName":"Andrew ","lastName":"Cap ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"B","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Hemorrhage: Alternative Storage of Platelets for Hemostatic Transfusion","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Thrombocytopenias, Technology and Procedures, Technology and Procedures - Blood Product Storage","combinedName":"doctor andrew cap"},{"sessionId":"11110","sessionTitle":"Targeting T-Cell Exhaustion","firstName":"Dario ","lastName":"Vignali ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biology of LAG3 Checkpoint Blockade","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Checkpoint Inhibitors","combinedName":"doctor dario vignali"},{"sessionId":"11110","sessionTitle":"Targeting T-Cell Exhaustion","firstName":"Arlene ","lastName":"Sharpe ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biology of PD-1 Checkpoint Blockade","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Signal Transduction, Therapies, Therapies - Biological, Therapies - Biological - Checkpoint Inhibitors","combinedName":"doctor arlene sharpe"},{"sessionId":"11110","sessionTitle":"Targeting T-Cell Exhaustion","firstName":"Rafi ","lastName":"Ahmed ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T-Cell Memory and Exhaustion","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Checkpoint Inhibitors","combinedName":"doctor rafi ahmed"},{"sessionId":"11110","sessionTitle":"Targeting T-Cell Exhaustion","firstName":"Dario ","lastName":"Vignali ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biology of LAG3 Checkpoint Blockade","keywords":"Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Genomics, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Checkpoint Inhibitors","combinedName":"doctor dario vignali"},{"sessionId":"11110","sessionTitle":"Targeting T-Cell Exhaustion","firstName":"Arlene ","lastName":"Sharpe ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biology of PD-1 Checkpoint Blockade","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Mechanisms - Signal Transduction, Therapies, Therapies - Biological, Therapies - Biological - Checkpoint Inhibitors","combinedName":"doctor arlene sharpe"},{"sessionId":"11110","sessionTitle":"Targeting T-Cell Exhaustion","firstName":"Rafi ","lastName":"Ahmed ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"B","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T-Cell Memory and Exhaustion","keywords":"Mechanisms, Mechanisms - Immune Mechanisms, Therapies, Therapies - Biological, Therapies - Biological - Checkpoint Inhibitors","combinedName":"doctor rafi ahmed"},{"sessionId":"11111","sessionTitle":"Special Scientific Symposium on Targeted Therapy: What Is the Best Target?","firstName":"Kimberly ","lastName":"Stegmaier ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Regulators of Differentiation","keywords":"","combinedName":"doctor kimberly stegmaier"},{"sessionId":"11111","sessionTitle":"Special Scientific Symposium on Targeted Therapy: What Is the Best Target?","firstName":"Neil ","lastName":"Shah ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Somatic Kinase Mutations","keywords":"","combinedName":"doctor neil shah"},{"sessionId":"11111","sessionTitle":"Special Scientific Symposium on Targeted Therapy: What Is the Best Target?","firstName":"Mark ","lastName":"Dawson ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting the Epigenome","keywords":"","combinedName":"doctor mark dawson"},{"sessionId":"11112","sessionTitle":"Special Scientific Symposium on Understanding and Modulating the DNA Damage Response","firstName":"Alan ","lastName":"D'Andrea","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:15:00","endTime":"14:30:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"DNA Repair Targets in Bone Marrow Failure and Cancer","keywords":"","combinedName":"doctor alan d'andrea"},{"sessionId":"11112","sessionTitle":"Special Scientific Symposium on Understanding and Modulating the DNA Damage Response","firstName":"Andre ","lastName":"Nussenzweig ","credentials":"PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:15:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genome Organization Drives Chromosome Fragility","keywords":"","combinedName":"doctor andre nussenzweig"},{"sessionId":"11112","sessionTitle":"Special Scientific Symposium on Understanding and Modulating the DNA Damage Response","firstName":"Feyruz ","lastName":"Rassool ","credentials":"PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"14:45:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting DNA Damage and Repair in Cancer: Bench to Bedside in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor feyruz rassool"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","firstName":"Rodney ","lastName":"Camire","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:30:00Z","startTime":"18:00:00","endTime":"18:10:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Best of ASH in Hemostasis and Thrombosis 1","keywords":"","combinedName":"doctor rodney camire"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","firstName":"David ","lastName":"Garcia","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:30:00Z","startTime":"18:10:00","endTime":"18:20:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Best of ASH in Hemostasis and Thrombosis 2","keywords":"","combinedName":"doctor david garcia"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","firstName":"Michael","lastName":"Holinstat","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:30:00Z","startTime":"18:20:00","endTime":"18:30:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Best of ASH in Hemostasis and Thrombosis 3","keywords":"","combinedName":"doctor michael holinstat"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","firstName":"Yunfeng ","lastName":"Chen ","credentials":"","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:30:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of a VWFA1 Mutation Attenuating Thrombus Growth but Not Platelet Adhesion","keywords":"","combinedName":"doctor yunfeng chen"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","firstName":"David ","lastName":"Gailani ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:30:00Z","startTime":"17:20:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Initiation of Surface-Mediated Thrombosis Events","keywords":"","combinedName":"doctor david gailani"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","firstName":"James ","lastName":"Huntington ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:30:00Z","startTime":"16:30:00","endTime":"16:55:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Activated Protein C to Treat Hemophilia","keywords":"","combinedName":"doctor james huntington"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","firstName":"Steve ","lastName":"Watson ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:30:00Z","startTime":"16:55:00","endTime":"17:20:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting ITAM Receptors in Disease With Ibrutinib and Other Tyrosine Kinase Inhibitors","keywords":"","combinedName":"doctor steve watson"},{"sessionId":"11114","sessionTitle":"Special Scientific Symposium on Hot Topics in Hematology: New Pathways Linking Hematopoiesis, Thrombosis, and Cardiovascular Disease","firstName":"Benjamin ","lastName":"Ebert","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Hematopoiesis Influences Cardiovascular Risk","keywords":"","combinedName":"doctor benjamin ebert"},{"sessionId":"11114","sessionTitle":"Special Scientific Symposium on Hot Topics in Hematology: New Pathways Linking Hematopoiesis, Thrombosis, and Cardiovascular Disease","firstName":"Alan ","lastName":"Tall ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lipids, Hematopoiesis, and Athero-Thrombosis","keywords":"","combinedName":"doctor alan tall"},{"sessionId":"11114","sessionTitle":"Special Scientific Symposium on Hot Topics in Hematology: New Pathways Linking Hematopoiesis, Thrombosis, and Cardiovascular Disease","firstName":"E. ","lastName":"Abel ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sex Matters: The Hormonal Milieu Regulates Thrombosis","keywords":"","combinedName":"doctor e abel"},{"sessionId":"11115","sessionTitle":"The Impact of the Microbiome on the Hematologic System: Thrombosis and Graft-Versus-Host Disease","firstName":"Stanley ","lastName":"Hazen ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gut Microbes, Platelet Function and Thrombosis Risk","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Platelet Disorders, Diseases - Bleeding and Clotting - Thrombosis, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Multi-Systemic Interactions, Mechanisms - Proteomics, Therapies, Therapies - Biological, Therapies - Biological - Enzyme Inhibitors","combinedName":"doctor stanley hazen"},{"sessionId":"11115","sessionTitle":"The Impact of the Microbiome on the Hematologic System: Thrombosis and Graft-Versus-Host Disease","firstName":"Pavan ","lastName":"Reddy ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Microbiome Metabolites Regulate Graft-Versus-Host Disease","keywords":"Diseases, Diseases - Immune Disorders, Diseases - Immune Disorders - GVHD, Mechanisms, Mechanisms - Cellular Interactions, Mechanisms - Immune Mechanisms, Mechanisms - Molecular Interactions, Mechanisms - Multi-Systemic Interactions, Therapies, Therapies - Non-Biological, Therapies - Non-Biological - Chemical Biology","combinedName":"doctor pavan reddy"},{"sessionId":"11116","sessionTitle":"Beyond Sequencing: Emerging Tools for Analysis of Multi-Omic Genomic Data in Acquired and Inherited Hematologic Disease","firstName":"Jinghui ","lastName":"Zhang ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Finding Driver Variants in Leukemia Genomic Datasets","keywords":"Diseases, Diseases - Lymphoid Malignancies, Diseases - Lymphoid Malignancies - Leukemia, Mechanisms, Mechanisms - Genomics, Mechanisms - Proteomics, Technology and Procedures, Technology and Procedures - NGS, Technology and Procedures - WGS","combinedName":"doctor jinghui zhang"},{"sessionId":"11116","sessionTitle":"Beyond Sequencing: Emerging Tools for Analysis of Multi-Omic Genomic Data in Acquired and Inherited Hematologic Disease","firstName":"Ernest ","lastName":"Turro ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Statistical and Genomic Approaches in Rare Disease Research","keywords":"Diseases, Diseases - Bleeding and Clotting, Diseases - Bleeding and Clotting - Bleeding Disorders, Diseases - Bleeding and Clotting - Platelet Disorders, Mechanisms, Mechanisms - Genomics, Mechanisms - Proteomics, Technology and Procedures, Technology and Procedures - NGS, Technology and Procedures - RNA Sequencing, Technology and Procedures - WGS","combinedName":"doctor ernest turro"},{"sessionId":"11139","sessionTitle":"Trainee Day Didactic Session 1: Statistics and Trial Design","firstName":"Sara ","lastName":"Vesely ","credentials":"PhD, MPH","sessionStartTime":"2017-12-08T12:00:00Z","sessionEndTime":"2017-12-08T13:15:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Grand Blrm D2-E- No. Twr- M4","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Statistics and Trial Design","keywords":"","combinedName":"doctor sara vesely"},{"sessionId":"11140","sessionTitle":"Trainee Day Didactic 2: Panel: Non-Traditional Career Development","firstName":"Ann ","lastName":"Farrell ","credentials":"MD","sessionStartTime":"2017-12-08T16:00:00Z","sessionEndTime":"2017-12-08T17:00:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Grand Blrm D2-E- No. Twr- M4","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Didactic Session 2: Non-Traditional Career Development: FDA","keywords":"","combinedName":"doctor ann farrell"},{"sessionId":"11140","sessionTitle":"Trainee Day Didactic 2: Panel: Non-Traditional Career Development","firstName":"Danielle ","lastName":"Townsley ","credentials":"MD, MSc","sessionStartTime":"2017-12-08T16:00:00Z","sessionEndTime":"2017-12-08T17:00:00Z","startTime":"16:15:00","endTime":"16:30:00","sessionLocation":"Grand Blrm D2-E- No. Twr- M4","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Didactic Session 2: Non-Traditional Career Development: NHLBI","keywords":"","combinedName":"doctor danielle townsley"},{"sessionId":"11140","sessionTitle":"Trainee Day Didactic 2: Panel: Non-Traditional Career Development","firstName":"Benjamin ","lastName":"Kim ","credentials":"MD, MPhil","sessionStartTime":"2017-12-08T16:00:00Z","sessionEndTime":"2017-12-08T17:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Grand Blrm D2-E- No. Twr- M4","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Didactic Session 2: Non-Traditional Career Development: Pharmaceutical Industry","keywords":"","combinedName":"doctor benjamin kim"},{"sessionId":"11142","sessionTitle":"Trainee Day Breakout 1: Statistical Considerations for Basic, Translational, and Phase I Trials","firstName":"Rosemarie ","lastName":"Mick ","credentials":"MS","sessionStartTime":"2017-12-08T13:30:00Z","sessionEndTime":"2017-12-08T14:30:00Z","startTime":"13:30:00","endTime":"13:45:00","sessionLocation":"Grand Blrm A- No. Twr- M4","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Breakout Rotation 1: Statistical Considerations for Basic/Translational / Phase I Trials","keywords":"","combinedName":"doctor rosemarie mick"},{"sessionId":"11143","sessionTitle":"Trainee Day Breakout 1: Statistical Considerations in Phase II and III Clinical Trials","firstName":"Mikkael ","lastName":"Sekeres","credentials":"MD, MS","sessionStartTime":"2017-12-08T13:30:00Z","sessionEndTime":"2017-12-08T14:30:00Z","startTime":"13:30:00","endTime":"13:45:00","sessionLocation":"Grand Blrm B- No. Twr- M4","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Breakout Rotation 1: Statistics and Trial Design; Statistical Considerations in Phase II/III Clinical Trials","keywords":"","combinedName":"doctor mikkael sekeres"},{"sessionId":"11144","sessionTitle":"Trainee Day Breakout 1: Statistical Considerations in Health Outcomes and Clinical Effectiveness Research","firstName":"Navneet ","lastName":"Majhail","credentials":"MD, MS","sessionStartTime":"2017-12-08T13:30:00Z","sessionEndTime":"2017-12-08T14:30:00Z","startTime":"13:30:00","endTime":"13:45:00","sessionLocation":"Grand Blrm C- No. Twr- M4","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Breakout Rotation 1: Statistical Considerations in Health Outcomes and Clinical Effectiveness Research","keywords":"","combinedName":"doctor navneet majhail"},{"sessionId":"11145","sessionTitle":"Trainee Day Breakout 2: Research Teams in Translational Studies","firstName":"Neil ","lastName":"Shah ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T14:45:00Z","sessionEndTime":"2017-12-08T15:45:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Grand Blrm A- No. Twr- M4","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Breakout Rotation 2: Research Teams in Translational Studies (including optimizing partners in the lab)","keywords":"","combinedName":"doctor neil shah"},{"sessionId":"11159","sessionTitle":"Trainee Didactic Session: Time Management and Balance","firstName":"Jean ","lastName":"Koff","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Time Management and Balance: Adult/ Clinical","keywords":"","combinedName":"doctor jean koff"},{"sessionId":"11159","sessionTitle":"Trainee Didactic Session: Time Management and Balance","firstName":"Sara E","lastName":"Meyer ","credentials":"PhD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Time Management and Balance: Peds/Lab","keywords":"","combinedName":"doctor sara e meyer"},{"sessionId":"11160","sessionTitle":"Trainee Didactic Session: Drug Development","firstName":"Michael ","lastName":"Grever ","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Trainee Didactic Session: Drug Development","keywords":"","combinedName":"doctor michael grever"},{"sessionId":"11161","sessionTitle":"Trainee Day Breakout 2: Research Teams in Clinical Trials","firstName":"David ","lastName":"Steensma ","credentials":"MD","sessionStartTime":"2017-12-08T14:45:00Z","sessionEndTime":"2017-12-08T15:45:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Grand Blrm B- No. Twr- M4","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"How to Build a Research Team; Research Teams in Clinical Trials","keywords":"","combinedName":"doctor david steensma"},{"sessionId":"11162","sessionTitle":"Trainee Day Breakout 2: How to Build a Health Outcomes and Clinical Effectiveness Research Team","firstName":"Linda ","lastName":"Burns","credentials":"MD","sessionStartTime":"2017-12-08T14:45:00Z","sessionEndTime":"2017-12-08T15:45:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Grand Blrm C- No. Twr- M4","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"How to Build a Research Team; Research Teams in Health Outcomes and Clinical Effectiveness Research","keywords":"","combinedName":"doctor linda burns"},{"sessionId":"11163","sessionTitle":"Trainee Didactic Session: How to Set Up a Laboratory Research Program","firstName":"Monica ","lastName":"Guzman","credentials":"PhD","sessionStartTime":"2017-12-11T12:15:00Z","sessionEndTime":"2017-12-11T13:15:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How to Set-up a Laboratory Research Program","keywords":"","combinedName":"doctor monica guzman"},{"sessionId":"11164","sessionTitle":"Trainee Didactic Session: Bridging the Translational Divide","firstName":"Nigel ","lastName":"Mackman ","credentials":"PhD","sessionStartTime":"2017-12-11T12:15:00Z","sessionEndTime":"2017-12-11T13:15:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bridging the Translational Divide","keywords":"","combinedName":"doctor nigel mackman"},{"sessionId":"11177","sessionTitle":"Hematology Course Directors Workshop","firstName":"Amy ","lastName":"O'Sullivan ","credentials":"PhD","sessionStartTime":"2017-12-10T07:00:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Grand Blrm A- No. Twr- M4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"An Overview of Qualitative Research Methodology","keywords":"","combinedName":"doctor amy o'sullivan"},{"sessionId":"11177","sessionTitle":"Hematology Course Directors Workshop","firstName":"Ariela ","lastName":"Marshall ","credentials":"MD","sessionStartTime":"2017-12-10T07:00:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Grand Blrm A- No. Twr- M4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"ASH Medical Educators Institute Spotlight","keywords":"","combinedName":"doctor ariela marshall"},{"sessionId":"11177","sessionTitle":"Hematology Course Directors Workshop","firstName":"Jennifer ","lastName":"Kesselheim","credentials":"MD, MEd","sessionStartTime":"2017-12-10T07:00:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Grand Blrm A- No. Twr- M4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Knowles Adult Learning Theory","keywords":"","combinedName":"doctor jennifer kesselheim"},{"sessionId":"11177","sessionTitle":"Hematology Course Directors Workshop","firstName":"Neil ","lastName":"Lachant ","credentials":"MD","sessionStartTime":"2017-12-10T07:00:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Grand Blrm A- No. Twr- M4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"The Flipped Classroom: Cons","keywords":"","combinedName":"doctor neil lachant"},{"sessionId":"11177","sessionTitle":"Hematology Course Directors Workshop","firstName":"Rajiv ","lastName":"Pruthi","credentials":"MBBS","sessionStartTime":"2017-12-10T07:00:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Grand Blrm A- No. Twr- M4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"The Flipped Classroom: Pros","keywords":"","combinedName":"doctor rajiv pruthi"},{"sessionId":"11178","sessionTitle":"Junior Faculty Development  Education Session: Grant Funding: How to Get It and How to Keep It Going","firstName":"Allison ","lastName":"King ","credentials":"MD, MPH, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How to Change Your K to an R","keywords":"","combinedName":"doctor allison king"},{"sessionId":"11178","sessionTitle":"Junior Faculty Development  Education Session: Grant Funding: How to Get It and How to Keep It Going","firstName":"Catherine ","lastName":"Smith ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How to Get Your First Grant","keywords":"","combinedName":"doctor catherine smith"},{"sessionId":"11178","sessionTitle":"Junior Faculty Development  Education Session: Grant Funding: How to Get It and How to Keep It Going","firstName":"Patrick ","lastName":"Brown ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How to Respond to the Pain of Reviewers' Critiques","keywords":"","combinedName":"doctor patrick brown"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Burton ","lastName":"Alexander III","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Clinical Careers in Hematology (Private Practice Careers)","keywords":"","combinedName":"doctor burton alexander iii"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Harriet ","lastName":"Bering ","credentials":"","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Clinical Careers in Hematology (Private Practice Careers)","keywords":"","combinedName":"doctor harriet bering"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Gabriel ","lastName":"Mannis ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Clinical Malignant Hematology/ BMT","keywords":"","combinedName":"doctor gabriel mannis"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Hetty ","lastName":"Carraway","credentials":"MD, MBA","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Clinical Malignant Hematology/ BMT","keywords":"","combinedName":"doctor hetty carraway"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Anita ","lastName":"Rajasekhar ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Clinical Non-Malignant Hematology","keywords":"","combinedName":"doctor anita rajasekhar"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Ted ","lastName":"Wun ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Clinical Non-Malignant Hematology","keywords":"","combinedName":"doctor ted wun"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Albert ","lastName":"Deisseroth ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Government Careers","keywords":"","combinedName":"doctor albert deisseroth"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Elaine ","lastName":"Jaffe ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Government Careers","keywords":"","combinedName":"doctor elaine jaffe"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"James ","lastName":"Bradner ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Industry Careers","keywords":"","combinedName":"doctor james bradner"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Patrick ","lastName":"Fogarty ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Industry Careers","keywords":"","combinedName":"doctor patrick fogarty"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Michelle ","lastName":"Sholzberg ","credentials":"MDCM, MSc","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Laboratory & Translational Hematology","keywords":"","combinedName":"doctor michelle sholzberg"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Neil ","lastName":"Shah ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Laboratory & Translational Hematology","keywords":"","combinedName":"doctor neil shah"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Karen ","lastName":"Hook ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Medical Educators in Hematology","keywords":"","combinedName":"doctor karen hook"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Martina ","lastName":"Trinkaus ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Medical Educators in Hematology","keywords":"","combinedName":"doctor martina trinkaus"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Anthony ","lastName":"Chan ","credentials":"MBBS","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Pediatric Hematology/ Oncology Careers","keywords":"","combinedName":"doctor anthony chan"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Cindy","lastName":"Neunert","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Pediatric Hematology/ Oncology Careers","keywords":"","combinedName":"doctor cindy neunert"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Nancy ","lastName":"Speck","credentials":"PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"PhD Careers","keywords":"","combinedName":"doctor nancy speck"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Tucker ","lastName":"LeBien ","credentials":"PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"PhD Careers","keywords":"","combinedName":"doctor tucker lebien"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Gary ","lastName":"Schiller ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Transfusion Medicine","keywords":"","combinedName":"doctor gary schiller"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","firstName":"Richard ","lastName":"Kaufman ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. E No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Transfusion Medicine","keywords":"","combinedName":"doctor richard kaufman"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"David ","lastName":"Portnoy ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Clinical Careers in Hematology (Private Practice Careers)","keywords":"","combinedName":"doctor david portnoy"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Kenneth ","lastName":"Adler ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Clinical Careers in Hematology (Private Practice Careers)","keywords":"","combinedName":"doctor kenneth adler"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Joseph ","lastName":"Antin ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Clinical Malignant Hematology/ BMT","keywords":"","combinedName":"doctor joseph antin"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Andrew ","lastName":"Leavitt ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Clinical Non-malignant Hematology","keywords":"","combinedName":"doctor andrew leavitt"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Cindy ","lastName":"Leissinger","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Clinical Non-malignant Hematology","keywords":"","combinedName":"doctor cindy leissinger"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Craig ","lastName":"Hooper ","credentials":"PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Government Careers","keywords":"","combinedName":"doctor craig hooper"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Keith ","lastName":"Hoots ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Government Careers","keywords":"","combinedName":"doctor keith hoots"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Sophia ","lastName":"Khaldoyanidi ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Industry Careers","keywords":"","combinedName":"doctor sophia khaldoyanidi"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Stephen ","lastName":"Simko ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Industry Careers","keywords":"","combinedName":"doctor stephen simko"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Kojo ","lastName":"Elenitoba-Johnson ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Laboratory & Translational  Hematology","keywords":"","combinedName":"doctor kojo elenitoba-johnson"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Karin ","lastName":"Finberg ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Laboratory & Translational Hematology","keywords":"","combinedName":"doctor karin finberg"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Elaine ","lastName":"Muchmore ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Medical Educators in Hematology","keywords":"","combinedName":"doctor elaine muchmore"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Kristie ","lastName":"Blum ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Medical Educators in Hematology","keywords":"","combinedName":"doctor kristie blum"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Naomi ","lastName":"Winick ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Pediatric Hematology/ Oncology Careers","keywords":"","combinedName":"doctor naomi winick"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Neil","lastName":"Goldenberg","credentials":"MD, PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Pediatric Hematology/ Oncology Careers","keywords":"","combinedName":"doctor neil goldenberg"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Patricia ","lastName":"Liaw ","credentials":"PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"PhD Careers","keywords":"","combinedName":"doctor patricia liaw"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Vesna ","lastName":"Najfeld ","credentials":"PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"PhD Careers","keywords":"","combinedName":"doctor vesna najfeld"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Cassandra ","lastName":"Josephson ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Transfusion Medicine","keywords":"","combinedName":"doctor cassandra josephson"},{"sessionId":"11182","sessionTitle":"Career Development Lunch Sessions: Room 2","firstName":"Lawrence Tim","lastName":"Goodnough ","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"11:15:00","endTime":"11:15:00","sessionLocation":"Int'l Blrm. F No. Twr. M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Transfusion Medicine","keywords":"","combinedName":"doctor lawrence tim goodnough"},{"sessionId":"11231","sessionTitle":"Training Program Directors Workshop","firstName":"Christian ","lastName":"Cable ","credentials":"MD","sessionStartTime":"2017-12-08T12:00:00Z","sessionEndTime":"2017-12-08T17:00:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Int'l Blrm. D No. Twr. M2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"ACGME Update 2017","keywords":"","combinedName":"doctor christian cable"},{"sessionId":"11231","sessionTitle":"Training Program Directors Workshop","firstName":"Alice ","lastName":"Cohen ","credentials":"MD","sessionStartTime":"2017-12-08T12:00:00Z","sessionEndTime":"2017-12-08T17:00:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Int'l Blrm. D No. Twr. M2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Having The Talk With Fellows","keywords":"","combinedName":"doctor alice cohen"},{"sessionId":"11231","sessionTitle":"Training Program Directors Workshop","firstName":"Gerald ","lastName":"Soff ","credentials":"MD","sessionStartTime":"2017-12-08T12:00:00Z","sessionEndTime":"2017-12-08T17:00:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Int'l Blrm. D No. Twr. M2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Having The Talk With Fellows","keywords":"","combinedName":"doctor gerald soff"},{"sessionId":"11231","sessionTitle":"Training Program Directors Workshop","firstName":"Alfred ","lastName":"Lee ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T12:00:00Z","sessionEndTime":"2017-12-08T17:00:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Int'l Blrm. D No. Twr. M2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Its in Our Blood","keywords":"","combinedName":"doctor alfred lee"},{"sessionId":"11231","sessionTitle":"Training Program Directors Workshop","firstName":"Michael ","lastName":"Borowitz ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T12:00:00Z","sessionEndTime":"2017-12-08T17:00:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Int'l Blrm. D No. Twr. M2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Its in Our Blood","keywords":"","combinedName":"doctor michael borowitz"},{"sessionId":"11316","sessionTitle":"Consultative Hematology Course","firstName":"Maureen Okam","lastName":"Achebe ","credentials":"MD, MPH","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T11:30:00Z","startTime":"07:40:00","endTime":"08:10:00","sessionLocation":"Int'l Blrm. A-D No. Twr. M2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Anemias in Pregnancy","keywords":"","combinedName":"doctor maureen okam achebe"},{"sessionId":"11316","sessionTitle":"Consultative Hematology Course","firstName":"Jason ","lastName":"Gotlib ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T11:30:00Z","startTime":"10:10:00","endTime":"10:40:00","sessionLocation":"Int'l Blrm. A-D No. Twr. M2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Eosinophilia & Mastocytosis: The Other White Cells","keywords":"","combinedName":"doctor jason gotlib"},{"sessionId":"11316","sessionTitle":"Consultative Hematology Course","firstName":"Michael","lastName":"Linenberger","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T11:30:00Z","startTime":"08:40:00","endTime":"09:10:00","sessionLocation":"Int'l Blrm. A-D No. Twr. M2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Hematologic Manifestations of Rheumatologic Disease & Vice Versa","keywords":"","combinedName":"doctor michael linenberger"},{"sessionId":"11316","sessionTitle":"Consultative Hematology Course","firstName":"Maureen Okam","lastName":"Achebe ","credentials":"MD, MPH","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T11:30:00Z","startTime":"09:10:00","endTime":"09:25:00","sessionLocation":"Int'l Blrm. A-D No. Twr. M2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Panel Discussion I","keywords":"","combinedName":"doctor maureen okam achebe"},{"sessionId":"11316","sessionTitle":"Consultative Hematology Course","firstName":"Jason","lastName":"Gotlib","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T11:30:00Z","startTime":"11:10:00","endTime":"11:25:00","sessionLocation":"Int'l Blrm. A-D No. Twr. M2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Panel Discussion II","keywords":"","combinedName":"doctor jason gotlib"},{"sessionId":"11316","sessionTitle":"Consultative Hematology Course","firstName":"Julie ","lastName":"Kanter ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T11:30:00Z","startTime":"08:10:00","endTime":"08:40:00","sessionLocation":"Int'l Blrm. A-D No. Twr. M2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Sickle Cell Disease in Adults: What does the consultant hematologist need to know?","keywords":"","combinedName":"doctor julie kanter"},{"sessionId":"11316","sessionTitle":"Consultative Hematology Course","firstName":"Stephan ","lastName":"Moll ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T11:30:00Z","startTime":"10:40:00","endTime":"11:10:00","sessionLocation":"Int'l Blrm. A-D No. Twr. M2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Thrombosis in Unusual Places","keywords":"","combinedName":"doctor stephan moll"},{"sessionId":"11316","sessionTitle":"Consultative Hematology Course","firstName":"Paula ","lastName":"James","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T11:30:00Z","startTime":"09:40:00","endTime":"10:10:00","sessionLocation":"Int'l Blrm. A-D No. Twr. M2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"Uncommon Coagulopathies","keywords":"","combinedName":"doctor paula james"},{"sessionId":"11399","sessionTitle":"Best of ASH","firstName":"Andrew ","lastName":"Weyrich","credentials":"PhD","sessionStartTime":"2017-12-12T11:30:00Z","sessionEndTime":"2017-12-12T13:00:00Z","startTime":"11:30:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/12/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Best of ASH 1","keywords":"","combinedName":"doctor andrew weyrich"},{"sessionId":"11399","sessionTitle":"Best of ASH","firstName":"Scott ","lastName":"Armstrong","credentials":"MD, PhD","sessionStartTime":"2017-12-12T11:30:00Z","sessionEndTime":"2017-12-12T13:00:00Z","startTime":"11:30:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/12/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Best of ASH 2","keywords":"","combinedName":"doctor scott armstrong"},{"sessionId":"11475","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Disordered Erythropoiesis","firstName":"Laura ","lastName":"Quotti Tubi ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoietic-Specific CSNK2B Loss in Mice Causes Impaired Erythropoiesis","keywords":"","combinedName":"doctor laura quotti tubi"},{"sessionId":"11475","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Disordered Erythropoiesis","firstName":"Sarah ","lastName":"Ducamp ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hscb, a Mitochondrial Iron-Sulfur Cluster Assembly Co-Chaperone, Is a Novel Candidate Gene for Congenital Sideroblastic Anemia","keywords":"","combinedName":"doctor sarah ducamp"},{"sessionId":"11475","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Disordered Erythropoiesis","firstName":"Silvana ","lastName":"Di Giandomenico ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Megakaryocytic TGF1 Partitions Hematopoiesis into Amplifying Stem and Progenitor Cells and Maturing Effector Cells","keywords":"","combinedName":"doctor silvana di giandomenico"},{"sessionId":"11475","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Disordered Erythropoiesis","firstName":"Mark C","lastName":"Wilkes ","credentials":"","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nemo-like Kinase Hyper-Activated in Erythroid Progenitors in Models of Diamond Blackfan Anemia","keywords":"","combinedName":"doctor mark c wilkes"},{"sessionId":"11475","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Disordered Erythropoiesis","firstName":"Rami ","lastName":"Khoriaty ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overlap of SEC23A and SEC23B Function Suggests a Novel Therapeutic Approach for Congenital Dyserythropoietic Anemia Type II","keywords":"","combinedName":"doctor rami khoriaty"},{"sessionId":"11475","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Disordered Erythropoiesis","firstName":"Michaela ","lastName":"Fontenay ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ribosome Biogenesis Controls Erythroid Differentiation Via a p53-Dependent Transcriptional Checkpoint and Its Limitation By RPS14 Haploinsufficiency Results in Selective Defects in Translation","keywords":"","combinedName":"doctor michaela fontenay"},{"sessionId":"11476","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Normal Erythropoiesis","firstName":"Brian M","lastName":"Dulmovits ","credentials":"MS","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Pharmacologic Approach Using Pomalidomide and Dexamethasone to Study Stage-Specific Regulation of Erythroid Progenitors","keywords":"","combinedName":"doctor brian m dulmovits"},{"sessionId":"11476","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Normal Erythropoiesis","firstName":"Aishwarya ","lastName":"Swaminathan ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Deletion of Tet2 or Tet3 Transiently Dysregulate Murine Erythropoiesis","keywords":"","combinedName":"doctor aishwarya swaminathan"},{"sessionId":"11476","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Normal Erythropoiesis","firstName":"Jing ","lastName":"Liu ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deubiquitinase USP7 Regulates Erythroid Development Via Deubiquinating GATA1","keywords":"","combinedName":"doctor jing liu"},{"sessionId":"11476","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Normal Erythropoiesis","firstName":"Lucia ","lastName":"De Franceschi ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fyn Kinase Is Involved in EPO Receptor Signaling and Is Required to Harmonize the Response to Oxidation","keywords":"","combinedName":"doctor lucia de franceschi"},{"sessionId":"11476","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Normal Erythropoiesis","firstName":"Charu ","lastName":"Mehta ","credentials":"MS","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program","keywords":"","combinedName":"doctor charu mehta"},{"sessionId":"11476","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Normal Erythropoiesis","firstName":"Harry ","lastName":"Lesmana ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RGL2 Deficiency Impairs Human Erythropoiesis By Altering Terminal Erythroid Differentiation and Apoptosis","keywords":"","combinedName":"doctor harry lesmana"},{"sessionId":"11477","sessionTitle":"102. Regulation of Iron Metabolism: Iron homeostasis and related pathophysiology","firstName":"Helene ","lastName":"Coppin ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deletion of BMP6 Worsens the Phenotype of Hemojuvelin-Deficient Mice and Attenuates Hepcidin Levels Reached after LPS Stimulation","keywords":"","combinedName":"doctor helene coppin"},{"sessionId":"11477","sessionTitle":"102. Regulation of Iron Metabolism: Iron homeostasis and related pathophysiology","firstName":"Karin ","lastName":"Finberg ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NCOA4 Acts in Hepatocytes to Regulate Ferritin Subunit Levels and Hepatic Iron Storage","keywords":"","combinedName":"doctor karin finberg"},{"sessionId":"11477","sessionTitle":"102. Regulation of Iron Metabolism: Iron homeostasis and related pathophysiology","firstName":"Giorgia ","lastName":"Federico ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NCOA4 Links Iron Bioavailability to DNA Metabolism","keywords":"","combinedName":"doctor giorgia federico"},{"sessionId":"11477","sessionTitle":"102. Regulation of Iron Metabolism: Iron homeostasis and related pathophysiology","firstName":"Francesca ","lastName":"Vinchi ","credentials":"","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Red Blood Cell Transfusions Shape Macrophages Towards an Anti-Inflammatory Functional Phenotype and Impair the Immune Response to Infectious Cues","keywords":"","combinedName":"doctor francesca vinchi"},{"sessionId":"11477","sessionTitle":"102. Regulation of Iron Metabolism: Iron homeostasis and related pathophysiology","firstName":"Antonella ","lastName":"Nai ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:15:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Macrophage Nuclear Receptor Coactivator 4 Counteracts Iron-Deficiency Anemia","keywords":"","combinedName":"doctor antonella nai"},{"sessionId":"11477","sessionTitle":"102. Regulation of Iron Metabolism: Iron homeostasis and related pathophysiology","firstName":"Xiuqi ","lastName":"Li ","credentials":"BS","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Tmprss6-/- Mouse Model of Iron Refractory Iron Deficiency Anemia (IRIDA) Exhibits Disrupted Phosphate Homeostasis, Elevated Circulating FGF23 Levels, and Increased Fgf23 Expression in Bone Marrow","keywords":"","combinedName":"doctor xiuqi li"},{"sessionId":"11478","sessionTitle":"102. Regulation of Iron Metabolism: Iron and erythropoiesis","firstName":"Barbora ","lastName":"Kralova ","credentials":"MSc","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:15:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of Iron Metabolism in Mouse Model of Congenital Polycythemia with Human Gain-of-Function Erythropoietin Receptor","keywords":"","combinedName":"doctor barbora kralova"},{"sessionId":"11478","sessionTitle":"102. Regulation of Iron Metabolism: Iron and erythropoiesis","firstName":"Kei ","lastName":"Saito ","credentials":"","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"14:45:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Establishment and Characterization of in Vitro Model of X-Linked Sideroblastic Anemia","keywords":"","combinedName":"doctor kei saito"},{"sessionId":"11478","sessionTitle":"102. Regulation of Iron Metabolism: Iron and erythropoiesis","firstName":"Amin ","lastName":"Sobh ","credentials":"","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:15:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genome-Wide CRISPR/Cas9-Mediated Loss-of-Function Screening in Human Erythroleukemic Cells Identifies Novel Cellular Components Involved in Iron and Heme Trafficking","keywords":"","combinedName":"doctor amin sobh"},{"sessionId":"11478","sessionTitle":"102. Regulation of Iron Metabolism: Iron and erythropoiesis","firstName":"Daniel ","lastName":"Moskop ","credentials":"","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Influential Role of Macrophages in Hepcidin Regulation in Apo-Transferrin Treated -Thalassemic Mice","keywords":"","combinedName":"doctor daniel moskop"},{"sessionId":"11478","sessionTitle":"102. Regulation of Iron Metabolism: Iron and erythropoiesis","firstName":"Nermi ","lastName":"Parrow ","credentials":"PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Iron Binding to Specific Lobes of Transferrin Differentially Affects Erythropoiesis and Hepcidin Signaling","keywords":"","combinedName":"doctor nermi parrow"},{"sessionId":"11478","sessionTitle":"102. Regulation of Iron Metabolism: Iron and erythropoiesis","firstName":"Laura","lastName":"Silvestri","credentials":"PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transient Reduction of Transferrin Saturation Contributes to Hepcidin Inhibition Independently of Erfe in Mice Treated with Erythropoietin","keywords":"","combinedName":"doctor laura silvestri"},{"sessionId":"11479","sessionTitle":"112. Thalassemia and Globin Gene Regulation I","firstName":"Tasha ","lastName":"Morrison ","credentials":"MPH,BA","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Long Noncoding RNA from the HBS1L-MYB Intergenic Region on Chr6q23 Regulates Human Fetal Hemoglobin Expression","keywords":"","combinedName":"doctor tasha morrison"},{"sessionId":"11479","sessionTitle":"112. Thalassemia and Globin Gene Regulation I","firstName":"Ante ","lastName":"Lundberg ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CRISPR/Cas9 Genome Editing to Treat Sickle Cell Disease and B-Thalassemia: Re-Creating Genetic Variants to Upregulate Fetal Hemoglobin Appear Well-Tolerated, Effective and Durable. ","keywords":"","combinedName":"doctor ante lundberg"},{"sessionId":"11479","sessionTitle":"112. Thalassemia and Globin Gene Regulation I","firstName":"Nan ","lastName":"Liu ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fetal Hemoglobin (HbF) Silencer BCL11A Acts through a Novel DNA-Motif in the Gamma-Globin Promoters, Simplifying the Model for Hemoglobin Switching","keywords":"","combinedName":"doctor nan liu"},{"sessionId":"11479","sessionTitle":"112. Thalassemia and Globin Gene Regulation I","firstName":"Falak ","lastName":"Sher ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Resolution CRISPR Functional Genomics Reveals Critical Vulnerabilities of the NuRD Complex for Fetal Hemoglobin Control","keywords":"","combinedName":"doctor falak sher"},{"sessionId":"11479","sessionTitle":"112. Thalassemia and Globin Gene Regulation I","firstName":"Yan ","lastName":"Dai ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"SIRT1 Increases the Expression of Fetal Hemoglobin Genes in Human Adult and Cord Blood Erythroblasts","keywords":"","combinedName":"doctor yan dai"},{"sessionId":"11479","sessionTitle":"112. Thalassemia and Globin Gene Regulation I","firstName":"Christophe ","lastName":"Lechauve ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ulk1 Kinase Mediates Clearance of Free a-Globin in -Thalassemia","keywords":"","combinedName":"doctor christophe lechauve"},{"sessionId":"11480","sessionTitle":"112. Thalassemia and Globin Gene Regulation II","firstName":"Janet ","lastName":"Kwiatkowski","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Outcomes up to 3 Years Following Lentiglobin Gene Therapy for Transfusion-Dependent -Thalassemia in the Northstar Hgb-204 Study","keywords":"","combinedName":"doctor janet kwiatkowski"},{"sessionId":"11480","sessionTitle":"112. Thalassemia and Globin Gene Regulation II","firstName":"Sarah ","lastName":"Marktel ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gene Therapy for Beta Thalassemia: Preliminary Results from the PHASE I/II Tiget-Bthal Trial of Autologous HematopoieticStem CellsGenetically Modified with GLOBE Lentiviral Vector","keywords":"","combinedName":"doctor sarah marktel"},{"sessionId":"11480","sessionTitle":"112. Thalassemia and Globin Gene Regulation II","firstName":"Serge ","lastName":"Pissard ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lesional Mechanism of Alpha Thalassemias: Towards a Common Mechanism Alpha Thal / Beta Thal","keywords":"","combinedName":"doctor serge pissard"},{"sessionId":"11480","sessionTitle":"112. Thalassemia and Globin Gene Regulation II","firstName":"Vivien","lastName":"Sheehan","credentials":"MD, PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Metformin Induction of Fetal Hemoglobin","keywords":"","combinedName":"doctor vivien sheehan"},{"sessionId":"11480","sessionTitle":"112. Thalassemia and Globin Gene Regulation II","firstName":"Donald ","lastName":"Lavelle ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Oral Administration of the LSD1 Inhibitor OG-S1335 Increases Fetal Hemoglobin in Humanized Transgenic Sickle Cell Disease Mice and in Baboons","keywords":"","combinedName":"doctor donald lavelle"},{"sessionId":"11480","sessionTitle":"112. Thalassemia and Globin Gene Regulation II","firstName":"Qiaochuan ","lastName":"Li ","credentials":"","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unrelated Donor Peripheral Blood Stem Cell Transplantation for Thalassaemia: A Single Institution Experience of 53 Patients","keywords":"","combinedName":"doctor qiaochuan li"},{"sessionId":"11481","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Sickle Cell DiseaseHematopoiesis and Fetal Hemoglobin Augmentation","firstName":"Abhijit ","lastName":"Ravindran ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clot Formation Under Physiological Flow Conditions Is Altered in Sickle Cell Disease As Measured By a Multiparameter Microfluidic System","keywords":"","combinedName":"doctor abhijit ravindran"},{"sessionId":"11481","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Sickle Cell DiseaseHematopoiesis and Fetal Hemoglobin Augmentation","firstName":"Vionnie ","lastName":"Yu ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CRISPR/Cas9 Gene-Edited Hematopoietic Stem Cell Therapy for Sickle Cell Disease","keywords":"","combinedName":"doctor vionnie yu"},{"sessionId":"11481","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Sickle Cell DiseaseHematopoiesis and Fetal Hemoglobin Augmentation","firstName":"Jeremy ","lastName":"Grevet ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Domain-Focused CRISPR-Cas9 Screen Identifies Hri Kinase As a Regulator of Fetal Hemoglobin in Adult Human Erythroid Cells","keywords":"","combinedName":"doctor jeremy grevet"},{"sessionId":"11481","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Sickle Cell DiseaseHematopoiesis and Fetal Hemoglobin Augmentation","firstName":"Tolulope O","lastName":"Rosanwo ","credentials":"BA","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enucleation and Beta-Globin Expression in Induced Red Blood Cells: A Platform to Model Sickle Cell Anemia","keywords":"","combinedName":"doctor tolulope o rosanwo"},{"sessionId":"11481","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Sickle Cell DiseaseHematopoiesis and Fetal Hemoglobin Augmentation","firstName":"Elayne ","lastName":"Chan-Penebre ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reawakening of Human Fetal Hemoglobin and an Epigenetic Path to the Clinic for Sickle Cell Disease and Beta-Thalassemia: Identification of an Orally-Available, Potent, and Selective Euchromatic Histone Lysine Methyltransferase 1 and 2 (EHMT1/2) Inhibitor","keywords":"","combinedName":"doctor elayne chan-penebre"},{"sessionId":"11481","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Sickle Cell DiseaseHematopoiesis and Fetal Hemoglobin Augmentation","firstName":"Hanan ","lastName":"Chweih ","credentials":"BSc","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role for Platelets in Mediating Neutrophil Recruitment in TNF-a Induced Vaso-Occlusive Processes in Animals with Sickle Cell Anemia","keywords":"","combinedName":"doctor hanan chweih"},{"sessionId":"11482","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Sickle Cell DiseasePathophysiology and Investigational Therapies","firstName":"Melinda ","lastName":"Wu","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Apocynin Improves Functional Microvascular Blood Flow in Sickle Cell Disease during Contractile Exercise","keywords":"","combinedName":"doctor melinda wu"},{"sessionId":"11482","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Sickle Cell DiseasePathophysiology and Investigational Therapies","firstName":"Huy ","lastName":"Tran ","credentials":"BSMedTech","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Critical Role of Protein Arginine Deiminase 4 in Mast Cell Extracellular Trap Formation Leading to Neuropathic Pain in Sickle Mice","keywords":"","combinedName":"doctor huy tran"},{"sessionId":"11482","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Sickle Cell DiseasePathophysiology and Investigational Therapies","firstName":"Samit ","lastName":"Ghosh ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enhanced Renal Clearance of Heme Triggers Acute Kidney Injury in Sickle Cell Disease","keywords":"","combinedName":"doctor samit ghosh"},{"sessionId":"11482","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Sickle Cell DiseasePathophysiology and Investigational Therapies","firstName":"Chao ","lastName":"Fang ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of Protein Disulfide Isomerase Ameliorates Vaso-Occlusion and Thrombosis in a Mouse Model of Sickle Cell Disease","keywords":"","combinedName":"doctor chao fang"},{"sessionId":"11482","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Sickle Cell DiseasePathophysiology and Investigational Therapies","firstName":"Parul ","lastName":"Rai ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Uncoupling Sickle Hematopoiesis Induced Angiotensin Receptor Signaling in Sickle Nephropathy","keywords":"","combinedName":"doctor parul rai"},{"sessionId":"11482","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Sickle Cell DiseasePathophysiology and Investigational Therapies","firstName":"Julia ","lastName":"Brittain ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Vitamin D Repletion Mitigates Oxidative Stress Induced Pulmonary Artery Remodeling in Sickle Cell Disease","keywords":"","combinedName":"doctor julia brittain"},{"sessionId":"11483","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical I","firstName":"Melanie E","lastName":"Fields ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cerebral Metabolic Stress Is Lower in Patients with Sickle Cell Anemia on Hydroxyurea Therapy","keywords":"","combinedName":"doctor melanie e fields"},{"sessionId":"11483","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical I","firstName":"Julie ","lastName":"Kanter ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Crizanlizumab 5.0 Mg/Kg Increased the Time to First on-Treatment Sickle Cell Pain Crisis: A Subgroup Analysis of the Phase II Sustain Study","keywords":"","combinedName":"doctor julie kanter"},{"sessionId":"11483","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical I","firstName":"Francoise ","lastName":"Bernaudin ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Health-Related Quality of Life at 1 Year in the Drepagreffe Trial Comparing Chronic Transfusion to Transplantation in Children with Sickle Cell Anemia and a History of Abnormal Cerebral Velocities","keywords":"","combinedName":"doctor francoise bernaudin"},{"sessionId":"11483","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical I","firstName":"Jodi-Anne T","lastName":"Stewart ","credentials":"BS","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:45:00","endTime":"12:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Children with Sickle Cell Anemia, Low Baseline BMI Is Associated with a Longitudinal Decline in FEV1 % Predicted","keywords":"","combinedName":"doctor jodi-anne t stewart"},{"sessionId":"11483","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical I","firstName":"Samuel A","lastName":"Oppong ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multi-Disciplinary Obstetrics and Sickle Cell Disease Clinic in Low Resource Setting Lowers Maternal and Perinatal Death Rates to the Same Levels As Those without Sickle Cell Disease","keywords":"","combinedName":"doctor samuel a oppong"},{"sessionId":"11483","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical I","firstName":"Patrick ","lastName":"McGann ","credentials":"MD, MS","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:15:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Personalized Hydroxyurea Dosing to Reduce Time to MTD and Optimize the HbF Response: Results from the TREAT Study","keywords":"","combinedName":"doctor patrick mcgann"},{"sessionId":"11484","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical II","firstName":"Takuto ","lastName":"Takahashi ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Chest Syndrome Among Hospitalized Children with Vaso-Occlusive Crisis: A Nationwide Study in the United States","keywords":"","combinedName":"doctor takuto takahashi"},{"sessionId":"11484","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical II","firstName":"Mengtian ","lastName":"Du ","credentials":"BA","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biomarker Signatures of Sickle Cell Disease Severity","keywords":"","combinedName":"doctor mengtian du"},{"sessionId":"11484","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical II","firstName":"Santosh ","lastName":"Saraf ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HMOX1 and Acute Kidney Injury in Sickle Cell Anemia","keywords":"","combinedName":"doctor santosh saraf"},{"sessionId":"11484","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical II","firstName":"Carolyn C","lastName":"Hoppe ","credentials":"MD ","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Initial Results from a Cohort in a Phase 2a Study (GBT440-007) Evaluating Adolescents with Sickle Cell Disease Treated with Multiple Doses of GBT440, a HbS Polymerization Inhibitor","keywords":"","combinedName":"doctor carolyn c hoppe"},{"sessionId":"11484","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical II","firstName":"Yutaka ","lastName":"Niihara ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 3 Study of L-Glutamine in Sickle Cell Disease: Analyses of Time to First and Second Crisis and Average Cumulative Recurrent Events","keywords":"","combinedName":"doctor yutaka niihara"},{"sessionId":"11484","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical II","firstName":"Valentine ","lastName":"Brousse ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:30:00","endTime":"15:45:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The First Two Years of Life in Sickle Cell Anemia Infants: Results of a Comprehensive Longitudinal Study ","keywords":"","combinedName":"doctor valentine brousse"},{"sessionId":"11485","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical III","firstName":"Winfred ","lastName":"Wang ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effects of Hydroxyurea (HU) on Neurocognitive Performance in Children with Sickle Cell Disease: A Prospective Trial","keywords":"","combinedName":"doctor winfred wang"},{"sessionId":"11485","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical III","firstName":"Andria L","lastName":"Ford ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased Volume and Distinct Pattern of Silent Cerebral Infarcts in Healthy, Young Adults with Sickle Cell Trait","keywords":"","combinedName":"doctor andria l ford"},{"sessionId":"11485","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical III","firstName":"Marthe-Sandrine ","lastName":"Eiymo Mwa Mpollo ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Methacholine Challenge Test Reveals a High Prevalence of Subclinical Severe Airway Hyper-Reactivity in Children and Yound Adults with Sickle Cell Disease Which Correlates with Higher Sickle Acute Events and Acute Chest","keywords":"","combinedName":"doctor marthe-sandrine eiymo mwa mpollo"},{"sessionId":"11485","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical III","firstName":"Russell ","lastName":"Ware ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Use of Hydroxyurea in an African Region with Malaria (NOHARM): A Randomized Controlled Trial","keywords":"","combinedName":"doctor russell ware"},{"sessionId":"11485","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical III","firstName":"Mariane ","lastName":"De Montalembert ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Off-Label Prescription of Hydroxycarbamide (Hydroxyurea, HU) for Severe Anemia: Preliminary Results from European Non-Interventional, Multicentric, Prospective Escort-HU Study","keywords":"","combinedName":"doctor mariane de montalembert"},{"sessionId":"11485","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical III","firstName":"Luke ","lastName":"Smart ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Simultaneous Point-of-Care Detection of Anemia and Sickle Cell Disease in Tanzania: The RAPID Study","keywords":"","combinedName":"doctor luke smart"},{"sessionId":"11486","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: SCN","firstName":"Benjamin ","lastName":"Dannenmann ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BAALC Is a Key Mediator of Leukemia Development in Congenital Neutropenia","keywords":"","combinedName":"doctor benjamin dannenmann"},{"sessionId":"11486","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: SCN","firstName":"Ivo ","lastName":"Touw ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combinatorial CSF3R and RUNX1 Mutations Involved in the Leukemic Progression of Severe Congenital Neutropenia Confer a G-CSF-Dependent Premalignant State in Mice","keywords":"","combinedName":"doctor ivo touw"},{"sessionId":"11486","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: SCN","firstName":"Masoud ","lastName":"Nasri ","credentials":"MSc","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Establishment of the Safe and Efficient CRISPR/Cas9-RNP Based Gene-Correction Platform of ELANEMutations in iPSCs of Severe Congenital Neutropenia (CN) Patients with No Response to G-CSF and High Risk to Develop Leukemia","keywords":"","combinedName":"doctor masoud nasri"},{"sessionId":"11486","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: SCN","firstName":"Jean ","lastName":"Donadieu ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoietic Stem Cell Transplantation May Lower the Risk of Leukemia in ELANE Neutropenia: Historical Trends from a French Severe Chronic Neutropenia Registry (FSCNR) Cohort","keywords":"","combinedName":"doctor jean donadieu"},{"sessionId":"11486","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: SCN","firstName":"David ","lastName":"Muench ","credentials":"BS","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Severe Congenital Neutropenia-Associated Mutations Reveal Stage-Specific Gfi1-Dependent Checkpoints in Myeloid Development","keywords":"","combinedName":"doctor david muench"},{"sessionId":"11486","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: SCN","firstName":"Vahagn ","lastName":"Makaryan ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Effect of the MK0339 Neutrophil Elastase Inhibitor on Proliferation and Maturation of iPSC Derived from Patients with ELANE, TCIRG1 and Whim Syndrome Associated Neutropenia","keywords":"","combinedName":"doctor vahagn makaryan"},{"sessionId":"11487","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages I","firstName":"Perihan ","lastName":"Mir ","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Abrogated GADD45b-Mediated Integrity Control of Hematopoietic Stem Cells upon ER Stress and DNA Damage Triggers Lymphopoiesis over Granulopoiesis in Congenital Neutropenia","keywords":"","combinedName":"doctor perihan mir"},{"sessionId":"11487","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages I","firstName":"Eman ","lastName":"Khatib-Massalha ","credentials":"MSc","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lactate Release By Bone Marrow Neutrophils Promotes Their Inflammatory Mobilization Via Endothelial GPR81 Signaling","keywords":"","combinedName":"doctor eman khatib-massalha"},{"sessionId":"11487","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages I","firstName":"Heather ","lastName":"Lau ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Hematologic Response to Oral Eliglustat in Treatment-Naive Patients with Gaucher Disease Type 1: Final Results from a Phase 2 and the Phase 3 Engage Trials","keywords":"","combinedName":"doctor heather lau"},{"sessionId":"11487","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages I","firstName":"Asumi ","lastName":"Yokota ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Monotcytes/Macrophages Are Involved in Erythrocytosis Caused By Both EPO-Dependent and -Independent Activation of EPOR","keywords":"","combinedName":"doctor asumi yokota"},{"sessionId":"11487","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages I","firstName":"Laura ","lastName":"Strauss ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PD-1 Mediates Lineage Fate Determination and Function of Myeloid Cells in Response to Tumor-Mediated Emergency Myelopoiesis","keywords":"","combinedName":"doctor laura strauss"},{"sessionId":"11487","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages I","firstName":"Boris ","lastName":"Tchernychev ","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Clinical-Stage sGC Stimulator IW-1701 Prevents Increase of Plasma Biomarkers of Intravascular Inflammation and Suppresses Leukocyte-Endothelial Interactions in Tnfa-Treated Mice","keywords":"","combinedName":"doctor boris tchernychev"},{"sessionId":"11488","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: T cell biology and therapies","firstName":"Nadia ","lastName":"Tchao ","credentials":"","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Amg592 Is an Investigational IL-2 Mutein That Induces Highly Selective Expansion of Regulatory T Cells","keywords":"","combinedName":"doctor nadia tchao"},{"sessionId":"11488","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: T cell biology and therapies","firstName":"Amlie ","lastName":"Montel-Hagen ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vitro Generation of Human Pluripotent Stem Cell-Derived T Cells for Immunotherapy","keywords":"","combinedName":"doctor amlie montel-hagen"},{"sessionId":"11488","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: T cell biology and therapies","firstName":"Lucrezia ","lastName":"Colonna ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:30:00","endTime":"15:45:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Modeling and Understanding the Biology of Transplant-Mediated HIV Cure in a Non-Human Primate Model","keywords":"","combinedName":"doctor lucrezia colonna"},{"sessionId":"11488","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: T cell biology and therapies","firstName":"Paul ","lastName":"Frohna ","credentials":"MD, PhD, PharmD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from a First-in-Human Study with Bnz-1: A Novel Peptide Inhibitor of IL-2, IL-9 and IL-15 for the Treatment of T-Cell Malignancies That Safely and Selectively Decreases Regulatory T-Cells, Natural Killer Cells, and CD8+ Central Memory T-Cells","keywords":"","combinedName":"doctor paul frohna"},{"sessionId":"11488","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: T cell biology and therapies","firstName":"Julie M","lastName":"Glanville ","credentials":"","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TCR-Identical CD8+ T-Cells Can Have Distinct Killing Efficacy Determined By Events Beyond the T-Cell Receptor","keywords":"","combinedName":"doctor julie m glanville"},{"sessionId":"11488","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: T cell biology and therapies","firstName":"Simon ","lastName":"Heidegger ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tumor-Intrinsic RIG-I Signaling Promotes Anti-CTLA-4 Checkpoint Inhibitor-Mediated Anticancer Immunity","keywords":"","combinedName":"doctor simon heidegger"},{"sessionId":"11489","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: B cells and Innate Immunity","firstName":"Jeffrey J","lastName":"Bednarski ","credentials":"MD, PhD ","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Spic/BCLAF1 Complex Suppresses Pre-B Cell Receptor Signaling in Response to RAG-Mediated DNA Breaks","keywords":"","combinedName":"doctor jeffrey j bednarski"},{"sessionId":"11489","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: B cells and Innate Immunity","firstName":"Michal ","lastName":"Sheffer ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification and Validation of Molecular Markers of Tumor Cell Resistance to Natural Killer Cells through CRISPR-Based Screens and Large-Scale Phenotypic Screens of Pooled Tumor Cell Lines","keywords":"","combinedName":"doctor michal sheffer"},{"sessionId":"11489","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: B cells and Innate Immunity","firstName":"Christopher ","lastName":"Seet ","credentials":"","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:45:00","endTime":"12:00:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Notch Signaling Promotes the Differentiation of Human CLEC9A+ Dendritic Cells from Hematopoietic Stem and Progenitor Cells","keywords":"","combinedName":"doctor christopher seet"},{"sessionId":"11489","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: B cells and Innate Immunity","firstName":"Mei ","lastName":"Yu ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phospholipase Cgamma Pathway-Dependent mTOR Signaling Controls IL-7-Mediated Early B Cell Development","keywords":"","combinedName":"doctor mei yu"},{"sessionId":"11489","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: B cells and Innate Immunity","firstName":"Konstantinos ","lastName":"Xanthopoulos ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:15:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Deubiquitinase Activity of CYLD Is Required for Maturation of B Cells","keywords":"","combinedName":"doctor konstantinos xanthopoulos"},{"sessionId":"11489","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: B cells and Innate Immunity","firstName":"Richard ","lastName":"James ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Using Multiplexed Genome Editing to Distinguish between Loss- and Gain-of-Function Variants in CARD11","keywords":"","combinedName":"doctor richard james"},{"sessionId":"11490","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Platelet Adhesion, Activation, and Biochemistry","firstName":"Xu ","lastName":"Han ","credentials":"BS, MS","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of a Naturally Occurring PAR4 Variant By Hydrogen/Deuterium Exchange Reveals Its Structural Rearrangement upon Activation By Thrombin and the Molecular Basis for Altered Reactivity","keywords":"","combinedName":"doctor xu han"},{"sessionId":"11490","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Platelet Adhesion, Activation, and Biochemistry","firstName":"Pravin ","lastName":"Patel ","credentials":"BA","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Apoptosis Signal-Regulating Kinase 1 (ASK1) Is a Novel Regulator of Heparin-Induced Thrombocytopenia and Thrombosis in Mice","keywords":"","combinedName":"doctor pravin patel"},{"sessionId":"11490","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Platelet Adhesion, Activation, and Biochemistry","firstName":"Alessandro ","lastName":"Zarpellon ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Expression of Functional Human Proteinase Activated Receptor (PAR)-1 on Mouse Platelets","keywords":"","combinedName":"doctor alessandro zarpellon"},{"sessionId":"11490","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Platelet Adhesion, Activation, and Biochemistry","firstName":"Jesse W","lastName":"Rowley ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mitochondrial Fission Protein Drp1 Regulates Megakaryocyte and Platelet Mitochondrial Morphology, Platelet Numbers, and Platelet Function","keywords":"","combinedName":"doctor jesse w rowley"},{"sessionId":"11490","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Platelet Adhesion, Activation, and Biochemistry","firstName":"Chad ","lastName":"Skaer ","credentials":"BA","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Cyclophilin D-Dependent Events Limit Venous Thrombotic Occlusion and Platelet Accretion","keywords":"","combinedName":"doctor chad skaer"},{"sessionId":"11490","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Platelet Adhesion, Activation, and Biochemistry","firstName":"Jesse W","lastName":"Rowley ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcript Expression, Intron Retention, and RNA Editing Are Conserved in Human Platelets over a 4 Year Period","keywords":"","combinedName":"doctor jesse w rowley"},{"sessionId":"11491","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Vascular Wall Biology and Endothelial Cells","firstName":"Barry ","lastName":"Coller ","credentials":"MD ","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of a Pure Small Molecule aV3 Antagonist","keywords":"","combinedName":"doctor barry coller"},{"sessionId":"11491","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Vascular Wall Biology and Endothelial Cells","firstName":"Yunfeng ","lastName":"Chen ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of a VWFA1 Mutation Attenuating Thrombus Growth but Not Platelet Adhesion","keywords":"","combinedName":"doctor yunfeng chen"},{"sessionId":"11491","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Vascular Wall Biology and Endothelial Cells","firstName":"Meghna Ulhas","lastName":"Naik ","credentials":"MS","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Junctional Adhesion Molecule-a, Suppresses Integrinav3 Activation to Control Neovascularization","keywords":"","combinedName":"doctor meghna ulhas naik"},{"sessionId":"11491","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Vascular Wall Biology and Endothelial Cells","firstName":"Rohan ","lastName":"Varshney ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mice Lacking Platelet TGF-1 Are Protected from Aortic Stenosis Progression","keywords":"","combinedName":"doctor rohan varshney"},{"sessionId":"11491","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Vascular Wall Biology and Endothelial Cells","firstName":"Alexander ","lastName":"Leatherdale ","credentials":"BA","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multimerin-1 Binds to Specific Motifs in Vessel Wall Collagens and Contributes to Thrombosis: Novel Insights Regarding the Mechanisms That Support Human and Mouse Platelet Adhesion","keywords":"","combinedName":"doctor alexander leatherdale"},{"sessionId":"11491","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Vascular Wall Biology and Endothelial Cells","firstName":"Jieqing ","lastName":"Zhu ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Structure of an Extended 3 Integrin","keywords":"","combinedName":"doctor jieqing zhu"},{"sessionId":"11492","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: clinical aspects","firstName":"Wojciech ","lastName":"Jurczak ","credentials":"PhD,MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Avatrombopag, a Novel Oral Thrombopoietin Receptor Agonist, Demonstrates Superiority to Placebo for the Treatment of Chronic Immune Thrombocytopenic Purpura in a Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial","keywords":"","combinedName":"doctor wojciech jurczak"},{"sessionId":"11492","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: clinical aspects","firstName":"Michael ","lastName":"Tarantino ","credentials":"","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)","keywords":"","combinedName":"doctor michael tarantino"},{"sessionId":"11492","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: clinical aspects","firstName":"James ","lastName":"Bussel ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results","keywords":"","combinedName":"doctor james bussel"},{"sessionId":"11492","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: clinical aspects","firstName":"Tadeusz ","lastName":"Robak ","credentials":"","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II, Multiple-Dose Study of Anti-FcRn Antibody, Rozanolixizumab (UCB7665), in Patients with Primary Immune Thrombocytopenia: Interim Analysis","keywords":"","combinedName":"doctor tadeusz robak"},{"sessionId":"11492","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: clinical aspects","firstName":"Miaomiao ","lastName":"Wang ","credentials":"","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recombinant Human Thrombopoietin (rhTPO) and High-Dose Dexamethasone (HD-DXM) Versus High-Dose Dexamethasone Monotherapy As Frontline Treatment in Newly Diagnosed Adult Immune Thrombocytopenia (ITP):a Prospective, Multicentre, Randomised, Controlled Trial","keywords":"","combinedName":"doctor miaomiao wang"},{"sessionId":"11492","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: clinical aspects","firstName":"Norah ","lastName":"Terrault ","credentials":"MD, MPH","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Superiority of Avatrombopag to Placebo in Increasing Platelet Counts in Patients with Chronic Liver Disease-Associated Thrombocytopenia Undergoing Scheduled Procedures: Results from 2, Phase 3 Randomized Studies","keywords":"","combinedName":"doctor norah terrault"},{"sessionId":"11493","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: pathophysiologic considerations","firstName":"Yuan ","lastName":"Kong ","credentials":"","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Atorvastatin May Reverse Corticosteroid-Resistant Immune Thrombocytopenia Via Improving Impaired Bone Marrow Endothelial Cells","keywords":"","combinedName":"doctor yuan kong"},{"sessionId":"11493","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: pathophysiologic considerations","firstName":"Anthony ","lastName":"Shock ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:15:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Blockade of the Neonatal Fc Receptor (FcRn) Represents an Effective Mechanism for the Removal of Pathogenic Autoantibodies in Primary Immune Thrombocytopenia","keywords":"","combinedName":"doctor anthony shock"},{"sessionId":"11493","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: pathophysiologic considerations","firstName":"Alan H","lastName":"Lazarus ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Erythrocyte-Specific Antibodies As a Potential New Therapeutic Modality in Autoimmune and Inflammatory Disorders Beyond Immune Thrombocytopenia (ITP)","keywords":"","combinedName":"doctor alan h lazarus"},{"sessionId":"11493","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: pathophysiologic considerations","firstName":"Panpan ","lastName":"Han ","credentials":"","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low-Dose Decitabine Restores Immune Tolerance in ITP By Modulating Regulatory T Cells","keywords":"","combinedName":"doctor panpan han"},{"sessionId":"11493","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: pathophysiologic considerations","firstName":"Jade ","lastName":"Sullivan ","credentials":"BSc","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Maternal Anti-aIIb Antibodies Target Fetal Hematopoietic Stem Cells and May Lead to Pancytopenia and Miscarriage in Fnait","keywords":"","combinedName":"doctor jade sullivan"},{"sessionId":"11493","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: pathophysiologic considerations","firstName":"Shixuan ","lastName":"Wang Jr.","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduced PTEN Involved in Primary Immune Thrombocytopenia Via Contributing to B Cell Hyper-Responsiveness","keywords":"","combinedName":"doctor shixuan wang jr "},{"sessionId":"11494","sessionTitle":"311. Disorders of Platelet Number or Function: Thrombosis in the setting of thrombocytopenia","firstName":"Pavel","lastName":"Davizon-Castillo","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aging-Associated Inflammation Due to Elevated Levels of TNF-a Increases Activation of the Integrin aIIb3 and the Procoagulant Potential of Platelets","keywords":"","combinedName":"doctor pavel davizon-castillo"},{"sessionId":"11494","sessionTitle":"311. Disorders of Platelet Number or Function: Thrombosis in the setting of thrombocytopenia","firstName":"Andrew L","lastName":"Frelinger III","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Avatrombopag, a Novel Thrombopoietin Receptor Agonist, Increases Platelet Counts without Increasing Platelet Activation in Patients with Thrombocytopenia Due to Chronic Liver Disease","keywords":"","combinedName":"doctor andrew l frelinger iii"},{"sessionId":"11494","sessionTitle":"311. Disorders of Platelet Number or Function: Thrombosis in the setting of thrombocytopenia","firstName":"Liang ","lastName":"Zheng ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lysine-Histone Triggers Thrombotic Thrombocytopenic Purpura in Zebrafish and Mice","keywords":"","combinedName":"doctor liang zheng"},{"sessionId":"11494","sessionTitle":"311. Disorders of Platelet Number or Function: Thrombosis in the setting of thrombocytopenia","firstName":"Nezam ","lastName":"Afdhal ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Response to Lusutrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease and Thrombocytopenia Undergoing Non-Emergency Invasive Procedures: Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Study","keywords":"","combinedName":"doctor nezam afdhal"},{"sessionId":"11494","sessionTitle":"311. Disorders of Platelet Number or Function: Thrombosis in the setting of thrombocytopenia","firstName":"Gerald ","lastName":"Soff ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial","keywords":"","combinedName":"doctor gerald soff"},{"sessionId":"11494","sessionTitle":"311. Disorders of Platelet Number or Function: Thrombosis in the setting of thrombocytopenia","firstName":"Angela ","lastName":"Huynh ","credentials":"BSc","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Identification of the Amino Acids on Platelet Factor 4 That Bind Pathogenic Antibodies in Heparin-Induced Thrombocytopenia","keywords":"","combinedName":"doctor angela huynh"},{"sessionId":"11495","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor VIII, Factor X, and Factor V","firstName":"Lacramioara ","lastName":"Ivanciu ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differential Role of Plasma and Platelet-Derived Factor V In Vivo","keywords":"","combinedName":"doctor lacramioara ivanciu"},{"sessionId":"11495","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor VIII, Factor X, and Factor V","firstName":"Karen L","lastName":"Zimowski ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factor V Atlanta: A Novel Mutation in the F5 Gene Reveals Potential New Cis-Acting Elements Involved in Regulating FV-Short and TFPI Levels","keywords":"","combinedName":"doctor karen l zimowski"},{"sessionId":"11495","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor VIII, Factor X, and Factor V","firstName":"Roland W","lastName":"Herzog ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lettuce Plants Expressing High Levels of Factor VIII Antigen in the Chloroplast for Oral Tolerance in Hemophilia a","keywords":"","combinedName":"doctor roland w herzog"},{"sessionId":"11495","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor VIII, Factor X, and Factor V","firstName":"Mark ","lastName":"Schreuder ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phe174-Mutated Human Factor X As Bypassing Agent to the Direct FXa Inhibitors","keywords":"","combinedName":"doctor mark schreuder"},{"sessionId":"11495","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor VIII, Factor X, and Factor V","firstName":"Randal Joseph","lastName":"Westrick ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet FV Deficiency Restores Survival of TFPI Null Mice Independently of Plasma FV","keywords":"","combinedName":"doctor randal joseph westrick"},{"sessionId":"11495","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor VIII, Factor X, and Factor V","firstName":"M. ","lastName":"Almeida-Porada ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prenatal Transplantation of Placental Cells Engineered to Express FVIII Leads to Corrective Plasma Levels of FVIII after Birth","keywords":"","combinedName":"doctor m almeida-porada"},{"sessionId":"11496","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor IX, FXII, FXIII, ADAMTS13, TFPI, and vWF","firstName":"Thomas James","lastName":"Girard ","credentials":"","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Re-Evaluation of Murine TFPI and Comparison to TFPI in Man: Murine Plasma TFPI Is Derived from TFPI?","keywords":"","combinedName":"doctor thomas james girard"},{"sessionId":"11496","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor IX, FXII, FXIII, ADAMTS13, TFPI, and vWF","firstName":"Tina M","lastName":"Misenheimer ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Activated Factor IX As a Candidate for the Initial Protease in the Coagulation Cascade","keywords":"","combinedName":"doctor tina m misenheimer"},{"sessionId":"11496","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor IX, FXII, FXIII, ADAMTS13, TFPI, and vWF","firstName":"Philip M","lastName":"Zakas ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ancestral Sequence Reconstruction of Von Willebrand Factor Reveals Highly Conserved Structure/Function","keywords":"","combinedName":"doctor philip m zakas"},{"sessionId":"11496","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor IX, FXII, FXIII, ADAMTS13, TFPI, and vWF","firstName":"Catherine ","lastName":"Zander ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hydrogen-Deuterium Exchange Plus Mass Spectrometry (HX-MS) Reveals a Novel Mechanism Underlying the pH-Dependent Regulation of ADAMTS13 Activity","keywords":"","combinedName":"doctor catherine zander"},{"sessionId":"11496","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor IX, FXII, FXIII, ADAMTS13, TFPI, and vWF","firstName":"Zhen ","lastName":"Gao ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mice Lacking Factor XIII Have Significant Protection from the Progression of Neuroinflammatory Disease","keywords":"","combinedName":"doctor zhen gao"},{"sessionId":"11496","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor IX, FXII, FXIII, ADAMTS13, TFPI, and vWF","firstName":"Michael ","lastName":"Wallisch ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:15:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Anti-Factor XII Antibody AB052 Is Antithrombotic without Hemostatic Impairment in a Primate Model of Extracorporeal Membrane Oxygenation","keywords":"","combinedName":"doctor michael wallisch"},{"sessionId":"11497","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Preclinical Studies in Bleeding Disorders","firstName":"David","lastName":"Lillicrap","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Von Willebrand Factor Fragment Acts As a Chaperone to Prolong the Half-Life of Recombinant Human FVIII (Simoctocog Alfa) in Hemophilia a Dogs and FVIII/VWF Double Knockout Mice","keywords":"","combinedName":"doctor david lillicrap"},{"sessionId":"11497","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Preclinical Studies in Bleeding Disorders","firstName":"Kathleen ","lastName":"Pratt ","credentials":"PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FVIII Proteins with a Modified Immunodominant T-Cell Epitope Exhibit Reduced Immunogenicity and Normal Procoagulant Activity","keywords":"","combinedName":"doctor kathleen pratt"},{"sessionId":"11497","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Preclinical Studies in Bleeding Disorders","firstName":"Moanaro ","lastName":"Biswas ","credentials":"PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:15:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Generation of FVIII-Specific Tregs Expressing a Chimeric Antigen Receptor (CAR) to Suppress Inhibitor Development in Hemophilia a Mice","keywords":"","combinedName":"doctor moanaro biswas"},{"sessionId":"11497","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Preclinical Studies in Bleeding Disorders","firstName":"Christine L","lastName":"Kempton ","credentials":"","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"14:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HLA-DRB1-Peptide Binding Prediction and Risk of Inhibitor Development in Non-Severe Hemophilia a","keywords":"","combinedName":"doctor christine l kempton"},{"sessionId":"11497","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Preclinical Studies in Bleeding Disorders","firstName":"Moanaro ","lastName":"Biswas ","credentials":"PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reprogrammed CD4+ T Cells That Express FoxP3+ Effectively Control Inhibitory Antibody Development in Hemophilic Mice","keywords":"","combinedName":"doctor moanaro biswas"},{"sessionId":"11497","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Preclinical Studies in Bleeding Disorders","firstName":"Tine ","lastName":"Wyseure ","credentials":"PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The CXCL12/CXCR4 and VEGF165/Nrp1 Pathways Have Differential Effects on Pathological Neo-Angiogenesis and Vascular Remodeling in Hemophilic Arthropathy","keywords":"","combinedName":"doctor tine wyseure"},{"sessionId":"11498","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Management of VWD and other Bleeding Disorders","firstName":"Azza ","lastName":"Abdelaal ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of the Pathogenicity of Novel Sequence Variants Identified in Type 1 VWD Subjects in the Zimmerman Program for the Molecular and Clinical Biology Study","keywords":"","combinedName":"doctor azza abdelaal"},{"sessionId":"11498","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Management of VWD and other Bleeding Disorders","firstName":"Rudolf ","lastName":"Hartmann ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Elucidating the Excessive Pro-Coagulant Effect of a Sequence Identical Analogue to ACE910 in Combination with Bypassing Agents","keywords":"","combinedName":"doctor rudolf hartmann"},{"sessionId":"11498","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Management of VWD and other Bleeding Disorders","firstName":"Christopher ","lastName":"Ng ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Endothelial Colony Forming Cells from Individuals with Low VWF Levels Demonstrate Impairment in Stimulated VWF Release","keywords":"","combinedName":"doctor christopher ng"},{"sessionId":"11498","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Management of VWD and other Bleeding Disorders","firstName":"Andreas ","lastName":"Tiede ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study","keywords":"","combinedName":"doctor andreas tiede"},{"sessionId":"11498","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Management of VWD and other Bleeding Disorders","firstName":"Pamela A","lastName":"Christopherson ","credentials":"","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genotype-Phenotype Relationship and the Role of Alloantibodies in Type 3 VWD in the Zimmerman Program","keywords":"","combinedName":"doctor pamela a christopherson"},{"sessionId":"11498","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Management of VWD and other Bleeding Disorders","firstName":"Stacy ","lastName":"Croteau","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Practical Application of the Athndataset: Evaluating Uptake of Extended Half-Life Factor Concentrates in Patients with Moderate and Severe Hemophilia","keywords":"","combinedName":"doctor stacy croteau"},{"sessionId":"11499","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Novel Therapies and Clinical Trials in Bleeding Disorders","firstName":"Victor ","lastName":"Jimenez-Yuste ","credentials":"","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Emicizumab Subcutaneous Dosing Every 4 Weeks for the Management of Hemophilia A: Preliminary Data from the Pharmacokinetic Run-in Cohort of a Multicenter, Open-Label, Phase 3 Study (HAVEN 4)","keywords":"","combinedName":"doctor victor jimenez-yuste"},{"sessionId":"11499","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Novel Therapies and Clinical Trials in Bleeding Disorders","firstName":"Guy ","lastName":"Young ","credentials":"","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors","keywords":"","combinedName":"doctor guy young"},{"sessionId":"11499","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Novel Therapies and Clinical Trials in Bleeding Disorders","firstName":"Bagirath ","lastName":"Gangadharan ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia ? New Insights from the Hemophilia Inhibitor PUP Study (HIPS)","keywords":"","combinedName":"doctor bagirath gangadharan"},{"sessionId":"11499","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Novel Therapies and Clinical Trials in Bleeding Disorders","firstName":"Howard ","lastName":"Levy ","credentials":"MBBCh, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 1/2 Trial of Subcutaneously Administered Factor IX Variant CB2679d/ISU304: Pharmacokinetics and Activity","keywords":"","combinedName":"doctor howard levy"},{"sessionId":"11499","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Novel Therapies and Clinical Trials in Bleeding Disorders","firstName":"Charles T","lastName":"Nakar ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pivotal Trial with Intravenous Plasminogen Replacement in Patients with Plasminogen Deficiency Demonstrates Long-Term Efficacy for Treatment and Prevention of Ligneous Lesions","keywords":"","combinedName":"doctor charles t nakar"},{"sessionId":"11499","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Novel Therapies and Clinical Trials in Bleeding Disorders","firstName":"Rebecca","lastName":"Kruse-Jarres","credentials":"","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)","keywords":"","combinedName":"doctor rebecca kruse-jarres"},{"sessionId":"11500","sessionTitle":"331. Pathophysiology of Thrombosis I","firstName":"Anand ","lastName":"Padmanabhan ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A New Assay for Platelet-Activating HIT Antibodies, the PEA, Is Specific, Reproducible and Relatively Independent of the Choice of Platelet Donor","keywords":"","combinedName":"doctor anand padmanabhan"},{"sessionId":"11500","sessionTitle":"331. Pathophysiology of Thrombosis I","firstName":"Romy ","lastName":"Kremers ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Applying Neural Networking Identifies Antiphospholipid Syndrome Patients with an Accuracy of 98.7%","keywords":"","combinedName":"doctor romy kremers"},{"sessionId":"11500","sessionTitle":"331. Pathophysiology of Thrombosis I","firstName":"Harshal ","lastName":"Nandurkar ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD39 and CD73 Activity Are Protective in a Mouse Model of Antiphospholipid Antibody-Induced Miscarriage","keywords":"","combinedName":"doctor harshal nandurkar"},{"sessionId":"11500","sessionTitle":"331. Pathophysiology of Thrombosis I","firstName":"Heiko ","lastName":"Rhl ","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of the Thrombophilic Response to rFVIIa-Induced Hemostasis Activation in Factor V Leiden Carriers By Monitoring of Activated Protein C (APC) In Vivo","keywords":"","combinedName":"doctor heiko rhl"},{"sessionId":"11500","sessionTitle":"331. Pathophysiology of Thrombosis I","firstName":"Karl ","lastName":"Desch ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Exome Sequencing Studies Identify Mutations in STAB2 As a Genetic Risk for Venous Thromboembolic Disease","keywords":"","combinedName":"doctor karl desch"},{"sessionId":"11500","sessionTitle":"331. Pathophysiology of Thrombosis I","firstName":"Anita ","lastName":"Hill ","credentials":"MBChB (Hons), PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fibrinogen and Clot Structure Is Affected By Eculizumab in Patients with Paroxysmal Nocturnal Haemoglobinuria ","keywords":"","combinedName":"doctor anita hill"},{"sessionId":"11501","sessionTitle":"331. Pathophysiology of Thrombosis II","firstName":"Darrko ","lastName":"Antic ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development and External Validation of Thrombosis Lymphoma /Throly/ Score - Interim Analysis","keywords":"","combinedName":"doctor darrko antic"},{"sessionId":"11501","sessionTitle":"331. Pathophysiology of Thrombosis II","firstName":"Annatina ","lastName":"Schnegg-Kaufmann ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Elevated Gas6 Plasma Level As a Predictor of Venous Thromboembolism Recurrence and Mortality in a Prospective Multicenter Cohort of Elderly Patients with Venous Thromboembolism","keywords":"","combinedName":"doctor annatina schnegg-kaufmann"},{"sessionId":"11501","sessionTitle":"331. Pathophysiology of Thrombosis II","firstName":"Marisol ","lastName":"Betensky ","credentials":"MD,MPH","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rebound Hypercoagulability Following a Conventional Course of Anticoagulationand the Risk ofRecurrent Venous ThromboembolisminYoung Patients: First Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank","keywords":"","combinedName":"doctor marisol betensky"},{"sessionId":"11501","sessionTitle":"331. Pathophysiology of Thrombosis II","firstName":"Tamara ","lastName":"Sussman ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNA Sequencing Approaches to Identify Novel Biomarkers for Venous Thromboembolism (VTE) in Lung Cancer","keywords":"","combinedName":"doctor tamara sussman"},{"sessionId":"11501","sessionTitle":"331. Pathophysiology of Thrombosis II","firstName":"Walid ","lastName":"Chayou ","credentials":"MSc","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Identification ofHigh Risk APS Patients for Thrombosis with Triple Antiphospholipid AntibodyPositivity Is Platform Dependent","keywords":"","combinedName":"doctor walid chayou"},{"sessionId":"11501","sessionTitle":"331. Pathophysiology of Thrombosis II","firstName":"Charlotte A","lastName":"Bradbury ","credentials":"PhD, MD, FRCPath, FRCP, MSc","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombotic Events in Patients with Myeloma Treated with Immunomodulatory Drugs; Results of the Myeloma XI Study","keywords":"","combinedName":"doctor charlotte a bradbury"},{"sessionId":"11502","sessionTitle":"332. Antithrombotic Therapy: Anticoagulation in Cancer and Beyond","firstName":"Holger","lastName":"Schnemann","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients","keywords":"","combinedName":"doctor holger schnemann"},{"sessionId":"11502","sessionTitle":"332. Antithrombotic Therapy: Anticoagulation in Cancer and Beyond","firstName":"Annie ","lastName":"Young ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism: Results of the Select-D Pilot Trial","keywords":"","combinedName":"doctor annie young"},{"sessionId":"11502","sessionTitle":"332. Antithrombotic Therapy: Anticoagulation in Cancer and Beyond","firstName":"Genmin ","lastName":"Lu ","credentials":"","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Andexanet-TFPI Interaction on in Vitro Thrombin Formation and Coagulation Markers in the TF-Pathway","keywords":"","combinedName":"doctor genmin lu"},{"sessionId":"11502","sessionTitle":"332. Antithrombotic Therapy: Anticoagulation in Cancer and Beyond","firstName":"Elena ","lastName":"Smolensky Koganov ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:45:00","endTime":"12:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"GLS-409, a Synergistic Inhibitor of Both P2Y1 and P2Y12: Efficacy in a Canine Model of Recurrent Coronary Thrombosis and Reversibility of Human Platelet Inhibition","keywords":"","combinedName":"doctor elena smolensky koganov"},{"sessionId":"11502","sessionTitle":"332. Antithrombotic Therapy: Anticoagulation in Cancer and Beyond","firstName":"Daniel E","lastName":"Ezekwudo ","credentials":"MD, Ph.D","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcome on Reinstitution of Anticoagulation Following Intracranial Hemorrhage: A Single Institutional Analysis","keywords":"","combinedName":"doctor daniel e ezekwudo"},{"sessionId":"11502","sessionTitle":"332. Antithrombotic Therapy: Anticoagulation in Cancer and Beyond","firstName":"Holger","lastName":"Schnemann","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Khorana Score for the Prediction of Venous Thromboembolism in Patients with Solid Cancer: An Individual Patient Data Meta-Analysis","keywords":"","combinedName":"doctor holger schnemann"},{"sessionId":"11503","sessionTitle":"332. Antithrombotic Therapy: Thrombotic Outcomes in Special Populations","firstName":"Anish ","lastName":"Sharda ","credentials":"MBBS, MPH","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aspirin Thromboprophylaxis in Joint Replacement Surgery","keywords":"","combinedName":"doctor anish sharda"},{"sessionId":"11503","sessionTitle":"332. Antithrombotic Therapy: Thrombotic Outcomes in Special Populations","firstName":"Adi ","lastName":"Klil-Drori ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:30:00","endTime":"15:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Risk of Acute Kidney Injury with Oral Anticoagulant Use Among Patients with Nonvalvular Atrial Fibrillation","keywords":"","combinedName":"doctor adi klil-drori"},{"sessionId":"11503","sessionTitle":"332. Antithrombotic Therapy: Thrombotic Outcomes in Special Populations","firstName":"Katherine L","lastName":"Harsh ","credentials":"BS","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diagnosis and Management of Paget-Schroetter Syndrome in Children: An Institutional Experience","keywords":"","combinedName":"doctor katherine l harsh"},{"sessionId":"11503","sessionTitle":"332. Antithrombotic Therapy: Thrombotic Outcomes in Special Populations","firstName":"Karen ","lastName":"Breen ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes Following Placement of Venous Stents for Treatment of Thrombotic Venous Disease","keywords":"","combinedName":"doctor karen breen"},{"sessionId":"11503","sessionTitle":"332. Antithrombotic Therapy: Thrombotic Outcomes in Special Populations","firstName":"Kirill ","lastName":"Lobastov ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Electrical Calf Muscle Stimulation on the Residual Venous Obstruction and DVT Recurrence after Cessation of Standard Anticoagulation","keywords":"","combinedName":"doctor kirill lobastov"},{"sessionId":"11503","sessionTitle":"332. Antithrombotic Therapy: Thrombotic Outcomes in Special Populations","firstName":"Surbhi ","lastName":"Saini ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unfractionated Heparin Use in Children: Clinical Outcomes in a Pediatric Cohort Managed Using an Anti-Factor Xa Based Nomogram","keywords":"","combinedName":"doctor surbhi saini"},{"sessionId":"11504","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Dissecting pathophysiology in transfusion medicine using mouse models","firstName":"Connie ","lastName":"Arthur ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anemic Conditions Acceptable in Restrictive Transfusion Practice Induce Gut Inflammation and Injury in an Animal Model of Preterm Infants","keywords":"","combinedName":"doctor connie arthur"},{"sessionId":"11504","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Dissecting pathophysiology in transfusion medicine using mouse models","firstName":"Rick","lastName":"Kapur","credentials":"MD,PhD,MSc","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gastrointestinal Flora Dictates the Biological Response in Murine Transfusion Related Acute Lung Injury (TRALI)","keywords":"","combinedName":"doctor rick kapur"},{"sessionId":"11504","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Dissecting pathophysiology in transfusion medicine using mouse models","firstName":"Mohammad ","lastName":"Abdelgawwad ","credentials":"MD,MSc","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelets Loaded with Recombinant ADAMTS13 Are Efficacious in Inhibiting Arterial Thrombosis Under Flow: A Potential Novel Therapeutic for Acquired TTP","keywords":"","combinedName":"doctor mohammad abdelgawwad"},{"sessionId":"11504","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Dissecting pathophysiology in transfusion medicine using mouse models","firstName":"Seema R","lastName":"Patel ","credentials":"BS, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Primed CD4 T Cells to an Intracellular Alloantigen Facilitate Alloimmunization Following Subsequent Transfusion","keywords":"","combinedName":"doctor seema r patel"},{"sessionId":"11504","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Dissecting pathophysiology in transfusion medicine using mouse models","firstName":"Karina ","lastName":"Yazdanbakhsh ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Protective Role of HO-1 Expressing CD16+ Patrolling Monocytes Against Hemolysis-Induced Endothelial Damage and Vaso-Occlusive Crisis in Sickle Cell Disease","keywords":"","combinedName":"doctor karina yazdanbakhsh"},{"sessionId":"11504","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Dissecting pathophysiology in transfusion medicine using mouse models","firstName":"Huiying ","lastName":"Zhi ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recreation of Fetal Neonatal Alloimmune Thrombocytopenia in CRISPR/Cas9 Gene-Edited Mice Expressing the Human Platelet Alloantigen, HPA-1a","keywords":"","combinedName":"doctor huiying zhi"},{"sessionId":"11505","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Clinical and translational studies in transfusion medicine","firstName":"Cheryl ","lastName":"Maier ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Antigen-Mediated Immune Suppression Is Antigen Specific","keywords":"","combinedName":"doctor cheryl maier"},{"sessionId":"11505","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Clinical and translational studies in transfusion medicine","firstName":"Richard O","lastName":"Francis ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:30:00","endTime":"15:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Glucose-6-Phosphate Dehydrogenase Deficiency in Blood Donors Is Associated with Decreased Post-Transfusion Red Cell Recovery","keywords":"","combinedName":"doctor richard o francis"},{"sessionId":"11505","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Clinical and translational studies in transfusion medicine","firstName":"Pieter ","lastName":"Van Der Meer ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hemostatic Efficacy of Pathogen-Inactivated Buffy Coat-Derived Platelet Concentrates in Hemato-Oncological Patients: Outcomes of the Prepares Trial","keywords":"","combinedName":"doctor pieter van der meer"},{"sessionId":"11505","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Clinical and translational studies in transfusion medicine","firstName":"Ulrich ","lastName":"Jaeger ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Term Efficacy, Safety and PK/PD Profile of the Anti-C1s Antibody (BIVV009) in Primary Cold Agglutinin Disease Patients ","keywords":"","combinedName":"doctor ulrich jaeger"},{"sessionId":"11505","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Clinical and translational studies in transfusion medicine","firstName":"Suzanne F","lastName":"Fustolo-Gunnink ","credentials":"","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Transfusions for Thrombocytopenic Preterm Neonates: The Monet Study","keywords":"","combinedName":"doctor suzanne f fustolo-gunnink"},{"sessionId":"11505","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Clinical and translational studies in transfusion medicine","firstName":"Celina ","lastName":"Montemayor Garcia ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prediction of Extended Red Blood Cell Phenotype from Exome Next Generation Sequencing Data","keywords":"","combinedName":"doctor celina montemayor garcia"},{"sessionId":"11506","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: HSC maintenance and differentiation","firstName":"Bin ","lastName":"Guo ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Antagonizing PPAR? Expands Human Hematopoietic Stem and Progenitor Cells By Switching on FBP1-Repressed Glycolysis and Preventing Differentiation","keywords":"","combinedName":"doctor bin guo"},{"sessionId":"11506","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: HSC maintenance and differentiation","firstName":"Wei ","lastName":"Du ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:30:00","endTime":"15:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FANCD2 and HES1 Synergistically Regulate the Immunometabolism of Hematopoietic Stem Cells through Transcriptional Suppression of Pparg-mediated Fatty Acid Oxidation and Oxidative Phosphorylation","keywords":"","combinedName":"doctor wei du"},{"sessionId":"11506","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: HSC maintenance and differentiation","firstName":"Katharina ","lastName":"Leonards ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fetal Inactivation of the Nuclear Interacting SET DomainProtein 1 Impairs Terminal Erythroid Maturation and Results in AcuteErythroleukemia in Mice","keywords":"","combinedName":"doctor katharina leonards"},{"sessionId":"11506","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: HSC maintenance and differentiation","firstName":"Darren Qiancheng ","lastName":"Tan ","credentials":"BS","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Ablation or Pharmacological Inhibition of PRMT5 Affects Maintenance of Genomic Integrity in Hematopoietic Stem Cells","keywords":"","combinedName":"doctor darren qiancheng tan"},{"sessionId":"11506","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: HSC maintenance and differentiation","firstName":"Mark J","lastName":"Althoff ","credentials":"BS","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Scribble Controls HSC Self-Renewal through Polarity-Dependent Activation of the Hippo Signaling Pathway","keywords":"","combinedName":"doctor mark j althoff"},{"sessionId":"11506","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: HSC maintenance and differentiation","firstName":"Jennifer ","lastName":"Grants ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single Cell-Resolution Analysis of HSC Dysfunction in Mir-146a knockout Mice","keywords":"","combinedName":"doctor jennifer grants"},{"sessionId":"11507","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Extrinsic and intrinsic HSC signaling","firstName":"Hideyuki ","lastName":"Oguro ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:45:00","endTime":"12:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"27-Hydroxycholesterol Induces Hematopoietic Stem Cell Mobilization and Extramedullary Hematopoiesis Mediated By Estrogen Receptor Alpha","keywords":"","combinedName":"doctor hideyuki oguro"},{"sessionId":"11507","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Extrinsic and intrinsic HSC signaling","firstName":"Simon ","lastName":"Haas ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Stem Cell-Based Epigenetic Memory Mediates Interferon Response-Heterogeneity within the Hematopoietic System","keywords":"","combinedName":"doctor simon haas"},{"sessionId":"11507","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Extrinsic and intrinsic HSC signaling","firstName":"Mareike ","lastName":"Frick ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Hematopoiesis: Cell of Origin, Lineage Repartition and Dynamic Evolution during Chemotherapy","keywords":"","combinedName":"doctor mareike frick"},{"sessionId":"11507","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Extrinsic and intrinsic HSC signaling","firstName":"Masayuki ","lastName":"Yamashita ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inflammation-Produced TNFa Protects HematopoieticStem Cells from Necroptosis via Canonical NF-?B Pathway","keywords":"","combinedName":"doctor masayuki yamashita"},{"sessionId":"11507","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Extrinsic and intrinsic HSC signaling","firstName":"Visnja ","lastName":"Radulovic ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Junctional Adhesion Molecule 2 Intensifies T Lymphopoiesis of Hematopoietic Stem Cells By Facilitating Notch/Delta Signaling","keywords":"","combinedName":"doctor visnja radulovic"},{"sessionId":"11507","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Extrinsic and intrinsic HSC signaling","firstName":"Ashwini ","lastName":"Hinge ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mitochondrial Morphology Controls Hematopoietic Stem Cell Self-Renewal and Confers Them Divisional Memory","keywords":"","combinedName":"doctor ashwini hinge"},{"sessionId":"11508","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Genetics, metabolism, and cell cycle regulation","firstName":"Peng ","lastName":"Huang ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Fetal and Adult Erythroid Chromosomal Architectures Identifies a Novel Fetal Hemoglobin Regulatory Region","keywords":"","combinedName":"doctor peng huang"},{"sessionId":"11508","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Genetics, metabolism, and cell cycle regulation","firstName":"Zhenhua ","lastName":"Yang ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Control of Hematopoietic Stem Cell Function through Epigenetic Regulation of Energy Metabolism and Genome Integrity","keywords":"","combinedName":"doctor zhenhua yang"},{"sessionId":"11508","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Genetics, metabolism, and cell cycle regulation","firstName":"Avik ","lastName":"Choudhuri ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Distinct Signaling Centers Define Stages of Human Erythropoiesis and Harbor Common Variations of Red Blood Cell Traits","keywords":"","combinedName":"doctor avik choudhuri"},{"sessionId":"11508","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Genetics, metabolism, and cell cycle regulation","firstName":"Emmalee ","lastName":"Adelman ","credentials":"BA","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrative Epigenetic and Single-Cell RNA-Seq Profiling of Human Hematopoietic Stem Cells Reveals Epigenetic Reprogramming of Enhancer and Regulatory Elements during Normal Aging","keywords":"","combinedName":"doctor emmalee adelman"},{"sessionId":"11508","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Genetics, metabolism, and cell cycle regulation","firstName":"Giridharan ","lastName":"Ramsingh ","credentials":"MD ","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Role of CEBP As a Transcriptional Repressor of Transposable Elements","keywords":"","combinedName":"doctor giridharan ramsingh"},{"sessionId":"11508","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Genetics, metabolism, and cell cycle regulation","firstName":"Benjamin ","lastName":"Povinelli ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unravelling Cell Cycle and Ontogeny Transcriptional Heterogeneity in Hematopoietic Stem Cells through Integrated Single Cell RNA-Seq","keywords":"","combinedName":"doctor benjamin povinelli"},{"sessionId":"11509","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment I","firstName":"Joji ","lastName":"Fujisaki ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adenosine from Niche-Associated Tregs Maintains Hematopoietic Stem Cell Quiescence","keywords":"","combinedName":"doctor joji fujisaki"},{"sessionId":"11509","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment I","firstName":"Corey M","lastName":"Hoffman ","credentials":"MS","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aging of Hematopoietic Stem Cells Is Driven By Regional Specialization of Marrow Macrophages","keywords":"","combinedName":"doctor corey m hoffman"},{"sessionId":"11509","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment I","firstName":"Pratibha ","lastName":"Singh ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Attenuation of CXCR4/SDF-1 Axis in Bone Marrow Mesenchymal Stromal Cells Impairs Hematopoietic Niche Activity and Promotes Stem Cell Aging","keywords":"","combinedName":"doctor pratibha singh"},{"sessionId":"11509","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment I","firstName":"Marta ","lastName":"Derecka ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"EBF1As a Novel Regulator of Bone MarrowMesenchymal StromalProgenitors","keywords":"","combinedName":"doctor marta derecka"},{"sessionId":"11509","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment I","firstName":"Dorian ","lastName":"Forte ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Leukemic Stem Cells Co-Opt Normal Bone Marrow Niches As a Source of Energy and Antioxidant Defence","keywords":"","combinedName":"doctor dorian forte"},{"sessionId":"11509","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment I","firstName":"Youmna ","lastName":"Kfoury ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Osteoblastic Cell-Derived Extracellular Vesicles Transfer Small RNAs That Alter the Physiology of Hematopoietic Cells In Vivo","keywords":"","combinedName":"doctor youmna kfoury"},{"sessionId":"11510","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment II","firstName":"Owen J","lastName":"Tamplin ","credentials":"PhD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"13:00:00","endTime":"13:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Correlative Lightsheet and Electron Microscopy Applied to a Zebrafish Model of Fetal Bone Marrow: Resolving the Ultrastructure of a Single Hematopoietic Stem Cell in the Niche","keywords":"","combinedName":"doctor owen j tamplin"},{"sessionId":"11510","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment II","firstName":"Young-Woong ","lastName":"Kim ","credentials":"PhD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Defective Notch Activation in Mesenchymal Cells Contributes to Myeloproliferative Neoplasm in Aged Mice","keywords":"","combinedName":"doctor young-woong kim"},{"sessionId":"11510","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment II","firstName":"Elliott ","lastName":"Hagedorn ","credentials":"Ph.D.","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Defining the Transcriptional Code That Specifies Sinusoidal Endothelial Cells in the HSPC Niche","keywords":"","combinedName":"doctor elliott hagedorn"},{"sessionId":"11510","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment II","firstName":"Katie A","lastName":"Matatall ","credentials":"PhD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"13:15:00","endTime":"13:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IFNg Increases HSC Homing and Induces Relocalization within the Bone Marrow Niche","keywords":"","combinedName":"doctor katie a matatall"},{"sessionId":"11510","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment II","firstName":"Peng ","lastName":"Zhang ","credentials":"PhD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Loss of ASXL1 in the Bone Marrow Niche Dysregulates Hematopoietic Stem Cell Fates through RNA Polymerase II Complex","keywords":"","combinedName":"doctor peng zhang"},{"sessionId":"11510","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment II","firstName":"Grant ","lastName":"Rowe ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Age of the Hematopoietic Microenvironment Specifies Lineage Commitment in MLL-Rearranged Leukemia","keywords":"","combinedName":"doctor grant rowe"},{"sessionId":"11511","sessionTitle":"508. Bone Marrow Failure: Inherited Bone Marrow Failure: Ribosomopathies and Related Disorders","firstName":"Jasmine ","lastName":"Rowell ","credentials":"BS, MS","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:15:00","endTime":"18:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Zebrafish Model of Diamond-Blackfan Anemia Results in Bone Marrow Failure and Demonstrates Defective Translation in Erythroid Cells By Ribosome Footprinting","keywords":"","combinedName":"doctor jasmine rowell"},{"sessionId":"11511","sessionTitle":"508. Bone Marrow Failure: Inherited Bone Marrow Failure: Ribosomopathies and Related Disorders","firstName":"Pekka ","lastName":"Jaako ","credentials":"PhD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:30:00","endTime":"19:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Attenuated Protein Synthesis Drives the Hematopoietic Defects in Shwachman-Diamond Syndrome","keywords":"","combinedName":"doctor pekka jaako"},{"sessionId":"11511","sessionTitle":"508. Bone Marrow Failure: Inherited Bone Marrow Failure: Ribosomopathies and Related Disorders","firstName":"Enikoe Amina","lastName":"Szvetnik ","credentials":"","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:00:00","endTime":"19:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diamond-Blackfan Anemia Phenotype Caused By Deficiency of Adenosine Deaminase 2","keywords":"","combinedName":"doctor enikoe amina szvetnik"},{"sessionId":"11511","sessionTitle":"508. Bone Marrow Failure: Inherited Bone Marrow Failure: Ribosomopathies and Related Disorders","firstName":"Carl ","lastName":"Novina ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:30:00","endTime":"18:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fetal Erythropoiesis Is Defective in Rpl11 Heterozygous Mice and Increases in Severity in Young Animals","keywords":"","combinedName":"doctor carl novina"},{"sessionId":"11511","sessionTitle":"508. Bone Marrow Failure: Inherited Bone Marrow Failure: Ribosomopathies and Related Disorders","firstName":"Raymond ","lastName":"Doty ","credentials":"PhD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:45:00","endTime":"19:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RPL11 Haploinsufficient Mice Have a CFU-E/Proerythroblast Block, Elevated Erythroblast Heme, Reduced Gata1, and Increased Ribosomal Protein Gene Expression","keywords":"","combinedName":"doctor raymond doty"},{"sessionId":"11511","sessionTitle":"508. Bone Marrow Failure: Inherited Bone Marrow Failure: Ribosomopathies and Related Disorders","firstName":"Melisa ","lastName":"Ruiz-Gutierrez ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:15:00","endTime":"19:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Activated TGF Pathway in Shwachman Diamond Syndrome Impairs Hematopoiesis and Is Down-Regulated By Deletion of 7q","keywords":"","combinedName":"doctor melisa ruiz-gutierrez"},{"sessionId":"11512","sessionTitle":"508. Bone Marrow Failure: Biology and Therapy","firstName":"Thomas ","lastName":"Winkler ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Eltrombopag for Refractory Severe Aplastic Anemia: Dosing Regimens, Long-Term Follow-up, Clonal Evolution and Somatic Mutation Profiling","keywords":"","combinedName":"doctor thomas winkler"},{"sessionId":"11512","sessionTitle":"508. Bone Marrow Failure: Biology and Therapy","firstName":"Kacey Linnea","lastName":"Guenther ","credentials":"BS","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Eltrombopag Promotes DNA Repair in Human Hematopoietic Stem and Progenitor Cells: Implications for the Treatment of Fanconi Anemia","keywords":"","combinedName":"doctor kacey linnea guenther"},{"sessionId":"11512","sessionTitle":"508. Bone Marrow Failure: Biology and Therapy","firstName":"Mohammad Fahad B","lastName":"Asad ","credentials":"MD, MBBS","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Extent and Clinical Implications of Subclonal Diversity in Paroxysmal Nocturnal Hemoglobinuria","keywords":"","combinedName":"doctor mohammad fahad b asad"},{"sessionId":"11512","sessionTitle":"508. Bone Marrow Failure: Biology and Therapy","firstName":"Jean ","lastName":"Donadieu ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Frequency and Evolution of TP53 Mutant Clones in Shwachman Diamond Syndrome. a Cohort Study from the French Severe Chronic Neutropenia (SCN) Registry","keywords":"","combinedName":"doctor jean donadieu"},{"sessionId":"11512","sessionTitle":"508. Bone Marrow Failure: Biology and Therapy","firstName":"Donna ","lastName":"Edwards ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient-Tailored Mouse Genome Editing Recapitulates Hematopoietic and Systemic Manifestations of Barth Syndrome","keywords":"","combinedName":"doctor donna edwards"},{"sessionId":"11512","sessionTitle":"508. Bone Marrow Failure: Biology and Therapy","firstName":"Xingmin ","lastName":"Feng ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tumor Necrosis Factor-a in Target Cells but Not in Effector Cells Plays Critical Roles in Development of Murine Immune-Mediated Bone Marrow Failure","keywords":"","combinedName":"doctor xingmin feng"},{"sessionId":"11513","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in acute myeloid leukemia","firstName":"Andrew ","lastName":"Volk ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemic Pathogenesis","keywords":"","combinedName":"doctor andrew volk"},{"sessionId":"11513","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in acute myeloid leukemia","firstName":"Sarah ","lastName":"Greenblatt ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CARM1/PRMT4 As a Novel Therapeutic Target for AML","keywords":"","combinedName":"doctor sarah greenblatt"},{"sessionId":"11513","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in acute myeloid leukemia","firstName":"Huacheng ","lastName":"Luo ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Disruption of CTCF Boundary Remodels Chromatin Domain and Reprograms HOX Gene Transcription in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor huacheng luo"},{"sessionId":"11513","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in acute myeloid leukemia","firstName":"Joseph B","lastName":"Fisher ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dot1l Reverses the Abnormal Self-Renewal Conferred on HSPCs through Cohesin Haploinsufficiency By Diminishing Expression of Hoxa7 and Hoxa9","keywords":"","combinedName":"doctor joseph b fisher"},{"sessionId":"11513","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in acute myeloid leukemia","firstName":"Sheng ","lastName":"Li ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetically-Defined AML Subgroups Represent Diverse Epigenetic Heterogeneity Landscape","keywords":"","combinedName":"doctor sheng li"},{"sessionId":"11513","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in acute myeloid leukemia","firstName":"Monica ","lastName":"Cusan ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:15:00","endTime":"16:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"LSD1 Inhibition Exerts Its Anti-Leukemic Effect By Recommissioning PU.1- and C/Ebpa-Dependent Enhancers in AML","keywords":"","combinedName":"doctor monica cusan"},{"sessionId":"11514","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered gene expression in myeloid and lymphoid leukemia","firstName":"John Anto ","lastName":"Pulikkan ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CBF-SMMHC Inhibition Disrupts Enhancer Chromatin Dynamics and Represses MYC Transcriptional Program in Inv(16) Leukemia","keywords":"","combinedName":"doctor john anto pulikkan"},{"sessionId":"11514","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered gene expression in myeloid and lymphoid leukemia","firstName":"Yuting ","lastName":"Tang ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Essential Role of c-MYC for Natural Killer Cell Development, Proliferation and Anti-Tumor Activity","keywords":"","combinedName":"doctor yuting tang"},{"sessionId":"11514","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered gene expression in myeloid and lymphoid leukemia","firstName":"Takuji ","lastName":"Yamauchi ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genome-Wide CRISPR/Cas9 Screen Reveals That the Dcps Scavenger Decapping Enzyme Is Essential for AML Cell Survival","keywords":"","combinedName":"doctor takuji yamauchi"},{"sessionId":"11514","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered gene expression in myeloid and lymphoid leukemia","firstName":"Yuqing ","lastName":"Sun ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HOXA9 Recruitment of Methyltransferase Complexes Alters Enhancer Landscape during Leukemic Transformation","keywords":"","combinedName":"doctor yuqing sun"},{"sessionId":"11514","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered gene expression in myeloid and lymphoid leukemia","firstName":"Molly A","lastName":"Smith ","credentials":"BS, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Splicesome Mutant MDS and AML Cells Activate Innate Immune Signaling By Regulating the Expression of Therapeutically Targetable IRAK4 Isoforms","keywords":"","combinedName":"doctor molly a smith"},{"sessionId":"11514","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered gene expression in myeloid and lymphoid leukemia","firstName":"Konstantinos ","lastName":"Tzelepis ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"SRPK1 Is a Therapeutic Vulnerability in Acute Myeloid Leukemia through Its Effects on Alternative Isoforms of Epigenetic Regulators Including BRD4","keywords":"","combinedName":"doctor konstantinos tzelepis"},{"sessionId":"11515","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in myeloid and lymphoid leukemia","firstName":"Yunchao ","lastName":"Chang ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CREBBP Histone Acetyltransferase Domain Mutations Result in Dexamethasone Resistance in B-Progenitor Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor yunchao chang"},{"sessionId":"11515","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in myeloid and lymphoid leukemia","firstName":"Hui ","lastName":"Yang ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gain-of-Function of ASXL1 Truncating Protein in the Pathogenesis of Myeloid Malignancies","keywords":"","combinedName":"doctor hui yang"},{"sessionId":"11515","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in myeloid and lymphoid leukemia","firstName":"Zhigang ","lastName":"Xie ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MMSET I Acts As an Oncoprotein and Regulates GLO1 Expression in T(4;14) Multiple Myeloma Cells","keywords":"","combinedName":"doctor zhigang xie"},{"sessionId":"11515","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in myeloid and lymphoid leukemia","firstName":"Shuhei ","lastName":"Asada ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutant ASXL1 Cooperates with BAP1 to Promote Myeloid Leukemogenesis","keywords":"","combinedName":"doctor shuhei asada"},{"sessionId":"11515","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in myeloid and lymphoid leukemia","firstName":"Franco ","lastName":"Izzo ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Cell Methylome and Transcriptome High-Resolution Maps Define the Effects of Epigenetic Modifiers on the Landscape of Hematopoietic Differentiation","keywords":"","combinedName":"doctor franco izzo"},{"sessionId":"11515","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in myeloid and lymphoid leukemia","firstName":"Yun ","lastName":"Huang ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TCF3-Hlf Hijacks ERG to Activate Leukemia-Critical Super-Enhancers in t(17;19) Leukemia","keywords":"","combinedName":"doctor yun huang"},{"sessionId":"11516","sessionTitle":"603. Oncogenes and Tumor Suppressors: Nuclear Export and Metabolic Regulation","firstName":"Lorenzo ","lastName":"Brunetti ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:15:00","endTime":"18:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Myeloid Leukemia with Mutated NPM1 Is Dependent on the Cytoplasmic Localization of NPM1c","keywords":"","combinedName":"doctor lorenzo brunetti"},{"sessionId":"11516","sessionTitle":"603. Oncogenes and Tumor Suppressors: Nuclear Export and Metabolic Regulation","firstName":"Danny ","lastName":"Jeyaraju ","credentials":"PhD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:15:00","endTime":"19:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibiting the Mitochondrial Sulfhydryl Oxidase Alr Reduces Cox17 and Alters Mitochondrial Cristae Structure Leading to the Differentiation of AML and Stem Cells","keywords":"","combinedName":"doctor danny jeyaraju"},{"sessionId":"11516","sessionTitle":"603. Oncogenes and Tumor Suppressors: Nuclear Export and Metabolic Regulation","firstName":"Justin ","lastName":"Taylor ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:45:00","endTime":"19:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Oncogenic Mutations in XPO1 Promote Lymphoid Transformation By Altering Nuclear/Cytoplasmic Localization of NF?B Signaling Intermediates","keywords":"","combinedName":"doctor justin taylor"},{"sessionId":"11516","sessionTitle":"603. Oncogenes and Tumor Suppressors: Nuclear Export and Metabolic Regulation","firstName":"Gang ","lastName":"Xiao ","credentials":"PhD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:30:00","endTime":"19:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PON2 Exemplifies a Unique Dependency of B Cell Lineage ALL Cells on Detoxifying Lactonases","keywords":"","combinedName":"doctor gang xiao"},{"sessionId":"11516","sessionTitle":"603. Oncogenes and Tumor Suppressors: Nuclear Export and Metabolic Regulation","firstName":"Xiaorong ","lastName":"Gu ","credentials":"PhD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:30:00","endTime":"18:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Mechanisms By Which Mutant-NPM1 Uncouples Differentiation from Proliferation Are Reversed By Several Drugs, Enabling Rational Multi-Component Non-Cytotoxic Differentiation Therapy","keywords":"","combinedName":"doctor xiaorong gu"},{"sessionId":"11516","sessionTitle":"603. Oncogenes and Tumor Suppressors: Nuclear Export and Metabolic Regulation","firstName":"Lina ","lastName":"Benajiba ","credentials":"","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:00:00","endTime":"19:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Vcp-Regulated Homologous Recombination Represents a New Druggable Vulnerability in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor lina benajiba"},{"sessionId":"11517","sessionTitle":"603. Oncogenes and Tumor Suppressors: Epigenetic and Post-Transcriptional Control","firstName":"Cristina ","lastName":"Di Genua ","credentials":"","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cell-Intrinsic Depletion of AML1-ETO-Positive Pre-Leukemic HSCs By Kras Activating Mutation","keywords":"","combinedName":"doctor cristina di genua"},{"sessionId":"11517","sessionTitle":"603. Oncogenes and Tumor Suppressors: Epigenetic and Post-Transcriptional Control","firstName":"Megan ","lastName":"McNerney ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deficiency of Cux1, Encoded on Human Chromosome 7q, Causes Aberrant Hematopoietic Stem Cell Function and Spontaneous Myeloproliferative Disease in Mice","keywords":"","combinedName":"doctor megan mcnerney"},{"sessionId":"11517","sessionTitle":"603. Oncogenes and Tumor Suppressors: Epigenetic and Post-Transcriptional Control","firstName":"Ly P","lastName":"Vu ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"m6a Regulates Differentiation State and mRNA Translation in Myeloid Leukemia","keywords":"","combinedName":"doctor ly p vu"},{"sessionId":"11517","sessionTitle":"603. Oncogenes and Tumor Suppressors: Epigenetic and Post-Transcriptional Control","firstName":"Yotaro ","lastName":"Ochi ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Stag2 regulates Hematopoietic Differentiation and Self-Renewal","keywords":"","combinedName":"doctor yotaro ochi"},{"sessionId":"11517","sessionTitle":"603. Oncogenes and Tumor Suppressors: Epigenetic and Post-Transcriptional Control","firstName":"Ayesh K","lastName":"Seneviratne ","credentials":"BSc, MSc","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tafazzin (TAZ) Regulates the Differentiation of AML Cells By Reducing Levels of the Phospholipid Phosphatidylethanolamine","keywords":"","combinedName":"doctor ayesh k seneviratne"},{"sessionId":"11517","sessionTitle":"603. Oncogenes and Tumor Suppressors: Epigenetic and Post-Transcriptional Control","firstName":"Florian ","lastName":"Perner ","credentials":"","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Cold-Shock Protein Ybx1 Is Required for Development and Maintenance of Acute Myeloid Leukemia (AML) in Vitro and In Vivo","keywords":"","combinedName":"doctor florian perner"},{"sessionId":"11518","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","firstName":"Susumu ","lastName":"Goyama ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A p53-MDM2 Interaction Inhibitor, DS-5272, Inhibits the Development of MLL-Fusion Leukemia with the Assistance of Tumor Immunity","keywords":"","combinedName":"doctor susumu goyama"},{"sessionId":"11518","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","firstName":"Justin ","lastName":"Taylor ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of Ntrk fusions and Therapeutic Response to Ntrk Inhibition in Hematologic Malignancies","keywords":"","combinedName":"doctor justin taylor"},{"sessionId":"11518","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","firstName":"Luis ","lastName":"Carvajal ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dual Inhibition of Mdmx and Mdm2 Using an Alpha-Helical P53 Stapled Peptide (ALRN-6924) As a Novel Therapeutic Strategy in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor luis carvajal"},{"sessionId":"11518","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","firstName":"Claudia ","lastName":"Bruedigam ","credentials":"","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrated Molecular Analysis Identifies Replicative Stress As Sensitizer to Imetelstat Therapy in AML","keywords":"","combinedName":"doctor claudia bruedigam"},{"sessionId":"11518","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","firstName":"Jason ","lastName":"Stephansky ","credentials":"","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Resistance to SL-401 in AML and BPDCN Is Associated with Loss of the Diphthamide Synthesis Pathway Enzyme DPH1 and Is Reversible By Azacitidine","keywords":"","combinedName":"doctor jason stephansky"},{"sessionId":"11518","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","firstName":"Ingrid G","lastName":"Winkler ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B207-B208","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Vascular E-Selectin Mediates Chemo-Resistance in Acute Myeloid Leukemia Initiating Cells Via Canonical Receptors PSGL-1 (CD162) and Hcell (CD44) and AKT Signaling","keywords":"","combinedName":"doctor ingrid g winkler"},{"sessionId":"11519","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","firstName":"Riikka ","lastName":"Karjalainen ","credentials":"","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Elevated Expression of the S100A8/S100A9 Complex in AML Correlates with Reduced Sensitivity to the BCL2 Inhibitor Venetoclax","keywords":"","combinedName":"doctor riikka karjalainen"},{"sessionId":"11519","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","firstName":"Uma ","lastName":"Borate ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factors Predicting Response and Resistance to Midostaurin in FLT3 Positive and FLT3 Negative AML in 483 Primary AML Patient Samples","keywords":"","combinedName":"doctor uma borate"},{"sessionId":"11519","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","firstName":"Christine ","lastName":"McMahon ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mechanisms of Acquired Resistance to Gilteritinib Therapy in Relapsed and Refractory FLT3-Mutated Acute Myeloid Leukemia","keywords":"","combinedName":"doctor christine mcmahon"},{"sessionId":"11519","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","firstName":"Dilshad ","lastName":"Khan ","credentials":"","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mitochondrial Carrier Homolog 2 (MTCH2) Regulates the Differentiation of AML Cells By Controlling Pyruvate Entry into the Mitochondria, Nuclear Localization of Pyruvate Dehydrogenase Complex and H3 and H4 Histone Acetylation","keywords":"","combinedName":"doctor dilshad khan"},{"sessionId":"11519","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","firstName":"David ","lastName":"Sharon ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Mitochondrial Translation Overcomes Venetoclax Resistance in Acute Myeloid Leukemia (AML) through Activation of the Integrated Stress Response","keywords":"","combinedName":"doctor david sharon"},{"sessionId":"11519","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","firstName":"Irum ","lastName":"Khan ","credentials":"MBBS","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of FOXM1 As a Therapeutic Target in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor irum khan"},{"sessionId":"11520","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: ALL and T-cell malignancies","firstName":"Guang ","lastName":"Yang ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel, Highly Selective IRAK1 Inhibitor Jh-X-119-01 Shows Synergistic Tumor Cell Killing with Ibrutinib in MYD88 Mutated B-Cell Lymphoma Cells","keywords":"","combinedName":"doctor guang yang"},{"sessionId":"11520","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: ALL and T-cell malignancies","firstName":"Zhengshan ","lastName":"Chen ","credentials":"MD-PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:30:00","endTime":"15:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autoimmunity Checkpoints As Therapeutic Targets in B- and T-Cell Malignancies","keywords":"","combinedName":"doctor zhengshan chen"},{"sessionId":"11520","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: ALL and T-cell malignancies","firstName":"Sujan ","lastName":"Piya ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BRD4 Proteolysis Targeting Chimera (PROTAC) ARV-825 Targets Both NOTCH1-MYC Regulatory Circuit and Leukemia-Microenvironment in T-ALL","keywords":"","combinedName":"doctor sujan piya"},{"sessionId":"11520","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: ALL and T-cell malignancies","firstName":"Akihiro ","lastName":"Kitadate ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Histone Deacetylase Inhibitors Downregulate CCR4 Expression and Decrease Mogamulizumab Efficacy in CCR4-Positive Mature T-Cell Lymphomas","keywords":"","combinedName":"doctor akihiro kitadate"},{"sessionId":"11520","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: ALL and T-cell malignancies","firstName":"Chelsea ","lastName":"Dieck ","credentials":"","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mechanisms of NT5C2 mutations Driving Thiopurine Resistance in Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor chelsea dieck"},{"sessionId":"11520","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: ALL and T-cell malignancies","firstName":"Christian ","lastName":"Hurtz ","credentials":"PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Redundant JAK, SRC and PI3 Kinase Signaling Pathways Regulate Cell Survival in Human Ph-like ALL Cell Lines and Primary Cells","keywords":"","combinedName":"doctor christian hurtz"},{"sessionId":"11521","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Chronic Lymphocytic Leukemia and other Lymphoid Diseases","firstName":"Hannah ","lastName":"Robinson ","credentials":"BA","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Activity of CD19/CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor hannah robinson"},{"sessionId":"11521","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Chronic Lymphocytic Leukemia and other Lymphoid Diseases","firstName":"Katia ","lastName":"Beider ","credentials":"","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Blocking of Transient Receptor Potential Vanilloid1 (TRPV1) Promotes Lysosomal Destabilization and Enhances Bortezomib-Induced ER Stress and Cell Death Via HSP70 and LAMP3 Down-Regulation: Novel Therapeutic Target for Multiple Myeloma","keywords":"","combinedName":"doctor katia beider"},{"sessionId":"11521","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Chronic Lymphocytic Leukemia and other Lymphoid Diseases","firstName":"Guang ","lastName":"Yang ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BTKCys481Ser Mutation Drives Ibrutinib Resistance through ERK1/2 Hyperactivation, and Can Confer a Protective Effect on Bystander Waldenstroms Macroglobulinemia and ABC DLBCL Cells through Paracrine Mediated Pro-Survival Signaling","keywords":"","combinedName":"doctor guang yang"},{"sessionId":"11521","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Chronic Lymphocytic Leukemia and other Lymphoid Diseases","firstName":"Joshua ","lastName":"Gustine ","credentials":"","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ibrutinib Discontinuation in Waldenstrm Macroglobulinemia: Etiologies, Outcomes, and IgM Rebound","keywords":"","combinedName":"doctor joshua gustine"},{"sessionId":"11521","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Chronic Lymphocytic Leukemia and other Lymphoid Diseases","firstName":"Gregory Ian","lastName":"Vladimer ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrated ATAC-Seq and Chemosensitivity Profiling Identifies Rational Drug Combinations in Ibrutinib-Treated CLL Patients","keywords":"","combinedName":"doctor gregory ian vladimer"},{"sessionId":"11521","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Chronic Lymphocytic Leukemia and other Lymphoid Diseases","firstName":"Ya ","lastName":"Zhang ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Maternal Embryonic Leucine Zipper Kinasewith OTSSP167 Displays Anti-Tumor Activities in Chronic Lymphocytic Leukemia through Down-Regulation of FoxM1","keywords":"","combinedName":"doctor ya zhang"},{"sessionId":"11522","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Advances in the Treatment of ALL","firstName":"Andrea","lastName":"Biondi","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Treatment Protocol with Imatinib and Intensive Chemotherapy for Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia Patients: A Single-Arm, Intergroup Study (EsPhALL 2010-2014)","keywords":"","combinedName":"doctor andrea biondi"},{"sessionId":"11522","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Advances in the Treatment of ALL","firstName":"Sarayu ","lastName":"Kumar ","credentials":"BA, BSPH","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Absence of Silent Inactivation Using Intravenous Pegaspargase in Pediatric Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor sarayu kumar"},{"sessionId":"11522","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Advances in the Treatment of ALL","firstName":"Stephen ","lastName":"Hunger ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)","keywords":"","combinedName":"doctor stephen hunger"},{"sessionId":"11522","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Advances in the Treatment of ALL","firstName":"Rosanna ","lastName":"Jackson ","credentials":"BSc, MSc","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dexamethasone Pharmacokinetics Following Standard and Short Dosing Schedules in Patients on the UKALL2011 Trial","keywords":"","combinedName":"doctor rosanna jackson"},{"sessionId":"11522","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Advances in the Treatment of ALL","firstName":"Giovanni ","lastName":"Martinelli ","credentials":"","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor giovanni martinelli"},{"sessionId":"11522","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Advances in the Treatment of ALL","firstName":"Maeve A","lastName":"O'Reilly ","credentials":"MB","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Incidence of Invasive Fungal Infections in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukaemia/Lymphoma Treated with the UKALL2011 Protocol: a Multicentre Retrospective Study","keywords":"","combinedName":"doctor maeve a o'reilly"},{"sessionId":"11523","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Immune-based therapies and rare subgroups","firstName":"Benjamin Ole","lastName":"Wolthers ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:45:00","endTime":"19:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Common Genetic Variants in Trypsin Regulating Genes Are Associated with AsparAginase-Associated Pancreatitis in Children with Acute Lymphoblastic Leukemia: A Ponte Di Legno Toxicity Working Group Study","keywords":"","combinedName":"doctor benjamin ole wolthers"},{"sessionId":"11523","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Immune-based therapies and rare subgroups","firstName":"Etan ","lastName":"Orgel ","credentials":"MD, MS","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:15:00","endTime":"18:30:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of ALL Therapy for WHO2016-Defined Mixed Phenotype Acute Leukemia: A Report from the Childrens Oncology Group","keywords":"","combinedName":"doctor etan orgel"},{"sessionId":"11523","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Immune-based therapies and rare subgroups","firstName":"Bijal ","lastName":"Shah ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:30:00","endTime":"19:45:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 1 Results of ZUMA-3: KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL)","keywords":"","combinedName":"doctor bijal shah"},{"sessionId":"11523","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Immune-based therapies and rare subgroups","firstName":"Reuben ","lastName":"Benjamin ","credentials":"","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:15:00","endTime":"19:30:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a First-in-Human Trial (CALM) in Adult Patients with CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor reuben benjamin"},{"sessionId":"11523","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Immune-based therapies and rare subgroups","firstName":"Partow","lastName":"Kebriaei","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:00:00","endTime":"19:15:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Remission Status and Prior Transplant in Optimizing Survival Outcomes Following Allogeneic Hematopoietic Stem Transplantation (HSCT) in Patients Who Received Inotuzumab Ozogamicin (INO) for Relapsed / Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)","keywords":"","combinedName":"doctor partow kebriaei"},{"sessionId":"11523","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Immune-based therapies and rare subgroups","firstName":"Stefanie ","lastName":"Junk ","credentials":"","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:30:00","endTime":"18:45:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TP53, ETV6 and RUNX1 Germline Variants in Patients Developing Secondary Neoplasms after Treatment for Childhood Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor stefanie junk"},{"sessionId":"11524","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Advances in Frontline Therapy: Induction, Consolidation, and Maintenance","firstName":"Laurne ","lastName":"Fenwarth ","credentials":"MSc, MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clofarabine-Based Consolidation Improves Relapse-Free Survival of Patients with Acute Myeloid Leukemia with Complex or Micro-Complex Karyotype: Results from the Randomized ALFA-0702 Study","keywords":"","combinedName":"doctor laurne fenwarth"},{"sessionId":"11524","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Advances in Frontline Therapy: Induction, Consolidation, and Maintenance","firstName":"Sylvie D","lastName":"Freeman ","credentials":"MBChB, DPhil","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Flow Cytometric Minimal Residual Disease As Risk Stratification Tool in Younger Adults with NPM1 Wild Type Standard Risk Acute Myeloid Leukemia","keywords":"","combinedName":"doctor sylvie d freeman"},{"sessionId":"11524","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Advances in Frontline Therapy: Induction, Consolidation, and Maintenance","firstName":"Konstanze ","lastName":"Dhner ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Impact of NPM1/FLT3-ITD genotypes from Randomized Patients with Acute Myeloid Leukemia (AML) Treated within the International Ratify Study","keywords":"","combinedName":"doctor konstanze dhner"},{"sessionId":"11524","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Advances in Frontline Therapy: Induction, Consolidation, and Maintenance","firstName":"Geert ","lastName":"Huls ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15)","keywords":"","combinedName":"doctor geert huls"},{"sessionId":"11524","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Advances in Frontline Therapy: Induction, Consolidation, and Maintenance","firstName":"Claude ","lastName":"Gardin ","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Allogeneic Reduced Intensity Conditioning Stem Cell Transplantation (RIC-SCT) in Older Patients with Acute Myeloid Leukemia (AML): Analysis of the ALFA-1200 Study","keywords":"","combinedName":"doctor claude gardin"},{"sessionId":"11524","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Advances in Frontline Therapy: Induction, Consolidation, and Maintenance","firstName":"Daniel ","lastName":"Sawler ","credentials":"MD, BSc","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Two Cycles of Consolidation Chemotherapy Are Associated with Similar Clinical Outcomes to Three Cycles in AML Patients with Favorable Risk Cytogenetics","keywords":"","combinedName":"doctor daniel sawler"},{"sessionId":"11525","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Novel Therapies for AML and APL","firstName":"Amer ","lastName":"Zeidan","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 1/2 Study of the Oral Novel JAK1 Inhibitor INCB052793 As Monotherapy and in Combination with Standard Therapies in Patients with Advanced Hematologic Malignancies","keywords":"","combinedName":"doctor amer zeidan"},{"sessionId":"11525","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Novel Therapies for AML and APL","firstName":"Daniel ","lastName":"Pollyea","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enasidenib Monotherapy Is Effective and Well-Tolerated in Patients with Previously Untreated Mutant-IDH2 (mIDH2) Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor daniel pollyea"},{"sessionId":"11525","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Novel Therapies for AML and APL","firstName":"Courtney ","lastName":"DiNardo","credentials":"MD, MSc","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutant Isocitrate Dehydrogenase (mIDH) Inhibitors, Enasidenib or Ivosidenib, in Combination with Azacitidine (AZA): Preliminary Results of a Phase 1b/2 Study in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor courtney dinardo"},{"sessionId":"11525","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Novel Therapies for AML and APL","firstName":"Honghu ","lastName":"Zhu ","credentials":"","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Oral Arsenic Plus Retinoic Acid Versus Intravenous Arsenic Plus Retinoic Acid for Non-High Risk Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trials","keywords":"","combinedName":"doctor honghu zhu"},{"sessionId":"11525","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Novel Therapies for AML and APL","firstName":"John ","lastName":"Godwin ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Results of a Phase 1 Study of Flotetuzumab, a CD123 x CD3 Bispecific Dart Protein, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome","keywords":"","combinedName":"doctor john godwin"},{"sessionId":"11525","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Novel Therapies for AML and APL","firstName":"Akihiro ","lastName":"Takeshita ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:45:00","endTime":"12:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tamibarotene As Maintenance Therapy for Acute Promyelocytic Leukemia Improved Long Term Relapse-Free Survival: 7-Year Results from a Randomized Controlled Trial, JALSG-APL204","keywords":"","combinedName":"doctor akihiro takeshita"},{"sessionId":"11526","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Risk Factors and Response-Adapted Personalized Medicine","firstName":"Remco J","lastName":"Molenaar ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IDH1/2-Mutated Acute Myeloid Leukemia Has Impaired DNA Damage Response and Is Sensitive to Monotherapy with the PARP Inhibitior Olaparib","keywords":"","combinedName":"doctor remco j molenaar"},{"sessionId":"11526","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Risk Factors and Response-Adapted Personalized Medicine","firstName":"Eunice ","lastName":"Wang","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low Relapse Rate in Younger Patients = 60 Years Old with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) Treated with Crenolanib and Cytarabine/Anthracycline Chemotherapy","keywords":"","combinedName":"doctor eunice wang"},{"sessionId":"11526","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Risk Factors and Response-Adapted Personalized Medicine","firstName":"Irene ","lastName":"Roberts ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mature Analysis of the Prospective Oxford Down Syndrome (DS) Cohort Study: Timing and Clinical Impact of Preleukemic GATA1 Mutations and Lessons for Management of Newborns with DS","keywords":"","combinedName":"doctor irene roberts"},{"sessionId":"11526","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Risk Factors and Response-Adapted Personalized Medicine","firstName":"Uwe ","lastName":"Platzbecker ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Minimal-Residual Disease Guided Treatment with Azacitidine in MDS/AML Patients at Imminent Risk of Relapse: Results of the Prospective RELAZA2 Trial","keywords":"","combinedName":"doctor uwe platzbecker"},{"sessionId":"11526","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Risk Factors and Response-Adapted Personalized Medicine","firstName":"James ","lastName":"Foran","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Epidemiology of Acute Myeloid Leukemia (AML): Novel Association of Clinical Epidemiologic Exposures with Unique Mutation Groups on Exome Sequencing of Leukemia DNA in the Mayo Clinic AML Epidemiology Cohort","keywords":"","combinedName":"doctor james foran"},{"sessionId":"11526","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Risk Factors and Response-Adapted Personalized Medicine","firstName":"Jorge ","lastName":"Sierra ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapy for Acute Myeloid Leukemia (AML) Adjusted to Genetic Data and Minimal Residual Disease: Results of the AML12 Trial of the Spanish Cetlam Group in Adults up to the Age of 70 Years","keywords":"","combinedName":"doctor jorge sierra"},{"sessionId":"11527","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: CAR-T Cell Immunotherapy","firstName":"Sara ","lastName":"Ghorashian ","credentials":"FRCPath, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Low Affinity CD19CAR Results in Durable Disease Remissions and Prolonged CAR T Cell Persistence without Severe CRS or Neurotoxicity in Patients with Paediatric ALL","keywords":"","combinedName":"doctor sara ghorashian"},{"sessionId":"11527","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: CAR-T Cell Immunotherapy","firstName":"Nirali N","lastName":"Shah ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD4/CD8 T-Cell Selection Enhances CD22 CAR-T Cell Transduction and in-Vivo CAR-T Expansion: Updated Results on Phase I Anti-CD22 CAR Dose Expansion Cohort","keywords":"","combinedName":"doctor nirali n shah"},{"sessionId":"11527","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: CAR-T Cell Immunotherapy","firstName":"Marco ","lastName":"Ruella ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Efficacy of Anti-CD22 Chimeric Antigen Receptor T Cells for B-Cell Acute Lymphoblastic Leukemia Is Correlated with the Length of the Scfv Linker and Can be Predicted Using Xenograft Models","keywords":"","combinedName":"doctor marco ruella"},{"sessionId":"11527","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: CAR-T Cell Immunotherapy","firstName":"Cameron ","lastName":"Turtle","credentials":"MBBS, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after CD19 CAR-T Cell Immunotherapy","keywords":"","combinedName":"doctor cameron turtle"},{"sessionId":"11527","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: CAR-T Cell Immunotherapy","firstName":"Haiying ","lastName":"Qin ","credentials":"MS","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel CD19/CD22 Bicistronic Chimeric Antigen Receptors Outperform Single or Bivalent Cars in Eradicating CD19+CD22+, CD19-, and CD22- Pre-B Leukemia","keywords":"","combinedName":"doctor haiying qin"},{"sessionId":"11527","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: CAR-T Cell Immunotherapy","firstName":"Julia ","lastName":"Wells ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Clinical Activity of Allogeneic Anti-CD22 CAR-T Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor julia wells"},{"sessionId":"11528","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Therapy, Excluding CAR-T Cell","firstName":"Hisayuki ","lastName":"Yao ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"13:15:00","endTime":"13:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Lymphoblastic Leukemia Cells Bypass the Blood Brain Barrier to Enter the CNS Via a Neuronal Developmental Pathway","keywords":"","combinedName":"doctor hisayuki yao"},{"sessionId":"11528","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Therapy, Excluding CAR-T Cell","firstName":"Nicola","lastName":"Goekbuget","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Minimal Residual Disease (MRD) and MRD-Based Treatment Decisions in Ph/BCR-ABL Negative Adult Acute Lymphoblastic Leukemia (ALL): Experience from the German Multicenter Study Group for Adult ALL (GMALL)","keywords":"","combinedName":"doctor nicola goekbuget"},{"sessionId":"11528","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Therapy, Excluding CAR-T Cell","firstName":"Morten ","lastName":"Tulstrup ","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Individualized 6-Mercaptopurine Increments in Consolidation Treatment of Childhood Acute Lymphoblastic Leukemia: A NOPHO ALL2008 Randomized Controlled Trial","keywords":"","combinedName":"doctor morten tulstrup"},{"sessionId":"11528","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Therapy, Excluding CAR-T Cell","firstName":"Nitin ","lastName":"Jain ","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"13:00:00","endTime":"13:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inotuzumab Ozogamicin in Combination with Bosutinib for Patients with Relapsed or Refractory Ph+ ALL or CML in Lymphoid Blast Phase","keywords":"","combinedName":"doctor nitin jain"},{"sessionId":"11528","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Therapy, Excluding CAR-T Cell","firstName":"Anne ","lastName":"Angiolillo ","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intensification of Oral Methotrexate Is Not Superior to Standard Methotrexate Dosing during Maintenance in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Childrens Oncology Group (COG) Study AALL0932 ","keywords":"","combinedName":"doctor anne angiolillo"},{"sessionId":"11528","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Therapy, Excluding CAR-T Cell","firstName":"John ","lastName":"Moppett ","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"UKALL 2011: Randomised Trial Investigating a Short Induction Dexamethasone Schedule for Children and Young Adults with Acute Lymphoblastic Leukaemia","keywords":"","combinedName":"doctor john moppett"},{"sessionId":"11529","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Innovative AML Treatment with Approved Agents","firstName":"Anjali ","lastName":"Advani ","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"13:15:00","endTime":"13:30:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML): Final Results","keywords":"","combinedName":"doctor anjali advani"},{"sessionId":"11529","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Innovative AML Treatment with Approved Agents","firstName":"Richard ","lastName":"Larson ","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Analysis of Maintenance Therapy and Post-Midostaurin Outcomes in the International Prospective Randomized, Placebo-Controlled, Double-Blind Trial (CALGB 10603/RATIFY [Alliance]) for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with FLT3 Mutations","keywords":"","combinedName":"doctor richard larson"},{"sessionId":"11529","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Innovative AML Treatment with Approved Agents","firstName":"Anna B","lastName":"Halpern ","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"13:00:00","endTime":"13:15:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (GCLAM) in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Grade Myeloid Neoplasms: Final Results from a Phase 1/2 Trial","keywords":"","combinedName":"doctor anna b halpern"},{"sessionId":"11529","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Innovative AML Treatment with Approved Agents","firstName":"Laura ","lastName":"Cicconi ","credentials":"","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prolonged Arsenic Trioxide (ATO) and All-Trans Retinoic Acid (ATRA) Therapy for Relapsed Acute Promyelocytic Leukemia","keywords":"","combinedName":"doctor laura cicconi"},{"sessionId":"11529","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Innovative AML Treatment with Approved Agents","firstName":"Maximilian ","lastName":"Stahl ","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of the Administration Schedule and Mutational Profile on Outcomes of Patients with Relapsed and Refractory Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Large, International, Multi-Center Analysis","keywords":"","combinedName":"doctor maximilian stahl"},{"sessionId":"11529","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Innovative AML Treatment with Approved Agents","firstName":"Jianxiang ","lastName":"Wang ","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Intermediate Dose Verse Conventional Dose Cytarabine in Induction Therapy in Adult Acute Myeloid Leukemia: A Phase ? Randomized Controlled Trial","keywords":"","combinedName":"doctor jianxiang wang"},{"sessionId":"11530","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Emerging Molecularly-Targeted Therapies in AML","firstName":"Lynn ","lastName":"Quek ","credentials":"FRCPath, DPhil, MBBS","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:30:00","endTime":"15:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Heterogeneity in Differentiation Response and Resistance to the IDH2 Inhibitor Enasidenib in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor lynn quek"},{"sessionId":"11530","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Emerging Molecularly-Targeted Therapies in AML","firstName":"Courtney ","lastName":"DiNardo","credentials":"MD, MSc","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ivosidenib (AG-120) in Mutant IDH1 AML and Advanced Hematologic Malignancies: Results of a Phase 1 Dose Escalation and Expansion Study","keywords":"","combinedName":"doctor courtney dinardo"},{"sessionId":"11530","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Emerging Molecularly-Targeted Therapies in AML","firstName":"Eytan ","lastName":"Stein ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ivosidenib or Enasidenib Combined with Standard Induction Chemotherapy Is Well Tolerated and Active in Patients with Newly Diagnosed AML with an IDH1 or IDH2 Mutation: Initial Results from a Phase 1 Trial","keywords":"","combinedName":"doctor eytan stein"},{"sessionId":"11530","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Emerging Molecularly-Targeted Therapies in AML","firstName":"Keith","lastName":"Pratz","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Results from a Phase 1 Study of Gilteritinib in Combination with Induction and Consolidation Chemotherapy in Subjects with Newly Diagnosed Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor keith pratz"},{"sessionId":"11530","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Emerging Molecularly-Targeted Therapies in AML","firstName":"Christoph","lastName":"Rollig","credentials":"MD, MSC","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial","keywords":"","combinedName":"doctor christoph rollig"},{"sessionId":"11530","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Emerging Molecularly-Targeted Therapies in AML","firstName":"Mahesh ","lastName":"Swaminathan ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial","keywords":"","combinedName":"doctor mahesh swaminathan"},{"sessionId":"11531","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML","firstName":"Tsila ","lastName":"Zuckerman ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:15:00","endTime":"19:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BST-236, a Novel Cytarabine Pro-Drug, Enables Safe and Effective Administration of High Dose Cytarabine to Older or Unfit Patients with Acute Leukemia. Results of a Phase I/II Study","keywords":"","combinedName":"doctor tsila zuckerman"},{"sessionId":"11531","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML","firstName":"Daniel ","lastName":"DeAngelo","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:30:00","endTime":"19:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"GMI-1271 Improves Efficacy and Safety of Chemotherapy in R/R and Newly Diagnosed Older Patients with AML: Results of a Phase 1/2 Study","keywords":"","combinedName":"doctor daniel deangelo"},{"sessionId":"11531","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML","firstName":"Andrew ","lastName":"Wei ","credentials":"MBBS, PhD, FRACP, FRCPA","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:30:00","endTime":"18:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 1/2 Study of Venetoclax with Low-Dose Cytarabine in Treatment-Naive, Elderly Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy: 1-Year Outcomes","keywords":"","combinedName":"doctor andrew wei"},{"sessionId":"11531","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML","firstName":"Gautam ","lastName":"Borthakur ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:00:00","endTime":"19:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II Study of CPX-351 (Cytarabine: Daunorubicin) Liposome Injection in Patients (Pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) at High Risk for Induction Mortality","keywords":"","combinedName":"doctor gautam borthakur"},{"sessionId":"11531","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML","firstName":"Norbert ","lastName":"Vey ","credentials":"","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:15:00","endTime":"18:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Randomized Phase2 Trial of Lirilumab (anti-KIR monoclonal antibody, mAb) As Maintenance Treatment in Elderly Patients (pts) with Acute Myeloid Leukemia (AML): Results of the Effikir Trial","keywords":"","combinedName":"doctor norbert vey"},{"sessionId":"11531","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML","firstName":"Hagop ","lastName":"Kantarjian","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:45:00","endTime":"19:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results of a Phase 3 Study of Elderly Patients with Newly Diagnosed AML Treated with Sapacitabine and Decitabine Administered in Alternating Cycles","keywords":"","combinedName":"doctor hagop kantarjian"},{"sessionId":"11532","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeted and Immune-based Approaches in the Treatment of AML","firstName":"Farhad","lastName":"Ravandi","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 2 Study of Combination of Cytarabine, Idarubicin, and Nivolumab for Initial Therapy of Patients with Newly Diagnosed Acute Myeloid Leukemia","keywords":"","combinedName":"doctor farhad ravandi"},{"sessionId":"11532","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeted and Immune-based Approaches in the Treatment of AML","firstName":"Naval","lastName":"Daver","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Results from a Phase Ib Study Evaluating BCL-2 Inhibitor Venetoclax in Combination with MEK Inhibitor Cobimetinib or MDM2 Inhibitor Idasanutlin in Patients with Relapsed or Refractory (R/R) AML","keywords":"","combinedName":"doctor naval daver"},{"sessionId":"11532","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeted and Immune-based Approaches in the Treatment of AML","firstName":"Lihua ","lastName":"Budde ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123-Specific CAR T Cells: A First-in-Human Clinical Trial","keywords":"","combinedName":"doctor lihua budde"},{"sessionId":"11532","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeted and Immune-based Approaches in the Treatment of AML","firstName":"Geoffrey ","lastName":"Uy ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Selinexor in Combination with Cladribine, Cytarabine and G-CSF for Relapsed or Refractory AML","keywords":"","combinedName":"doctor geoffrey uy"},{"sessionId":"11532","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeted and Immune-based Approaches in the Treatment of AML","firstName":"Samir ","lastName":"Barghout ","credentials":"BSPharm, MSc","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TAK-243 Is a Selective UBA1 Inhibitor That Displays Preclinical Activity in Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor samir barghout"},{"sessionId":"11532","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeted and Immune-based Approaches in the Treatment of AML","firstName":"Yinon ","lastName":"Ben-Neriah ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting the Transcriptional Addiction of Leukemia Stem Cells By a New Class of Protein Kinase Inhibitors","keywords":"","combinedName":"doctor yinon ben-neriah"},{"sessionId":"11533","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Promoting leukemogenesis and risk factors","firstName":"Bernhard ","lastName":"Lehnertz ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"H3K27M/I Mutations Promote Context-Dependent Transformation in Acute Myeloid Leukemia with RUNX1 Alterations","keywords":"","combinedName":"doctor bernhard lehnertz"},{"sessionId":"11533","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Promoting leukemogenesis and risk factors","firstName":"Christopher B","lastName":"Benton ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"JAK2 Variants Associated with Secondary-AML from MPN","keywords":"","combinedName":"doctor christopher b benton"},{"sessionId":"11533","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Promoting leukemogenesis and risk factors","firstName":"Elie","lastName":"Traer","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Marrow Stromal Cells Secrete FGF2 in Exosomes, Providing Paracrine Protection for Leukemia Cells from Kinase Inhibitors","keywords":"","combinedName":"doctor elie traer"},{"sessionId":"11533","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Promoting leukemogenesis and risk factors","firstName":"Casey J","lastName":"Brewer ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MiR-126 Promotes Leukemogenesis in Inv(16) Acute Myeloid Leukemia","keywords":"","combinedName":"doctor casey j brewer"},{"sessionId":"11533","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Promoting leukemogenesis and risk factors","firstName":"Alina ","lastName":"Rudorf ","credentials":"MSc","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NPM1c Alters FLT3-D835Y Localization and Signaling Thereby Inducing a Fulminant Myeloproliferative Disorder in Mice","keywords":"","combinedName":"doctor alina rudorf"},{"sessionId":"11533","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Promoting leukemogenesis and risk factors","firstName":"Andrew L","lastName":"Young ","credentials":"BA","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Utility of Detecting Rare Clonal Hematopoiesis for Predicting Leukemic Transformation in Healthy Individuals","keywords":"","combinedName":"doctor andrew l young"},{"sessionId":"11534","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic and predictive markers","firstName":"Raphael ","lastName":"Itzykson ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Interference of Signaling Mutations Holds Prognostic Relevance in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor raphael itzykson"},{"sessionId":"11534","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic and predictive markers","firstName":"Juliette ","lastName":"Lambert ","credentials":"","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Detection of WT1 minimal Residual Disease Predicts Outcome in Acute Myeloid Leukemia and Identify Patients with High Risk of Relapse Independently of Allogeneic Stem Cell Transplantation","keywords":"","combinedName":"doctor juliette lambert"},{"sessionId":"11534","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic and predictive markers","firstName":"Katherine","lastName":"Tarlock","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional Properties of Exon 17 KIT Mutations in Pediatric CBF AML Predict for Inferior Outcome and Enhanced Response to Tyrosine Kinase Inhibition: A Report from the Childrens Oncology Group","keywords":"","combinedName":"doctor katherine tarlock"},{"sessionId":"11534","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic and predictive markers","firstName":"Prajwal ","lastName":"Boddu ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Response Kinetics and Factors Predicting Survival Among Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor prajwal boddu"},{"sessionId":"11534","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic and predictive markers","firstName":"Stanley ","lastName":"Ng ","credentials":"","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Simultaneous Identification and Stratification of Low Molecular Risk AML Patients Using a Single LSC17-Based Nanostring Assay at Diagnosis","keywords":"","combinedName":"doctor stanley ng"},{"sessionId":"11534","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic and predictive markers","firstName":"Jenny ","lastName":"Smith ","credentials":"MSc, MEd","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The LSC17 Leukemic Stem Cell Signature Predicts Outcome in Pediatric Acute Myeloid Leukemia","keywords":"","combinedName":"doctor jenny smith"},{"sessionId":"11535","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic information and therapeutic implication","firstName":"Bei ","lastName":"Jia ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Eomes+ T-betint CD8 T Cells Are Functionally Impaired and Associate with Primary Refractory Disease in Patients with Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor bei jia"},{"sessionId":"11535","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic information and therapeutic implication","firstName":"Rhonda ","lastName":"Ries ","credentials":"MA","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Cancer Testis Antigens (CTAs) As Immuno-Therapeutic Targets in Pediatric AML","keywords":"","combinedName":"doctor rhonda ries"},{"sessionId":"11535","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic information and therapeutic implication","firstName":"Ann-Kathrin ","lastName":"Eisfeld ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutation Patterns Identify Adult Patients with De Novo Acute Myeloid Leukemia (AML) Aged 60 Years or Older Who Respond Favorably to Standard Chemotherapy: an Analysis of Alliance Studies","keywords":"","combinedName":"doctor ann-kathrin eisfeld"},{"sessionId":"11535","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic information and therapeutic implication","firstName":"Vera ","lastName":"Adema ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Therapeutic Targets for DNMT3A Mutant Myeloid Neoplasms","keywords":"","combinedName":"doctor vera adema"},{"sessionId":"11535","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic information and therapeutic implication","firstName":"Vincent-Philippe ","lastName":"Lavallee ","credentials":"M.D.","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Podoplanin Expression in the Bleeding Complications of Acute Promyelocytic Leukemias","keywords":"","combinedName":"doctor vincent-philippe lavallee"},{"sessionId":"11535","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic information and therapeutic implication","firstName":"Motohiro ","lastName":"Kato ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RARB Translocations in Acute Promyelocytic Leukemia without Raratranslocation","keywords":"","combinedName":"doctor motohiro kato"},{"sessionId":"11536","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Therapeutic targeting and clonal evolution in B-ALL","firstName":"Hui ","lastName":"Zhang ","credentials":"PhD, MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of Causal Variants at the GATA3 Loci Associated with Susceptibility to Ph-like Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor hui zhang"},{"sessionId":"11536","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Therapeutic targeting and clonal evolution in B-ALL","firstName":"Humberto ","lastName":"Contreras Trujillo ","credentials":"BS","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Competition of Cancer Cells during Acute Lymphoblastic Leukemia Treatment","keywords":"","combinedName":"doctor humberto contreras trujillo"},{"sessionId":"11536","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Therapeutic targeting and clonal evolution in B-ALL","firstName":"Eric A","lastName":"Severson ","credentials":"MD, PhD, MMSc","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Genomic Profiling Identifies Genomic Alterations That Define Philadelphia-like B-Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor eric a severson"},{"sessionId":"11536","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Therapeutic targeting and clonal evolution in B-ALL","firstName":"Shalini ","lastName":"Reshmi ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic and Outcome Analyses of Philadelphia Chromosome-like (Ph-like) NCI Standard Risk B-Acute Lymphoblastic Leukemia (SR B-ALL) Patients Treated on Childrens Oncology Group (COG) AALL0331","keywords":"","combinedName":"doctor shalini reshmi"},{"sessionId":"11536","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Therapeutic targeting and clonal evolution in B-ALL","firstName":"Allen Eng Juh","lastName":"Yeoh","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intensifying Treatment in Childhood B-Lymphoblastic Leukemia with IKZF1 Deletions Negates Its Adverse Outcome: Results of Ma-Spore ALL 2003 and 2010 Studies","keywords":"","combinedName":"doctor allen eng juh yeoh"},{"sessionId":"11536","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Therapeutic targeting and clonal evolution in B-ALL","firstName":"Ameera ","lastName":"Alsadeq ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting of the Interleukin-7 Receptor Alpha-Chain (IL-7Ra) Blocks B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Development and Reduces Leukemic Infiltration to the Central Nervous System (CNS)","keywords":"","combinedName":"doctor ameera alsadeq"},{"sessionId":"11537","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Biology, Signaling Mechanisms, and Response in ALL","firstName":"Waitman ","lastName":"Aumann ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Role for the CRM1 Nuclear Export Receptor in HOXA Gene Deregulation and CALM-AF10 Leukemogenesis","keywords":"","combinedName":"doctor waitman aumann"},{"sessionId":"11537","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Biology, Signaling Mechanisms, and Response in ALL","firstName":"Jingliao ","lastName":"Zhang ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aberrant FLT3 Transcription Arised from Polycomb Repressive Complex 2 Inactivation Indiactes a Potential Therapy Target for Pediatric T Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor jingliao zhang"},{"sessionId":"11537","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Biology, Signaling Mechanisms, and Response in ALL","firstName":"Bela","lastName":"Wrench","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adipocyte Induced Antagonism of ALL Growth Highlightsa Novel Inhibitory Niche and Potential Therapeutic Opportunity","keywords":"","combinedName":"doctor bela wrench"},{"sessionId":"11537","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Biology, Signaling Mechanisms, and Response in ALL","firstName":"Signe ","lastName":"Modvig ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Flow Cytometry Based MRD Monitoring Is an Accurate Risk Stratification Tool in Acute T-Lymphoblastic Leukemia","keywords":"","combinedName":"doctor signe modvig"},{"sessionId":"11537","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Biology, Signaling Mechanisms, and Response in ALL","firstName":"Melissa ","lastName":"Burns ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hedgehog Pathway Mutations Drive Oncogenic Transformation in High-Risk T-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor melissa burns"},{"sessionId":"11537","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Biology, Signaling Mechanisms, and Response in ALL","firstName":"Nitesh ","lastName":"Sharma ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"SOCS5 Regulates JAK-STAT Signaling and T-ALL Development","keywords":"","combinedName":"doctor nitesh sharma"},{"sessionId":"11538","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Genetic and Metabolomic Profiling in ALL","firstName":"Miriam ","lastName":"Butler ","credentials":"MSc","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A CRISPR/Cas9 Based Kinome Screen Identifies Bruton Tyrosine Kinase (BTK) As an Important Determinant of Asparaginase Treatment Response in Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor miriam butler"},{"sessionId":"11538","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Genetic and Metabolomic Profiling in ALL","firstName":"Carolina ","lastName":"Caserta ","credentials":"MS","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Distinct MiR-126 Expression Describes a Non-Genetic but Functional Intra-Tumoral Heterogeneity in Primary Human B-ALL and Can be Prospectively Used to Identify Aggressive Subclones in NSG Mice","keywords":"","combinedName":"doctor carolina caserta"},{"sessionId":"11538","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Genetic and Metabolomic Profiling in ALL","firstName":"Sofie ","lastName":"Gottschalk Hjfeldt ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Variants in the HLA-genes Are Associated with PEG-asparaginase Allergy - a Genome Wide Association Study on the NOPHO ALL2008 Protocol","keywords":"","combinedName":"doctor sofie gottschalk hjfeldt"},{"sessionId":"11538","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Genetic and Metabolomic Profiling in ALL","firstName":"Adam ","lastName":"de Smith ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Large Multi-Ethnic Genome Wide Association Study Reveals Novel Genetic Associations with Childhood Acute Lymphoblastic Leukemia at Chromosomes 8q24 and 17q12","keywords":"","combinedName":"doctor adam de smith"},{"sessionId":"11538","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Genetic and Metabolomic Profiling in ALL","firstName":"Jeremy ","lastName":"Schraw ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Metabolomic Profiling Improves Prediction of Early Disease Response and Relapse in Pediatric Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor jeremy schraw"},{"sessionId":"11538","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Genetic and Metabolomic Profiling in ALL","firstName":"Maoxiang ","lastName":"Qian ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TP53 Germline Variations Influence the Predisposition and Prognosis of Acute Lymphoblastic Leukemia in Children","keywords":"","combinedName":"doctor maoxiang qian"},{"sessionId":"11539","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Genomic characterization of lymphoma and beyond","firstName":"Bruno ","lastName":"Grande ","credentials":"BSc","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma","keywords":"","combinedName":"doctor bruno grande"},{"sessionId":"11539","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Genomic characterization of lymphoma and beyond","firstName":"Daisuke ","lastName":"Ennishi ","credentials":"MD,PhD,","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Characterization and Clinical Impact of Loss of MHC Class I and II Expression in De NovoDiffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor daisuke ennishi"},{"sessionId":"11539","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Genomic characterization of lymphoma and beyond","firstName":"Bjoern ","lastName":"Chapuy ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetically-Defined Diffuse Large B-Cell Lymphoma Subsets Arise By Distinct Pathogenetic Mechanisms and Predict Outcome","keywords":"","combinedName":"doctor bjoern chapuy"},{"sessionId":"11539","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Genomic characterization of lymphoma and beyond","firstName":"Pierre ","lastName":"Milpied ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Germinal Center Program De-Synchronization and Intra-Patient Heterogeneity in Follicular Lymphoma B-Cells Revealed By Integrative Single-Cell Analysis","keywords":"","combinedName":"doctor pierre milpied"},{"sessionId":"11539","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Genomic characterization of lymphoma and beyond","firstName":"Ryan ","lastName":"Morin ","credentials":"PhD,BSc,MSc","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Recurrent Non-Coding Driver Mutations in Non-Hodgkin Lymphomas through Integrative Genomic Analysis of 777 Patients","keywords":"","combinedName":"doctor ryan morin"},{"sessionId":"11539","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Genomic characterization of lymphoma and beyond","firstName":"Sandeep","lastName":"Dave","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrative Analysis of 1001 Diffuse Large B Cell Lymphoma Identifies Novel Oncogenic Roles for Rhoa","keywords":"","combinedName":"doctor sandeep dave"},{"sessionId":"11540","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Molecular approaches to describe, monitor, and target lymphoma","firstName":"David ","lastName":"Kurtz","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Circulating Tumor DNA Is a Reliable Measure of Tumor Burden at Diagnosis of Diffuse Large B Cell Lymphoma: An International Reproducibility Study","keywords":"","combinedName":"doctor david kurtz"},{"sessionId":"11540","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Molecular approaches to describe, monitor, and target lymphoma","firstName":"Fabrice ","lastName":"Jardin ","credentials":"","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Genotype Analysis of Tumor and Cell-Free DNA By Ultra-Deep Targeted Sequencing: Correlation with PET-Scan Imaging in a Prospective Cohort of Diffuse Large B-Cell Lymphoma Patients","keywords":"","combinedName":"doctor fabrice jardin"},{"sessionId":"11540","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Molecular approaches to describe, monitor, and target lymphoma","firstName":"Rossella ","lastName":"Marullo ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Exportin-1 Connects Dynamic Transcription and Translation of Genotoxic Stress Genes in Diffuse Large B-Cell Lymphoma Patients","keywords":"","combinedName":"doctor rossella marullo"},{"sessionId":"11540","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Molecular approaches to describe, monitor, and target lymphoma","firstName":"Valeria ","lastName":"Spina ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genotyping of Classical Hodgkin Lymphoma on the Liquid Biopsy","keywords":"","combinedName":"doctor valeria spina"},{"sessionId":"11540","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Molecular approaches to describe, monitor, and target lymphoma","firstName":"Joseph G","lastName":"Schroers-Martin ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hierarchy in Somatic Mutations Detected in Circulating and Tissue-Resident Follicular Lymphoma Precursors before Clinical Diagnosis","keywords":"","combinedName":"doctor joseph g schroers-martin"},{"sessionId":"11540","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Molecular approaches to describe, monitor, and target lymphoma","firstName":"Kristy ","lastName":"Stengel ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapeutic Targeting of HDAC3 in FOXO1-Mutant DLBCL","keywords":"","combinedName":"doctor kristy stengel"},{"sessionId":"11541","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Novel Mechanisms Implicated in Lymphoma Biology","firstName":"Paul ","lastName":"Galardy ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Catalytically Active UCH-L1 Is Required for MYC Driven B-Cell Lymphomagenesis","keywords":"","combinedName":"doctor paul galardy"},{"sessionId":"11541","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Novel Mechanisms Implicated in Lymphoma Biology","firstName":"Nan ","lastName":"Hu ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional Analyses of BTK Mutations in Follicular Lymphoma","keywords":"","combinedName":"doctor nan hu"},{"sessionId":"11541","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Novel Mechanisms Implicated in Lymphoma Biology","firstName":"Maria Nieves ","lastName":"Calvo Vidal ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HSP90 Facilitates Oncogene-Induced Metabolic Reprogramming in B-Cell Lymphomas","keywords":"","combinedName":"doctor maria nieves calvo vidal"},{"sessionId":"11541","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Novel Mechanisms Implicated in Lymphoma Biology","firstName":"Mariateresa ","lastName":"Fulciniti ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:45:00","endTime":"12:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PAK4 Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldestrostom Macroglobulinemia","keywords":"","combinedName":"doctor mariateresa fulciniti"},{"sessionId":"11541","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Novel Mechanisms Implicated in Lymphoma Biology","firstName":"Meng ","lastName":"Li ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"SIRT3 Is a Novel Metabolic Driver of and Therapeutic Target for Chemotherapy Resistant Dlbcls","keywords":"","combinedName":"doctor meng li"},{"sessionId":"11541","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Novel Mechanisms Implicated in Lymphoma Biology","firstName":"Changju ","lastName":"QU ","credentials":"MD PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Smoothened Stabilizes and Protects TRAF6 from Proteosomal Degradation: A Novel Non-Canonical Role of Smoothened with Implications in Lymphoma Biology","keywords":"","combinedName":"doctor changju qu"},{"sessionId":"11542","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Prognostic Biomarkers and Immune Mechanisms in Lymphoma","firstName":"Maria Florencia","lastName":"Cayrol ","credentials":"","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of the Integrin aV3 Improves the Immune and Anti-Lymphoma Effects of Bexarotene in Cutaneous T-Cell Lymphoma (CTCL)","keywords":"","combinedName":"doctor maria florencia cayrol"},{"sessionId":"11542","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Prognostic Biomarkers and Immune Mechanisms in Lymphoma","firstName":"Cedric ","lastName":"Menard ","credentials":"","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lenalidomide Treatment Restores In Vivo T Cell Activity in Relapsed/Refractory FL and DLBCL","keywords":"","combinedName":"doctor cedric menard"},{"sessionId":"11542","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Prognostic Biomarkers and Immune Mechanisms in Lymphoma","firstName":"Magdalena ","lastName":"Klanova ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials","keywords":"","combinedName":"doctor magdalena klanova"},{"sessionId":"11542","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Prognostic Biomarkers and Immune Mechanisms in Lymphoma","firstName":"Yasunori ","lastName":"Kogure ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:30:00","endTime":"15:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Mechanism of Post-Transcriptional Regulation of PD-L1 Expression By 3-UTR Binding Proteins","keywords":"","combinedName":"doctor yasunori kogure"},{"sessionId":"11542","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Prognostic Biomarkers and Immune Mechanisms in Lymphoma","firstName":"Masao ","lastName":"Nakagawa ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T-Cell Leukemia/Lymphoma","keywords":"","combinedName":"doctor masao nakagawa"},{"sessionId":"11542","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Prognostic Biomarkers and Immune Mechanisms in Lymphoma","firstName":"Joshua ","lastName":"Tobin ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Tumor Microenvironment Is Independently Prognostic of Conventional and Clinicogenetic Risk Models in Follicular Lymphoma","keywords":"","combinedName":"doctor joshua tobin"},{"sessionId":"11543","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Follicular Lymphoma, First Line","firstName":"Andrew ","lastName":"Evens","credentials":"DO, MSc","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A 3-Arm Randomized Phase II Trial with Bendamustine/Rituximab Therapy in Untreated High Risk (HR) Follicular Lymphoma (FL): Bortezomib Induction or Novel IMiD Continuation (BIONIC) Study from the ECOG-ACRIN Cancer Research Group","keywords":"","combinedName":"doctor andrew evens"},{"sessionId":"11543","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Follicular Lymphoma, First Line","firstName":"Brad ","lastName":"Kahl","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessment of Maintenance Rituximab after First-Line Bendamustine-Rituximab in Patients with Follicular Lymphoma: An Analysis from the BRIGHT Trial","keywords":"","combinedName":"doctor brad kahl"},{"sessionId":"11543","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Follicular Lymphoma, First Line","firstName":"Mathias J","lastName":"Rummel ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Four Versus Two Years of Rituximab Maintenance (R-maintenance) Following Bendamustine Plus Rituximab (B-R): Initial Results of a Prospective, Randomized Multicenter Phase 3 Study in First-Line Follicular Lymphoma (the StiL NHL7-2008 MAINTAIN study)","keywords":"","combinedName":"doctor mathias j rummel"},{"sessionId":"11543","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Follicular Lymphoma, First Line","firstName":"Gilles ","lastName":"Salles ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Term Follow-up of the PRIMA Study: Half of Patients Receiving Rituximab Maintenance Remain Progression Free at 10 Years","keywords":"","combinedName":"doctor gilles salles"},{"sessionId":"11543","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Follicular Lymphoma, First Line","firstName":"Kristie ","lastName":"Blum ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Randomized Phase 2 Trial of Ofatumumab and Bendamustine Versus Ofatumumab, Bendamustine, and Bortezomib Induction and Maintenance Therapy in Patients (pts) with Previously Untreated High Risk Follicular Lymphoma (FL): Results from CALGB 50904 (Alliance)","keywords":"","combinedName":"doctor kristie blum"},{"sessionId":"11543","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Follicular Lymphoma, First Line","firstName":"Anas","lastName":"Younes","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Atezolizumab in Combination with Obinutuzumab and Bendamustine in Patients with Previously Untreated Follicular Lymphoma: An Interim Analysis","keywords":"","combinedName":"doctor anas younes"},{"sessionId":"11544","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Mantle Cell Lymphoma, New Therapies","firstName":"Michael ","lastName":"Wang ","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"13:00:00","endTime":"13:15:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in the Phase 2 ACE-LY-004 Study","keywords":"","combinedName":"doctor michael wang"},{"sessionId":"11544","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Mantle Cell Lymphoma, New Therapies","firstName":"Jia ","lastName":"Ruan ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Initial Treatment with Lenalidomide Plus Rituximab for Mantle Cell Lymphoma: 5-Year Follow-up and Correlative Analysis from a Multi-Center Phase II Study","keywords":"","combinedName":"doctor jia ruan"},{"sessionId":"11544","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Mantle Cell Lymphoma, New Therapies","firstName":"Simon ","lastName":"Rule ","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Median 3.5-Year Follow-up of Ibrutinib Treatment in Patients with Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis","keywords":"","combinedName":"doctor simon rule"},{"sessionId":"11544","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Mantle Cell Lymphoma, New Therapies","firstName":"Eva ","lastName":"Hoster ","credentials":"","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rituximab Maintenance after First-Line Immunochemotherapy in Mantle Cell Lymphoma: Long-Term Follow-up of the Randomized European MCL Elderly Trial","keywords":"","combinedName":"doctor eva hoster"},{"sessionId":"11544","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Mantle Cell Lymphoma, New Therapies","firstName":"Constantine ","lastName":"Tam ","credentials":"MBBS, MD, FRACP, FRCPA","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Patients with Indolent and Aggressive Non Hodgkins Lymphoma","keywords":"","combinedName":"doctor constantine tam"},{"sessionId":"11544","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Mantle Cell Lymphoma, New Therapies","firstName":"Xavier ","lastName":"Troussard ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"13:15:00","endTime":"13:30:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Vemurafenib in Advanced Patients with Hairy Cell Leukemia (HCL): Results of the Acs Phase II Trial","keywords":"","combinedName":"doctor xavier troussard"},{"sessionId":"11545","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Indolent Lymphomas, Novel Therapies, and Diagnostics","firstName":"Jean-Marie ","lastName":"Michot ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CC-122, a Novel Cereblon Modulating Agent, in Combination with Obinutuzumab (GA101) in Patients with Relapsed and Refractory (R/R) BCell NonHodgkin Lymphoma (NHL)","keywords":"","combinedName":"doctor jean-marie michot"},{"sessionId":"11545","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Indolent Lymphomas, Novel Therapies, and Diagnostics","firstName":"Emmanuel ","lastName":"Bachy ","credentials":"","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"13:00:00","endTime":"13:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Discovery and Validation of a Simplified Scoring System (the PRIMA-Prognostic Index) in De NovoFollicular Lymphoma Treated Initially with Immunochemotherapy","keywords":"","combinedName":"doctor emmanuel bachy"},{"sessionId":"11545","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Indolent Lymphomas, Novel Therapies, and Diagnostics","firstName":"Loretta","lastName":"Nastoupil","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"13:15:00","endTime":"13:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Complete Response Rates with Pembrolizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: Results of an Open-Label, Phase II Study","keywords":"","combinedName":"doctor loretta nastoupil"},{"sessionId":"11545","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Indolent Lymphomas, Novel Therapies, and Diagnostics","firstName":"Andres ","lastName":"Forero-Torres ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from a Phase 1/2 Study of INCB050465, a Highly Selective and Highly Potent PI3Kd Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies (CITADEL-101)","keywords":"","combinedName":"doctor andres forero-torres"},{"sessionId":"11545","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Indolent Lymphomas, Novel Therapies, and Diagnostics","firstName":"Enrico ","lastName":"Tiacci ","credentials":"","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Chemotherapy-Free Combination of Vemurafenib and Rituximab Produces Deep and Durable Responses in Relapsed or Refractory Hairy Cell Leukemia (HCL) Patients","keywords":"","combinedName":"doctor enrico tiacci"},{"sessionId":"11545","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Indolent Lymphomas, Novel Therapies, and Diagnostics","firstName":"Carla ","lastName":"Casulo ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in Follicular Lymphoma: Results from the Follicular Lymphoma Analysis of Surrogacy Hypothesis (FLASH) Investigation Using Individual Data from 5,453 Patients on 13 Clinical Trials","keywords":"","combinedName":"doctor carla casulo"},{"sessionId":"11546","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Hodgkin LymphomaChemotherapy and PET Studies","firstName":"Anita ","lastName":"Kumar ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 20 Gy Involved-Site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma","keywords":"","combinedName":"doctor anita kumar"},{"sessionId":"11546","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Hodgkin LymphomaChemotherapy and PET Studies","firstName":"James ","lastName":"Russell ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Advanced-Stage Hodgkin Lymphoma in the East of England Cancer Network: A 10-Year Comparative Analysis of Outcomes for Patients Treated with ABVD or Escalated BEACOPPin the Non-Trial Setting Compared with Age-Matched Patients Treated in the Multinational RATHLTrial","keywords":"","combinedName":"doctor james russell"},{"sessionId":"11546","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Hodgkin LymphomaChemotherapy and PET Studies","firstName":"Peter ","lastName":"Borchmann ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Interim PET in Patients with Advanced-Stage Hodgkins Lymphoma Treated within the Phase 3 GHSG HD18 Study","keywords":"","combinedName":"doctor peter borchmann"},{"sessionId":"11546","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Hodgkin LymphomaChemotherapy and PET Studies","firstName":"Luc-Matthieu ","lastName":"Fornecker ","credentials":"","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:30:00","endTime":"15:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup","keywords":"","combinedName":"doctor luc-matthieu fornecker"},{"sessionId":"11546","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Hodgkin LymphomaChemotherapy and PET Studies","firstName":"Robert ","lastName":"Chen","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II Study of Brentuximab Vedotin Plus Ibrutinib for Patients with Relapsed/Refractory Hodgkin Lymphoma","keywords":"","combinedName":"doctor robert chen"},{"sessionId":"11546","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Hodgkin LymphomaChemotherapy and PET Studies","firstName":"Andrew ","lastName":"Evens","credentials":"DO, MSc","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sequential Brentuximab Vedotin (Bv) before and after Adriamycin, Vinblastine, and Dacarbazine (Bv-AVD) for Older Patients with Untreated Classical Hodgkin Lymphoma (cHL): Final Results from a Multicenter Phase II Study","keywords":"","combinedName":"doctor andrew evens"},{"sessionId":"11547","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Hodgkin Lymphoma Immunotherapy Studies; nodular lymphocyte predominant Hodgkin lymphoma clinical studies","firstName":"Sven ","lastName":"Borchmann ","credentials":"","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:45:00","endTime":"12:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Active Surveillance for Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma","keywords":"","combinedName":"doctor sven borchmann"},{"sessionId":"11547","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Hodgkin Lymphoma Immunotherapy Studies; nodular lymphocyte predominant Hodgkin lymphoma clinical studies","firstName":"Cdric ","lastName":"Rossi ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of Chemotherapy or Chemo-Anti-PD-1 Combination after Unsatisfactory Response of Anti-PD-1 Therapy for Relapsed and Refractory Hodgkin Lymphoma: A Retrospective Series from Lysa Centers","keywords":"","combinedName":"doctor cdric rossi"},{"sessionId":"11547","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Hodgkin Lymphoma Immunotherapy Studies; nodular lymphocyte predominant Hodgkin lymphoma clinical studies","firstName":"Radhakrishnan ","lastName":"Ramchandren ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:15:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nivolumab for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma (cHL): Results from the Phase 2 Checkmate 205 Study","keywords":"","combinedName":"doctor radhakrishnan ramchandren"},{"sessionId":"11547","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Hodgkin Lymphoma Immunotherapy Studies; nodular lymphocyte predominant Hodgkin lymphoma clinical studies","firstName":"Jonathon B","lastName":"Cohen","credentials":"MD,MS","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 Checkmate 205 Study","keywords":"","combinedName":"doctor jonathon b cohen"},{"sessionId":"11547","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Hodgkin Lymphoma Immunotherapy Studies; nodular lymphocyte predominant Hodgkin lymphoma clinical studies","firstName":"Jakub","lastName":"Svoboda","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pilot Study of Non-Viral, RNA-Redirected Autologous Anti-CD19 Chimeric Antigen Receptor Modified T-Cells in Patients with Refractory/Relapsed Hodgkin Lymphoma (HL)","keywords":"","combinedName":"doctor jakub svoboda"},{"sessionId":"11547","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Hodgkin Lymphoma Immunotherapy Studies; nodular lymphocyte predominant Hodgkin lymphoma clinical studies","firstName":"Alex ","lastName":"Herrera","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from a Phase 1/2 Study of Brentuximab Vedotin in Combination with Nivolumab in Patients with Relapsed or Refractory Hodgkin Lymphoma","keywords":"","combinedName":"doctor alex herrera"},{"sessionId":"11548","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: T-Cell Lymphoma Clinical Studies","firstName":"Neha ","lastName":"Mehta-Shah ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase Ib/IIa Trial of the Combination of Romidepsin, Lenalidomide and Carfilzomib in Patients with Relapsed/Refractory Lymphoma Shows Complete Responses in Relapsed and Refractory B- and T-Cell Lymphomas","keywords":"","combinedName":"doctor neha mehta-shah"},{"sessionId":"11548","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: T-Cell Lymphoma Clinical Studies","firstName":"Youn ","lastName":"Kim ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anti-CCR4 Monoclonal Antibody, Mogamulizumab, Demonstrates Significant Improvement in PFS Compared to Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma (CTCL): Results from the Phase III M&#65;&#86;&#79;&#82;&#73;&#67;Study","keywords":"","combinedName":"doctor youn kim"},{"sessionId":"11548","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: T-Cell Lymphoma Clinical Studies","firstName":"Alison ","lastName":"Moskowitz","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vitro, In Vivo, and Parallel Phase I Evidence Support the Safety and Activity of Duvelisib, a PI3K-d,? Inhibitor, in Combination with Romidepsin or Bortezomib in Relapsed/Refractory T-Cell Lymphoma","keywords":"","combinedName":"doctor alison moskowitz"},{"sessionId":"11548","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: T-Cell Lymphoma Clinical Studies","firstName":"Christiane ","lastName":"Querfeld ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 1 Study of the Safety and Efficacy of MRG-106, a Synthetic Inhibitor of microRNA-155, in CTCL Patients","keywords":"","combinedName":"doctor christiane querfeld"},{"sessionId":"11548","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: T-Cell Lymphoma Clinical Studies","firstName":"Andrei ","lastName":"Shustov ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pralatrexate in Combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL): A Phase 1 Dose-Escalation Study","keywords":"","combinedName":"doctor andrei shustov"},{"sessionId":"11548","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: T-Cell Lymphoma Clinical Studies","firstName":"Martin Bjerregrd","lastName":"Pedersen ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their ALK, DUSP22 and TP63 Gene Rearrangement Status  a Joined Nordic Lymphoma Group and Mayo Clinic Analysis","keywords":"","combinedName":"doctor martin bjerregrd pedersen"},{"sessionId":"11549","sessionTitle":"625.  Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Novel targeted therapies for Non-Hodgkin's Lymphomas","firstName":"Bernd ","lastName":"Boidol ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"First in Human Response of BCL-2 Inhibitor Venetoclax in T-Cell Prolymphocytic Leukemia","keywords":"","combinedName":"doctor bernd boidol"},{"sessionId":"11549","sessionTitle":"625.  Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Novel targeted therapies for Non-Hodgkin's Lymphomas","firstName":"Arturo ","lastName":"Molina ","credentials":"MD,MS, FACP","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Frequency of CD74 Expression in B-Cell Non-Hodgkins Lymphoma (NHL) and Targeting with S?RO-001, a Novel Anti-CD74 Antibody Drug Conjugate (ADC) with Potent In Vitro Cytotoxicty and In Vivo Anti-Tumor Activity","keywords":"","combinedName":"doctor arturo molina"},{"sessionId":"11549","sessionTitle":"625.  Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Novel targeted therapies for Non-Hodgkin's Lymphomas","firstName":"Raphael","lastName":"Koch","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vitro and pre-Clinical In Vivo evidence Support MDMX/MDM2 As Common Vulnerabilities across TP53-Wild-Type T-Cell Lymphomas That Are Targetable with the a-Helical p53 Stapled Peptide Alrn-6924","keywords":"","combinedName":"doctor raphael koch"},{"sessionId":"11549","sessionTitle":"625.  Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Novel targeted therapies for Non-Hodgkin's Lymphomas","firstName":"Jonathan ","lastName":"Rink ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled By Functional Lipoprotein Nanoparticles and the B Cell Receptor Inhibitor Ibrutinib: A Therapeutic Strategy Dependent on Cell of Origin (COO)","keywords":"","combinedName":"doctor jonathan rink"},{"sessionId":"11549","sessionTitle":"625.  Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Novel targeted therapies for Non-Hodgkin's Lymphomas","firstName":"Tran ","lastName":"Nguyen ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting T-Cell Receptor Signaling Pathway in Angioimmunoblastic T-Cell Lymphoma","keywords":"","combinedName":"doctor tran nguyen"},{"sessionId":"11549","sessionTitle":"625.  Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Novel targeted therapies for Non-Hodgkin's Lymphomas","firstName":"Changying ","lastName":"Jiang ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting the Paracaspase MALT1: A Potential Therapy to Overcome Ibrutinib Resistance in Relapsed/Refractory Mantle Cell Lymphoma Patients","keywords":"","combinedName":"doctor changying jiang"},{"sessionId":"11550","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas","firstName":"Steven E","lastName":"Kauder ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ALX148 Is a High Affinity Sirpa Fusion Protein That Blocks CD47, Enhances the Activity of Anti-Cancer Antibodies and Checkpoint Inhibitors, and Has a Favorable Safety Profile in Preclinical Models","keywords":"","combinedName":"doctor steven e kauder"},{"sessionId":"11550","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas","firstName":"Moritz ","lastName":"Bewarder ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"B-Cell Receptor Antigens As the Targeting Moiety for Bispecific Constructs  a Novel Treatment Approach for B-Cell Lymphomas","keywords":"","combinedName":"doctor moritz bewarder"},{"sessionId":"11550","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas","firstName":"Sneha ","lastName":"Purvey ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD19-Chimeric Antigen Receptor (CAR) Engineered Natural Killer (NK) Cell Therapy: Novel Off the Shelf Immunotherapy in CD20 Resistant B-Cell Non-Hodgkin Lymphoma (NHL) Cell Lines, Primary NHL Cells, and aHuman Lymphoma Xenograft Model","keywords":"","combinedName":"doctor sneha purvey"},{"sessionId":"11550","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas","firstName":"Idit ","lastName":"Sagiv Barfi ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Eradication of Systemic Lymphoma By Local Immunotherapy","keywords":"","combinedName":"doctor idit sagiv barfi"},{"sessionId":"11550","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas","firstName":"Danilo ","lastName":"Fiore ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Generation and Application of T-Cell Lymphoma Patient Derived Tumor Xenograft Models","keywords":"","combinedName":"doctor danilo fiore"},{"sessionId":"11550","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas","firstName":"Cody ","lastName":"Ramirez ","credentials":"BS","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integration of Whole Exome and RNA Sequencing Identifies Neoepitope Vaccine Candidates in >90 Percent of Follicular Lymphoma Patients","keywords":"","combinedName":"doctor cody ramirez"},{"sessionId":"11551","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Immune-Based Therapeutic Approaches","firstName":"Sattva ","lastName":"Neelapu","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Comparison of One Year Outcomes in ZUMA-1 (axicabtagene ciloleucel) and SCHOLAR-1 in Patients with Refractory, Aggressive Non-Hodgkinlymphoma (NHL)","keywords":"","combinedName":"doctor sattva neelapu"},{"sessionId":"11551","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Immune-Based Therapeutic Approaches","firstName":"Luke Paul ","lastName":"Akard ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ACTR087, Autologous T Lymphocytes Expressing Antibody Coupled T-Cell Receptors (ACTR), Induces Complete Responses in Patients with Relapsed or Refractory CD20-Positive B-Cell Lymphoma, in Combination with Rituximab","keywords":"","combinedName":"doctor luke paul akard"},{"sessionId":"11551","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Immune-Based Therapeutic Approaches","firstName":"Jeanette ","lastName":"Doorduijn ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Rituximab in Primary Central Nervous System Lymphoma  results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study","keywords":"","combinedName":"doctor jeanette doorduijn"},{"sessionId":"11551","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Immune-Based Therapeutic Approaches","firstName":"Jeremy ","lastName":"Abramson ","credentials":"MD, MMSc","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Durable CR Rates in Relapsed/Refractory (R/R) Aggressive B-NHL Treated with the CD19-Directed CAR T Cell Product JCAR017 (TRANSCEND NHL 001): Defined Composition Allows for Dose-Finding and Definition of Pivotal Cohort","keywords":"","combinedName":"doctor jeremy abramson"},{"sessionId":"11551","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Immune-Based Therapeutic Approaches","firstName":"Sattva ","lastName":"Neelapu","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Follow-up ZUMA-1: A Pivotal Trial of Axicabtagene Ciloleucel (Axi-Cel; KTE-C19) in Patients with Refractory Aggressive Non-Hodgkin Lymphoma (NHL)","keywords":"","combinedName":"doctor sattva neelapu"},{"sessionId":"11551","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Immune-Based Therapeutic Approaches","firstName":"Stephen ","lastName":"Schuster","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Primary Analysis of Juliet: A Global, Pivotal, Phase 2 Trial of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor stephen schuster"},{"sessionId":"11552","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Novel Agents and Upfront Approaches","firstName":"Peter ","lastName":"Martin ","credentials":"FRCPC, MD, MS","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase I, Open-Label, Multicenter Trial of Oral Azacitidine (CC-486) Plus R-CHOP in Patients with High-Risk, Previously Untreated Diffuse Large B-Cell Lymphoma, Grade 3B Follicular Lymphoma, or Transformed Lymphoma","keywords":"","combinedName":"doctor peter martin"},{"sessionId":"11552","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Novel Agents and Upfront Approaches","firstName":"Jakub","lastName":"Svoboda","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Brentuximab Vedotin with R-CHP Chemotherapy As Frontline Treatment for Patients with CD30 Positive Primary Mediastinal Large B-Cell, Diffuse Large B-Cell, and Grey Zone Lymphomas: Results of a Phase I/II Multisite Trial","keywords":"","combinedName":"doctor jakub svoboda"},{"sessionId":"11552","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Novel Agents and Upfront Approaches","firstName":"Brad ","lastName":"Kahl","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:15:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Encouraging Early Results from the First in-Human Clinical Trial of Adct-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate, in Relapsed/Refractory B-Cell Lineage Non-Hodgkin Lymphoma","keywords":"","combinedName":"doctor brad kahl"},{"sessionId":"11552","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Novel Agents and Upfront Approaches","firstName":"Jason ","lastName":"Westin ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"14:45:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lenalidomide and Obinutuzumab with CHOP for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Final Phase I/II Results","keywords":"","combinedName":"doctor jason westin"},{"sessionId":"11552","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Novel Agents and Upfront Approaches","firstName":"Rene-Olivier ","lastName":"Casasnovas ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Obinutuzumab Versus Rituximab in Combination with ACVBP-14 or CHOP-14 Following a PET-Driven Strategy in Aa-IPI 1-3 DLBCL Patients (< 60 years): Third Planned Interim and Final Analyses of the Gained Trial","keywords":"","combinedName":"doctor rene-olivier casasnovas"},{"sessionId":"11552","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Novel Agents and Upfront Approaches","firstName":"Mark ","lastName":"Roschewski ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:15:00","endTime":"14:30:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk-Adapted Therapy in Adults with Burkitt Lymphoma: Results of NCI 9177, a Multicenter Prospective Phase II Study of DA-EPOCH-R","keywords":"","combinedName":"doctor mark roschewski"},{"sessionId":"11553","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: PET-Guided Therapy and Prognostic Models in Diffuse Large B-Cell Lymphoma","firstName":"Lale ","lastName":"Kostakoglu ","credentials":"","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Baseline PET-Derived Metabolic Tumor Volume Metrics Predict Progression-Free and Overall Survival in DLBCL after First-Line Treatment: Results from the Phase 3 GOYA Study","keywords":"","combinedName":"doctor lale kostakoglu"},{"sessionId":"11553","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: PET-Guided Therapy and Prognostic Models in Diffuse Large B-Cell Lymphoma","firstName":"David ","lastName":"Kurtz","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of a Dynamic Model for Personalized Risk Assessment in Large B-Cell Lymphoma","keywords":"","combinedName":"doctor david kurtz"},{"sessionId":"11553","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: PET-Guided Therapy and Prognostic Models in Diffuse Large B-Cell Lymphoma","firstName":"Amir ","lastName":"Behdad ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diffuse Large B-Cell Lymphomas Transformed from or with Concurrent Follicular Lymphoma Demonstrate Similar Clinical Outcomes As De-Novo Diffuse Large B-Cell Lymphomas, Except for Cases Harboring Double Hit Rearrangements","keywords":"","combinedName":"doctor amir behdad"},{"sessionId":"11553","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: PET-Guided Therapy and Prognostic Models in Diffuse Large B-Cell Lymphoma","firstName":"Antonio ","lastName":"Gutierrez ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of the MD Anderson Tumor Score and Their Tumor Related Prognostic Variables in the Rituximab Era","keywords":"","combinedName":"doctor antonio gutierrez"},{"sessionId":"11553","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: PET-Guided Therapy and Prognostic Models in Diffuse Large B-Cell Lymphoma","firstName":"Ciara Louise","lastName":"Freeman ","credentials":"MRCP, MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Results of PET-Guided Radiation Therapy in Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma Treated with R-CHOP in British Columbia","keywords":"","combinedName":"doctor ciara louise freeman"},{"sessionId":"11553","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: PET-Guided Therapy and Prognostic Models in Diffuse Large B-Cell Lymphoma","firstName":"Mohamed ","lastName":"Shanavas ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 3- Georgia BR 1-3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The T-Cell Receptor Repertoire Predicts Interim-PET in Patients with DLBCL Treated with R-CHOP: An Observational Study from a Prospective Clinical Trial","keywords":"","combinedName":"doctor mohamed shanavas"},{"sessionId":"11554","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Molecular Characterization of Diffuse Large B Cell Lymphoma","firstName":"Thierry Jo","lastName":"Molina ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A New Immunohistochemical Algorithm Using Four Antibodies Has a High Concordance with Gene Expression Profiling Defined ABC and GCB Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor thierry jo molina"},{"sessionId":"11554","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Molecular Characterization of Diffuse Large B Cell Lymphoma","firstName":"Edith ","lastName":"Szafer-Glusman ","credentials":"","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"13:00:00","endTime":"13:15:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Simulation Analysis to Evaluate the Effect of Prospective Biomarker Testing on Progression-Free Survival (PFS) in DLBCL","keywords":"","combinedName":"doctor edith szafer-glusman"},{"sessionId":"11554","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Molecular Characterization of Diffuse Large B Cell Lymphoma","firstName":"Edith ","lastName":"Szafer-Glusman ","credentials":"","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BCL2 Expression Identifies a Population with Unmet Medical Need in Previously Untreated (1L) Patients with DLBCL","keywords":"","combinedName":"doctor edith szafer-glusman"},{"sessionId":"11554","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Molecular Characterization of Diffuse Large B Cell Lymphoma","firstName":"Jo-Anne ","lastName":"Vergilio ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays","keywords":"","combinedName":"doctor jo-anne vergilio"},{"sessionId":"11554","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Molecular Characterization of Diffuse Large B Cell Lymphoma","firstName":"Allison ","lastName":"Barraclough ","credentials":"MBBS","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated with R-CHOP  Radiotherapy: An International Multi-Center Retrospective Study","keywords":"","combinedName":"doctor allison barraclough"},{"sessionId":"11554","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Molecular Characterization of Diffuse Large B Cell Lymphoma","firstName":"Tomohiro ","lastName":"Yabushita ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"13:15:00","endTime":"13:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Prognostic Significance of the Complete IgH Rearrangement Pattern Using the BIOMED-2 Protocol in Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor tomohiro yabushita"},{"sessionId":"11555","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Predicting Efficacy and Safety of CAR-T cells and Checkpoint Blockade","firstName":"Yucai ","lastName":"Wang ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Characteristics and Outcome of Diffuse Large B-Cell Lymphoma with 9p24.1 Copy Number Alterations","keywords":"","combinedName":"doctor yucai wang"},{"sessionId":"11555","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Predicting Efficacy and Safety of CAR-T cells and Checkpoint Blockade","firstName":"Zijun Yidan","lastName":"Xu-Monette ","credentials":"PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Significance of PD-1 and PD-L1 Expression and Ongoing Interaction in the Tumor Microenvironment in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP","keywords":"","combinedName":"doctor zijun yidan xu-monette"},{"sessionId":"11555","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Predicting Efficacy and Safety of CAR-T cells and Checkpoint Blockade","firstName":"Ronald ","lastName":"McCord ","credentials":"","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"14:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Expression of Programmed Death-Ligand 1 (PD-L1) Correlates with Macrophage Gene Expression and Is Associated with Prolonged Progression-Free Survival (PFS) in Patients (pts) with First-Line (1L) Diffuse Large B-Cell Lymphoma (DLBCL)","keywords":"","combinedName":"doctor ronald mccord"},{"sessionId":"11555","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Predicting Efficacy and Safety of CAR-T cells and Checkpoint Blockade","firstName":"Tanaya ","lastName":"Shree ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased Incidence of Autoimmune and Infectious Diseases Among a Large Group of Diffuse Large B-Cell Lymphoma (DLBCL) Survivors: A Population-Based Study","keywords":"","combinedName":"doctor tanaya shree"},{"sessionId":"11555","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Predicting Efficacy and Safety of CAR-T cells and Checkpoint Blockade","firstName":"Tanya","lastName":"Siddiqi","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient Characteristics and Pre-Infusion Biomarkers of Inflammation Correlate with Clinical Outcomes after Treatment with the Defined Composition, CD19-Targeted CAR T Cell Product, JCAR017","keywords":"","combinedName":"doctor tanya siddiqi"},{"sessionId":"11555","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Predicting Efficacy and Safety of CAR-T cells and Checkpoint Blockade","firstName":"Christina ","lastName":"Swanson ","credentials":"PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:15:00","endTime":"14:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predicting Clinical Response and Safety of JCAR017 in B-NHL Patients: Potential Importance of Tumor Microenvironment Biomarkers and CAR T-Cell Tumor Infiltration","keywords":"","combinedName":"doctor christina swanson"},{"sessionId":"11556","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Outcomes in Rare Entities: HTLV-1 ATLL, Gray Zone Lymphoma, Primary CNS Lymphoma, and Intravascular DLBCL","firstName":"Luis E","lastName":"Malpica Castillo ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epidemiology, Clinical Features, and Outcome of HTLV-1 Related Adult T-Cell Leukemia-Lymphoma in a Prevalent Area in the United States","keywords":"","combinedName":"doctor luis e malpica castillo"},{"sessionId":"11556","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Outcomes in Rare Entities: HTLV-1 ATLL, Gray Zone Lymphoma, Primary CNS Lymphoma, and Intravascular DLBCL","firstName":"Andrew ","lastName":"Evens","credentials":"DO, MSc","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gray Zone Lymphoma (GZL) with Features Intermediate between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): A Pathologic Consensus Study with Patient Outcomes and Prognosticationacross 15 North American Centers","keywords":"","combinedName":"doctor andrew evens"},{"sessionId":"11556","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Outcomes in Rare Entities: HTLV-1 ATLL, Gray Zone Lymphoma, Primary CNS Lymphoma, and Intravascular DLBCL","firstName":"Elisabeth ","lastName":"Schorb ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Induction Chemo-Immunotherapy with the Matrix Regimen in Patients with Newly Diagnosed PCNSL  a Multicenter Retrospective Analysis on Feasibility and Effectiveness in Routine Clinical Practice","keywords":"","combinedName":"doctor elisabeth schorb"},{"sessionId":"11556","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Outcomes in Rare Entities: HTLV-1 ATLL, Gray Zone Lymphoma, Primary CNS Lymphoma, and Intravascular DLBCL","firstName":"Yasuhito ","lastName":"Suehara ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Liquid Biopsy for the Identification of Intravascular Large B-Cell Lymphoma","keywords":"","combinedName":"doctor yasuhito suehara"},{"sessionId":"11556","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Outcomes in Rare Entities: HTLV-1 ATLL, Gray Zone Lymphoma, Primary CNS Lymphoma, and Intravascular DLBCL","firstName":"Marcus ","lastName":"Geer ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multicenter Retrospective Study of Features and Outcomes of Patients with Intravascular DLBCL Treated at Academic Institutions within the United States","keywords":"","combinedName":"doctor marcus geer"},{"sessionId":"11556","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Outcomes in Rare Entities: HTLV-1 ATLL, Gray Zone Lymphoma, Primary CNS Lymphoma, and Intravascular DLBCL","firstName":"Luis E","lastName":"Malpica Castillo ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting CD30 Expression in Adult T-Cell Leukemia-Lymphoma (ATLL)","keywords":"","combinedName":"doctor luis e malpica castillo"},{"sessionId":"11557","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Novel Targets and CML Stem Cell Biology","firstName":"Ghayas ","lastName":"Issa ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical and Molecular Characterization of Clonal Chromosomal Abnormalities Appearing in Philadelphia-Negative Metaphases of Chronic Phase CML","keywords":"","combinedName":"doctor ghayas issa"},{"sessionId":"11557","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Novel Targets and CML Stem Cell Biology","firstName":"Mario ","lastName":"Mauri ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"De Novo UBE2A Mutations Are Recurrently Acquired during CML Progression and Interfere with Myeloid Differentiation Pathways","keywords":"","combinedName":"doctor mario mauri"},{"sessionId":"11557","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Novel Targets and CML Stem Cell Biology","firstName":"Hein ","lastName":"Than ","credentials":"MD, FRCPath, MRCP","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of Nucleocytoplasmic Export Enhances Selective Elimination of Leukemic Stem Cells in Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor hein than"},{"sessionId":"11557","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Novel Targets and CML Stem Cell Biology","firstName":"Jeevisha ","lastName":"Bajaj ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Regulation of Asymmetric Division in Myeloid Leukemogenesis","keywords":"","combinedName":"doctor jeevisha bajaj"},{"sessionId":"11557","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Novel Targets and CML Stem Cell Biology","firstName":"Manuela ","lastName":"Mancini ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"SETD2 Loss of Function Is a Recurrent Event in Advanced-Phase Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor manuela mancini"},{"sessionId":"11557","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Novel Targets and CML Stem Cell Biology","firstName":"Danilo ","lastName":"Perrotti ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Bone Marrow Niche Uses Mir-300 As a Biological Rheostat to Selectively Control Stem Cell-Driven Malignant Hematopoiesis and Innate Anti-Cancer Immunity","keywords":"","combinedName":"doctor danilo perrotti"},{"sessionId":"11558","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Results of Clinical Trials","firstName":"Carlo","lastName":"Gambacorti-Passerini","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:30:00","endTime":"18:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bosutinib Vs Imatinib for Newly Diagnosed Chronic Myeloid Leukemia (CML) in the BFORE Trial: 18 Month Follow-up","keywords":"","combinedName":"doctor carlo gambacorti-passerini"},{"sessionId":"11558","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Results of Clinical Trials","firstName":"Rdiger ","lastName":"Hehlmann ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:45:00","endTime":"19:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Final Evaluation of Randomized CML-Study IV: 10-Year Survival and Evolution of Terminal Phase","keywords":"","combinedName":"doctor rdiger hehlmann"},{"sessionId":"11558","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Results of Clinical Trials","firstName":"Franck Emmanuel","lastName":"Nicolini ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:15:00","endTime":"19:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nilotinib Versus Nilotinib Combined to Pegylated-Interferon Alfa 2a in First-Line Chronic Phase Chronic Myelogenous Leukemia Patients. Interim Analysis of a Phase III Trial","keywords":"","combinedName":"doctor franck emmanuel nicolini"},{"sessionId":"11558","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Results of Clinical Trials","firstName":"Anna G","lastName":"Turkina ","credentials":"Prof., MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:15:00","endTime":"18:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PF-114 Mesylate, a Novel Third Generation ATP-Competitive BCR-ABL Tyrosine Kinase Inhibitor: First Safety and Efficacy Data from a Phase I Study in Patients with CML with Failure of Prior TKI Therapy","keywords":"","combinedName":"doctor anna g turkina"},{"sessionId":"11558","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Results of Clinical Trials","firstName":"Meinolf ","lastName":"Suttorp ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:00:00","endTime":"19:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Response to Front-Line Imatinib Treatment in Children and Adolescents with CML  Data from a Large Pediatric Cohort","keywords":"","combinedName":"doctor meinolf suttorp"},{"sessionId":"11558","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Results of Clinical Trials","firstName":"Tim ","lastName":"Brmmendorf ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:30:00","endTime":"19:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Second-Line Bosutinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CP CML) Resistant or Intolerant to Prior Imatinib: An 8-Year Update","keywords":"","combinedName":"doctor tim brmmendorf"},{"sessionId":"11559","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: NGS-based and Mechanistic Studies","firstName":"Zimu ","lastName":"Gong ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cytogenetics-Based Risk Prediction of Blastic Transformation of CML Treated with Tyrosine Kinase Inhibitors","keywords":"","combinedName":"doctor zimu gong"},{"sessionId":"11559","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: NGS-based and Mechanistic Studies","firstName":"Shady ","lastName":"Adnan Awad ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Progression-Associated Mutations in Chronic Myeloid Leukemia (CML) By Comparative Genomic Analysis","keywords":"","combinedName":"doctor shady adnan awad"},{"sessionId":"11559","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: NGS-based and Mechanistic Studies","firstName":"Georg-Nikolaus ","lastName":"Franke ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence of Low Level Mutations in Newly Diagnosed CML Patients: A Substudy of the German Tiger Trial","keywords":"","combinedName":"doctor georg-nikolaus franke"},{"sessionId":"11559","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: NGS-based and Mechanistic Studies","firstName":"Susan ","lastName":"Branford ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrative Genomics Reveals Cancer Associated Mutations Are Common at Diagnosis of CML in Patients with Poor Response to TKI Therapy","keywords":"","combinedName":"doctor susan branford"},{"sessionId":"11559","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: NGS-based and Mechanistic Studies","firstName":"Monica ","lastName":"Bocchia ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Persistence of Residual Circulating CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients in Treatment Free Remission","keywords":"","combinedName":"doctor monica bocchia"},{"sessionId":"11559","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: NGS-based and Mechanistic Studies","firstName":"Simona ","lastName":"Soverini ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:15:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whats Next in CML  a Prospective Study EvaluatingSanger Sequencing and Next Generation Sequencing (NGS) for BCR-ABL1 Kinase Domain (KD) Mutation Screening","keywords":"","combinedName":"doctor simona soverini"},{"sessionId":"11560","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators","firstName":"Susanne","lastName":"Saussele","credentials":"MD ","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"\"Duration of Deep Molecular Response\" Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - Results from the EURO-SKI Trial","keywords":"","combinedName":"doctor susanne saussele"},{"sessionId":"11560","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators","firstName":"Frdric ","lastName":"Millot ","credentials":"","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Advanced Phases at Diagnosis of Childhood Chronic Myeloid Leukemia : The Experience of the International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped Study)","keywords":"","combinedName":"doctor frdric millot"},{"sessionId":"11560","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators","firstName":"Neil ","lastName":"Shah ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dasatinib Discontinuation in Patients (Pts) with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) and Stable Deep Molecular Response (DASFREE)","keywords":"","combinedName":"doctor neil shah"},{"sessionId":"11560","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators","firstName":"Young Rok ","lastName":"Do ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deeper Molecular Response in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 36 Months Follow-up","keywords":"","combinedName":"doctor young rok do"},{"sessionId":"11560","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators","firstName":"Delphine ","lastName":"Rea ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Responses after Switching from a Standard-Dose Twice-Daily Nilotinib Regimen to a Reduced-Dose Once-Daily Schedule in Patients with Chronic Myeloid Leukemia: A Real Life Observational Study (NILO-RED)","keywords":"","combinedName":"doctor delphine rea"},{"sessionId":"11560","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators","firstName":"Adi ","lastName":"Klil-Drori ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Persistence with Generic Imatinib for Chronic Myeloid Leukemia: A Matched Cohort Study","keywords":"","combinedName":"doctor adi klil-drori"},{"sessionId":"11561","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant  ","firstName":"Bridget ","lastName":"Marcellino ","credentials":"MD. Ph.D.","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Advanced Forms of the Myeloproliferative Neoplasms AreAssociated with  Chromosomal Abnormalities Involving 1q and 12q: Implicating MDM2 and MDM4 in Disease Progression","keywords":"","combinedName":"doctor bridget marcellino"},{"sessionId":"11561","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant  ","firstName":"Lucia ","lastName":"Masarova ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"14:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics and Survival of Patients with Chronic Phase Myelofibrosis and Elevated Blasts (5-9%), and the Effect of Therapy with JAK2 Inhibitor Ruxolitinib","keywords":"","combinedName":"doctor lucia masarova"},{"sessionId":"11561","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant  ","firstName":"Haris ","lastName":"Ali ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Survival in Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation Using Fludarabine/Melphalan Conditioning Regimen","keywords":"","combinedName":"doctor haris ali"},{"sessionId":"11561","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant  ","firstName":"Alessandro ","lastName":"Vannucchi","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:15:00","endTime":"14:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MIPSS70: Mutation-Enhanced Prognostic System for Transplant Age Patients with Primary Myelofibrosis","keywords":"","combinedName":"doctor alessandro vannucchi"},{"sessionId":"11561","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant  ","firstName":"Kamal ","lastName":"Menghrajani ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"SETBP1 and NRAS Mutations Are Frequent Events in Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML) Lacking JAK-STAT Activating Mutations","keywords":"","combinedName":"doctor kamal menghrajani"},{"sessionId":"11561","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant  ","firstName":"Tiziano ","lastName":"Barbui ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor tiziano barbui"},{"sessionId":"11562","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase III and Long-Term Outcome Studies in MPNs","firstName":"Anna ","lastName":"Godfrey ","credentials":"BMBCh, PhD, MRCP, FRCPath","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hydroxycarbamide Plus Aspirin Vs Aspirin Alone in Intermediate Risk Essential Thrombocythemia: Results of the PT-1 International, Prospective, Randomized Clinical Trial","keywords":"","combinedName":"doctor anna godfrey"},{"sessionId":"11562","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase III and Long-Term Outcome Studies in MPNs","firstName":"Jean-Christophe ","lastName":"Ianotto ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Term Outcome of Patients with MPN-Associated Myelofibrosis Treated with Peg-Interferon-a2a, a French Intergroup of Myeloproliferative Neoplasms (FIM) Study","keywords":"","combinedName":"doctor jean-christophe ianotto"},{"sessionId":"11562","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase III and Long-Term Outcome Studies in MPNs","firstName":"Jiwon ","lastName":"Kim ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pulmonary Hypertension Independently Shortens Survival of Patients with Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor jiwon kim"},{"sessionId":"11562","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase III and Long-Term Outcome Studies in MPNs","firstName":"Jean-Jacques ","lastName":"Kiladjian ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from the 208-Week (4-Year) Follow-up of RESPONSETrial, a Phase 3 Study Comparing Ruxolitinib (Rux) with Best Available Therapy (BAT) for the Treatment of Polycythemia Vera (PV)","keywords":"","combinedName":"doctor jean-jacques kiladjian"},{"sessionId":"11562","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase III and Long-Term Outcome Studies in MPNs","firstName":"Heinz ","lastName":"Gisslinger ","credentials":"","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ropeginterferon Alfa-2b Induces High Rates of Clinical, Hematological and Molecular Responses in Polycythemia Vera: Two-Year Results from the First Prospective Randomized Controlled Trial","keywords":"","combinedName":"doctor heinz gisslinger"},{"sessionId":"11562","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase III and Long-Term Outcome Studies in MPNs","firstName":"Abdulraheem ","lastName":"Yacoub ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Arm Salvage Therapy with Pegylated Interferon Alfa-2a for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia Who Are Either Hydroxyurea-Resistant or Intolerant: Final Results of the Myeloproliferative Disorders-Research Consortium (MPD-RC) Protocol 111 Global Phase II Trial","keywords":"","combinedName":"doctor abdulraheem yacoub"},{"sessionId":"11563","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase I/II Trials of Novel Agents in MPNs","firstName":"Alessandro ","lastName":"Rambaldi ","credentials":"MD, Prof","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Two-Part Study of Givinostat in Patients with Polycythemia Vera: The Maximum Tolerated Dose Selection and the Proof of Concept Final Results","keywords":"","combinedName":"doctor alessandro rambaldi"},{"sessionId":"11563","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase I/II Trials of Novel Agents in MPNs","firstName":"Naveen ","lastName":"Pemmaraju ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim Phase 2 Clinical Trial Results for LCL161, an Oral Smac Mimetic, in Patients with Intermediate or High Risk Myelofibrosis ","keywords":"","combinedName":"doctor naveen pemmaraju"},{"sessionId":"11563","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase I/II Trials of Novel Agents in MPNs","firstName":"John","lastName":"Mascarenhas","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:15:00","endTime":"16:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Open Label Phase I Study of Single Agent Oral RG7388 (idasanutlin) in Patients with Polycythemia Vera and Essential Thrombocythemia","keywords":"","combinedName":"doctor john mascarenhas"},{"sessionId":"11563","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase I/II Trials of Novel Agents in MPNs","firstName":"Eli L","lastName":"Diamond ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 2 Trial of Single-Agent Cobimetinib for Adults with BRAF V600-Mutant and Wild-Type Histiocytic Disorders","keywords":"","combinedName":"doctor eli l diamond"},{"sessionId":"11563","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase I/II Trials of Novel Agents in MPNs","firstName":"Aaron ","lastName":"Gerds ","credentials":"MD,MS","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I/II Trial of Glasdegib in Heavily Pre-Treated Patients with Primary or Secondary Myelofibrosis","keywords":"","combinedName":"doctor aaron gerds"},{"sessionId":"11563","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase I/II Trials of Novel Agents in MPNs","firstName":"Prithviraj ","lastName":"Bose ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sotatercept (ACE-011) Alone and in Combination with Ruxolitinib in Patients (pts) with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) and Anemia","keywords":"","combinedName":"doctor prithviraj bose"},{"sessionId":"11564","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Identification of novel targets for the treatment of myeloproliferative neoplasms","firstName":"Shannon ","lastName":"Elf ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional and Molecular Basis of Thrombopoietin Receptor Activation By Mutant Calreticulin","keywords":"","combinedName":"doctor shannon elf"},{"sessionId":"11564","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Identification of novel targets for the treatment of myeloproliferative neoplasms","firstName":"Cansu ","lastName":"Cimen Bozkus ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Checkpoint Blockade Enhances Mutated Calreticulin-Induced T Cell Immunity in Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor cansu cimen bozkus"},{"sessionId":"11564","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Identification of novel targets for the treatment of myeloproliferative neoplasms","firstName":"Eleni ","lastName":"Louka ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular and Functional Characterization of Disease-Propagating Stem Cells in Juvenile Myelomonocytic Leukemia","keywords":"","combinedName":"doctor eleni louka"},{"sessionId":"11564","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Identification of novel targets for the treatment of myeloproliferative neoplasms","firstName":"Sara ","lastName":"Meyer ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Cell Non-Autonomous MAPK Activation As a Novel Therapeutic Strategy in Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor sara meyer"},{"sessionId":"11564","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Identification of novel targets for the treatment of myeloproliferative neoplasms","firstName":"Zhimin ","lastName":"Gu ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting the Epigenetic and Metabolic Vulnerabilities of Ezh2-Deficiency-Induced Myeloid Neoplasms","keywords":"","combinedName":"doctor zhimin gu"},{"sessionId":"11564","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Identification of novel targets for the treatment of myeloproliferative neoplasms","firstName":"Sakiko ","lastName":"Suzuki ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting the Mechanism of c-Mpl Exon-Inclusion through Antisense Oligonucleotides Yields a Dominant Negative Isoform","keywords":"","combinedName":"doctor sakiko suzuki"},{"sessionId":"11565","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Molecular events occurring within the myeloproliferative neoplasms","firstName":"Bethan ","lastName":"Psaila ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Single-Cell Approach to Unraveling Abnormal Megakaryocyte Differentiation and Function in Myelofibrosis","keywords":"","combinedName":"doctor bethan psaila"},{"sessionId":"11565","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Molecular events occurring within the myeloproliferative neoplasms","firstName":"Christopher ","lastName":"Hahn ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Duplication on Chromosome 14q Identified in Familial Predisposition to Myeloid Malignancies and Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor christopher hahn"},{"sessionId":"11565","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Molecular events occurring within the myeloproliferative neoplasms","firstName":"Linda ","lastName":"Resar ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Mobility Group A1 Chromatin Remodeling Proteins: Potential Therapeutic Targets Involved in Polycythemia Vera Transformation to Acute Leukemia in Humans and JAK2 V617F Transgenic Mouse Models","keywords":"","combinedName":"doctor linda resar"},{"sessionId":"11565","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Molecular events occurring within the myeloproliferative neoplasms","firstName":"Norihiro ","lastName":"Murakami ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrated Molecular Profiling of Juvenile Myelomonocytic Leukemia","keywords":"","combinedName":"doctor norihiro murakami"},{"sessionId":"11565","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Molecular events occurring within the myeloproliferative neoplasms","firstName":"Hamza ","lastName":"Celik ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Jarid2 Restricts Long-Term Repopulating Stem Cell Capacity in Multipotent Progenitors and Acts As Tumor Suppressor in Chronic Myeloid Neoplasms","keywords":"","combinedName":"doctor hamza celik"},{"sessionId":"11565","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Molecular events occurring within the myeloproliferative neoplasms","firstName":"Jacob ","lastName":"Grinfeld ","credentials":"MBChB, BSc, MRCP, FRCPath","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Personalized Prognostic Predictions for Patients with Myeloproliferative Neoplasms through Integration of Comprehensive Genomic and Clinical Information","keywords":"","combinedName":"doctor jacob grinfeld"},{"sessionId":"11566","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Immune and niche dysfunction in MDS","firstName":"Syed A","lastName":"Mian ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bone Marrow Stem Cells from Patients with Myelodysplastic Syndrome (MDS) Engraft and Migrate in-between the Humanized Niches in Immuno-Compromised Mouse Models","keywords":"","combinedName":"doctor syed a mian"},{"sessionId":"11566","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Immune and niche dysfunction in MDS","firstName":"Sheng ","lastName":"Wei ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immunodepletion of MDSC By AMV564, a Novel Tetravalent Bispecific CD33/CD3 T Cell Engager Restores Immune Homeostasis in MDS in Vitro","keywords":"","combinedName":"doctor sheng wei"},{"sessionId":"11566","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Immune and niche dysfunction in MDS","firstName":"Darlene ","lastName":"Monlish ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Loss of Toll-like Receptor 2 Results in Accelerated Leukemogenesis in the NUP98-HOXD13 Mouse Model of MDS","keywords":"","combinedName":"doctor darlene monlish"},{"sessionId":"11566","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Immune and niche dysfunction in MDS","firstName":"Yue ","lastName":"Wei ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overexpression of Histone Demethylase KDM6B in the Hematopoietic Compartment Promotes the Effect of Innate Immune Activation and Results in Myelodysplastic Syndrome (MDS)-like Phenotype in Mice","keywords":"","combinedName":"doctor yue wei"},{"sessionId":"11566","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Immune and niche dysfunction in MDS","firstName":"Erika ","lastName":"Eksioglu ","credentials":"PhD, MS","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The S100A9/Fto Axis Induces Formation of RNA:DNA Hybrids That Serve As Damps Initiating Myeloid Skewing & Genetic Injury in MDS","keywords":"","combinedName":"doctor erika eksioglu"},{"sessionId":"11566","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Immune and niche dysfunction in MDS","firstName":"May ","lastName":"Daher ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The TGF-/SMAD Signaling Pathway As a Mediator of NK Cell Dysfunction and Immune Evasion in Myelodysplastic Syndrome","keywords":"","combinedName":"doctor may daher"},{"sessionId":"11567","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Molecular Mechanisms of MDS","firstName":"Kyung-Rok ","lastName":"Yu ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Non-Human Primate CRISPR/Cas9 Model of Clonal Hematopoiesis of Indeterminate Potential Demonstrates Expansion of TET2-Disrupted Clones","keywords":"","combinedName":"doctor kyung-rok yu"},{"sessionId":"11567","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Molecular Mechanisms of MDS","firstName":"Mai ","lastName":"Aly ","credentials":"M.D.","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional and Biological Implications of CUX1 Mutations and Deletions in Myeloid Neoplasms","keywords":"","combinedName":"doctor mai aly"},{"sessionId":"11567","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Molecular Mechanisms of MDS","firstName":"Masahiro ","lastName":"Uni ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Modeling ASXL1 Mutation Revealed Myelodysplasia Caused By Derepression of p16Ink4a through Aberrant PRC1-Mediated Histone Modification","keywords":"","combinedName":"doctor masahiro uni"},{"sessionId":"11567","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Molecular Mechanisms of MDS","firstName":"Yi-Jou ","lastName":"Huang ","credentials":"BS","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RUNX1 Deficiency and SRSF2 Mutation Cooperate to Promote Myelodysplastic Syndrome Development","keywords":"","combinedName":"doctor yi-jou huang"},{"sessionId":"11567","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Molecular Mechanisms of MDS","firstName":"Wan Yee ","lastName":"Leong ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Spliceosomal Mutations Induce R Loop-Associated ATR Signaling","keywords":"","combinedName":"doctor wan yee leong"},{"sessionId":"11567","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Molecular Mechanisms of MDS","firstName":"Eric A","lastName":"Severson ","credentials":"MD, PhD, MMSc","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unrecognized Clonal Hematopoiesis of Indeterminate Potential in Solid Tumors: Implications for Interpretation of Molecular Testing","keywords":"","combinedName":"doctor eric a severson"},{"sessionId":"11568","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Predicting Drug Response Using Novel Genomic Algorithms","firstName":"Aziz","lastName":"Nazha","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Personalized Prediction Model to Risk Stratify Patients with Myelodysplastic Syndromes (MDS)","keywords":"","combinedName":"doctor aziz nazha"},{"sessionId":"11568","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Predicting Drug Response Using Novel Genomic Algorithms","firstName":"Raphael ","lastName":"Itzykson ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Prognostic Classifier Based on Early Platelet Drop in Lower-Risk MDS. a Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry","keywords":"","combinedName":"doctor raphael itzykson"},{"sessionId":"11568","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Predicting Drug Response Using Novel Genomic Algorithms","firstName":"Panagiotis Theodorou","lastName":"Diamantopoulos ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"13:00:00","endTime":"13:15:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bone Marrow Levels of PARP1 mRNA Predict Response to Treatment with 5-Azacytidine in Patients with Myelodysplastic Syndrome","keywords":"","combinedName":"doctor panagiotis theodorou diamantopoulos"},{"sessionId":"11568","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Predicting Drug Response Using Novel Genomic Algorithms","firstName":"Aziz","lastName":"Nazha","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Biomarkers to Predict Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS)","keywords":"","combinedName":"doctor aziz nazha"},{"sessionId":"11568","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Predicting Drug Response Using Novel Genomic Algorithms","firstName":"Matthieu ","lastName":"Duchmann ","credentials":"","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia (CMML) Patients Treated with Hypomethylating Agents. a Report on 183 Patients","keywords":"","combinedName":"doctor matthieu duchmann"},{"sessionId":"11568","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Predicting Drug Response Using Novel Genomic Algorithms","firstName":"Eric ","lastName":"Padron ","credentials":"MD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"13:15:00","endTime":"13:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Promising Results of a Phase 1/2 Clinical Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia","keywords":"","combinedName":"doctor eric padron"},{"sessionId":"11569","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Inflammation, Immunity, and Iron","firstName":"Elina K","lastName":"Cook ","credentials":"","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"13:15:00","endTime":"13:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Feeding the Fire: The Comorbid and Inflammatory Backdrop of Clonal Hematopoiesis of Indeterminate Potential (CHIP) By Mutation Subtype","keywords":"","combinedName":"doctor elina k cook"},{"sessionId":"11569","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Inflammation, Immunity, and Iron","firstName":"Remco J","lastName":"Molenaar ","credentials":"","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Rates of Atherosclerotic Disease-Related Mortalityin Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Patients Associated with TET2-Mutations","keywords":"","combinedName":"doctor remco j molenaar"},{"sessionId":"11569","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Inflammation, Immunity, and Iron","firstName":"David A","lastName":"Sallman ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Checkpoint Profiling of TP53 Mutant and Wild-Type Myeloid Malignancies: TP53 Mutations Direct Immune Tolerance Via an Immunosuppressive Phenotype","keywords":"","combinedName":"doctor david a sallman"},{"sessionId":"11569","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Inflammation, Immunity, and Iron","firstName":"Marlijn ","lastName":"Hoeks ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"13:00:00","endTime":"13:15:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Treatment with Iron Chelation Therapy in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry","keywords":"","combinedName":"doctor marlijn hoeks"},{"sessionId":"11569","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Inflammation, Immunity, and Iron","firstName":"Yazan ","lastName":"Madanat ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutational Signatures Associated with Intensity and Duration of Smoking in Myelodysplastic Syndromes (MDS)","keywords":"","combinedName":"doctor yazan madanat"},{"sessionId":"11569","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Inflammation, Immunity, and Iron","firstName":"Maximilian ","lastName":"Stahl ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Use of Immunosuppressive Therapy (IST) in Patients with the Myelodysplastic Syndromes (MDS): Clinical Outcomes and Their Predictors in a Large International Patient Cohort","keywords":"","combinedName":"doctor maximilian stahl"},{"sessionId":"11570","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Genes Inform Genes, Morphology, and Clinical Outcomes","firstName":"Bing ","lastName":"Li ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Features and Biological Implications of U2AF1 Mutations in Myelodysplastic Syndromes","keywords":"","combinedName":"doctor bing li"},{"sessionId":"11570","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Genes Inform Genes, Morphology, and Clinical Outcomes","firstName":"Raphael ","lastName":"Itzykson ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Granulomonocytic Progenitors (GMPs) Are Key Target Cells of Azacitidine in MDS and AML","keywords":"","combinedName":"doctor raphael itzykson"},{"sessionId":"11570","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Genes Inform Genes, Morphology, and Clinical Outcomes","firstName":"ELISA ","lastName":"Bono ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hypoplastic Myelodysplastic Syndrome: Clinical, Histopathological and Molecular Characterization","keywords":"","combinedName":"doctor elisa bono"},{"sessionId":"11570","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Genes Inform Genes, Morphology, and Clinical Outcomes","firstName":"Yasunobu ","lastName":"Nagata ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Non-Random Interactions between Founder and Subclonal Mutations Shape the Clinical and Morphological Features of MDS","keywords":"","combinedName":"doctor yasunobu nagata"},{"sessionId":"11570","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Genes Inform Genes, Morphology, and Clinical Outcomes","firstName":"Maher ","lastName":"Albitar ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Potential Familial Predisposition to Hematologic Neoplasm Detected Incidentally in Adult Patients Presenting with Myeloid Neoplasms","keywords":"","combinedName":"doctor maher albitar"},{"sessionId":"11570","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Genes Inform Genes, Morphology, and Clinical Outcomes","firstName":"Vera ","lastName":"Adema ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Somatic PRPF8 Mutations in Myeloid Neoplasia","keywords":"","combinedName":"doctor vera adema"},{"sessionId":"11571","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Therapeutic Resistance in CLL","firstName":"Giovanni ","lastName":"Del Poeta ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Apoptosis ResistanceandNOTCH1 MutationsImpair Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) Patients Treatedwith Ibrutinib","keywords":"","combinedName":"doctor giovanni del poeta"},{"sessionId":"11571","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Therapeutic Resistance in CLL","firstName":"Fary ","lastName":"Diop ","credentials":"MSc","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:15:00","endTime":"16:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BRAF and BIRC3 Mutations Stratify a Poor Prognostic Subgroup in FCR Treated Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor fary diop"},{"sessionId":"11571","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Therapeutic Resistance in CLL","firstName":"Eric ","lastName":"Eldering ","credentials":"","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dissecting the Role of Individual Bcl-2 Members in Response and Resistance to Ibrutinib or Venetoclax in CLL","keywords":"","combinedName":"doctor eric eldering"},{"sessionId":"11571","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Therapeutic Resistance in CLL","firstName":"Lukas ","lastName":"Frenzel ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mechanisms of Venetoclax Resistance in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor lukas frenzel"},{"sessionId":"11571","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Therapeutic Resistance in CLL","firstName":"Elisa ","lastName":"Ten Hacken ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Splicing Modulation Perturbs Key Survival Pathways and Sensitizes Chronic Lymphocytic Leukemia to Venetoclax Treatment","keywords":"","combinedName":"doctor elisa ten hacken"},{"sessionId":"11571","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Therapeutic Resistance in CLL","firstName":"Jonathan C","lastName":"Strefford ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Contribution of Gene Mutations to Long-Term Clinical Outcomes: Data from the Randomised UK LRF CLL4 Trial","keywords":"","combinedName":"doctor jonathan c strefford"},{"sessionId":"11572","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: CLL in Its Microenvironment","firstName":"Zhuting ","lastName":"Hu ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Defining the Diversity and Specificity of Neoantigen-Specific T Cells in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor zhuting hu"},{"sessionId":"11572","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: CLL in Its Microenvironment","firstName":"Annika ","lastName":"Scheffold ","credentials":"","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High IGF1R Expression Is Associated with Worse Prognosis in CLL and Impacts Response to PI3K-d Inhibitor Treatment","keywords":"","combinedName":"doctor annika scheffold"},{"sessionId":"11572","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: CLL in Its Microenvironment","firstName":"Shih-Shih ","lastName":"Chen ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ibrutinib Disrupts IL-4R - IL-4 Axis By Inhibiting IL-4R Signaling and Reversing Th2/Th1 Polarization through Diminished CLECL1 in CLL B Cells","keywords":"","combinedName":"doctor shih-shih chen"},{"sessionId":"11572","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: CLL in Its Microenvironment","firstName":"Bola S","lastName":"Hanna ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IL-10 Receptor Deficiency Aggravates Exhaustion of CD8+ T-Cells and Impedes Their Control of Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor bola s hanna"},{"sessionId":"11572","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: CLL in Its Microenvironment","firstName":"Md Kamrul ","lastName":"Hasan ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Wnt5a Induces ROR1 to Bind and Activate Cortactin, Which Functions in Planar Cell Polarity and Migration of Chronic Lymphocytic Leukemia Cells","keywords":"","combinedName":"doctor md kamrul hasan"},{"sessionId":"11572","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: CLL in Its Microenvironment","firstName":"Md Kamrul ","lastName":"Hasan ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Wnt5a Induces ROR1 to Complex with DOCK2 and Promote Proliferation of Chronic Lymphocytic Leukemia Cells","keywords":"","combinedName":"doctor md kamrul hasan"},{"sessionId":"11573","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Epigenetics, Evolution, and the B Cell Receptor","firstName":"Jonathan C","lastName":"Strefford ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Importance of DNA Methylation Signatures in Chronic Lymphocytic Leukaemia Patients Treated with Chemo-Immunotherapy","keywords":"","combinedName":"doctor jonathan c strefford"},{"sessionId":"11573","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Epigenetics, Evolution, and the B Cell Receptor","firstName":"Yun ","lastName":"Liu ","credentials":"MS","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CLL Stereotyped Subset #4 Igs Acquire Binding to Viable B Lymphocyte Surfaces By Somatic Mutations, Isotype Class Switching, and with the Prerequisite of IG Self-Association","keywords":"","combinedName":"doctor yun liu"},{"sessionId":"11573","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Epigenetics, Evolution, and the B Cell Receptor","firstName":"Richard ","lastName":"Rosenquist ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors","keywords":"","combinedName":"doctor richard rosenquist"},{"sessionId":"11573","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Epigenetics, Evolution, and the B Cell Receptor","firstName":"Davide ","lastName":"Bagnara ","credentials":"","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IGHV-D-J Repertoire Analysis Obtained By High-Throughput Sequencing of CD5+ B-Cells in CLL Patients: Prognostic Markers and Disease Development Implications","keywords":"","combinedName":"doctor davide bagnara"},{"sessionId":"11573","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Epigenetics, Evolution, and the B Cell Receptor","firstName":"Rossana ","lastName":"Maffei ","credentials":"","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interferon Regulatory Factor 4 Orchestrates the Response to B-Cell Receptor in Chronic Lymphocytic Leukemia Cells By Regulating Ikaros","keywords":"","combinedName":"doctor rossana maffei"},{"sessionId":"11573","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Epigenetics, Evolution, and the B Cell Receptor","firstName":"Ronan ","lastName":"Chaligne ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Cell Joint Methylomics and Transcriptomics Define the Epigenetic Evolution and Lineage Histories of Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor ronan chaligne"},{"sessionId":"11574","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL Through Combinations of Novel Agents and Antibody ","firstName":"Jennifer ","lastName":"Woyach ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"13:15:00","endTime":"13:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acalabrutinib with Obinutuzumab in Relapsed/Refractory and Treatment-Naive Patients with Chronic Lymphocytic Leukemia: The Phase 1b/2 ACE-CL-003 Study","keywords":"","combinedName":"doctor jennifer woyach"},{"sessionId":"11574","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL Through Combinations of Novel Agents and Antibody ","firstName":"Nitin ","lastName":"Jain ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Venetoclax and Ibrutinib for Patients with Previously Untreated High-Risk CLL, and Relapsed/Refractory CLL: A Phase II Trial","keywords":"","combinedName":"doctor nitin jain"},{"sessionId":"11574","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL Through Combinations of Novel Agents and Antibody ","firstName":"Peter ","lastName":"Hillmen ","credentials":"MBChB, FRCP, FRCPath, PhD ","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Initial Results of Ibrutinib Plus Venetoclax in Relapsed, Refractory CLL (Bloodwise TAP CLARITY Study): High Rates of Overall Response, Complete Remission and MRD Eradication after 6 Months of Combination Therapy","keywords":"","combinedName":"doctor peter hillmen"},{"sessionId":"11574","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL Through Combinations of Novel Agents and Antibody ","firstName":"Kerry ","lastName":"Rogers ","credentials":"MD ","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"13:00:00","endTime":"13:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Initial Results of the Phase 2 Treatment Naive Cohort in a Phase 1b/2 Study of Obinutuzumab, Ibrutinib, and Venetoclax in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor kerry rogers"},{"sessionId":"11574","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL Through Combinations of Novel Agents and Antibody ","firstName":"Jan ","lastName":"Burger ","credentials":"MD, PhD ","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Randomized Trial of Ibrutinib Versus Ibrutinib Plus Rituximab (Ib+R) in Patients with Chronic Lymphocytic Leukemia (CLL)","keywords":"","combinedName":"doctor jan burger"},{"sessionId":"11574","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL Through Combinations of Novel Agents and Antibody ","firstName":"Ian ","lastName":"Flinn","credentials":"MD, PhD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety, Efficacy and MRD Negativity of a Combination of Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia  Results from a Phase 1b Study (GP28331)","keywords":"","combinedName":"doctor ian flinn"},{"sessionId":"11575","sessionTitle":"642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT","firstName":"Anthony ","lastName":"Mato","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of PET-CT to Identify Richters Transformation in 167 Patients with Disease Progression Following Kinase Inhibitor Therapy","keywords":"","combinedName":"doctor anthony mato"},{"sessionId":"11575","sessionTitle":"642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT","firstName":"Michael ","lastName":"Choi ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Durable and Specific Inhibition of ROR1 SignalingAssociates with Prolonged Progression Free Survival in Patients with Chronic Lymphocytic Leukemia Treated with Cirmtuzumab","keywords":"","combinedName":"doctor michael choi"},{"sessionId":"11575","sessionTitle":"642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT","firstName":"Jeffrey ","lastName":"Sharman ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluating the Efficacy, Safety, and Dose Dependent Activities of Entospletinib in Patients with Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor jeffrey sharman"},{"sessionId":"11575","sessionTitle":"642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT","firstName":"Kerry ","lastName":"Rogers ","credentials":"MD ","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence and Type of Opportunistic Infections during Ibrutinib Treatment at a Single Academic Center","keywords":"","combinedName":"doctor kerry rogers"},{"sessionId":"11575","sessionTitle":"642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT","firstName":"Tait ","lastName":"Shanafelt ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevalence of Low Count (LC) Monoclonal B Cell Lymphocytosis (MBL) and Serious Infections in a Population-Based Cohort of U.S. Adults Participating in a Large Bio-Repository","keywords":"","combinedName":"doctor tait shanafelt"},{"sessionId":"11575","sessionTitle":"642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT","firstName":"Anas","lastName":"Younes","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of the Combination of Ibrutinib and Nivolumab in Patients with Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor anas younes"},{"sessionId":"11576","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL with Combinations of Novel Agents and Chemoimmunotherapy Regimens, New Treatments","firstName":"Matthew ","lastName":"Davids","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients","keywords":"","combinedName":"doctor matthew davids"},{"sessionId":"11576","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL with Combinations of Novel Agents and Chemoimmunotherapy Regimens, New Treatments","firstName":"John ","lastName":"Byrd ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Updated Results from the Phase 1/2 ACE-CL-001 Study","keywords":"","combinedName":"doctor john byrd"},{"sessionId":"11576","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL with Combinations of Novel Agents and Chemoimmunotherapy Regimens, New Treatments","firstName":"Paula ","lastName":"Cramer ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bendamustine Followed By Ofatumumab and Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL): CLL2-BIO Trial of the German CLL Study Group (GCLLSG)","keywords":"","combinedName":"doctor paula cramer"},{"sessionId":"11576","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL with Combinations of Novel Agents and Chemoimmunotherapy Regimens, New Treatments","firstName":"Nitin ","lastName":"Jain ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (GA101) (iFCG) for First-Line Treatment of Patients with CLL with Mutated IGHV and without TP53 Aberrations","keywords":"","combinedName":"doctor nitin jain"},{"sessionId":"11576","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL with Combinations of Novel Agents and Chemoimmunotherapy Regimens, New Treatments","firstName":"Pierre ","lastName":"Feugier ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II, Multicenter Trial, Exploring Chemo-Sparing Strategy Associating Obinutuzumab+Ibrutinib Followed By a MRD Driven Strategy, in Previously Untreated Symptomatic Medically Fit Chronic Lymphocytic Leukemia Patients (CLL): Preliminary Results of the Induction Phase of the Icll-07 Filo Study","keywords":"","combinedName":"doctor pierre feugier"},{"sessionId":"11576","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL with Combinations of Novel Agents and Chemoimmunotherapy Regimens, New Treatments","firstName":"Ian ","lastName":"Flinn","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 3-4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from the Phase 3 DUOTM Trial: A Randomized Comparison of Duvelisib Vs Ofatumumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","keywords":"","combinedName":"doctor ian flinn"},{"sessionId":"11577","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: New Insights into the Role of the Immune Microenvironment of Multiple Myeloma","firstName":"Xiaoxiao ","lastName":"Hao ","credentials":"","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Apoptotic Osteocytes Promote Myeloma Dissemination to New Bone Sites Via Suppression of Immune Surveillance in Bone Marrow ","keywords":"","combinedName":"doctor xiaoxiao hao"},{"sessionId":"11577","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: New Insights into the Role of the Immune Microenvironment of Multiple Myeloma","firstName":"Kevin ","lastName":"Lynch ","credentials":"BSc, MSc","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mesenchymal Stromal Cell Sialylation Enhances Immune Suppression in Multiple Myeloma","keywords":"","combinedName":"doctor kevin lynch"},{"sessionId":"11577","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: New Insights into the Role of the Immune Microenvironment of Multiple Myeloma","firstName":"Carolyne ","lastName":"Falank ","credentials":"PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Bone Cell Type Identified As Driver of Drug Resistance in Multiple Myeloma: The Bone Marrow Adipocyte","keywords":"","combinedName":"doctor carolyne falank"},{"sessionId":"11577","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: New Insights into the Role of the Immune Microenvironment of Multiple Myeloma","firstName":"Serika ","lastName":"Naicker ","credentials":"BSc, PhD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient Data Supports the Rationale of Low Dose Cyclophosphamide to Potentiate the Anti-Myeloma Activity of Daratumumab throughAugmentation of Macrophage-Induced ADCP","keywords":"","combinedName":"doctor serika naicker"},{"sessionId":"11577","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: New Insights into the Role of the Immune Microenvironment of Multiple Myeloma","firstName":"Xiaoxuan ","lastName":"Xu ","credentials":"","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Runx2 Deficiency in Committed Osteoblasts Promotes Myeloma Cell Homing to and Progression in New Bone Sites","keywords":"","combinedName":"doctor xiaoxuan xu"},{"sessionId":"11577","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: New Insights into the Role of the Immune Microenvironment of Multiple Myeloma","firstName":"Paola","lastName":"Neri","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single Cell Resolution Profiling Defines the Innate and Adaptive Immune Repertoires Modulated By Daratumumab and IMiDs Treatment in Multiple Myeloma (MM)","keywords":"","combinedName":"doctor paola neri"},{"sessionId":"11578","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Transcriptional Regulatory Circuitries of Multiple Myeloma","firstName":"Sara ","lastName":"Nasser ","credentials":"","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Identification of Fusion Transcripts in Multiple Myeloma: An Mmrf Commpass Analysis","keywords":"","combinedName":"doctor sara nasser"},{"sessionId":"11578","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Transcriptional Regulatory Circuitries of Multiple Myeloma","firstName":"Brian A","lastName":"Walker","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Novel Oncogenes and Tumor Suppressor Genes in Newly Diagnosed Multiple Myeloma","keywords":"","combinedName":"doctor brian a walker"},{"sessionId":"11578","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Transcriptional Regulatory Circuitries of Multiple Myeloma","firstName":"Charles Y","lastName":"Lin ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mapping of the Multiple Myeloma Transcriptional Core Regulatory Circuitry Reveals TCF3 As a Novel Dependency and an Oncogenic Collaborator of MYC","keywords":"","combinedName":"doctor charles y lin"},{"sessionId":"11578","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Transcriptional Regulatory Circuitries of Multiple Myeloma","firstName":"Aneta ","lastName":"Mikulasova ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MYC Rearrangements in Multiple Myeloma Are Complex, Can Involve More Than Five Different Chromosomes, and Correlate with Increased Expression of MYC and a Distinct Downstream Gene Expression Pattern","keywords":"","combinedName":"doctor aneta mikulasova"},{"sessionId":"11578","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Transcriptional Regulatory Circuitries of Multiple Myeloma","firstName":"David ","lastName":"Melnekoff ","credentials":"BS, MSc","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Cell RNA Sequencing Reveals Distinct Transcriptomic Profiles of Multiple Myeloma with Implications for Personalized Medicine","keywords":"","combinedName":"doctor david melnekoff"},{"sessionId":"11578","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Transcriptional Regulatory Circuitries of Multiple Myeloma","firstName":"Paola","lastName":"Neri","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcriptional Plasticity Compensates for Ikaros and Aiolos Proteasomal Degradation and Mediates Resistance to IMiDs in Multiple Myeloma (MM)","keywords":"","combinedName":"doctor paola neri"},{"sessionId":"11579","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics of The Pathogenesis and Progression of Multiple Myeloma","firstName":"Nicoletta ","lastName":"Testoni ","credentials":"BSc","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Risk Cytogenetics in Newly Diagnosed Multiple Myeloma: Prognostic Relevance of Co-Segregations and Analysis of the Role of Double Versus Single Autotransplantation","keywords":"","combinedName":"doctor nicoletta testoni"},{"sessionId":"11579","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics of The Pathogenesis and Progression of Multiple Myeloma","firstName":"Niamh ","lastName":"Keane ","credentials":"MB, MRCP","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MYC Translocations Identified By Sequencing Panel in Smoldering Multiple Myeloma Strongly Predict for Rapid Progression to Multiple Myeloma","keywords":"","combinedName":"doctor niamh keane"},{"sessionId":"11579","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics of The Pathogenesis and Progression of Multiple Myeloma","firstName":"Mark ","lastName":"Bustoros ","credentials":"","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Next Generation Sequencing Identifies Smoldering Multiple Myeloma Patients with a High Risk of Disease Progression","keywords":"","combinedName":"doctor mark bustoros"},{"sessionId":"11579","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics of The Pathogenesis and Progression of Multiple Myeloma","firstName":"John R","lastName":"Jones ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Mutational Landscape of Relapse in High Risk Myeloma Is Significantly Impacted By the Depth of Response but Not Maintenance Lenalidomide","keywords":"","combinedName":"doctor john r jones"},{"sessionId":"11579","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics of The Pathogenesis and Progression of Multiple Myeloma","firstName":"Daniel ","lastName":"Auclair ","credentials":"PhD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Utility of Clinical-Grade Sequencing of Relapsed Multiple Myeloma Patients; Interim Analysis of the Multiple Myeloma Research Foundation (MMRF) Molecular Profiling Protocol","keywords":"","combinedName":"doctor daniel auclair"},{"sessionId":"11579","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics of The Pathogenesis and Progression of Multiple Myeloma","firstName":"Ankit ","lastName":"Dutta ","credentials":"","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg B- Lvl 3- B304-B305","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whole Exome Sequencing of Paired MGUS/SMM to MM Patients Reveals Novel Subclonal Tumour Evolution Models in Disease Progression of Multiple Myeloma","keywords":"","combinedName":"doctor ankit dutta"},{"sessionId":"11580","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Novel Immunotherapeutic Strategies in Multiple Myeloma","firstName":"Yu-Tzu ","lastName":"Tai ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A First in Class APRIL Fully Blocking Antibody Targets Novel Immune Regulation of APRIL in Multiple Myeloma: Further Therapeutic Implication","keywords":"","combinedName":"doctor yu-tzu tai"},{"sessionId":"11580","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Novel Immunotherapeutic Strategies in Multiple Myeloma","firstName":"Christina ","lastName":"de Zafra ","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preclinical Characterization of AMG 424, a Novel Humanized T CellRecruiting Bispecific Anti-CD3/CD38 Antibody","keywords":"","combinedName":"doctor christina de zafra"},{"sessionId":"11580","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Novel Immunotherapeutic Strategies in Multiple Myeloma","firstName":"Xinxin ","lastName":"Wang ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Production of Universal Anti-Bcma CAR-T Cells with Reduced Alloreactivity, but Potent Effector Function for the Treatment of Multiple Myeloma","keywords":"","combinedName":"doctor xinxin wang"},{"sessionId":"11580","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Novel Immunotherapeutic Strategies in Multiple Myeloma","firstName":"Ben ","lastName":"Buelow ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T Cell Engagement without Cytokine Storm: A Novel Bcma x CD3 Antibody Killing Myeloma Cells with Minimal Cytokine Secretion","keywords":"","combinedName":"doctor ben buelow"},{"sessionId":"11580","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Novel Immunotherapeutic Strategies in Multiple Myeloma","firstName":"Norris ","lastName":"Lam ","credentials":"BS","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T Cells Expressing Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptors with Antigen Recognition Domains Made up of Only Single Human Heavy Chain Variable Domains Specifically Recognize Bcma and Eradicate Tumors in Mice","keywords":"","combinedName":"doctor norris lam"},{"sessionId":"11580","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Novel Immunotherapeutic Strategies in Multiple Myeloma","firstName":"Rohit ","lastName":"Mathur ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Universal SLAMF7-Specific CAR T-Cells As Treatment for Multiple Myeloma","keywords":"","combinedName":"doctor rohit mathur"},{"sessionId":"11581","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Emerging New Targets and Mechanisms of Resistance","firstName":"Karen L","lastName":"Burger ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A CK1d/CK1e-to--Catenin Circuit Is a Therapeutic Vulnerability for Primary and Drug Resistant Multiple Myeloma","keywords":"","combinedName":"doctor karen l burger"},{"sessionId":"11581","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Emerging New Targets and Mechanisms of Resistance","firstName":"Hemant ","lastName":"Murthy ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Computational Modeling of Protein Networks Predicts Treatment Outcomes in Multiple Myeloma (MM)","keywords":"","combinedName":"doctor hemant murthy"},{"sessionId":"11581","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Emerging New Targets and Mechanisms of Resistance","firstName":"Christopher ","lastName":"Marlein ","credentials":"BSc","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mitochondria Are Transferred from Non-Malignant Stroma Cells to Malignant Plasma Cells, Via Tunnelling Nanotubules in a CD38 Dependent Mechanism, a Process That Promotes Myeloma Proliferation","keywords":"","combinedName":"doctor christopher marlein"},{"sessionId":"11581","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Emerging New Targets and Mechanisms of Resistance","firstName":"Jiye ","lastName":"Liu ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Mechanisms Underlying IMiDs Resistance in Multiple Myeloma: Therapeutic Implications","keywords":"","combinedName":"doctor jiye liu"},{"sessionId":"11581","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Emerging New Targets and Mechanisms of Resistance","firstName":"Makoto ","lastName":"Nakagawa ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Stem Cell-Targeted Therapy for Multiple Myeloma Based on Dual Inhibition of EZH1/2","keywords":"","combinedName":"doctor makoto nakagawa"},{"sessionId":"11581","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Emerging New Targets and Mechanisms of Resistance","firstName":"Reinaldo ","lastName":"Franqui-Machin ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Interaction of NEK2 with USP7 Causes Resistance to Proteasome Inhibitor in Multiple Myeloma","keywords":"","combinedName":"doctor reinaldo franqui-machin"},{"sessionId":"11582","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Immunotherapy in Myeloma and Amyloid","firstName":"Murielle ","lastName":"Roussel ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Prospective Phase II of Daratumumab in Previously-Treated Systemic Light-Chain (AL) Amyloidosis","keywords":"","combinedName":"doctor murielle roussel"},{"sessionId":"11582","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Immunotherapy in Myeloma and Amyloid","firstName":"Lingzhi ","lastName":"Yan ","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Infusion of CD19 and Bcma-Specific Chimeric Antigen Receptor T Cells for RRMM: Initial Safety and Efficacy Report from a Clinical Pilot Study","keywords":"","combinedName":"doctor lingzhi yan"},{"sessionId":"11582","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Immunotherapy in Myeloma and Amyloid","firstName":"Craig C","lastName":"Hofmeister ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab Monotherapy for Patients with Intermediate or High-Risk Smoldering Multiple Myeloma (SMM): Centaurus, a Randomized, Open-Label, Multicenter Phase 2 Study","keywords":"","combinedName":"doctor craig c hofmeister"},{"sessionId":"11582","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Immunotherapy in Myeloma and Amyloid","firstName":"Suzanne ","lastName":"Lentzsch ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Final Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with Relapsed or Refractory AL Amyloidosis","keywords":"","combinedName":"doctor suzanne lentzsch"},{"sessionId":"11582","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Immunotherapy in Myeloma and Amyloid","firstName":"Adam ","lastName":"Cohen ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T Cells (CART-BCMA) with Cyclophosphamide Conditioning for Refractory Multiple Myeloma (MM)","keywords":"","combinedName":"doctor adam cohen"},{"sessionId":"11582","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Immunotherapy in Myeloma and Amyloid","firstName":"Vaishali ","lastName":"Sanchorawala ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Tolerability of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Preliminary Results of a Phase II Study","keywords":"","combinedName":"doctor vaishali sanchorawala"},{"sessionId":"11583","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Studies in Relapsed and Refractory Multiple Myeloma","firstName":"Laurent ","lastName":"Garderet ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Multicenter Open Label Phase II Study of Pomalidomide, Cyclophosphamide and Dexamethasone in Relapse Multiple Myeloma Patients Initially Treated with Lenalidomide, Bortezomib and Dexamethasone","keywords":"","combinedName":"doctor laurent garderet"},{"sessionId":"11583","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Studies in Relapsed and Refractory Multiple Myeloma","firstName":"Vittorio ","lastName":"Montefusco ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bortezomib/Cyclophosphamide/Dexamethasone Versus Lenalidomide/ Cyclophosphamide/Dexamethasone in Multiple Myeloma Patients at First Relapse: Final Results of a Phase III Study","keywords":"","combinedName":"doctor vittorio montefusco"},{"sessionId":"11583","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Studies in Relapsed and Refractory Multiple Myeloma","firstName":"Kwee ","lastName":"Yong ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Carfilzomib, Cyclophosphamide and Dexamethasone (KCD) Versus Bortezomib, Cyclophosphamide and Dexamethasone (VCD) for Treatment of First Relapse or Primary Refractory Multiple Myeloma (MM): First Final Analysis of the Phase 2 Muk Five Study","keywords":"","combinedName":"doctor kwee yong"},{"sessionId":"11583","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Studies in Relapsed and Refractory Multiple Myeloma","firstName":"Robert J ","lastName":"Pelham ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Predictors of Progression-Free Survival Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Carfilzomib and Dexamethasone or Bortezomib and Dexamethasone in the Phase 3 Endeavor Trial","keywords":"","combinedName":"doctor robert j pelham"},{"sessionId":"11583","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Studies in Relapsed and Refractory Multiple Myeloma","firstName":"Sheeba ","lastName":"Thomas ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Results of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant in Patients with Multiple Myeloma","keywords":"","combinedName":"doctor sheeba thomas"},{"sessionId":"11583","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Studies in Relapsed and Refractory Multiple Myeloma","firstName":"Ajai ","lastName":"Chari ","credentials":"","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Subcutaneous Delivery of Daratumumab in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM): Pavo, an Open-Label, Multicenter, Dose Escalation Phase 1b Study","keywords":"","combinedName":"doctor ajai chari"},{"sessionId":"11584","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance","firstName":"Naoki ","lastName":"Takezako ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Elotuzumab Plus Lenalidomide/Dexamethasone (ELd) Vs Ld in Patients with Newly Diagnosed Multiple Myeloma: Phase 2, Randomized, Open-Label Study in Japan","keywords":"","combinedName":"doctor naoki takezako"},{"sessionId":"11584","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance","firstName":"Sonja ","lastName":"Zweegman ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Initial Results from the Randomized Phase II HOVON-126/Nmsg 21.13 Trial","keywords":"","combinedName":"doctor sonja zweegman"},{"sessionId":"11584","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance","firstName":"Graham ","lastName":"Jackson ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lenalidomide Maintenance Significantly Improves Outcomes Compared to Observation Irrespective of Cytogenetic Risk: Results of the Myeloma XI Trial","keywords":"","combinedName":"doctor graham jackson"},{"sessionId":"11584","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance","firstName":"Herv ","lastName":"Avet-Loiseau ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Minimal Residual Disease in Multiple Myeloma: Final Analysis of the IFM2009 Trial","keywords":"","combinedName":"doctor herv avet-loiseau"},{"sessionId":"11584","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance","firstName":"Andrew ","lastName":"Branagan ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"13:15:00","endTime":"13:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Two Dose Series of High-Dose Influenza Vaccine Is Associated with Longer Duration of Serologic Immunity in Patients with Plasma Cell Disorders","keywords":"","combinedName":"doctor andrew branagan"},{"sessionId":"11584","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance","firstName":"Krina ","lastName":"Patel ","credentials":"MD MSc","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"13:00:00","endTime":"13:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Update on a Phase II Study of Ixazomib with Lenalidomide As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma","keywords":"","combinedName":"doctor krina patel"},{"sessionId":"11585","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: T cell regeneration and donor graft effects on HCT","firstName":"Kate H","lastName":"Gartlan ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Critical Role for Donor-Derived IL-22 in Cutaneous Chronic Gvhd","keywords":"","combinedName":"doctor kate h gartlan"},{"sessionId":"11585","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: T cell regeneration and donor graft effects on HCT","firstName":"Jarrod A","lastName":"Dudakov ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mechanisms Governing Endogenous Thymic Regeneration","keywords":"","combinedName":"doctor jarrod a dudakov"},{"sessionId":"11585","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: T cell regeneration and donor graft effects on HCT","firstName":"Timothy ","lastName":"Olson ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduction in Bone Marrow Insulin-like Growth Factor-1 Levels Enhances Long-Term Hematopoietic Stem Cell Engraftment Following Bone Marrow Transplantation","keywords":"","combinedName":"doctor timothy olson"},{"sessionId":"11585","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: T cell regeneration and donor graft effects on HCT","firstName":"Kimon ","lastName":"Argyropoulos ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Damage Sensory Molecule TRPA1 Positively Regulates Endogenous Thymic Regeneration after Damage","keywords":"","combinedName":"doctor kimon argyropoulos"},{"sessionId":"11585","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: T cell regeneration and donor graft effects on HCT","firstName":"Cameron ","lastName":"Bader ","credentials":"BS","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Innate Immune Sensor Sting Can Augment or Ameliorate Graft-Versus-Host Disease Dependent on the Genetic Disparity between Donors and Recipients","keywords":"","combinedName":"doctor cameron bader"},{"sessionId":"11585","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: T cell regeneration and donor graft effects on HCT","firstName":"Hidenori ","lastName":"Kasahara ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Vitamin C Stabilizes Foxp3 Expression in Induced Treg Cells By Targeted DNA Demethylation and Prevents Murine Model of Acute Graft Versus Host Disease","keywords":"","combinedName":"doctor hidenori kasahara"},{"sessionId":"11586","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Novel T cell targets in regulation of GVHD and GVL","firstName":"Benjamin ","lastName":"Vincent ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bim Regulates the Survival and Suppressive Capability of CD8+ Foxp3+ Regulatory T Cells during Graft Versus Host Disease","keywords":"","combinedName":"doctor benjamin vincent"},{"sessionId":"11586","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Novel T cell targets in regulation of GVHD and GVL","firstName":"Shan ","lastName":"He ","credentials":"PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Id3 Is Essential for Mediating Ezh2-Regulated Persistence of Alloreactive T Cells in Gvhd Target Tissues in Mice","keywords":"","combinedName":"doctor shan he"},{"sessionId":"11586","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Novel T cell targets in regulation of GVHD and GVL","firstName":"Jefferson ","lastName":"Lansford ","credentials":"BS","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"14:45:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Leukemia Associated Minor Histocompatibility Antigens through Computational Prediction and Targeted Mass Spectrometry","keywords":"","combinedName":"doctor jefferson lansford"},{"sessionId":"11586","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Novel T cell targets in regulation of GVHD and GVL","firstName":"Anusara ","lastName":"Daenthanasanmak ","credentials":"","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of Sirt-1 Alleviates Acute and Chronic Graft-Versus-Host-Disease While Preserving Graft-Versus-Leukemia Effect","keywords":"","combinedName":"doctor anusara daenthanasanmak"},{"sessionId":"11586","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Novel T cell targets in regulation of GVHD and GVL","firstName":"Sandeepkumar ","lastName":"Kuril ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:15:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lysosomal Acid Lipase Is a Potential Therapeutic Target for Controlling Gvhd after Allogeneic Hematopoietic Cell Transplantation in Mice","keywords":"","combinedName":"doctor sandeepkumar kuril"},{"sessionId":"11586","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Novel T cell targets in regulation of GVHD and GVL","firstName":"Jennifer ","lastName":"Tsai ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nrf2 Is a Critical Mediator of CD4 T Cell-Induced Acute Graft-Versus-Host Disease","keywords":"","combinedName":"doctor jennifer tsai"},{"sessionId":"11587","sessionTitle":"703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies","firstName":"Matt L","lastName":"Cooper ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Off-the-Shelf, Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies","keywords":"","combinedName":"doctor matt l cooper"},{"sessionId":"11587","sessionTitle":"703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies","firstName":"Shinichi ","lastName":"Kageyama ","credentials":"","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cytokine Release Syndrome and Tumor Responses in a First-in-Man Trial of a Novel Affinity-Enhanced TCR-Gene Transduced T Cell Transfer Targeting NY-ESO-1 Antigen","keywords":"","combinedName":"doctor shinichi kageyama"},{"sessionId":"11587","sessionTitle":"703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies","firstName":"Sarwish ","lastName":"Rafiq ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enhancing CAR T Cell Anti-Tumor Efficacy through Secreted Single Chain Variable Fragment (scFv) Immune Checkpoint Blockade","keywords":"","combinedName":"doctor sarwish rafiq"},{"sessionId":"11587","sessionTitle":"703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies","firstName":"Gongbo ","lastName":"Li ","credentials":"PhD, MBBS","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mouse CD19-Targeted Chimeric Antigen Receptors That Include a 41BB Co-Stimulatory Domain Induce NFkB Signaling to Enhance T Cell Proliferation, Viability, and Leukemia Killing","keywords":"","combinedName":"doctor gongbo li"},{"sessionId":"11587","sessionTitle":"703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies","firstName":"Aaron ","lastName":"Rapoport ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I/IIa Study of Genetically Engineered NY-ESO-1 SPEAR T-Cells Administered Following Autologous Stem Cell Transplant in HLA-a*02+ Patients with Advanced Multiple Myeloma: Long Term Follow-up (NCT01352286)","keywords":"","combinedName":"doctor aaron rapoport"},{"sessionId":"11587","sessionTitle":"703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies","firstName":"Liang ","lastName":"Huang ","credentials":"M.D. Ph.D.","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for Adult Patients with Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor liang huang"},{"sessionId":"11588","sessionTitle":"703. Adoptive Immunotherapy: Immune Therapeutics for Hematologic Cancers: Artificial Receptors and Beyond","firstName":"Yinmeng ","lastName":"Yang ","credentials":"Ph.D.","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Chronic Endogenous Antigen Stimulation on CAR T Cell Persistence and Memory Formation","keywords":"","combinedName":"doctor yinmeng yang"},{"sessionId":"11588","sessionTitle":"703. Adoptive Immunotherapy: Immune Therapeutics for Hematologic Cancers: Artificial Receptors and Beyond","firstName":"Sjoukje ","lastName":"Van Der Stegen ","credentials":"PhD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Generation of Clonal Antigen Specific CD8a+ Cytotoxic T Lymphocytes from Renewable Pluripotent Stem Cells for Off-the-Shelf T Cell Therapeutics","keywords":"","combinedName":"doctor sjoukje van der stegen"},{"sessionId":"11588","sessionTitle":"703. Adoptive Immunotherapy: Immune Therapeutics for Hematologic Cancers: Artificial Receptors and Beyond","firstName":"Dyantha ","lastName":"Van Der Lee ","credentials":"BSc","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"13:15:00","endTime":"13:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutated NPM1 As Target for Immunotherapy of Acute Myeloid Leukemia","keywords":"","combinedName":"doctor dyantha van der lee"},{"sessionId":"11588","sessionTitle":"703. Adoptive Immunotherapy: Immune Therapeutics for Hematologic Cancers: Artificial Receptors and Beyond","firstName":"Melissa ","lastName":"Berrien-Elliott ","credentials":"PhD","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"13:00:00","endTime":"13:15:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NKG2A Represents an Important Immune Checkpoint for Human Cytokine-Induced Memory-like NK Cells in Patients with AML","keywords":"","combinedName":"doctor melissa berrien-elliott"},{"sessionId":"11588","sessionTitle":"703. Adoptive Immunotherapy: Immune Therapeutics for Hematologic Cancers: Artificial Receptors and Beyond","firstName":"Premal ","lastName":"Lulla ","credentials":"MBBS","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Adoptively Transferred Donor-Derived Tumor-Directed T Cells with Relapsed AML Post-Allogeneic HSCT","keywords":"","combinedName":"doctor premal lulla"},{"sessionId":"11588","sessionTitle":"703. Adoptive Immunotherapy: Immune Therapeutics for Hematologic Cancers: Artificial Receptors and Beyond","firstName":"Supinya ","lastName":"Iamsawat ","credentials":"","sessionStartTime":"2017-12-09T12:00:00Z","sessionEndTime":"2017-12-09T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting JAK2 Kinase Promotes Foxp3 Stability and Function of CD8iTregs in Prevention of Graft-Versus-Host Disease","keywords":"","combinedName":"doctor supinya iamsawat"},{"sessionId":"11589","sessionTitle":"711. Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture","firstName":"Frank ","lastName":"Cichocki ","credentials":"","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Translation of Pluripotent Cell-Derived Off-the-Shelf Natural Killer Cell Cancer Immunotherapy","keywords":"","combinedName":"doctor frank cichocki"},{"sessionId":"11589","sessionTitle":"711. Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture","firstName":"Tony ","lastName":"Peled ","credentials":"","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enhanced In Vivo Persistence and Proliferation of NK Cells Expanded in Culture with the Small Molecule Nicotinamide: Development of a Clinical-Applicable Method for NK Expansion","keywords":"","combinedName":"doctor tony peled"},{"sessionId":"11589","sessionTitle":"711. Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture","firstName":"Kevin ","lastName":"Goncalves ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phenotype Does Not Always Equal Function: HDAC Inhibitors and UM171, but Not SR1, Lead to Rapid Upregulation of CD90 on Non-Engrafting CD34+CD90-Negative Human Cells","keywords":"","combinedName":"doctor kevin goncalves"},{"sessionId":"11589","sessionTitle":"711. Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture","firstName":"Sandra ","lastName":"Cohen ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single UM171 Expanded Cord Blood Transplant Is Feasible, Safe, and Permits Transplantation of Better HLA Matched Cords with Very Low Transplant Related Mortality","keywords":"","combinedName":"doctor sandra cohen"},{"sessionId":"11589","sessionTitle":"711. Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture","firstName":"Michal ","lastName":"Abraham ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:45:00","endTime":"12:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The CXCR4 Antagonist BL-8040 Induces a Robust Mobilization of CD34+CD38-CD45RA-CD90+ CD49f+ HSCs with Long-Term and Secondary Myeloid and Lymphoid Repopulating Activity","keywords":"","combinedName":"doctor michal abraham"},{"sessionId":"11589","sessionTitle":"711. Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture","firstName":"Eran ","lastName":"Zimran ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Exhaustion of Adult Hematopoietic Stem Cells in Ex Vivo Cultures Can Be Overcome by a Histone Deacetylase Inhibitor","keywords":"","combinedName":"doctor eran zimran"},{"sessionId":"11590","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants","firstName":"Razan ","lastName":"Mohty ","credentials":"","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Infectious Complications after Haploidentical Stem Cell Transplantation in Adult Patients with Hematologic Malignancies","keywords":"","combinedName":"doctor razan mohty"},{"sessionId":"11590","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants","firstName":"Javid ","lastName":"Gaziev ","credentials":"","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcra+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies","keywords":"","combinedName":"doctor javid gaziev"},{"sessionId":"11590","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants","firstName":"Frederic ","lastName":"Baron ","credentials":"","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Graft Failures after Umbilical Cord Blood Transplantation in Acute Leukemia: A Study from Eurocord and the Acute Leukemia Working Party of the EBMT","keywords":"","combinedName":"doctor frederic baron"},{"sessionId":"11590","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants","firstName":"John ","lastName":"Wagner ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 2 Trials with Mgta-456, Single Cord Blood Units (CBU) Expanded with an Aryl Hydrocarbon Receptor (AHR) Antagonist, Demonstrate Uniform Engraftment and Rapid Hematopoietic Recovery in Patients Following Myeloablative or Non-Myeloablative Conditioning","keywords":"","combinedName":"doctor john wagner"},{"sessionId":"11590","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants","firstName":"Jacopo ","lastName":"Mariotti ","credentials":"","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Severe Cytokine Release Syndrome Is a Fatal Complication after PBSC, but Not after BM Haploidentical Transplantation with Post-Transplant Cyclophosphamide","keywords":"","combinedName":"doctor jacopo mariotti"},{"sessionId":"11590","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants","firstName":"Ang ","lastName":"Li ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:45:00","endTime":"12:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transplant-Associated Thrombotic Microangiopathy (TA-TMA): Not a Singular Entity","keywords":"","combinedName":"doctor ang li"},{"sessionId":"11591","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens ","firstName":"Sherilyn A","lastName":"Tuazon ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:00:00","endTime":"19:15:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase I Trial of 90Y-BC8-DOTA (Anti-CD45) Monoclonal Antibody in Combination with Fludarabine and TBI As Conditioning for Allogeneic Peripheral Blood Stem Cell Transplant to Treat High Risk Multiple Myeloma","keywords":"","combinedName":"doctor sherilyn a tuazon"},{"sessionId":"11591","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens ","firstName":"Federica ","lastName":"SORA ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:45:00","endTime":"19:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Busulfan Fludarabine (BU-FLU) Compared to Thiotepa Busulfan Fludarabine (TBF) for Allogeneic Transplants in Acute Myeloid Leukemia (AML) or Refractory Anemia with Excess Blasts (RAEB) in Remission","keywords":"","combinedName":"doctor federica sora"},{"sessionId":"11591","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens ","firstName":"Andre Manfred","lastName":"Willasch ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:15:00","endTime":"19:30:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy?  a Multicenter EBMT-PDWP Study","keywords":"","combinedName":"doctor andre manfred willasch"},{"sessionId":"11591","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens ","firstName":"Bipin ","lastName":"Savani ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:15:00","endTime":"18:30:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloablative Versus Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in Patients with Prior Myelodysplastic Syndrome/ Myeloproliferative Disorders: An ALWP of EBMT Study","keywords":"","combinedName":"doctor bipin savani"},{"sessionId":"11591","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens ","firstName":"Isaac ","lastName":"Yaniv ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:30:00","endTime":"19:45:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Second Allogeneic Hematopoietic Stem Cell Transplantation for Post-Transplant Relapsed Acute Leukemia in Children - an EBMT PDWP Retrospective Study","keywords":"","combinedName":"doctor isaac yaniv"},{"sessionId":"11591","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens ","firstName":"Federico ","lastName":"Monaco ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:30:00","endTime":"18:45:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Total Body Irradiation (TBI) Dose Escalation Decreases Risk of Progression and Graft Rejection after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Myelodysplastic Syndrome (MDS) or Myeloproliferative Neoplasms (MPN)","keywords":"","combinedName":"doctor federico monaco"},{"sessionId":"11592","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Microbiota, CMV, and GVHD","firstName":"Patricia ","lastName":"Huezo-Diaz ","credentials":"","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Protective Role of DNA Repair Genes Against Acute Graft Versus Host Disease in Children","keywords":"","combinedName":"doctor patricia huezo-diaz"},{"sessionId":"11592","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Microbiota, CMV, and GVHD","firstName":"Susan ","lastName":"Prockop ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adoptive T-Cell Therapy with 3rd Party CMV-pp65-Specific CTLs for CMV Viremia and Disease Arising after Allogeneic Hematopoietic Stem Cell Transplant","keywords":"","combinedName":"doctor susan prockop"},{"sessionId":"11592","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Microbiota, CMV, and GVHD","firstName":"Jose F","lastName":"Camargo ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional Signatures Revealed By Deep Phenotyping of CMV-Specific CD8+ T Cells Predict Risk of Early CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor jose f camargo"},{"sessionId":"11592","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Microbiota, CMV, and GVHD","firstName":"Anthony ","lastName":"Sung ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoietic Stem Cell Transplantation at Home","keywords":"","combinedName":"doctor anthony sung"},{"sessionId":"11592","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Microbiota, CMV, and GVHD","firstName":"Sagar ","lastName":"Patel ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:30:00","endTime":"15:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Influence of MHC Class I Chain-Related Gene ? (MICA) Polymorphisms on Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor sagar patel"},{"sessionId":"11592","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Microbiota, CMV, and GVHD","firstName":"Jonathan ","lastName":"Peled ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intestinal Microbiota Injury during Allo-Hsct Is Generalizable across Transplantation Centers and Is Associated with Increased Mortality, Broad-Spectrum Antibiotics, and Decreased Calorie Intake","keywords":"","combinedName":"doctor jonathan peled"},{"sessionId":"11593","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention","firstName":"Pietro ","lastName":"Merli ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:15:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Donor T Cells Genetically Modified with a Novel Suicide Gene (inducible Caspase 9, iC9) Expand and Persist over Time after Post-Allograft Infusion in Patients Given a T-Cell and B-Cell Depleted HLA-Haploidentical Allogeneic Stem Cell Transplantation (a haplo-HSCT) Contributing to Accelerate Immune Recovery","keywords":"","combinedName":"doctor pietro merli"},{"sessionId":"11593","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention","firstName":"Wolfgang ","lastName":"Bethge ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"14:45:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"First Results of a Prospective Multicenter Phase I/II Clinical Trial in Adult Patients Using Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning","keywords":"","combinedName":"doctor wolfgang bethge"},{"sessionId":"11593","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention","firstName":"Shannon ","lastName":"McCurdy ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Grade II Acute Gvhd Improves Progression-Free Survival after Myeloablative HLA-Matched Bone Marrow Transplant with Posttransplantation Cyclophosphamide","keywords":"","combinedName":"doctor shannon mccurdy"},{"sessionId":"11593","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention","firstName":"Annalisa","lastName":"Ruggeri","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor for Patients with Acute Leukemia, on Behalf of ALWP-EBMT","keywords":"","combinedName":"doctor annalisa ruggeri"},{"sessionId":"11593","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention","firstName":"Peter ","lastName":"Lang ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial","keywords":"","combinedName":"doctor peter lang"},{"sessionId":"11593","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention","firstName":"Leslie","lastName":"Kean","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:15:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival","keywords":"","combinedName":"doctor leslie kean"},{"sessionId":"11594","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Treatment","firstName":"Lenneke F J","lastName":"Groningen ","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase I/II Study on the Anti-CD3/CD7 Immunotoxin Combination (T-GuardTM) for the Treatment of Steroid-Refractory Acute Gvhd","keywords":"","combinedName":"doctor lenneke f j groningen"},{"sessionId":"11594","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Treatment","firstName":"Shanelle ","lastName":"Fernando ","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Day 100 Levels of Blood Immune Cells Are Prognostic Biomarkers for Allogeneic Hematopoietic Stem Cell Transplant Outcomes: Results from BMT CTN 0201","keywords":"","combinedName":"doctor shanelle fernando"},{"sessionId":"11594","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Treatment","firstName":"John","lastName":"Koreth","credentials":"MBBS, DPhil","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Extra-Corporeal Photopheresis Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Efficacy, Safety and Immune Correlates","keywords":"","combinedName":"doctor john koreth"},{"sessionId":"11594","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Treatment","firstName":"Sarah ","lastName":"Nikiforow ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I Trial of Regulatory T-Cell Donor Lymphocyte Infusion Plus Daily Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Versus-Host Disease","keywords":"","combinedName":"doctor sarah nikiforow"},{"sessionId":"11594","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Treatment","firstName":"Eva M","lastName":"Weissinger ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Multicentre, Double-Blinded, Placebo-Controlled Clinical-Trial (Pre-GvHD) for Prediction and Pre-Emptive Treatment of Acute GvHD","keywords":"","combinedName":"doctor eva m weissinger"},{"sessionId":"11594","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Treatment","firstName":"Peter ","lastName":"Bader ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment of Patients with Therapy-Refractory Acute GvHD with the Novel MSC Product MSC-Ffm Resulted in Excellent Response and Low Mortality: Post-Approval Observational Data from 69 Consecutive Patients","keywords":"","combinedName":"doctor peter bader"},{"sessionId":"11595","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology","firstName":"Shernan ","lastName":"Holtan ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802","keywords":"","combinedName":"doctor shernan holtan"},{"sessionId":"11595","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology","firstName":"Giancarlo ","lastName":"Fatobene ","credentials":"MD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Chronic Graft-Versus-Host Disease Severity and Functional Status after Cord Blood, Haploidentical Related and 1-Allele Mismatched Unrelated Donor Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor giancarlo fatobene"},{"sessionId":"11595","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology","firstName":"Jennifer A","lastName":"Ball ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Human Gastro-Intestinal Graft-Versus-Host Disease Is Mediated By Retinoic Acid-Responsive CD8+ Effector T-Cells Under IL-23 Polarising Conditions","keywords":"","combinedName":"doctor jennifer a ball"},{"sessionId":"11595","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology","firstName":"Amy ","lastName":"Suthers ","credentials":"PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased TLR7 Signaling of BCR-Activated B Cells in Chronic Graft-Versus Host Disease (cGVHD)","keywords":"","combinedName":"doctor amy suthers"},{"sessionId":"11595","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology","firstName":"Yusuke ","lastName":"Kamihara ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low-Dose Interleukin-2 Therapy Activates Circulating T Follicular Regulatory Cells and Suppresses Circulating T Follicular Helper Cells in Patients with Chronic Gvhd","keywords":"","combinedName":"doctor yusuke kamihara"},{"sessionId":"11595","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology","firstName":"Alice ","lastName":"Bertaina ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T07:30:00Z","sessionEndTime":"2017-12-09T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcome of Children Developing Grade III-IV Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Report on Behalf of the EBMT Paediatric Diseases Working Party","keywords":"","combinedName":"doctor alice bertaina"},{"sessionId":"11596","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse  ","firstName":"Mohamed A","lastName":"Kharfan-Dabaja","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adoptive Cellular Therapy with Donor Lymphocyte Infusion Versus a Second Allogeneic Hematopoietic Cell Transplant for Post-Allograft Relapsed Acute Myeloid Leukemia: An Intent-to-Treat Analysis on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)","keywords":"","combinedName":"doctor mohamed a kharfan-dabaja"},{"sessionId":"11596","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse  ","firstName":"Charles ","lastName":"Craddock ","credentials":"","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Azacitidine and High Dose Lenalidomide Therapy Is Well Tolerated and Clinically Active in Patients Who Relapse after Allogeneic Stem Cell Transplantation for Actue Myeloid Leukemia: Results of the Uk Trials Acceleration Programme Viola Trial","keywords":"","combinedName":"doctor charles craddock"},{"sessionId":"11596","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse  ","firstName":"Rizwan","lastName":"Romee","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"First-in-Human Clinical Trial of the IL-15 Super-Agonist Complex ALT-803 for Patients Relapsed after Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor rizwan romee"},{"sessionId":"11596","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse  ","firstName":"Taehyung ","lastName":"Kim ","credentials":"MSc","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Next Generation Sequencing (NGS)-Based Post-Transplant Monitoring in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HCT)","keywords":"","combinedName":"doctor taehyung kim"},{"sessionId":"11596","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse  ","firstName":"Matthew ","lastName":"Davids","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimizing Checkpoint Blockade As a Treatment for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor matthew davids"},{"sessionId":"11596","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse  ","firstName":"Theodor ","lastName":"Uden ","credentials":"","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:15:00","endTime":"16:30:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcome of Children Relapsing after First Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia: A Retrospective I-BFM Analysis of 336 Children between 2005 and 2016","keywords":"","combinedName":"doctor theodor uden"},{"sessionId":"11597","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Progress in survivorship care of transplant patients ","firstName":"Moshe ","lastName":"Yeshurun ","credentials":"","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Hematopoietic Cell Transplantation Causes Accelerated Aging Both of the Hematopoietic and Somatic Systems","keywords":"","combinedName":"doctor moshe yeshurun"},{"sessionId":"11597","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Progress in survivorship care of transplant patients ","firstName":"Aaron Seth","lastName":"Rosenberg ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Autologous Hematopoietic Stem Cell Transplant (aHSCT) on the Development of Second Primary Malignancies (SPM) in Multiple Myeloma Patients","keywords":"","combinedName":"doctor aaron seth rosenberg"},{"sessionId":"11597","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Progress in survivorship care of transplant patients ","firstName":"Navneet ","lastName":"Majhail","credentials":"MD, MS","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Individualized Treatment Summaries and Survivorship Care Plans (SCPs) for Hematopoietic Cell Transplant (HCT) Survivors Reduces Cancer Treatment Distress in a Randomized, Multicenter Study","keywords":"","combinedName":"doctor navneet majhail"},{"sessionId":"11597","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Progress in survivorship care of transplant patients ","firstName":"Maxim ","lastName":"Norkin ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Late Fatal Infections Remain Higher Than Expected in Adults Receiving Allogeneic Stem Cell Transplant","keywords":"","combinedName":"doctor maxim norkin"},{"sessionId":"11597","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Progress in survivorship care of transplant patients ","firstName":"Maxim ","lastName":"Norkin ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Late Fatal Infections Remains Frequent Cause of Mortality in Pediatric Allogeneic Stem Cell Transplant Recipients","keywords":"","combinedName":"doctor maxim norkin"},{"sessionId":"11597","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Progress in survivorship care of transplant patients ","firstName":"Mukta ","lastName":"Arora ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Morbidity Associated with Chronic Graft Vs. Host Disease (cGvHD)  a Blood or Marrow Transplant Survivor Study (BMTSS)","keywords":"","combinedName":"doctor mukta arora"},{"sessionId":"11598","sessionTitle":"731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches","firstName":"Muzaffar ","lastName":"Qazilbash","credentials":"MD ","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma","keywords":"","combinedName":"doctor muzaffar qazilbash"},{"sessionId":"11598","sessionTitle":"731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches","firstName":"Michele ","lastName":"Cavo ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autologous Stem Cell Transplantation Versus Bortezomib-Melphalan-Prednisonefor Newly Diagnosed Multiple Myeloma: Second Interim Analysis of the Phase 3 EMN02/HO95 Study","keywords":"","combinedName":"doctor michele cavo"},{"sessionId":"11598","sessionTitle":"731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches","firstName":"Murielle ","lastName":"Roussel ","credentials":"","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bortezomib and High-Dose Melphalan Vs. High-Dose Melphalan As Conditioning Regimen before Autologous Stem Cell Transplantation in De Novo Multiple Myeloma Patients: A Phase 3 Study of the Intergroupe Francophone Du Myelome (IFM 2014-02)","keywords":"","combinedName":"doctor murielle roussel"},{"sessionId":"11598","sessionTitle":"731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches","firstName":"Maria-Victoria","lastName":"Mateos","credentials":"","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Curative Strategy for High-Risk Smoldering Myeloma (GEM-CESAR): Carfilzomib, Lenalidomide and Dexamethasone (KRd) As Induction Followed By HDT-ASCT, Consolidation with Krd and Maintenance with Rd","keywords":"","combinedName":"doctor maria-victoria mateos"},{"sessionId":"11598","sessionTitle":"731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches","firstName":"Michele ","lastName":"Cavo ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Double Autologous Stem Cell Transplantation Significantly Prolongs Progression-Free Survival and Overall Survival in Comparison with Single Autotransplantation in Newly Diagnosed Multiple Myeloma: An Analysis of Phase 3 EMN02/HO95 Study","keywords":"","combinedName":"doctor michele cavo"},{"sessionId":"11598","sessionTitle":"731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches","firstName":"Hartmut ","lastName":"Goldschmidt ","credentials":"MD","sessionStartTime":"2017-12-10T09:30:00Z","sessionEndTime":"2017-12-10T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Response-Adapted Lenalidomide Maintenance in Newly Diagnosed, Transplant-Eligible Multiple Myeloma: Results from the Multicenter Phase III GMMG-MM5 Trial","keywords":"","combinedName":"doctor hartmut goldschmidt"},{"sessionId":"11599","sessionTitle":"731. Clinical Autologous Transplantation: Results: Modern Indications & Post-Transplant Check Point Inhibitors in Lymphoma and Myeloma","firstName":"James Nathan","lastName":"Gerson ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era","keywords":"","combinedName":"doctor james nathan gerson"},{"sessionId":"11599","sessionTitle":"731. Clinical Autologous Transplantation: Results: Modern Indications & Post-Transplant Check Point Inhibitors in Lymphoma and Myeloma","firstName":"Norbert Claude","lastName":"Gorin ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimizing the Pretransplant Regimen for Autologous Stem Cell Transplantation in Acute Myelogenous Leukemia: Better Outcomes with Busulfan and Melphalan Compared with Busulfan and Cyclophosphamide in High Risk Patients Autografted in First Complete Remission","keywords":"","combinedName":"doctor norbert claude gorin"},{"sessionId":"11599","sessionTitle":"731. Clinical Autologous Transplantation: Results: Modern Indications & Post-Transplant Check Point Inhibitors in Lymphoma and Myeloma","firstName":"Attaphol ","lastName":"Pawarode ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients","keywords":"","combinedName":"doctor attaphol pawarode"},{"sessionId":"11599","sessionTitle":"731. Clinical Autologous Transplantation: Results: Modern Indications & Post-Transplant Check Point Inhibitors in Lymphoma and Myeloma","firstName":"Alan P","lastName":"Skarbnik ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (I) and Nivolumab (N) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematologic Malignancies  Cpit-001 Trial","keywords":"","combinedName":"doctor alan p skarbnik"},{"sessionId":"11599","sessionTitle":"731. Clinical Autologous Transplantation: Results: Modern Indications & Post-Transplant Check Point Inhibitors in Lymphoma and Myeloma","firstName":"Anna Sallfors","lastName":"Holmqvist ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduction in Late Mortality after Autologous Blood or Marrow Transplantation (autoBMT) in Childhood  a Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)","keywords":"","combinedName":"doctor anna sallfors holmqvist"},{"sessionId":"11599","sessionTitle":"731. Clinical Autologous Transplantation: Results: Modern Indications & Post-Transplant Check Point Inhibitors in Lymphoma and Myeloma","firstName":"Steven I","lastName":"Park ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of Upfront Hematopoietic Stem Cell Transplantation (HSCT) in Peripheral T-Cell Lymphoma (PTCL) Patients in Complete Remission (CR) with a Special Focus on Nodal PTCL: Report from theComprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE), a Prospective Multicenter Cohort Study","keywords":"","combinedName":"doctor steven i park"},{"sessionId":"11600","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era","firstName":"Bronwen ","lastName":"Shaw ","credentials":"PhD, MRCP, FRCPath","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival","keywords":"","combinedName":"doctor bronwen shaw"},{"sessionId":"11600","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era","firstName":"Jonathan ","lastName":"Canaani ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Donor Age Determines Outcome in Acute Leukemia Patients Undergoing Haploidentical Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor jonathan canaani"},{"sessionId":"11600","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era","firstName":"Francesca ","lastName":"Lorentino ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Haploidentical T-Repleted Stem Cell Transplantation (SCT) Has Comparable Survival to 10/10 and 9/10 Unrelated SCT in Poor-Cytogenetics Risk Acute Myeloid Leukemia in First Complete Remission: A Studyon Behalf of the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)","keywords":"","combinedName":"doctor francesca lorentino"},{"sessionId":"11600","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era","firstName":"Mitchell ","lastName":"Horwitz","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nicord Single Unit Expanded Umbilical Cord Blood Transplantation: Final Results of a Multicenter Phase I/ II Trial","keywords":"","combinedName":"doctor mitchell horwitz"},{"sessionId":"11600","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era","firstName":"Tara ","lastName":"Robinson ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Selecting between HLA-Matched Siblings and HLA- Haploidentical Related Donors for Acute Leukemia in the Era of Post-Transplant Cyclophosphamide: The Center for International Blood and Marrow Transplant Registry and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant","keywords":"","combinedName":"doctor tara robinson"},{"sessionId":"11600","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era","firstName":"Clio E","lastName":"Franklin ","credentials":"MBBS, BSc, MRCP","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Fountain of Youth: Outcomes of Nonmyeloablative (NMA), HLA-Haploidentical Related (Haplo) Bone Marrow Transplantation (BMT) with Post-Transplantation Cyclophosphamide (PTCy) Best with Younger Donors Regardless of Relationship to Patient","keywords":"","combinedName":"doctor clio e franklin"},{"sessionId":"11601","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning","firstName":"Mary ","lastName":"Eapen ","credentials":"MBBS, MS","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes","keywords":"","combinedName":"doctor mary eapen"},{"sessionId":"11601","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning","firstName":"Xavier ","lastName":"Poire ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia with Monosomy 7 or Deletion 7q: A Study from the Acute Leukemia Working Party (ALWP) of the European Society of Blood and Marrow Transplantation (EBMT)","keywords":"","combinedName":"doctor xavier poire"},{"sessionId":"11601","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning","firstName":"Marina ","lastName":"Diaz Beya ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with t(6;9)(p23;q34);dek-NUP214 Is Followed By a Low Relapse Risk and Favorable Outcome in Early Phase- a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)","keywords":"","combinedName":"doctor marina diaz beya"},{"sessionId":"11601","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning","firstName":"Martin ","lastName":"Sauer ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-Mnster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia","keywords":"","combinedName":"doctor martin sauer"},{"sessionId":"11601","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning","firstName":"Saurabh ","lastName":"Chhabra ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Outcomes after Myeloablative Versus Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor saurabh chhabra"},{"sessionId":"11601","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning","firstName":"Qiaochuan ","lastName":"Li ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Idarubicin Intensified Bucy Regimen in Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Myeloid Leukemia: A Multicenter, Randomized Study (NCT 01766375)","keywords":"","combinedName":"doctor qiaochuan li"},{"sessionId":"11602","sessionTitle":"801. Gene Therapy and Transfer: Immune Disorders, CAR-T Cells, and B-hemoglobinopathies","firstName":"Katelyn E","lastName":"Masiuk ","credentials":"BS","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of a Treg Lineage Specific Lentiviral Vector for the Treatment of IPEX Syndrome","keywords":"","combinedName":"doctor katelyn e masiuk"},{"sessionId":"11602","sessionTitle":"801. Gene Therapy and Transfer: Immune Disorders, CAR-T Cells, and B-hemoglobinopathies","firstName":"Jing ","lastName":"PAN ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Low Dose CD22-Directed CAR-T Cell Therapy in 10 Relapsed B Acute Lymphoblastic Leukemia Patients","keywords":"","combinedName":"doctor jing pan"},{"sessionId":"11602","sessionTitle":"801. Gene Therapy and Transfer: Immune Disorders, CAR-T Cells, and B-hemoglobinopathies","firstName":"Julie ","lastName":"Kanter ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease","keywords":"","combinedName":"doctor julie kanter"},{"sessionId":"11602","sessionTitle":"801. Gene Therapy and Transfer: Immune Disorders, CAR-T Cells, and B-hemoglobinopathies","firstName":"Ewelina ","lastName":"Mamcarz ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim Results from a Phase I/II Clinical Gene Therapy Study for Newly Diagnosed Infants with X-Linked Severe Combined Immunodeficiency Using a Safety-Modified Lentiviral Vector and Targeted Reduced Exposure to Busulfan","keywords":"","combinedName":"doctor ewelina mamcarz"},{"sessionId":"11602","sessionTitle":"801. Gene Therapy and Transfer: Immune Disorders, CAR-T Cells, and B-hemoglobinopathies","firstName":"Mark ","lastName":"Walters ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from the Hgb-207 (Northstar-2) Trial: A Phase 3 Study to Evaluate Safety and Efficacy of Lentiglobin Gene Therapy for Transfusion-Dependent -Thalassemia (TDT) in Patients with Non-0/0 Genotypes","keywords":"","combinedName":"doctor mark walters"},{"sessionId":"11602","sessionTitle":"801. Gene Therapy and Transfer: Immune Disorders, CAR-T Cells, and B-hemoglobinopathies","firstName":"Jennifer ","lastName":"Brudno ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor with a CD28 Costimulatory Moiety Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma ","keywords":"","combinedName":"doctor jennifer brudno"},{"sessionId":"11603","sessionTitle":"801. Gene Therapy and Transfer: Gene Therapy for Hemophilia and Improving Lentiviral Vectors","firstName":"Diego A","lastName":"Espinoza ","credentials":"BA","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aberrant Clonal Hematopoiesis of the Erythroid and Myeloid Lineages in a Lentivirally Barcoded Rhesus Macaque","keywords":"","combinedName":"doctor diego a espinoza"},{"sessionId":"11603","sessionTitle":"801. Gene Therapy and Transfer: Gene Therapy for Hemophilia and Improving Lentiviral Vectors","firstName":"K. ","lastName":"Pasi ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Achievement of Normal Circulating Factor VIII Activity Following Bmn 270 AAV5-FVIII Gene Transfer: Interim, Long-Term Efficacy and Safety Results from a Phase 1/2 Study in Patients with Severe Hemophilia a","keywords":"","combinedName":"doctor k pasi"},{"sessionId":"11603","sessionTitle":"801. Gene Therapy and Transfer: Gene Therapy for Hemophilia and Improving Lentiviral Vectors","firstName":"Alessio ","lastName":"Cantore ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Liver-Directed Gene Therapy for Hemophilia B with Immune Stealth Lentiviral Vectors","keywords":"","combinedName":"doctor alessio cantore"},{"sessionId":"11603","sessionTitle":"801. Gene Therapy and Transfer: Gene Therapy for Hemophilia and Improving Lentiviral Vectors","firstName":"Lindsey ","lastName":"George ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Spk-8011: Preliminary Results from a Phase 1/2 Dose Escalation Trial of an Investigational AAV-Mediated Gene Therapy for Hemophilia a","keywords":"","combinedName":"doctor lindsey george"},{"sessionId":"11603","sessionTitle":"801. Gene Therapy and Transfer: Gene Therapy for Hemophilia and Improving Lentiviral Vectors","firstName":"Lindsey ","lastName":"George ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Spk-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B  1 Year Follow up and Impact of Baseline Characteristics on Transgene-Derived Factor IX Activity and Persistence","keywords":"","combinedName":"doctor lindsey george"},{"sessionId":"11603","sessionTitle":"801. Gene Therapy and Transfer: Gene Therapy for Hemophilia and Improving Lentiviral Vectors","firstName":"Frank ","lastName":"Leebeek ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg C- Lvl 1- C101 Aud","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Stable Elevations in FIX Activity and Reductions in Annualized Bleeding Rate over up to 2 Years of Follow-up of Adults with Severe or Moderate-Severe Hemophilia B Treated with AMT-060 (AAV5-hFIX) Gene Therapy","keywords":"","combinedName":"doctor frank leebeek"},{"sessionId":"11604","sessionTitle":"802. Chemical Biology and Experimental Therapeutics:  Functional Approaches for Diagnostics, Biomarker Development, and Discovery of New Targeting Strategies","firstName":"Shruti ","lastName":"Bhatt ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Functional Approach to Precision Medicine Identifies Targeted Therapies for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor shruti bhatt"},{"sessionId":"11604","sessionTitle":"802. Chemical Biology and Experimental Therapeutics:  Functional Approaches for Diagnostics, Biomarker Development, and Discovery of New Targeting Strategies","firstName":"Ileana ","lastName":"Antony-Debre ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Direct Pharmacological Inhibition of the Transcription Factor PU.1in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor ileana antony-debre"},{"sessionId":"11604","sessionTitle":"802. Chemical Biology and Experimental Therapeutics:  Functional Approaches for Diagnostics, Biomarker Development, and Discovery of New Targeting Strategies","firstName":"Disha ","lastName":"Malani ","credentials":"MRes","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification and Clinical Exploration of Individualized Targeted Therapeutic Approaches in Acute Myeloid Leukemia Patients By Integrating Drug Response and Deep Molecular Profiles","keywords":"","combinedName":"doctor disha malani"},{"sessionId":"11604","sessionTitle":"802. Chemical Biology and Experimental Therapeutics:  Functional Approaches for Diagnostics, Biomarker Development, and Discovery of New Targeting Strategies","firstName":"Philipp Bernhard","lastName":"Staber ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Next-Generation Functional Drug Screening for Patients with Aggressive Hematologic Malignancies","keywords":"","combinedName":"doctor philipp bernhard staber"},{"sessionId":"11604","sessionTitle":"802. Chemical Biology and Experimental Therapeutics:  Functional Approaches for Diagnostics, Biomarker Development, and Discovery of New Targeting Strategies","firstName":"Fabiana ","lastName":"Perna ","credentials":"MD ","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Systematic Combinatorial Chimeric Antigen Receptor Therapies to AML","keywords":"","combinedName":"doctor fabiana perna"},{"sessionId":"11604","sessionTitle":"802. Chemical Biology and Experimental Therapeutics:  Functional Approaches for Diagnostics, Biomarker Development, and Discovery of New Targeting Strategies","firstName":"Xi ","lastName":"Jiang ","credentials":"PhD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Inhibition of STAT/TET1 Axis As a Potent Therapeutic Strategy for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor xi jiang"},{"sessionId":"11605","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Consultative Hematology","firstName":"Regis ","lastName":"Peffault De Latour ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Retrospective Chart Review to Assess Burden of Illness Among Patients with Severe Aplastic Anemia with Insufficient Response to Immunosuppressive Therapy","keywords":"","combinedName":"doctor regis peffault de latour"},{"sessionId":"11605","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Consultative Hematology","firstName":"Nicholas ","lastName":"Burwick ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Monoclonal Gammopathies: Electronic Subspecialty Consultation","keywords":"","combinedName":"doctor nicholas burwick"},{"sessionId":"11605","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Consultative Hematology","firstName":"Smith ","lastName":"Giri ","credentials":"MBBS","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:15:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Relationship between Hospital Volume and Inpatient Mortality Among Patients Diagnosed with Thrombotic Thrombocytopenic Purpura (TTP) in the United States","keywords":"","combinedName":"doctor smith giri"},{"sessionId":"11605","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Consultative Hematology","firstName":"Neel S","lastName":"Bhatt ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Trends of Splenectomy in Pediatric Patients with Immune Thrombocytopenia before and after the ASH 2011 Evidence-Based Practice Guidelines","keywords":"","combinedName":"doctor neel s bhatt"},{"sessionId":"11605","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Consultative Hematology","firstName":"Samuel ","lastName":"Yamshon ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:45:00","endTime":"12:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Venous Thromboembolism in Patients with B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Lenalidomide","keywords":"","combinedName":"doctor samuel yamshon"},{"sessionId":"11605","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Consultative Hematology","firstName":"Amanda ","lastName":"Jacobson ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Von Willebrand Disease Screening in Women Undergoing Hysterectomy for Heavy Menstrual Bleeding","keywords":"","combinedName":"doctor amanda jacobson"},{"sessionId":"11606","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Sickle Cell Disease","firstName":"Mariam ","lastName":"Kayle ","credentials":"PhD, RN","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Health Care Utilization Trajectories and Associated Factors for Transitioning Adolescents/Young Adults with Sickle Cell Disease","keywords":"","combinedName":"doctor mariam kayle"},{"sessionId":"11606","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Sickle Cell Disease","firstName":"Djamila Labib","lastName":"Ghafuri ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:30:00","endTime":"09:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Prevalence of Severe Acute Malnutrition in Children with Sickle Cell Anemia over 5 Years of Age in Northern Nigeria","keywords":"","combinedName":"doctor djamila labib ghafuri"},{"sessionId":"11606","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Sickle Cell Disease","firstName":"Ashima ","lastName":"Singh ","credentials":"PhD, MS","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"09:45:00","endTime":"10:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Longitudinal Trend in Emergency Department Reliance for Pain Among Sickle Cell Disease Patients in Wisconsin","keywords":"","combinedName":"doctor ashima singh"},{"sessionId":"11606","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Sickle Cell Disease","firstName":"Sophie ","lastName":"Lanzkron ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:00:00","endTime":"10:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Men with Sickle Cell Disease Show Significant Concerns over Safety While Being Treated for Vaso-Occlusive Crises: Preliminary Observations from the Escaped Trial","keywords":"","combinedName":"doctor sophie lanzkron"},{"sessionId":"11606","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Sickle Cell Disease","firstName":"Samir ","lastName":"Ballas ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:15:00","endTime":"10:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Opioid Utilization Patterns in United States Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor samir ballas"},{"sessionId":"11606","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Sickle Cell Disease","firstName":"Omar ","lastName":"Niss ","credentials":"MD","sessionStartTime":"2017-12-09T09:30:00Z","sessionEndTime":"2017-12-09T11:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevention of Acute Chest Syndrome By Implementing a Standardized Process to Improve Incentive Spirometry Use in Hospitalized Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor omar niss"},{"sessionId":"11607","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Thrombosis","firstName":"Samuel ","lastName":"Merrill ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adult Hemophagocytic Lymphohistiocytosisa Quality Improvement Initiative","keywords":"","combinedName":"doctor samuel merrill"},{"sessionId":"11607","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Thrombosis","firstName":"Bruce ","lastName":"Davidson ","credentials":"MD, MPH","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:15:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population","keywords":"","combinedName":"doctor bruce davidson"},{"sessionId":"11607","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Thrombosis","firstName":"Ajay ","lastName":"Gupta ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased Toxicity Among Adolescents and Young Adults Treated for Acute Lymphoblastic Leukemia at U.S. Childrens Hospitals","keywords":"","combinedName":"doctor ajay gupta"},{"sessionId":"11607","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Thrombosis","firstName":"Yu-Wei ","lastName":"Chen ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"14:45:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevalence of Venous Thromboembolism in Cancer Patients in the Emergency Department and Associated Healthcare Resource Utilization and Expenditure in the United States","keywords":"","combinedName":"doctor yu-wei chen"},{"sessionId":"11607","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Thrombosis","firstName":"Jordan ","lastName":"Schaefer ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease","keywords":"","combinedName":"doctor jordan schaefer"},{"sessionId":"11607","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Thrombosis","firstName":"Chris ","lastName":"Holmes ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:15:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic (VTE-PACC):a Systems-Based, Personalized, Multidisciplinary Program to Increase Venous Thromboembolism (VTE) Risk Assessment, Education and Anticoagulant Prophylaxis in Cancer Outpatients Initiating Therapy","keywords":"","combinedName":"doctor chris holmes"},{"sessionId":"11608","sessionTitle":"902. Health Services ResearchMalignant Diseases: Pediatric and AYA Outcomes","firstName":"Joseph ","lastName":"Horowitz ","credentials":"","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Multicenter Comparison of Rates of Central Venous Catheter-Associated Bloodstream Infections By Central Venous Catheter Type Among Pediatric Patients Receiving Treatment for Newly Diagnosed Acute Myeloid Leukemia","keywords":"","combinedName":"doctor joseph horowitz"},{"sessionId":"11608","sessionTitle":"902. Health Services ResearchMalignant Diseases: Pediatric and AYA Outcomes","firstName":"Lori ","lastName":"Muffly ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Are Adolescents and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL) Receiving Pediatric or Adult ALL Regimens: A Population-Based Statewide Evaluation of the Approach to AYA ALL across Pediatric and Adult Cancer Centers","keywords":"","combinedName":"doctor lori muffly"},{"sessionId":"11608","sessionTitle":"902. Health Services ResearchMalignant Diseases: Pediatric and AYA Outcomes","firstName":"Yanni ","lastName":"Hao ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cost-Effectiveness Analysis of CTL019 for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in the United States","keywords":"","combinedName":"doctor yanni hao"},{"sessionId":"11608","sessionTitle":"902. Health Services ResearchMalignant Diseases: Pediatric and AYA Outcomes","firstName":"Lena ","lastName":"Winestone ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recession Increases Need for Intensive Care in Pediatric Hematologic Malignancy Presentation","keywords":"","combinedName":"doctor lena winestone"},{"sessionId":"11608","sessionTitle":"902. Health Services ResearchMalignant Diseases: Pediatric and AYA Outcomes","firstName":"Chun ","lastName":"Chao ","credentials":"PhD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:15:00","endTime":"07:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk of Subsequent Malignant Neoplasms in Survivors of Adolescent and Young Adult (AYA) Lymphoma and Leukemia","keywords":"","combinedName":"doctor chun chao"},{"sessionId":"11608","sessionTitle":"902. Health Services ResearchMalignant Diseases: Pediatric and AYA Outcomes","firstName":"Justine ","lastName":"Kahn ","credentials":"MD","sessionStartTime":"2017-12-11T07:00:00Z","sessionEndTime":"2017-12-11T08:30:00Z","startTime":"07:00:00","endTime":"07:15:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Childrens Oncology Group Trials","keywords":"","combinedName":"doctor justine kahn"},{"sessionId":"11609","sessionTitle":"902. Health Services ResearchMalignant Diseases: Race-Ethnic and Age-Related Disparities","firstName":"Bindu","lastName":"Kanapuru","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enrollment of Older Adults in Clinical Trials Evaluating Patients with Hematologic Malignancies  the Food and Drug Administration (FDA) Experience","keywords":"","combinedName":"doctor bindu kanapuru"},{"sessionId":"11609","sessionTitle":"902. Health Services ResearchMalignant Diseases: Race-Ethnic and Age-Related Disparities","firstName":"Sikander ","lastName":"Ailawadhi ","credentials":"","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factors Determining Utilization of Stem Cell Transplant (SCT) for Initial Therapy of Multiple Myeloma (MM) By Patient Race: Exploring Intra-Racial Healthcare Disparities","keywords":"","combinedName":"doctor sikander ailawadhi"},{"sessionId":"11609","sessionTitle":"902. Health Services ResearchMalignant Diseases: Race-Ethnic and Age-Related Disparities","firstName":"Annatina ","lastName":"Schnegg-Kaufmann ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improvement of Relative Survival in Elderly Patients with Acute Myeloid Leukemia Emerging from Population-Based Cancer Registries in Switzerland from 2001-2013","keywords":"","combinedName":"doctor annatina schnegg-kaufmann"},{"sessionId":"11609","sessionTitle":"902. Health Services ResearchMalignant Diseases: Race-Ethnic and Age-Related Disparities","firstName":"Mark ","lastName":"Fiala ","credentials":"MSW","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Race Is Associated with Bortezomib but Not Lenalidomide Utilization during First-Line Treatment of Multiple Myeloma","keywords":"","combinedName":"doctor mark fiala"},{"sessionId":"11609","sessionTitle":"902. Health Services ResearchMalignant Diseases: Race-Ethnic and Age-Related Disparities","firstName":"Tania ","lastName":"Jain ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Racial Differences in Disease Characteristics: Understanding Multiple Myeloma in Hispanics","keywords":"","combinedName":"doctor tania jain"},{"sessionId":"11609","sessionTitle":"902. Health Services ResearchMalignant Diseases: Race-Ethnic and Age-Related Disparities","firstName":"Kedar ","lastName":"Kirtane ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Racial Disparities in End-of-Life Care Planning and Hospital Utilization: A Single Center Retrospective Study","keywords":"","combinedName":"doctor kedar kirtane"},{"sessionId":"11610","sessionTitle":"902. Health Services ResearchMalignant Diseases: Adult Outcomes","firstName":"Adam J","lastName":"Olszewski ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Application and Outcomes of Bendamustine- or Bortezomib-Based Therapy for Waldenstroms Macroglobulinemia","keywords":"","combinedName":"doctor adam j olszewski"},{"sessionId":"11610","sessionTitle":"902. Health Services ResearchMalignant Diseases: Adult Outcomes","firstName":"Oreofe ","lastName":"Odejide","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hospice Use Among Patients with Myeloma","keywords":"","combinedName":"doctor oreofe odejide"},{"sessionId":"11610","sessionTitle":"902. Health Services ResearchMalignant Diseases: Adult Outcomes","firstName":"Maximilian ","lastName":"Stahl ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Survival of Older Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agent Therapy: A Large Population-Based Analysis","keywords":"","combinedName":"doctor maximilian stahl"},{"sessionId":"11610","sessionTitle":"902. Health Services ResearchMalignant Diseases: Adult Outcomes","firstName":"Amy ","lastName":"Morris ","credentials":"PharmD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prospective Study of an Antifungal Program to Reduce Invasive Fungal Infections in Patients with Acute Myeloid Leukemia Receiving Induction and Re-Induction Chemotherapy","keywords":"","combinedName":"doctor amy morris"},{"sessionId":"11610","sessionTitle":"902. Health Services ResearchMalignant Diseases: Adult Outcomes","firstName":"Raffi ","lastName":"Tchekmedyian ","credentials":"BS","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Survival Among Acute Lymphocytic Leukemia Patients Conditional on Years Already Survived and Relative to the General Population in the United States","keywords":"","combinedName":"doctor raffi tchekmedyian"},{"sessionId":"11610","sessionTitle":"902. Health Services ResearchMalignant Diseases: Adult Outcomes","firstName":"Raffi ","lastName":"Tchekmedyian ","credentials":"BS","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Survival Among Acute Myeloid Leukemia Patients Conditional on Years Already Survived and Relative to the General Population in the United States","keywords":"","combinedName":"doctor raffi tchekmedyian"},{"sessionId":"11611","sessionTitle":"902. Health Services ResearchMalignant Diseases: Innovative Predictors and Outcomes","firstName":"Ashley T","lastName":"Freeman ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of NCI Comprehensive Cancer Center Designation, Provider Specialization and Patient Sharing with Community Providers on Outcomes for Patients with Multiple Myeloma","keywords":"","combinedName":"doctor ashley t freeman"},{"sessionId":"11611","sessionTitle":"902. Health Services ResearchMalignant Diseases: Innovative Predictors and Outcomes","firstName":"Leah J","lastName":"McGrath ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patterns and Predictors of Initiation of Intravenous Bisphosphonates Among Patients with Multiple Myeloma in the United States","keywords":"","combinedName":"doctor leah j mcgrath"},{"sessionId":"11611","sessionTitle":"902. Health Services ResearchMalignant Diseases: Innovative Predictors and Outcomes","firstName":"Girish ","lastName":"Kunapareddy ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predictors for Recurrent 30-Day Unplanned Readmissions in Patients with Hematologic Malignancies","keywords":"","combinedName":"doctor girish kunapareddy"},{"sessionId":"11611","sessionTitle":"902. Health Services ResearchMalignant Diseases: Innovative Predictors and Outcomes","firstName":"Nandita ","lastName":"Khera ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevalence and Risk-Factors for Financial Burden in Patients with Chronic Graft-Versus-Host Disease: A Cross-Sectional Survey from the Chronic Gvhd Consortium","keywords":"","combinedName":"doctor nandita khera"},{"sessionId":"11611","sessionTitle":"902. Health Services ResearchMalignant Diseases: Innovative Predictors and Outcomes","firstName":"Yishai ","lastName":"Ofran ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"the Impact of Dedicated Emergency and Admission Units on Infection and Death Risks in Hematological Patients Presented to a Tertiary Care Center ","keywords":"","combinedName":"doctor yishai ofran"},{"sessionId":"11611","sessionTitle":"902. Health Services ResearchMalignant Diseases: Innovative Predictors and Outcomes","firstName":"Lanair Amaad","lastName":"Lett ","credentials":"BA, MS","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B206","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Using Electronic Medical Record Data and Block Group Level Estimates of Poverty to Investigate the Association between Socioeconomic Status and Bloodstream Infection Among Pediatric Patients with Acute Leukemia","keywords":"","combinedName":"doctor lanair amaad lett"},{"sessionId":"11612","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Sickle Cell Disease","firstName":"Cecelia ","lastName":"Calhoun ","credentials":"MD, MPHS","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Current Healthcare Utilization Patterns and Most Common Reasons for Admission Amongst Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor cecelia calhoun"},{"sessionId":"11612","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Sickle Cell Disease","firstName":"Kerry A","lastName":"Morrone ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Decreased Hospital Readmissions for Vaso Occlusive Crisis with Implementation of a Sickle Cell Pain Action Plan (SPAP)","keywords":"","combinedName":"doctor kerry a morrone"},{"sessionId":"11612","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Sickle Cell Disease","firstName":"Arlene ","lastName":"Smaldone ","credentials":"PhD, CPNP","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Habit, a Feasibility Trial to Improve Hydroxyurea Adherence, Improves Quality of Life in Youth with Sickle Cell Disease","keywords":"","combinedName":"doctor arlene smaldone"},{"sessionId":"11612","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Sickle Cell Disease","firstName":"Varsha ","lastName":"Kulkarni ","credentials":"MBBS","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Sickle Cell Therapies on Growth Patterns","keywords":"","combinedName":"doctor varsha kulkarni"},{"sessionId":"11612","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Sickle Cell Disease","firstName":"Amanda ","lastName":"Payne ","credentials":"MPH","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mortality Trends and Causes of Death in Persons with Sickle Cell Disease in the United States, 1979-2014","keywords":"","combinedName":"doctor amanda payne"},{"sessionId":"11612","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Sickle Cell Disease","firstName":"Sarah ","lastName":"Kappa ","credentials":"","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Education after an Emergency Department Visit Increases Hydroxyurea Initiation in Children with Sickle Cell Anemia","keywords":"","combinedName":"doctor sarah kappa"},{"sessionId":"11613","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Health Impact and Mortality","firstName":"Daniel ","lastName":"Douce ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enhancing the Khorana Score: Traditional VTE Risk Factors Are Important in Predicting Long Term VTE Risk in Cancer Patients Initiating Chemotherapy","keywords":"","combinedName":"doctor daniel douce"},{"sessionId":"11613","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Health Impact and Mortality","firstName":"Rachael ","lastName":"Grace","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Health Related Quality of Life and Fatigue Improve on Second Line Treatments in Pediatric Immune Thrombocytopenia (ITP)","keywords":"","combinedName":"doctor rachael grace"},{"sessionId":"11613","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Health Impact and Mortality","firstName":"Anjlee ","lastName":"Mahajan ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:30:00","endTime":"15:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence of Venous Thromboembolism and Impact on Mortalityin Patients with Primary CNS Lymphoma: A Population Based Study","keywords":"","combinedName":"doctor anjlee mahajan"},{"sessionId":"11613","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Health Impact and Mortality","firstName":"Amanda ","lastName":"Payne ","credentials":"MPH","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mortality Trends and Causes of Death in Persons with Hemophilia in the United States, 1999-2014","keywords":"","combinedName":"doctor amanda payne"},{"sessionId":"11613","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Health Impact and Mortality","firstName":"Maria Domenica","lastName":"Cappellini","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quality of Life in Patients with -Thalassemia: Transfusion Dependent Versus Non-Transfusion Dependent","keywords":"","combinedName":"doctor maria domenica cappellini"},{"sessionId":"11613","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Health Impact and Mortality","firstName":"Michael ","lastName":"Wang ","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Relationship of Joint Range of Motion to Factor Activity in Patients with Hemophilia a and B without Prophylaxis: A Longitudinal Assessment of the CDC-UDC Hemophilia Dataset","keywords":"","combinedName":"doctor michael wang"},{"sessionId":"11614","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Impacting Healthcare Utilization and End of Life Care","firstName":"Kathryn ","lastName":"Cappell ","credentials":"PhD, MD, BS","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:15:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Advance Directive Utilization Decreases Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor kathryn cappell"},{"sessionId":"11614","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Impacting Healthcare Utilization and End of Life Care","firstName":"Ron ","lastName":"Ram ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bolus Versus Prolonged Infusion of Broad-Spectrum Beta-Lactams for Patients with Hematologic Malignancies and High Risk Febrile Neutropenia  a Single Center Prospective Unblinded Randomized Trial","keywords":"","combinedName":"doctor ron ram"},{"sessionId":"11614","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Impacting Healthcare Utilization and End of Life Care","firstName":"Girish ","lastName":"Kunapareddy ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Creation of Individualized Care Plans in High Risk Oncology Patients: A Team Based Model to Decrease Unnecessary Hospitalizations and ED Utilization","keywords":"","combinedName":"doctor girish kunapareddy"},{"sessionId":"11614","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Impacting Healthcare Utilization and End of Life Care","firstName":"Matthew ","lastName":"Cheung ","credentials":"MD, MS, FRCP","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Days Spent at Home in the Last 6 Months of Life. a Potential Patient-Determined Quality Indicator for Patients with Hematologic Malignancies at the End of Life","keywords":"","combinedName":"doctor matthew cheung"},{"sessionId":"11614","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Impacting Healthcare Utilization and End of Life Care","firstName":"Kareem ","lastName":"Jamani ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quality of Life of Informal Caregivers of Hematopoietic Cell Transplant Recipients","keywords":"","combinedName":"doctor kareem jamani"},{"sessionId":"11614","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Impacting Healthcare Utilization and End of Life Care","firstName":"Adam J","lastName":"Olszewski ","credentials":"MD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transfusion Dependence and Use of Hospice Among Medicare Beneficiaries with Leukemia","keywords":"","combinedName":"doctor adam j olszewski"},{"sessionId":"11615","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Survivorship and Quality of Life in Lymphoid Malignancies","firstName":"Carrie A","lastName":"Thompson ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:15:00","endTime":"19:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Changes in Quality of Life in Indolent Non-Hodgkin Lymphoma 3 Years after Diagnosis","keywords":"","combinedName":"doctor carrie a thompson"},{"sessionId":"11615","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Survivorship and Quality of Life in Lymphoid Malignancies","firstName":"Jordan ","lastName":"Goldstein ","credentials":"BS","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:00:00","endTime":"19:15:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Insurance Status ImpactsSurvivalin Burkitt Lymphoma","keywords":"","combinedName":"doctor jordan goldstein"},{"sessionId":"11615","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Survivorship and Quality of Life in Lymphoid Malignancies","firstName":"Max J","lastName":"Gordon ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:30:00","endTime":"19:45:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Medical Comorbidities Assessed By CIRS Negatively Impact Survival in the Era of Targeted Therapies in CLL: A Multicenter Retrospective Analysis","keywords":"","combinedName":"doctor max j gordon"},{"sessionId":"11615","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Survivorship and Quality of Life in Lymphoid Malignancies","firstName":"Vivek ","lastName":"Kumar ","credentials":"","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:15:00","endTime":"18:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Secondary Cancers in Hodgkin Lymphoma: A Comprehensive Analysis of Incidence and Trends in Survivors","keywords":"","combinedName":"doctor vivek kumar"},{"sessionId":"11615","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Survivorship and Quality of Life in Lymphoid Malignancies","firstName":"Qian ","lastName":"Wang ","credentials":"MD, MPH","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:45:00","endTime":"19:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Survival Outcome and Insurance Status Among Hodgkins Lymphoma (HL) Patients: Data from SEER 2007-2014","keywords":"","combinedName":"doctor qian wang"},{"sessionId":"11615","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Survivorship and Quality of Life in Lymphoid Malignancies","firstName":"Priyanka ","lastName":"Pophali ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:30:00","endTime":"18:45:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Level of Physical Activity before and after Lymphoma Diagnosis Impacts Overall and Lymphoma-Specific Survival","keywords":"","combinedName":"doctor priyanka pophali"},{"sessionId":"11616","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Impact of Disease Burden in Myeloma and Other Hematologic Malignancies","firstName":"Gregory ","lastName":"Abel","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:45:00","endTime":"12:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Financial Burden and Patient-Reported Outcomes after Hematopoietic Cell Transplantation: Impact of Pre-Treatment Awareness of Transplant-Associated Costs","keywords":"","combinedName":"doctor gregory abel"},{"sessionId":"11616","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Impact of Disease Burden in Myeloma and Other Hematologic Malignancies","firstName":"Jeffrey ","lastName":"Sharman ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine","keywords":"","combinedName":"doctor jeffrey sharman"},{"sessionId":"11616","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Impact of Disease Burden in Myeloma and Other Hematologic Malignancies","firstName":"Joshua R","lastName":"Richter ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence and Survival Impact of Self-Reported Symptom and Psychological Distress Among Patients with Multiple Myeloma","keywords":"","combinedName":"doctor joshua r richter"},{"sessionId":"11616","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Impact of Disease Burden in Myeloma and Other Hematologic Malignancies","firstName":"Luciano ","lastName":"Costa ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Population Trends in Incidence of Second Malignant Neoplasm and Cause-Specific Mortality in Patients with Multiple Myeloma","keywords":"","combinedName":"doctor luciano costa"},{"sessionId":"11616","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Impact of Disease Burden in Myeloma and Other Hematologic Malignancies","firstName":"Ehsan ","lastName":"Malek ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reducing Gastrointestinal Toxicity Associated with Autologous Transplantation for Multiple Myeloma without Compromising Its Anti-Myeloma Effect","keywords":"","combinedName":"doctor ehsan malek"},{"sessionId":"11616","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Impact of Disease Burden in Myeloma and Other Hematologic Malignancies","firstName":"Loretta ","lastName":"Williams ","credentials":"PhD, MSN, BSN, BA","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:15:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Symptom Burden of Busulfan and Melphalan Versus Melphalan Alone for Multiple Myeloma","keywords":"","combinedName":"doctor loretta williams"},{"sessionId":"11617","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Quality Of Life and Outcomes in Myelodysplastic Syndromes and Leukemias","firstName":"Fabio ","lastName":"Efficace ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Transfusion Dependency on Health-Related Quality of Life Outcomes in Newly Diagnosed Patients with Myelodysplastic Syndromes (MDS). Analysis on 669 Patients By Disease Risk","keywords":"","combinedName":"doctor fabio efficace"},{"sessionId":"11617","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Quality Of Life and Outcomes in Myelodysplastic Syndromes and Leukemias","firstName":"Areej ","lastName":"El-Jawahri ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Perceptions of Prognosis and Treatment Risk in Older Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor areej el-jawahri"},{"sessionId":"11617","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Quality Of Life and Outcomes in Myelodysplastic Syndromes and Leukemias","firstName":"Omer ","lastName":"Jamy ","credentials":"","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk and Outcomes of Second Malignant Neoplasms in Chronic Myeloid Leukemia Survivors","keywords":"","combinedName":"doctor omer jamy"},{"sessionId":"11617","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Quality Of Life and Outcomes in Myelodysplastic Syndromes and Leukemias","firstName":"Nikolai ","lastName":"Podoltsev ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Essential Thrombocythemia","keywords":"","combinedName":"doctor nikolai podoltsev"},{"sessionId":"11617","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Quality Of Life and Outcomes in Myelodysplastic Syndromes and Leukemias","firstName":"Nikolai ","lastName":"Podoltsev ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Phlebotomy and Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Polycythemia Vera","keywords":"","combinedName":"doctor nikolai podoltsev"},{"sessionId":"11617","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Quality Of Life and Outcomes in Myelodysplastic Syndromes and Leukemias","firstName":"Julie ","lastName":"Wolfson ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg A- Lvl 4- A411-A412","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Understanding Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia in a Real-World Setting","keywords":"","combinedName":"doctor julie wolfson"},{"sessionId":"11618","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I","firstName":"Simon ","lastName":"Raffel ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Branched Chain Amino Acid Catabolism Restricts Alpha-Ketoglutarate Levels Resembling IDHmut-Driven DNA Hypermethylation in AML Stem Cells","keywords":"","combinedName":"doctor simon raffel"},{"sessionId":"11618","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I","firstName":"Terrence N","lastName":"Wong ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cellular Stressors Contribute to the Expansion of Multiple Hematopoietic Clones of Varying Leukemic Potential","keywords":"","combinedName":"doctor terrence n wong"},{"sessionId":"11618","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I","firstName":"Shinichi ","lastName":"Kotani ","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Pathogenesis of Progressive Refractoriness in MLL-Rearranged AML","keywords":"","combinedName":"doctor shinichi kotani"},{"sessionId":"11618","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I","firstName":"Tianjiao ","lastName":"Wang ","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Necessity of Smc3 in Embryonic and Adult Hematopoiesis with an Emphasis on Myeloid Compartment","keywords":"","combinedName":"doctor tianjiao wang"},{"sessionId":"11618","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I","firstName":"Sagi ","lastName":"Abelson ","credentials":"PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Progression to AML Is Predictable and Distinct from Age Related Clonal Hematopoiesis","keywords":"","combinedName":"doctor sagi abelson"},{"sessionId":"11618","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I","firstName":"Akihide ","lastName":"Yoshimi ","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Spliceosomal Dysfunction Is a Critical Mediator of IDH2 Mutant Leukemogenesis","keywords":"","combinedName":"doctor akihide yoshimi"},{"sessionId":"11619","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II","firstName":"Pinkal ","lastName":"Desai ","credentials":"MD,MPH","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"13:15:00","endTime":"13:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Myeloid Leukemia (AML) Patients Demonstrate Increased Prevalence of AML-Defining Mutations in Peripheral Blood Years Prior to the Development of Overt Leukemia: A Case-Control Study","keywords":"","combinedName":"doctor pinkal desai"},{"sessionId":"11619","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II","firstName":"Francine ","lastName":"Garrett-Bakelman","credentials":"MD,PhD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:15:00","endTime":"12:30:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Landscapes in Elderly AML","keywords":"","combinedName":"doctor francine garrett-bakelman"},{"sessionId":"11619","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II","firstName":"Maher ","lastName":"Albitar ","credentials":"MD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:30:00","endTime":"12:45:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IDH1 and IDH2: Founding or Progressor Mutations in Myeloid Neoplasms","keywords":"","combinedName":"doctor maher albitar"},{"sessionId":"11619","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II","firstName":"Alice ","lastName":"Marceau-Renaut ","credentials":"PharmD","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:00:00","endTime":"12:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Profiling Defines Distinct Prognostic Subgroups in Chilhood Acute Myeloid Leukemia: A Report from the French ELAM02 Study Group","keywords":"","combinedName":"doctor alice marceau-renaut"},{"sessionId":"11619","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II","firstName":"Juliane ","lastName":"Grimm ","credentials":"","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"12:45:00","endTime":"13:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Impact of Clonal Hematopoiesis in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission","keywords":"","combinedName":"doctor juliane grimm"},{"sessionId":"11619","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II","firstName":"Todd M","lastName":"Cooper","credentials":"DO","sessionStartTime":"2017-12-10T12:00:00Z","sessionEndTime":"2017-12-10T13:30:00Z","startTime":"13:00:00","endTime":"13:15:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Revised Risk Stratification Criteria for Children with Newly Diagnosed Acute Myeloid Leukemia: A Report from the Childrens Oncology Group","keywords":"","combinedName":"doctor todd m cooper"},{"sessionId":"11620","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III","firstName":"Patrick ","lastName":"Williams ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Checkpoint Expression By Acute Myeloid Leukemia (AML) and the Immune Microenvironment Suppresses Adaptive Immunity","keywords":"","combinedName":"doctor patrick williams"},{"sessionId":"11620","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III","firstName":"Silke ","lastName":"Kapp-Schwoerer ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:30:00","endTime":"14:45:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Relevance of Minimal Residual Disease Monitoring in NPM1 Mutated AML: A Study of the AML Study Group (AMLSG)","keywords":"","combinedName":"doctor silke kapp-schwoerer"},{"sessionId":"11620","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III","firstName":"Laura ","lastName":"Schmalbrock ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:15:00","endTime":"14:30:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Evolution of FLT3-ITD Positive AML in Patients Treated with Midostaurin in Combination with Chemotherapy within the Ratify (CALGB 10603) and AMLSG 16-10 Trials","keywords":"","combinedName":"doctor laura schmalbrock"},{"sessionId":"11620","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III","firstName":"Sanne ","lastName":"Noort ","credentials":"MD, MSc","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Distinct Outcome Based on Fusion Transcript in t(16;21) Rearranged Pediatric AML, a Collaborative Retrospective Analysis By the I-BFM SG","keywords":"","combinedName":"doctor sanne noort"},{"sessionId":"11620","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III","firstName":"Ann-Kathrin ","lastName":"Eisfeld ","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Neurofibromin 1 gene Mutations Are Recurrent Events in Adult Patients with Acute Myeloid Leukemia (AML), Associate with Poor Outcome and Refine the Adverse European Leukemianet (ELN) Risk Category","keywords":"","combinedName":"doctor ann-kathrin eisfeld"},{"sessionId":"11620","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III","firstName":"Daniel ","lastName":"Pollyea","credentials":"MD","sessionStartTime":"2017-12-09T14:00:00Z","sessionEndTime":"2017-12-09T15:30:00Z","startTime":"14:00:00","endTime":"14:15:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Venetoclax (Ven) with Azacitidine (Aza) for Untreated Elderly Acute Myeloid Leukemia (AML) Patients (Pts) Unfit for Induction Chemotherapy: Single Center Clinical Experience and Mechanistic Insights from Correlative Studies","keywords":"","combinedName":"doctor daniel pollyea"},{"sessionId":"11622","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Prognosis ","firstName":"Michael ","lastName":"Chapman ","credentials":"PhD, MRCP, FRCPath","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Seven Gene Signature to Distinguish Bortezomib- and Lenalidomide-Responsive Myeloma: Rnaseq from the Padimac Study","keywords":"","combinedName":"doctor michael chapman"},{"sessionId":"11622","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Prognosis ","firstName":"Alessandro ","lastName":"Lagana ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adar-Mediated Aberrant a-to-I RNA Editing Is Driven By 1q Amplification and Contributes to Proteasome Inhibitor Resistance in Multiple Myeloma","keywords":"","combinedName":"doctor alessandro lagana"},{"sessionId":"11622","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Prognosis ","firstName":"Nicola","lastName":"Lehners","credentials":"","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:15:00","endTime":"16:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Genomic Characterization of Refractory Multiple Myeloma Reveals a Complex Mutational and Structural Landscape Associated with Drug Resistance","keywords":"","combinedName":"doctor nicola lehners"},{"sessionId":"11622","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Prognosis ","firstName":"Andrew P","lastName":"Dervan ","credentials":"","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Crowdsourcing a High-Risk Classifier for Multiple Myeloma Patients","keywords":"","combinedName":"doctor andrew p dervan"},{"sessionId":"11622","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Prognosis ","firstName":"Santiago ","lastName":"Barrio Garcia ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IKZF1/3 and CRL4CRBN E3 Ubiquitin Ligase Mutations Associate with IMiD Resistance in Relapsed Multiple Myeloma","keywords":"","combinedName":"doctor santiago barrio garcia"},{"sessionId":"11622","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Prognosis ","firstName":"Nasrin ","lastName":"Rastgoo ","credentials":"PhD","sessionStartTime":"2017-12-09T16:00:00Z","sessionEndTime":"2017-12-09T17:30:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of the Epigenetic Modifier EZH2 By Mir-138 Upregulates Tumor Suppressor Gene Rbpms and Contributes to Drug Susceptibility in Preclinical Model of Multiple Myeloma","keywords":"","combinedName":"doctor nasrin rastgoo"},{"sessionId":"11623","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics ","firstName":"Alessandro ","lastName":"Lagana ","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:30:00","endTime":"07:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Evolution in Newly Diagnosed Multiple Myeloma Patients: A Follow-up Study from the Mmrf Commpass Genomics Project","keywords":"","combinedName":"doctor alessandro lagana"},{"sessionId":"11623","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics ","firstName":"Jens G","lastName":"Lohr ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:30:00","endTime":"08:45:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Discovery and Clonal Tracking in Multiple Myeloma By Cell Free DNA Sequencing","keywords":"","combinedName":"doctor jens g lohr"},{"sessionId":"11623","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics ","firstName":"Jonathan ","lastName":"Keats","credentials":"PhD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"07:45:00","endTime":"08:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrative Analysis of the Genomic Landscape Underlying Multiple Myeloma at Diagnosis: An Mmrf Commpass Analysis","keywords":"","combinedName":"doctor jonathan keats"},{"sessionId":"11623","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics ","firstName":"Raphael ","lastName":"Szalat ","credentials":"MD","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:15:00","endTime":"08:30:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrative Oncogenomic Analysis Combining Whole Genome, Transcriptome and Epigenome Identifies Altered Chromatin Accessibility Landscape in Multiple Myeloma","keywords":"","combinedName":"doctor raphael szalat"},{"sessionId":"11623","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics ","firstName":"Bernhard ","lastName":"Gerber ","credentials":"","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:00:00","endTime":"08:15:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasma Cell Disease Genotyping with the Liquid Biopsy","keywords":"","combinedName":"doctor bernhard gerber"},{"sessionId":"11623","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics ","firstName":"Francesco ","lastName":"Maura ","credentials":"","sessionStartTime":"2017-12-10T07:30:00Z","sessionEndTime":"2017-12-10T09:00:00Z","startTime":"08:45:00","endTime":"09:00:00","sessionLocation":"Bldg B- Lvl 3- B302-B303","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Genomic Landscape of Multiple Myeloma Complex Structural Variations","keywords":"","combinedName":"doctor francesco maura"},{"sessionId":"11625","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation II","firstName":"Anjali ","lastName":"Mookerjee ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:30:00","endTime":"19:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bortezomib, Lenalidomide and Low-Dose Dexamethasone (VRD) Versus Lenalidomide and Low-Dose Dexamethasone (Ld) for Newly-Diagnosed Multiple Myeloma- a Randomized Phase III Study","keywords":"","combinedName":"doctor anjali mookerjee"},{"sessionId":"11625","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation II","firstName":"Meletios ","lastName":"Dimopoulos","credentials":"","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:30:00","endTime":"18:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Long-Term Ixazomib Maintenance Therapy in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Not Undergoing Transplant: An Integrated Analysis of Four Phase 1/2 Studies","keywords":"","combinedName":"doctor meletios dimopoulos"},{"sessionId":"11625","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation II","firstName":"Bruno","lastName":"Paiva","credentials":"PhD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:15:00","endTime":"19:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Next-Generation Flow (NGF) Minimal Residual Disease (MRD) Monitoring in Multiple Myeloma (MM): Results from the Pethema/GEM2012 Trial","keywords":"","combinedName":"doctor bruno paiva"},{"sessionId":"11625","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation II","firstName":"Sara ","lastName":"Bringhen ","credentials":"MD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:15:00","endTime":"18:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Term Outcome of Lenalidomide-Dexamethasone (Rd) Vs Melphalan-Lenalidomide-Prednisone (MPR) Vs Cyclophosphamide-Prednisone-Lenalidomide (CPR) As Induction Followed By Lenalidomide-Prednisone (RP) Vs Lenalidomide (R) As Maintenance in a Community-Based Newly Diagnosed Myeloma Population: Updated Analysis of EMN01 Phase III Study","keywords":"","combinedName":"doctor sara bringhen"},{"sessionId":"11625","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation II","firstName":"Ruth M","lastName":"de Tute ","credentials":"PhD, FRCPath","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"19:00:00","endTime":"19:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Minimal Residual Disease in the Maintenance Setting in Myeloma: Prognostic Significance and Impact of Lenalidomide","keywords":"","combinedName":"doctor ruth m de tute"},{"sessionId":"11625","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation II","firstName":"Mark T","lastName":"Drayson ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:15:00Z","sessionEndTime":"2017-12-11T19:45:00Z","startTime":"18:45:00","endTime":"19:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C4","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tackling Early Morbidity and Mortality in Myeloma (TEAMM): Assessing the Benefit of Antibiotic Prophylaxis and Its Effect on Healthcare Associated Infections in 977 Patients","keywords":"","combinedName":"doctor mark t drayson"},{"sessionId":"11626","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation I","firstName":"Meletios ","lastName":"Dimopoulos","credentials":"","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in Relapsed or Refractory Multiple Myeloma (RRMM): Updated Efficacy and Safety Analysis of Pollux","keywords":"","combinedName":"doctor meletios dimopoulos"},{"sessionId":"11626","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation I","firstName":"Suzanne ","lastName":"Trudel ","credentials":"MD, FRCP(C)","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:15:00","endTime":"15:30:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deep and Durable Responses in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (MM) Treated with Monotherapy GSK2857916, an Antibody Drug Conjugate Against B-Cell Maturation Antigen (BCMA): Preliminary Results from Part 2 of Study BMA117159","keywords":"","combinedName":"doctor suzanne trudel"},{"sessionId":"11626","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation I","firstName":"Eric L","lastName":"Smith ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:30:00","endTime":"15:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development and Evaluation of a Human Single Chain Variable Fragment (scFv) Derived Bcma Targeted CAR T Cell Vector Leads to a High Objective Response Rate in Patients with Advanced MM","keywords":"","combinedName":"doctor eric l smith"},{"sessionId":"11626","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation I","firstName":"James ","lastName":"Kochenderfer","credentials":"MD","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:00:00","endTime":"15:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Durable Clinical Responses in Heavily Pretreated Patients with Relapsed/Refractory Multiple Myeloma: Updated Results from a Multicenter Study of bb2121 Anti-Bcma CAR T Cell Therapy","keywords":"","combinedName":"doctor james kochenderfer"},{"sessionId":"11626","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation I","firstName":"Alessandra ","lastName":"Larocca ","credentials":"","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"16:00:00","endTime":"16:15:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Bortezomib- or Lenalidomide-Based Induction Treatment on High Risk Cytogenetic Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Enrolled in the Gimema-MM-03-05 and EMN01 Trials","keywords":"","combinedName":"doctor alessandra larocca"},{"sessionId":"11626","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation I","firstName":"A. ","lastName":"Stewart","credentials":"MBChB, MBA","sessionStartTime":"2017-12-11T14:45:00Z","sessionEndTime":"2017-12-11T16:15:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C1","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overall Survival (OS) of Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Versus Lenalidomide and Dexamethasone (Rd): Final Analysis from the Randomized Phase 3 Aspire Trial","keywords":"","combinedName":"doctor a stewart"},{"sessionId":"11627","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes","firstName":"Jordi ","lastName":"Esteve ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:00:00","endTime":"11:15:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Adult Patients with t(4;11)(q21;q23) KMT2A/AFF1 (MLL/AF4) B-Acute Lymphoblastic Leukemia in First Complete Remission (CR1): Favorable Outcome of Patients with Negative Minimal Residual Disease (MRD) Status at Transplant. a Report from the Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation (ALWP-EBMT)","keywords":"","combinedName":"doctor jordi esteve"},{"sessionId":"11627","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes","firstName":"Anna Sallfors","lastName":"Holmqvist ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:45:00","endTime":"12:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Decline in Late Mortality after Allogeneic Blood or Marrow Transplantation (alloBMT) Performed in Childhood - a Report from the BMT Survivor Study-2 (BMTSS-2)","keywords":"","combinedName":"doctor anna sallfors holmqvist"},{"sessionId":"11627","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes","firstName":"Jennifer ","lastName":"Yonkof ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:30:00","endTime":"11:45:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Transplant Improves Outcomes in Patients with Chronic Granulomatous Disease: Results from United States Immunodeficiency Network (USIDNET)","keywords":"","combinedName":"doctor jennifer yonkof"},{"sessionId":"11627","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes","firstName":"Haesook T","lastName":"Kim ","credentials":"PhD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:30:00","endTime":"10:45:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocyteic Leukemia Patients Who Underwent Reduced Intensity Conditioning Allogeneit HCT: A CIBMTR Report","keywords":"","combinedName":"doctor haesook t kim"},{"sessionId":"11627","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes","firstName":"Scott R","lastName":"Solomon ","credentials":"MD","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"11:15:00","endTime":"11:30:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Selecting the Best Donor for T Cell-Replete Haploidentical Transplantation: Importance of HLA Disparity, NK Alloreactivity, and Other Clinical Variables","keywords":"","combinedName":"doctor scott r solomon"},{"sessionId":"11627","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes","firstName":"Roni ","lastName":"Shouval ","credentials":"","sessionStartTime":"2017-12-11T10:30:00Z","sessionEndTime":"2017-12-11T12:00:00Z","startTime":"10:45:00","endTime":"11:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transplantation Outcome By Disease Risk and Donor Type over Time: An Analysis of 100,000 Allogeneic Stem Cell Transplantation on Behalf of the Acute Leukemia Working Party of the EBMT","keywords":"","combinedName":"doctor roni shouval"},{"sessionId":"11628","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: GVH and GVL","firstName":"Dietrich W","lastName":"Beelen ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Final Results of a Prospective Randomized Multicenter Phase III Trial Comparing Treosulfan/Fludarabine to Reduced Intensity Conditioning with Busulfan/Fludarabine Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Elderly or Comorbid Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome","keywords":"","combinedName":"doctor dietrich w beelen"},{"sessionId":"11628","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: GVH and GVL","firstName":"Rohtesh ","lastName":"Mehta","credentials":"MD,MPH,MS","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Adults","keywords":"","combinedName":"doctor rohtesh mehta"},{"sessionId":"11628","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: GVH and GVL","firstName":"Moshe ","lastName":"Yeshurun ","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Graft-Vs-Leukemia Effect in Acute Lymphoblastic Leukemia: Mild Acute Graft-Vs-Host Disease Protects Against Relapse and Improves Survival after Allogeneic Transplantation: A CIBMTR Analysis","keywords":"","combinedName":"doctor moshe yeshurun"},{"sessionId":"11628","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: GVH and GVL","firstName":"Edouard ","lastName":"Forcade ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of In Vivo T-Cell Depletion in Patients with Myelodysplastic Syndromes Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Registry Study from the Chronic Malignancies Working Party of the EBMT","keywords":"","combinedName":"doctor edouard forcade"},{"sessionId":"11628","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: GVH and GVL","firstName":"Francesca","lastName":"Bonifazi","credentials":"","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prophylaxis with ATLG Significantly ImprovesChronic Graft-Versus-Host Disease/Relapse-Free Survivaland Quality of Lifeafter a Myeloablative HLA Identical Sibling Transplant for Acute Leukemia Patients in Complete Remission. Long-Term Follow-up of the Randomized ATG Familystudy","keywords":"","combinedName":"doctor francesca bonifazi"},{"sessionId":"11628","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: GVH and GVL","firstName":"Maria ","lastName":"Gilleece ","credentials":"MD, FRCPath, MB, BSc, FRCP","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:45:00","endTime":"18:00:00","sessionLocation":"Bldg C- Lvl 2- C211-C213","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Measurable Residual Disease Status of Acute Myeloid Leukemia in First Complete Remission at Allogeneic Hematopoietic Cell Transplantation Interacts with Conditioning Intensity to Predict Outcome","keywords":"","combinedName":"doctor maria gilleece"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Seong-Ho ","lastName":"Kang ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bok Promotes Erythropoiesis in a Mouse Model of Myelodysplastic Syndrome","keywords":"","combinedName":"doctor seong-ho kang"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Christine ","lastName":"Min ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chuvash Polycythemia Patients from Afghanistan and Southern India Share a Common VHL Gene Haplotype. Support for Its Origin before Asians and Europeans Diverged","keywords":"","combinedName":"doctor christine min"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Aishwarya ","lastName":"Ravindran ","credentials":"MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical and Serological Characteristics of Cold Autoimmune Hemolytic Anemia with Concomitant Cold Agglutinin and Donath-Landsteiner Antibodies","keywords":"","combinedName":"doctor aishwarya ravindran"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Xing ","lastName":"Fan ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Tracking of the Source of Red Cell and Platelet Production in Rhesus Macaques","keywords":"","combinedName":"doctor xing fan"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Slim ","lastName":"Azouzi ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Proteomics and Functional Analysis of Red Blood Cell Membrane Proteins in the Rare in(Lu) Blood Type","keywords":"","combinedName":"doctor slim azouzi"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Jacky ","lastName":"Chung ","credentials":"Ph.D.","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Examining the CREB Transcriptional Program in Erythropoiesis","keywords":"","combinedName":"doctor jacky chung"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Mark A","lastName":"Vickers ","credentials":"MD, MA, MBBChir","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Exteriorisation of Mannoses on Human Erythrocyte Membrane Skeleton Provides Eat Me Signals for Oxidatively Damaged Cells to be Cleared By Macrophages: A Pathway Mediating Hemolysis in Sickle Cell Disease","keywords":"","combinedName":"doctor mark a vickers"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Natasha ","lastName":"Archer ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fine Temporal Mapping of Plasmodium Falciparum growth Inhibition in Hypoxic Sickle Cell Trait Erythrocytes","keywords":"","combinedName":"doctor natasha archer"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Yuelong ","lastName":"Guo ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"GWAS of Complete Blood Count (CBC) Measures in 13,403 Blood Donors in the Multi-Racial RBC-Omics Study Reveal Novel Genetic Loci in Minority Populations Which Provide Insights into the Pathways That May Connect Them to Disease","keywords":"","combinedName":"doctor yuelong guo"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Xu ","lastName":"Zhang ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hypoxic Response-Dependent Genetic Regulation Revealed By Allele-Specific Expression in Reticulocytes of Chuvash Polycythemia","keywords":"","combinedName":"doctor xu zhang"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Catherine ","lastName":"Broome ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence of Thromboembolic Events Is Increased in a Retrospective Analysis of a Large Cold Agglutinin Disease (CAD) Cohort","keywords":"","combinedName":"doctor catherine broome"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Romy ","lastName":"Kronstein-Wiedemann ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of the Transcription Factor RUNX1 Causes Glycosyltransferase a Repression","keywords":"","combinedName":"doctor romy kronstein-wiedemann"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Aurelio ","lastName":"Maggio ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Is the Time of Revisiting Classification of Thalassemia Syndromes According with the Phenotype Severity?","keywords":"","combinedName":"doctor aurelio maggio"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Elena ","lastName":"Brindley ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RASA3 Deficiency Contributes to Anemia By Multiple Mechanisms","keywords":"","combinedName":"doctor elena brindley"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"John G","lastName":"Conboy ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"SF3B1 Gene Expression in Erythroid Cells Is Regulated By Intron Retention Via a Posttranscriptional Mechanism Involving Cryptic Exons Proposed to Function As Splicing Decoys","keywords":"","combinedName":"doctor john g conboy"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Taiju ","lastName":"Utsugisawa ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Flow Cytometric Osmotic Fragility Test Is an Effective Screening Method for Dehydrated Hereditary Stomatocytosis","keywords":"","combinedName":"doctor taiju utsugisawa"},{"sessionId":"11629","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster I","firstName":"Katie ","lastName":"Giger Seu ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"VPS4A: A Novel Candidate Gene for Congenital Dyserythropoietic Anemia","keywords":"","combinedName":"doctor katie giger seu"},{"sessionId":"11630","sessionTitle":"102. Regulation of Iron Metabolism: Poster I","firstName":"Elisa ","lastName":"Brilli ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effects of Sucrosomial iron in Pre-Clinical and Clinical Conditions of Inflammation","keywords":"","combinedName":"doctor elisa brilli"},{"sessionId":"11630","sessionTitle":"102. Regulation of Iron Metabolism: Poster I","firstName":"Yuki ","lastName":"Morimoto ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Generation of Patient-Derived Human Induced Pluripotent Stem Cells in X-Linked Sideroblastic Anemia and Novel Therapeutic Strategies","keywords":"","combinedName":"doctor yuki morimoto"},{"sessionId":"11630","sessionTitle":"102. Regulation of Iron Metabolism: Poster I","firstName":"Aurelio ","lastName":"Maggio ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inadequacy of Ferritin Trends for Predicting Changes in LIC Risk Category in Transfusion Depedent and Well Chelated Patients with Haemoglobinopathies","keywords":"","combinedName":"doctor aurelio maggio"},{"sessionId":"11630","sessionTitle":"102. Regulation of Iron Metabolism: Poster I","firstName":"Nathan ","lastName":"Schloemer ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phlebotomy for Pediatric and Young Adult Oncology Patients Treats Transfusional Iron Overload","keywords":"","combinedName":"doctor nathan schloemer"},{"sessionId":"11630","sessionTitle":"102. Regulation of Iron Metabolism: Poster I","firstName":"Ahmed ","lastName":"Abdalla ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevalence of Occult Celiac Disease in Females with Iron Deficiency in the United States: An Nhanes Analysis.","keywords":"","combinedName":"doctor ahmed abdalla"},{"sessionId":"11630","sessionTitle":"102. Regulation of Iron Metabolism: Poster I","firstName":"Namita ","lastName":"Kumari ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Restriction of HIV-1 Infection in Sickle Cell Disease Trait","keywords":"","combinedName":"doctor namita kumari"},{"sessionId":"11630","sessionTitle":"102. Regulation of Iron Metabolism: Poster I","firstName":"Michael ","lastName":"Minkley ","credentials":"BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Systemic Biomarkers Show Elevated Oxidative Stress and Chronic Inflammation in Two Disorders of Neurodegeneration with Brain Iron Accumulation (NBIA)","keywords":"","combinedName":"doctor michael minkley"},{"sessionId":"11630","sessionTitle":"102. Regulation of Iron Metabolism: Poster I","firstName":"Peter ","lastName":"Peterson ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TP-0184 Inhibits ALK2/ACVR1, Decreases Hepcidin Levels, and Demonstrates Activity in Preclinical Mouse Models of Functional Iron Deficiency","keywords":"","combinedName":"doctor peter peterson"},{"sessionId":"11631","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster I","firstName":"Supachai ","lastName":"Ekwattanakit ","credentials":"BSc, PhD, MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Urgent Need for Improving Thalassemia Care in Adult Patients Due to a Wide Gap on Current Real-Life Practice and Recommended Clinical Practice Guidelines","keywords":"","combinedName":"doctor supachai ekwattanakit"},{"sessionId":"11631","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster I","firstName":"Bowen ","lastName":"Yan ","credentials":"Ph. D","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"GATA-1 Deacetylation and Interaction with HDAC1 Is Critical for GATA-1 Mediated Gene Transcription","keywords":"","combinedName":"doctor bowen yan"},{"sessionId":"11631","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster I","firstName":"Stefania ","lastName":"Crippa ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impairment in the Mesenchymal Bone-Marrow Niche of Beta-Thalassemia Patients and Association with Prolonged Iron Exposure","keywords":"","combinedName":"doctor stefania crippa"},{"sessionId":"11631","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster I","firstName":"Kim ","lastName":"Vanuytsel ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Induced Pluripotent Stem Cell (iPSC)-Based Mapping of Globin Expression throughout Human Erythropoietic Development","keywords":"","combinedName":"doctor kim vanuytsel"},{"sessionId":"11631","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster I","firstName":"Nikoleta ","lastName":"Psatha ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Introduction of Two Simultaneous Mutations By Genome Editing Greatly Enhances the Accumulation of the Endogenous Fetal Hemoglobin in Human Normal Erythroid Cells","keywords":"","combinedName":"doctor nikoleta psatha"},{"sessionId":"11631","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster I","firstName":"Osama ","lastName":"Tanous ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Leptin Is Associated with the Degree of Anemia and the Erythropoietin Levels in  Thalassemia Patients","keywords":"","combinedName":"doctor osama tanous"},{"sessionId":"11631","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster I","firstName":"Paolo ","lastName":"Moi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low Impact of Genetic Modifiers on the Phenotype of Homozygous Beta Thalassemia in the Last Decennial Cohort of Thalassemia Newborns in Sardinia","keywords":"","combinedName":"doctor paolo moi"},{"sessionId":"11631","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster I","firstName":"Osama ","lastName":"Tanous ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Renal Function in Transfusion-Dependent -Thalassemia Patients: A Decade of Follow-up and Comparison between Chelation Regimes","keywords":"","combinedName":"doctor osama tanous"},{"sessionId":"11631","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster I","firstName":"Jaira ","lastName":"de Vasconcellos ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Let-7 Chronoregulatory Cascade Components May Act Independently to Regulate Fetal Hemoglobin in Human Adult Erythroblasts","keywords":"","combinedName":"doctor jaira de vasconcellos"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"James ","lastName":"Taylor ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Locus on Chromosome 5 Is Associated with Red Cell Allo-Immunization in Adults with Sickle Cell Disease","keywords":"","combinedName":"doctor james taylor"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Erdem ","lastName":"Kucukal ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adhesion of Sickle RBCs to Heme-Activated Endothelial Cells Correlates with Patient Clinical Phenotypes","keywords":"","combinedName":"doctor erdem kucukal"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Alexis ","lastName":"Leonard ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bone Marrow Characterization in Sickle Cell Disease: Inflammation and Stress Erythropoiesis Lead to Suboptimal CD34 Recovery Compared to Normal Volunteer Bone Marrow","keywords":"","combinedName":"doctor alexis leonard"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Carolyn C","lastName":"Hoppe ","credentials":"MD ","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Candidate Gene Associations with Vaso-Occlusive Crisis in Children with Sickle Cell Anemia Enrolled in the Multinational DOVE Trial","keywords":"","combinedName":"doctor carolyn c hoppe"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Prithu ","lastName":"Sundd ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hairy Platelet-Derived Extracellular Vesicles Promote Lung Vaso-Occlusion in Sickle Cell Disease","keywords":"","combinedName":"doctor prithu sundd"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Cuong ","lastName":"Le ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In VivoEffects of LSD1 Inhibition By Small Chemical Inhibitors in Sickle Cell Mice","keywords":"","combinedName":"doctor cuong le"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Jane ","lastName":"Little","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Longitudinal Monitoring of RBC Adhesion in Patients with SCD Is Heterogeneous and Clinically informative ","keywords":"","combinedName":"doctor jane little"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Xingguo ","lastName":"Zhu ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Loss of NRF2 Function Worsens the Pathophysiology of Sickle Cell Disease in a Transgenic Mouse Model","keywords":"","combinedName":"doctor xingguo zhu"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Erich Vinicius","lastName":"De Paula ","credentials":"MD, PhD ","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PADI4 Gene Polymorphism As a Risk Factor for Acute Chest Syndrome in Sickle Cell Anemia Patients","keywords":"","combinedName":"doctor erich vinicius de paula"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Anren ","lastName":"Song ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pathological Role of Halted Proteasome Machinery in Sickle Cell Disease","keywords":"","combinedName":"doctor anren song"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Umut ","lastName":"Gurkan ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient-Specific Adhesion of Sickle Red Blood Cells in Shear-Gradient Microscale Flow","keywords":"","combinedName":"doctor umut gurkan"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Xionghao ","lastName":"Lin ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantitative Proteomics Identify Urinary Hgfl Protein As a Potential Marker for the Development of Chronic Kidney Disease in Sickle Cell Disease Patients","keywords":"","combinedName":"doctor xionghao lin"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Athos Rodrigues","lastName":"De Moraes ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rock Inhibitor Fasudil Reduces LeukocyteEndothelium Interactions in the Microvasculature of a Sickle Cell Mouse Model of Allergic Inflammation","keywords":"","combinedName":"doctor athos rodrigues de moraes"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Marina ","lastName":"Jerebtsova ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RON Kinase Inhibition Reduces Renal Endothelial Injury in Sickle Cell Disease Mice","keywords":"","combinedName":"doctor marina jerebtsova"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Patricia ","lastName":"Shi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Studies of White Cell, Platelet, and Coagulation Activation with Plerixafor Administration in Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor patricia shi"},{"sessionId":"11632","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster I","firstName":"Enrico M","lastName":"Novelli ","credentials":"MD, MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tissue-Resident TSP1-CD47 Signaling Promotes Sickle Cell-Associated Arterial Vasculopathy and Pulmonary Hypertension","keywords":"","combinedName":"doctor enrico m novelli"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Robert J","lastName":"Charnigo ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 1b, Randomized, Double-Blind, Placebo-Controlled Study of PF-04447943 in Patients with Stable Sickle Cell Disease: Changes in Exploratory Biomarkers","keywords":"","combinedName":"doctor robert j charnigo"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Deva ","lastName":"Sharma ","credentials":"MD, MS ","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Vaso-Occlusive Pain Associated with the Onset of Menstruation Is Distinct from Dysmenorrhea in Sickle Cell Disease","keywords":"","combinedName":"doctor deva sharma"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Divya G","lastName":"Moodalbail ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ambulatory Hypertension in a Pediatric Cohort of Sickle Cell Disease","keywords":"","combinedName":"doctor divya g moodalbail"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Divya G","lastName":"Moodalbail ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Apolipoprotein L1 Genetic Variants Are Associated with Evidence of Early Kidney Injury in Sickle Cell Disease","keywords":"","combinedName":"doctor divya g moodalbail"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Nancy ","lastName":"Green ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE): Interim Overall Results","keywords":"","combinedName":"doctor nancy green"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Ann M","lastName":"Brunson ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cancer and Sickle Cell Disease (SCD): Predictors of Incident Cancer and Survival Compared to Non-SCD Patients in California","keywords":"","combinedName":"doctor ann m brunson"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Martha ","lastName":"Brucato ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Developmental Outcomes of Children Exposed to Maternal Sickle Cell Disease (SCD)","keywords":"","combinedName":"doctor martha brucato"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Bruno Deltreggia","lastName":"Benites ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Echocardiografic Abnormalities in Patients with Sickle Cell/-Thalassemia Do Not Depend on the -Thalassemia Phenotype","keywords":"","combinedName":"doctor bruno deltreggia benites"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Maa-Ohui ","lastName":"Quarmyne ","credentials":"MBChB","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Acute Transfusion on Cerebral Oxygenation in Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor maa-ohui quarmyne"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Michael ","lastName":"Callaghan","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Elipsis: A Longitudinal Study of Electronic Patient-Reported Outcomes, Actigraphy and Biomarkers to Identify and Assess at-Home Vaso-Occlusive Crises in Adults and Adolescents with Sickle Cell Disease","keywords":"","combinedName":"doctor michael callaghan"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Russell D","lastName":"Keenan ","credentials":"MBChB, PhD, FRCP, FRCPath","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hydroxyurea Therapy Prevents High Risk Trans-Cranial Doppler Development in Children with Sickle Cell Disorders","keywords":"","combinedName":"doctor russell d keenan"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Ryan A","lastName":"Virden ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Patient-Specific Factors Associated with Alloimmunization in Sickle Cell Disease","keywords":"","combinedName":"doctor ryan a virden"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Titilola ","lastName":"Akingbola ","credentials":"MBBS, FWACP","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low Fixed Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Disease in Nigeria","keywords":"","combinedName":"doctor titilola akingbola"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Deepika ","lastName":"Darbari ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pain and Opioid Use after Reversal of Sickle Cell Disease Following Hematopoietic Stem Cell Transplant","keywords":"","combinedName":"doctor deepika darbari"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Peter ","lastName":"Buontempo ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pegylated Carboxyhemoglobin Bovine (SANGUINATE) Restores RBCs Roundness and Reduces Pain during a Sickle Cell Vaso-Occlusive Crisis","keywords":"","combinedName":"doctor peter buontempo"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Brengre ","lastName":"Koehl ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease","keywords":"","combinedName":"doctor brengre koehl"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Bart ","lastName":"Biemond ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predictive Value of Gradual Change in Renal Function on Vasculopathy Related Complications and Mortality in Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor bart biemond"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Brigitte ","lastName":"Ranque ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevalence and Correlates of Growth Failure in African Patients with Sickle Cell Disease: A Multinational Study","keywords":"","combinedName":"doctor brigitte ranque"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Pablo ","lastName":"Bartolucci ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prospective Controlled Trial on Endurance Exercise Training in Adult Sickle Cell Disease Patients","keywords":"","combinedName":"doctor pablo bartolucci"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Lena ","lastName":"Vaclavu ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduced Cerebrovascular Reserve Capacity in Adults with Sickle Cell Disease","keywords":"","combinedName":"doctor lena vaclavu"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"John F","lastName":"Tisdale ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Successful Plerixafor-Mediated Mobilization, Apheresis, and Lentiviral Vector Transduction of Hematopoietic Stem Cells in Patients with Severe Sickle Cell Disease","keywords":"","combinedName":"doctor john f tisdale"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Carla B","lastName":"Washington ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Pharmacokinetics (PK) of GBT440 Following Single Doses in Pediatric Patients with Sickle Cell Disease (SCD)","keywords":"","combinedName":"doctor carla b washington"},{"sessionId":"11633","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster I","firstName":"Ameet ","lastName":"Patel ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism Is Associated with a Significant Decrease in Incidence of Bleeding Compared to Vitamin K Antagonists and Low-Molecular-Weight Heparins","keywords":"","combinedName":"doctor ameet patel"},{"sessionId":"11634","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster I","firstName":"Karsten ","lastName":"Roth, N Meyer ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparability of Pharmacodynamics and Immunogenicity of B12019, a Proposed Pegfilgrastim Biosimilar to Neulasta","keywords":"","combinedName":"doctor karsten roth, n meyer"},{"sessionId":"11634","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster I","firstName":"Devin ","lastName":"Malik ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluating the Clinical Utility of Testing for Autoimmune Disorders in the Setting of Leukopenia/Neutropenia in an Ambulatory Hematology Clinic. ","keywords":"","combinedName":"doctor devin malik"},{"sessionId":"11634","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster I","firstName":"Wulin ","lastName":"Aerbajinai ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Glia Maturation Factor-Gamma Modulates M2 Activation of Macrophage Via Suppression of Mitochondria Function","keywords":"","combinedName":"doctor wulin aerbajinai"},{"sessionId":"11634","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster I","firstName":"David ","lastName":"Dale ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Outcomes for G-CSF Treatment of Patients with Glycogen-Sstorage Disease Type Ib","keywords":"","combinedName":"doctor david dale"},{"sessionId":"11634","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster I","firstName":"Chanchal ","lastName":"Sur Chowdhury ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Metabolic Remodeling of Neutrophils at Inflammatory Site Drives Invadosome Formation Favoring Transcellular Migration","keywords":"","combinedName":"doctor chanchal sur chowdhury"},{"sessionId":"11634","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster I","firstName":"Muhua ","lastName":"Cao ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Neutrophil Extracellular Traps Exacerbate Inflammatory Responses and Thrombotic Tendency in Both a Murine Colitis Model and Patients with Inflammatory Bowel Disease","keywords":"","combinedName":"doctor muhua cao"},{"sessionId":"11634","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster I","firstName":"Kandace ","lastName":"Gollomp ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Factor 4 (PF4)-Mediated Neutrophil Extracellular Trap Compaction Limits Endothelial Injury and Promotes Survival Following Lipopolysaccharide Challenge","keywords":"","combinedName":"doctor kandace gollomp"},{"sessionId":"11634","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster I","firstName":"Jin ","lastName":"Fengyan ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting the NF-?b-Dependent HIF-1 Pathway Reprograms Macrophage Polarization Induced By Oxidized LDL","keywords":"","combinedName":"doctor jin fengyan"},{"sessionId":"11634","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster I","firstName":"Nataly ","lastName":"Podolnikova ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Interaction between Integrin Mac-1 (aM2, CD11b/CD18) and Sirpa Mediates Macrophage Fusion","keywords":"","combinedName":"doctor nataly podolnikova"},{"sessionId":"11634","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster I","firstName":"Anna ","lastName":"Hayden ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of Soluble Interleukin-2 Receptor (sIL-2r) in Diagnosis of Adult Hemophagocytic Lymphohistiocytosis (HLH): A Single Center Retrospective Study","keywords":"","combinedName":"doctor anna hayden"},{"sessionId":"11634","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster I","firstName":"David ","lastName":"Dale ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"X4P-001: A Novel Molecularly-Targeted Oral Therapy for Whim Syndrome","keywords":"","combinedName":"doctor david dale"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Caroline ","lastName":"Besson ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Coinfection with HCV or HBV Increases the Risk of Lymphoma in HIV-Positive Patients: A Combined Analysis of the Lymphovir-ANRS-CO16 and Fhdh-ANRS-CO4 Cohorts","keywords":"","combinedName":"doctor caroline besson"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Lorenzo ","lastName":"Iovino ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cytokine Release from Stimulated PBMC after-HSCT: Results of a Post-Transplant Zinc Oral Supplementation Trial (ZENITH)","keywords":"","combinedName":"doctor lorenzo iovino"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Emily ","lastName":"Mace ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Discrete Modes of Migration Define Human NK Cell Development from Hematopoietic Stem Cells","keywords":"","combinedName":"doctor emily mace"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Jenny ","lastName":"Shim ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early B Cell Development Is Impaired in Patients with Active Hemophagocytic Lymphohistiocytosis","keywords":"","combinedName":"doctor jenny shim"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Ekaterina ","lastName":"Minskaia ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epigenetic Control of Foxp3, CAMTA1 and FUT7 Genes in Human Regulatory T Cells","keywords":"","combinedName":"doctor ekaterina minskaia"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Shabnum ","lastName":"Patel ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hiv Specific T Cells Generated from Hiv Naive Adult and Cord Blood Donors Target a Range of Novel Viral Epitopes: Implications for a Cure Strategy after Allogeneic HSCT and CBT","keywords":"","combinedName":"doctor shabnum patel"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Tatiana ","lastName":"Lobanova ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Human Herpes-Virus 6 Infection in Immunocompromised Patients after Chemotherapy and Autologous Stem Cell Transplantation","keywords":"","combinedName":"doctor tatiana lobanova"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Tomoki ","lastName":"Ito ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lenalidomide Acts As a Positive Immunomodulator through Modulating the Functions of Human Plasmacytoid Dendritic Cells","keywords":"","combinedName":"doctor tomoki ito"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Miyoung ","lastName":"Lee ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Obesity-Induced Chronic Inflammation Suppresses the Function of Non-Malignant Immune Cells While Upregulating PD-L1 on Human B-ALL Cell Lines","keywords":"","combinedName":"doctor miyoung lee"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Brooks ","lastName":"Scull ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasma InflammatoryProtein Profiles Distinguish Hemophagocytic Lymphohistiocytosis from Sepsis and SIRS","keywords":"","combinedName":"doctor brooks scull"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"TONG ","lastName":"WU ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prostaglandin E2 Promotes Recovery of Thymus in Survivors of the Hematopoietic Acute Radiation Syndrome (H-ARS)","keywords":"","combinedName":"doctor tong wu"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Sandra ","lastName":"Rajme ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Bone Marrow Aspirate and Biopsy in the Diagnosis of HIV Patients Presenting with Low Blood Counts","keywords":"","combinedName":"doctor sandra rajme"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Dan ","lastName":"Ma ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of HO-1 in B Lymphocyte Proliferation and Development in Mice","keywords":"","combinedName":"doctor dan ma"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"Julia ","lastName":"Messina ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Timing and Epidemiology of Enterococcus Faecium and E. Faecalis Bloodstream Infections (BSI) in Patients with Acute Leukemia Receiving Chemotherapy","keywords":"","combinedName":"doctor julia messina"},{"sessionId":"11635","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster I","firstName":"David ","lastName":"Bastian ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"U Distinct Roles of IL-12R1 and IL-23R in the Development of Acute and Chronic Gvhd","keywords":"","combinedName":"doctor david bastian"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"K. ","lastName":"Vijayan ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Agonist-Induced Signaling and Integrin-Mediated Function in Murine Platelets Is Distinctly Regulated By the a Isoform of the Catalytic Subunit of Protein Phosphatase 1","keywords":"","combinedName":"doctor k vijayan"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Alex ","lastName":"Sternisha ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anatomy of the Extracellular Clasps That Regulate Platelet aIIb3 and av3 Function","keywords":"","combinedName":"doctor alex sternisha"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Kalyan ","lastName":"Golla ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ASK1 Activation in Platelets By Oxidized LDL Is Independent of CD36","keywords":"","combinedName":"doctor kalyan golla"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Lisa ","lastName":"Van Der Vorm ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of a Nanobody That Binds Von Willebrand Factor and Prevents Von Willebrand Factor Cleavage By Plasmin","keywords":"","combinedName":"doctor lisa van der vorm"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Jeong-A ","lastName":"Kim ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fractalkine Treated of CD11b+CX3CR1+Monocytes Promotes Angiogenesis through Pigment Epithelium-Derived Factor","keywords":"","combinedName":"doctor jeong-a kim"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Renata ","lastName":"Grozovsky ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"GPVI Intracellular Signaling Is Activated in Platelets from Patients with Essential Thrombocythemia","keywords":"","combinedName":"doctor renata grozovsky"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Phillip LR","lastName":"Nicolson ","credentials":"MA, MBBChir, MRCP","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of Btk Does Not Block Platelet Activation By GPVI: Studies with Ibrunitib, Acalabrutinib and Patients with X-Linked Agammaglobulinaemia","keywords":"","combinedName":"doctor phillip lr nicolson"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Indranil ","lastName":"Basak ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Microrna-15a-5p Regulates Multiple Components of GPVI-Mediated Platelet and Megakaryocyte Activation Pathway","keywords":"","combinedName":"doctor indranil basak"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Claudia ","lastName":"Buitrago ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Activation and Shear-dependent Changes in Filamin a Conformation Downstream of Ligand Binding to aIIb3, GPIb and a21 Are Reversible in Time, but Those Downstream of Fibrin Binding to alphaIIbbeta3 Are Not","keywords":"","combinedName":"doctor claudia buitrago"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Ruben ","lastName":"Bierings ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Protein Kinase C-Dependent Von Willebrand Factor Secretion Is a Dual-Phased Process That Originates from 2 Distinct Intracellular Compartments","keywords":"","combinedName":"doctor ruben bierings"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Vaishali ","lastName":"Inamdar ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PTPN7 Tyrosine Phosphatase Negatively Regulates Thromboxane Generation and Erk Phosphorylation in Platelets","keywords":"","combinedName":"doctor vaishali inamdar"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Silvia","lastName":"Giannini","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"1,4-Galactosyltransferase 1 Is a Key Regulator of Thrombopoiesis","keywords":"","combinedName":"doctor silvia giannini"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Wei ","lastName":"Yang ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ultra-Low Von Willebrand Factor (VWF) Adsorption Under Shear with a Polymer Coating for Blood-Contacting Devices","keywords":"","combinedName":"doctor wei yang"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Rustem ","lastName":"Litvinov ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unique Transmembrane Domain Interactions Differentially Modulate Platelet aIIb3 and av3 Function","keywords":"","combinedName":"doctor rustem litvinov"},{"sessionId":"11636","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster I","firstName":"Noppacharn ","lastName":"Uaprasert ","credentials":"MB, BCH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Vascular and Hemostatic Alterations Associated with Pulmonary Hypertension in -Thalassemia Hemoglobin E Patients Receiving Regular Transfusion and Iron Chelation","keywords":"","combinedName":"doctor noppacharn uaprasert"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Leila ","lastName":"Noetzli ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A CRISPR-Cas9 Generated Etv6 mutant Mouse Exhibits Decreased Platelet Counts and Functional Platelet Defects","keywords":"","combinedName":"doctor leila noetzli"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Elizabeth ","lastName":"Davis ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry","keywords":"","combinedName":"doctor elizabeth davis"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Congcong ","lastName":"Sun ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Landscape of Transcriptome Sequencing in Childhood Immune Thrombocytopenia(ITP)","keywords":"","combinedName":"doctor congcong sun"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Qi ","lastName":"Chen ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aberrant Level of Estrogen Correlateswith Defective Thrombopoiesis during Pregnancy in Patients with Immune Thrombocytopenia","keywords":"","combinedName":"doctor qi chen"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Eric ","lastName":"Mullins ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Multiple Electrode Impedance-Based Platelet Aggregometry to Light Transmission Aggregometry for Diagnosis of Qualitative Platelet Defects","keywords":"","combinedName":"doctor eric mullins"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"David J","lastName":"Kuter ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of the Effects of the Thrombopoietin (TPO) Receptor Agonist Romiplostim in Patients with Immune Thrombocytopenia (ITP) for =1 Year Vs. >1 Year","keywords":"","combinedName":"doctor david j kuter"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"John ","lastName":"Grainger ","credentials":"MD, MRCP, FRPATH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Vaccination Associated and Non-Vaccination Associated Paediatric Immune Thrombocytopenia","keywords":"","combinedName":"doctor john grainger"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Xiao-Lu ","lastName":"Zhu ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Corticosteroids PlusIntravenous Immunoglobulin Compared with Corticosteroids for the Treatment of Immune Thrombocytopenia in Pregnancy: An Observational Multicenter Study in China","keywords":"","combinedName":"doctor xiao-lu zhu"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Midori ","lastName":"Ishiyama ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Increased Platelet Count Is a Predictive Factor for a Long-Term Response in High-Dose Dexamethasone Treatment for Newly-Diagnosed Immune Thrombocytopenia Patients.","keywords":"","combinedName":"doctor midori ishiyama"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Mihee ","lastName":"Park ","credentials":"MD, BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effective Treatment of Thrombotic Microangiopathy Associated with Lupus Nephritis with Eculizumab:a Series of 8 Cases","keywords":"","combinedName":"doctor mihee park"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Charlotte A","lastName":"Bradbury ","credentials":"PhD, MD, FRCPath, FRCP, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Glucocorticoids Reduce the Number and Function of CD19+CD24hiCD38hi Regulatory B Cells in Patients with Immune Thrombocytopenia","keywords":"","combinedName":"doctor charlotte a bradbury"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Li ","lastName":"Guo ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased MHC Class I Expression on Platelets in Human and Murine Sepsis","keywords":"","combinedName":"doctor li guo"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Guoyang ","lastName":"Zhang ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mesenchymal Stem Cells Improve Platelet Counts in Mice with ITP","keywords":"","combinedName":"doctor guoyang zhang"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Chen-Cong ","lastName":"Wang ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MT-Associated Protein Dysfunction May Lead to Impaired Ppf of Megakaryocytes in Corticosteroid-Resistant/Relapse Immune Thrombocytopenia Patients","keywords":"","combinedName":"doctor chen-cong wang"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Raymond SM","lastName":"Wong ","credentials":"MRCP,FRCP","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Occurrence and Management of Cataracts in Adult Patients (pts) with Chronic Immune Thrombocytopenia (cITP) during Long-Term Treatment with Eltrombopag (EPAG): Results from the Extend Study","keywords":"","combinedName":"doctor raymond sm wong"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Guillaume ","lastName":"Moulis ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevalence of Cardiovascular Risk Factors and Incidence of Venous and Arterial Thrombosis in Non-Splenectomized Immune Thrombocytopenia Adult Patients in Sweden and France. Results from Two Nationwide Studies","keywords":"","combinedName":"doctor guillaume moulis"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Claire L","lastName":"Langrish ","credentials":"PhD, BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PRN1008, a Reversible Covalent BTK Inhibitor in Clinical Development for Immune Thrombocytopenic Purpura","keywords":"","combinedName":"doctor claire l langrish"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Chen-Cong ","lastName":"Wang ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pro-Platelet Formation Is Impaired in Megakaryocytes of MYH9-Related Disease Patients","keywords":"","combinedName":"doctor chen-cong wang"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Guillaume ","lastName":"Moulis ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk Factors for Bleeding, Including Platelet Count Threshold, in Newly Diagnosed ITP Patients","keywords":"","combinedName":"doctor guillaume moulis"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Hanny ","lastName":"Al-Samkari ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Romiplostim for the Management of Perioperative Thrombocytopenia","keywords":"","combinedName":"doctor hanny al-samkari"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Sufia ","lastName":"Amini ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sequestration Pattern in ITP Liver/Spleen Scan Correlates with the Presence of Anti-Glycoprotein V Antibodies in ITP Patients","keywords":"","combinedName":"doctor sufia amini"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Mohsen Saleh ","lastName":"Elalfy ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Cytomegalovirus (CMV) Reactivation on Clinical Course and Immunomodulatory Effect in Children with Immune-Thrombocytopenia (ITP)","keywords":"","combinedName":"doctor mohsen saleh elalfy"},{"sessionId":"11637","sessionTitle":"311. Disorders of Platelet Number or Function: Poster I","firstName":"Yunjing ","lastName":"Zheng ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The WASP P460S Mutation Causes a New Phenotype of WASP Mutations Related Disorder ??X-Linked Pancytopenia","keywords":"","combinedName":"doctor yunjing zheng"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Ze ","lastName":"Zheng ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Hepatocyte Transcription Repressor DACH1 Inhibits Fibrinolysis and Increases Risk of Thrombosis","keywords":"","combinedName":"doctor ze zheng"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Amy E","lastName":"Siebert ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Missense Mutation in the Loss-of-Function Intolerant Actr2 Gene Suppresses Thrombosis Via Multiple Mechanisms","keywords":"","combinedName":"doctor amy e siebert"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Sanjay P","lastName":"Ahuja ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessment of a Novel Dielectric Microsensor for Monitoring Coagulation Factor Therapy in Children with Hemophilia with and without Inhibitors","keywords":"","combinedName":"doctor sanjay p ahuja"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Andaleb ","lastName":"Kholmukhamedov ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cytoplasmic Phospholipase A2 Is Essential in GPVI Signaling Initiated Procoagulant Platelet Formation","keywords":"","combinedName":"doctor andaleb kholmukhamedov"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Davide ","lastName":"Matino ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Plasma-Derived FVII Efficacy for the Treatment of Bleeding in a Murine Model of Hemophilia a","keywords":"","combinedName":"doctor davide matino"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Joe ","lastName":"Salas ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Extravascular Distribution of Conventional and Ehl FIX Products Using In Vivo SPECT Imaging Analysis in Hemophilia B Mice","keywords":"","combinedName":"doctor joe salas"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Melanie ","lastName":"Muller ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Extrinsic Complex Structure Developed through Novel Simulation Methodology: Key Putative Atomic-Level Interactions Identified","keywords":"","combinedName":"doctor melanie muller"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Valerie Anne","lastName":"Novakovic ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factor VIII Binds to an Acidic Fibrinogen Variant, a Critical Component of the High-Affinity Fibrin Binding Site, Resulting in Increased Cofactor Activity","keywords":"","combinedName":"doctor valerie anne novakovic"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Thomas James","lastName":"Girard ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interfering with Protein Z Dependent Inhibition of Factor Xa Improves Coagulation in Hemophilia","keywords":"","combinedName":"doctor thomas james girard"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Allison ","lastName":"Remiker ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mechanisms Linking Fibrin(ogen) Structure/Function to Tumor Metastasis","keywords":"","combinedName":"doctor allison remiker"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Triston ","lastName":"Burnham ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasminogen Activator Inhibitor Type 1 (PAI-1) and Thrombophilia: A 10 Year Retrospective Review of Clinical Data at a Large Children's Hospital","keywords":"","combinedName":"doctor triston burnham"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Walid ","lastName":"Chayou ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Poor Agreement between Commercially Available Anti-Cardiolipin and Anti-2glycoprotein I IgG and IgM Solid Phase Assays Hampers Uniformity in the Classification of Antiphospholipid Syndrome Patients","keywords":"","combinedName":"doctor walid chayou"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Jeremy ","lastName":"Wood ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prothrombinase Inhibition By Tfpia Requires Three Distinct Interactions with Factors Va and X","keywords":"","combinedName":"doctor jeremy wood"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Anna ","lastName":"Protopopova ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantitative Structural Characterization of Fibrinogen's aC Regions in Fibrin Monomers and Oligomers","keywords":"","combinedName":"doctor anna protopopova"},{"sessionId":"11638","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster I","firstName":"Glaivy ","lastName":"Batsuli ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Specific Factor VIII Domains on Uptake By Dendritic Cells","keywords":"","combinedName":"doctor glaivy batsuli"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Rudolf ","lastName":"Hartmann ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Bispecific Antibody Lacks Measurability in Routine Coagulation Assays and Comparability to Factor VIII","keywords":"","combinedName":"doctor rudolf hartmann"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Saad ","lastName":"Yousuf ","credentials":"MD, BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Single Institutional Study on Pregnancy Outcomes in Patients with Von Willebrand Disease","keywords":"","combinedName":"doctor saad yousuf"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Jorge ","lastName":"Castillo ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acquired Von Willebrand Disease in Patients with Waldenstrm Macroglobulinemia","keywords":"","combinedName":"doctor jorge castillo"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Robert L","lastName":"Meller III","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Alterations in Cytokine Profiles Have Potential Uses As Biomarkers for Pediatric Venous Thromboembolism","keywords":"","combinedName":"doctor robert l meller iii"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Jeremy ","lastName":"Rupon ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Open-Label Study of the Safety and Efficacy of Morotocog Alfa (AF-CC) in Previously Untreated Patients Aged <6 Years in Usual Care Settings","keywords":"","combinedName":"doctor jeremy rupon"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Kapil ","lastName":"Saxena ","credentials":"MD, MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bay 81-8973 Prophylaxis Frequency and Long-Term Bleed Outcomes in the Leopold I Extension Study","keywords":"","combinedName":"doctor kapil saxena"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Amanda ","lastName":"Walborn ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biomarkers of Endothelial Function in Sepsis-Associated Disseminated Intravascular Coagulation","keywords":"","combinedName":"doctor amanda walborn"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Michael ","lastName":"Dockal ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bispecific Antibodies with Native Human IgG Structure As Mimetics for FVIII Activity","keywords":"","combinedName":"doctor michael dockal"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Johannes ","lastName":"Oldenburg ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bleeding Events and Safety Outcomes in Pediatric Persons with Hemophilia A with Inhibitors: The First Non-Interventional Study (NIS) from a Real-World Setting","keywords":"","combinedName":"doctor johannes oldenburg"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Jessica ","lastName":"Garcia ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD ","keywords":"","combinedName":"doctor jessica garcia"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Roman ","lastName":"Kotln ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dysfibrinogenemias Affecting Platelet Aggregation","keywords":"","combinedName":"doctor roman kotln"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Maria Elisa","lastName":"Mancuso ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Emicizumab Prophylaxis in Adolescent/Adult Patients with Hemophilia A Previously Receiving Episodic or Prophylactic Bypassing Agent Treatment: Updated Analyses from the HAVEN 1 Study","keywords":"","combinedName":"doctor maria elisa mancuso"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Mario ","lastName":"Von Depka ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immunohistochemical Analyses and Quantitative RT-PCR of Angiogenic Factors in a Porcine Von Willebrand Disease Model","keywords":"","combinedName":"doctor mario von depka"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Alessandro ","lastName":"Gringeri ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence of Thrombo-Embolic Events in Relation to Activated Prothrombin Complex Concentrate Exposure: A Literature Meta-Analysis","keywords":"","combinedName":"doctor alessandro gringeri"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Alok ","lastName":"Srivastava ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Meaningful Reduction of Annual Bleeding Rate with Lower Dose Prophylaxis in Minimally Treated Children with Hemophilia in India","keywords":"","combinedName":"doctor alok srivastava"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Susan ","lastName":"Kearney ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nonacog Beta Pegol for Prophylactic Treatment of Children with Hemophilia B: Up to 3.5-Year Data from the Paradigm5 Clinical Trial","keywords":"","combinedName":"doctor susan kearney"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Craig ","lastName":"Seaman ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Perioperative Management of Von Willebrand Disease: An Institutional Experience","keywords":"","combinedName":"doctor craig seaman"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Barbara A","lastName":"Solecka-Witulska ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacokinetics of Subcutaneously Administered Simoctocog Alfa with Von Willebrand Factor Fragment Candidates in a Minipig Model","keywords":"","combinedName":"doctor barbara a solecka-witulska"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Sandra L","lastName":"Haberichter ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantitative Analysis of Von Willebrand Factor (VWF) Multimers in Von Willebrand Disease (VWD) Patients Recruited through the Zimmerman Program for the Molecular and Clinical Biology of VWD","keywords":"","combinedName":"doctor sandra l haberichter"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Bryce ","lastName":"Kerlin ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Hypofibrinolytic Defect of Nephrotic Syndrome Is Directly Proportional to Disease Severity","keywords":"","combinedName":"doctor bryce kerlin"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Amir ","lastName":"Warwar ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Risk for Major Cardiovascular Event and Venous Thromboembolism in Patients with Factor VII and Factor V Deficiency. ","keywords":"","combinedName":"doctor amir warwar"},{"sessionId":"11639","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster I","firstName":"Paola ","lastName":"Ranalli ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Von Willebrand Factor Levels in Polycythemia Vera Are Not Reduced and Can be Predicted By Erythrocyte Counts","keywords":"","combinedName":"doctor paola ranalli"},{"sessionId":"11640","sessionTitle":"331. Pathophysiology of Thrombosis: Poster I","firstName":"Tomasz ","lastName":"Brzoska ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Arteriolar Bottle-Necks in the Lung Are the Site of Pulmonary Thrombo-Embolism","keywords":"","combinedName":"doctor tomasz brzoska"},{"sessionId":"11640","sessionTitle":"331. Pathophysiology of Thrombosis: Poster I","firstName":"Tzu-Fei ","lastName":"Wang ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Atorvastatin As an Adjunct Therapy in Patients with Acute Venous Thromboembolism","keywords":"","combinedName":"doctor tzu-fei wang"},{"sessionId":"11640","sessionTitle":"331. Pathophysiology of Thrombosis: Poster I","firstName":"Aditi B","lastName":"Kamdar ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Children with CVC-VTE: A Very High Risk Group for Recurrent Thrombosis","keywords":"","combinedName":"doctor aditi b kamdar"},{"sessionId":"11640","sessionTitle":"331. Pathophysiology of Thrombosis: Poster I","firstName":"Harry E","lastName":"Fuentes ","credentials":"MD, MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development and Validation of a 30-Day Mortality Prediction Model for Patients with Cancer-Associated Thrombosis (CAT) in the Riete Database","keywords":"","combinedName":"doctor harry e fuentes"},{"sessionId":"11640","sessionTitle":"331. Pathophysiology of Thrombosis: Poster I","firstName":"Jean-Philippe ","lastName":"Galanaud ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epidemiology and Long-Term Outcomes of Estrogen/Progesterone Associated Distal Deep-Vein Thrombosis","keywords":"","combinedName":"doctor jean-philippe galanaud"},{"sessionId":"11640","sessionTitle":"331. Pathophysiology of Thrombosis: Poster I","firstName":"Sara ","lastName":"Calzavarini ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of the Hemostatic Profile in Mice with Chronic Liver Disease: Effects of Protein S and Combined Gas6 and Protein S Deficiencies","keywords":"","combinedName":"doctor sara calzavarini"},{"sessionId":"11640","sessionTitle":"331. Pathophysiology of Thrombosis: Poster I","firstName":"Florian ","lastName":"Posch ","credentials":"MD, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Longitudinal Haemostatic Biomarker Trajectories Predict Cancer-Associated Venous Thromboembolism","keywords":"","combinedName":"doctor florian posch"},{"sessionId":"11640","sessionTitle":"331. Pathophysiology of Thrombosis: Poster I","firstName":"Xiao ","lastName":"Liu ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Profile of Thrombosis Distribution Following Haploidentical and Identical-Sibling Transplantation: A 15-Year Experience at a Single Center in China","keywords":"","combinedName":"doctor xiao liu"},{"sessionId":"11640","sessionTitle":"331. Pathophysiology of Thrombosis: Poster I","firstName":"Michael ","lastName":"Cho ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombin Generation As a Predictive Biomarker for Venous Thromboembolism in Patients with Pancreatic and Lung Cancer Undergoing Systemic Therapy","keywords":"","combinedName":"doctor michael cho"},{"sessionId":"11640","sessionTitle":"331. Pathophysiology of Thrombosis: Poster I","firstName":"Alok ","lastName":"Khorana","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tissue Factor-Related Biomarkers and Prediction of Cancer-Associated VTE: Correlative Analyses of the Phacs Trial","keywords":"","combinedName":"doctor alok khorana"},{"sessionId":"11640","sessionTitle":"331. Pathophysiology of Thrombosis: Poster I","firstName":"Julie ","lastName":"Smith ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of Outcome Instrumentsfor Venous Thrombosis in Children","keywords":"","combinedName":"doctor julie smith"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Yun ","lastName":"Choi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Apixaban Is Safe and Effective in Morbidly Obese Patients: A Retrospective Analysis of 390 Patients with BMI =40","keywords":"","combinedName":"doctor yun choi"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Lana A","lastName":"Castellucci ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Bleeding Risk between Rivaroxaban and Apixaban - a Pilot Feasibility Study","keywords":"","combinedName":"doctor lana a castellucci"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Craig ","lastName":"Coleman ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effectiveness and Safety of Rivaroxaban Versus Warfarin for Treatment of Venous Thromboembolism in Patients with Known Primary Hypercoagulable States","keywords":"","combinedName":"doctor craig coleman"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Avi ","lastName":"Leader ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factors Influencing Management of Anticoagulation in Thrombocytopenic Patients with Hematological Malignancy","keywords":"","combinedName":"doctor avi leader"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Julie ","lastName":"Peterson ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Laboratory Assays to Address the Problem of Heparin-Protamine Balance Following Neonatal Open Heart Surgery","keywords":"","combinedName":"doctor julie peterson"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Matthew ","lastName":"Bunce ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Measuring the Anticoagulation Effects of Exosite I Thrombin Inhibitors: Utility and Limitations of Clotting Assays, Thromboelastography, and Calibrated Automated Thrombography","keywords":"","combinedName":"doctor matthew bunce"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Jameel ","lastName":"Abdulrehman ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Peak Plasma Rivaroxaban Levels in Individuals Weighing over 120 Kilograms","keywords":"","combinedName":"doctor jameel abdulrehman"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Claudette ","lastName":"Bethune ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacokinetics and Pharmacodynamics of Ionis-FXIRx, an Antisense Inhibitor of FactorXI, in Patients with End-Stage Renal Disease on Hemodialysis","keywords":"","combinedName":"doctor claudette bethune"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Patrick ","lastName":"Van Dreden ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Procoagulant Phospholipid Dependent Clotting Time: A New Tool for the Identification of Multiple Myeloma Patients at Risk Poor Treatment Response","keywords":"","combinedName":"doctor patrick van dreden"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Jan ","lastName":"Beyer-Westendorf ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Splanchnic Vein Thrombosis Treatment with Rivaroxaban - a Case Series from the Prospective Dresden Noac Registry (NCT01588119)","keywords":"","combinedName":"doctor jan beyer-westendorf"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Gary ","lastName":"Peters ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation","keywords":"","combinedName":"doctor gary peters"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Scott ","lastName":"Berkowitz ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Effects of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients Treated for Venous Thromboembolism","keywords":"","combinedName":"doctor scott berkowitz"},{"sessionId":"11641","sessionTitle":"332. Antithrombotic Therapy: Poster I","firstName":"Azin ","lastName":"Ahrari ","credentials":"MD, BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment of Venous Thromboembolism in Acute Leukemia: A Systematic Review","keywords":"","combinedName":"doctor azin ahrari"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Sergey ","lastName":"Shevkoplyas ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A New Centrifugation-Free Approach for Reducing IgA Levels in Units of Stored Red Blood Cells","keywords":"","combinedName":"doctor sergey shevkoplyas"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Maximilian ","lastName":"Stahl ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Beliefs and Patterns of Practice in the Management of Hyperleukocytosis and Leukostasis Among Health Care Providers for Patients with Acute Leukemia: A Large North American Web-Based Survey","keywords":"","combinedName":"doctor maximilian stahl"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Jeanne ","lastName":"Hendrickson ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epidemiologic Characterization of Transfusion Recipients with Red Blood Cell Alloantibodies from Four US Regions: Evidence from the REDS-III Recipient Database","keywords":"","combinedName":"doctor jeanne hendrickson"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Phuong ","lastName":"Vo ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Final Result of a Pilot Study Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Allo-Immunized Patients Receiving HLA Mismatched Platelets","keywords":"","combinedName":"doctor phuong vo"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Grier ","lastName":"Page ","credentials":"PhD, BS, MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"GWAS of Osmotic Hemolysis in 12,352 Healthy Blood Donors Identifies Red Cell Genetic Variants Associated with Steady State Hemolysis in Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor grier page"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Bruno Ribeiro","lastName":"Cruz ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Extended Molecular RBC Antigen Matching between Blood Donors and Patients with Hematological Diseases","keywords":"","combinedName":"doctor bruno ribeiro cruz"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"James ","lastName":"Bynum ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased Mitochondrial DNA in an ECMO Model Is Associated with Loss of Platelet Function","keywords":"","combinedName":"doctor james bynum"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Raymond ","lastName":"Piatt ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Murine Studies to Test the Efficacy of Platelet Transfusions in the Management of Platelet Function Disorders","keywords":"","combinedName":"doctor raymond piatt"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Marsha M","lastName":"Wheeler ","credentials":"Ph.D.","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Next Generation DNA Sequencing of the RH Locus in 1135 DonorsImplicates RHCE-RHD(2)-RHCE Hybrid Alleles As Causative of C+ Antigen","keywords":"","combinedName":"doctor marsha m wheeler"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Prajeeda M","lastName":"Nair ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Aggregation Is Important for Efficient Clot Retraction","keywords":"","combinedName":"doctor prajeeda m nair"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Amudan J","lastName":"Srinivasan ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Transfusion Rejuvenation of RBCs for Red Blood Cell Exchange: Report of Feasibility","keywords":"","combinedName":"doctor amudan j srinivasan"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"James ","lastName":"Szymanski ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Retrospective Analysis Using Statistical Modeling on the Effect of Repeated Stimulated Granulocyte Donation on Hematopoietic Indices in Granulocytapheresis Donors","keywords":"","combinedName":"doctor james szymanski"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Melissa ","lastName":"Cushing ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safe and Effective Implementation of a Red Blood Cell (RBC) Transfusion Hemoglobin (Hb) Threshold of 7 g/Dl on an Inpatient Stem Cell Transplant Unit: A Single Institution Experience","keywords":"","combinedName":"doctor melissa cushing"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Trisha ","lastName":"Plastini ","credentials":"DO","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sanguinate: A Novel Blood Substitute Product","keywords":"","combinedName":"doctor trisha plastini"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Kristin ","lastName":"Reddoch Cardenas ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Specialized Proresolving Mediators (SPMs) Help to Alleviate the Cold Platelet Storage Lesion","keywords":"","combinedName":"doctor kristin reddoch cardenas"},{"sessionId":"11642","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster I","firstName":"Jock ","lastName":"Simpson ","credentials":"FRACP, FRCPA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transfusion Associated Circulatory Overload in Ambulatory Transfusions","keywords":"","combinedName":"doctor jock simpson"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Dhvanit I","lastName":"Shah","credentials":"PhD, PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Bioreactor Simulating Pulse-Pressure Mediated Circumferential Stretch Stimulates Hematopoietic Stem Cell Formation","keywords":"","combinedName":"doctor dhvanit i shah"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Luca ","lastName":"Bertamini ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Patients with Coronary Artery Disease and in Centenarians. Further Clues Linking Chip with Cardiovascular Risk","keywords":"","combinedName":"doctor luca bertamini"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Takashi ","lastName":"Yahata ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"G-CSF Signaling Counteracts TGF--PAI-1-Dependent Retention of Hematopoietic Stem Cells in the Niche","keywords":"","combinedName":"doctor takashi yahata"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Manuel ","lastName":"Buscarlet ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gene-Specific Lineage Involvement of Age-Related Clonal Hematopoiesis","keywords":"","combinedName":"doctor manuel buscarlet"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Wei-Kai ","lastName":"Hua ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HDAC8 Regulates Long-Term Hematopoietic Stem Cell Maintenance Under Stress By Modulating p53 Activity","keywords":"","combinedName":"doctor wei-kai hua"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Laura R","lastName":"Goldberg ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoietic Stem Cell Potential within the Primary Sorted Lineage Positive Population: What Are We Losing with Hematopoietic Stem Cell Purification?","keywords":"","combinedName":"doctor laura r goldberg"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"He ","lastName":"Huang ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IL6 SignalingRegulates Embryonic HematopoieticStem CellEmergence","keywords":"","combinedName":"doctor he huang"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Mi Ae ","lastName":"Park ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Induction of Arterial Type of Hemogenic Endothelium from Human Pluripotent Stem Cells","keywords":"","combinedName":"doctor mi ae park"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Wei","lastName":"Tong","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lnk/Sh2b3 Deficiency Restores Hematopoietic Stem Cell Function and Genome Integrity in Fanconi Anemia","keywords":"","combinedName":"doctor wei tong"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Zhanping ","lastName":"Lu ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Determinants for Polycomb Group Protein YY1 Control of Hematopoietic Stem Cell Quiescence","keywords":"","combinedName":"doctor zhanping lu"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Weiping ","lastName":"Yuan ","credentials":"PhD,MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PDK1 Regulates HSCs Via the Foxo Pathway during Murine Fetal Liver Hematopoiesis","keywords":"","combinedName":"doctor weiping yuan"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Enrico ","lastName":"Velardi ","credentials":"PhD, BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacological Inhibition of Luteinizing Hormone Signaling Promotes HSC Quiescence and Hematopoietic Regeneration","keywords":"","combinedName":"doctor enrico velardi"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Thomas","lastName":"Ernst","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevalence and Dynamics of Clonal Hematopoiesis Caused By Leukemia Associated Mutations in Elderly Individuals without Hematologic Disorders","keywords":"","combinedName":"doctor thomas ernst"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Michael A","lastName":"Amrein ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Traf2 and Nck-Interacting Kinase Is a Conserved Regulator of Self-Renewal in Hematopoietic and Leukemia Stem Cells","keywords":"","combinedName":"doctor michael a amrein"},{"sessionId":"11643","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster I","firstName":"Lindsay ","lastName":"Theodore ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"YAP Regulates Hematopoietic Stem Cell Formation in Response to the Biophysical Forces of Blood Flow","keywords":"","combinedName":"doctor lindsay theodore"},{"sessionId":"11644","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster I","firstName":"Carsten ","lastName":"Bahr ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Cluster of Enhancer Modules Directs Differential Myc Expression Along the Normal and Leukemic Hematopoietic Stem Cell Hierarchies","keywords":"","combinedName":"doctor carsten bahr"},{"sessionId":"11644","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster I","firstName":"Liu ","lastName":"Hong ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adenosine Signaling Regulates Erythroid Commitment Via Modulation of Metabolic Reprogramming in Stress Erythropoiesis","keywords":"","combinedName":"doctor liu hong"},{"sessionId":"11644","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster I","firstName":"Tatsuya ","lastName":"Morishima ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cell-Stage Dependent Outcomes of the NAMPT/SIRT2-Mediated Activation of LMO2 By Deacetylation in Normal Hematopoiesis and in T-ALL","keywords":"","combinedName":"doctor tatsuya morishima"},{"sessionId":"11644","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster I","firstName":"Rahul ","lastName":"Bhansali ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differential Phosphoproteomics Provides New Insights into Role of DYRK1A in Lymphopoiesis","keywords":"","combinedName":"doctor rahul bhansali"},{"sessionId":"11644","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster I","firstName":"Atsushi ","lastName":"Sato ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"mTOR-C/EBP-c-Myc Axis Regulates the Behavior of Myeloid-Biased Hematopoietic Stem Cells Under Stress Conditions","keywords":"","combinedName":"doctor atsushi sato"},{"sessionId":"11644","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster I","firstName":"Pierre-Jacques ","lastName":"Hamard ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PRMT5 Regulates DNA Repair By Controlling the Alternative Splicing of Epigenetic Factors","keywords":"","combinedName":"doctor pierre-jacques hamard"},{"sessionId":"11644","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster I","firstName":"Liqiong ","lastName":"Liu ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prostaglandin E2 Protects HSC from DNA Damage Induced By Ionizing Radiation By Preventing Generation of Reactive Oxygen Species and Histone Acetylation","keywords":"","combinedName":"doctor liqiong liu"},{"sessionId":"11644","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster I","firstName":"Michiko ","lastName":"Ichii ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Signal-Transducing Adaptor Protein-2 Blocks B Cell Recovery Under Hematological Stress at Pre-B Stage Via TLR4 Signaling","keywords":"","combinedName":"doctor michiko ichii"},{"sessionId":"11644","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster I","firstName":"Masaru ","lastName":"Yamaguchi ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombopoietin-Receptor Agonist Romiplostim Attenuates Hematopoietic System Injury By Promoting the Recovery of Early Hematopoiesis and the Hematopoietic Environment in the Bone Marrow and Spleen of Mice Exposed to Lethal Total Body ?-Irradiation","keywords":"","combinedName":"doctor masaru yamaguchi"},{"sessionId":"11645","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster I","firstName":"Richard J","lastName":"Burt ","credentials":"MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Lymphoblastic Leukaemia (ALL) Cells and Commonly-Used Chemotherapy Drugs Can Induce Bone Marrow-Derived Mesenchymal Stromal Cells to Become Cancer Associated Fibroblasts (CAF), Leading to Enhanced ALL Proliferation and Treatment Resistance","keywords":"","combinedName":"doctor richard j burt"},{"sessionId":"11645","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster I","firstName":"Hamenth kumar","lastName":"Palani ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bone Marrow Stromal Cell Mediated Drug Resistance in AML Cells: Role of Extracellular Vesicles and AKT Signaling","keywords":"","combinedName":"doctor hamenth kumar palani"},{"sessionId":"11645","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster I","firstName":"Venkata Lokesh ","lastName":"Battula ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bone Marrow Stromal Cells Induce ALDH+ Stem Cell Phenotype and Chemotherapy Resistance in AML Cells through TGF-1 Mediated Signaling: Reversal By TGF Inhibitor Galunisertib","keywords":"","combinedName":"doctor venkata lokesh battula"},{"sessionId":"11645","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster I","firstName":"Juan Pablo ","lastName":"Ruiz ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Concurrent Ex Vivo Differentiation of a Vascular Niche and Hematopoietic Stem/Progenitor Cells from Human iPSCs","keywords":"","combinedName":"doctor juan pablo ruiz"},{"sessionId":"11645","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster I","firstName":"Tomoaki ","lastName":"Ueda ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Endothelial Cell-Selective Adhesion Molecule (ESAM) Plays Important Roles in the Adult-Type Hemoglobin Synthesis during Fetal Erythropoiesis","keywords":"","combinedName":"doctor tomoaki ueda"},{"sessionId":"11645","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster I","firstName":"Rita I","lastName":"Azevedo ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mechanisms of Regulatory T Cell Recruitment By Mesenchymal Stem Cells in Vitro","keywords":"","combinedName":"doctor rita i azevedo"},{"sessionId":"11645","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster I","firstName":"Swathi ","lastName":"Namburi ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasma-Derived Exosomes in Acute Myeloid Leukemia Carry Dipeptidylpeptidase-4 and Inhibit Normal Human Hematopoiesis","keywords":"","combinedName":"doctor swathi namburi"},{"sessionId":"11645","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster I","firstName":"Jun ","lastName":"Shen ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sequential Cellular Niche Plays a Crucial Role in the Generation of Enucleated Erythrocytes from Human Pluripotent Stem Cells","keywords":"","combinedName":"doctor jun shen"},{"sessionId":"11645","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster I","firstName":"Christoph Ralf ","lastName":"Schnemann ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The E3 Ligase Itch Is a Regulator of Bone Marrow Mesenchymal Stem Cells and the Hematopoietic Stem Cell Niche","keywords":"","combinedName":"doctor christoph ralf schnemann"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Sofie ","lastName":"Lundgren ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acquired Somatic Mutations in T Cells in Patients with Aplastic Anemia and Hypoplastic Myelodysplastic Syndromes","keywords":"","combinedName":"doctor sofie lundgren"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Orna ","lastName":"Steinberg Shemer ","credentials":"MD, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization and Genotype-Phenotype Correlation of Fanconi Anemia Patients in Israel","keywords":"","combinedName":"doctor orna steinberg shemer"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Biju ","lastName":"George ","credentials":"MD,DM","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Donor Telomere Length Influences Engraftment and Outcome in Aplastic Anemia Patients Undergoing Matched Related Stem CellTransplantation","keywords":"","combinedName":"doctor biju george"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Jong-Wook ","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematologic Response to Romiplostim Treatment Is Associated with Stimulation of Primitive Stem/Progenitor Cells and Stromal Cells in Patients with Aplastic Anemia Refractory to Immunosuppressive Therapy: A 2-Year Interim Exploratory Analysis of a Phase 2 Clinical Trial","keywords":"","combinedName":"doctor jong-wook lee"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Elise ","lastName":"LeMelle ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Frequency of Subclonal Myeloid Mutations Can be Found in Large Granular Lymphocyte Leukemia","keywords":"","combinedName":"doctor elise lemelle"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Ji ","lastName":"Zha ","credentials":"PhD, BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inducible SBDS Deficiency and Germline FANCC/FANCG Deficiency Differentially Impact the Capacity of Bone Marrow Niches to Engraft Hematopoietic Stem Cells after Transplantation","keywords":"","combinedName":"doctor ji zha"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Kamila ","lastName":"Bujko ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of the C5aC5aR Axis By the L-Aptamer Aon-D21 As a New Strategy to Ameliorate Uncontrolled Migration/Motility of Hematopoietic Stem Cells - Potential Therapeutic Implications for Paroxysmal Nocturnal Hemoglobinuria","keywords":"","combinedName":"doctor kamila bujko"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Xiaoyong ","lastName":"Chen ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MCM2-7 and FANCD2 Are Required for RAD51 Function in Homologous Recombination and ICL Repair","keywords":"","combinedName":"doctor xiaoyong chen"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Kasiani ","lastName":"Myers ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MDS and AML in Shwachman-Diamond Syndrome: Clinical Features and Outcomes","keywords":"","combinedName":"doctor kasiani myers"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Marcin ","lastName":"Wlodarski","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutations in Ribosomal Protein Genes L9 and L15 Link to DBA with Specific Clinical Phenotypes","keywords":"","combinedName":"doctor marcin wlodarski"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Zora ","lastName":"Rogers ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Immunosuppressive Therapy for Pediatric Aplastic Anemia: A North American Pediatric Aplastic Anemia Consortium (NAPAAC) Study","keywords":"","combinedName":"doctor zora rogers"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Michael ","lastName":"Clemente ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Paroxysmal Nocturnal Hemoglobinuria Results from Initial Clonal PIG-a Mosaicism","keywords":"","combinedName":"doctor michael clemente"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Po-Shen ","lastName":"Ko ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Peripheral Stem Cell Transplantation Versus Bone Marrow Transplantation in Severe Aplastic Anemia - a Cohort of 149 Patients from a Single Medical Center in Taiwan","keywords":"","combinedName":"doctor po-shen ko"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Hiroki ","lastName":"Mizumaki ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PNH-Phenotype Cells and HLA Class I Allele-Lacking Leukocytes Shared By Family Members Who Developed Acquire Aplastic Anemia: Studies on Six Pairs of Patients in Different Families","keywords":"","combinedName":"doctor hiroki mizumaki"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"William ","lastName":"Morello ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Results of Gau-PED Study: Prevalence of Gaucher Disease in Paediatric Patients Selected By an Appropriate Diagnostic Algorithm","keywords":"","combinedName":"doctor william morello"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Rong ","lastName":"Fu ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantities and Functions of NK Cells in Severe Aplastic Anemia","keywords":"","combinedName":"doctor rong fu"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Parinda A","lastName":"Mehta ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quercetin: A Novel Targeted Chemoprevention for Patients with Fanconi Anemia (FA)","keywords":"","combinedName":"doctor parinda a mehta"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Toru ","lastName":"Kawakami ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recurrent STAT3 Mutations in the Lymphocytes of Pure Red Cell Aplasia without T-Cell Large Granular Lymphocytic Leukemia","keywords":"","combinedName":"doctor toru kawakami"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Steven ","lastName":"Green ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Retrospective Outcomes of Prolonged-Duration Calcineurin Inhibitor Immunosuppression in Severe Aplastic Anemia","keywords":"","combinedName":"doctor steven green"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Victor ","lastName":"Chiu ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tacrolimus Is Effective Immunosuppressive Therapy in Aplastic Anemia","keywords":"","combinedName":"doctor victor chiu"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Moonjung ","lastName":"Jung ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Clinical and Hematologic Course of Fanconi Anemia Amongst Affected Siblings","keywords":"","combinedName":"doctor moonjung jung"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Morag ","lastName":"Griffin ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombosis in Non-Hemolytic Paroxysmal Nocturnal Haemogloinuria","keywords":"","combinedName":"doctor morag griffin"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Lucia ","lastName":"Gargiulo ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Two Distinct but Functionally Related Autoreactive T Cell Populations in Paroxysmal Nocturnal Hemoglobinuria and Idiopathic Aplastic Anemia: Glycosylphosphatidylinositol-Specific and IFN?-Producing T Cells","keywords":"","combinedName":"doctor lucia gargiulo"},{"sessionId":"11646","sessionTitle":"508. Bone Marrow Failure: Poster I","firstName":"Jens ","lastName":"Lichtenberg ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whole Genome Sequencing to Detect Small Deletions in Ribosomal Protein Genes in Diamond Blackfan Anemia Patients","keywords":"","combinedName":"doctor jens lichtenberg"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Xia ","lastName":"Liu ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aberrant HCK Survival Signaling By Mutated MYD88 Requires PAX5 in Waldenstroms Macroglobulinemia and ABC DLBCL Cells","keywords":"","combinedName":"doctor xia liu"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Rosanna ","lastName":"Krakowsky ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Abrogating Treatment Resistance By Mir-451 in FLT3-ITD-Positive Acute Myeloid Leukemia","keywords":"","combinedName":"doctor rosanna krakowsky"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Leslie ","lastName":"Crews ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ADAR1-Mediated GLI1 Editing Promotes Malignant Self-Renewal in Multiple Myeloma","keywords":"","combinedName":"doctor leslie crews"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Xianwen ","lastName":"Yang ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Altered Enhancer Activity Represses CEBPEExpression in MLL-Rearranged Leukemia","keywords":"","combinedName":"doctor xianwen yang"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Ben ","lastName":"Doron ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AML Differentially Alters Fate and Function of Mesenchymal Stem- and Osteolineage Cells in the Leukemic Niche","keywords":"","combinedName":"doctor ben doron"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Norris ","lastName":"Igbineweka ","credentials":"MBBS, BSc, MRCP","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Common Fetal Hemoglobin Variants Modify Hematological Phenotypes in MDS/MPN/Myeloma Patients Receiving Cytotoxic Drugs","keywords":"","combinedName":"doctor norris igbineweka"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Lina ","lastName":"Benajiba ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Creatine Kinase Pathway Inhibition Alters GSK3 and WNT Signaling in EVI1-Positive Acute Myeloid Leukemia","keywords":"","combinedName":"doctor lina benajiba"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Makoto ","lastName":"Yamagishi ","credentials":"Ph.D.","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"EZH1/2, SWI/SNF, and MLL2 Dependent Heterochromatin Formation and Abnormal Transcriptome in Hematological Malignancies","keywords":"","combinedName":"doctor makoto yamagishi"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Ricardo ","lastName":"De Matos Simoes ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional Genomic Landscape of Epigenetic Dependencies in Myeloma","keywords":"","combinedName":"doctor ricardo de matos simoes"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Janine ","lastName":"Hntschel ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Expression of the DNMT3A Embedded Pri-Mir-1301 Associates with Improved Outcome in Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor janine hntschel"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Shi Hao ","lastName":"Tan ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Long Non-Coding RNAs Regulated By the TAL1 Complex in T-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor shi hao tan"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Jacob L","lastName":"Glass","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lineage Deconvolution Using Chromatin Accessibility and DNA Methylation Shows a Spectrum of Lineage Characteristics and Differentiation States across Acute Leukemias","keywords":"","combinedName":"doctor jacob l glass"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Edward F","lastName":"Greenberg ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Modulation of TET2 Activity with Ascorbic Acid in Myeloid Neoplasia: Diagnostic and Therapeutic Implications","keywords":"","combinedName":"doctor edward f greenberg"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Xinyue ","lastName":"Chen ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloid Progenitors of Defined Features Provide Permissiveness to Leukemic Transformation","keywords":"","combinedName":"doctor xinyue chen"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Valentina ","lastName":"Caputo ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloma Cell Addiction to the Transcription Factor TCF11","keywords":"","combinedName":"doctor valentina caputo"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Alison E","lastName":"Meyer ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nmp1 and Cohesin Mutations Cooperate to Generate Acute Myeloid Leukemia","keywords":"","combinedName":"doctor alison e meyer"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Lai N","lastName":"Chan ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reciprocal Regulation of BCL6 and MLL Expression As a Vulnerability in MLL-Rearranged Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor lai n chan"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Pigazzi ","lastName":"Martina ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rhob Overexpression Boosts Relapse of t(8;21)RUNX1-RUNX1T1 Rearranged Acute Myeloid Leukemia.","keywords":"","combinedName":"doctor pigazzi martina"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Andrew ","lastName":"White ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Spatially Resolved, Multiplexed Digital Characterization of Protein Distribution and Abundance in Formalin-Fixed, Paraffin-Embedded (FFPE) Diffuse Large B Cell Lymphoma Tissue Sections Based on the Nanostring Digital Spatial Profiling (DSP) Technology","keywords":"","combinedName":"doctor andrew white"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Shilpa ","lastName":"Sampathi ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5 and 3 Ends of Genes","keywords":"","combinedName":"doctor shilpa sampathi"},{"sessionId":"11647","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I","firstName":"Jenny ","lastName":"Smith ","credentials":"MSc, MEd","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcriptomic and Network Signatures of Cryptic Fusion CBFA2T3-GLIS2 in Pediatric AML Reveals Clinical Considerations and Implications","keywords":"","combinedName":"doctor jenny smith"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Simon E","lastName":"Richardson ","credentials":"MA, MD, PhD, MRCP, FRPATH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction As a Developmental Susceptibility to ETV6-RUNX1","keywords":"","combinedName":"doctor simon e richardson"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Ali ","lastName":"Bazarbachi ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Arsenic Trioxide and Interferon-Alpha Eradicate Adult T Cell Leukemia Initiating Cells through PML/p53 Senescence and Activation of Innate Immunity","keywords":"","combinedName":"doctor ali bazarbachi"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Lai N","lastName":"Chan ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BCL6 Enables RAS-Driven Pre-B Cell Transformation in Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor lai n chan"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Xiaona ","lastName":"You ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Canonical Notch Signaling Is Required for KrasG12D-Induced Myeloproliferative Neoplasm","keywords":"","combinedName":"doctor xiaona you"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Mina ","lastName":"Noura ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cell-Autonomous Feedback Loop of RUNX1-p53-CBFB in Acute Myeloid Leukemia Cells","keywords":"","combinedName":"doctor mina noura"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"David ","lastName":"Wald ","credentials":"PhD, MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Changes in Subcellular Localization of GSK3 As a Novel Driver of AML","keywords":"","combinedName":"doctor david wald"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Zheng ","lastName":"Ge ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Significance of Phd Finger Protein 2 As a Novel Ikaros Target in Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor zheng ge"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Tomasz ","lastName":"Sewastianik ","credentials":"MSc,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Constitutive Activation of Ras and Inactivation of Ink4a/Arf Allele Induce a Fully Penetrant B-Cell Acute Lymphoblastic Leukemia Phenotype in Mice","keywords":"","combinedName":"doctor tomasz sewastianik"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Faisal ","lastName":"Basheer ","credentials":"MBBChir, MA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Contrasting Stage Dependent Requirements for the Histone Methyltransferase EZH2 during the Evolution of Acute Myeloid Leukemia","keywords":"","combinedName":"doctor faisal basheer"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Catherine ","lastName":"Hockings ","credentials":"MBBChir, MA, FRCPath, MRCP","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Delineating the Functional Consequences of CEBPA Mutations in Acute Myeloid Leukaemia","keywords":"","combinedName":"doctor catherine hockings"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Min ","lastName":"Wu ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"DOCK2 Knockdown Mitigates Disease Progression in Murine Models Harboring a FLT3/ITD Mutation","keywords":"","combinedName":"doctor min wu"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Kerstin Maria","lastName":"Kampa-Schittenhelm ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dysregulation of the ASPP Protein Family (Apoptosis Stimulating Proteins of TP53) Is a Common Feature in High-Risk Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor kerstin maria kampa-schittenhelm"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Chiara ","lastName":"Pighi ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FBXO11 Is Recurrently Mutated in Burkitt Lymphoma and Its Inactivation Accelerates Lymphomagenesis in E-Myc mice","keywords":"","combinedName":"doctor chiara pighi"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Lina ","lastName":"Wang ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fbxw11 Triggers a Dual Signaling Axis to Exert Proliferation Effects on Lymphocytic Leukemia","keywords":"","combinedName":"doctor lina wang"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Sarah E","lastName":"Arthur ","credentials":"BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional Investigation of the Gene Nfkbiz and the Impact of 3'UTR Mutations in Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor sarah e arthur"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Noemi ","lastName":"Zambetti ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Validation of the Palmitoylation/Depalmitoylation Cycle As a Drug Target in NRAS Mutant Hematologic Malignancies In Vivo","keywords":"","combinedName":"doctor noemi zambetti"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Ricardo ","lastName":"De Matos Simoes ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integration of Functional Dependencies and Molecular Alterations of Myeloma Cells","keywords":"","combinedName":"doctor ricardo de matos simoes"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Mariko ","lastName":"Eguchi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Leukemogenic Pathway of MLL-AF4 Fusion-Positive Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor mariko eguchi"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Fang ","lastName":"Dong ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Loss of CDKN2C Accelerates Progression of Notch-1 Induced T Lymphoblastic Leukemia Via Activation of LMO2","keywords":"","combinedName":"doctor fang dong"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Hidetsugu ","lastName":"Kawai ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overcoming Tyrosine Kinase Inhibitor Resistance to SEPT9-ABL1 Chimeric Fusion Protein Using CRM1 Inhibitors","keywords":"","combinedName":"doctor hidetsugu kawai"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Joseph Thomas","lastName":"Greene ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Par-4 Overexpression Impedes Leukemogenesis in the E-TCL1 Leukemia Model","keywords":"","combinedName":"doctor joseph thomas greene"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Chieko ","lastName":"Tokushige ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RUNX1 Enhances Leukemia Cell Engraftment in the Vascular Niche through up-Regulating E-Selectin","keywords":"","combinedName":"doctor chieko tokushige"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Mylne ","lastName":"Gerritsen ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RUNX1 Mutations Lead to a Myeloid Differentiation Block in Association with Enhanced Proliferation By Altering the RUNX1 Transcriptional Program","keywords":"","combinedName":"doctor mylne gerritsen"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Xiaodan ","lastName":"Luo ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Small Interfering RNA-Mediated Knockdown of SATB1 Increases Cell Proliferation through NF-?b Activation in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor xiaodan luo"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Ling ","lastName":"Tian ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of Kdm6a in Malignant Hematopoiesis","keywords":"","combinedName":"doctor ling tian"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Francis R","lastName":"LeBlanc ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapeutic Efficacy of Mcl-1 Antagonism in Large Granular Lymphocyte Leukemia","keywords":"","combinedName":"doctor francis r leblanc"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Sinisa ","lastName":"Dovat ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcriptional Regulation of the CDC42 Signaling Pathway By Ikaros in T-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor sinisa dovat"},{"sessionId":"11648","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster I","firstName":"Elodie ","lastName":"Pronier ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Wt1 Haploinsufficiency Induces an Age-Dependent Enhancement in Stem Cell Self-Renewal and Cooperates with FLT3-ITD to Drives Leukemogenesis","keywords":"","combinedName":"doctor elodie pronier"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"David J","lastName":"Young ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Method for Overcoming Plasma Protein Inhibition of FLT3 Tyrosine Kinase Inhibitors","keywords":"","combinedName":"doctor david j young"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Ayato ","lastName":"Tsukamoto ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acquired Gene Mutation of MAP4K2 Identified from Myelodysplastic Syndromes Patients Confers Azacitidine Resistance","keywords":"","combinedName":"doctor ayato tsukamoto"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Tetsuzo ","lastName":"Tauchi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combining Effects of the SMO Inhibitor and BCL-2 Inhibitor in MDS-Derived Induced Potent Stem Cells (iPSC)","keywords":"","combinedName":"doctor tetsuzo tauchi"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Shivani ","lastName":"Kapoor ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Concurrent Treatment with Pim Kinase Inhibitor Downregulates Alternative Non-Homologous End-Joining Repair and Decreases Genomic Instability in FLT3-ITD Cells Treated with Topoisomerase 2 Inhibitor Chemotherapy Drugs","keywords":"","combinedName":"doctor shivani kapoor"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Pamela ","lastName":"Sung ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cytokine Activation of JAK Kinases Rescues FLT3-Mutant AML from FLT3 Inhibition and Requires PIM Kinases","keywords":"","combinedName":"doctor pamela sung"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Graham ","lastName":"Bailey ","credentials":"PhD, BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"DNA Damaging Agents Cause a Sub-Cellular Re-Localisation of Nucleophosmin in annpm1 Mutated Acute Myeloid Leukemia (AML) Cell Line and in Primary AML Cells Carrying an npm1 Mutation","keywords":"","combinedName":"doctor graham bailey"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Seemana ","lastName":"Bhattacharya ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of Unc-51 like Autophagy Activating Kinase 1 (ULK1) Is Highly Synergistic with Chemotherapy and Bcl2 Inhibition in Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor seemana bhattacharya"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Tobias ","lastName":"Berg ","credentials":"MD ","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"LSD1 Inhibition Leads to Differentiation in Hoxa9/Meis1- but Not in MN1-Induced Acute Myeloid Leukemia","keywords":"","combinedName":"doctor tobias berg"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Sreeja ","lastName":"Karathedath ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular and Pharmacological Inhibition of ATP Binding Cassette Transporter ABCB6 Decreases Chemoresistance in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor sreeja karathedath"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Yoko ","lastName":"Tabe ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Oxidative Phosphorylation Inhibitor Iacs-010759 Induces AMPK-Dependent Apoptosis of AML Cells","keywords":"","combinedName":"doctor yoko tabe"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Swagata ","lastName":"Goswami ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"OSU-2S, a Novel PKC Activator, Mediates PKC Dependent Cell Death, Differentiation and Cell Cycle Arrest in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor swagata goswami"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Lisa ","lastName":"Deng ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacologic Inhibition of PI3K Prolongs Survival of Mutant Shp2E76K-Expressing Mice","keywords":"","combinedName":"doctor lisa deng"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Dyana ","lastName":"Saenz ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Therapy with BET Protein and Beta-Catenin Antagonists Against Ruxolitinib Resistant Post-Myeloproliferative Neoplasm (MPN) Secondary (s) AML Cells","keywords":"","combinedName":"doctor dyana saenz"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Yubin ","lastName":"Ge ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting PI3K, mTOR, ERK, and Bcl-2 Signaling Network Shows Superior Antileukemic Activity Against AML","keywords":"","combinedName":"doctor yubin ge"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Bruna Alves","lastName":"Fenerich ","credentials":"BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Pharmacological IGF1R-IRS1/2 Inhibitor NT157 Presents Multiple Anti-Neoplastic Effects in Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor bruna alves fenerich"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Yasuhiro ","lastName":"Shingai ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Variable Expression Levels of the Hematopoietic Stem Cell Surface Antigen ESAM Depict Heterogeneity and Fluctuations in Leukemic Stem Cells","keywords":"","combinedName":"doctor yasuhiro shingai"},{"sessionId":"11649","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster I","firstName":"Yoko ","lastName":"Tabe ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"XPO1 Inhibition Targets Transcriptional Vulnerability of FLT3-ITD+D835 Double Mutant AML through p53 Accumulation and Inhibition of Oncogenic Transcription Factors: Lesson Learned from Cage Sequencing of Primary AML Cells","keywords":"","combinedName":"doctor yoko tabe"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Patricia ","lastName":"Johansson ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CDK9 Inhibition with LDC526 Is an Effective Treatment for T-Cell Prolymphocytic Leukemia (T-PLL) in Vitro","keywords":"","combinedName":"doctor patricia johansson"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Kensuke ","lastName":"Kojima ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Downregulation of BMI-1 By the Small Molecule PTC596 Induces Mitochondrial Apoptosis in Mantle Cell Lymphoma","keywords":"","combinedName":"doctor kensuke kojima"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Feng ","lastName":"Jin ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Exposure-Response of the Bruton Tyrosine Kinase Inhibitor, Acalabrutinib, in the Treatment of Hematologic Malignancies","keywords":"","combinedName":"doctor feng jin"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Michael ","lastName":"Amatangelo ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FOXM1 Is Associated with Development of Therapeutic Resistance in Multiple Myeloma","keywords":"","combinedName":"doctor michael amatangelo"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Kubra ","lastName":"Kamisoglu ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Greater Efficacy and Potency of Obinutuzumab Compared with Rituximab in Chronic Lymphocytic Leukemia Patients Confirmed By a Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Model","keywords":"","combinedName":"doctor kubra kamisoglu"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Lenka ","lastName":"Besse ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Glutathione and NAD(P)H Levels, and Increased Protein Folding Capacity Are Involved in Mediating Proteasome Inhibitor-Resistance in Multiple Myeloma","keywords":"","combinedName":"doctor lenka besse"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Alexandra Albertsson","lastName":"Lindblad ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ibrutinib in Combination with Anti-CD20-Antibody Negatively Affects Antibody Dependent Cellular Cytotoxic (ADCC) on Mantle Cell Lymphoma Cell Lines, Not Reversed By the Addition of Lenalidomide","keywords":"","combinedName":"doctor alexandra albertsson lindblad"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Takeshi ","lastName":"Yoroidaka ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Imatinib Induces Apoptosis of NK/T Cell Neoplasms by Inhibiting Hematopoietic Cell Kinase and NQO2","keywords":"","combinedName":"doctor takeshi yoroidaka"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Franck ","lastName":"Morschhauser ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacodynamic Study of Copanlisib in Patients with Non-Hodgkin's Lymphoma and Advanced Solid Tumors: Confirmation of on-Target PI3K Inhibitory Activity","keywords":"","combinedName":"doctor franck morschhauser"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Baohua ","lastName":"Sun ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preclinical Activity of Novel BET Protein Proteolysis Targeting Chimeras (BETP-PROTACs) and Their Combination with Venetoclax or CDK4/6 Inhibitor Against Human Mantle Cell Lymphoma (MCL) Cells","keywords":"","combinedName":"doctor baohua sun"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Kayleigh ","lastName":"Gallagher ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Repression of the Orphan Nuclear Receptor Esrrb Results in Glucocorticoid Resistance in ALL","keywords":"","combinedName":"doctor kayleigh gallagher"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Emma ","lastName":"Vilventhraraja ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sustained Reduction of Intracellular Calcium Is Important to Maximise GA101-Mediated Direct Cell Death in B-Cell Lymphomas","keywords":"","combinedName":"doctor emma vilventhraraja"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Pavani ","lastName":"Malla ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting of Glutamine Pathways Restores Sensitivity in Venetoclax Resistant Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor pavani malla"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Maryam ","lastName":"Ebadi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Meninges Enhance Acute Lymphoblastic Leukemia Chemoresistance in the Central Nervous System","keywords":"","combinedName":"doctor maryam ebadi"},{"sessionId":"11650","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster I","firstName":"Aneel ","lastName":"Paulus ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Oral Proteasome Inhibitor Ixazomib, Alone and in Combination with Ibrutinib, Induces Lethality in Waldenstrom Macroglobulinemia Cells That Are Resistant to Ibrutinib","keywords":"","combinedName":"doctor aneel paulus"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Kevin ","lastName":"Miller ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Lymphoblastic Leukemia/Lymphoma in the Elderly: The Mayo Clinic Experience","keywords":"","combinedName":"doctor kevin miller"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Uma ","lastName":"Athale ","credentials":"M.D., M.Sc.","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Age and ABO Blood Group Are Significant Predictors of Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001","keywords":"","combinedName":"doctor uma athale"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Ulla ","lastName":"Wartiovaara-Kautto ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Asparaginase-Triggered Hyperglycerimedia: An Analysis on Germline Regulatory Gene Variations in Adult Acute Lymphoblastic Leukemia Patients","keywords":"","combinedName":"doctor ulla wartiovaara-kautto"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Nirali N","lastName":"Shah ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Beyond Cytokine Storm: Optimizing Treatment Strategies to Target the Complex Interplay between CAR Mediated Inflammatory Response, Disseminated Intravascular Coagulation and Macrophage Activation Syndrome","keywords":"","combinedName":"doctor nirali n shah"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Mark Blaine","lastName":"Geyer ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical and Pathological Features of B-Cell Acute Lymphoblastic Leukemia Following Maintenance Treatment with Lenalidomide for Multiple Myeloma","keywords":"","combinedName":"doctor mark blaine geyer"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Theodore W","lastName":"Laetsch ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CTL019 Therapy Appears Safe and Effective in Pediatric Patients with Down Syndrome with Relapsed/ Refractory (r/r) Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor theodore w laetsch"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Khaled M","lastName":"Ghanem ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Decreasing Dose and Duration of Dexamethasone Therapy for Low-Risk Childhood Acute Lymphoblastic Leukemia Aiming to Avoid Serious Viral Infections Results in Significant Increase in Isolated CNS Relapse: A Prospective Study","keywords":"","combinedName":"doctor khaled m ghanem"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Sarah ","lastName":"Elitzur ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epstein Barr Virus-Associated Lymphoproliferative Disorder during Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor sarah elitzur"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Francois Xavier ","lastName":"Gros ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Feasibility and Outcome of Late Intensification with Native L-Asparaginase for Acute Lymphoblastic Leukemia in the Elderly : A Single Center Experience","keywords":"","combinedName":"doctor francois xavier gros"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Chih-Hsiang ","lastName":"Yu ","credentials":"Ph. D student","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Profiling in Childhood T-Cell Acute Lymphoblastic Leukemia By Targeted Sequencing","keywords":"","combinedName":"doctor chih-hsiang yu"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Isabel ","lastName":"Jerchel ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High PDGFRA Expression Does Not Serve As Effective Therapeutic Target in ERG-Deleted B-Cell Precursor Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor isabel jerchel"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Karen Thudium","lastName":"Mueller ","credentials":"PharmD,MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Humoral Immunogenicity (Anti-mCAR19 Antibodies) on CTL019 Cellular Kinetics, Efficacy, and Safety","keywords":"","combinedName":"doctor karen thudium mueller"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Hagop ","lastName":"Kantarjian","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the Global Phase 3 INO-VATE Trial: Efficacy and Safety By Baseline CD22 Expression Level","keywords":"","combinedName":"doctor hagop kantarjian"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Birgitte Klug","lastName":"Albertsen ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intermittent Vs Continuous Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study","keywords":"","combinedName":"doctor birgitte klug albertsen"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Sunil S","lastName":"Raikar ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Isolated Myeloperoxidase Expression in Pediatric B/Myeloid Mixed Phenotype Acute Leukemia Is Associated with Improved Survival Using ALL-Only Regimens","keywords":"","combinedName":"doctor sunil s raikar"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Hirozumi ","lastName":"Sano ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lack of Certain Level of Myelosuppression during Induction Phase Is Associated with Poor Prognosis in Children and Adolescent with B-Cell Precursor Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor hirozumi sano"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Kenichi ","lastName":"Sakamoto ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low Incidence of Osteonecrosis in Childhood Acute Lymphoblastic Leukemia Treated with ALL-97 and ALL-02 Study of Japan Association of Childhood Leukemia Study Group","keywords":"","combinedName":"doctor kenichi sakamoto"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Jochen ","lastName":"Bchner ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Coagulopathy Associated with CTL019 CAR T-Cell Therapy","keywords":"","combinedName":"doctor jochen bchner"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Hassan ","lastName":"Sibai ","credentials":"MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Migration in the Management of Philadelphia Positive ALL: Towards a Lower Risk of VTE","keywords":"","combinedName":"doctor hassan sibai"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Stine ","lastName":"Nygaard Nielsen ","credentials":"PhD, MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"No Association between Relapse Risk and Thiopurine Methyltransferase Activity By Either Geno- or Phenotype in the NOPHO ALL-2008 Protocol","keywords":"","combinedName":"doctor stine nygaard nielsen"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Jianda ","lastName":"Hu ","credentials":"Prof MD PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nucleolin As a Survival Predictor in Acute Lymphoblastic Leukemia and Its Promotion to Drug Resistance By ERK Pathway","keywords":"","combinedName":"doctor jianda hu"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Paola ","lastName":"Minetto ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient and Therapy-Related Factors Affecting the Toxicity of Pegylated-Asparaginase for the Treatment of Adult Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor paola minetto"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Deborah ","lastName":"McCue ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pneumocystis Jiroveci Pneunomia Prophylaxis during Maintenance Therapy with Hyper-CVAD Regimens for Adult Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor deborah mccue"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Waseem ","lastName":"Qasim ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product in a First-in-Human Trial (PALL) in Pediatric Patients with CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor waseem qasim"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Josep-Maria ","lastName":"Ribera ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results of the Full Pediatric, Minimal Residual Disease (MRD)-Oriented Trial LAL-RI/2008 for Adolescents and Young Adults (AYA) with Standard Risk (SR), Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL)","keywords":"","combinedName":"doctor josep-maria ribera"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Wenyu ","lastName":"Yang ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Correlation Studies between Central Nervous System Involvement By Flow Cytometry and the Prognosis of Children Acute Lymphoblastic Leukemia: A Single Chinese Centers Experience By Cclg- ALL 2008","keywords":"","combinedName":"doctor wenyu yang"},{"sessionId":"11651","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I","firstName":"Sumit ","lastName":"Gupta ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Widening Survival Disparities between AYA with ALL Treated in Pediatric Vs. Adult Centers: A Population-Based Study Using the IMPACT Cohort","keywords":"","combinedName":"doctor sumit gupta"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Elzbieta ","lastName":"Patkowska ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Comparison of Clinical Characteristics and Treatment Outcome in Myeloid Sarcoma Versus Acute Myeloid Leukemia Patients without Extramedullary Involvement  Case Control Study of the Polish Adult Leukemia Group (PALG)","keywords":"","combinedName":"doctor elzbieta patkowska"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Megan ","lastName":"Othus ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival (Potential Cure) over the Past Four Decades: Analysis of SWOG Trial Data","keywords":"","combinedName":"doctor megan othus"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Lene Sofie Granfeldt","lastName":"Oestgaard ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autoimmune Diseases, Infections, Use of Antibiotics and the Risk of Acute Myeloid Leukemia: A National Population-Based Case-Control Study","keywords":"","combinedName":"doctor lene sofie granfeldt oestgaard"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Jie ","lastName":"Jin ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Subcutaneous Injection Versus Intravenous Infusion of Cytarabine for Induction Therapy in Acute Myeloid Leukemia: Results of a Prospective, Randomized, Multicenter, Noninferiority Phase 3 Trial","keywords":"","combinedName":"doctor jie jin"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Eytan ","lastName":"Stein ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Continuing Enasidenib Treatment for Patients with Mutant-IDH2 (mIDH2) Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) with Stable Disease May Result in Improved Survival and Responses over Time","keywords":"","combinedName":"doctor eytan stein"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Lene Sofie Granfeldt","lastName":"stgrd ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Does NSAID Consumption Reduce the Risk of Acute Myeloid Leukemia? a National Population-Based Case-Control Study","keywords":"","combinedName":"doctor lene sofie granfeldt stgrd"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Erika ","lastName":"Borlenghi ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Decitabine As First-Line Therapy for Elderly Patients with Acute Myeloid Leukemia.aReal Life Multicentric Experience of the Northern Italy","keywords":"","combinedName":"doctor erika borlenghi"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Christophe ","lastName":"Willekens ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of 5-Azacitidine on IDH1/2 Acute Myeloid Leukemia/Myelodysplastic Syndromes and Correlation with 2-Hydroxyglutarate Production","keywords":"","combinedName":"doctor christophe willekens"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Peter ","lastName":"Von Dem Borne ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Excessive Early Death after Intensive Chemotherapy for Acute Myeloid Leukemia Occurs in Patients over 65 Years with High Co-Morbidity, and in Patients over 50 Years with High Co-Morbidity When Postponed Early Death Is Included","keywords":"","combinedName":"doctor peter von dem borne"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Jorge ","lastName":"Cortes","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate (ADC) Demonstrates Initial Antileukemia Activity in Patients with Relapsed or Refractory Acute Myeloid Leukemia","keywords":"","combinedName":"doctor jorge cortes"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Aida ","lastName":"Sousa ","credentials":"MD ","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Invasive Aspergillosis (IA) in Acute Myeloid Leukemia (AML): When Is Prophylaxis Appropriate?","keywords":"","combinedName":"doctor aida sousa"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Zachary ","lastName":"Epstein-Peterson ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloid Malignancies Following Luminal Gastrointestinal Cancer: High Incidence of Deletion 5q and DNTM3A Mutations","keywords":"","combinedName":"doctor zachary epstein-peterson"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Ditte Juel Adolfsen","lastName":"Lhmann ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Obesity Is Associated with Favorable Cytogenetic Abnormalities in Pediatric Acute Myeloid Leukemia","keywords":"","combinedName":"doctor ditte juel adolfsen lhmann"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Medhavi ","lastName":"Gupta ","credentials":"MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I Clinical Trials in Acute Myeloid Leukemia: A Pooled Analysis","keywords":"","combinedName":"doctor medhavi gupta"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Fahrettin ","lastName":"Covut ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Impact of Morphological Cellularity in Early Assessment Bone Marrow Biopsy after 7+3 Induction in Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor fahrettin covut"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Naveen ","lastName":"Pemmaraju ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results of Pivotal Phase 2 Trial of SL-401 in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)","keywords":"","combinedName":"doctor naveen pemmaraju"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Bachir ","lastName":"Berbari ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tetraploidy in Acute Myeloid Leukemia Is Associated with Poor Outcomes Regardless of the Presence of Favorable Risk Features, and Requires an Allogeneic Stem Cell Transplant in First Remission","keywords":"","combinedName":"doctor bachir berbari"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Jui-Che ","lastName":"Chen ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Clinical Implication and Prognostic Impact of Dynamic Molecular Evolution in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor jui-che chen"},{"sessionId":"11652","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster I","firstName":"Junshik ","lastName":"Hong ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapy-Related Myeloid NeoplasmsAre Not Always Dismal If They Have Better Cytogenetic Profile and LongerLatency Period from Preceding Anti-Cancer Treatment","keywords":"","combinedName":"doctor junshik hong"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Hyery ","lastName":"Kim ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Association of APEX1 and NUDT15 Polymorphisms with Mercaptopurine-Related Neutropenia in Pediatric Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor hyery kim"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Dina Ahmed Said Aly","lastName":"Okasha ","credentials":"MBBS, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bone Marrow Infiltrating T-Cell Signatures Following Allo-HCT for Adult Acute Lymphoblastic Leukaemia Differentiate between Patients in Continuous CR and Those with Persistent Minimal Residual Disease or Relapse","keywords":"","combinedName":"doctor dina ahmed said aly okasha"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Tim ","lastName":"Chan ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD19-Specific Chimeric Antigen Receptor-Modified T Cells with Safety Switch Produced Under Point-of-Care Using the Sleeping Beauty System for the Very Rapid Manufacture and Treatment of B-Cell Malignancies","keywords":"","combinedName":"doctor tim chan"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Chi ","lastName":"Zhang ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD9 Blockade Effectively Suppresses Disease Progression of Pediatric B-Precursor Acute Lymphoblastic Leukemia and Enhances Chemosensitivity","keywords":"","combinedName":"doctor chi zhang"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Andrew ","lastName":"Lewis ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chemical Inhibition of the Macrophage Inhibitor Factor (MIF) Induces Cell Cycle Arrest and Apoptosis in Lymphoid and Myeloid Leukemia","keywords":"","combinedName":"doctor andrew lewis"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Shannon L","lastName":"Maude","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Durable Remissions with Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in CAR-Naive and CAR-Exposed Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor shannon l maude"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Kevin ","lastName":"Curran ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Dose Cyclophosphamide and Pre-Treatment Disease Burden Dictate Response and Survival in a Multicenter Clinical Trial Using CD19-Specific CAR T Cells for Relapsed/Refractory B-ALL","keywords":"","combinedName":"doctor kevin curran"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Nitin ","lastName":"Jain ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim Data from a Phase 1 Study Evaluating Pyrrolobenzodiazepine-Based Antibody Drug Conjugate Adct-402 (Loncastuximab Tesirine) Targeting CD19 for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor nitin jain"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Pere ","lastName":"Barba ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Is the Outcome of Patients with High Risk T-Cell Acute Lymphoblastic Leukemia Improving in the Era of Pediatric- Inspired Protocols? a Comparison of 2 Consecutive Pethema Trials","keywords":"","combinedName":"doctor pere barba"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Mark ","lastName":"Wunderlich ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PD-1 Inhibition Enhances Blinatumomab Response in a UCB/PDX Model of B-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor mark wunderlich"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Nitin ","lastName":"Jain ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ruxolitinib or Dasatinib in Combination with Chemotherapy for Patients with Relapsed/Refractory Philadelphia (Ph)-like Acute Lymphoblastic Leukemia: A Phase I-II Trial","keywords":"","combinedName":"doctor nitin jain"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Jaclyn ","lastName":"Rosenthal ","credentials":"BSN","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Semi-Quantitative Analysis of CD19 and CD22 Expression in B-Lymphoblastic Leukemia and Implications for Targerted Immunotherapy","keywords":"","combinedName":"doctor jaclyn rosenthal"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Theresa ","lastName":"Leon ","credentials":"PhD, MSc, BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Synthetic Lethal Screening Identifies CHK1 Inhibition As an Exploitable Vulnerability in EZH2 Deficient T-ALL","keywords":"","combinedName":"doctor theresa leon"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Julia ","lastName":"Snider ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Economic Value of CTL019 Therapy for Pediatric Patients with Relapsed and Refractory Acute Lymphoblastic Leukemia in the United Kingdom","keywords":"","combinedName":"doctor julia snider"},{"sessionId":"11653","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster I","firstName":"Thomas ","lastName":"LeBlanc ","credentials":"MD, MA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Real-World US Practices","keywords":"","combinedName":"doctor thomas leblanc"},{"sessionId":"11654","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster I","firstName":"Molly M","lastName":"Gallogly ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Study of Midostaurin and 5-Azacitidine for Elderly Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor molly m gallogly"},{"sessionId":"11654","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster I","firstName":"Honghu ","lastName":"Zhu ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Determinants of Early Death and Outcomes for Acute Promyelocytic Leukemia in the Arsenic Era: A Real World Study","keywords":"","combinedName":"doctor honghu zhu"},{"sessionId":"11654","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster I","firstName":"Pedro H","lastName":"Prata ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcome of NPM1 Mutated Acute Myeloid Leukemia (AML) Treated with Hypomethylating Agents (HMAs): A Report on 71 Cases","keywords":"","combinedName":"doctor pedro h prata"},{"sessionId":"11654","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster I","firstName":"Gail ","lastName":"Roboz","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Radius-X: An Expanded Treatment Protocol of Midostaurin in Adults with Newly Diagnosed FLT3-MutationPositive Acute Myeloid Leukemia Eligible for Standard Chemotherapy","keywords":"","combinedName":"doctor gail roboz"},{"sessionId":"11654","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster I","firstName":"Nadia ","lastName":"Jaekel ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Response-Adapted Sequential Treatment with Azacitidine and Intensive Chemotherapy in Patients > 60 Years Old with Newly Diagnosed AML: Results of the RAS-Azic Trial of the East German Study Group (OSHO)","keywords":"","combinedName":"doctor nadia jaekel"},{"sessionId":"11654","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster I","firstName":"Daniel ","lastName":"Pollyea","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sequential Azacitidine (Aza) and Lenalidomide (Len) for Patients (Pts) with Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML): Clinical Results and Predictive Modeling Using Computational Analysis and Serial Genomics","keywords":"","combinedName":"doctor daniel pollyea"},{"sessionId":"11654","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster I","firstName":"Stephen Yang","lastName":"Liang ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Systemic Inflammatory Response Syndrome As Initial Therapy and Oral Arsenic Based Consolidation Regimen for Acute Promyelocytic Leukemia","keywords":"","combinedName":"doctor stephen yang liang"},{"sessionId":"11654","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster I","firstName":"Huihui ","lastName":"Zhao ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Synergy of Vitamin C with Decitabine Activates TET2 in Leukemic Cells and Significantly Improves Overall Survival in Elderly Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor huihui zhao"},{"sessionId":"11654","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster I","firstName":"Tara ","lastName":"Lin","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment with Low-Dose Daunorubicin Reduces the Number of Leukemia Stem Cells in Patients with Relapsed/Refractory Acute Myeloid Leukemia","keywords":"","combinedName":"doctor tara lin"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Xian ","lastName":"Zhang ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A 11-Year Clinical Summary of DC - CIK / NK Cell Immunotherapy for 152 Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor xian zhang"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Naval","lastName":"Daver","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase I Study of FLX925, a Dual FLT3 and CDK4/6 Inhibitor in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor naval daver"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Gautam ","lastName":"Borthakur ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase I Study of GSK525762, a Selective Bromodomain (BRD) and Extra Terminal Protein (BET) Inhibitor: Results from Part 1 of Phase I/II Open Label Single Agent Study in Patients with Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor gautam borthakur"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Naval","lastName":"Daver","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"a Phase I/II Study of Selinexor (SEL) with Sorafenib in Patients (pts) with Relapsed and/or Refractory (R/R) FLT3 Mutated Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor naval daver"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Yimamu ","lastName":"Maimaitili ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An mTORC1/2 Kinase Inhibitor Remarkably Enhances the Cytotoxicity of Gemtuzumab Ozogamicin By Activating Lysosomal Function and Cell Cycle Promotion in AML Cells","keywords":"","combinedName":"doctor yimamu maimaitili"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Weixu ","lastName":"Meng ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anti-IL1RAP/CD3 Bispecific Antibody (BsAb) Is a Promising Novel and Effective Therapy for Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor weixu meng"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Tim ","lastName":"Chan ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autologous T Cells Modified to Co-Express CD33-Specific Chimeric Antigen Receptor and a Kill Switch for Treatment of CD33+ Acute Myeloid Leukemia","keywords":"","combinedName":"doctor tim chan"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Qi ","lastName":"Zhang ","credentials":"PhD, MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BCL-2 Antagonist ABT-199 Combined with Complex I Inhibitor Iacs-010759 Blocks Mitochondrial Respiration and Facilitates Anti-Leukemia Efficacy in Pre-Clinical AML Models","keywords":"","combinedName":"doctor qi zhang"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Hardikkumar ","lastName":"Jetani ","credentials":"BPharm, MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CAR T Cells Targeting FLT3 on AML Confer Potent Anti-Leukemic Activity and Act Synergistically with the FLT3 Inhibitor Midostaurin","keywords":"","combinedName":"doctor hardikkumar jetani"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Dimitrios ","lastName":"Mougiakakos ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD33/CD3-Bispecific T-Cell Engaging (BiTE) Antibody Constructs Efficiently Target Monocytic CD14+hla-DRlow IDO+aml-MDSCs","keywords":"","combinedName":"doctor dimitrios mougiakakos"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Kamalika ","lastName":"Banerjee ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CPX-351 Exposure-Response Based on Cumulative Dose of Cytarabine and Daunorubicin in Patients with Newly Diagnosed, Treatment-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes","keywords":"","combinedName":"doctor kamalika banerjee"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Samiksha ","lastName":"Tarun ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Direct Comparison of Anti-CD33 and Anti-CD123 Chimeric Antigen Receptor T Cells with CD28 or 41BB Co-Stimulatory Domains for Treatment of Acute Myeloid Leukemia","keywords":"","combinedName":"doctor samiksha tarun"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Santhana Gowri ","lastName":"Thangavelu Devaraj ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"DNA Aptamer Against Anti- Programmed Cell Death-1 (Anti-PD1-Apt) Induces Robust Anti-Leukemic Activity in Vitro and In Vivo Humanized NSG Mice with Myeloid Leukemia Xenografts","keywords":"","combinedName":"doctor santhana gowri thangavelu devaraj"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Rebecca ","lastName":"Goldstein ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of a FLT3 Bite for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor rebecca goldstein"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Ehab ","lastName":"Atallah ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of the Correlation between Response and Duration of Treatment in a Phase 2 Study of Pracinostat Plus Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor ehab atallah"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Rita ","lastName":"Assi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Final Results of Phase 2, Open-Label Study of E7070, Idarubicin and Cytarabine in Patients (Pts) with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)","keywords":"","combinedName":"doctor rita assi"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Raghuveer Singh ","lastName":"Mali ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FLT3-ITD Activation Mediates Resistance to the BCL-2 Selective Antagonist, Venetoclax, in FLT3-ITD Mutant AML Models","keywords":"","combinedName":"doctor raghuveer singh mali"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Jerome ","lastName":"Boyd-Kirkup ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HMBD004, a Novel Anti-CD47xCD33 Bispecific Antibody Displays Potent Anti-Tumor Effects in Pre-Clinical Models of AML","keywords":"","combinedName":"doctor jerome boyd-kirkup"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Myrna ","lastName":"Nahas ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hypomethylating Agent Leads to Enhanced Immunogenicity of a Dendritic Cell/Acute Myeloid Leukemia Fusion Vaccine and Prolonged Survival in an Immunocompetent Mouse Model","keywords":"","combinedName":"doctor myrna nahas"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Sharlene ","lastName":"Adams ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IMGN779, a Next Generation CD33-Targeting ADC, Combines Effectively with Cytarabine in Acute Myeloid Leukemia (AML) Preclinical Models, Resulting in Increased DNA Damage Response, Cell Cycle Arrest and Apoptosis In Vitro and Prolonged Survival In Vivo","keywords":"","combinedName":"doctor sharlene adams"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Natalia ","lastName":"Baran ","credentials":"PhD, MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of Oxphos with Iacs-010759 Depletes AML Leukemia Initiating Cells (LIC) in Vitro and Improves Survival in Pre-Clinical AML Models","keywords":"","combinedName":"doctor natalia baran"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Le Xuan Truong ","lastName":"Nguyen ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of ROS-Induced Nrf2 Antioxidant Pathway Activation May Explain Synergy between Venetoclax and Hypomethylating Agents Against Acute Myeloid Leukemia","keywords":"","combinedName":"doctor le xuan truong nguyen"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Scott ","lastName":"Portwood ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of the Histone Chaperone, FACT (Facilitates Chromatin Transcription) By the Novel Small Molecule CBL0137 (Curaxin) Shows Promising Efficacy in Pre-Clinical Models of Acute Myeloid Leukemia","keywords":"","combinedName":"doctor scott portwood"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Heeje ","lastName":"Kim ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Modulating the Immunologic Microenvironment in AML By Blocking Both CXCR4 and PD-L1","keywords":"","combinedName":"doctor heeje kim"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Naval","lastName":"Daver","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nivolumab (Nivo) with Azacytidine (AZA) in Patients (pts) with Relapsed Acute Myeloid Leukemia (AML) orFrontline Elderly AML","keywords":"","combinedName":"doctor naval daver"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Johnnie ","lastName":"Orozco ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Bispecific AntibodyTargeting CD45 and 90Y-DOTA Is Effective Therapyfor Acute Myeloid Leukemia in Preclinical Murine Models","keywords":"","combinedName":"doctor johnnie orozco"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Honghu ","lastName":"Zhu ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Oral Arsenic and Retinoic Acid for Children with Non High-Risk Acute Promyelocytic Leukemia","keywords":"","combinedName":"doctor honghu zhu"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Joshua F","lastName":"Zeidner ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor joshua f zeidner"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Antonio ","lastName":"Cavazos ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Clinical Activity of SN37169, a Novel Hypoxia-Activated FLT3 Inhibitor Prodrug in FLT3-Mutated AML","keywords":"","combinedName":"doctor antonio cavazos"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Wolfram ","lastName":"Brugger ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preclinical and Early Phase 1 Clinical Data of AZD2811 Nanoparticle in AML, an Aurora B Kinase Inhibitor","keywords":"","combinedName":"doctor wolfram brugger"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Michael P","lastName":"Rettig ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Translational Results from an Ongoing Phase 1 Study of Flotetuzumab, a CD123 x CD3 Dart, in AML/MDS: Rationale for Combining Flotetuzumab and Anti-PD-1/PD-L1 Immunotherapies","keywords":"","combinedName":"doctor michael p rettig"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Marla ","lastName":"Weetall ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PTC299 Is a Novel DHODH Inhibitor That Modulates VEGFA mRNA Translation and Inhibits Proliferation of a Broad Range of Leukemia Cells","keywords":"","combinedName":"doctor marla weetall"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Roland ","lastName":"Walter ","credentials":"MD, PhD, MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Randomized Study of CPX-351 for Medically Less-Fit Adults with Newly Diagnosed Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasm","keywords":"","combinedName":"doctor roland walter"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Bruno C","lastName":"Medeiros ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rates of Adverse Events per Patient-Year in a Randomized, Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, Treatment-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes","keywords":"","combinedName":"doctor bruno c medeiros"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Caitlin R","lastName":"Rausch ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results of Off-Label Venetoclax Use in Combination with Low-Intensity Chemotherapy in Patients with Relapsed and Refractory Myeloid Malignancies","keywords":"","combinedName":"doctor caitlin r rausch"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Anuhar ","lastName":"Chaturvedi ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Synergistic Activity of IDH1 Inhibitor Bay-1436032 with Azacitidine in IDH1 Mutant Acute Myeloid Leukemia","keywords":"","combinedName":"doctor anuhar chaturvedi"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Rita ","lastName":"Assi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Combination of Ruxolitinib (RUX) with Decitabine (DAC) in Patients (Pts) with Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML): Interim Report of a Phase I/II Trial","keywords":"","combinedName":"doctor rita assi"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Sonja ","lastName":"Loges ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Orally Available Selective Axl Inhibitor BGB324 Induces Diversification of the Immune Repertoire and Specific Changes in Plasma Biomarker Profiles","keywords":"","combinedName":"doctor sonja loges"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Saar I","lastName":"Gill ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treating Relapsed / Refractory (RR) AML with Biodegradable Anti-CD123 CAR Modified T Cells","keywords":"","combinedName":"doctor saar i gill"},{"sessionId":"11655","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster I","firstName":"Aaron D","lastName":"Goldberg","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Venetoclax Combined with Either a Hypomethylating Agent or Low-Dose Cytarabine Shows Activity in Relapsed and Refractory Myeloid Malignancies ","keywords":"","combinedName":"doctor aaron d goldberg"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Elsa ","lastName":"Bernard ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Knowledge-Based Approach for Clinical Annotation of Oncogenic Variants to Support Patient-Tailored Diagnosis in Myeloid Disease","keywords":"","combinedName":"doctor elsa bernard"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Ling ","lastName":"Zhong ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A New Valuable Tool in Monitoring Minimal Residual Disease for Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor ling zhong"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Aziz","lastName":"Nazha","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"APersonalized Prediction Model to Risk Stratify Patients with Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor aziz nazha"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Amina ","lastName":"Abdul-Aziz ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Myeloid Leukaemia Induces p16 Driven Senescence in the Bone Marrow Microenvironment to Support Their Proliferation and Survival","keywords":"","combinedName":"doctor amina abdul-aziz"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Linus ","lastName":"Angenendt ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aldehyde Dehydrogenase 2 (ALDH2) Expression Predicts a Poor Prognosis in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor linus angenendt"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Xiufen ","lastName":"Chen ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AML1/ETO and FLT3-ITD Cooperate to Induce Acute Myeloid Leukemia in Mice","keywords":"","combinedName":"doctor xiufen chen"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Bor-Sheng ","lastName":"Ko ","credentials":"M.D., Ph.D.","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Artificial Intelligence Approach in Classifying Acute Myeloid Leukemia and Myelodysplastic Syndrome for Minimal Residual Disease Detection with Post Induction Prognosis Analysis Using Flow Cytometry","keywords":"","combinedName":"doctor bor-sheng ko"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Abdelrahman ","lastName":"Elsayed ","credentials":"BSc, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Association between Gene Expression Levels of Candidate Cytarabine Pathway and Treatment Outcome Using Publically Available Data from Target Project","keywords":"","combinedName":"doctor abdelrahman elsayed"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Yusuke ","lastName":"Hara ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biology and Prognostic Markers in Young Children with Acute Myeloid Leukemia -the Jccg Study, JPLSG AML-05-","keywords":"","combinedName":"doctor yusuke hara"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Genki ","lastName":"Yamato ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Features and Prognostic Impact of RUNX1 and PTPN11 Mutations in Pediatric Acute Myeloid Leukemia the Jccg Study, JPLSG AML-05","keywords":"","combinedName":"doctor genki yamato"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Aili ","lastName":"Chen ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Outcomes and Mutation Clearance in Children with Acute Myeloid Leukemia Treated with Low-Dose Chemotherapy Plus G-CSF for Remission Induction","keywords":"","combinedName":"doctor aili chen"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Hans Beier","lastName":"Ommen ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Progression during First Course of Chemotherapy in Acute Myeloid Leukemia Suboptimal Responders Heralds Reinduction Failure and Early Death","keywords":"","combinedName":"doctor hans beier ommen"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Orsola ","lastName":"Di Martino ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combinatorial Use of Bexarotene Plus ATRA for the Treatment of Acute Myeloid Leukemia","keywords":"","combinedName":"doctor orsola di martino"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Catherine ","lastName":"Smith ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Assessment of FLT3 Variant Allele Frequency By Capillary Electrophoresis and Next-Generation Sequencing in FLT3mut+ patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) Who Received Gilteritinib Therapy","keywords":"","combinedName":"doctor catherine smith"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Paul W","lastName":"Manley ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of the Profile of the AML Drug Midostaurin (Rydapt) As a Kinase Inhibitor with Those of Its Predominant Primary Human Metabolites","keywords":"","combinedName":"doctor paul w manley"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Samer ","lastName":"Khaled ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Concordance between Bone Marrow and Peripheral Blood Samples for Assessment of FLT3 Internal Tandem Duplication (ITD) Mutations: Data from Patients Screened for Participation in Quantum-R, a Global, Randomized, Open-Label, Phase 3 Study Examining the Effect of Quizartinib Monotherapy Vs Salvage Chemotherapy on Overall Survival in Patients with FLT3- ITD - Mutated AML Who Are Refractory to or Have Relapsed after First-Line Therapy","keywords":"","combinedName":"doctor samer khaled"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Christopher ","lastName":"Eide ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differential Ex Vivo Sensitivity Patterns to Small-Molecule Inhibitors and Combination Therapies Among Acute Myeloid Leukemia Patients Harboring Both FLT3 and NPM1 Mutations","keywords":"","combinedName":"doctor christopher eide"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Peter ","lastName":"Ruvolo ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Galectin 3 Protein Network Analysis By Reverse Protein Arrays Demonstrates Regulation of MCL-1, PKC Delta and CD74 Associated with Poor Survival in Patients with AML","keywords":"","combinedName":"doctor peter ruvolo"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Ashwini ","lastName":"Kumar ","credentials":"MRes","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gene-Drug Interactions in AML Patients Identified By RNA Sequencing and Comprehensive Ex Vivo Drug Sensitivity and Resistance Testing","keywords":"","combinedName":"doctor ashwini kumar"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Salma ","lastName":"Bargal ","credentials":"BSPharm","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genome-Wide Association Study (GWAS) Identifies SNPs in GPR56 and IGF1R Predictive of Leukemic Cell in Vitro cytarabine Sensitivity in Pediatric AML","keywords":"","combinedName":"doctor salma bargal"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Steven ","lastName":"Kornblau ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Histone Modification Patterns Using RPPA-Based Profiling Predict Outcome in Acute Myeloid Leukemia Patients","keywords":"","combinedName":"doctor steven kornblau"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Josee ","lastName":"Hebert ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HMGA2 Gene Expression Profile Improves Risk Stratification in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor josee hebert"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Fredrik B","lastName":"Thoren ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of HLA-B Dimorphism in the Leader Peptide on Clinical Outcome in AML","keywords":"","combinedName":"doctor fredrik b thoren"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Julia ","lastName":"Schueler ","credentials":"DVM, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Implantation of Patient-Derived Acute Leukemia Cells into the Hematopoietic Niche of Immunocompromised Mice Favors Faithful Recapitulation of the Disseminated Growth of Human Leukemia","keywords":"","combinedName":"doctor julia schueler"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Alexander ","lastName":"Hllein ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Depth Molecular Characterization of AML with RUNX1-RUNX1T1 at Diagnosis and Relapse","keywords":"","combinedName":"doctor alexander hllein"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Deepak ","lastName":"Sahasrabudhe ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IQGAP1: A Potential Therapeutic Target in Acute Myelogenous Leukemia (AML)","keywords":"","combinedName":"doctor deepak sahasrabudhe"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Rita ","lastName":"Assi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"JAK3Variants in Adults with Myeloid Malignancies and Potential for Response to JAK3 Inhibition","keywords":"","combinedName":"doctor rita assi"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Thomas ","lastName":"Ollila ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Marrow Hypocellularity, but Not Residual Blast Count, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor thomas ollila"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Andrzej ","lastName":"Lange ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1 Gene Prevailed inFlt3-ITD Negative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease","keywords":"","combinedName":"doctor andrzej lange"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Di ","lastName":"Zhou ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MiR-181a Down-Regulates PARP1 By Enhancing Its Acetylation in MLL-Rearranged AML","keywords":"","combinedName":"doctor di zhou"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Krzysztof","lastName":"Mrzek","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Landscape and Clinical Features of Acute Myeloid Leukemia (AML) with Complex Karyotype (CK)","keywords":"","combinedName":"doctor krzysztof mrzek"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Chetasi ","lastName":"Talati ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Negative Impact of FLT3-ITD Mutation in Elderly Acute Myeloid Leukemia Patients (Age =70) Is Karyotype Dependent","keywords":"","combinedName":"doctor chetasi talati"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Francis ","lastName":"Lacombe ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Concepts of Flow Cytometry Analysis in Oncohematology: Application to Diagnosis and Follow up (Minimal Residual Disease) in AML, ALL and MDS","keywords":"","combinedName":"doctor francis lacombe"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Alexander ","lastName":"Hllein ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NPM1 Mutated AML Can Relapse with Wildtype NPM1 and Evolve with Novel Mutations: Implications for Pathobiology and MRD Monitoring","keywords":"","combinedName":"doctor alexander hllein"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Eric ","lastName":"Konnick ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcome of Acute Myeloid Leukemia Patients with Abnormal 12p after Allogeneic Hematopoietic Cell Transplantation at Fred Hutchinson Cancer Research Center","keywords":"","combinedName":"doctor eric konnick"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Chetasi ","lastName":"Talati ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes in Older Adults (age = 70) with Acute Myeloid Leukemia Based on Choice of Frontline Treatment for Proliferative or Non-Proliferative Phenotype","keywords":"","combinedName":"doctor chetasi talati"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Aziz","lastName":"Nazha","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patterns of Genomic Associations Can Define Acute Myeloid Leukemia (AML) Phenotype","keywords":"","combinedName":"doctor aziz nazha"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Sousuke ","lastName":"Nakamura ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Personalized Circulating Tumor DNA Dynamically Predicts Response and/or Relapse in Hematological Malignancies","keywords":"","combinedName":"doctor sousuke nakamura"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Frauke ","lastName":"Theis ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacodynamic Monitoring of Targeted Therapy with MidostaurinBy Plasma Inhibitor Activity (PIA) Analysis in FLT3-ITD Positive AML Patients Enrolled in the AMLSG16-10 Trial: A Study of the AML Study Group (AMLSG)","keywords":"","combinedName":"doctor frauke theis"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Wenbin ","lastName":"Xiao ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PHF6 Mutations Defines a Subgroup of Mixed Phenotype of Acute Leukemia with Aberrant T-Cell Differentiation","keywords":"","combinedName":"doctor wenbin xiao"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Winnie ZY","lastName":"Teo ","credentials":"MRCP, MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Presence of Post Induction Minimal Residual Disease (MRD) Is an Independent Predictor for Relapse and Is Associated with Inferior Survival in Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor winnie zy teo"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Prajwal ","lastName":"Boddu ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Implications of Minimal Residual Disease Detection in Acute Myeloid Leukemia (AML) with Cytarabine Based Therapy of Differing Dose Intensities","keywords":"","combinedName":"doctor prajwal boddu"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Dimitrios","lastName":"Papaioannou","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recurrent Genetic Variants of Long Non-Coding RNAs (lncRNAs) Independently Associate with Clinical Outcome of Younger Adults with Cytogenetically Normal Acute Myeloid Leukemia","keywords":"","combinedName":"doctor dimitrios papaioannou"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Norio ","lastName":"Shiba ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNA Sequencing Illustrates the Genetic Backgrounds of Pediatric Acute Myeloid Leukemia","keywords":"","combinedName":"doctor norio shiba"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Chiu ","lastName":"Po-Ju ","credentials":"M.D.","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Clinical and Biological Implications of Aberrant Alternative Splicing in Patients with De Novo, Non-M3 Acute Myeloid Leukemia","keywords":"","combinedName":"doctor chiu po-ju"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Frederic ","lastName":"Baron ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Cytogenetic Clonality on Outcomes in Younger Acute Myeloid Leukemia Patients: Results on 1290 Patients Included in the EORTC/Gimema AML-10 and AML-12 Trials","keywords":"","combinedName":"doctor frederic baron"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Gabriel ","lastName":"Mannis ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of Comprehensive Mutational Profiling in Predicting Patients Who May Benefit from Autologous Hematopoietic Cell Transplant for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor gabriel mannis"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Martin ","lastName":"Schnlein ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapy-Induced Senescence Is a Predictor of Treatment Outcome in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor martin schnlein"},{"sessionId":"11656","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Umut ","lastName":"Aypar ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whole-Genome Mate Pair Sequencing Transforms Cytogenetic Analysis of Hematologic Malignancies: Development of a Targeted Panel to Detect Diagnostic/Prognostic Chromosomal Rearrangements and Copy Number Changes in AML","keywords":"","combinedName":"doctor umut aypar"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Maliha ","lastName":"Khan ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cathepsin G Is Expressed By B Cell Acute Lymphoblastic Leukemia and Is an Effective Immunotherapeutic Target","keywords":"","combinedName":"doctor maliha khan"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Leylah ","lastName":"Drusbosky ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Computational Biology Model of ETP-ALL Used to Accurately Classify ETP-ALL Vs Non ETP-ALL Patients with Genomic Input","keywords":"","combinedName":"doctor leylah drusbosky"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Parth ","lastName":"Sitlani ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development and Validation of an Rnaseq NGS Assay to Comprehensively Detect Clinically Relevant ALL Gene Fusions ","keywords":"","combinedName":"doctor parth sitlani"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Musa ","lastName":"Yilmaz ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dynamics of Measurable Disease at Remission Determines Survival in Patients (pts) with Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia (ALL)","keywords":"","combinedName":"doctor musa yilmaz"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Nitin ","lastName":"Jain ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"GATA3 rs3824662A Allele Is Overrepresented in Adult Patients with Ph-like ALL, Especially in Patients with CRLF2 Abnormalities","keywords":"","combinedName":"doctor nitin jain"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Renate ","lastName":"De Smedt ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Activation and Therapeutic Targeting of PIM1 in T-Cell Acute Lymphoblastic Leukemia/Lymphoma","keywords":"","combinedName":"doctor renate de smedt"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Li ","lastName":"Fei ","credentials":"PhD, MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Heterogeneous BCR-ABL Signal Patterns Identified By Fluorescence in Situ Hybridization Can Predict Leukemic Clonal Evolution and Poor Prognosis in BCR-ABL-Positive Leukemia","keywords":"","combinedName":"doctor li fei"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Dino ","lastName":"Maic ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Label-Free Analyses of Minimal Residual Disease in ALL Using Deep Learning and Imaging Flow Cytometry","keywords":"","combinedName":"doctor dino maic"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"David ","lastName":"Cordas dos Santos ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MAP3K7 Is Recurrently Deleted in Pediatric T-Lymphoblastic Leukemia and Affects Cell Proliferation Independently of NF-?B","keywords":"","combinedName":"doctor david cordas dos santos"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Malgorzata ","lastName":"Dawidowska ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"miRNA Profiling in Pediatric T-ALL with Use of Next-Generation Sequencing: Focus on T-ALL Pathobiology and Heterogeneity","keywords":"","combinedName":"doctor malgorzata dawidowska"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Madeleine ","lastName":"Turcotte ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Personalized Therapy Design for Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Using Computational Biology Modeling with in Vitro Validation","keywords":"","combinedName":"doctor madeleine turcotte"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Musa ","lastName":"Yilmaz ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Index for Survival in Adult Patients with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia (ALL)","keywords":"","combinedName":"doctor musa yilmaz"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Aleksandr","lastName":"Lazaryan","credentials":"MD, PhD, MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Significance of Cytogenetic Abnormalities in Patients with Philadelphia-Negative ALL Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission: A CIBMTR Analysis","keywords":"","combinedName":"doctor aleksandr lazaryan"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Bronislawa ","lastName":"Szarzynska-Zawadzka ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PTEN Alterations Are Related to Unfavorable Prognosis in Children with T-Cell Acute Lymphoblastic Leukemia Treated According to ALL IC-BFM Protocols","keywords":"","combinedName":"doctor bronislawa szarzynska-zawadzka"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Esperanza ","lastName":"Such ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rapid Screening of Targetable Kinase Gene Fusions in Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor esperanza such"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Zhengshan ","lastName":"Chen ","credentials":"MD-PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Stat5 Feedback Control Switches MYC- and BCL6-Dependent Cell Fates in Normal and Transformed B Cells","keywords":"","combinedName":"doctor zhengshan chen"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Shunsuke ","lastName":"Kimura ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Epigenetic and Genetic Landscapes of Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)","keywords":"","combinedName":"doctor shunsuke kimura"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Ute ","lastName":"Fischer ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Landscape of Circular RNAs in Drug Resistant TCF3-Rearranged Childhood Leukemia","keywords":"","combinedName":"doctor ute fischer"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Minjun ","lastName":"Yang ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Proteogenomic Landscape of High Hyperdiploid and ETV6/RUNX1-Positive Childhood Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor minjun yang"},{"sessionId":"11657","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I","firstName":"Ibrahim ","lastName":"Aldoss ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapy-Related ALL Has Distinct Clinical and Pathologic Features Compared to De Novo ALL","keywords":"","combinedName":"doctor ibrahim aldoss"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Kerstin ","lastName":"Wenzl ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Beyond MYD88: Implications of TNFAIP3 Loss on MYD88 Driven Lymphomas","keywords":"","combinedName":"doctor kerstin wenzl"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Chloe Beate","lastName":"Steen ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Clinical and Gene Expression Score Identifies Follicular Lymphoma Patients with High Risk of Transformation in the Rituximab Era","keywords":"","combinedName":"doctor chloe beate steen"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Caroline ","lastName":"Besson ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Common Genetic Polymorphisms Contribute to the Association between Non-Melanoma Skin Cancer and Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor caroline besson"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Alexander ","lastName":"Hllein ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deletion 7q Is Associated with KLF2 and NOTCH2 Mutations and Is Strongly Correlated with Splenic Marginal Zone Lymphoma but Also Found in Lymphoplasmacytic Lymphoma and Hairy Cell Leukemia Variant","keywords":"","combinedName":"doctor alexander hllein"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Akihiro ","lastName":"Tomita ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Detection of Recurrent Genetic Mutations in Intravascular Large B-Cell Lymphoma By Comprehensive Genetic Analyses Using Peripheral Blood Circulating Cell-Free DNA","keywords":"","combinedName":"doctor akihiro tomita"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Csaba ","lastName":"Bdr ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dissection of Clonal Evolution By Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib","keywords":"","combinedName":"doctor csaba bdr"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Rebecca ","lastName":"Boddicker ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"DUSP22 Rearrangements Identify a Molecularly Distinct Type of Anaplastic Large Cell Lymphoma Characterized By DNA Hypomethylation and Lack of Activated STAT3","keywords":"","combinedName":"doctor rebecca boddicker"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Margaretha ","lastName":"Roemer ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Expression of Major Histocompatibility Complex (MHC) Class II, but Not MHC Class I, Predicts Outcome in Patients with Classical Hodgkin Lymphoma (cHL) Treated with Nivolumab (Programmed Death-1 [PD-1] Blockade)","keywords":"","combinedName":"doctor margaretha roemer"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Hui ","lastName":"Guo ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FoxM1: A New Therapeutic Target for Mantle Cell Lymphoma","keywords":"","combinedName":"doctor hui guo"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Yusuke ","lastName":"Okuno ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Background of Chronic Active EpsteinBarr Virus Disease","keywords":"","combinedName":"doctor yusuke okuno"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Erel ","lastName":"Joffe ","credentials":"MD,MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Characteristics Clinical Phenotype and Disease Course of TP53 Mutated Diffuse Large B Cell Lymphoma at Diagnosis and Relapse","keywords":"","combinedName":"doctor erel joffe"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Xiaolong Alan","lastName":"Zhou ","credentials":"MD, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Landscape of Primary Cutaneous Diffuse Large B Cell Lymphoma, Leg Type","keywords":"","combinedName":"doctor xiaolong alan zhou"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Aharon ","lastName":"Freud ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Malignant NK Cells from EBV(+) Human Extranodal NK/T Cell Lymphoma Exhibit Features of a Distinct NK Cell Developmental Subset Found in Mucosal Associated Lymphoid Tissue","keywords":"","combinedName":"doctor aharon freud"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Nickolas ","lastName":"Tsakmaklis ","credentials":"BA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutated MYD88 Homozygosity Is Increased in Previously Treated Patients with Waldenstroms Macroglobulinemia, and Associates with CXCR4 Mutation Status and Ibrutinib Exposure","keywords":"","combinedName":"doctor nickolas tsakmaklis"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Joo ","lastName":"Song ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutation Spectrum of Transformed Nodular Lymphocyte Predominant Hodgkin Lymphoma and Comparison with De Novo Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor joo song"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Urvi A","lastName":"Shah ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"North American Adult T Cell Leukemia Lymphoma (ATLL) Is Characterized By Distinct, Therapeutically Targetable Mutations in Epigenetic Modifiers","keywords":"","combinedName":"doctor urvi a shah"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Takeshi ","lastName":"Sugio ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Subtypes Based on Microenvironment Immune Signature Provides Prognostic Stratification and Therapeutic Strategy in Peripheral T-Cell Lymphoma","keywords":"","combinedName":"doctor takeshi sugio"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Christiane ","lastName":"Querfeld ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PD-L1 Is Regulated By Interferon Gamma and Interleukin 6 through STAT1 and STAT3 Signaling in Cutaneous T-Cell Lymphoma ","keywords":"","combinedName":"doctor christiane querfeld"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Joanne ","lastName":"Soo ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reproducibility of m7-FLIPI Risk Scores in Follicular Lymphoma Using Tumor Biopsies and Blood Specimens","keywords":"","combinedName":"doctor joanne soo"},{"sessionId":"11658","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster I","firstName":"Yalu ","lastName":"Liu ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Intracellular TCR Signaling Pathway As a Novel Therapeutic Target in AITL Patients","keywords":"","combinedName":"doctor yalu liu"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Aladin ","lastName":"Samara ","credentials":"BSc, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deferasirox Induces Apoptosis in Mantle Cell Lymphoma in a Mechanism Involving Cyclin-D1, p53 and the Ribonucleotide Reductase","keywords":"","combinedName":"doctor aladin samara"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Hiroto ","lastName":"Horiguchi ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deletion of Rhoh Accelerates Development of Diffuse Large B Cell Lymphoma in Bcl-6 Transgenic Mouse Model","keywords":"","combinedName":"doctor hiroto horiguchi"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Ioanna ","lastName":"Xagoraris ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Downregulation of the Tumor Suppressor SAMHD1 in Classical Hodgkin Lymphoma","keywords":"","combinedName":"doctor ioanna xagoraris"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Ravi ","lastName":"Dashnamoorthy ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Harnessing Microfluidic Single Cell (MF-SC) and 3D Organ-on-Chip Assay Technologies for the Investigation of Immunotherapy and Study of Tumor Microenvironment (TME) in Antibody-Resistant Non-Hodgkin Lymphoma (NHL)","keywords":"","combinedName":"doctor ravi dashnamoorthy"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Poonam ","lastName":"Nagpal ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Expression of FGF2/SDC1 Signaling Contributes to Poor Clinical Outcome in Hodgkin Lymphoma Patients and SDC1 siRNA Suppresses Proliferation, Migration, and Invasion in Hodgkin Lymphoma Cells","keywords":"","combinedName":"doctor poonam nagpal"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Corrado ","lastName":"Tarella ","credentials":"MD, Prof","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low Circulating B Lymphocytes in Newly Diagnosed Follicular and Diffuse Large B Cell Lymphoma: Differences Compared to Normal Subjects and Possible Prognostic Role","keywords":"","combinedName":"doctor corrado tarella"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Kohta ","lastName":"Miyawaki ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lymphoma Microenvironment Signature Predicts Clinical Outcomes in Diffuse Large B-Cell Lymphoma Patients","keywords":"","combinedName":"doctor kohta miyawaki"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Binbin ","lastName":"Chen ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Maria: Accurate Prediction of MHC-II Peptide Presentation with Deep-Learning and Lymphoma Patient MHC-II Ligandome","keywords":"","combinedName":"doctor binbin chen"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Jon ","lastName":"Aster ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Microenvironment-Specific Activation of Notch2 in Splenic Marginal Zone Lymphoma","keywords":"","combinedName":"doctor jon aster"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"George ","lastName":"Rassidakis ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PD-L1 Expression and Gene Amplification in CD30+ Diffuse Large B-Cell Lymphoma (DLBCL): Significance of TP53 Genetic Impact and Clinicopathologic Characteristics","keywords":"","combinedName":"doctor george rassidakis"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Imran ","lastName":"Siddiqi ","credentials":"MD PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Precision in PD-L1 Assessment in Diffuse Large B Cell Lymphoma: Greater Biological Insight Using in Situ Hybridization Approach","keywords":"","combinedName":"doctor imran siddiqi"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Mette ","lastName":"Pedersen ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Stratification By MYC Protein Expression Level Improves the Prognostic Impact of MYC Translocation in Patients with Large B-Cell Lymphoma","keywords":"","combinedName":"doctor mette  pedersen"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Mamta ","lastName":"Gupta ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Bromodomain and External Domain Epigenetic Reader Protein As Effective Strategy for Double-Hit and Triple-Hit B-Cell Lymphoma","keywords":"","combinedName":"doctor mamta gupta"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Carolyne ","lastName":"Falank ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Burkitt's Lymphoma Using Novel, Discrete Carbon Nanotubes","keywords":"","combinedName":"doctor carolyne falank"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Julie ","lastName":"Devin ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting DNA Repair Mechanisms to Overcome Drug Resistance in Diffuse Large B Cell Lymphoma","keywords":"","combinedName":"doctor julie devin"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Claudia M","lastName":"Wever ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Understanding Apoptotic Blocks in Double Hit and Other Non-Hodgkin Lymphomas By BH3 Profiling","keywords":"","combinedName":"doctor claudia m wever"},{"sessionId":"11659","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster I","firstName":"Kyle ","lastName":"Runckel ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"XIAP Knockdown Can Increase the Activity of Caspase 3 and 7, and Restore the Apoptotic Response in Cell Line Models of Rituximab Relapse/Refractory B-Cell Lymphoma","keywords":"","combinedName":"doctor kyle runckel"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Jorge ","lastName":"Castillo ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bendamustine and Bortezomib-Containing Regimens Produce Higher Response Rates and More Durable Responses Versus Cyclophosphamide-Based Therapy in Frontline Waldenstrom Macroglobulinemia","keywords":"","combinedName":"doctor jorge castillo"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Won Seog ","lastName":"Kim ","credentials":"M.D., Ph. D.","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Factors Impact on Pharmacokinetics of CT-P10 and Reference Rituximab in Patients with Advanced-Stage Follicular Lymphoma","keywords":"","combinedName":"doctor won seog kim"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Irl Brian","lastName":"Greenwell ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Complex Karyotype Predicts the Prognostics Impact of WBC Count in Untreated Mantle Cell Lymphoma and Is Associated with Shortened Survival Independent of Specific Cytogenetic Abnormalities","keywords":"","combinedName":"doctor irl brian greenwell"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Aino ","lastName":"Launonen ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Disease Progression Predicts Poorer Survival in Patients with Follicular Lymphoma (FL)in the GALLIUM Study","keywords":"","combinedName":"doctor aino launonen"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Kathryn ","lastName":"Kolibaba ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Ofatumumab and Bendamustine Followed By Ofatumumab Maintenance in Patients with Relapsed Indolent Non-Hodgkins Lymphoma after Prior Rituximab","keywords":"","combinedName":"doctor kathryn kolibaba"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Min ","lastName":"Fang ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Alterations Important for the Prognosis in Patients with Follicular Lymphoma Treated on SWOG Study S0016","keywords":"","combinedName":"doctor min fang"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Anastasios ","lastName":"Stathis ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IELSG-38: A Phase II Study of Chlorambucil in Combination with Rituximab Followed By Maintenance Therapy with Subcutaneous Rituximab in Patients with Extranodal Marginal Zone B-Cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT)","keywords":"","combinedName":"doctor anastasios stathis"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Anna ","lastName":"Alperovich ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of PET Staging of Follicular Lymphoma on Treatment Outcomes and Prognosis","keywords":"","combinedName":"doctor anna alperovich"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Sarah ","lastName":"Caulfield ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Initial Salvage Approaches for Relapsed/Refractory Mantle Cell Lymphoma Have Comparable Response Rates, Progression-Free and Overall Survival","keywords":"","combinedName":"doctor sarah caulfield"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Elise ","lastName":"Chong ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Outcomes of Lenalidomide and Rituximabin Rituximab-Resistant Patients with Indolent B Cell and Mantle Cell Lymphomas","keywords":"","combinedName":"doctor elise chong"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Ahmad ","lastName":"Halwani ","credentials":"MD ","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Maintenance Rituximab after First Line Treatment in Veterans with Follicular Lymphoma Is Associated with Prolonged Overall Survival","keywords":"","combinedName":"doctor ahmad halwani"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Adi ","lastName":"Klil-Drori ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Metformin and the Incidence of Lymphoid Malignancies in Patients with Type 2 Diabetes","keywords":"","combinedName":"doctor adi klil-drori"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"David A","lastName":"Bond ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Patients with Primary Refractory Mantle Cell Lymphoma, a Single Center Retrospective Study","keywords":"","combinedName":"doctor david a bond"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Danielle ","lastName":"Canioni ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Value of P53 and Myc Protein Expression in Follicular Lymphomas in the PRIMA Trial in the Lysa Group","keywords":"","combinedName":"doctor danielle canioni"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Jorge ","lastName":"Castillo ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prospective Phase II Study of Ixazomib, Dexamethasone and Rituximab in Previously Untreated Patients with Waldenstrm Macroglobulinemia","keywords":"","combinedName":"doctor jorge castillo"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Steven ","lastName":"Le Gouill ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"R-DHA-Oxaliplatin before Autologous Stem Cell Transplantation Prolongs PFS and OS As Compared to R-DHA-Carboplatin and R-DHA-Cisplatin in Patients with Mantle Cell Lymphoma, a Subgroup Analysis of the LyMa Trial","keywords":"","combinedName":"doctor steven le gouill"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Irene ","lastName":"Defrancesco ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real Life Data on Clinical Aspects and Treatment of Marginal Zone Lymphoma: An Analysis from the NF10 Project, an International, Prospective, Observational Study of the Fondazione Italiana Linfomi","keywords":"","combinedName":"doctor irene defrancesco"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Ale ","lastName":"Obr ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rituximab Maintenance Failure in Mantle Cell Lymphoma Is Associated with High Risk of Death: Analysis of the Czech Lymphoma Study Group (CLSG)","keywords":"","combinedName":"doctor ale obr"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Max ","lastName":"Topp ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Preliminary Antitumor Activity of the Anti-PD-1 Monoclonal Antibody REGN2810 Alone or in Combination with REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with B-Lymphoid Malignancies","keywords":"","combinedName":"doctor max topp"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Christiane ","lastName":"Pott ","credentials":"M.D., Ph.D.","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Standardized IGH-Based Next-Generation Sequencing for MRD Detection in Follicular Lymphoma","keywords":"","combinedName":"doctor christiane pott"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Max ","lastName":"Goldman ","credentials":"BA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Surveillance Imaging during First-Remission in Follicular Lymphoma Does Not Impact Overall Survival","keywords":"","combinedName":"doctor max goldman"},{"sessionId":"11660","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster I","firstName":"Ibrahim ","lastName":"Tohidi-Esfahani ","credentials":"B Med","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whimsical (Waldenstrms Macroglobulinemia Study Involving CArt-wheeL): Empowering Patients Internationally to Contribute Patient-Derived Data for Observational Research","keywords":"","combinedName":"doctor ibrahim tohidi-esfahani"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Anne ","lastName":"Kerber ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 1 Study Investigating the Combination of AFM13 and the Monoclonal Anti-PD-1 Antibody Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymphoma after Brentuximab Vedotin Failure: Data from the Dose Escalation Part of the Study","keywords":"","combinedName":"doctor anne kerber"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Lorenzo ","lastName":"Falchi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 1/2 Study of Oral 5-Azacitidine and Romidepsin in Patients with Lymphoid Malignancies Reveals Promising Activity in Heavily Pretreated Peripheral T-Cell Lymphoma (PTCL)","keywords":"","combinedName":"doctor lorenzo falchi"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Jacqueline ","lastName":"Poston ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Pilot Study of Weekly Brentuximab Vedotin in Patients with CD30+ Malignancies Resistant to Every 3 Week Brentuximab Vedotin","keywords":"","combinedName":"doctor jacqueline poston"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Liliya ","lastName":"Gorenkova ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Single Institutional Experience of 49 Patients with Large Granular Lymphocytic Leukemia: Clinical and Immunophenotypic Characteristics and the Significance of Immune Therapy","keywords":"","combinedName":"doctor liliya gorenkova"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Radhakrishnan ","lastName":"Ramchandren ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"APhase II Multicenter Single Arm Study of Ibrutinib in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma","keywords":"","combinedName":"doctor radhakrishnan ramchandren"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Simonetta ","lastName":"Viviani ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Reduction of Serum TARC Levels Predicts Prognosis of Patients Treated with a PET-Adapted Strategy for Advanced Stage Hodgkin Lymphoma (HL) in the GITIL/FIL HD0607 Trial","keywords":"","combinedName":"doctor simonetta viviani"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"M S","lastName":"Rauf ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FDG-PET Utilizing Deauville Scoring Is Superior to Conventional Imaging for Staging and Response Assessment in Pediatric and Adult Patients with Nodular Lymphocyte Predominant Hodgkins Lymphoma","keywords":"","combinedName":"doctor m s rauf"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Reinhard ","lastName":"Marks ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Throughput T Cell Receptor Sequencing Augments Diagnosis and Response Assessment in Patients with Angioimmunoblastic T Cell Lymphoma","keywords":"","combinedName":"doctor reinhard marks"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Antoine ","lastName":"Machet ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hodgkin Lymphoma and Female Fertility: A Multicenter Study of Fertility in Women Treated with Doxorubicin, Bleomycin, Vinblastine and Dacarbazine","keywords":"","combinedName":"doctor antoine machet"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Motoko ","lastName":"Yamaguchi ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improved Prognosis of Extranodal NK/T-Cell Lymphoma, Nasal Type (ENKL) of Nasal Origin but Not Extranasal Origin: An Analysis of NKEA Study","keywords":"","combinedName":"doctor motoko yamaguchi"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Steven ","lastName":"Horwitz ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim Results from a Phase 1 Study of Adct-301 (Camidanlumab Tesirine) Show Promising Activity of a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate in Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma","keywords":"","combinedName":"doctor steven horwitz"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Johanne Marie ","lastName":"Holst ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lympho- and Myeloproliferative Malignancies Occurring in the Same Host: Description of a Nationwide Discovery Cohort","keywords":"","combinedName":"doctor johanne marie holst"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Mariko ","lastName":"Yabe ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Measurement of PD-1 Expression on Lymphoma Cells By Flow Cytometry Is a Useful Tool in Diagnosing and Monitoring Minimal Residual Disease in Angioimmunoblastic T-Cell Lymphoma","keywords":"","combinedName":"doctor mariko yabe"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Francine M","lastName":"Foss ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcome of Patients with Gamma Delta T Cell Lymphomas: Analysis of 1429 Cases Registered in the Prospective T-Cell Project","keywords":"","combinedName":"doctor francine m foss"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"James Anton","lastName":"Kuzich ","credentials":"MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Factors and the Impact of Frontline Therapy in Peripheral T-Cell Lymphoma: A Multicenter Australian Study","keywords":"","combinedName":"doctor james anton kuzich"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Nataliia ","lastName":"Mikhailova ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Regaining the Tumor Control in Relapsed/Refractory Hodgkin Lymphoma after Nivolumab Failure with Addition of Another Antineoplastic Agent","keywords":"","combinedName":"doctor nataliia mikhailova"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Upama ","lastName":"Giri ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Second Primary Malignancies and Cardiovascular Mortality in Hodgkin disease Survivors  a Surveillance, Epidemiology, and End Results Registry Database Study","keywords":"","combinedName":"doctor upama giri"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"David ","lastName":"Sibon ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Systemic ALK-Positive Anaplastic Large-Cell Lymphoma (ALCL): Final Analysis of an International, Individual Patient Data Study of 263 Adults","keywords":"","combinedName":"doctor david sibon"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Go-Un ","lastName":"Woo ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of FDG PET for Evaluation of Bone Marrow Status and Prognosis in T Cell Lymphomas","keywords":"","combinedName":"doctor go-un woo"},{"sessionId":"11661","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster I","firstName":"Steven ","lastName":"Horwitz ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Updated Analyses of the International, Open-Label, Randomized, Phase 3 Alcanza Study: Longer-Term Evidence for Superiority of Brentuximab Vedotin Versus Methotrexate or Bexarotene for CD30-Positive Cutaneous T-Cell Lymphoma (CTCL)","keywords":"","combinedName":"doctor steven horwitz"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Matthew ","lastName":"Frank ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Antibody-Cell Conjugation Method to Enhance Cellular Therapies for the Treatment of Hematological Malignancies","keywords":"","combinedName":"doctor matthew frank"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Asfar Sohail","lastName":"Azmi ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bruton Tyrosine Kinase Inhibition in Classical Hodgkin Lymphoma Cell Lines and Animal Models","keywords":"","combinedName":"doctor asfar sohail azmi"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Robert ","lastName":"Booher ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combination of IRAK4 Inhibitor CA-4948 with BCL2 Inhibitor Venetoclax Induces Tumor Regression in an ABC-DLBCL Xenograft Model","keywords":"","combinedName":"doctor robert booher"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Hsiling ","lastName":"Chiu ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combination of Lenalidomide and Rituximab (R2) Targets Immune Dysfunction in FL By Activating T and NK CellsEx Vivoand Is Differentiated from Chemotherapy","keywords":"","combinedName":"doctor hsiling chiu"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Peipei ","lastName":"Xu ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Doxorubicin-Loaded Platelets Conjugated with Anti-CD22 Mabs: A Novel Targeted Delivery System for B-Cell Lymphoma Treatment with Cardiac Avoidance","keywords":"","combinedName":"doctor peipei xu"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Ryutaro ","lastName":"Kotaki ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ibrutinib As a Possible Therapeutic Strategy for Epstein-Barr Virus-Positive Lymphoma/Leukemia","keywords":"","combinedName":"doctor ryutaro kotaki"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Aradhana ","lastName":"Tiwari ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Polatuzumab Vedotin Alone or in Combination with Obinutuzumab Synergistically Enhances in-Vitro Cytotoxicity and Cytokine Release Against CD20+/ CD79b+ Burkitt Lymphoma (BL) /Primary Mediastinal Large B Cell Lymphoma (PMBL)","keywords":"","combinedName":"doctor aradhana tiwari"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Cory ","lastName":"Mavis ","credentials":"BSc, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Clinical Development of Targeted Therapies for Double Hit (DH) Diffuse Large B-Cell Lymphoma (DLBCL)","keywords":"","combinedName":"doctor cory mavis"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Peggy A","lastName":"Thompson ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preclinical Evaluation of eFT226, a Novel, Potent and Selective eIF4A Inhibitor with Anti-Tumor Activity in B-Cell Malignancies","keywords":"","combinedName":"doctor peggy a thompson"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Scott R","lastName":"Best ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TAK-243, a Small Molecule Inhibitor of Ubiquitin-Activating Enzyme (UAE), Induces ER Stress and Apoptosis in Diffuse Large B-Cell Lymphoma (DLBCL) Cells","keywords":"","combinedName":"doctor scott r best"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Aneel ","lastName":"Paulus ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting CD38 with Daratumumab Suppresses B-Cell Receptor Signaling and Enhances the Activity of Ibrutinib in Waldenstrom Macroglobulinemia Cells","keywords":"","combinedName":"doctor aneel paulus"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Shalin ","lastName":"Kothari ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Mcl-1 By Proteasome Inhibitors Enhances the Anti-Tumor Activity of Venetoclax in Mantle Cell Lymphoma Pre-Clinical Models","keywords":"","combinedName":"doctor shalin kothari"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Jonathan A","lastName":"Pachter ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Dual PI3K-d,? Inhibitor Duvelisib Stimulates Anti-Tumor Immunity and Enhances Efficacy of Immune Checkpoint and Co-Stimulatory Antibodies in a B Cell Lymphoma Model","keywords":"","combinedName":"doctor jonathan a pachter"},{"sessionId":"11662","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster I","firstName":"Ryo ","lastName":"Koike ","credentials":"DDS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Humanized EBV-LPD Recaptilates Human Non GC DLBCL","keywords":"","combinedName":"doctor ryo koike"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Jonathan E","lastName":"Brammer ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Multicenter Phase I Dose-Finding and Preliminary Efficacy Study of the Histone Deacetylase Inhibitor Romidepsin in Combination with Pegylated Liposomal Doxorubicin for the Treatment of Adults with Relapsed or Refractory Cutaneous and Peripheral T-Cell Lymphomas","keywords":"","combinedName":"doctor jonathan e brammer"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Daniel","lastName":"Persky","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Intergroup Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL): SWOG Study S1001 (NCT01359592)","keywords":"","combinedName":"doctor daniel persky"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Myrna ","lastName":"Candelaria ","credentials":"MD,PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Randomized, Double-Blind, Phase III Study Comparing Proposed Biosimilar Rituximab (RTXM83) Versus Reference Rituximab, Both in Combination with CHOP, in the First Line Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)","keywords":"","combinedName":"doctor myrna candelaria"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Vincent ","lastName":"Ribbag ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CC-122 DLBCL-001: Phase Ib Study of CC-122 Plus Rituximab in Patients with Chemo-Refractory Diffuse Large B-Cell Lymphoma (DLBCL)","keywords":"","combinedName":"doctor vincent ribbag"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Ling ","lastName":"Li ","credentials":"MSPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Novel Targeted Drug Apatinib in Relapse or Refractory Non-Hodgkin Lymphoma: An Open Label, Single-Armed, Exploratory Study","keywords":"","combinedName":"doctor ling li"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Michael ","lastName":"Pfreundschuh ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Excellent Outcome of Elderly Patients with Favourable-Prognosis DLBCL Treated with 4 Cycles CHOP/Chlip-14 Plus 8 Applications of Rituximab and a PET-Based Intensification Strategy That Includes Involved-Site Radiotherapy (IS-RT): Results of the First 120 Patients of the OPTIMAL>60 Trial of the Dshnhl","keywords":"","combinedName":"doctor michael pfreundschuh"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Eva ","lastName":"Gonzalez-Barca ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Follow-up of a Prospective Phase II Trial of Extended Treatment with Rituximab in Patients with B-Cell Post-Transplant Lymphoproliferative Disease and Comparison with a Cohort of Patients Treated in Real Life. Analysis on Behalf of the Spanish Lymphoma Group (GELTAMO)","keywords":"","combinedName":"doctor eva gonzalez-barca"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Daniel ","lastName":"Landsburg ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Objective Responses Achieved in Patients with MYC-Altered Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with the Dual PI3K and HDAC Inhibitor CUDC-907","keywords":"","combinedName":"doctor daniel landsburg"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Jason ","lastName":"Kaplan ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 1 Study of TAK-659, an Investigational Reversible Dual SYK/FLT-3 Inhibitor, in Patients (Pts) with Lymphoma: Updated Results from Dose-Escalation and Expansion Cohorts","keywords":"","combinedName":"doctor jason kaplan"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Frederick ","lastName":"Locke","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Results of Prophylactic Tocilizumab after Axicabtageneciloleucel (axi-cel; KTE-C19) Treatment for Patients with Refractory,Aggressive Non-Hodgkin Lymphoma (NHL)","keywords":"","combinedName":"doctor frederick locke"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"David ","lastName":"Maloney","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Safety Profile of the CD19-Directed Defined Composition CAR T Cell Product JCAR017 in Relapsed/Refractory Aggressive B-NHL Patients: Potential for Outpatient Administration","keywords":"","combinedName":"doctor david maloney"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Seo-Yeon ","lastName":"Ahn ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Significance of Interim 11c-Methionine PET for the Treatment of Primary Central Nervous System Lymphoma (PCNSL)","keywords":"","combinedName":"doctor seo-yeon ahn"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Rajat","lastName":"Bannerji","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Preliminary Clinical Activity of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with B-NHL Previously Treated with CD20-Directed Antibody Therapy","keywords":"","combinedName":"doctor rajat bannerji"},{"sessionId":"11663","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster I","firstName":"Mikkel ","lastName":"Oestergaard ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Superiority of Obinutuzumab over Rituximab in a New Molecular Follicular Lymphoma-like Subgroup of DLBCL: Results from an Exploratory Analysis of the Phase 3 GOYA Trial","keywords":"","combinedName":"doctor mikkel oestergaard"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Mitchell ","lastName":"Hughes ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" Clinical Outcomes of Anti PD-1 Immunotherapy in Patients with Relapsed/Refractory Non Hodgkin Lymphomas ","keywords":"","combinedName":"doctor mitchell hughes"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Caglar ","lastName":"Caglayan ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Multi-State Model for Senior Patients with Diffuse Large B Cell Lymphoma","keywords":"","combinedName":"doctor caglar caglayan"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Raffaella ","lastName":"Marcheselli ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Absolute Monocyte Count at Diagnosis Could Improve the Prognostic Role of Final FDG-PET in Diffuse Large B Cell Lymphoma Patients","keywords":"","combinedName":"doctor raffaella marcheselli"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Eric ","lastName":"Vick ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Age-Related Chromosomal Aberrations in Patients with Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor eric vick"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Luisa ","lastName":"Verga ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Central Nervous System Relapse in HIV Positive Patients Affected By Diffuse Large B Cell Lymphoma. Is the CNS-IPI Score Useful in This Population?","keywords":"","combinedName":"doctor luisa verga"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Sharon ","lastName":"Ben Barouch ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics, Management and Outcome of DLBCL Patients Presenting with Simultaneous Systemic and CNS Disease at Diagnosis - a Retrospective Multicenter Study","keywords":"","combinedName":"doctor sharon ben barouch"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Vanja ","lastName":"Zeremski ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Clinical Features and Outcomes in Patients with Primary Central Nervous System Lymphoma Treated within and Outside a Clinical Trial: A Retrospective Study","keywords":"","combinedName":"doctor vanja zeremski"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Bhagirathbhai ","lastName":"Dholaria ","credentials":"MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"DA.R-EPOCH Vs. R-CHOP for High-Risk Diffuse Large B- Cell Lymphoma: The Mayo Clinic Florida Experience","keywords":"","combinedName":"doctor bhagirathbhai dholaria"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Rudy ","lastName":"Birsen ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Intensive Etoposide Aracytine Consolidation Following Rituximab Methotrexate Temozolomide Induction in Newly Diagnosed Primary Central Nervous System Lymphoma","keywords":"","combinedName":"doctor rudy birsen"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Carlos ","lastName":"Montalban ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Geltamo-IPI Distinctly Identifies a Very High Risk Group in Difuse Large B-Cell Lymphoma (DLBCL) of Non B-Germinal-Center Origin Treated with Chemo-Immunotherapy","keywords":"","combinedName":"doctor carlos montalban"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Tarec Christoffer","lastName":"El-Galaly ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gender-Based Differences in Efficacy of Immuno-Chemotherapy for Diffuse Large B-Cell Lymphoma Revisited: A Danish Population-Based Study","keywords":"","combinedName":"doctor tarec christoffer el-galaly"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Michael P","lastName":"Gilbertson ","credentials":"MBBS,FRACP,FRCPA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hypercalcaemia at Diagnosis Is an Independent Predictor of Poor Survival in Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor michael p gilbertson"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Jean ","lastName":"Koff ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Post-Transplant Lymphoproliferative Disorder Subtype on Survival","keywords":"","combinedName":"doctor jean koff"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"James K R","lastName":"Stevenson ","credentials":"MD, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improved Survival in Overweight and Obese Patients with Non-Hodgkin's Lymphoma Treated with Rituximab Containing Chemotherapy for Curative Intent","keywords":"","combinedName":"doctor james k r stevenson"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Marta ","lastName":"Rojas Vasquez ","credentials":"MD, FRCPC","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Monomorphic Post Transplant Lymphoproliferative Disorder (Diffuse Large B Cell Lymphoma subtype) Successfully Treated without Chemotherapy after Solid Organ Transplant in Children","keywords":"","combinedName":"doctor marta rojas vasquez"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Fatemeh ","lastName":"Majidi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multicenter Case Series of Primary Adrenal Lymphoma (PAL)","keywords":"","combinedName":"doctor fatemeh majidi"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Hian Li Esther ","lastName":"Chan ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcome of Primary Mediastinal B Cell Lymphoma: Comparative Analysis of 123 Patients Treated with Different Strategies","keywords":"","combinedName":"doctor hian li esther chan"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Kazuna ","lastName":"Tanba ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Impact of Past History of Other Malignancies in Diffuse Large B Cell Lymphoma","keywords":"","combinedName":"doctor kazuna tanba"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"C ","lastName":"De Vriendt ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real World Outcome in a Patient Cohort with Newly Diagnosed Diffuse Large B Cell Lymphoma","keywords":"","combinedName":"doctor c de vriendt"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Tove ","lastName":"Wsterlid ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Six Cycles of R-CHOP-21 Is Non-Inferior to 8 Cycles for Treatment of Diffuse Large B-Cell Lymphoma - a Nordic Lymphoma Group Population Based Study","keywords":"","combinedName":"doctor tove wsterlid"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Dai ","lastName":"Chihara ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Stage I Lymphoma: Difference in Survival Outcome By Site of Involvement","keywords":"","combinedName":"doctor dai chihara"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Donald Edward","lastName":"Tsai ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Changing Face of Adult Posttransplant Lymphoproliferative Disorder: Dramatic Changes in Histology between 1999-2013","keywords":"","combinedName":"doctor donald edward tsai"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Michael Roost","lastName":"Clausen ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Pre-Therapeutic Haemoglobin Levels on the Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with Anthracycline Containing Chemotherapy before and after the Introduction of Rituximab: A Nation-Wide Cohort Study","keywords":"","combinedName":"doctor michael roost clausen"},{"sessionId":"11664","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster I","firstName":"Thomas ","lastName":"Guerrero ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Bortezomib-Containing Regimens in the Frontline Treatment of Patients with Plasmablastic Lymphoma: A Multicenter Retrospective Analysis","keywords":"","combinedName":"doctor thomas guerrero"},{"sessionId":"11665","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Tetsuzo ","lastName":"Tauchi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ABL001 with Catalytic-Site Inhibitors Limit the CML Immature Cell Population: Re-Differentiation of CML-iPSCs Study","keywords":"","combinedName":"doctor tetsuzo tauchi"},{"sessionId":"11665","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Wenjing ","lastName":"Tao ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allosteric Bcr-Abl Inhibitor ABL001 Overcomes Bcr-Abl Tyrosine Kinase Inhibitor Resistance and Enhances MDM2 Inhibitor CGM097 Activity in Blast Crisis CML Cells","keywords":"","combinedName":"doctor wenjing tao"},{"sessionId":"11665","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Puneet ","lastName":"Agarwal ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CXCL12-Expressing Bone Marrow Niches Differentially Regulate CML Compared to Normal Stem Cells","keywords":"","combinedName":"doctor puneet agarwal"},{"sessionId":"11665","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Constance Regina","lastName":"Baer ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutation Screening at Diagnosis Reveals a High Frequency of ASXL1 Mutations in CML Patients Who Fail to Achieve Molecular Remission Criteria after One Year of TKI Treatment","keywords":"","combinedName":"doctor constance regina baer"},{"sessionId":"11665","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Amy ","lastName":"Hughes ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nilotinib/Interferon-a Combination Rapidly Enhances Leukaemia-Associated Antigen-Specific Cytotoxic T-Lymphocyte Immune Responses, Limits Natural Killer Cell Maturation and Triggers B Cell Remodelling","keywords":"","combinedName":"doctor amy hughes"},{"sessionId":"11665","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Jun ","lastName":"Toda ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Signal Transducing Adaptor Protein (STAP) Family in Chronic Myelogenous Leukemia","keywords":"","combinedName":"doctor jun toda"},{"sessionId":"11665","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Chetasi ","lastName":"Talati ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Somatic Mutations in Clonal Evolution of Chronic Myeloid Leukemia from Chronic Phase to Blast Phase","keywords":"","combinedName":"doctor chetasi talati"},{"sessionId":"11665","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Manuela ","lastName":"Mancini ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting WEE1 Kinase after G2/M Checkpoint Arrest Induces Apoptosis in Chronic Myeloid Leukemia Progenitors","keywords":"","combinedName":"doctor manuela mancini"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Simone ","lastName":"Claudiani ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"10-Year Outcome of Chronic Myeloid Leukemia Patients Resistant to Frontline Imatinib","keywords":"","combinedName":"doctor simone claudiani"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Valentn ","lastName":"Garca Gutirrez ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Conservative Tailoring of Ponatinib Dose in Chronic Myeloid Leukemia Patients Can Diminish Adverse Events While Maintaining Efficacy","keywords":"","combinedName":"doctor valentn garca gutirrez"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Mario ","lastName":"Tiribelli ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ABCG2 but Not ABCB1 RNA Levels at Diagnosis and during Treatment Correlates with Response to Imatinib and 2G-Tkis Front-Line Therapy in Chronic Phase CML Patients","keywords":"","combinedName":"doctor mario tiribelli"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Sameer Ahmad ","lastName":"Guru ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Altered Expression of Pdgfra and Its Downstream Signalling Components May be Causal in the Development of Imatinib Induced Thrombocytopenia in CML Patients Receiving Imatinib Treatment","keywords":"","combinedName":"doctor sameer ahmad guru"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Mariella ","lastName":"D'adda ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An e13a2 Type of BCR-ABL Transcript Has a Significant Adverse Impact on the Achievement of a Sustained Deep Molecular Response and on the Maintenance of a Treatment Free Remission after Stopping Tyrosine Kinase Inhibitors","keywords":"","combinedName":"doctor mariella d'adda"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Gabriele ","lastName":"Gugliotta ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Arterial Thrombotic Events in CML Patients Treated with First-Line Nilotinib: Incidence, Management and Impact on the Long Term Outcome - a Gimema CML WP Analysis","keywords":"","combinedName":"doctor gabriele gugliotta"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Michael ","lastName":"Mauro ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bosutinib in Newly Diagnosed Chronic Myeloid Leukemia (CML): Gastrointestinal (GI), Liver, and Hematological Safety Characterization in the BFORE Trial","keywords":"","combinedName":"doctor michael mauro"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Andreas ","lastName":"Hochhaus ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bosutinib Vs Imatinib for Newly Diagnosed Chronic Myeloid Leukemia in the BFORE Trial: Results By 3-Month BCR-ABL1 Transcript Level","keywords":"","combinedName":"doctor andreas hochhaus"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Emir ","lastName":"Hadzijusufovic ","credentials":"DVM","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cardiovascular Scoring and Age-Related Mutations Predict the Occurrence of Adverse Vascular Events in CML Patients during Nilotinib Therapy","keywords":"","combinedName":"doctor emir hadzijusufovic"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Louise ","lastName":"Caldwell ","credentials":"BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Changes in RT-qPCR Levels during and after TKI Interruptions for Attempted Conceptions in Women with CML","keywords":"","combinedName":"doctor louise caldwell"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Yi-Jiun ","lastName":"Su ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study","keywords":"","combinedName":"doctor yi-jiun su"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Naranie ","lastName":"Shanmuganathan ","credentials":"MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cumulative Incidence of Treatment-Free Remission (TFR) for Patients with Chronic Myeloid Leukemia (CML): The Adelaide Experience","keywords":"","combinedName":"doctor naranie shanmuganathan"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Tatsuro ","lastName":"Jo ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dasatinib-Induced Lymphocyte Elevation and Imbalance of T Cell Receptor V Beta Gene Expression in Chronic Phase Chronic Myelogenous Leukemia Patients","keywords":"","combinedName":"doctor tatsuro jo"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Shun ","lastName":"Liao ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dynamics of Methylation Profiling in Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor shun liao"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Katia B","lastName":"Pagnano ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"E14a2 and e14a2+e13a2 BCR-ABL Transcripts Are Associated with Earlier Cytogenetic and Molecular Response Rates in CML-CP Treated with Imatinib","keywords":"","combinedName":"doctor katia b pagnano"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Andreas ","lastName":"Hochhaus ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Ponatinib in Chronic Phase-Chronic Myeloid Leukemia (CP-CML) According to the Extent of Treatment with Prior Tyrosine Kinase Inhibitors (TKIs): Final (5-Year) Results of the PACE Study","keywords":"","combinedName":"doctor andreas hochhaus"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Kiran ","lastName":"Naqvi ","credentials":"MD,MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluating the Role of Lower Dose Dasatinib in Newly Diagnosed Early Chronic Phase-Chronic Myeloid Leukemia (CML-CP)","keywords":"","combinedName":"doctor kiran naqvi"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Gwendolyn ","lastName":"McMillin ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of an Automated Immunoassay for Quantification of Imatinib in Plasma","keywords":"","combinedName":"doctor gwendolyn mcmillin"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Fausto","lastName":"Castagnetti","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"First-Line Dasatinib in BCR-ABL1+ Chronic Myeloid Leukemia in Early Chronic Phase: A Gimema Prospective Multicentric Observational Study","keywords":"","combinedName":"doctor fausto castagnetti"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Simone ","lastName":"Claudiani ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of a Safe Haven for RT-qPCR Responses in CML: Can We Reduce the Frequency of Molecular Monitoring?","keywords":"","combinedName":"doctor simone claudiani"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Dietger ","lastName":"Niederwieser ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Imatinib (IM) in Combination with Hydroxyurea Showed Significantly Lower Major Molecular Response Rates at 6 Months but Similar MMR at 18 Months in Patients with CML1st CP Compared to IM Alone. Final Results of the CML2004 Study. NCT 02480608","keywords":"","combinedName":"doctor dietger niederwieser"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Hlne ","lastName":"Haguet ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of BCR-ABL Tyrosine Kinase Inhibitors on Atherosclerosis Plaque Rupture","keywords":"","combinedName":"doctor hlne haguet"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Giuseppe ","lastName":"Saglio ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Treatment Cessation on Overall Disease Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Attempting Treatment-Free Remission (TFR): Findings from Enestfreedom and Enestop","keywords":"","combinedName":"doctor giuseppe saglio"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Hlne ","lastName":"Haguet ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vitro Effects of BCR-ABL Tyrosine Kinase Inhibitors on Endothelial Cells Survival and Functions","keywords":"","combinedName":"doctor hlne haguet"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Koji ","lastName":"Sasaki ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence of Secondary Malignancies in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Era of Tyrosine Kinase Inhibitors (TKI)","keywords":"","combinedName":"doctor koji sasaki"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Dennis ","lastName":"Kim ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim Results of the Canadian Tyrosine Kinase Inhibitor Discontinuation Trial for 2nd Attempt of Treatment Free Remission: Treatment Free Remission Accomplished By Dasatinib (TRAD)","keywords":"","combinedName":"doctor dennis kim"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Jorge ","lastName":"Cortes","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Cardiac, Vascular and Hypertensive Safety of Bosutinib in Patients with Philadelphia Chromosome-Positive (Ph+) Leukemia Resistant or Intolerant to Prior Therapy","keywords":"","combinedName":"doctor jorge cortes"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Timothy ","lastName":"Hughes ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Follow-up of the ALLG CML8 Twister Study of Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia (CML)","keywords":"","combinedName":"doctor timothy hughes"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Fiorina ","lastName":"Giona ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib. the Italian Experience","keywords":"","combinedName":"doctor fiorina giona"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Kamal ","lastName":"Chamoun ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Outcome of CML Patients Treated with Second-Generation Tyrosine Kinase Inhibitors in the Second Line: A Single Center Experience","keywords":"","combinedName":"doctor kamal chamoun"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Markus ","lastName":"Pfirrmann ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Recurrence-Free Survival (MRecFS) Following Imatinib Vs. Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Matched Analysis of Patients in EURO-SKI and Enestfreedom","keywords":"","combinedName":"doctor markus pfirrmann"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Carmen ","lastName":"Fava ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Observational Study of CML Italian Patients Who Discontinued TKIs","keywords":"","combinedName":"doctor carmen fava"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Jee Hyun ","lastName":"Kong ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes after Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Phase Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor jee hyun kong"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Katia B","lastName":"Pagnano ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pilot Study of Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia with Deep Molecular Response (EDI-PIO)  Evaluation of Pioglitazone in Treatment-Free Remission","keywords":"","combinedName":"doctor katia b pagnano"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Bhagwan ","lastName":"Yadav ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasma Fms-Related Tyrosine Kinase 3 Ligand (Flt3L) Levels at Diagnosis Correlate with Treatment Response in Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor bhagwan yadav"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Mamta Sumi","lastName":"Sumi ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RIZ1 Gene Promoter Methylation Increases with Progression of Chronic Myeloid Leukaemia to Advanced Phases","keywords":"","combinedName":"doctor mamta sumi sumi"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Fabio ","lastName":"Stagno ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Second Generation Tyrosine Kinase Inhibitors (2G-TKI) in the Frontline Treatment of Elderly Patients with Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor fabio stagno"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Hamzah Munir","lastName":"Alqam ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Survival Outcome of Secondary Solid Cancer in Patients with Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor hamzah munir alqam"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Qian ","lastName":"Jiang ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Variables Associated with Patient-Reported Symptoms in Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors","keywords":"","combinedName":"doctor qian jiang"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Won-Sik ","lastName":"Lee ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors","keywords":"","combinedName":"doctor won-sik lee"},{"sessionId":"11666","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster I","firstName":"Gwo-Jen ","lastName":"Day ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Xpert BCR-ABL Ultra, a High Sensitivity Assay, Demonstrates a Limit of Detection Reaching MR4.5 and below","keywords":"","combinedName":"doctor gwo-jen day"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Guido ","lastName":"Finazzi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Long-Term Safety and Efficacy Study of Givinostat in Patients with Polycythemia Vera: The First 4 Years of Treatment","keywords":"","combinedName":"doctor guido finazzi"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Naseema ","lastName":"Gangat ","credentials":"MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Multicenter, Open-Label, Pilot Study of Alisertib (MLN8237), a Novel Inhibitor of Aurora Kinase a, in Myelofibrosis","keywords":"","combinedName":"doctor naseema gangat"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Mark W","lastName":"Drummond ","credentials":"MB ChB, PhD, FRCPath","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase Ib Study to Assess the Safety and Tolerability ofRuxolitinib in Combination with Azacitidine in Patients with Advanced Phase Myeloproliferative Neoplasms (MPN), Including Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukaemia (AML) Arising from MPN (The Bloodwise / TAP PHAZAR Study on Behalf of the UK MPN CSG)","keywords":"","combinedName":"doctor mark w drummond"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Francesca ","lastName":"Palandri ","credentials":"PhD, MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Age Is Not a Predictive Marker in Molecularly Annotated Elderly Patients with Myelofibrosis Treated with Ruxolitinib: a Multicenter Study on 277 Patients.","keywords":"","combinedName":"doctor francesca palandri"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Jingbo ","lastName":"Yu ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics of 809 Patients with Essential Thrombocythemia in Real-World Clinical Practice: A Chart Review Study in the United States","keywords":"","combinedName":"doctor jingbo yu"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Inga ","lastName":"Hofmann ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Congenital Thrombocytopenia and Myelofibrosis Due to Germline Mutations in G6b-B, a Megakaryocyte-Specific Immunoreceptor Tyrosine-Based Inhibitory Motif (ITIM) Receptor","keywords":"","combinedName":"doctor inga hofmann"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Lucia ","lastName":"Masarova ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Correlation of Mutational Profile and Response in Patients with Polycythemia Vera and Essential Thrombocythemia Treated with Pegylated Interferon Alfa 2a As Part of a Prospective Phase II Study","keywords":"","combinedName":"doctor lucia masarova"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Michael Richard","lastName":"Grunwald ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Examining the Treatment Patterns and Blood Counts Among Patients with Polycythemia Vera Treated with Hydroxyurea in the United States: An Analysis from the Reveal Study","keywords":"","combinedName":"doctor michael richard grunwald"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Ronan ","lastName":"Hsieh ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Extreme Thrombocytosis: Influence of Care Setting and Likelihood of Occult Malignancy","keywords":"","combinedName":"doctor ronan hsieh"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Elisa ","lastName":"Roncoroni ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Profiling of Blast Phase in Philadelphia-Negative Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor elisa roncoroni"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Laurent ","lastName":"Mauvieux ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Germline Mutations Occurring Outside the Negatively Charged Amino Acid Stretches of the Exon 9 of Calr: A Predisposition to Hematological Malignancies?","keywords":"","combinedName":"doctor laurent mauvieux"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Giulia ","lastName":"Benevolo ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Ruxolitinib-Response Feature on Outcome in Myelofibrosis: A Multicentre Study on 356 Patients","keywords":"","combinedName":"doctor giulia benevolo"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Heinz ","lastName":"Gisslinger ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"JAK2-Inhibitor Therapy Associated Lymphomas in Myelofibrosis: Distinct Clinico-Pathological Features Recapitulated in a Mouse Model","keywords":"","combinedName":"doctor heinz gisslinger"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Allison ","lastName":"Scotch ","credentials":"MD, MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: Results from the MPN Experimental Assessment of Symptoms By Utilizing Repetitive Evaluation (MEASURE) Trial","keywords":"","combinedName":"doctor allison scotch"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Harinder ","lastName":"Gill ","credentials":"MD,FRCP,MBBS,MRCP","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Next-Generation Sequencing with a 54-Gene Panel Identifies Unique Mutational Profile and Prognostic Markers in Chinese Patients with Myelofibrosis","keywords":"","combinedName":"doctor harinder gill"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Prithviraj ","lastName":"Bose ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 2 Study of Pracinostat in Combination with Ruxolitinib in Patients (pts) with Myelofibrosis (MF)","keywords":"","combinedName":"doctor prithviraj bose"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Silvia ","lastName":"Betti ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phenotypic and Prognostic Relevance of the Who Diagnostic Distinction between Polycythemia Vera and JAK2-Mutated Essential Thrombocythemia: Combined Analysis of 785 Informative Cases","keywords":"","combinedName":"doctor silvia betti"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Andrew ","lastName":"Kuykendall ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Relative Lymphocytosis Is Associated with Improved Outcome in Myelofibrosis and May Account for the Favorable Prognosis of the Calr mutation","keywords":"","combinedName":"doctor andrew kuykendall"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Jingbo ","lastName":"Yu ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Symptom Burden in Disability Leave Among Patients with Myeloproliferative Neoplasms (MPNs): Findings from the Living with MPN Patient Survey","keywords":"","combinedName":"doctor jingbo yu"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Chiara ","lastName":"Elena ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Selection and Efficacy of Cytoreductive Agents in Patients with Mastocytosis Included in the Registry of the European Competence Network on Mastocytosis (ECNM)","keywords":"","combinedName":"doctor chiara elena"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Terra ","lastName":"Lasho ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Sequencing of Paired Samples in Patients Evolving from Chronic to Blast Phase Myelofibrosis with Parallel Cytogenetic Information","keywords":"","combinedName":"doctor terra lasho"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Alessandro ","lastName":"Andriani ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment of Myeloproliferative Neoplasms in Blastic Phase with Azacytidine. Clinical Results and Identification of Prognostic Factors","keywords":"","combinedName":"doctor alessandro andriani"},{"sessionId":"11667","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster I","firstName":"Pamela ","lastName":"Acha ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Usefulness of a Sequencing Panel in Myeloproliferative Neoplasms Lacking Mutations in Driver Genes","keywords":"","combinedName":"doctor pamela acha"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Paola ","lastName":"Guglielmelli ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Distinct Mutation Profile Might Contribute to the Dismal Outcome of Triple Negative Patients with Primary Myelofibrosis","keywords":"","combinedName":"doctor paola guglielmelli"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Jakub ","lastName":"Zmajkovic ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Gain-of-Function Mutation in EPO Gene Causes Familial Erythrocytosis","keywords":"","combinedName":"doctor jakub zmajkovic"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Jinqin ","lastName":"Liu ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ASXL1 Mutation Change the Migration Ability in JAK2V617F Positive Cell Lines through SDF-1/CXCR4 Axis","keywords":"","combinedName":"doctor jinqin liu"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Ioanna ","lastName":"Triviai ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chromatin Regulator Mutations Are Drivers of Clonal Evolution in the Early Multipotent HSC Compartment of Primary Myelofibrosis","keywords":"","combinedName":"doctor ioanna triviai"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Evan M","lastName":"Braunstein ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Germline ERBB2 Variants Associate with Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor evan m braunstein"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Yoko ","lastName":"Nishinaka-Arai ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Candidate Progenitor Populations Which Causes Transient Abnormal Myelopoiesis","keywords":"","combinedName":"doctor yoko nishinaka-arai"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Xiaoli ","lastName":"Wang ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Imetelstat, a Telomerase Inhibitor, Is Capable of Depleting Myelofibrosis Hematopoietic Stem Cells and Progenitor Cells","keywords":"","combinedName":"doctor xiaoli wang"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Jan ","lastName":"Stetka ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"JAK2 V617F Progenitors Utilize Adaptations to Cell-Autonomous and Microenvironment-Dependent Inflammatory Stress in Polycythemia Vera, Likely Exhibiting Barrier Against Rapid Transformation to Myelofibrosis","keywords":"","combinedName":"doctor jan stetka"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Nami ","lastName":"Masubuchi ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Localization of Mutant Calreticulin in the Golgi Apparatus Is Required for Its Oncogenic Capacity","keywords":"","combinedName":"doctor nami masubuchi"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Ivo ","lastName":"Veletic ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Neoplastic Monocyte-Derived Osteoclasts Are Highly Proliferative, but Sub-Functional in MPN-Associated Myelofibrosis","keywords":"","combinedName":"doctor ivo veletic"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Caroline ","lastName":"Marty ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rare Type 1-like and Type 2-like Calrecticulin Mutants Induce Similar Myeloproliferative Neoplasms Than Type 1 and Type 2 Mutants in Mice","keywords":"","combinedName":"doctor caroline marty"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Orly ","lastName":"Leiva ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Regulation of Lysyl Oxidase, a Key Regulator of Bone Marrow Fibrosis, in Myelofibrosis","keywords":"","combinedName":"doctor orly leiva"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Dongqing ","lastName":"Yan ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Selective Inhibition of Nucleocytoplasmic Transport Overcomes Ruxolitinib Resistance in Myelofibrosis","keywords":"","combinedName":"doctor dongqing yan"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Gary ","lastName":"Reuther ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Pan-PIM Inhibitor INCB053914 Displays Potent Synergy at Low Doses in Combination with Ruxolitinib in Pre-Clinical Models of MPNs","keywords":"","combinedName":"doctor gary reuther"},{"sessionId":"11668","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster I","firstName":"Chiara ","lastName":"Rossi ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of the Axis TGF-1/Mir-382-5p/SOD2 in the Induction of Oxidative Stress in CD34+ Hematopoietic Stem/Progenitor Cells from Primary Myelofibrosis","keywords":"","combinedName":"doctor chiara rossi"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Bonnie W","lastName":"Lau ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aberrant Hedgehog Signaling in Myelodysplastic Syndrome Accelerates Leukemic Transformation Via Smoothened-Dependent and Smoothened-Independent Gli1 Activation","keywords":"","combinedName":"doctor bonnie w lau"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Catharina ","lastName":"Wenk ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Azacitidine Directly Acts on the Mesenchymal Stromal Cell Compartment in Myelodysplastic Syndromes to Alter Niche Function and Suppress Malignant Hematopoeitic Stem/Progenitor Cells","keywords":"","combinedName":"doctor catharina wenk"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Teodora ","lastName":"Kuzmanovic ","credentials":"BA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chemotherapy and Radiation Results in Distinct Patterns of Somatic Mutations in Subsequent Myeloid Disease","keywords":"","combinedName":"doctor teodora kuzmanovic"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Niroshan ","lastName":"Nadarajah ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Variant Interpretation between Manual Expert Curator and Automated in-Silico Classification Using Acmg/AMP Guidelines in Myeloid Malignancies in a Routine NGS Setting","keywords":"","combinedName":"doctor niroshan nadarajah"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Victor ","lastName":"Pastor Loyola ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Constitutional SAMD9L Mutations Cause Familial Myelodisplastic Syndrome with Monosomy 7 and Stable Revertant Mosaicism","keywords":"","combinedName":"doctor victor pastor loyola"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Zhiyong ","lastName":"Poon ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluating the Mesenchymal Stromal Cell (MSCs) Contribution in Pre-Leukemic Myelodysplastic Syndromes in Different Patient Risk Groups","keywords":"","combinedName":"doctor zhiyong poon"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Bhumika ","lastName":"Patel ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evolution in Myeloid Neoplasms Clonal Architecture Post Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor bhumika patel"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Yasunobu ","lastName":"Nagata ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Germline SAMD9 and SAMD9L Alterations in Adult Myelodysplastic Syndromes","keywords":"","combinedName":"doctor yasunobu nagata"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Tomoya ","lastName":"Muto ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Innate Immune Signal Pathway Activation Induced By Combined Loss of Del(5q) MDS Genes, Tifab and Mir-146a, Accelerates Hematopoietic Stem Cell Exhaustion Driven By Chronic Exposure to a TLR Ligands","keywords":"","combinedName":"doctor tomoya muto"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Diego ","lastName":"Coutinho ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Killer Immunoglobulin-like Receptors (KIR) in Low-Risk Myelodysplastic Syndrome: Genotyping and Gene Expression Evaluation","keywords":"","combinedName":"doctor diego coutinho"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Annette ","lastName":"Fasan ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Genetics Provides Important Information for Initial Evaluation of Patients with Suspected MDS","keywords":"","combinedName":"doctor annette fasan"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Sarah K","lastName":"Tasian","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutation-Specific Signaling Profiles and Therapeutic Vulnerabilities of Induced Pluripotent Stem Cell Models of Juvenile Myelomonocytic Leukemia","keywords":"","combinedName":"doctor sarah k tasian"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Allison ","lastName":"Li ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel In Vivo Models Uncover Non-Cell-Autonomous Effects of Myelodysplastic Syndrome (MDS) on Marrow Osteolineage Cells and Hematopoietic Dysfunction","keywords":"","combinedName":"doctor allison li"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Edward F","lastName":"Greenberg ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TET2 and MSH6: A Novel Role for MMR in the Pathogenesis of Myeloid Malignancies","keywords":"","combinedName":"doctor edward f greenberg"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Ana M","lastName":"Hurtado ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcriptome of DNA Repair Genes in CMML: Rationale for TargetingERCC1 andCDKN1AAs a Synthetic Lethality Approach","keywords":"","combinedName":"doctor ana m hurtado"},{"sessionId":"11669","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster I","firstName":"Eric ","lastName":"Duncavage ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ultra-Deep Sequencing As a Predictive Tool for MDS Progression after Allogeneic Hematopoietic Cell Transplant","keywords":"","combinedName":"doctor eric duncavage"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Devendra K","lastName":"Hiwase ","credentials":"MBBS, MD, FRACP, FRCPA, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Geriatric Screening Tool (G8) Provides an Independent Prognostic Index for Azacitidine Treated Elderly MDS Patients","keywords":"","combinedName":"doctor devendra k hiwase"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Alessandro ","lastName":"Liquori ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Single Next-Generation Sequencing (NGS) Approach for the Molecular Karyotyping and Genotyping of Patients with Myelodysplastic Syndromes","keywords":"","combinedName":"doctor alessandro liquori"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Roman M","lastName":"Shapiro ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Simple Tool for the Prediction of Azacytidine Treatment Failure in Patients with Myelodysplastic Syndrome","keywords":"","combinedName":"doctor roman m shapiro"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Rena ","lastName":"Buckstein ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An MDS Specific Frailty Index Based on Cumulative Deficits Adds Independent Prognostic Value to Established Clinical Prognostic Scoring Systems","keywords":"","combinedName":"doctor rena buckstein"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Kalman ","lastName":"Filanovsky ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Benefit and Improvement of Mitochondrial Function in Low Risk Myelodysplastic Syndrome Treated By Combination Ultra Coenzyme Q10 and L-Carnitine","keywords":"","combinedName":"doctor kalman filanovsky"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Wenbin ","lastName":"An ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Implication of Gene Mutations in Children Myelodysplastic Syndromes","keywords":"","combinedName":"doctor wenbin an"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Ki Sun ","lastName":"Jung ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Outcomes of Decitabine Treatment for Patients with Lower-Risk Myelodysplastic Syndrome By the International Prognostic Scoring System","keywords":"","combinedName":"doctor ki sun jung"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Abhishek ","lastName":"Mangaonkar ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cytokine Receptor-like Factor 2 (CRLF2) Overexpression in Myeloid Malignancies Secondary to Multiple Isodicentric Y Chromosomes: A Novel Cytogenetic Entity?","keywords":"","combinedName":"doctor abhishek mangaonkar"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Shumpei ","lastName":"Uchida ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diagnostic Value of Flow CytometryTechnique By European Leukemianet for Idiopathic Cytopenia of Undetermined Significance","keywords":"","combinedName":"doctor shumpei uchida"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Sophie ","lastName":"Park ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS","keywords":"","combinedName":"doctor sophie park"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Fumihito ","lastName":"Tajima ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Azacitidine on CD4+CD25+Foxp3+ Regulatory T Cell on Immunity in Myelodysplastic Syndrome Survivors","keywords":"","combinedName":"doctor fumihito tajima"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Eric ","lastName":"Padron ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Germline Tissues and DNA Sequencing Analysis Methods for Optimal Somatic Variant Detection in Myelodysplastic Syndrome (MDS)","keywords":"","combinedName":"doctor eric padron"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Andres ","lastName":"Jerez ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Global and Targeted RNA-Sequencing Assessment of Cancer Testis Antigen Re-Expression Following Azacitidine in Myelodysplastic Syndromes","keywords":"","combinedName":"doctor andres jerez"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Tara ","lastName":"Robinson ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immunological Correlates of Treatment with the CTLA-4 Inhibitor Ipilimumab in Patients with Refractory Myelodysplastic Syndromes (MDS)","keywords":"","combinedName":"doctor tara robinson"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Louise ","lastName":"De Swart ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Red Blood Cell Transfusion Intensity on Progression-Free Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS Registry","keywords":"","combinedName":"doctor louise de swart"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Cesar ","lastName":"Gentille Sanchez ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Infections in Patients with Myelodysplastic Syndrome. Looking for the Escape Clause!","keywords":"","combinedName":"doctor cesar gentille sanchez"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Rami ","lastName":"Komrokji","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcome of Myelodysplastic Syndrome Patients with TP53 Mutation Treated with Hypomethylating Agents","keywords":"","combinedName":"doctor rami komrokji"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Argiris ","lastName":"Symeonidis ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patients with Myelodysplastic Syndromes, Other Than Del(5)q Syndrome, Exhibiting Del(5)q Alone or Associated with One Additional Chromosomal Abnormality Have Comparable Probability and Duration of Response to Lenalidomide, with Patients Classified As Del(5)q Syndrome","keywords":"","combinedName":"doctor argiris symeonidis"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Luca","lastName":"Malcovati","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevalence of Clonal Hematopoiesis and Mutation Patterns in Unexplained Anemia of Community-Dwelling Elderly Individuals: A Case-Control Study","keywords":"","combinedName":"doctor luca malcovati"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Abi ","lastName":"Vijenthira ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rates of Severe Bleeding Are Low in Patients with MDS and Severe Thrombocytopenia and May be Mitigated By Tranexamic Acid","keywords":"","combinedName":"doctor abi vijenthira"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Azra ","lastName":"Raza ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rigosertib Oral in Transfusion Dependent Lower Risk Myelodysplastic Syndromes (LR-MDS): Optimization of Dose and Rate of Transfusion Independence (TI) or Transfusion Reduction (TR) in a Single-Arm Phase 2 Study","keywords":"","combinedName":"doctor azra raza"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Tara ","lastName":"Lin","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Subanalysis of Patients with Secondary Acute Myeloid Leukemia (sAML) with Refractory Anemia with Excess of Blasts in Transformation (RAEB-t) Enrolled in a Phase 3 Study of CPX-351 Versus Conventional 7+3 Cytarabine and Daunorubicin","keywords":"","combinedName":"doctor tara lin"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Panagiotis Theodorou","lastName":"Diamantopoulos ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Clinical Significance of Chromosome 17 Abnormalities in Myelodysplastic Syndrome Treated with 5-Azacytidine. Results from the Hellenic 5-Azacytidine Registry","keywords":"","combinedName":"doctor panagiotis theodorou diamantopoulos"},{"sessionId":"11670","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster I","firstName":"Sotirios ","lastName":"Papageorgiou ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Outcome of Patients with High Risk MDS Achieving Stable Disease after Treatment with 5- Azacitidine. a Retrospective Analysis of the Hellenic (Greek) Mds Study Group","keywords":"","combinedName":"doctor sotirios papageorgiou"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Fanny ","lastName":"Baran-Marszak ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Retrospective Analysis of 450 TP53 Mutations in a Real Life Cohort of CLL from the French Innovative Leukemia Organization (FILO) Group","keywords":"","combinedName":"doctor fanny baran-marszak"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Danielle ","lastName":"Brander ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Applicability of the Chronic Lymphocytic Leukemia (CLL)-IPI on Patients Treated with Front-Line Ibrutinib in the Real World: The Case for New Prognostic Models","keywords":"","combinedName":"doctor danielle brander"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Isabel ","lastName":"Jimnez ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Progression of Chronic Lymphocytic Leukemia (CLL) Is Characterized By a Progressive Increase of the Exhausted T-Cell Phenotype and Immunosuppression Induced By Leukemic Cells","keywords":"","combinedName":"doctor isabel jimnez"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Blanca ","lastName":"Ferrer ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical, Genomic Profile and Recurrent Somatic Mutations in 205 Chronic Lymphocytic Leukemia Treatment-Naive Patients","keywords":"","combinedName":"doctor blanca ferrer"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Uri ","lastName":"Rozovski ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CLL Cell-Derived Exosomes Promote Bone Marrow Fibrosis and Inhibit Normal Hematopoietic Colony Proliferation","keywords":"","combinedName":"doctor uri rozovski"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Andreas ","lastName":"Agathangelidis ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CLL-Specific B Cell Receptor Immunoglobulin Stereotypes Are Very Infrequent in Low Count Monoclonal B Cell Lymphocytosis: Implications for Disease Ontogeny","keywords":"","combinedName":"doctor andreas agathangelidis"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Sabine ","lastName":"Jeromin ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Evolution of Molecular and Cytogenetic Aberrations in 80 CLL Patients","keywords":"","combinedName":"doctor sabine jeromin"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Tharshika ","lastName":"Thavayogarajah ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Co-Expression and Functional Interaction between CXCR4 and CD74 in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor tharshika thavayogarajah"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Alicia ","lastName":"Serrano ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development and Validation of a New Tool for the Characterization of Immunoglobulin Gene Rearrangements in Patients with Chronic Lymphocytic Leukemia By Deep Next Generation Sequencing","keywords":"","combinedName":"doctor alicia serrano"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Alankrita ","lastName":"Taneja ","credentials":"MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Prevalence of Multiple B Cell Clones in Patients with Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor alankrita taneja"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Tiziana ","lastName":"Vaisitti ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hyper-Activation of the Adenosinergic Axis in the E-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Therapeutic Opportunities","keywords":"","combinedName":"doctor tiziana vaisitti"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Andrea Nicola","lastName":"Mazzarello ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IgM and IgD Differential CLL BCRs Organization and Interaction with Co-Receptors before and during Ibrutinib Therapy","keywords":"","combinedName":"doctor andrea nicola mazzarello"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Brandy ","lastName":"Perkins ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immunoglobulin Heavy Chain Variable Region (IgHV) Unmutated, but Not Mutated, Chronic Lymphocytic Leukemia (CLL) Arises in a CD34+ Progenitor","keywords":"","combinedName":"doctor brandy perkins"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Alessandro ","lastName":"Pastore ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrative Epigenomics Reveals Novel Chronic Lymphocytic Leukemia-Specific Chromatin States Associated with Epigenetic and Transcriptional Heterogeneity","keywords":"","combinedName":"doctor alessandro pastore"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Loic ","lastName":"Ysebaert ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"International, Practice-Based Recommendations for Prediction of Bleedings and Anti-Platelet/Anti-Coagulant (AP/AC) Co-Medications in CLL Patients Taking Ibrutinib","keywords":"","combinedName":"doctor loic ysebaert"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Xavier ","lastName":"Troussard ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Generation Sequencing of Targeted Genes in Hairy Cell Leukemia Highlighted Mutations Associated to BRAFV600E and a New Recurrent Altered Gene, KDM6A, in Hairy Cell Leukemia Variant Patients","keywords":"","combinedName":"doctor xavier troussard"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Mauro ","lastName":"Di Ianni ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells","keywords":"","combinedName":"doctor mauro di ianni"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Michael Asger","lastName":"Andersen ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prediagnostic Progression of Lymphocytosis in Chronic Lymphocytic Leukemia Is Predictive of Progression Free Survival As Early As Five Years Prior to Diagnosis","keywords":"","combinedName":"doctor michael asger andersen"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Lindsay D","lastName":"Smith ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Regulation and Impact of BCR Induced Autophagy in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor lindsay d smith"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Billy Michael Chelliah","lastName":"Jebaraj ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Short Telomeres Are Independent Prognostic Factors Associated with Poor Outcome in Chronic Lymphocytic Leukemia (CLL) Treated with Chlorambucil with or without the Addition of Rituximab or Obinutuzumab: Results from CLL11 Trial of the Gcllsg","keywords":"","combinedName":"doctor billy michael chelliah jebaraj"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Florence ","lastName":"Nguyen-Khac ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Gain of the Short Arm of Chromosome 2 (2pgain) Plays an Important Role in CLL Drug Resistance, and Has to be Systematically Considered before Deciding an Adapted Therapy","keywords":"","combinedName":"doctor florence nguyen-khac"},{"sessionId":"11671","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Clare","lastName":"Sun","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcriptome Analysis of the Lymph Node Microenvironment in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor clare sun"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Farrukh ","lastName":"Awan ","credentials":"MD, MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 2 Trial of Early Intervention with Ibrutinib in Patients with Asymptomatic, High-Risk CLL","keywords":"","combinedName":"doctor farrukh awan"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Ramona ","lastName":"Cassin ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice?","keywords":"","combinedName":"doctor ramona cassin"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Constantine ","lastName":"Tam ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BGB-3111 in Combination with Obinutuzumab in Patients with Chronic Lymphocytic Leukemia and Follicular Lymphoma","keywords":"","combinedName":"doctor constantine tam"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Stefano ","lastName":"Molica ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chronic Lymphocytic Leukemia International Prognostic INDEX (CLL-IPI) Predicts Prognosis of CLL: A Systematic Review and Meta-Analysis","keywords":"","combinedName":"doctor stefano molica"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Alak ","lastName":"Manna ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab Decreases Treg-Mediated Immunosuppression and Potentiates CD8+ T-Cell-Induced Killing of Chronic Lymphocytic Leukemia (CLL) Cells Ex Vivo","keywords":"","combinedName":"doctor alak manna"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Andrew ","lastName":"Roberts ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Do Statins Enhance the Anti-Cancer Activity of Venetoclax?","keywords":"","combinedName":"doctor andrew roberts"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Benjamin ","lastName":"Lampson ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy Results of a Phase 2 Trial Evaluating Idelalisib Plus Ofatumumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor benjamin lampson"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Sneha ","lastName":"Gupta ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Exposure-Response of Entospletinib (ENTO) for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor sneha gupta"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Emelie Curovic","lastName":"Curovic Rotbain ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IGHV Mutation Status and Outcome in CLL Patients Treated with Chemoimmunotherapy: A Nationwide Analysis","keywords":"","combinedName":"doctor emelie curovic curovic rotbain"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Martin ","lastName":"Gauthier ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Recovery Refines the Prognostic Impact of Minimal Residual Disease on Overall and Progression Free Survivals after Frontline Fludarabine, Cyclophosphamide and Rituximab (FCR) in CLL Patients","keywords":"","combinedName":"doctor martin gauthier"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Jennifer ","lastName":"Brown ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence of and Risk Factors for Major Hemorrhage in Patients Treated with Ibrutinib: Results from an Integrated Analysis","keywords":"","combinedName":"doctor jennifer brown"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Othman ","lastName":"Al-Sawaf ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mode of Progression after First Line Treatment Correlates with Outcome of Chronic Lymphocytic Leukemia (CLL)","keywords":"","combinedName":"doctor othman al-sawaf"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Fiona ","lastName":"Fernando ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multicentre Retrospective Analysis of Chronic Lymphocytic Leukaemia Patients Treated with Idelalisib, Real World Data from the UK and Republic of Ireland  a Cohort of 68 Patients","keywords":"","combinedName":"doctor fiona fernando"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Januario E","lastName":"Castro ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Obinutuzumab (Gazyva) and High-Dose Methylprednisolone (HDMP) Combination for Patients with Chronic Lymphocytic Leukemia (CLL) - a Phase Ib/II Study","keywords":"","combinedName":"doctor januario e castro"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Sandra ","lastName":"Eketorp Sylvan ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcome of Patients with Chronic Lymphocytic Leukemia (CLL) Receiving First Line Therapy: A Swedish Nation-Wide Study on 1053 Consecutive Patients Treated between 2007 and 2013","keywords":"","combinedName":"doctor sandra eketorp sylvan"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Todd ","lastName":"Covey ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacodynamic Evaluation of Acalabrutinib in Relapsed/Refractory and Treatment-Naive Patients with Chronic Lymphocytic Leukemia (CLL) in the Phase 1/2 ACE-CL-001 Study","keywords":"","combinedName":"doctor todd covey"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Alessandra ","lastName":"Tedeschi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prolonged Improvement in Patient-Reported Outcomes (PROs) and Well-&#98;eing in Older Patients &#87;ith Treatment-Na&#239;ve (TN) Chronic Lymphocytic Leukemia Treated &#87;ith Ibrutinib (Ibr): 3-Year Follow-up of the R&#69;&#83;&#79;&#78;&#65;&#84;&#69;-2 Study","keywords":"","combinedName":"doctor alessandra tedeschi"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Sven ","lastName":"Estenfelder ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RPS15 mutations and Treatment Outcome in Chronic Lymphocytic Leukemia - Results from the CLL11 Phase III Trial (Chlorambucil (Clb) with or without the Addition of Rituximab (R) or Obinutuzumab (GA101, G)) of the German CLL Study Group","keywords":"","combinedName":"doctor sven estenfelder"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Tatyana ","lastName":"Kapustyan ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sequencing Therapy in Chronic Lymphocytic Leukemia (CLL): Treatment Patterns and Associated Outcomes in Community Practice for Patients with Relapsed/Refractory CLL in the United States","keywords":"","combinedName":"doctor tatyana kapustyan"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Tadeusz ","lastName":"Robak ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Agent Ibrutinib Vs Chemoimmunotherapy Regimens for Treatment-Nave Patients with Chronic Lymphocytic Leukemia (CLL): A Cross-Trial Comparison","keywords":"","combinedName":"doctor tadeusz robak"},{"sessionId":"11672","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster I","firstName":"Alexey ","lastName":"Kuvshinov ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Strategy of the Management of Patients with Chronic Lymphocytic Leukemia in the Post-Induction Period Based on the Results of the Evaluation of Minimal Residual Disease","keywords":"","combinedName":"doctor alexey kuvshinov"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Sheri ","lastName":"Skerget ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Molecular Analysis of Cereblon-Related Immunomodulatory DrugResistance in Commpass Multiple Myeloma Patients","keywords":"","combinedName":"doctor sheri skerget"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Yawara ","lastName":"Kawano ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Altered Expression of CCR10 Indicates Malignant Transformation of Bone Marrow Plasma Cells","keywords":"","combinedName":"doctor yawara kawano"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Alessandra ","lastName":"Romano ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Arginine Deprivation Sustains Plasma Cell Fitness Via GCN2: A Novel Immuno-Metabolic Check-Point","keywords":"","combinedName":"doctor alessandra romano"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Francesco ","lastName":"Maura ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biological and Prognostic Impact of Apobec-Induced Mutations in the Spectrum of Plasma Cell Dyscrasias","keywords":"","combinedName":"doctor francesco maura"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Giovanni ","lastName":"Palladini ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biomarker-Based Screening of Organ Dysfunction in Patients with MGUS Allows Early Diagnosis of AL Amyloidosis","keywords":"","combinedName":"doctor giovanni palladini"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Xin ","lastName":"Zhan ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Investigation of Mitochondrial Biogenesis in Multiple Myeloma","keywords":"","combinedName":"doctor xin zhan"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Anil ","lastName":"Aktas Samur ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonality Analysis Reveals the Order of Acquisition of Copy Number Alterations in Multiple Myeloma","keywords":"","combinedName":"doctor anil aktas samur"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Angelique ","lastName":"Bruyer ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Inhibition of Chk1 and Wee1 As a New Therapeutic Strategy for High-Risk Multiple Myeloma Patients","keywords":"","combinedName":"doctor angelique bruyer"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Samuel ","lastName":"Danziger ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deconvolution of the Immune Microenvironment Can Predict the Outcome of Myeloma Patients and Inform Potential Intervention Strategies","keywords":"","combinedName":"doctor samuel danziger"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Natalia ","lastName":"Neparidze ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of New Scoring System for Whole Body Magnetic Resonance Imaging for Evaluation of Multiple Myeloma Lesions","keywords":"","combinedName":"doctor natalia neparidze"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Christof ","lastName":"Scheid ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Direct Assessment of IgA and IgG Paraprotein By Hevylite Assay and Correlation to IMWG Response and Progression-Free Survival in Newly Diagnosed, Transplant-Eligible Multiple Myeloma Patients in the Prospective Phase III GMMG-MM5 Trial","keywords":"","combinedName":"doctor christof scheid"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Laure ","lastName":"Maneix ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dynamic Regulation of Histone Acetylation By Nuclear Proteolysis Controls Cell Cycle Gene Expression and Chromosome Integrity in Multiple Myeloma","keywords":"","combinedName":"doctor laure maneix"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Benjamin ","lastName":"Barwick ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Risk Myeloma Is Demarcated By Immunoglobulin Lambda Light Chain Translocations","keywords":"","combinedName":"doctor benjamin barwick"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Benoit ","lastName":"Tessoulin ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Human Myeloma Cell Lines Mutation Landscape: Toward a Rationale Use of Cell Lines to Assess Drug Efficacy Prediction in Myeloma","keywords":"","combinedName":"doctor benoit tessoulin"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Kentaro ","lastName":"Serizawa ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of a Patients-Derived CD34+ Myeloma Cell Population with Tumor-Propagating Capacity and Resistance to Anticancer Drugs","keywords":"","combinedName":"doctor kentaro serizawa"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Haimeng ","lastName":"Yan ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IL-32? Induces M2 Macrophage Polarization with Enhanced Ability of Macrophage-Mediated Drug Resistance in Myeloma Cells through STAT3 and NF-?b Activation","keywords":"","combinedName":"doctor haimeng yan"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Amy L","lastName":"Sherborne ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improving Outcomes for Patients with High-Risk Myeloma Via Prospective Trial Evidence: The Myeloma UK Nine Optimum Trial","keywords":"","combinedName":"doctor amy l sherborne"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Phaik Ju ","lastName":"Teoh ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"JMJD3 Is a Potential Tumor Suppressor Gene That Cooperates with TP53in Chromosome 17p13","keywords":"","combinedName":"doctor phaik ju teoh"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Hugues ","lastName":"de Boussac ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Kinome Expression Profiling in Multiple Myeloma Identifies New Therapeutic Targets","keywords":"","combinedName":"doctor hugues de boussac"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Samar ","lastName":"Masoumi Moghaddam ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"KRAS-Mutated Myeloma Cells Exploit Autophagy and Macropinocytosis to Tolerate Glutamine-Deprived Conditions","keywords":"","combinedName":"doctor samar masoumi moghaddam"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Giovanni ","lastName":"Palladini ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Liver Involvement and d FLC Level Affect Survival of Patients with Non-Cardiac Light Chain Amyloidosis: A European Study of 334 Patients","keywords":"","combinedName":"doctor giovanni palladini"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Nicola ","lastName":"Amodio ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"LNA -Gapmer Antisense Oligonucleotides Targeting the Oncogenic Lncrna MALAT1 Trigger Anti-Multiple Myeloma Activity By Proteasome Blockade","keywords":"","combinedName":"doctor nicola amodio"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Gabriel ","lastName":"Pagnotti ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low Intensity Vibration Treatment Reduces Myeloma Cell-Induced Osteoclast Formation By Inhibiting IL-6 and GFI-1 Production By MM Cells","keywords":"","combinedName":"doctor gabriel pagnotti"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Tina ","lastName":"Bagratuni ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Characterization of WaldenstrMs Macroglobulinemia Patients Using Peripheral Blood Cell-Free Tumor DNA","keywords":"","combinedName":"doctor tina bagratuni"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Albana ","lastName":"Lico ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloma Lytic Bone Lesions Characterization with WB-LDCT and 18f-FDG PET/MRI","keywords":"","combinedName":"doctor albana lico"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Heather ","lastName":"Fairfield ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloma-Associated Adipocytes Exhibit Reduced Adipogenic Gene Expression and Delipidation","keywords":"","combinedName":"doctor heather fairfield"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Xi ","lastName":"Huang ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NEDD4-1 Modulates the Resistance of Multiple Myeloma to Bortezomib Via PTEN/PI3K/Akt Signaling Pathway","keywords":"","combinedName":"doctor xi huang"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Alejandro ","lastName":"Medina ","credentials":"BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Alternatives for the Evaluation of Minimal Residual Disease (MRD) Detection By Next Generation Sequencing in Multiple Myeloma","keywords":"","combinedName":"doctor alejandro medina"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Hiroki ","lastName":"Kobayashi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Significance of Medullary Abnormalities of the Appendicular Skeleton Detected By Low-Dose Whole-Body Multidetector Computed Tomography in Patients with Multiple Myeloma","keywords":"","combinedName":"doctor hiroki kobayashi"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"David ","lastName":"Coffey ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Simultaneous Detection of Single Nucleotide Variants and Expression of RNA and Protein in Multiple Myeloma Bone Marrow Aspirates","keywords":"","combinedName":"doctor david coffey"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Syed ","lastName":"Mehdi ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Cell Analysis of Mesenchymal Stem Cells Reveals Their Molecular and Functional Heterogeneity in Myeloma","keywords":"","combinedName":"doctor syed mehdi"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Moritz ","lastName":"Binder ","credentials":"MD,MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Substratification of Patients with Newly Diagnosed Standard-Risk Multiple Myeloma","keywords":"","combinedName":"doctor moritz binder"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Fani ","lastName":"Ziouti ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Remodeling of the Tumor Microenvironment Via Mechanical Stimulation Defines a Novel Therapeutic Strategy in Myeloma Bone Disease","keywords":"","combinedName":"doctor fani ziouti"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Emanuela ","lastName":"Vicario ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Exosomes-Derived EGFR Ligand Amphiregulin (AREG) Is a New Pro-Osteoclastogenic Factor in Multiple Myeloma","keywords":"","combinedName":"doctor emanuela vicario"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Marina ","lastName":"Martello ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Pliancy of Plasma Cell Differentiation Status Conceals a Gradient of Chromosomal Instability in Newly Diagnosed Multiple Myeloma Patients","keywords":"","combinedName":"doctor marina martello"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Moshe ","lastName":"Gatt ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of CD24 in Multiple Myeloma Tumorigenicity and the Effect of the Microenvironment on CD24 Expression","keywords":"","combinedName":"doctor moshe gatt"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Nicholas ","lastName":"Banovich ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Using Single Cell RNA Sequencing to Characterize Cell-Type Specific Gene Expression in a Mouse Model of Multiple Myeloma Treated with the cIAP Antagonist LCL161","keywords":"","combinedName":"doctor nicholas banovich"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Shebli ","lastName":"Atrash ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of Dynamic Biomarker-Based Risk Progression Model for Smoldering Multiple Myeloma","keywords":"","combinedName":"doctor shebli atrash"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Fotios ","lastName":"Asimakopoulos ","credentials":"PhD,MBBChir,","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Versican (VCAN) Proteolysis Predicts T-Cell Infiltration in Myeloma Bone Marrow Post- Autologous Stem Cell Transplant (ASCT)","keywords":"","combinedName":"doctor fotios asimakopoulos"},{"sessionId":"11673","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I","firstName":"Yan ","lastName":"Xu ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ywhae Located on Chromosome 17p13 Promotes Myeloma Cells Proliferation Via Induction of Anti-Apoptosis and Survival Signaling Pathways","keywords":"","combinedName":"doctor yan xu"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Aki ","lastName":"Yanagi ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"B Cell-Derived Induced Pluripotent Stem Cells Are Useful for Determining the Cellular Origin of Abnormal B Cells in Multiple Myeloma","keywords":"","combinedName":"doctor aki yanagi"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Katja ","lastName":"Klausz ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD75s Represents a Therapeutic Target for Antibody-Based Immunotherapy of B Cell Lymphoma and Multiple Myeloma","keywords":"","combinedName":"doctor katja klausz"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Pritesh ","lastName":"Patel ","credentials":"MB, CHB","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Nanoparticle Delivery of PARP and DNA-PK Inhibition for Multiple Myeloma","keywords":"","combinedName":"doctor pritesh patel"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Stefan ","lastName":"Mller ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epigenetic Modifications of the Bone Marrow (BM) Niche in Multiple Myeloma (MM) - a Three-Dimensional (3D) in Vitro Approach","keywords":"","combinedName":"doctor stefan mller"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Shirong ","lastName":"Li ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Germinal Center Kinase As a Therapeutic Target in Multiple Myeloma","keywords":"","combinedName":"doctor shirong li"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Paola ","lastName":"Minetto ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Glutamine-Dependence Targeting By Asparaginase Significantly Increases Anti-Myeloma Activity of Proteasome Inhibitors","keywords":"","combinedName":"doctor paola minetto"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Jason ","lastName":"Brayer ","credentials":"PhD,MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HDAC11 Is a Candidate Therapeutic Target in Multiple Myeloma","keywords":"","combinedName":"doctor jason brayer"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Arghya ","lastName":"Ray ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Metabolic Enzymes ENO1 and KMO As Novel Immunotherapeutic Targets in Myeloma","keywords":"","combinedName":"doctor arghya ray"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Enguerran ","lastName":"Mouly ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inecalcitol Induces CD38 Expression in Multiple Myeloma Cell Lines More Efficiently Than All-Trans Retinoic Acid (ATRA)","keywords":"","combinedName":"doctor enguerran mouly"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Queenie ","lastName":"Vong ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibiting TGF Signaling in CAR T-Cells May Significantly Enhance Efficacy of Tumor Immunotherapy","keywords":"","combinedName":"doctor queenie vong"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Melissa ","lastName":"Works ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lenalidomide Enhances Anti-Bcma Chimeric Antigen Receptor T Cell Function Against Multiple Myeloma","keywords":"","combinedName":"doctor melissa works"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Barbara ","lastName":"Castella ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Pathways Responsible for Adaptive Resistance to Single-Checkpoint Inhibition May Reveal Biomarkers and Immunotherapy Targets in Multiple Myeloma Patients","keywords":"","combinedName":"doctor barbara castella"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Kylee H","lastName":"Maclachlan ","credentials":"FRACP,FRCPA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Combination Therapies with the RNA Polymerase I Inhibitor CX-5461 Significantly Improve Efficacy in Multiple Myeloma","keywords":"","combinedName":"doctor kylee h maclachlan"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Arnold ","lastName":"Bolomsky ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preclinical Evaluation of the First in Class BMI1 Inhibitor PTC-028 Confirms Potent Efficacy to Target BMI1-Addiction in Multiple Myeloma","keywords":"","combinedName":"doctor arnold bolomsky"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Stephen ","lastName":"Russell ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ruxolitinib Rescues Mice from Lethal Interferon Beta Toxicity and TLS","keywords":"","combinedName":"doctor stephen russell"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Michael ","lastName":"O'Dwyer ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Siglec-7: A Novel Immunotherapeutic Approach to Potentiate the Cytotoxic Functions of Natural Killer Cells Against Multiple Myeloma","keywords":"","combinedName":"doctor michael o'dwyer"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Arne ","lastName":"Scholz ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Combination of Radium-223 Dichloride and Bortezomib Effectively Reduces Tumor Burden and Lesion Area in the Syngeneic, Systemic 5TGM1 Multiple Myeloma Mouse Model","keywords":"","combinedName":"doctor arne scholz"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Pasquale ","lastName":"Fedele ","credentials":"FRACP, FRCPA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Immunomodulatory Drugs, through Loss of Ikaros and Aiolos,DerepressCD38and FunctionallySynergise with Daratumumab","keywords":"","combinedName":"doctor pasquale fedele"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Marta ","lastName":"Chesi ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Translational Research of PT-112, a Clinical Agent in Advanced Phase I Development: Evident Bone Tropism, Synergy in Vitro with Bortezomib and Lenalidomide, and Potent Efficacy in the Vk*MYC Mouse Model of Multiple Myeloma","keywords":"","combinedName":"doctor marta chesi"},{"sessionId":"11674","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I","firstName":"Estefania ","lastName":"Garcia-Guerrero ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Upregulation of CD38 Expression on Multiple Myeloma Cells By the HDAC Inhibitor Ricolinostat Augments the Efficacy of Daratumumab","keywords":"","combinedName":"doctor estefania garcia-guerrero"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Tim ","lastName":"Luetkens ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vivo Vaccination Effect in Clinical Responders to Anti-Myeloma Monoclonal Antibody Isatuximab","keywords":"","combinedName":"doctor tim luetkens"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Darrell J","lastName":"White ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase Ib/II Trial of Selinexor Combined with Lenalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma","keywords":"","combinedName":"doctor darrell j white"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Noa ","lastName":"Biran ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Trial of the Anti -PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) + Lenalidomide + Dexamethasone As Post Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Multiple Myeloma","keywords":"","combinedName":"doctor noa biran"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Sujith ","lastName":"Dhanasiri ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Systematic Review and Network Meta-Analysis of Maintenance Treatment for Patients with Newly Diagnosed Multiple Myeloma PostAutologous Stem Cell Transplant","keywords":"","combinedName":"doctor sujith dhanasiri"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Maria Jos","lastName":"Cejalvo ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Activity and Safety of Daratumumab Monotheray in Patients with Relapsed and Refractory Multiple Myeloma Requiring Dialysis: Preliminary Results of Spanish, Retrospective, Multicenter Trial","keywords":"","combinedName":"doctor maria jos cejalvo"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Katja ","lastName":"Weisel ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Addition of Cyclophosphamide to Pomalidomide and Dexamethasone in Case of Suboptimal Response to Pomalidomide and Dexamethasone Alone in Relapsed and/or Refractory Multiple Myeloma: Results of the GMMG-Perspective Trial","keywords":"","combinedName":"doctor katja weisel"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Siyang ","lastName":"Leng ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Open-Label Phase I/II Study of Carfilzomib, Bendamustine and Dexamethasone (CBD) in Newly Diagnosed Multiple Myeloma Patients","keywords":"","combinedName":"doctor siyang leng"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Neill ","lastName":"Storrar ","credentials":"MBBChir","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Apixaban Is Safe and Effective Thromboprophylaxis in Myeloma Patients Treated with Immunomodulatory Therapy","keywords":"","combinedName":"doctor neill storrar"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"John ","lastName":"Dulos ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bion-1301, a First-in-Class APRIL Neutralizing Antibody for the Treatment of Multiple Myeloma: Preclinical Safety, and Analysis of Pharmacokinetics - Pharmacodynamics Relationship","keywords":"","combinedName":"doctor john dulos"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Richez ","lastName":"Valentine ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Carfilzomib Weekly 20/56mg/m, Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma","keywords":"","combinedName":"doctor richez valentine"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Maria ","lastName":"Chaudhry ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Carfilzomib-Based Combination Regimens Are Highly Effective Frontline Therapies for Multiple Myeloma and WaldenstrMs Macroglobulinemia","keywords":"","combinedName":"doctor maria chaudhry"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Hian Li Esther ","lastName":"Chan ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Benefit of Depth of Response for Relapsed/Refractory Multiple Myeloma Patients Treated on Clinical Trials: Retrospective Analysis from Two Tertiary Centres","keywords":"","combinedName":"doctor hian li esther chan"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Ajay","lastName":"Nooka","credentials":"MD,MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Characteristics and Outcomes of Myeloma Patients Exhibiting Translocation (14;16): An Ultra-High-Risk Group of Myeloma Patients","keywords":"","combinedName":"doctor ajay nooka"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Iman ","lastName":"Aboudalle ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Consolidation with Bortezomib, Lenalidomide and Dexamethasone Upgrades the Complete Remission Rate after Autologous Hematopoietic Cell Transplantation in Patients with Multiple Myeloma","keywords":"","combinedName":"doctor iman aboudalle"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Charlotte","lastName":"Pawlyn","credentials":"BA,PhD,MBBChir,MRCP,FRCPath","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Continuous Treatment with Lenalidomide Improves Outcomes in Newly Diagnosed Myeloma Patients Not Eligible for Autologous Stem Cell Transplant: Results of the Myeloma XI Trial","keywords":"","combinedName":"doctor charlotte pawlyn"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Claudie ","lastName":"Lavoie-Gagnon ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) Compared to Bortezomib-Dexamethasone (Vel-Dex) As Induction Therapy for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma","keywords":"","combinedName":"doctor claudie lavoie-gagnon"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Al-Ola ","lastName":"Abdallah ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab Combined with Pomalidomide and Dexamethasone (DPd) for Patients with Relapsed/Refractory Multiple Myeloma in a Single Institution","keywords":"","combinedName":"doctor al-ola abdallah"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Sagar","lastName":"Lonial","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab in Combination with Carfilzomib and Dexamethasone in Patients (pts) with Relapsed Multiple Myeloma (MMY1001): An Open-Label, Phase 1b Study","keywords":"","combinedName":"doctor sagar lonial"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Torben ","lastName":"Plesner ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (GEN503): Final Results of an Open-Label, Phase 1/2 Study","keywords":"","combinedName":"doctor torben plesner"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Thierry ","lastName":"Facon ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab in Combination with Pomalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma (RRMM) Patients with =2 Prior Lines of Therapy: Updated Analysis of MMY1001","keywords":"","combinedName":"doctor thierry facon"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Jack ","lastName":"Khouri ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab Is Safe and Highly Effective in AL Amyloidosis","keywords":"","combinedName":"doctor jack khouri"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Christoph ","lastName":"Kimmich ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab Monotherapy in Thirty-Two Heavily Pre-Treated Patients with Advanced Systemic Light-Chain Amyloidosis","keywords":"","combinedName":"doctor christoph kimmich"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Suzanne ","lastName":"Lentzsch ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM) Patients: An Update of Overall Survival in Castor","keywords":"","combinedName":"doctor suzanne lentzsch"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Philippe","lastName":"Moreau","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in Relapsed or Refractory Multiple Myeloma (RRMM) Based on Prior Treatment History, Renal Function, and Cytogenetic Risk: Subgroup Analyses of Pollux","keywords":"","combinedName":"doctor philippe moreau"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Howard ","lastName":"Terebelo ","credentials":"DO","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of a Prognostic Model That Predicts 3- and 5-Year Overall Survival in Multiple Myeloma Using the Connect MM Patient Registry","keywords":"","combinedName":"doctor howard terebelo"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Blythe Duke","lastName":"Sather ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of JCARH125: Optimization of a Fully Human Anti-Bcma CAR for Use in the Treatment of Multiple Myeloma","keywords":"","combinedName":"doctor blythe duke sather"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Ajai ","lastName":"Chari ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Duration of Therapy (DOT) and Time to Next Therapy (TTNT) of Bortezomib, Carfilzomib and Ixazomib Combinations with Lenalidomide/Dexamethasone (VRd, KRd, IRd) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Clinical Practice in the United States Vs Clinical Trial Experience","keywords":"","combinedName":"doctor ajai chari"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Ravi ","lastName":"Potluri ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Duration of Treatment of Multiple Myeloma Regimens in Patients with Relapsed or Refractory Multiple Myeloma: Findings in US Clinical Practice Settings","keywords":"","combinedName":"doctor ravi potluri"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Dante ","lastName":"Descalzi-Montoya ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Regulatory and Memory T Cell Profiles Post-ASCT in the Presence of Checkpoint Inhibitor (Nivolimumab+Ipilimumab) Double Therapy in Patients with High-Risk Multiple Myeloma","keywords":"","combinedName":"doctor dante descalzi-montoya"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"David M","lastName":"Foureau ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Immunomodulatory Drugs (IMiDs) on Immune Effectors after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma","keywords":"","combinedName":"doctor david m foureau"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Pilar ","lastName":"De La Puente ","credentials":"PhD, M.Sc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enhancing Proteasome-Inhibitory Activity and Specificity of Bortezomib By Endocytosis-Mediated Uptake of CD38 Targeted Nanoparticles in Multiple Myeloma","keywords":"","combinedName":"doctor pilar de la puente"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Heinz","lastName":"Ludwig","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma during Treatment with Ixazomib-Thalidomide-Dexamethasone Followed By Ixazomib Maintenance","keywords":"","combinedName":"doctor heinz ludwig"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Sridurga ","lastName":"Mithraprabhu ","credentials":"PhD, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Acetylation, Immune Cell Alterations and Gene Signature As Dynamic Biomarkers of Response to Panobinostat Treatment in Multiple Myeloma Patients","keywords":"","combinedName":"doctor sridurga mithraprabhu"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Enrique ","lastName":"Ocio ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Predictors of Response to Pembrolizumab Monotherapy As Consolidation in Multiple Myeloma Patients: Results of the GEM-Pembresid Clinical Trial","keywords":"","combinedName":"doctor enrique ocio"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Max ","lastName":"Qian ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Profile of Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM) Treated with Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) + Daratumumab (DARA) in the Second Line Immediately after Lenalidomide (LEN)","keywords":"","combinedName":"doctor max qian"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Loc ","lastName":"Renaud ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Pneumococcal Vaccination on Multiple Myeloma","keywords":"","combinedName":"doctor loc renaud"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Lorenza ","lastName":"Torti ","credentials":"PhD, MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Infections and Immune System Impairment in Multiple Myeloma: Increasing Frequency of Serious Complications in the Novel Agents Era. a Retrospective Real Life Analysis","keywords":"","combinedName":"doctor lorenza torti"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Peter ","lastName":"Voorhees ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim Safety Analysis of a Phase 2 Randomized Study of Daratumumab ?Dara?, Lenalidomide ?R?, Bortezomib ?V?, and Dexamethasone ?d; Dara-Rvd? Vs. Rvd in Patients ?Pts? with Newly Diagnosed Multiple Myeloma ?MM? Eligible for High-Dose Therapy ?HDT? and Autologous Stem Cell Transplantation ?ASCT?","keywords":"","combinedName":"doctor peter voorhees"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Galina ","lastName":"Lagos ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Term Follow up of Patients with Relapsed/Refractory Systemic Light Chain (AL) Amyloidosis Treated with Bendamustine and Dexamethasone in a Phase 2 Study","keywords":"","combinedName":"doctor galina lagos"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Rahma ","lastName":"Warsame ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Outcomes of IMiD Based Trials in Patients with Immunoglobulin Light Chain Amyloidosis (AL): A Pooled Analysis","keywords":"","combinedName":"doctor rahma warsame"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Maria-Victoria","lastName":"Mateos","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Melflufen Therapy for Relapsed Refractory Multiple Myeloma (RRMM) Patients Refractory to Daratumumab and/or Pomalidomide; A Report on Early Efficacy","keywords":"","combinedName":"doctor maria-victoria mateos"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Victor ","lastName":"Jimenez-Zepeda ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Minimal Residual Disease (MRD) Assessed By Flow Cytometry in Patients with AL Amyloidosis Treated with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD)","keywords":"","combinedName":"doctor victor jimenez-zepeda"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Cyrille ","lastName":"Hulin ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Miroir: A National, Multicenter, Non-Interventional Study of Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM) Treated with Pomalidomide (POM) in France","keywords":"","combinedName":"doctor cyrille hulin"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Pieter","lastName":"Sonneveld","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MM-013 Phase 2, Multicenter Study of Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI): Pharmacokinetics (PK) Analysis ","keywords":"","combinedName":"doctor pieter sonneveld"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Amy L","lastName":"Sherborne ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Profiling of Relapsed and Refractory Myeloma Identifies Frequent Bi-Allelic Driver Events  Interim Results of the Myeloma UK Seven Biomarker Trial","keywords":"","combinedName":"doctor amy l sherborne"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Efstathios ","lastName":"Kastritis ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Natural History and Outcomes of Asymptomatic IgM Monoclonal Gammopathy","keywords":"","combinedName":"doctor efstathios kastritis"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Felicitas -","lastName":"Hitz ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II trial - SAKK 39/10","keywords":"","combinedName":"doctor felicitas - hitz"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Selma ","lastName":"Bekri ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Neoantigen Synthetic Peptide Vaccine for Multiple Myeloma Elicits T Cell Immunity in a Pre-Clinical Model","keywords":"","combinedName":"doctor selma bekri"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Hallie ","lastName":"Barr ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ninety-Minute Daratumumab Infusion Is Safe in Multiple Myeloma","keywords":"","combinedName":"doctor hallie barr"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Sharmilan ","lastName":"Thanendrarajan ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nivolumab for Treatment of Advanced, Refractory, High-Risk Multiple Myeloma","keywords":"","combinedName":"doctor sharmilan thanendrarajan"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Ujjawal H","lastName":"Gandhi ","credentials":"PhD,MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Cardiac Biopsy Scoring Tool to Predict Clinical Outcomes in Cardiac Light Chain (AL) Amyloidosis","keywords":"","combinedName":"doctor ujjawal h gandhi"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Kwee ","lastName":"Yong ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Stratification to ASCT or Not Based on Depth of Response: Results of a Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Multiple Myeloma Patients with Deferred ASCT (PADIMAC)","keywords":"","combinedName":"doctor kwee yong"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Katja ","lastName":"Weisel ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overall Survival of Patients with Relapsed Multiple Myeloma Treated with Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone According to Prior Line of Therapy and Previous Exposure to Bortezomib: Secondary Analysis of the Phase 3 Endeavor Study","keywords":"","combinedName":"doctor katja weisel"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Ruben ","lastName":"Niesvizky ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overall Survival of Relapsed/Refractory Multiple Myeloma Patients Treated with Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone: Results from the Phase 3 Endeavor Study According to Age Subgroup","keywords":"","combinedName":"doctor ruben niesvizky"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Yonggang ","lastName":"Sha ","credentials":"Ph.D","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pan-PIM Kinase Inhibitors Enhance Lenalidomides Anti-Myeloma Activity Via Cereblon-IKZF1/3 Cascade","keywords":"","combinedName":"doctor yonggang sha"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Jooeun ","lastName":"Bae ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pembrolizumab (anti-PD-1) Treatment Increases Anti-Tumor Activities of XBP1/CD138/CS1-Specific Cytotoxic T Lymphocytes Against Multiple Myeloma","keywords":"","combinedName":"doctor jooeun bae"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Attaya ","lastName":"Suvannasankha ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 2 Study of Carfilzomib and Bone Metabolism in Patients with Relapsed Multiple Myeloma","keywords":"","combinedName":"doctor attaya suvannasankha"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"David ","lastName":"Siegel ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) Safety and Efficacy in Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM) Previously Treated with a Proteasome Inhibitor (PI) and in Whom Last Prior Therapy with Lenalidomide (LEN) Failed","keywords":"","combinedName":"doctor david siegel"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Hilma J","lastName":"van der Horst ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Potent Ex Vivo Anti-Tumor Activity in Relapsed Refractory Multiple Myeloma Using Novel DR5-Specific Antibodies with Enhanced Capacity to Form Hexamers upon Target Binding","keywords":"","combinedName":"doctor hilma j van der horst"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Antoine ","lastName":"Machet ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Significance of Plasmablastic Plasma Cells in the Era of Novel Agents in Multiple Myeloma","keywords":"","combinedName":"doctor antoine machet"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Richa ","lastName":"Manwani ","credentials":"MBBS, FRCPath, BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prolonged Progression Free Survival and Time to Next Treatment Are Achievable Outcomes in Patients with Systemic AL Amyloidosis Treated with Novel Agent Chemotherapy: Analysis of the Alchemy Study","keywords":"","combinedName":"doctor richa manwani"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Robert Frank","lastName":"Cornell ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prospective Study of Cardiac Events during Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma","keywords":"","combinedName":"doctor robert frank cornell"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Ivan ","lastName":"Spicka ","credentials":"MD PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Randomized Phase III Study (ADMYRE) of Plitidepsin in Combination with Dexamethasone Vs. Dexamethasone Alone in Patients with Relapsed/Refractory Multiple Myeloma","keywords":"","combinedName":"doctor ivan spicka"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Gergely ","lastName":"Varga ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real World Data on the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program","keywords":"","combinedName":"doctor gergely varga"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Maria-Victoria ","lastName":"Mateos ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Relapsed or Refractory Multiple Myeloma Patients Treated with Second-Line Carfilzomib and Categorized By Prior Exposure to Bortezomib: A Subgroup Analysis of the Randomized Phase 3 Aspire and Endeavor Trials","keywords":"","combinedName":"doctor maria-victoria mateos"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Yara ","lastName":"Torres ","credentials":"CPA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Renal Response in Relapsed Refractory Multiple Myeloma Patients with Severe Renal Impairment at treatment Initiation: Intermediate Data of a Large, Observational, Prospective Study","keywords":"","combinedName":"doctor yara torres"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Habte ","lastName":"Yimer ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results of an Interim Safety Analysis of a Phase 2 Study of Daratumumab (Dara) Plus Cyclophosphamide, Bortezomib, and Dexamethasone ?CyBorD? in Previously Untreated and Relapsed Patients ?Pts? with Multiple Myeloma ?MM?","keywords":"","combinedName":"doctor habte yimer"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Richa ","lastName":"Manwani ","credentials":"MBBS, FRCPath, BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Deferred Autologous Stem Cell Transplantation in Patients with Systemic AL Amyloidosis with Significant Cardiac Involvement at Presentation","keywords":"","combinedName":"doctor richa manwani"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Enrique ","lastName":"Ocio ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Filanesib in Combination with Pomalidomide and Dexamethasone in Refractory MM Patients. Phase Ib/II Pomdefil Clinical Trial Conducted By the Spanish MM Group","keywords":"","combinedName":"doctor enrique ocio"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"David ","lastName":"Siegel ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) + Daratumumab (DARA) As Second- or Third-Line Therapy in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM) after Lenalidomide (LEN)-Based Treatment (Tx)Failure","keywords":"","combinedName":"doctor david siegel"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Shivaprasad ","lastName":"Manjappa ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Statin Use Is Associated with Decreased Mortality in Multiple Myeloma- a SEER Medicare Study","keywords":"","combinedName":"doctor shivaprasad manjappa"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Meletios ","lastName":"Dimopoulos","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Superior Efficacy of Carfilzomib and Dexamethasone (Kd56) Vs Bortezomib and Dexamethasone (Vd) in Multiple Myeloma (MM) Patients with Moderate or Serious Renal Failure: A Subgroup Analysis of the Phase 3 Endeavor Study","keywords":"","combinedName":"doctor meletios dimopoulos"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Jianjun ","lastName":"Zhao ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting the MALAT1/PARP1/LIG3 Complex Induces DNA Damage and Apoptosis in Multiple Myeloma Mouse Models","keywords":"","combinedName":"doctor jianjun zhao"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Sang-A ","lastName":"Kim ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thalidomide and Dexamethasone Maintenance after Autologous Stem Cell Transplantation in Newly Diagnosed Korean Multiple Myeloma Patients: A Prospective Multi-Center Study in Asia","keywords":"","combinedName":"doctor sang-a kim"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Zack ","lastName":"Breckenridge ","credentials":"BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Evolving Impact on Survival Outcomes in Multiple Myeloma with Greater Access to Novel Treatment Regimens: Experience in a Real-World Cohort","keywords":"","combinedName":"doctor zack breckenridge"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Mohamed ","lastName":"Awwad ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Prognostic and Predictive Value of IKZF1 and IKZF3 Expression in T-Cells in Patients with Multiple Myeloma","keywords":"","combinedName":"doctor mohamed awwad"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Ho Sup ","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"the Safety and Efficacy of Pomalidomide in Combination with Cyclophosphamide and Dexamethasone (PCD) in the Transplant-Ineligible Patients with Relapsed and/or Refractory Multiple Myeloma (MM) Who Had Lenalidomide Plus Dexamethasone (LD) Following Frontline Bortezomib Combined Chemotherapy, Open-Labeled, Multicenter Phase II Study","keywords":"","combinedName":"doctor ho sup lee"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Stephanie ","lastName":"Guidez ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Time to Improve Bortezomib and Lenalidomide Lines of Therapy","keywords":"","combinedName":"doctor stephanie guidez"},{"sessionId":"11675","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster I","firstName":"Paul G","lastName":"Richardson ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Updated Results from a Phase Ib Study of Isatuximab Plus Pomalidomide (Pom) and Dexamethasone (dex) in Relapsed/Refractory Multiple Myeloma (RRMM)","keywords":"","combinedName":"doctor paul g richardson"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Craig ","lastName":"Byersdorfer ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Role for AMP-Activated Protein Kinase (AMPK)in Controlling T Cell Sensitivity to IL-6","keywords":"","combinedName":"doctor craig byersdorfer"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Mark ","lastName":"Wroblewski ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BET-Inhibition By JQ1 Promotes Proliferation and Self-Renewal Capacity of Hematopoietic Stem Cells","keywords":"","combinedName":"doctor mark wroblewski"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Nicholas ","lastName":"Ahn ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Utero Hematopoietic Cell Transplantation of Lineage- c-Kit- Sca-1- Cells Is Responsible for Tolerance Induction","keywords":"","combinedName":"doctor nicholas ahn"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Makoto ","lastName":"Nakamura ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Liposomal Alpha-Galactosylceramide Ameliorates Graft-Versus-Host Disease with Remaining Intensified GVL Gained By Dose-Reduction of Posttransplant Cyclophosphamaide after Haploidentical HSCT","keywords":"","combinedName":"doctor makoto nakamura"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Adam ","lastName":"Hartigan ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Non-Genotoxic Conditioning for Hematopoietic Stem Cell Transplant Using a Human Antibody Drug Conjugate Targeting C-KIT","keywords":"","combinedName":"doctor adam hartigan"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Steven D","lastName":"Levin ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Variant Ig Domain (vIgD) Proteins Generated Via Directed Evolution of Igsf Domains Have Therapeutic Efficacy in Animal Models of Graft Versus Host Disease","keywords":"","combinedName":"doctor steven d levin"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Anna ","lastName":"Staffas ","credentials":"PhD, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone-Marrow Transplantation in Mice","keywords":"","combinedName":"doctor anna staffas"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Lan ","lastName":"Zhou ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"O-Fucose and Fringe-Modified Recombinant Notch Peptides As Decoy Molecules to Promote Hematopoietic Progenitor Mobilization","keywords":"","combinedName":"doctor lan zhou"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Toshihiro ","lastName":"Fujiki ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prophylactic Effects of Recombinant Thrombomodulin Against Sclerodermatous Chronic Graft-Versus-Host Disease in a Rodent Model","keywords":"","combinedName":"doctor toshihiro fujiki"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Susan ","lastName":"Dewolf ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantifying the Size and Diversity of the Human Alloresponse Via High-Throughput T Cell Receptor Sequencing","keywords":"","combinedName":"doctor susan dewolf"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Ying ","lastName":"Huang ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Glucose Transporter 1 in Graft-Versus-Host Disease and Graft-Versus-Tumor Effect","keywords":"","combinedName":"doctor ying huang"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"James ","lastName":"Driscoll ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Cell Transcriptomicsof Human Plasma Cells from HLA-Sensitized PatientsReveals Population Heterogeneity and Drug Resistance Adaptations","keywords":"","combinedName":"doctor james driscoll"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Julian D","lastName":"Down ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Application of 'Drug-Reversible' CAR-T Cells Directed Against Recipient Hematopoietic Cells As a Selective Conditioning Strategy for Stem Cell Transplantation","keywords":"","combinedName":"doctor julian d down"},{"sessionId":"11676","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster I","firstName":"Toshihito ","lastName":"Hirai ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment of Donors with Liposomal Alpha-Galactosylceramide Results in the In Vivo Expansion of Invariant Natural Killer T Cells and Reduced Incidence of Acute Graft Versus Host Disease","keywords":"","combinedName":"doctor toshihito hirai"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Emily ","lastName":"Blyth ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"3rd Party CMV-Specific T Cells Provide Long Term Protection Against Episodes of Recurrent CMV after Allogeneic Stem Cell Transplant Despite Lack of Persistence in Peripheral Blood","keywords":"","combinedName":"doctor emily blyth"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Wai-Hang ","lastName":"Leung ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Drug-Regulated CAR Platform (DARIC) Induces Effective and Reversible Tumor Control In Vivo Using Non-Immunosuppressive Rapamycin Dosing","keywords":"","combinedName":"doctor wai-hang leung"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Ramakrishnan ","lastName":"Gopalakrishnan ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Method for Highly Sensitive Detection and Isolation of Chimeric Antigen Receptor and Cancer Associated Antigen-Expressing Cells","keywords":"","combinedName":"doctor ramakrishnan gopalakrishnan"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Benjamin ","lastName":"Boyerinas ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel TGF-/Interleukin Receptor Signal Conversion Platform That Protects CAR/TCR T Cells from TGF--Mediated Immune Suppression and Induces T Cell Supportive Signaling Networks","keywords":"","combinedName":"doctor benjamin boyerinas"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Wei ","lastName":"Zhang ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anti-CD123 CAR T-Cell Therapy for the Treatment of Myelodysplastic Syndrome","keywords":"","combinedName":"doctor wei zhang"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Joseph A","lastName":"Fraietta ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Evidence That Deficiency of the Methylcytosine Dioxygenase TET2 Gene Promotes the Clonal Expansion and Therapeutic Efficacy of CD19-Directed T Cells","keywords":"","combinedName":"doctor joseph a fraietta"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Hung D","lastName":"Nguyen ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Complement Promotes Gvhdthrough Suppressing Autophagy in Recipient Dendritic Cells after Allogeneic Hematopoietic Cell Transplantation in Mice","keywords":"","combinedName":"doctor hung d nguyen"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Marcel ","lastName":"Maluski ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Co-Transplantation of CAR-Gene Engineered Precursor T Cells Leads to Suppressed T Cell Development and Increased NK Cell-Based CAR-Mediated Anti-Leukemic Activity","keywords":"","combinedName":"doctor marcel maluski"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Masaki ","lastName":"Maruta ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of T-Cell Therapy By Exploiting Modified Antibodies Specific for A2/NY-ESO-1 for Refractory Myeloma","keywords":"","combinedName":"doctor masaki maruta"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Lauren C","lastName":"Fleischer ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Engineering CD5-Targeted Chimeric Antigen Receptors and Edited T Cells for the Treatment of T-Cell Leukemia","keywords":"","combinedName":"doctor lauren c fleischer"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Ye Ethan Ethan","lastName":"Li ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Engineering Human Induced Pluripotent Stem Cells with Novel Chimeric Antigen Receptors to Generate Natural Killer (NK) Cell Cancer Immunotherapies with Targeted Anti-Tumor Activity","keywords":"","combinedName":"doctor ye ethan ethan li"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Premal ","lastName":"Lulla ","credentials":"MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluating Cyclin A1 As an Immunotherapeutic Target in Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor premal lulla"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Michael S","lastName":"Magee ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gene Editing of TracLocus Utilizing Megatal Nucleases Increases Expression of Transgenic TCRs Delivered Via Lentiviral Vector-Mediated Gene Transfer","keywords":"","combinedName":"doctor michael s magee"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Christian ","lastName":"Seitz ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Adapter Chimeric Antigen Receptor (aCAR) T Cells for Temporally Controllable Targeting of Single and Multiple Tumor Antigens","keywords":"","combinedName":"doctor christian seitz"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Kazusa ","lastName":"Ishii ","credentials":"MD,MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Perforin Is Dispensable for Anti-CD19 CAR-T Cell Cytotoxicity but Contributes to CAR-T Cell Contraction and Regulates Host Inflammatory Response","keywords":"","combinedName":"doctor kazusa ishii"},{"sessionId":"11677","sessionTitle":"703. Adoptive Immunotherapy: Poster I","firstName":"Ram K","lastName":"Malladi ","credentials":"FRCPath","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Vaccination with a DNA and MVA 'Prime-Boost' Regimen Induces Strong CD8+ T-Cell Responses Against the Immunodominant Minor Histocompatibility Antigen, HA-1: Results of a First-in-Man Phase I Clinical Trial","keywords":"","combinedName":"doctor ram k malladi"},{"sessionId":"11678","sessionTitle":"711. Cell Collection and Processing: Poster I","firstName":"Sergey ","lastName":"Shevkoplyas ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel High-Throughput Microfluidic Technology for Isolating Lymphocytes from Buffy Coats for Allogeneic Cellular Therapies","keywords":"","combinedName":"doctor sergey shevkoplyas"},{"sessionId":"11678","sessionTitle":"711. Cell Collection and Processing: Poster I","firstName":"Nicole ","lastName":"Prokopishyn ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bone Marrow Transplant Product Quality Has Decreased over Time, a Retrospective Examination of NMDP Collected Bone Marrow Products from 1994-2016","keywords":"","combinedName":"doctor nicole prokopishyn"},{"sessionId":"11678","sessionTitle":"711. Cell Collection and Processing: Poster I","firstName":"Michael ","lastName":"Chu ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Detection of Minimal Residual Disease in Autograft Is Prognostic of Survival Following Stem Cell Transplant in Multiple Myeloma","keywords":"","combinedName":"doctor michael chu"},{"sessionId":"11678","sessionTitle":"711. Cell Collection and Processing: Poster I","firstName":"Lotte ","lastName":"van der Wagen ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of Bone Marrow Derived MSC for Steroid Refractory Acute Gvhd Associates with Age and a Defined Molecular Profile of MSC Donors","keywords":"","combinedName":"doctor lotte van der wagen"},{"sessionId":"11678","sessionTitle":"711. Cell Collection and Processing: Poster I","firstName":"Cynthia ","lastName":"Giver ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hierarchical Differences in Defensin Gene Expression in Plasmacytoid Dendritic Cells and Progenitor Cells from Five Different Hematopoietic Stem Cell Transplant Graft Types","keywords":"","combinedName":"doctor cynthia giver"},{"sessionId":"11678","sessionTitle":"711. Cell Collection and Processing: Poster I","firstName":"Conrad Russell Young","lastName":"Cruz","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Human Papillomavirus (HPV)--Specific T-Cells Can be Generated from Unimmunized Donors for Third Party Cell Therapy of HPV-Associated Neoplasms","keywords":"","combinedName":"doctor conrad russell young cruz"},{"sessionId":"11678","sessionTitle":"711. Cell Collection and Processing: Poster I","firstName":"Issa ","lastName":"Khouri ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ofatumumab, Very Late Antigen 4 (VLA4), and Dendritic Cells inPatients Undergoing Autologous Peripheral Blood Stem Cell (PBSC) Mobilization and Transplantation (ASCT) for Relapsedb-Cell Non-Hodgkins Lymphomas (NHL)","keywords":"","combinedName":"doctor issa khouri"},{"sessionId":"11678","sessionTitle":"711. Cell Collection and Processing: Poster I","firstName":"Talib ","lastName":"Dosani ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plerixafor Overcomes Lenalidomide-Associated Stem Cell Collection Failure and Affects Collected Myeloid and Erythroid Progenitors","keywords":"","combinedName":"doctor talib dosani"},{"sessionId":"11678","sessionTitle":"711. Cell Collection and Processing: Poster I","firstName":"Patrick ","lastName":"Falahee ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Combination of GRO and AMD3100 Leads to Rapid and Robust Mobilization of Hematopoietic Stem Cells in Nonhuman Primates","keywords":"","combinedName":"doctor patrick falahee"},{"sessionId":"11678","sessionTitle":"711. Cell Collection and Processing: Poster I","firstName":"Sergey ","lastName":"Shevkoplyas ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Towards a Closed System for Extracting Lymphocytes from Whole Blood","keywords":"","combinedName":"doctor sergey shevkoplyas"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Yago ","lastName":"Nieto ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" Gemcitabine/Clofarabine/Busulfan: A New MyeloablativeReduced-Toxicity Conditioning Regimen with High Activity for Allogeneic Stem-Cell Transplant (alloSCT) in Aggressive Lymphomas  ","keywords":"","combinedName":"doctor yago nieto"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Karen ","lastName":"Sweiss ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Kidney Injury before Day 90 Predicts for Both Early and Late Mortality after FluBu4","keywords":"","combinedName":"doctor karen sweiss"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Kazuhiko ","lastName":"Ikeda ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adverse Events Associated with Cryopreserved and Non-Cryopreserved Hematopoietic Stem Cell Infusion: A Prospective and Multicenter Surveillance Study","keywords":"","combinedName":"doctor kazuhiko ikeda"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Stefan ","lastName":"Ciurea ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Transplantation for TP53+ AML: Prognostic Factors for Survival","keywords":"","combinedName":"doctor stefan ciurea"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Jung Yoon ","lastName":"Choi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of Genetic Variants Related to the Hepatic Veno-Occlusive Disease in Pediatric Patients Receiving HSCT with Targeted Dose Busulfan Based Conditioning","keywords":"","combinedName":"doctor jung yoon choi"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Timo ","lastName":"Funk ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of Risk Factors Regarding Short- and Long-Term Mortality of Critically Ill Patients with Hematologic Malignancies or Following Stem Cell Transplantation Requiring Treatment on the Intensive Care Unit","keywords":"","combinedName":"doctor timo funk"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Amandine ","lastName":"Le Bourgeois ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clofarabine/Busulfan-Based Reduced Intensity Conditioning Regimens Provides Very Good Survivals in Patients Allografted in Remission for Acute Myeloid Leukemia: A Retrospective Study on Behalf of the SFGM-TC","keywords":"","combinedName":"doctor amandine le bourgeois"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Patrice ","lastName":"Chevallier ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clofarabine-Based Reduced Intensity Conditioning Regimen with Post-Transplant Cyclophosphamide and Peripheral Stem Cell Graft in Adults with Myeloid Malignancies: Results of the Clo-Baltimore Regimen","keywords":"","combinedName":"doctor patrice chevallier"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Joshua ","lastName":"Fein ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comorbidity-Driven Risk across Preparative Regimens for Allogeneic Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor joshua fein"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Eun Sang ","lastName":"Rhee ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparable Clinical Outcomes between Haploidentical Family Donor and Other Donor Types after Hematopoietic Stem Cell Transplantation for Rare Pediatric Rare non-Malignant Diseases","keywords":"","combinedName":"doctor eun sang rhee"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Angeliki ","lastName":"Xagorari ","credentials":"DPhil","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Evaluation of CD34+/CD33+/CD3+/CD19+ Microparticles in Peripheral Blood of Patients during Allogeneic Stem Cell Transplantation","keywords":"","combinedName":"doctor angeliki xagorari"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Nico ","lastName":"Gagelmann ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in Allogeneic Stem Cell Transplantation: Systematic Literature Review and Network Meta-Analysis","keywords":"","combinedName":"doctor nico gagelmann"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Phuong ","lastName":"Vo ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Durable Remission of Refractory and Advanced Stage Mycosis Fungoides/Sezary Syndrome (MF/SS) Utilizing an Outpatient Alemtuzumab and Fludarabine-Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)","keywords":"","combinedName":"doctor phuong vo"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Armin ","lastName":"Rashidi ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early HHV-6 Reactivation in CMV-Seronegative Cord Blood Transplant Recipients Is Associated with Inferior Relapse-Free and Overall Survival","keywords":"","combinedName":"doctor armin rashidi"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Nancy ","lastName":"Kernan ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Defibrotide in Pediatric Patients with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Stem Cell Transplantation (HSCT): Final Results from the Expanded-Access Program","keywords":"","combinedName":"doctor nancy kernan"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Ivan S","lastName":"Moiseev ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Clinical and Morphological Practices in the Diagnosis of Transplant-Associated Microangiopathy: A Study on Behalf of the Complications and Quality of Life Working Party of the EBMT","keywords":"","combinedName":"doctor ivan s moiseev"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Nelli ","lastName":"Bejanyan ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HHV-6 Prophylaxis with Foscanet Improves Hematopoietic Engraftment after Umbilical Cord Blood Transplantation","keywords":"","combinedName":"doctor nelli bejanyan"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"David J M","lastName":"Routledge ","credentials":"MSc, PGCert, MRCP, FRCPath","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hospital in the Home Delivery of Conditioning Therapy for Allogeneic Haematopoietic Stem Cell Transplantation: A Novel Single Centre Patient Focused Approach","keywords":"","combinedName":"doctor david j m routledge"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Stalin ","lastName":"Ramprakash ","credentials":"MD, MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Splenomegaly on Outcomes of Fully Matched Sibling Bone Marrow Transplant Among Children with Low Risk Thalassemia","keywords":"","combinedName":"doctor stalin ramprakash"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Yannick ","lastName":"LE Bris ","credentials":"MD,PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mixed Chimerism of Bone Marrow CD34+ Sorted Cells after Matched or Haploidentical Allogeneic Stem Cell Transplantation for Myeloid Malignancies Is Predictive of Relapse","keywords":"","combinedName":"doctor yannick le bris"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Jeremy ","lastName":"Pappacena ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)","keywords":"","combinedName":"doctor jeremy pappacena"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Lizamarie ","lastName":"Bachier Rodriguez ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Risk Factors for Epstein-Barr Virus (EBV) Reactivation and Post-Transplant Lymphoproliferative Disorder (PTLD) after Allogeneic Hematopoietic Stem Cell Transplant","keywords":"","combinedName":"doctor lizamarie bachier rodriguez"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Perla Rocio","lastName":"Colunga Pedraza ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center","keywords":"","combinedName":"doctor perla rocio colunga pedraza"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Paul G","lastName":"Richardson ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pooled Analysis of Day +100 Survival for Defibrotide-Treated Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) and Ventilator or Dialysis Dependence Following Hematopoietic Stem Cell Transplantation (HSCT)","keywords":"","combinedName":"doctor paul g richardson"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Ramzi ","lastName":"Abboud ","credentials":"MD, BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pretransplant Clinical Factors Can be Used to Predict the Risk of Cytokine Release Syndrome after Haploidentical Peripheral Blood Transplantation","keywords":"","combinedName":"doctor ramzi abboud"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Satoru ","lastName":"Nanno ","credentials":"MD,PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Transplant Transferrin Saturation Levels As a Predictive Marker for Invasive Fungal Disease Following Allogeneic Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor satoru nanno"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Josu ","lastName":"de la Fuente ","credentials":"FRCP, PhD, FRCPath","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Transplantation Suppression of Haemopoiesis Is Associated with a High Rate of Macrophage Activation Syndrome in Ptcy Haploidentical Transplantation for Haemoglobinopathies","keywords":"","combinedName":"doctor josu de la fuente"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Senji ","lastName":"Kasahara ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prospective Phase? Study of Reduced Toxicity Conditioning Consisted of High Dose-Cytarabine, Fludarabine, Cyclophosphamide +/- Total Body Irradiation Followed By Allogeneic Stem Cell Transplantation","keywords":"","combinedName":"doctor senji kasahara"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Sumithira ","lastName":"Vasu ","credentials":"MD,MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Response Rates, Non-Relapse Mortality, and Financial Implications of Transplant-Associated Thrombotic Microangiopathy Treated with Eculizumab","keywords":"","combinedName":"doctor sumithira vasu"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Karen ","lastName":"Sweiss ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Similar Survival but Increased Toxicity with a Sequential Versus Concurrent FluBu4 Regimen","keywords":"","combinedName":"doctor karen sweiss"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Issam ","lastName":"Hamadeh ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tacrolimus Pharmacogenetics and Steady State Drug Concentrations in Cancer Patients Undergoing Allogeneic Stem Cell Transplantation","keywords":"","combinedName":"doctor issam hamadeh"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Yasser ","lastName":"Khaled ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T-Cell Replete Peripheral Blood Haploidentical Transplant Using Immunogenic Dose of Cyclophosphamide with Fludarabine and Melphalan Results in Enhanced Cytokine Release Syndrome (CRS) with Robust Immune Recovery and Low Relapse Rates","keywords":"","combinedName":"doctor yasser khaled"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Monica ","lastName":"Fung ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Discover Trial: Application of the Karius Plasma Next-Generation Sequencing Test for Pathogen Detection in Allogeneic Stem-Cell Transplant Patients","keywords":"","combinedName":"doctor monica fung"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Dolores ","lastName":"Grosso ","credentials":"DNP, CRNP","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Presence of Recipient CMV Immunodominant Human Leukocyte Antigen (HLA) Alleles Affect Outcomes after Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)","keywords":"","combinedName":"doctor dolores grosso"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Martin ","lastName":"Schmidt-Hieber ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Prognostic Impact of the Donor/Recipient CMV Serostatus in Patients with Different Chronic Hematological Disorders after Allogeneic Hematopoietic Stem Cell Transplantation: A Report from the Infectious Diseases Working Party of EBMT","keywords":"","combinedName":"doctor martin schmidt-hieber"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Paolo ","lastName":"Caimi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment of Secondary Post-Transplant Engraftment Failure with Donor CD34+ Enriched, T-Cell Depleted Peripheral Blood Stem Cells Isolated By the Clinimacs System","keywords":"","combinedName":"doctor paolo caimi"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Tapani ","lastName":"Ruutu ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Busulfan in Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Adults: A Survey By the Complications and Quality of Life Working Party of the EBMT","keywords":"","combinedName":"doctor tapani ruutu"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Anant ","lastName":"Gokarn ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant","keywords":"","combinedName":"doctor anant gokarn"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Abhinita S","lastName":"Mohanty ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Next Generation Sequencing and Single Nucleotide Polymorphism (SNP) Fingerprinting to Assess Post Transplant Engraftment Status","keywords":"","combinedName":"doctor abhinita s mohanty"},{"sessionId":"11679","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I","firstName":"Zinaida ","lastName":"Peric ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Variability of Nutritional Practices in Peritransplant Period after Allogeneic Hematopoietic Stem Cell Transplantation: A Survey By the Complications and Quality of Life Working Party of the EBMT","keywords":"","combinedName":"doctor zinaida peric"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Ifigeneia ","lastName":"Tzannou ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adoptive Immunotherapy with Rapidly-Generated Multivirus-Specific T Cells Against Adv, EBV, CMV, HHV6 and BK after Allogeneic Hematopoietic Stem Cell Transplant","keywords":"","combinedName":"doctor ifigeneia tzannou"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"George ","lastName":"Chen ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of Anti-CMV T-Cell Immunity and CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor george chen"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Betty ","lastName":"Hamilton ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Breath Analysis in Gastrointestinal Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation (HCT)","keywords":"","combinedName":"doctor betty hamilton"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Maria Teresa ","lastName":"Lupo Stanghellini ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"cGvHD - CIBMTR Risk Score Stratification in 207 Consecutive Adults after Unmanipulated PBSC Haploidentical Stem Cell Transplantation","keywords":"","combinedName":"doctor maria teresa lupo stanghellini"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Shahinaz M","lastName":"Gadalla ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chromosome 6 Loss-of-Heterozygosity in Pre-Transplant Blood Samples of Patients with Severe Aplastic Anemia Is Associated with Lower Risk of Acute Graft-Versus-Host Disease","keywords":"","combinedName":"doctor shahinaz m gadalla"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Monica M","lastName":"Rivera Franco ","credentials":"M.D.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of T Cell Subsets and Cytokines between Steady-State and G-CSF-Primed Bone Marrow and Its Association with Graft-Versus-Host-Disease","keywords":"","combinedName":"doctor monica m rivera franco"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Robert ","lastName":"Korngold ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Day 90 Post-Allogeneic Hematopoietic Cell Transplantation T Cell Receptor Diversity Level Correlates with Risk of Relapse in Patients with Multiple Myeloma","keywords":"","combinedName":"doctor robert korngold"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Jan ","lastName":"Styczynski ","credentials":"MD PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Donor EBV-Positive Serostatus Increases the Risk of Chronic GvHD in Patients with Myeloid and Lymphoid Malignancies Other Than Acute Leukemia: Infectious Diseases Working Party EBMT Study","keywords":"","combinedName":"doctor jan styczynski"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Zhenkun ","lastName":"Wang ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Donor-Derived Marrow Mesenchymal Stem Cells Co-Transplantation Following Haploidentical Hematopoietic Stem Cell Transplantation: A Multicenter Clinical Study in 35 Severe Aplastic Anemia Children","keywords":"","combinedName":"doctor zhenkun wang"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Maddalena ","lastName":"Noviello ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early and Profound Exhausted Phenotype of Central Memory and Memory Stem T Cells in the Bone Marrow of AML Patients Characterizes and Predicts Relapse after Allo-HSCT","keywords":"","combinedName":"doctor maddalena noviello"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Ivan S","lastName":"Moiseev ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis","keywords":"","combinedName":"doctor ivan s moiseev"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Monzr ","lastName":"Al Malki ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Incidence of CMV Reactivation after Haploidentical Donor Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide, and Its Impact on Transplant Outcomes","keywords":"","combinedName":"doctor monzr al malki"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Giuseppe ","lastName":"Milone ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Level of IL-2-Receptor and of TIM-3 in Plasma at Day +18 after Allogeneic Transplantation Can Identify Early Patients at Risk for Treatment Related Mortality","keywords":"","combinedName":"doctor giuseppe milone"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Bita ","lastName":"Sahaf ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ibrutinib Inhibits Cgvhd Pathogenic Pre-Germinal Center B-Cells and Follicular Helper Cells While Preserving Immune Memory and Th1 T-Cells","keywords":"","combinedName":"doctor bita sahaf"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Satu ","lastName":"Mustjoki ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Somatic Mutations in Expanded T Cell Clones of Patients with Chronic Graft-Versus-Host Disease (GVHD)","keywords":"","combinedName":"doctor satu mustjoki"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Mindy ","lastName":"Hsiao ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Investigating the Relationship between Graft-Versus-Host Disease Incidence and Increased Risk of Death within Three Years after Allogeneic Hematopoietic Stem Cell Transplantation in Patients Receiving Antibiotics Containing Activity Against Obligate Anaerobes","keywords":"","combinedName":"doctor mindy hsiao"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Takahiko ","lastName":"Miyama ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Landscape of Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation Is Superdominated By Distinct T Cell Populations Bearing T-Cell Receptor Clonotypes Shared Among Different Individuals","keywords":"","combinedName":"doctor takahiko miyama"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Mauricette ","lastName":"Michallet ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Outcome of Patients Receiving Extracorporeal Photopheresis for Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies: Results from an Observational Study on 106 Patients","keywords":"","combinedName":"doctor mauricette michallet"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Mari ","lastName":"Morita ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low Peripheral Blood Eosinophil Counts in Patients with Acute Graft-Versus-Host-Disease Prior to Systemic Corticosteroid Therapy Is Associated with Poor Prognosis","keywords":"","combinedName":"doctor mari morita"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Emily ","lastName":"Blyth ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mass Cytometry Reveals the Broad Effect of CMV Reactivation on Adaptive and Innate Immune Recovery in HSCT Patients Undergoing Adoptive T Cell Therapy for Viral Infections","keywords":"","combinedName":"doctor emily blyth"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Ya ","lastName":"Gao ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MSCs Derived from Human Amnion Possess a Higher Proliferation Activity and Clearer Stem Cell PropertiesThan from Bone Marrows and They Exhibit Similar Immunosuppressive Ability in Vitro","keywords":"","combinedName":"doctor ya gao"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Margaret ","lastName":"MacMillan ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pediatric Acute Gvhd Grade, Risk Prediction and Response to Upfront Steroids in 370 Children Treated at the University of Minnesota","keywords":"","combinedName":"doctor margaret macmillan"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Marie ","lastName":"Robin ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Potential of Plasmatic Biomarkers to Predict Acute Gvhd Severity: A Validation Study in a Prospective Cohort of 177 Patients","keywords":"","combinedName":"doctor marie robin"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Richard ","lastName":"Maziarz ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pro-Tmune, the Next Generation Graft for Allogeneic Hematopoietic Cell Transplantation: Phase 1 Safety and Efficacy Data","keywords":"","combinedName":"doctor richard maziarz"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Nauman Saleem ","lastName":"Siddiqui ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk Factors for Occurrence and Outcome of Acute Graft Versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant: Analysis of 7 Year Health Care Utilization Project Data","keywords":"","combinedName":"doctor nauman saleem siddiqui"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Belinda ","lastName":"Lovelace ","credentials":"PharmD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Second Line Systemic Treatments Including Extracorporeal Photopheresis Among Patients with Chronic Graft Versus Host Disease (cGVHD) in the United States, 2009-2016","keywords":"","combinedName":"doctor belinda lovelace"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Mehrdad ","lastName":"Hefazi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"the Efficacy of Extra-Corporal Photopheresis for Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: A Retrospective, Matched, Case-Control Study","keywords":"","combinedName":"doctor mehrdad hefazi"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Katsuyuki ","lastName":"Nishi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of the Use and Type of Antibiotics on Acute-Versus-Host Disease","keywords":"","combinedName":"doctor katsuyuki nishi"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Jacopo ","lastName":"Mariotti ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Minnesota Refined Acute Gvhd Score Predicts Response to Initial Therapy, Survival and Non-Relapse Mortality after Haploidentical Transplantation with Post-Transplant Cyclophosphamide","keywords":"","combinedName":"doctor jacopo mariotti"},{"sessionId":"11680","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster III","firstName":"Sarah A","lastName":"Wall ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transplant Associated Thrombotic Microangiopathy (TA-TMA) Commonly Occurs after Steroid-Refractory or Dependent Gastrointestinal (GI) Graft Versus Host Disease (GVHD) and Contributes to Post-Transplant Morbidity","keywords":"","combinedName":"doctor sarah a wall"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Bartlomiej ","lastName":"Getta ","credentials":"FRCPA, FRACP, MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Benefits Patients with Persistent Disease and Results in a High Rate of Residual Disease Clearance","keywords":"","combinedName":"doctor bartlomiej getta"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"C. ","lastName":"Wilk ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of the Hematopoietic System in Long-Term Survivors of Allogeneic Stem Cell Transplantation and Their Respective Donors","keywords":"","combinedName":"doctor c wilk"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Paul D E","lastName":"Miller ","credentials":"MD MRCP","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autoimmune Cytopenias (AIC) Following Allogeneic Haematopoietic Stem Cell Transplant for Acquired Aplastic Anaemia: A Joint Study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT)","keywords":"","combinedName":"doctor paul d e miller"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Claire ","lastName":"Roddie ","credentials":"PhD, MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Automated Manufacture of CAR19 Donor Lymphocytes Incorporated into an Escalated Dose DLI Protocol: Preliminary Results from the CARD Study","keywords":"","combinedName":"doctor claire roddie"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Xin ","lastName":"Zhao ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Profile of Posterior Reversible Encephalopathy Syndrome(PRES)-Related Epilepsy in Patients Following Haploidentical Hematopoietic Stem Cell Transplantation:a 10-Year Study","keywords":"","combinedName":"doctor xin zhao"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Michael ","lastName":"Spinner ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Consolidative CD8+ Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor michael spinner"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Lohith ","lastName":"Gowda ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Maintenance with Tyrosine Kinase Inhibitors Post Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Improves Survival in Ph+ Acute Lymphoblastic Leukemia (ALL) Patients","keywords":"","combinedName":"doctor lohith gowda"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Elizabeth ","lastName":"Stenger ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor elizabeth stenger"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Monzr ","lastName":"Al Malki ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Melphalan-Based Regimen Is a Safe and Effective Conditioning Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Older Adults (=70 years) with Hematological Malignancies","keywords":"","combinedName":"doctor monzr al malki"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Yoshimitsu ","lastName":"Shimomura ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Minimal Residual Disease after Allogeneic Stem Cell Transplantation Was Associated with Poor Outcomes in Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor yoshimitsu shimomura"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Samer ","lastName":"Srour ","credentials":"MB ChB, MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloid Mixed Chimerism and Relapse in Myelofibrosis after Allogeneic Stem Cell Transplant","keywords":"","combinedName":"doctor samer srour"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Michaela ","lastName":"Kuhlen ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Osteonecrosis after Allogeneic HSCT in Children with High-Risk or Relapsed ALL Treated in the ALL-SCT 2003 Trial","keywords":"","combinedName":"doctor michaela kuhlen"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Robin ","lastName":"Williams ","credentials":"MD,MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Transplant Exhausted Marrow Infiltrating T Lymphocytes in MRD Negative Patients with Acute Leukemia Predict Early Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor robin williams"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Xiaosu ","lastName":"Zhao ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Transplant Minimal Residual Disease Determined By Multiparameter Flow Cytometry Is Better Than RQ-PCR to Predict the Outcomes of Ph+ALL Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor xiaosu zhao"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Xiaoning ","lastName":"Gao ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prophylactic Modified Donor Lymphocyte Infusion after Allogeneic Peripheral Blood Stem Cell Transplantation for Very High-Risk Hematological Malignancies: Low Incidence of Relapse without Increasing the Risk of Graft-Versus-Host Disease","keywords":"","combinedName":"doctor xiaoning gao"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Christina ","lastName":"Rautenberg ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantitative Next-Generation Sequencing (NGS) Based Monitoring of Minimal Residual Disease (MRD) Predicts Imminent Relapse in Patients with Myeloid Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor christina rautenberg"},{"sessionId":"11681","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I","firstName":"Saro ","lastName":"Armenian","credentials":"DO,MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sarcopenia Is a Clinically Relevant and Independent Predictor of Adverse Outcomes after Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor saro armenian"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Victor ","lastName":"Chow ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Trial Evaluating the Efficacy of Radioiodinated Tositumomab (Anti-CD20) Antibody, Etoposide and Cyclophosphamide Followed By Autologous Transplantation, for High-Risk Relapsed or Refractory Non-Hodgkins Lymphoma","keywords":"","combinedName":"doctor victor chow"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Elias K","lastName":"Mai ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Predictive Score for Early Mortality during Induction Therapy in Newly Diagnosed Transplant-Eligible Multiple Myeloma - an Analysis from Five GMMG and HOVON Multicenter Phase III Trials","keywords":"","combinedName":"doctor elias k mai"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Ankit ","lastName":"Kansagra ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis and Outcomes of Non-Utilization of Collected Peripheral Blood Stem Cell (PBSC) for Autologous Stem Cell Transplants (ASCT) in Transplant Eligible Patients Undergoing Treatment of Multiple Myeloma (MM)","keywords":"","combinedName":"doctor ankit kansagra"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Laura ","lastName":"Rosinol ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bortezomib, Lenalidomide and Dexamethasone (VRD-GEM) As Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Prospective Phase III Pethema/GEM Trial","keywords":"","combinedName":"doctor laura rosinol"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Karen ","lastName":"Sweiss ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Immune Score of Lymphocyte to Monocyte Ratio and Immunoglobulin Levels Predicts Progression-Free Survival of Myeloma Patients after Autologous Transplant","keywords":"","combinedName":"doctor karen sweiss"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Miriam ","lastName":"Lpez-Parra ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of Autologous Stem Cell Transplantation in First Complete Remission in Patients with Peripheral T-Cell Lymphoma: A Multicenter Geltamo/FIL Study","keywords":"","combinedName":"doctor miriam lpez-parra"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Gunjan ","lastName":"Shah ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)","keywords":"","combinedName":"doctor gunjan shah"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Jung Yoon ","lastName":"Choi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoietic, Immune Recovery and Outcomes after Autologous Stem Cell Transplantation Following Plerixafor Plus G-CSF Versus Chemotherapy and G-CSF Based Mobilization in Pediatric Patients","keywords":"","combinedName":"doctor jung yoon choi"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Josie-Anne ","lastName":"Boisjoly ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Carmustine (BCNU) Substitution for Bendamustine in the Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation for the Treatment of Lymphoma","keywords":"","combinedName":"doctor josie-anne boisjoly"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Rajshekar ","lastName":"Chakraborty ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Duration of Induction Therapy on Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Undergoing Upfront Autologous Stem Cell Transplantation","keywords":"","combinedName":"doctor rajshekar chakraborty"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Charalampia ","lastName":"Kyriakou ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Indications for Hematopoietic Stem Cell Transplantation in Patients with Waldenstroms Macroglobulinemia: A Consensus Project of the EBMT Lymphoma Working Party (LWP)/ European Consortium for Waldenstrom's Macroglobulinemia (ECWM)/International Waldenstrom's Macroglobulinemia Foundation (IWMF)","keywords":"","combinedName":"doctor charalampia kyriakou"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Philippe","lastName":"Moreau","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ixazomib-Lenalidomide-Dexamethasone (IRd) Combination before and after Autologous Stem Cell Transplantation (ASCT) Followed By Ixazomib Maintenance Is a Safe and Effective Strategy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Phase 2 Study from the Intergroupe Francophone Du MyLome (IFM)","keywords":"","combinedName":"doctor philippe moreau"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Eva ","lastName":"Gonzalez-Barca ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management and Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsed after Autologous Hemopoietic Stem Cell Transplantation (auto-HSCT): A Retrospective Analysis of the Lymphoma Working Party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT)","keywords":"","combinedName":"doctor eva gonzalez-barca"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Michele ","lastName":"Donato ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Autologous Stem Cell Transplantation in Very Elderly Patients with Multiple Myeloma","keywords":"","combinedName":"doctor michele donato"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Shen ","lastName":"Li ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Potential Utility of Event-Free Survival (EFS) As Surrogate Endpoint for Overall Survival (OS) in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) after Autologous Stem Cell Transplantation (ASCT): A Subgroup Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Randomized Phase III Trial","keywords":"","combinedName":"doctor shen li"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Donna ","lastName":"Reece ","credentials":"BA, MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real World Outcomes of Newly Diagnosed High-Risk Multiple Myeloma Patients Treated at Princess Margaret Cancer Centre: A Retrospective Chart Review","keywords":"","combinedName":"doctor donna reece"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Sathish ","lastName":"Kumar ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Revised-International Staging System (R-ISS) Is Independently Predictive and Prognostic for Early Relapse (<24 months) after Upfront Autologous Hematopoietic Cell Transplantation (AHCT) for Newly Diagnosed Multiple Myeloma (MM","keywords":"","combinedName":"doctor sathish kumar"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Pavan ","lastName":"Tenneti ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of High Dose Chemotherapy and Autologous Stem Cell Transplant in Relapsed Ewing's Sarcoma - a Systematic Review","keywords":"","combinedName":"doctor pavan tenneti"},{"sessionId":"11682","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster I","firstName":"Yazeed ","lastName":"Sawalha ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of Upfront Autologous Hematopoietic Cell Transplantation in the Treatment of Mantle Cell Lymphoma, a Population Based Study Using the National Cancer Data Base (NCDB)","keywords":"","combinedName":"doctor yazeed sawalha"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Parvez ","lastName":"Ahmed ","credentials":"FCPS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Haematopoietic Cell Transplantation in Aplastic Anaemia: A Dataset of 240 Cases","keywords":"","combinedName":"doctor parvez ahmed"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Raynier ","lastName":"Devillier ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Hematopoietic Stem Cell Transplantation for Patients over 60 Years with Acute Myeloid Leukemia: A Single Center Donor Comparison","keywords":"","combinedName":"doctor raynier devillier"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Chi-Cheng ","lastName":"Li ","credentials":"M.D.","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Artificial Intelligence Approach for Predicting Allogeneic Hematopoietic Stem Cell Transplantation Outcome By Detecting Pre-Transplant Minimal Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry Data","keywords":"","combinedName":"doctor chi-cheng li"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Johnnie ","lastName":"Orozco ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anti-CD45 Radioimmunotherapy Followed By Haploidentical Allogeneic Hematopoietic Cell Transplantation for Advanced Acute Leukemia or High-Risk MDS","keywords":"","combinedName":"doctor johnnie orozco"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Issa ","lastName":"Khouri ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bfr (bendamustine, fludarabine, rituximab) Nonmyeloablative Allogeneic Conditioning for Lymphoid Malignancies: 8-Year Results ","keywords":"","combinedName":"doctor issa khouri"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Jianda ","lastName":"Hu ","credentials":"Prof MD PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Challenging the Prognostic Value of MRD:Sequential Tumor-Ablative Conditioning of FA5-Bucy for Ph-Positive Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor jianda hu"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Nathalie ","lastName":"Jacque ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Mobilized Peripheral Blood Stem Cells Versus Unmanipulated Bone Marrow Haploidentical Transplantation Using Post-Transplant Cyclophosphamide: A Retrospective Study of SFGM-TC in 176 Patients","keywords":"","combinedName":"doctor nathalie jacque"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Jose Ignacio Ignacio","lastName":"Trucco ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Outcomes after Matched Sibling, Unrelated, or Haploidentical Allogeneic Hematopoietic Cell Transplantations (HCT). a Real World Experience of Gatmo (Grupo Argentino de Trasplante de Mdula sea)","keywords":"","combinedName":"doctor jose ignacio ignacio trucco"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Dipenkumar ","lastName":"Modi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Outcomes of Post-Transplant Cyclophosphamide between Haplo-Identical and Matched/Mismatched Donor Peripheral Blood Stem Cell Transplantation","keywords":"","combinedName":"doctor dipenkumar modi"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Roberto ","lastName":"Crocchiolo ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Current IST-Free/Relapse-Free Survival As a Surrogate Estimate of OS after Allotransplant for Acute Leukemia","keywords":"","combinedName":"doctor roberto crocchiolo"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Lan-Ping ","lastName":"Xu ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"First-Line Choice for Severe Aplastic Anemia in Children: Transplantation from a Haplo-Identical Donor Versus Immunosuppressive Therapy","keywords":"","combinedName":"doctor lan-ping xu"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Han-Seung ","lastName":"Park ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fludarabine/Melphalan 100 Conditioning Therapy Followed By Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis","keywords":"","combinedName":"doctor han-seung park"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Rohtesh ","lastName":"Mehta","credentials":"MD,MPH,MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Pediatric Patients","keywords":"","combinedName":"doctor rohtesh mehta"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Samia ","lastName":"Harbi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Haploidentical Hematopoietic Stem Cell Allogeneic Transplantation with High Dose Post Transplantation Cyclophosphamide for Patients over 60 Years of Age","keywords":"","combinedName":"doctor samia harbi"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Nicolaus ","lastName":"Kroeger ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Haplo-Identical Stem Cell Transplantation for Patients with Multiple Myeloma Who Relapsed after Autografting. a Study from the Cmwp of EBMT","keywords":"","combinedName":"doctor nicolaus kroeger"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Frederic ","lastName":"Baron ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Donor Type in Patients with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Cell Transplantation after Low-Dose TBI Based Regimen: A Study from the Acute Leukemia Working Party of the EBMT and Eurocord","keywords":"","combinedName":"doctor frederic baron"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Stefanie ","lastName":"Beinicke ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In AML RAS pathway Mutations Confer Worse Outcome in IDH1 and IDH2 Mutated AML Patients Receiving Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor stefanie beinicke"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Heeje ","lastName":"Kim ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Follow-up on Adult Patients with Philadelphia-Chromosome Positive Acute Myeloid Leukemia Who Were Treated with Interim Imatinib Followed By Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor heeje kim"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Melhem M","lastName":"Solh ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloablative Hematopoietic Cell Transplantation (HCT) for Low and Intermediate Disease Risk Index Myeloid Malignancies Results in Better Outcomes Compared to Reduced Intensity HCT","keywords":"","combinedName":"doctor melhem m solh"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Giorgia ","lastName":"Battipaglia ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Siblings Versus Unmanipulated Haploidentical Donors in Relapsing or Refractory Acute Myeloid Leukemia: A Retrospective Study from the ALWP of the EBMT","keywords":"","combinedName":"doctor giorgia battipaglia"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Juliana ","lastName":"Montibeller Furtado E Silva ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Unrelated Cord Blood Transplantation for Familial Hemophagocytic Lymphohistiocytosis: Risk Factors and Long Term Follow-up. an Analysis on Behalf of Eurocord, Cord Blood Committee of Cellular Therapy and Immunobiology Working Party of the EBMT and Inborn Errors Working Party of the EBMT","keywords":"","combinedName":"doctor juliana montibeller furtado e silva"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Kyoko ","lastName":"Fuse ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient-Based Prediction Algorithm of Relapse after Allo-HSCT for Acute Leukemia Using Machine Learning Approach","keywords":"","combinedName":"doctor kyoko fuse"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Mirjam ","lastName":"Belderbos ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Poor Outcome of Domino Hematopoietic Stem Cell Transplantation in Humans  an International Case Series","keywords":"","combinedName":"doctor mirjam belderbos"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Young-Woo ","lastName":"Jeon ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk Factors Predicting Graft-Versus-Host Disease and Relapse-Free Survival (GRFS) after Allogeneic Hematopoietic Stem Cell Transplantation in Relapse/Refractory Non-Hodgkin Lymphomas","keywords":"","combinedName":"doctor young-woo jeon"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Martin ","lastName":"Maiers ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Selecting Optimal Cord Blood Units: The Limitations of Cell Dose","keywords":"","combinedName":"doctor martin maiers"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Li ","lastName":"Xuan ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Effect of Sorafenib Therapy on the Outcome of Acute Myeloid Leukemia with FLT3-ITD Undergoing Allogeneic Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor li xuan"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Sheng-Hsuan ","lastName":"Chien ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The European Group for Blood and Marrow Transplantation Risk Score Predicts Outcome of Elderly Patients with Allogeneic Stem Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome","keywords":"","combinedName":"doctor sheng-hsuan chien"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Betul","lastName":"Oran","credentials":"MD,MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Prognostic Impact of Minimal ResidualDisease on Risk of Progression and Progression Free Survival in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor betul oran"},{"sessionId":"11683","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster I","firstName":"Martin ","lastName":"Carre ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of Scores Predicting Non-Relapse Mortality in Patients with Myelodysplastic Syndrome: A Study on 1276 Patients on Behalf the Chronic Malignancies Working Party of the EBMT","keywords":"","combinedName":"doctor martin carre"},{"sessionId":"11684","sessionTitle":"801. Gene Therapy and Transfer: Poster I","firstName":"Michael ","lastName":"Holmes ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Potential Therapy for Beta-Thalassemia (ST-400) and Sickle Cell Disease (BIVV003)","keywords":"","combinedName":"doctor michael holmes"},{"sessionId":"11684","sessionTitle":"801. Gene Therapy and Transfer: Poster I","firstName":"Rajeswari ","lastName":"Jayavaradhan ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Precise Tool to Edit Human Hematopoietic Stem Cells at High Efficiency and Decipher and Optimize the Different Double Strand Break Repair Outcomes","keywords":"","combinedName":"doctor rajeswari jayavaradhan"},{"sessionId":"11684","sessionTitle":"801. Gene Therapy and Transfer: Poster I","firstName":"Laurel C","lastName":"Truscott ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Engineering Precision Medicine to Enhance Graft-Versus-Lymphoma Activity:Hematopoietic Stem Cells Modified with Chimeric Antigen Receptors","keywords":"","combinedName":"doctor laurel c truscott"},{"sessionId":"11684","sessionTitle":"801. Gene Therapy and Transfer: Poster I","firstName":"Partow","lastName":"Kebriaei","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Term Follow up after Adoptive Transfer of CD19-Specific CAR+T Cells Genetically Modified Via Non-Viral Sleeping Beauty System Following Hematopoietic Stem Cell Transplantation (HSCT)","keywords":"","combinedName":"doctor partow kebriaei"},{"sessionId":"11684","sessionTitle":"801. Gene Therapy and Transfer: Poster I","firstName":"Chen-Yuan ","lastName":"Kao ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Megakaryocytic Microparticles for Gene- and Cell- Therapies","keywords":"","combinedName":"doctor chen-yuan kao"},{"sessionId":"11684","sessionTitle":"801. Gene Therapy and Transfer: Poster I","firstName":"Lorena ","lastName":"Perez Amill ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Antibcma-CAR for Multiple Myeloma","keywords":"","combinedName":"doctor lorena perez amill"},{"sessionId":"11684","sessionTitle":"801. Gene Therapy and Transfer: Poster I","firstName":"Dawei ","lastName":"Wang ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet-Targeted Gene Therapy of Hemophilia a Using Hematopoietic Stem Cells Derived from Genome-Edited Induced Pluripotent Stem Cells","keywords":"","combinedName":"doctor dawei wang"},{"sessionId":"11684","sessionTitle":"801. Gene Therapy and Transfer: Poster I","firstName":"Ying Poi ","lastName":"Liu ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predictable Protein Expression with Enhanced Factor IX Activity Following Administration of a Modified AAV5-hFIX Vector to Nonhuman Primates","keywords":"","combinedName":"doctor ying poi liu"},{"sessionId":"11684","sessionTitle":"801. Gene Therapy and Transfer: Poster I","firstName":"Partow","lastName":"Kebriaei","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Shortening the Time to Manufacture CAR+ T Cells with Sleeping BeautySystem Supports T-Cell Engraftment and Anti-Tumor Effects in Patients with Refractory CD19+Tumors","keywords":"","combinedName":"doctor partow kebriaei"},{"sessionId":"11684","sessionTitle":"801. Gene Therapy and Transfer: Poster I","firstName":"Daniel J","lastName":"Hui ","credentials":"PhD, BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Spk-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B Achieves Sustained Factor IX with Minimal Immune Response","keywords":"","combinedName":"doctor daniel j hui"},{"sessionId":"11684","sessionTitle":"801. Gene Therapy and Transfer: Poster I","firstName":"Ben ","lastName":"Samelson-Jones ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of Transgene Levels in Immune Tolerance Induction after AAV Gene Therapy in Hemophilia B Canine Models","keywords":"","combinedName":"doctor ben samelson-jones"},{"sessionId":"11684","sessionTitle":"801. Gene Therapy and Transfer: Poster I","firstName":"Jakrawadee ","lastName":"Julamanee ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Synergistic T-Cell Signal By CD79A/CD40 Costimulatory Endodomain Enhances CD19 Chimeric Antigen Receptor T-Cell Proliferation and Survival","keywords":"","combinedName":"doctor jakrawadee julamanee"},{"sessionId":"11685","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster I","firstName":"Thomas ","lastName":"Friess ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical BET Inhibitor RG6146 Demonstrates Potent and on-Target Activity in Pre-Clinical Models of Hematological Malignancy and Combines with Anti-CD20 and BCL-2 Inhibition to Provide Superior Efficacy","keywords":"","combinedName":"doctor thomas friess"},{"sessionId":"11685","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster I","firstName":"Daisuke ","lastName":"Honma ","credentials":"Ph.D.","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development and Characterization of the Novel Orally Bioavailable EZH1/2 Dual Inhibitor DS-3201","keywords":"","combinedName":"doctor daisuke honma"},{"sessionId":"11685","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster I","firstName":"Sanil ","lastName":"Bhatia ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of Novel Proteasome-HDAC6 Hybrid Inhibitors for Resistant ALL Phenotype","keywords":"","combinedName":"doctor sanil bhatia"},{"sessionId":"11685","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster I","firstName":"Lina ","lastName":"Benajiba ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Exploiting an Asp-Glu Switch in Glycogen Synthase Kinase 3 to Design Paralog Selective Inhibitors for Acute Myeloid Leukemia Treatment","keywords":"","combinedName":"doctor lina benajiba"},{"sessionId":"11685","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster I","firstName":"Stephen E","lastName":"Kurtz ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Effective Combinations of Targeted Drugs for DNMT3A and NPM1 Mutated Acute Myeloid Leukemia","keywords":"","combinedName":"doctor stephen e kurtz"},{"sessionId":"11685","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster I","firstName":"Haytham ","lastName":"Khoury ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of WHSC1 As a Promising Therapeutic Strategy in Childhood ALL","keywords":"","combinedName":"doctor haytham khoury"},{"sessionId":"11685","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster I","firstName":"Hiroyuki ","lastName":"Takamatsu ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Human Anti-HLA-Bw4 and B61 Monoclonal Antibodies Kill Malignant B Cells Via CDC/ADCC While Sparing Normal Peripheral Blood Cells","keywords":"","combinedName":"doctor hiroyuki takamatsu"},{"sessionId":"11685","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster I","firstName":"Ana Luz","lastName":"Quiroga-Campano ","credentials":"BSc, MSc, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Precision Chemotherapy for Patients with Acute Myeloid Leukemia Using the pIchemo Prediction and Optimization Tool","keywords":"","combinedName":"doctor ana luz quiroga-campano"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Evashin ","lastName":"Pillay ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A New Era in Malaria Diagnosis and Surveillance Using an Automated Analyzer","keywords":"","combinedName":"doctor evashin pillay"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Thidarat ","lastName":"Suksangpleng ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel System for Newborn Screening of Thalassemia and Hemoglobinopathies Using Capillary Electrophoresis Is Superior Than Isoelectric Focusing","keywords":"","combinedName":"doctor thidarat suksangpleng"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Shradha ","lastName":"Ahuja ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bleeding Events and Obstetric Complications of Pregnancy in Hospitalized Patients with Hemophilia: Results from Nationwide Inpatient Sample Database 2003-2011","keywords":"","combinedName":"doctor shradha ahuja"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Marc ","lastName":"Ellis ","credentials":"BSc,MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Catheter-Related Thrombosis Incidence and Risk Factors in Adult Cancer Patients with Central Venous Access Devices","keywords":"","combinedName":"doctor marc ellis"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Sujit ","lastName":"Sheth ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical and Economic Burden of Transfusion-Dependent -Thalassemia in Adult Patients in the United States","keywords":"","combinedName":"doctor sujit sheth"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Marion K","lastName":"Mateos ","credentials":"MBBS FRACP","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical and Germline Risk Factors for the Occurrence of Multiple Treatment Toxicities during Childhood Acute Lymphoblastic Leukemia (ALL) Therapy","keywords":"","combinedName":"doctor marion k mateos"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Harry ","lastName":"Menon ","credentials":"DO, MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cost Reduction with Enoxaparin Vs. Heparin for Prophylactic and Therapeutic Use: A Retrospective Analysis in a Community Hospital Setting","keywords":"","combinedName":"doctor harry menon"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Amy ","lastName":"Sobota ","credentials":"MD, MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Developing a Problem-Solving Intervention to Address Methods of Self-Management and Transition Challenges in Adolescents with Sickle Cell Disease: A Qualitative Investigation","keywords":"","combinedName":"doctor amy sobota"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Ali ","lastName":"Antmen ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Direct Medical Care Cost Associated with -Thalassemia Care in Turkey","keywords":"","combinedName":"doctor ali antmen"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Prajwal ","lastName":"Dhakal ","credentials":"MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Do Sequential Compression Devices Prevent Venous Thromboembolism in Hospital Inpatients?","keywords":"","combinedName":"doctor prajwal dhakal"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Anuja ","lastName":"Roy ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Treatment Patterns Among Patients with Newly Diagnosed, Persistent, and Chronic Immune Thrombocytopenia (ITP) Treated with Eltrombopag in Real World Setting in the US","keywords":"","combinedName":"doctor anuja roy"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Ryma ","lastName":"Ihaddadene ","credentials":"BHSc, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evidence-Based Diagnosis of Venous Thromboembolism: A Systematic Review","keywords":"","combinedName":"doctor ryma ihaddadene"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Meghan ","lastName":"Foe ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factors Related to Iron Chelation Therapy Adherence in Young Adults with Thalassemia: A Framework from the Patient Perspective","keywords":"","combinedName":"doctor meghan foe"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Justin ","lastName":"Fongemie ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Implementation and Impact of a Multidisciplinary Coagulation Factor Stewardship Program","keywords":"","combinedName":"doctor justin fongemie"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Courtney","lastName":"Thornburg","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Implementation of Electronic Health Record Tools for Prevention of Venous Thromboembolism in Hospitalized Children with Cancer and Blood Disorders","keywords":"","combinedName":"doctor courtney thornburg"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Meagan ","lastName":"Scott ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence of Bleeding Events in Acute Myeloid Leukemia (AML) Patients Receiving Anticoagulation Therapy for Treatment of Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE) Who Are Also Undergoing Induction or Re-Induction Therapy","keywords":"","combinedName":"doctor meagan scott"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Meghan ","lastName":"Jackson ","credentials":"DO","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increasing Ideal Coagulation Factor Dosing in the Pediatric Emergency Department: A Quality Improvement Study","keywords":"","combinedName":"doctor meghan jackson"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Gail ","lastName":"Wygant ","credentials":"RN","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Major Bleeding and Bleeding Events Requiring Hospitalization in the First Three Months Following Vitamin K Antagonists Therapy in Patients with First Venous Thromboembolism","keywords":"","combinedName":"doctor gail wygant"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Holly ","lastName":"Pacenta ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimizing Iron Overload Screening in a Pediatric Center for Cancer and Blood Disorders","keywords":"","combinedName":"doctor holly pacenta"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Julie ","lastName":"Kanter ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quality of Care in United States Children with Sickle Cell Anemia","keywords":"","combinedName":"doctor julie kanter"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Winghan Jacqueline","lastName":"Kwong ","credentials":"PhD, PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real World Outcomes of Ferric Carboxymaltose and Ferumoxytol Iron Replacement Therapy: A Retrospective Analysis of Electronic Health Records","keywords":"","combinedName":"doctor winghan jacqueline kwong"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Madan ","lastName":"Aryal ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recent Trends in the Incidence and Outcomes of Thrombotic Thrombocytopenic Purpura in the United States: Data from the 2009-2014 National Inpatient Sample","keywords":"","combinedName":"doctor madan aryal"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Ranjan ","lastName":"Pathak ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recent Trends in the Incidence of Heparin-Induced Thrombocytopenia: Data from the 2009-2014 National Inpatient Sample","keywords":"","combinedName":"doctor ranjan pathak"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Ari ","lastName":"Zimran ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduction in Intravenous Infusion Duration of Enzyme Replacement Therapy to Ten Minutes with Velaglucerase Alfa in Adult Patients with Type 1 Gaucher Disease","keywords":"","combinedName":"doctor ari zimran"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Amarjot ","lastName":"Padda ","credentials":"BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Supplemental Oxygen during Air Travel in Sickle Cell Disease Common Clinical Practices","keywords":"","combinedName":"doctor amarjot padda"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Emily Riehm","lastName":"Meier","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Transition:a NovelPartnership withFamily Medicine to Enhance Quality of Care and Outcomes for Adolescents and Young Adults with Sickle Cell Disease","keywords":"","combinedName":"doctor emily riehm meier"},{"sessionId":"11686","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster I","firstName":"Robert ","lastName":"Sidonio ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"US Economic Impact of Recombinant FVIII Vs Plasma-Derived FVIII/VWF in Previously Untreated Hemophilia a Patients","keywords":"","combinedName":"doctor robert sidonio"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Ghada ","lastName":"Zakout ","credentials":"FRCPath, MRCP, MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Collaborative Pharmacist-Physician Multi-Professional Pre-Chemotherapy Assessment in Hematology Cancer Patients Is an Efficient & Cost-Effective Model for Service Delivery of Outpatient Systemic Anti-Cancer Therapy (SACT)","keywords":"","combinedName":"doctor ghada zakout"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Jonathan ","lastName":"Caranfa ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Meta-Analysis of the Prognostic Accuracy of Clinical Prediction Rules for Post-Pulmonary Embolism Mortality in Patients with Cancer","keywords":"","combinedName":"doctor jonathan caranfa"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Matthew ","lastName":"Davids","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Quality Improvement Initiative Advancing CLL Care Practices across Four US Health Systems","keywords":"","combinedName":"doctor matthew davids"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Louise ","lastName":"Man ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AMultidisciplinary Effort to Decrease Time from Admission to Chemotherapy on an Inpatient Oncology Unit","keywords":"","combinedName":"doctor louise man"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Erika ","lastName":"Correa ","credentials":"MD, MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Lymphoblastic Leukemia in the Elderly: Trends in Mortality Rates, Hospital Cost, Lengthof Stay, and Complication Rates in Patients Aged 60 and Older","keywords":"","combinedName":"doctor erika correa"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Joanne ","lastName":"Buzaglo ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chronic Lymphocytic Leukemia Patient Reported Outcomes and Quality of Life: Findings from the Cancer Experience Registry","keywords":"","combinedName":"doctor joanne buzaglo"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"William G","lastName":"Wierda ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Benefits of Achieving Deep Remission to Second-Line Therapy in Patients with Relapse/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)  a Real-World Study","keywords":"","combinedName":"doctor william g wierda"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Karen ","lastName":"Sweiss ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Collaborative Physician-Pharmacist Multiple Myeloma Clinic Improves Guideline Adherence and Prevents Treatment Delays","keywords":"","combinedName":"doctor karen sweiss"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Pablo ","lastName":"Gonzalez-Montalvo ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Collaborative Risk-Adapted Treatment for Pediatric Acute Lymphoblastic Leukemia in Mexico","keywords":"","combinedName":"doctor pablo gonzalez-montalvo"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Carla ","lastName":"Mamolo ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Efficacy and Safety of Gemtuzumab Ozogamicin (GO) Plus Daunorubicin-Cytarabine Combination and Comparators As Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia","keywords":"","combinedName":"doctor carla mamolo"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Chadi","lastName":"Nabhan","credentials":"MD, MBA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Costs and Health Care Resource Utilization (HRU) in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Front-Line Ibrutinib or Chemoimmunotherapy","keywords":"","combinedName":"doctor chadi nabhan"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Yuzhou ","lastName":"Liu ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Costs and in-Hospital Mortality Rates in Autologous Stem Cell Transplant for Multiple Myeloma: An Analysis of the Nationwide Inpatient Sample (NIS) Database","keywords":"","combinedName":"doctor yuzhou liu"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Michelle ","lastName":"Deveaux ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Counseling Patients (pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS) Regarding Expected Survival with Azacitidine (aza) Therapy: Are We Using Accurate Estimates?","keywords":"","combinedName":"doctor michelle deveaux"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Stella ","lastName":"Bowcock ","credentials":"MD, BA, FRCP, FRCPath, MA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diagnostic Pathways of Myeloma Patients Presenting to Hospital Care and Relationship to End Organ Damage: An Analysis from the Teamm (Tackling EArly Morbidity and Mortality in Myeloma) Trial in 977 Patients","keywords":"","combinedName":"doctor stella bowcock"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Kim ","lastName":"Klein ","credentials":"MD, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differences in Infection Prophylaxis between Pediatric AML Study Groups within the International BFM Study Group","keywords":"","combinedName":"doctor kim klein"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Stephen ","lastName":"Smith ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Disease Factors and Not Comorbidity Drives Clinical Decisions in Elderly Patients with Follicular Lymphoma","keywords":"","combinedName":"doctor stephen smith"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Alejandro ","lastName":"Garcia-Horton ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Distribution of Lymphomas in Mexico: A Descriptive Study","keywords":"","combinedName":"doctor alejandro garcia-horton"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Elif G","lastName":"Umit ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Economic Analysis of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Undergoing Remission Induction Chemotherapy from a Hospital Management Perspective","keywords":"","combinedName":"doctor elif g umit"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Scott","lastName":"Huntington","credentials":"MD,MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Financial Incentives and Rituximab Maintenance: Association of Treatment Location with Prolonged Maintenance in Non-Hodgkin Lymphoma Patients Treated in the United States","keywords":"","combinedName":"doctor scott huntington"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Angela ","lastName":"Ricci ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Health Care Utilization and Cost of Allogeneic Hematopoietic Cell Transplantation in Children with Malignant and Non-Malignant Diseases","keywords":"","combinedName":"doctor angela ricci"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Anita ","lastName":"Kumar ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Longer Length of Stay and No Chemotherapy Is Associated with Greater Likelihood of Death during Hospitalization in Patients with Diffuse Large B-Cell Lymphoma: An Analysis from the National Inpatient Sample (NIS)","keywords":"","combinedName":"doctor anita kumar"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Ruth ","lastName":"Kim ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Out-of-Pocket (OOP) Costs Associated with Tyrosine Kinase Inhibitors (TKIs) Used for the Treatment of US Patients Diagnosed with Chronic Myeloid Leukemia (CML): A US Retrospective Claims Analysis","keywords":"","combinedName":"doctor ruth kim"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Anthony ","lastName":"Sung ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient Interest in and Feasibility of a Mobile Health App to Support Patients Undergoing Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor anthony sung"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Gustavo ","lastName":"Milone ","credentials":"MD ","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Post-Marketing Surveillance with a Biosimilar of Rituximab (Novex) in Argentina","keywords":"","combinedName":"doctor gustavo milone"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"David ","lastName":"Straus ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real World Clinical and Economic Burden of Patients with Hodgkin Lymphoma (HL) Who Fail Frontline (FL) Therapy in the US","keywords":"","combinedName":"doctor david straus"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Bhavik J","lastName":"Pandya ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real-World Occurrence of Symptoms and Toxicities and Associated Cost Implications in Acute Myeloid Leukemia (AML) Treatment Episodes: A Retrospective Database Analysis in the US","keywords":"","combinedName":"doctor bhavik j pandya"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Vania T M","lastName":"Hungria","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Patterns and Survival Outcomes in Latin American Patients with Newly Diagnosed Multiple Myeloma: A Retrospective Medical Chart Review Study, 2008-2016","keywords":"","combinedName":"doctor vania t m hungria"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Siyang ","lastName":"Leng ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Herpes Zoster Prophylaxis in Myeloma Patients Treated with Proteasome Inhibitors","keywords":"","combinedName":"doctor siyang leng"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Sikander ","lastName":"Ailawadhi ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Utilization of Palliative Care Among Patients with Hematologic Malignancies: An Extensive National Analysis to Define Trends and Patterns","keywords":"","combinedName":"doctor sikander ailawadhi"},{"sessionId":"11687","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster I","firstName":"Ryan P","lastName":"Topping ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Variance between Experts and Oncology Healthcare Providers in Managing Polycythemia Vera and Myelofibrosis: Analysis of an Online Treatment Decision Support Tool","keywords":"","combinedName":"doctor ryan p topping"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Kimberly S","lastName":"Esham ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessment of Health-Related Quality of Life in Adults Hospitalized with Sickle Cell Disease Vaso-Occlusive Crisis","keywords":"","combinedName":"doctor kimberly s esham"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Nicholas ","lastName":"Burwick ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Association of Monoclonal Gammopathy with Progression to End-Stage Renal Disease Among a National Cohort of US Veterans","keywords":"","combinedName":"doctor nicholas burwick"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Menaka ","lastName":"Bhor ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cost-Consequence Model Comparing Eltrombopag and Romiplostim for Pediatric Patients with Previously-Treated Chronic Immune Thrombocytopenia","keywords":"","combinedName":"doctor menaka bhor"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Houry ","lastName":"Leblebjian ","credentials":"PharmD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Direct Oral Anticoagulants in Anti-Phospholipid Syndrome","keywords":"","combinedName":"doctor houry leblebjian"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Saqib ","lastName":"Abbasi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Disseminated Intravascular Coagulation and Annual Trends in in-Hospital Outcomes Based on Etiology from 2002 to 2014","keywords":"","combinedName":"doctor saqib abbasi"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Sabrina ","lastName":"Mueller ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Does Treatment Satisfaction Influence Adherence to Treatment?:Impact of AF Patients Treatment Satisfaction on Adherence to Oral Anticoagulation Treatment","keywords":"","combinedName":"doctor sabrina mueller"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Susan ","lastName":"Kearney ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Health-Related Quality of Life and Satisfaction of Children with Severe Hemophilia a Treated with Turoctocog Alfa Pegol (N8-GP)","keywords":"","combinedName":"doctor susan kearney"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Jifang ","lastName":"Zhou ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Delayed Anticoagulant Initiation in Patients with Sickle Cell Disease and Newly Diagnosed Venous Thromboembolism: A Population-Based Cohort Study","keywords":"","combinedName":"doctor jifang zhou"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Saqib ","lastName":"Abbasi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Hospital Burden of Venous Thromboembolism in Cancer: A 13 Year Analysis","keywords":"","combinedName":"doctor saqib abbasi"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Lise ","lastName":"Estcourt ","credentials":"DPhil, FRCPath, MBBChir, MRCP, MSc, MA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Is Sepsis a Risk Factor for Bleeding in Adults with Hematologic Malignancies?","keywords":"","combinedName":"doctor lise estcourt"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Susan T","lastName":"Paulukonis ","credentials":"MA, MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mortality Among Californias Sickle Cell Data Collection Cohort, 2005-2015","keywords":"","combinedName":"doctor susan t paulukonis"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Jerlym ","lastName":"Porter ","credentials":"PhD, MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Provider Perspectives of Necessary Factors in Sickle Cell Disease Health Care Transition: Results from an Online Survey","keywords":"","combinedName":"doctor jerlym porter"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Damon ","lastName":"Houghton ","credentials":"MD, MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Apixaban and Rivaroxaban for the Treatment of Upper Extremity Deep Vein Thrombosis","keywords":"","combinedName":"doctor damon houghton"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Chatree ","lastName":"Chai-Adisaksopha ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sexual Health in Patients with Hemophilia; The Insights from the Patient Reported Outcomes, Burdens and Experiences (PROBE) Study","keywords":"","combinedName":"doctor chatree chai-adisaksopha"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Aukje ","lastName":"Kreuger ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Identification of Cases with Major Hemorrhage in Routinely Recorded Healthcare Data","keywords":"","combinedName":"doctor aukje kreuger"},{"sessionId":"11688","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster I","firstName":"Robert J","lastName":"Klaassen ","credentials":"MD, FRCPC","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of the Modified Self-Administered Pediatric Bleeding Assessment Questionnaire (Self-PBQ) in Children Aged 8-12 Years","keywords":"","combinedName":"doctor robert j klaassen"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Caglar ","lastName":"Caglayan ","credentials":"MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Multi-State Model for Follicular Lymphoma in Patients with Early Progression to Second Line Therapy","keywords":"","combinedName":"doctor caglar caglayan"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Faouzi ","lastName":"Djebbari ","credentials":"MSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Age (=75 years) and Not Choice of First-Line Therapy Improves Overall Survival in Transplant Ineligible NDMM Patients: Results from a Large UK Real-World Dataset","keywords":"","combinedName":"doctor faouzi djebbari"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Carrie A","lastName":"Thompson ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Association between Patient-Reported Outcomes and Physical Activity Measured on the Apple Watch in Patients with Hematological Malignancies","keywords":"","combinedName":"doctor carrie a thompson"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Geffen ","lastName":"Kleinstern ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autoimmune Diseases and Prognosis across Lymphoma Subtypes","keywords":"","combinedName":"doctor geffen kleinstern"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Aneel ","lastName":"Paulus ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Analysis of Gene Expression Status to Predict Response to Initial Multiple Myeloma Treatment: Utility of the Mmrf Commpass Database in Validating Historical Findings","keywords":"","combinedName":"doctor aneel paulus"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Marcus ","lastName":"Tan ","credentials":"BPharm","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cost Effectiveness of Nivolumab for the Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma (cHL) after Failure of Autologous Stem Cell Transplantation (ASCT) and Treatment with Brentuximab Vedotin (BV) Treatment in Australia","keywords":"","combinedName":"doctor marcus tan"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Elysia ","lastName":"Alvarez ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Decreased Early Mortality in Young Adults with Acute Lymphoblastic Leukemia Treated at Specialized Cancer Centers in California","keywords":"","combinedName":"doctor elysia alvarez"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Maximilian ","lastName":"Schinke ","credentials":"BSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deutsche Studiengruppe Multiples Myelom (DSMM) Evaluation of the Risk of Relapse and Survival Using a Conditional Survival Approach in 815 MM Patients with Extensive, Complete and Repeated and Long-Term Follow-up","keywords":"","combinedName":"doctor maximilian schinke"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Leslie","lastName":"Padrnos","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Duration Matters: Impact of Time from Diagnosis on Symptoms in Patients with Hematologic Malignancies","keywords":"","combinedName":"doctor leslie padrnos"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Aaron ","lastName":"Galaznik ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Economic Impact and Healthcare Utilization in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in Routine Clinical Care in the United States (US)  a Claims Database Study","keywords":"","combinedName":"doctor aaron galaznik"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Geffen ","lastName":"Kleinstern ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factors Associated with Non-Melanoma Skin Cancer (NMSC) Among Chronic Lymphocytic Leukemia (CLL) Patients","keywords":"","combinedName":"doctor geffen kleinstern"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Aaron ","lastName":"Galaznik ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Healthcare Burden of Patients with Follicular Lymphoma (FL) in Routine Clinical Care in the United States","keywords":"","combinedName":"doctor aaron galaznik"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Curtis A","lastName":"Lachowiez ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Healthcare Consumption Amongst Older Patients with High Risk AML Treated with Hypomethylating Agents Is Similar to That of Patients Receiving Induction Chemotherapy","keywords":"","combinedName":"doctor curtis a lachowiez"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Pushpendra ","lastName":"Goswami ","credentials":"PhD, MSc, BPharm","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HM-PRO: A Novel Patient-Reported Outcome Measure in Hematological Malignancy for Use in Clinical Practice","keywords":"","combinedName":"doctor pushpendra goswami"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Jason ","lastName":"Tay ","credentials":"MD, FRCPC","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Active Maintenance Treatment (MT) Compared to No MT on the Quality of Life (QoL) of Patients with Multiple Myeloma (MM) Following First Autologous Stem Cell Transplant (ASCT)","keywords":"","combinedName":"doctor jason tay"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Elias ","lastName":"Jabbour","credentials":"MD ","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Earlier Vs. Later Monitoring on Disease Progression and Economic Outcomes Among Patients with Chronic Myeloid Leukemia in the Real-World Setting","keywords":"","combinedName":"doctor elias jabbour"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Tatiana ","lastName":"Ionova ","credentials":"DSc","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Is Quality of Life (QOL) Predictive for Clinical Response in Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients Treated with Dasatinib?","keywords":"","combinedName":"doctor tatiana ionova"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Parameswaran ","lastName":"Hari ","credentials":"MD, MRCP, MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma Post Autologous Stem Cell Transplant: A Comparison of Real-World Treatment Outcomes and Costs","keywords":"","combinedName":"doctor parameswaran hari"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Tsofia ","lastName":"Inbar ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low Risk for Viral Reactivation during Induction for Acute Myeloid Leukemia in Hepatitis B Silent Carriers Who Are Negative for Hepatitis B Surface Antigen","keywords":"","combinedName":"doctor tsofia inbar"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Christopher ","lastName":"Kim ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multiple Myeloma Patients and Risk of Skeletal Related Events  Real-World Evidence in US Oncology Clinics","keywords":"","combinedName":"doctor christopher kim"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Leslie","lastName":"Padrnos","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloproliferative Neoplasms and Depressive Symptoms, Diagnosis, and Associations","keywords":"","combinedName":"doctor leslie padrnos"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Robyn ","lastName":"Scherber","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nutrition and Supplement Use Characteristics in the Myeloproliferative Neoplasms: Results from the Nutrient Survey","keywords":"","combinedName":"doctor robyn scherber"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Jimmy ","lastName":"He ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient-Reported Disease Burden in the Elderly Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor jimmy he"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Thomas ","lastName":"LeBlanc ","credentials":"MD, MA","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient-Reported Distress in Hodgkin Lymphoma Patients on Active Therapy Vs. Long-Term Survivors","keywords":"","combinedName":"doctor thomas leblanc"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Bastian ","lastName":"von Tresckow ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient-Reported Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab Monotherapy, Results of a Phase 2 Study","keywords":"","combinedName":"doctor bastian von tresckow"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Meinolf ","lastName":"Karthaus ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quality of Life and Patient Reported Outcome (PRO) in Patients Receiving High and Moderate Emetogenic Chemotherapy (Ctx) - Results of a German Non-Interventional Study with NEPA  a Netupitant/Palonosetron Fixed Dose Combination","keywords":"","combinedName":"doctor meinolf karthaus"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Amylou ","lastName":"Dueck ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantitative Testing of the Myelofibrosis Symptom Assessment Form Version 4.0, a Harmonized Patient-Reported Outcome Measure for Collecting Key Secondary Endpoint Data in Myelofibrosis Clinical Trials","keywords":"","combinedName":"doctor amylou dueck"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Ajai ","lastName":"Chari ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real-World Treatment Outcomes in Patients with Newly Diagnosed Multiple Myeloma Treated with Triplet Therapy without Stem Cell Transplant: An Enhanced Electronic Health Records Database","keywords":"","combinedName":"doctor ajai chari"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Martin ","lastName":"Schoen ","credentials":"MD,MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk of Herpes Zoster in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine or Bendamustine","keywords":"","combinedName":"doctor martin schoen"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Yucai ","lastName":"Wang ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Second Primary Malignancies in Patients with Non-Hodgkin Lymphoma","keywords":"","combinedName":"doctor yucai wang"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Cameron ","lastName":"Dell ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Similar Survival for African American and Caucasian Multiple Myeloma Patients Receiving Auto-SCT","keywords":"","combinedName":"doctor cameron dell"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Christine ","lastName":"Rini ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Social Support Source and Effectiveness Are Associated with Distress Among Hematopoietic Stem Cell Transplant Survivors Experiencing Stress Due to Negative Life Events after Treatment","keywords":"","combinedName":"doctor christine rini"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Stefan ","lastName":"Suciu ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Socioeconomic Outcomes Among Long-Term Childhood Acute Lymphoblastic Leukemia Survivors Enrolled between 1971 and 1998 in the EORTC Children Leukemia Group Trials 58741, 58831/2 and 58881","keywords":"","combinedName":"doctor stefan suciu"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Kristen ","lastName":"Corrao ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Successful Implementation of a Blood Management Program for Patients with Hematologic Malignancies","keywords":"","combinedName":"doctor kristen corrao"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Omer ","lastName":"Jamy ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Survival of Chronic MyeloidLeukemiaPatients in Comparison to General Population in the Tyrosine Kinase InhibitorsEra: A US Population Based Study","keywords":"","combinedName":"doctor omer jamy"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Aaron ","lastName":"Galaznik ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Survival Outcomes after First-Line Therapy in Follicular Lymphoma Patients Treated with Bendamustine and Rituximab Vs Other Rituximab Combinations in the United States","keywords":"","combinedName":"doctor aaron galaznik"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Sikander ","lastName":"Ailawadhi ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Survival Trends in Young Patients with Multiple Myeloma: Focus on Racial-Ethnic Minorities","keywords":"","combinedName":"doctor sikander ailawadhi"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Jill A","lastName":"Bell ","credentials":"PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Characteristics and Outcomes for Newly Diagnosed Elderly Patients with Acute Myeloid Leukemia (AML) Treated in the United States with Either 7+3 or a Hypomethylating Agent (HMA)","keywords":"","combinedName":"doctor jill a bell"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"James ","lastName":"Griffin ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Patterns and Healthcare Resource Utilization in Patients with FLT3-Mut and FLT3-Wt Acute Myeloid Leukemia: A Multi-Country Medical Chart Study","keywords":"","combinedName":"doctor james griffin"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Amer ","lastName":"Zeidan","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Sequence of Lenalidomide (LEN) and Hypomethylating Agents (HMAs) and the Impact on Clinical Outcomes for Patients with Myelodysplastic Syndromes (MDS)","keywords":"","combinedName":"doctor amer zeidan"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Qian ","lastName":"Wang ","credentials":"MD, MPH","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Trends and Outcomes in the Use of Radiation Therapy and Chemotherapy for the Treatment of Hodgkins Lymphoma: An Analysis from SEER Database 1985-2014","keywords":"","combinedName":"doctor qian wang"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Dianne ","lastName":"Pulte ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Updated Population Based Survival Analysis in Patients with Chronic Myeloid Leukemia: Increased Survival but Continued Disparities for Older Patients","keywords":"","combinedName":"doctor dianne pulte"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Binod","lastName":"Dhakal","credentials":"MBBS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Using Big-Data to Evaluate in-Hospital Morbidity and Mortality in Systemic Light Chain (AL) Amyloidosis after High Dose Therapy and Autologous Stem Cell Transplant (HDT/ASCT)","keywords":"","combinedName":"doctor binod dhakal"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Maneesha ","lastName":"Mehra ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Utilization of Hypomethylating Agents and Associated Outcomes in Elderly Acute Myeloid Leukemia (AML) Patients: A Population Based Study","keywords":"","combinedName":"doctor maneesha mehra"},{"sessionId":"11689","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster I","firstName":"Ketan ","lastName":"Kulkarni ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Venous Thrombotic Events Are Independently Associated with Inferior Survival Outcome in Pediatric Cancer Patients: A Multicenter Study","keywords":"","combinedName":"doctor ketan kulkarni"},{"sessionId":"11713","sessionTitle":"New Findings From Population Studies of B-Cell Lymphoma and Leukemia ","firstName":"Marta","lastName":"Epeldegui","credentials":"PhD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:25:00Z","startTime":"13:30:00","endTime":"13:45:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Prospective Study of Serum Microbial Translocation and Inflammation Associated Biomarkers and Risk of AIDS-Related Non-Hodgkin Lymphoma","keywords":"","combinedName":"doctor marta epeldegui"},{"sessionId":"11713","sessionTitle":"New Findings From Population Studies of B-Cell Lymphoma and Leukemia ","firstName":"Smita","lastName":"Bhatia","credentials":"MD, MPH","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:25:00Z","startTime":"14:10:00","endTime":"14:25:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adherence to Oral Chemotherapy in Children with ALL: Contribution to Disparities in Outcomes","keywords":"","combinedName":"doctor smita bhatia"},{"sessionId":"11713","sessionTitle":"New Findings From Population Studies of B-Cell Lymphoma and Leukemia ","firstName":"Maria ","lastName":"Oliveira","credentials":"","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:25:00Z","startTime":"13:55:00","endTime":"14:10:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early-Age Leukemias in Brazil","keywords":"","combinedName":"doctor maria oliveira"},{"sessionId":"11713","sessionTitle":"New Findings From Population Studies of B-Cell Lymphoma and Leukemia ","firstName":"Susan ","lastName":"Slager","credentials":"PhD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:25:00Z","startTime":"13:20:00","endTime":"13:30:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Risk Factors for CLL Precursors in Families","keywords":"","combinedName":"doctor susan slager"},{"sessionId":"11713","sessionTitle":"New Findings From Population Studies of B-Cell Lymphoma and Leukemia ","firstName":"Jeffrey ","lastName":"Switchenko","credentials":"PhD, MS","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:25:00Z","startTime":"13:05:00","endTime":"13:20:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Geospatial Exposure to Benzene and Lymphoma Risk in Georgia ","keywords":"","combinedName":"doctor jeffrey switchenko"},{"sessionId":"11713","sessionTitle":"New Findings From Population Studies of B-Cell Lymphoma and Leukemia ","firstName":"Wendy","lastName":"Cozen","credentials":"DO, MPH","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:25:00Z","startTime":"13:45:00","endTime":"13:55:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immunological Aging in Adolescent/Young Adult Hodgkin Lymphoma Survivors Compared to Their Unaffected Twins","keywords":"","combinedName":"doctor wendy cozen"},{"sessionId":"11714","sessionTitle":"Epidemiology of Myeloid Malignancy: Precursor States and Risk Factor Update ","firstName":"Lene Sofie Granfeldt","lastName":"Oestgaard ","credentials":"MD,PhD","sessionStartTime":"2017-12-08T14:35:00Z","sessionEndTime":"2017-12-08T15:35:00Z","startTime":"15:20:00","endTime":"15:35:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Epidemiology & Impact of Therapy-Related AML","keywords":"","combinedName":"doctor lene sofie granfeldt oestgaard"},{"sessionId":"11714","sessionTitle":"Epidemiology of Myeloid Malignancy: Precursor States and Risk Factor Update ","firstName":"Koichi ","lastName":"Takahashi ","credentials":"MD","sessionStartTime":"2017-12-08T14:35:00Z","sessionEndTime":"2017-12-08T15:35:00Z","startTime":"14:50:00","endTime":"15:05:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Next Steps with Chip and Myeloid Neoplasms  Informing Risk &amp; Prevention","keywords":"","combinedName":"doctor koichi takahashi"},{"sessionId":"11714","sessionTitle":"Epidemiology of Myeloid Malignancy: Precursor States and Risk Factor Update ","firstName":"Nancy ","lastName":"Gillis ","credentials":"PharmD, PhD","sessionStartTime":"2017-12-08T14:35:00Z","sessionEndTime":"2017-12-08T15:35:00Z","startTime":"14:35:00","endTime":"14:50:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Existing Chip and Risk of Therapy-Related Myeloid Neoplasms","keywords":"","combinedName":"doctor nancy gillis"},{"sessionId":"11714","sessionTitle":"Epidemiology of Myeloid Malignancy: Precursor States and Risk Factor Update ","firstName":"Sudipto","lastName":"Mukherjee","credentials":"MD, PhD, MPH","sessionStartTime":"2017-12-08T14:35:00Z","sessionEndTime":"2017-12-08T15:35:00Z","startTime":"15:05:00","endTime":"15:20:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk Prediction for MDS: Novel Clinical and Molecular Risk Factors and Development of Prevention Strategies","keywords":"","combinedName":"doctor sudipto mukherjee"},{"sessionId":"11715","sessionTitle":"Understanding the Risk Pathway of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma: Contributions From Epidemiology ","firstName":"Kenneth ","lastName":"Carson ","credentials":"MD","sessionStartTime":"2017-12-08T15:45:00Z","sessionEndTime":"2017-12-08T17:05:00Z","startTime":"16:50:00","endTime":"17:05:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Can We Move Towards Prevention in Multiple Myeloma?","keywords":"","combinedName":"doctor kenneth carson"},{"sessionId":"11715","sessionTitle":"Understanding the Risk Pathway of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma: Contributions From Epidemiology ","firstName":"Elizabeth E","lastName":"Brown ","credentials":"PhD, MPH","sessionStartTime":"2017-12-08T15:45:00Z","sessionEndTime":"2017-12-08T17:05:00Z","startTime":"16:20:00","endTime":"16:35:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differential DNA Methylation Consistent with Progression of Multiple Myeloma ","keywords":"","combinedName":"doctor elizabeth e brown"},{"sessionId":"11715","sessionTitle":"Understanding the Risk Pathway of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma: Contributions From Epidemiology ","firstName":"Catherine ","lastName":"Marinac ","credentials":"PhD","sessionStartTime":"2017-12-08T15:45:00Z","sessionEndTime":"2017-12-08T17:05:00Z","startTime":"15:45:00","endTime":"15:55:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Elucidating the Association of Obesity with Multiple Myeloma Risk: Prospective Studies of Body Size throughout Life and Weight Stability ","keywords":"","combinedName":"doctor catherine marinac"},{"sessionId":"11715","sessionTitle":"Understanding the Risk Pathway of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma: Contributions From Epidemiology ","firstName":"Niels ","lastName":"Weinhold ","credentials":"PhD","sessionStartTime":"2017-12-08T15:45:00Z","sessionEndTime":"2017-12-08T17:05:00Z","startTime":"16:05:00","endTime":"16:20:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional Follow-up of Potential Risk Variants","keywords":"","combinedName":"doctor niels weinhold"},{"sessionId":"11715","sessionTitle":"Understanding the Risk Pathway of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma: Contributions From Epidemiology ","firstName":"Mark ","lastName":"Fiala ","credentials":"MSW","sessionStartTime":"2017-12-08T15:45:00Z","sessionEndTime":"2017-12-08T17:05:00Z","startTime":"16:35:00","endTime":"16:50:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inequalities in Treatment and Outcomes in Multiple Myeloma","keywords":"","combinedName":"doctor mark fiala"},{"sessionId":"11715","sessionTitle":"Understanding the Risk Pathway of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Myeloma: Contributions From Epidemiology ","firstName":"Sigurur Yngvi","lastName":"Kristinsson ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T15:45:00Z","sessionEndTime":"2017-12-08T17:05:00Z","startTime":"15:55:00","endTime":"16:05:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"iStopMM - A Nationwide Screening Study of MGUS","keywords":"","combinedName":"doctor sigurur yngvi kristinsson"},{"sessionId":"11716","sessionTitle":"T-and NK-cell Lymphoma/Leukemia: Challenges and Opportunities for Epidemiologic Research ","firstName":"Amanda","lastName":"Termuhlen","credentials":"","sessionStartTime":"2017-12-08T17:05:00Z","sessionEndTime":"2017-12-08T17:45:00Z","startTime":"17:05:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Review of Epidemiology and Risk Factors for Pediatric T-Cell Lymphoma/Leukemia","keywords":"","combinedName":"doctor amanda termuhlen"},{"sessionId":"11716","sessionTitle":"T-and NK-cell Lymphoma/Leukemia: Challenges and Opportunities for Epidemiologic Research ","firstName":"Sophia ","lastName":"Wang","credentials":"PhD","sessionStartTime":"2017-12-08T17:05:00Z","sessionEndTime":"2017-12-08T17:45:00Z","startTime":"17:15:00","endTime":"17:30:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Review of Epidemiology of Risk Factors for Adult Peripheral T-Cell Lymphoma/Leukemia ","keywords":"","combinedName":"doctor sophia wang"},{"sessionId":"11716","sessionTitle":"T-and NK-cell Lymphoma/Leukemia: Challenges and Opportunities for Epidemiologic Research ","firstName":"Fredrik","lastName":"Ellin","credentials":"MD, MSc","sessionStartTime":"2017-12-08T17:05:00Z","sessionEndTime":"2017-12-08T17:45:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T-Cell Lymphomas on a Nation-Wide Level - Experiences from the Population-Based Swedish Lymphoma Registry","keywords":"","combinedName":"doctor fredrik ellin"},{"sessionId":"11718","sessionTitle":"Identification of Germline Syndromes ","firstName":"Christian ","lastName":"Kratz ","credentials":"MD","sessionStartTime":"2017-12-08T13:10:00Z","sessionEndTime":"2017-12-08T13:55:00Z","startTime":"13:10:00","endTime":"13:20:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Children with Cancer Predisposition Syndromes in Germany: Activities of the Society of Pediatric Oncology and Hematology","keywords":"","combinedName":"doctor christian kratz"},{"sessionId":"11718","sessionTitle":"Identification of Germline Syndromes ","firstName":"Courtney ","lastName":"DiNardo","credentials":"MD, MSc","sessionStartTime":"2017-12-08T13:10:00Z","sessionEndTime":"2017-12-08T13:55:00Z","startTime":"13:30:00","endTime":"13:40:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incorporating MDS/AML Molecular Profiling at Diagnosis into the Evaluation of Hereditary Leukemia Predispositions","keywords":"","combinedName":"doctor courtney dinardo"},{"sessionId":"11718","sessionTitle":"Identification of Germline Syndromes ","firstName":"Christopher ","lastName":"Hahn ","credentials":"PhD","sessionStartTime":"2017-12-08T13:10:00Z","sessionEndTime":"2017-12-08T13:55:00Z","startTime":"13:20:00","endTime":"13:30:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Surprises in \"Solving\" Families with Predisposition to Hematopoietic Malignancy","keywords":"","combinedName":"doctor christopher hahn"},{"sessionId":"11718","sessionTitle":"Identification of Germline Syndromes ","firstName":"Sarah ","lastName":"Bannon ","credentials":"MS","sessionStartTime":"2017-12-08T13:10:00Z","sessionEndTime":"2017-12-08T13:55:00Z","startTime":"13:40:00","endTime":"13:55:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unique Role of Genetic Counselors in Hematologic Malignancies","keywords":"","combinedName":"doctor sarah bannon"},{"sessionId":"11719","sessionTitle":"Novel Aspects of Known Predisposition Syndrome","firstName":"Jorge","lastName":"Di Paola","credentials":"MD","sessionStartTime":"2017-12-08T13:55:00Z","sessionEndTime":"2017-12-08T14:40:00Z","startTime":"14:15:00","endTime":"14:25:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Murine Model of an ETV6 Germline Mutation","keywords":"","combinedName":"doctor jorge di paola"},{"sessionId":"11719","sessionTitle":"Novel Aspects of Known Predisposition Syndrome","firstName":"Bianca ","lastName":"Tesi ","credentials":"MD","sessionStartTime":"2017-12-08T13:55:00Z","sessionEndTime":"2017-12-08T14:40:00Z","startTime":"14:25:00","endTime":"14:40:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical and Molecular Features of Patients with SAMD9L-Germline Mutations","keywords":"","combinedName":"doctor bianca tesi"},{"sessionId":"11719","sessionTitle":"Novel Aspects of Known Predisposition Syndrome","firstName":"Hideki ","lastName":"Makishima ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T13:55:00Z","sessionEndTime":"2017-12-08T14:40:00Z","startTime":"14:05:00","endTime":"14:15:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Evaluation of DDX41 Risk Alleles in Non-Familial Cases, General Individuals, and Donor-Derived Leukemias","keywords":"","combinedName":"doctor hideki makishima"},{"sessionId":"11719","sessionTitle":"Novel Aspects of Known Predisposition Syndrome","firstName":"Emilia ","lastName":"Kozyra ","credentials":"MSc","sessionStartTime":"2017-12-08T13:55:00Z","sessionEndTime":"2017-12-08T14:40:00Z","startTime":"13:55:00","endTime":"14:05:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Synonymous Exonic Substitutions Constitute a New Class of Mutations Causing GATA2 Deficiency","keywords":"","combinedName":"doctor emilia kozyra"},{"sessionId":"11720","sessionTitle":"Emerging New Syndromes","firstName":"Ian ","lastName":"Majewski ","credentials":"","sessionStartTime":"2017-12-08T14:40:00Z","sessionEndTime":"2017-12-08T15:25:00Z","startTime":"14:50:00","endTime":"15:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A New Cancer Predisposition Syndrome with a Common Path to AML","keywords":"","combinedName":"doctor ian majewski"},{"sessionId":"11720","sessionTitle":"Emerging New Syndromes","firstName":"Ana ","lastName":"Rio-Machin ","credentials":"PhD","sessionStartTime":"2017-12-08T14:40:00Z","sessionEndTime":"2017-12-08T15:25:00Z","startTime":"15:00:00","endTime":"15:10:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Challenge of Identifying Novel Predisposing Variants in Familial MDS/AML","keywords":"","combinedName":"doctor ana rio-machin"},{"sessionId":"11720","sessionTitle":"Emerging New Syndromes","firstName":"Tim ","lastName":"Ripperger ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T14:40:00Z","sessionEndTime":"2017-12-08T15:25:00Z","startTime":"15:10:00","endTime":"15:25:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mecom/EVI1: A Novel Candidate Gene for Hereditary Hematological Malignancies","keywords":"","combinedName":"doctor tim ripperger"},{"sessionId":"11720","sessionTitle":"Emerging New Syndromes","firstName":"Victor ","lastName":"Pastor Loyola ","credentials":"MSc","sessionStartTime":"2017-12-08T14:40:00Z","sessionEndTime":"2017-12-08T15:25:00Z","startTime":"14:40:00","endTime":"14:50:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Spectrum of SAMD9/SAMD9L-Related Bone Marrow Failure and Myeloid Neoplasia","keywords":"","combinedName":"doctor victor pastor loyola"},{"sessionId":"11721","sessionTitle":"Effects of Combinations of Germline Variants Including Penetrance/Molecular Progression","firstName":"Thomas ","lastName":"Laframboise ","credentials":"PhD","sessionStartTime":"2017-12-08T15:40:00Z","sessionEndTime":"2017-12-08T16:25:00Z","startTime":"16:00:00","endTime":"16:10:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Germline Contributors to Myeloid Malignancy Susceptibility: Integrating Clues from the Malignant Genome","keywords":"","combinedName":"doctor thomas laframboise"},{"sessionId":"11721","sessionTitle":"Effects of Combinations of Germline Variants Including Penetrance/Molecular Progression","firstName":"Kim ","lastName":"Nichols ","credentials":"MD","sessionStartTime":"2017-12-08T15:40:00Z","sessionEndTime":"2017-12-08T16:25:00Z","startTime":"16:10:00","endTime":"16:25:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hiding Beneath the Surface: Unbiased Screening of the Germline Identifies Unsuspected Cancer Predispositions in Pediatric Leukemia Patients","keywords":"","combinedName":"doctor kim nichols"},{"sessionId":"11721","sessionTitle":"Effects of Combinations of Germline Variants Including Penetrance/Molecular Progression","firstName":"Csaba ","lastName":"Bdr ","credentials":"PhD","sessionStartTime":"2017-12-08T15:40:00Z","sessionEndTime":"2017-12-08T16:25:00Z","startTime":"15:50:00","endTime":"16:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"JAK/STAT Pathway Aberrations in RUNX1 Mutated Patients","keywords":"","combinedName":"doctor csaba bdr"},{"sessionId":"11721","sessionTitle":"Effects of Combinations of Germline Variants Including Penetrance/Molecular Progression","firstName":"Inga ","lastName":"Hofmann ","credentials":"MD","sessionStartTime":"2017-12-08T15:40:00Z","sessionEndTime":"2017-12-08T16:25:00Z","startTime":"15:40:00","endTime":"15:50:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predisposition to Pediatric Myelofibrosis and Thrombocytopenia","keywords":"","combinedName":"doctor inga hofmann"},{"sessionId":"11722","sessionTitle":"Reporting of Families and Variant Interpretation","firstName":"Matthew ","lastName":"Collin ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T16:25:00Z","sessionEndTime":"2017-12-08T17:10:00Z","startTime":"16:55:00","endTime":"17:10:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Defects Associated with GATA2 Mutation","keywords":"","combinedName":"doctor matthew collin"},{"sessionId":"11722","sessionTitle":"Reporting of Families and Variant Interpretation","firstName":"Isabelle","lastName":"Plo","credentials":"PhD","sessionStartTime":"2017-12-08T16:25:00Z","sessionEndTime":"2017-12-08T17:10:00Z","startTime":"16:35:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predisposition to Familial MPNs","keywords":"","combinedName":"doctor isabelle plo"},{"sessionId":"11722","sessionTitle":"Reporting of Families and Variant Interpretation","firstName":"Karin ","lastName":"Wadt ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T16:25:00Z","sessionEndTime":"2017-12-08T17:10:00Z","startTime":"16:25:00","endTime":"16:35:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reporting in Scandanavian Populations","keywords":"","combinedName":"doctor karin wadt"},{"sessionId":"11722","sessionTitle":"Reporting of Families and Variant Interpretation","firstName":"Jeffery ","lastName":"Klco ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T16:25:00Z","sessionEndTime":"2017-12-08T17:10:00Z","startTime":"16:45:00","endTime":"16:55:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"SAMD9/9L Germline Mutations in Familial MDS/AML","keywords":"","combinedName":"doctor jeffery klco"},{"sessionId":"11727","sessionTitle":"ASH-FDA Joint Symposium on New Drug Approvals in Acute Myeloid Leukemia","firstName":"Jessica ","lastName":"Altman","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:04:00","endTime":"17:14:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Perspective","keywords":"","combinedName":"doctor jessica altman"},{"sessionId":"11727","sessionTitle":"ASH-FDA Joint Symposium on New Drug Approvals in Acute Myeloid Leukemia","firstName":"Laura ","lastName":"Michaelis","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:14:00","endTime":"17:24:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Perspective","keywords":"","combinedName":"doctor laura michaelis"},{"sessionId":"11727","sessionTitle":"ASH-FDA Joint Symposium on New Drug Approvals in Acute Myeloid Leukemia","firstName":"Aviva ","lastName":"Krauss ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:46:00","endTime":"16:52:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daunorubicin/Cytarabine","keywords":"","combinedName":"doctor aviva krauss"},{"sessionId":"11727","sessionTitle":"ASH-FDA Joint Symposium on New Drug Approvals in Acute Myeloid Leukemia","firstName":"Ashley ","lastName":"Ward ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:30:00","endTime":"16:40:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Defining Clinical Benefit: Evolving Regulatory Considerations for Drug Development in AML","keywords":"","combinedName":"doctor ashley ward"},{"sessionId":"11727","sessionTitle":"ASH-FDA Joint Symposium on New Drug Approvals in Acute Myeloid Leukemia","firstName":"Ashley ","lastName":"Ward ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:58:00","endTime":"17:04:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enasidenib","keywords":"","combinedName":"doctor ashley ward"},{"sessionId":"11727","sessionTitle":"ASH-FDA Joint Symposium on New Drug Approvals in Acute Myeloid Leukemia","firstName":"Kelly ","lastName":"Norsworthy ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:52:00","endTime":"16:58:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gemtuzumab Ozogamicin","keywords":"","combinedName":"doctor kelly norsworthy"},{"sessionId":"11727","sessionTitle":"ASH-FDA Joint Symposium on New Drug Approvals in Acute Myeloid Leukemia","firstName":"Ashley ","lastName":"Ward ","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"16:40:00","endTime":"16:46:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Midostaurin","keywords":"","combinedName":"doctor ashley ward"},{"sessionId":"11727","sessionTitle":"ASH-FDA Joint Symposium on New Drug Approvals in Acute Myeloid Leukemia","firstName":"Richard","lastName":"Pazdur","credentials":"MD","sessionStartTime":"2017-12-11T16:30:00Z","sessionEndTime":"2017-12-11T18:00:00Z","startTime":"17:24:00","endTime":"17:44:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Panel Discussion","keywords":"","combinedName":"doctor richard pazdur"},{"sessionId":"11729","sessionTitle":"ASH-FDA Joint Symposium on New Drug Approvals in Acute Lymphoid Leukemia and Non-Hodgkin Lymphoma","firstName":"R. ","lastName":"De Claro ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Drug Options for Patients: FDA at Work","keywords":"","combinedName":"doctor r de claro"},{"sessionId":"11731","sessionTitle":"Stem Cells ","firstName":"Grant Anthony","lastName":"Challen","credentials":"PhD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T13:50:00Z","startTime":"13:35:00","endTime":"13:50:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Kdm6b Is Required for Hematopoietic Stem Cell Self-Renewal Under Proliferative Stress","keywords":"","combinedName":"doctor grant anthony challen"},{"sessionId":"11731","sessionTitle":"Stem Cells ","firstName":"Wei","lastName":"Tong","credentials":"PhD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T13:50:00Z","startTime":"13:25:00","endTime":"13:35:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lnk/Sh2b3 Deficiency Restores Hematopoietic Stem Cell Function and Genome Integrity in Fanconi Anemia","keywords":"","combinedName":"doctor wei tong"},{"sessionId":"11731","sessionTitle":"Stem Cells ","firstName":"Snoeck ","lastName":"Hans-Willem ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T13:50:00Z","startTime":"13:05:00","endTime":"13:15:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mitochondrial Regulation of Hematopoietic Stem Cells","keywords":"","combinedName":"doctor snoeck hans-willem"},{"sessionId":"11731","sessionTitle":"Stem Cells ","firstName":"Kira ","lastName":"Gritsman ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T13:50:00Z","startTime":"13:15:00","endTime":"13:25:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The PI3 Kinases Alpha and Delta Are Required for the Loss of Hematopoietic Stem Cell Quiescence during Stress","keywords":"","combinedName":"doctor kira gritsman"},{"sessionId":"11732","sessionTitle":"Signaling and Developmental Hematopoiesis ","firstName":"Andreas ","lastName":"Trumpp ","credentials":"Prof, PhD","sessionStartTime":"2017-12-08T13:50:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"14:00:00","endTime":"14:10:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BCAT1 Restricts a-Ketoglutarate Levels in AML Stem Cells Leading to DNA Hypermethylation Mimicking Idhmut-AML","keywords":"","combinedName":"doctor andreas trumpp"},{"sessionId":"11732","sessionTitle":"Signaling and Developmental Hematopoiesis ","firstName":"Toshio ","lastName":"Kitamura ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T13:50:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"14:20:00","endTime":"14:35:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of Hematopoietic Stem Cells and Progenitors Using a Novel Mouse Expressing a G0 Marker","keywords":"","combinedName":"doctor toshio kitamura"},{"sessionId":"11732","sessionTitle":"Signaling and Developmental Hematopoiesis ","firstName":"Jian ","lastName":"Xu ","credentials":"PhD","sessionStartTime":"2017-12-08T13:50:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"14:10:00","endTime":"14:20:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interplay between Epigenetics and Metabolism in Hematopoiesis and Leukemia","keywords":"","combinedName":"doctor jian xu"},{"sessionId":"11732","sessionTitle":"Signaling and Developmental Hematopoiesis ","firstName":"Britta ","lastName":"Will ","credentials":"PhD","sessionStartTime":"2017-12-08T13:50:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"13:50:00","endTime":"14:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Labile Iron Pool As a Rheostat for Hematopoietic Stem Cell Function","keywords":"","combinedName":"doctor britta will"},{"sessionId":"11733","sessionTitle":"Myeloid Malignancies","firstName":"Jun ","lastName":"Lu ","credentials":"PhD","sessionStartTime":"2017-12-08T17:00:00Z","sessionEndTime":"2017-12-08T17:45:00Z","startTime":"17:20:00","endTime":"17:30:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Non-Cell-Intrinsic Tumor-Promoting Function of Tet2 in Myeloid Cells","keywords":"","combinedName":"doctor jun lu"},{"sessionId":"11733","sessionTitle":"Myeloid Malignancies","firstName":"Chris ","lastName":"Vakoc ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T17:00:00Z","sessionEndTime":"2017-12-08T17:45:00Z","startTime":"17:00:00","endTime":"17:10:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Domain-Focused CRISPR Dropout Screens in AML","keywords":"","combinedName":"doctor chris vakoc"},{"sessionId":"11733","sessionTitle":"Myeloid Malignancies","firstName":"Takahiro ","lastName":"Maeda ","credentials":"MD,PhD","sessionStartTime":"2017-12-08T17:00:00Z","sessionEndTime":"2017-12-08T17:45:00Z","startTime":"17:30:00","endTime":"17:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genome-Wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway","keywords":"","combinedName":"doctor takahiro maeda"},{"sessionId":"11733","sessionTitle":"Myeloid Malignancies","firstName":"Yana ","lastName":"Pikman ","credentials":"MD","sessionStartTime":"2017-12-08T17:00:00Z","sessionEndTime":"2017-12-08T17:45:00Z","startTime":"17:10:00","endTime":"17:20:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Therapeutic Targets in AML","keywords":"","combinedName":"doctor yana pikman"},{"sessionId":"11734","sessionTitle":"Transcription Factors/Epigenetics","firstName":"Omar","lastName":"Abdel-Wahab","credentials":"MD","sessionStartTime":"2017-12-08T16:15:00Z","sessionEndTime":"2017-12-08T17:00:00Z","startTime":"16:15:00","endTime":"16:25:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identifying Novel Therapeutic Vulnerabilities in Spliceosomal Mutant Leukemias","keywords":"","combinedName":"doctor omar abdel-wahab"},{"sessionId":"11734","sessionTitle":"Transcription Factors/Epigenetics","firstName":"Lucio ","lastName":"Castilla","credentials":"PhD","sessionStartTime":"2017-12-08T16:15:00Z","sessionEndTime":"2017-12-08T17:00:00Z","startTime":"16:35:00","endTime":"16:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Cbfbsmmhc / RUNX1 in Maintaining MYC Levels By Modulating Chromatin Dynamics in AML","keywords":"","combinedName":"doctor lucio castilla"},{"sessionId":"11734","sessionTitle":"Transcription Factors/Epigenetics","firstName":"Shai","lastName":"Izraeli","credentials":"MD","sessionStartTime":"2017-12-08T16:15:00Z","sessionEndTime":"2017-12-08T17:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T/Myeloid Biphenotypic Leukemia Caused By the Fusion Translocation ETV6-NCOA2 (TEL-TIF2)","keywords":"","combinedName":"doctor shai izraeli"},{"sessionId":"11734","sessionTitle":"Transcription Factors/Epigenetics","firstName":"Megan ","lastName":"McNerney ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T16:15:00Z","sessionEndTime":"2017-12-08T17:00:00Z","startTime":"16:25:00","endTime":"16:35:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The 7q Tumor Suppressor, CUX1, Inhibits MDS/MPN in Mice","keywords":"","combinedName":"doctor megan mcnerney"},{"sessionId":"11735","sessionTitle":"New Investigators ","firstName":"Siddhartha ","lastName":"Jaiswal ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T14:35:00Z","sessionEndTime":"2017-12-08T15:25:00Z","startTime":"14:45:00","endTime":"14:55:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Hematopoiesis in Human Aging and Disease","keywords":"","combinedName":"doctor siddhartha jaiswal"},{"sessionId":"11735","sessionTitle":"New Investigators ","firstName":"Robert ","lastName":"Signer ","credentials":"PhD","sessionStartTime":"2017-12-08T14:35:00Z","sessionEndTime":"2017-12-08T15:25:00Z","startTime":"14:35:00","endTime":"14:45:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoietic Stem Cells Depend on Low Protein Synthesis to Maintain the Integrity of Their Proteome","keywords":"","combinedName":"doctor robert signer"},{"sessionId":"11735","sessionTitle":"New Investigators ","firstName":"Rebekka ","lastName":"Schneider ","credentials":"MD,PhD","sessionStartTime":"2017-12-08T14:35:00Z","sessionEndTime":"2017-12-08T15:25:00Z","startTime":"15:05:00","endTime":"15:15:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Megakaryocyte-Mediated Activation of the Transcription Factor Gli1 in Fibrosis-Driving Cells in Myelofibrosis","keywords":"","combinedName":"doctor rebekka schneider"},{"sessionId":"11735","sessionTitle":"New Investigators ","firstName":"Vijay ","lastName":"Sankaran ","credentials":"MD","sessionStartTime":"2017-12-08T14:35:00Z","sessionEndTime":"2017-12-08T15:25:00Z","startTime":"15:15:00","endTime":"15:25:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis","keywords":"","combinedName":"doctor vijay sankaran"},{"sessionId":"11735","sessionTitle":"New Investigators ","firstName":"Robert ","lastName":"Welner ","credentials":"PhD","sessionStartTime":"2017-12-08T14:35:00Z","sessionEndTime":"2017-12-08T15:25:00Z","startTime":"14:55:00","endTime":"15:05:00","sessionLocation":"Bldg A- Lvl 4- Marcus Aud.","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcriptional Hierarchy within the Bone Marrow Niche","keywords":"","combinedName":"doctor robert welner"},{"sessionId":"11737","sessionTitle":"Stem Cells and Aging ","firstName":"Michael Gustave","lastName":"Poulos","credentials":"PhD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:05:00Z","startTime":"13:05:00","endTime":"13:20:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aging Vascular Endothelium Modulate Hematopoietic Stem Cell Activity","keywords":"","combinedName":"doctor michael gustave poulos"},{"sessionId":"11737","sessionTitle":"Stem Cells and Aging ","firstName":"Cynthia ","lastName":"Dunbar","credentials":"MD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:05:00Z","startTime":"13:50:00","endTime":"14:05:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Creation of a Non-Human Primate Model for Hematopoietic Aging and for Chip","keywords":"","combinedName":"doctor cynthia dunbar"},{"sessionId":"11737","sessionTitle":"Stem Cells and Aging ","firstName":"Laura ","lastName":"Calvi","credentials":"MD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:05:00Z","startTime":"13:35:00","endTime":"13:50:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Defects in Aging Marrow Macrophages Regulate Hematopoietic Stem Cells","keywords":"","combinedName":"doctor laura calvi"},{"sessionId":"11737","sessionTitle":"Stem Cells and Aging ","firstName":"Gerald","lastName":"De Haan","credentials":"PhD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:05:00Z","startTime":"13:20:00","endTime":"13:35:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Mechanisms That Contribute to Hematopoietic Stem Cell Aging","keywords":"","combinedName":"doctor gerald de haan"},{"sessionId":"11738","sessionTitle":"Aging, Inflammation and Immune Function ","firstName":"Bindu","lastName":"Kanapuru","credentials":"MD","sessionStartTime":"2017-12-08T14:20:00Z","sessionEndTime":"2017-12-08T15:05:00Z","startTime":"14:50:00","endTime":"15:05:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immunotherapy in Older Adults with Hematological Malignancies","keywords":"","combinedName":"doctor bindu kanapuru"},{"sessionId":"11738","sessionTitle":"Aging, Inflammation and Immune Function ","firstName":"Hartmut","lastName":"Geiger","credentials":"PhD","sessionStartTime":"2017-12-08T14:20:00Z","sessionEndTime":"2017-12-08T15:05:00Z","startTime":"14:20:00","endTime":"14:35:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Stem Cells Aging and Immunity","keywords":"","combinedName":"doctor hartmut geiger"},{"sessionId":"11738","sessionTitle":"Aging, Inflammation and Immune Function ","firstName":"Fabienne","lastName":"Lucas","credentials":"MD PhD","sessionStartTime":"2017-12-08T14:20:00Z","sessionEndTime":"2017-12-08T15:05:00Z","startTime":"14:35:00","endTime":"14:50:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transplant as a Model for Accelerated T-Cell Aging","keywords":"","combinedName":"doctor fabienne lucas"},{"sessionId":"11740","sessionTitle":"Thrombosis and Aging","firstName":"Alisa ","lastName":"Wolberg","credentials":"PhD","sessionStartTime":"2017-12-08T15:35:00Z","sessionEndTime":"2017-12-08T16:20:00Z","startTime":"15:50:00","endTime":"16:05:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vitro and In Vivo Models to Dissect the Pathophysiology of Thrombosis in Aging","keywords":"","combinedName":"doctor alisa wolberg"},{"sessionId":"11740","sessionTitle":"Thrombosis and Aging","firstName":"Matthew ","lastName":"Rondina","credentials":"MD","sessionStartTime":"2017-12-08T15:35:00Z","sessionEndTime":"2017-12-08T16:20:00Z","startTime":"15:35:00","endTime":"15:50:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Reprogramming and Thrombosis in Aging","keywords":"","combinedName":"doctor matthew rondina"},{"sessionId":"11740","sessionTitle":"Thrombosis and Aging","firstName":"Pavel","lastName":"Davizon-Castillo","credentials":"MD","sessionStartTime":"2017-12-08T15:35:00Z","sessionEndTime":"2017-12-08T16:20:00Z","startTime":"16:05:00","endTime":"16:20:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Megakaryocyte-Platelet Axis and Pro-Thrombotic Functional Responses in a Murine Model of Aging","keywords":"","combinedName":"doctor pavel davizon-castillo"},{"sessionId":"11741","sessionTitle":"Clinical and Biologic Correlates of Frailty in Hematology","firstName":"Raul","lastName":"Cordoba","credentials":"MD, PhD","sessionStartTime":"2017-12-08T16:35:00Z","sessionEndTime":"2017-12-08T17:20:00Z","startTime":"17:05:00","endTime":"17:20:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Brief Comprehensive Geriatric Assessment in Older Patients with Hematological Malignancies: The Gah Scale. a Nation-Wide Dissemination Strategy to Implement the Tool in Spain","keywords":"","combinedName":"doctor raul cordoba"},{"sessionId":"11741","sessionTitle":"Clinical and Biologic Correlates of Frailty in Hematology","firstName":"Marlise ","lastName":"Luskin","credentials":"MD, MSCE","sessionStartTime":"2017-12-08T16:35:00Z","sessionEndTime":"2017-12-08T17:20:00Z","startTime":"16:35:00","endTime":"16:50:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Creation of Clinical Infrastructure to Identify Genetic Determinants of Frailty for Patients with Blood Cancers","keywords":"","combinedName":"doctor marlise luskin"},{"sessionId":"11741","sessionTitle":"Clinical and Biologic Correlates of Frailty in Hematology","firstName":"Paul ","lastName":"Hamlin","credentials":"MD","sessionStartTime":"2017-12-08T16:35:00Z","sessionEndTime":"2017-12-08T17:20:00Z","startTime":"16:50:00","endTime":"17:05:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Geriatric Assessment Among Older Adults with Lymphoma","keywords":"","combinedName":"doctor paul hamlin"},{"sessionId":"11761","sessionTitle":"Special Session on Systems-Based Hematology","firstName":"Colleen","lastName":"Morton","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:45:00","endTime":"17:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"From One System to Another: Systems-Based Hematology Success in the Academic and Community Settings","keywords":"","combinedName":"doctor colleen morton"},{"sessionId":"11761","sessionTitle":"Special Session on Systems-Based Hematology","firstName":"Ravi ","lastName":"Sarode ","credentials":"MD","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"16:30:00","endTime":"16:45:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lessons Learned from a Choosing Wisely Champion","keywords":"","combinedName":"doctor ravi sarode"},{"sessionId":"11761","sessionTitle":"Special Session on Systems-Based Hematology","firstName":"Nathan ","lastName":"Connell","credentials":"MD, MPH","sessionStartTime":"2017-12-10T16:30:00Z","sessionEndTime":"2017-12-10T18:00:00Z","startTime":"17:00:00","endTime":"17:15:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Future of Systems-Based Hematology Education at the ASH Annual Meeting","keywords":"","combinedName":"doctor nathan connell"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Danitza ","lastName":"Nebor ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Potential Role for Genes within the mTORC1 Pathway in the Regulation of Embryonic Globin Expression Revealed By ChIP-Seq, RNA-Seq and eQTL Mapping in the Nan Anemia Mouse Model","keywords":"","combinedName":"doctor danitza nebor"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Soo Jin ","lastName":"Kim ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Study of Novel Beta Globin Mutation Associated with Dominant Beta-Thalassemia, Aberrant Erythroid Maturation and Differentiation Compounded with Hereditary Pyropoikilocytosis","keywords":"","combinedName":"doctor soo jin kim"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Ritama ","lastName":"Gupta ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Absence of Interleukin-6 Protects Murine Bone Marrow Erythropoiesis Under Inflammation, in a Process Reversible By Iron Mediated Reactive Oxygen Species Upregulation","keywords":"","combinedName":"doctor ritama gupta"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Kenzaburo ","lastName":"Tani ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dysregulated Transcriptional Upregulation of Cell-Cycle Regulators By KLF1 Mutation E325K Induces Cell-Cycle Arrest in Erythroid Cells Differentiated from the Congenital Dyserythropoietic Anemia (CDA)-Patient Specific Induced Pluripotent Stem Cells","keywords":"","combinedName":"doctor kenzaburo tani"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Makiko ","lastName":"Osato ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Elucidation of Autoinflammatory Mechanism in Pigt-PNH","keywords":"","combinedName":"doctor makiko osato"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Ricardo ","lastName":"Amaru ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Erythroid and Cardiovascular High Altitude-Selected Haplotypes in Andean Aymaras and Tibetans","keywords":"","combinedName":"doctor ricardo amaru"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Tamanna ","lastName":"Haque ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"First Report of Reversible Macrocytic Anemia with Dysplastic Features Associated with Palbociclib Use in Patients with Metastatic Breast Cancer","keywords":"","combinedName":"doctor tamanna haque"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Brian M","lastName":"Dulmovits ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Mobility Group Box 1 Protein (HMGB1) Mediates Anemia of Inflammation through Lineage Skewing and Direct Inhibition of EPO Signaling","keywords":"","combinedName":"doctor brian m dulmovits"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Mengyao ","lastName":"Wu ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Human Hematopoietic Progenitor Cells and Erythrocytes Generated from Human iPSCs Lacking CD55","keywords":"","combinedName":"doctor mengyao wu"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Zhangbiao ","lastName":"Long ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Possible Driver Gene in Patients with Acquired Pure Red Cell Aplasia","keywords":"","combinedName":"doctor zhangbiao long"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Jane A","lastName":"Thanassi ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vitro Combination Studies of ACH-4471 with Eculizumab to Assess a Potential Switch Treatment Approach for Paroxysmal Nocturnal Hemoglobinuria","keywords":"","combinedName":"doctor jane a thanassi"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Rachael ","lastName":"Grace","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results Update from the DRIVE PK Study: Effects of AG-348, a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency","keywords":"","combinedName":"doctor rachael grace"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Maria Carolina Costa Melo","lastName":"Svidnicki ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Screening of Mutations Related to Hereditary Anemias Using NGS-Targeted Sequencing Panel","keywords":"","combinedName":"doctor maria carolina costa melo svidnicki"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Giuseppe ","lastName":"Rossi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Short Course of Bortezomib in Anemic Patients with Refractory or Relapsed Cold Agglutinin Disease. a Phase II Prospective Study By the Gimema Group","keywords":"","combinedName":"doctor giuseppe rossi"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Anna Rita ","lastName":"Migliaccio ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Systematic Analyses of Clinically Relevant Single Nucleotide Polymorphisms (SNPs) of NR3C1 in Patients from the Italian Registry of Diamond Blackfan Anemia","keywords":"","combinedName":"doctor anna rita migliaccio"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Xiaoli ","lastName":"Qu ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TET2 Deficiency Led to Expansion of Dysfunctional Erythroid Progenitors","keywords":"","combinedName":"doctor xiaoli qu"},{"sessionId":"11775","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster II","firstName":"Omar ","lastName":"Niss ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The First Registry for Patients with Congenital Dyserythropoietic Anemia in North America: Design and Preliminary Results","keywords":"","combinedName":"doctor omar niss"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Ivan C","lastName":"Moura ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Syndrome of IgA-Related Polycythemia","keywords":"","combinedName":"doctor ivan c moura"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Hubert ","lastName":"Schrezenmeier ","credentials":"MD ","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of Baseline Clinical Characteristics and Disease Burden in Patients Enrolled in the International Paroxysmal Nocturnal Hemoglobinuria Registry","keywords":"","combinedName":"doctor hubert schrezenmeier"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Darren J","lastName":"Newton ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessment of Eculizumab and C5 Levels in PNH Treatment: Molar Ratio of Eculizumab to C5 Level Effectively Predicts Ongoing Dosage Changes in a Cohort of 50 Patients Treated with Eculizumab","keywords":"","combinedName":"doctor darren j newton"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Jun Ho ","lastName":"Jang ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Baseline Clinical Characteristics between Asian Vs. Non-Asian Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) from International PNH Registry","keywords":"","combinedName":"doctor jun ho jang"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Valentina ","lastName":"Brancaleoni ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Digital PCR Assay to Assess the Alternative Splicing and Absolute Ferrochelatase Expression","keywords":"","combinedName":"doctor valentina brancaleoni"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Jong-Wook ","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and High Disease Activity with or without History of Aplastic Anemia in the International PNH Registry","keywords":"","combinedName":"doctor jong-wook lee"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Claire E","lastName":"McKinley ","credentials":"BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Extravascular Hemolysis Due to C3-Loading in Patients with PNH Treated with Eculizumab: Defining the Clinical Syndrome","keywords":"","combinedName":"doctor claire e mckinley"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Roussel ","lastName":"Camille ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fast Determination of Projected Surface Area in Red Blood Cells from Splenectomised Patients with Imaging Flow Cytometry","keywords":"","combinedName":"doctor roussel camille"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Oluwabukola ","lastName":"Gbotosho ","credentials":"BSc, MSc, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Free Heme Induces a Heme Importer, Heme Catabolism and an Angiogenic Factor in Multiple Organs in Mice: Implications for Organ-Specific Response to Intravascular Hemolysis","keywords":"","combinedName":"doctor oluwabukola gbotosho"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Paola ","lastName":"Bianchi ","credentials":"BSc, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genotype-Phenotype Correlation and Molecular Heterogeneity in Pyruvate Kinase Deficiency: Data from the PKD Natural History Study","keywords":"","combinedName":"doctor paola bianchi"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Supachai ","lastName":"Ekwattanakit ","credentials":"BSc, PhD, MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of a Digenic Inheritance ofPklr andKLF1 Mutations Resulting in Hemolytic Anemia in a Neonate from a Study of Genotype-Phenotype Correlation of Globin,Pklr andKLF1 in Thai Patients with Pyruvate Kinase (PK) Deficiency","keywords":"","combinedName":"doctor supachai ekwattanakit"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Irene ","lastName":"Motta ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vitro Erythropoietic Response to Enzyme Replacement Therapy in Gaucher Type 1 Patients","keywords":"","combinedName":"doctor irene motta"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Anita ","lastName":"Hill ","credentials":"MBChB (Hons), PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim Analysis of Safety Outcomes during Treatment with Eculizumab: Results from the International Paroxysmal Nocturnal Hemoglobinuria Registry","keywords":"","combinedName":"doctor anita hill"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Fabio H","lastName":"Silva ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intravascular Hemolysis Leads to Increased Esophagus Smooth Muscle Contractions in Mice: Implication for Dysphagia and Odynophagia","keywords":"","combinedName":"doctor fabio h silva"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Jana ","lastName":"Volejnikova ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Large Deletions and Novel Mutations in Genes Coding forRibosomal Proteins (RPL11, RPL35A, RPS19) in theCzech National Registry ofDiamond-Blackfan Anemia (DBA)","keywords":"","combinedName":"doctor jana volejnikova"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Priti ","lastName":"Azad ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Basis of Hypoxia-Induced Excessive Erythrocytosis: Critical Role of SENP1 gene Regulation","keywords":"","combinedName":"doctor priti azad"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Kenneth R","lastName":"Peterson ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"O-Glcnacylation Modulates Erythropoiesis: O-Glcnac Transferase (OGT) Is an Essential Gene","keywords":"","combinedName":"doctor kenneth r peterson"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Alexander ","lastName":"Roeth ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimization of Dose Regimen for ALXN1210, a Novel Complement C5 Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results of 2 Phase 1/2 Studies","keywords":"","combinedName":"doctor alexander roeth"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Bruno ","lastName":"Fattizzo ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevalence of Bone Marrow Fibrosis in 47 Cases of Autoimmune Hemolytic Anemia Patients: Clinical and Biologic Relationships","keywords":"","combinedName":"doctor bruno fattizzo"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Allan ","lastName":"Doctor ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sepsis Induced Red Cell Dysfunction (SiRD): Physiology and Mechanisms","keywords":"","combinedName":"doctor allan doctor"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Laurence ","lastName":"Blumberg ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"SYNT001: A Humanized IgG4 Monoclonal Antibody That Disrupts the Interaction of FcRn and IgG for the Treatment of IgG-Mediated Autoimmune Diseases","keywords":"","combinedName":"doctor laurence blumberg"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Yung ","lastName":"Hwang ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The IL-17 Receptor IL-17RA Is Expressed By Early Erythroid Progenitors and Stimulates Erythropoiesis","keywords":"","combinedName":"doctor yung hwang"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Jason ","lastName":"Marcero ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of TCA Cycle Compounds in Erythroid Heme Synthesis and Its Regulation during an Inflammatory Response","keywords":"","combinedName":"doctor jason marcero"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Elisa ","lastName":"Fermo ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Next Generation Sequencing Panel to Clarify Undiagnosed Cases of Hereditary Hemolytic Anemias","keywords":"","combinedName":"doctor elisa fermo"},{"sessionId":"11776","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Poster III","firstName":"Rong ","lastName":"Fu ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whole-Exome Sequencing of Paroxysmal Nocturnal Hemoglobinuria","keywords":"","combinedName":"doctor rong fu"},{"sessionId":"11777","sessionTitle":"102. Regulation of Iron Metabolism: Poster II","firstName":"Verena ","lastName":"Petzer ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" Non-Transferrin-Bound Iron Serves As Iron Source for Aspergillus Fumigatus Growth ","keywords":"","combinedName":"doctor verena petzer"},{"sessionId":"11777","sessionTitle":"102. Regulation of Iron Metabolism: Poster II","firstName":"Gordon ","lastName":"McLaren ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Association of GNPAT p.D519G with Higher Iron Phenotypes in Women with HFE p.C282Y Homozygosity","keywords":"","combinedName":"doctor gordon mclaren"},{"sessionId":"11777","sessionTitle":"102. Regulation of Iron Metabolism: Poster II","firstName":"Sule ","lastName":"Unal Cangul ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Endocrinological Abnormalities Among Adult Thallasemic Patients","keywords":"","combinedName":"doctor sule unal cangul"},{"sessionId":"11777","sessionTitle":"102. Regulation of Iron Metabolism: Poster II","firstName":"Eliane ","lastName":"Sardh ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Explore: A Prospective, Multinational Natural History Study of Patients with Acute Hepatic Porphyrias (AHP) with Recurrent Attacks","keywords":"","combinedName":"doctor eliane sardh"},{"sessionId":"11777","sessionTitle":"102. Regulation of Iron Metabolism: Poster II","firstName":"Tim ","lastName":"St Pierre ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Measurement of Liver Iron Concentration in a Population of Non-Transfusion Dependent Thalassemia Patients Using a Trained Artificial Neural Network to Analyse Magnetic Resonance Images","keywords":"","combinedName":"doctor tim st pierre"},{"sessionId":"11777","sessionTitle":"102. Regulation of Iron Metabolism: Poster II","firstName":"Justin ","lastName":"Keen ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I Trial Results of a Solid Dispersion Formulation of Deferasirox with Enhanced Bioavailability Relative to Exjade and JadenuTM","keywords":"","combinedName":"doctor justin keen"},{"sessionId":"11777","sessionTitle":"102. Regulation of Iron Metabolism: Poster II","firstName":"Simon ","lastName":"Knight ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Splitting the Functions of a Mitochondrial Iron/Pyrimidine Carrier","keywords":"","combinedName":"doctor simon knight"},{"sessionId":"11777","sessionTitle":"102. Regulation of Iron Metabolism: Poster II","firstName":"Elisa ","lastName":"Brilli ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sucrosomial Iron Absorption Involve M Cells Interaction","keywords":"","combinedName":"doctor elisa brilli"},{"sessionId":"11778","sessionTitle":"102. Regulation of Iron Metabolism: Poster III","firstName":"Brett ","lastName":"Houston ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of Iron Therapy on Fatigue and Work Capacity in Non-Anemic Iron Deficient Adults: A Systematic Review of Randomized Controlled Trials","keywords":"","combinedName":"doctor brett houston"},{"sessionId":"11778","sessionTitle":"102. Regulation of Iron Metabolism: Poster III","firstName":"Maria G","lastName":"Kapetanaki ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Heme Regulates the Expression in Erythroblasts of Placenta Growth Factor, a Contributor to Pulmonary Hypertension in Sickle Cell Disease, through the Oxidant Response Transcription Factor NRF2","keywords":"","combinedName":"doctor maria g kapetanaki"},{"sessionId":"11778","sessionTitle":"102. Regulation of Iron Metabolism: Poster III","firstName":"Daniel ","lastName":"Garcia dos Santos ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Heme Synthesis Is Inhibited in Erythroid Cells Derived from Beta-Thalassemic Mice","keywords":"","combinedName":"doctor daniel garcia dos santos"},{"sessionId":"11778","sessionTitle":"102. Regulation of Iron Metabolism: Poster III","firstName":"Namita ","lastName":"Kumari ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hemin and Iron Modulated Intrinsic Cellular Factors Regulate HIV-1 Replication in Sickle Cell Disease","keywords":"","combinedName":"doctor namita kumari"},{"sessionId":"11778","sessionTitle":"102. Regulation of Iron Metabolism: Poster III","firstName":"Margrt Gudrun","lastName":"Gunnarsdttir ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Investigation of Circulating Plasma Micro RNAs As Biomarkers for Iron Status in Blood Donors","keywords":"","combinedName":"doctor margrt gudrun gunnarsdttir"},{"sessionId":"11778","sessionTitle":"102. Regulation of Iron Metabolism: Poster III","firstName":"Michael ","lastName":"Auerbach ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Randomized, Double-Blind Trial of Ferumoxytol Compared to Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia: Safety and Efficacy","keywords":"","combinedName":"doctor michael auerbach"},{"sessionId":"11778","sessionTitle":"102. Regulation of Iron Metabolism: Poster III","firstName":"Amel ","lastName":"Hamdi ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Heme in the Regulation of Transferrin Receptor Expression in Erythroid Cells","keywords":"","combinedName":"doctor amel hamdi"},{"sessionId":"11778","sessionTitle":"102. Regulation of Iron Metabolism: Poster III","firstName":"Esther Natalie","lastName":"Oliva ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Surrogate Thresholds for Iron Chelation in Patients with Hematological Malignancies","keywords":"","combinedName":"doctor esther natalie oliva"},{"sessionId":"11778","sessionTitle":"102. Regulation of Iron Metabolism: Poster III","firstName":"Arun S","lastName":"Shet ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The KAP 2 Study: Preliminary Results from a Pragmatic Cluster Randomized Trial of a Community Education Intervention to Support Childhood Anemia Control in India","keywords":"","combinedName":"doctor arun s shet"},{"sessionId":"11779","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster II","firstName":"Alessia ","lastName":"Pepe ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" Splenectomy Is a Risk Factor for Cardiac Complications in TM ","keywords":"","combinedName":"doctor alessia pepe"},{"sessionId":"11779","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster II","firstName":"Li ","lastName":"Liu ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of a HBB-Locus Fetal Chromatin Domain Region during Adult Erythropoiesis","keywords":"","combinedName":"doctor li liu"},{"sessionId":"11779","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster II","firstName":"Siddhesh Arun","lastName":"Kalantri ","credentials":"MD Medicine","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Decitabine As Hemoglobin F Inducer in Hemoglobin E/ Thalassemia","keywords":"","combinedName":"doctor siddhesh arun kalantri"},{"sessionId":"11779","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster II","firstName":"Xiaofei ","lastName":"Yu ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MBD2-NuRD but Not MBD3-NuRD Mediates Strong Silencing of Fetal ?-Globin Gene Expression in Human Adult Erythroid Cells","keywords":"","combinedName":"doctor xiaofei yu"},{"sessionId":"11779","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster II","firstName":"Yankai ","lastName":"Zhang ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Piceatannol Induces Fetal Hemoglobin in Erythroid Progenitor Cells from Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor yankai zhang"},{"sessionId":"11779","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster II","firstName":"Norman Alan","lastName":"Mazer ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantifying the Pathophysiology of Beta-Thalassemia Using a Novel in-Silico Model of Red Blood Cell Production and Lifespan","keywords":"","combinedName":"doctor norman alan mazer"},{"sessionId":"11779","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster II","firstName":"Alessandro ","lastName":"Matt ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ReprogrammingCell-Signaling By Delivering the Catalytic Domain of Ptpgr Ameliorates Anemia of -Thalassemia","keywords":"","combinedName":"doctor alessandro matt"},{"sessionId":"11779","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster II","firstName":"Yankai ","lastName":"Zhang ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Screening Fetal Hemoglobin Inducing Compounds in Human Umbilical Cord Blood-Derived Erythroid Progenitor Cells","keywords":"","combinedName":"doctor yankai zhang"},{"sessionId":"11779","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster II","firstName":"Alessia ","lastName":"Pepe ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Strong Link between Pancreas and Heart in Thalassemia Major","keywords":"","combinedName":"doctor alessia pepe"},{"sessionId":"11780","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster III","firstName":"Sorasak ","lastName":"Makmettakul ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cardiorenal Syndrome in Thalassemia Patients","keywords":"","combinedName":"doctor sorasak makmettakul"},{"sessionId":"11780","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster III","firstName":"Immacolata ","lastName":"Tartaglione ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia","keywords":"","combinedName":"doctor immacolata tartaglione"},{"sessionId":"11780","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster III","firstName":"Dipanjan ","lastName":"Haldar ","credentials":"MBBS, MD, DM","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Endocrine Functions in Hb E Thalassemia Patients with Special Reference to Assessment of Growth and Puberty","keywords":"","combinedName":"doctor dipanjan haldar"},{"sessionId":"11780","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster III","firstName":"Sarah ","lastName":"Lane ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Isolation and Chelation Activity of Plant Phenolic Root Exudates As Potential Clinical Iron Chelators","keywords":"","combinedName":"doctor sarah lane"},{"sessionId":"11780","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster III","firstName":"Alessia ","lastName":"Pepe ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Term Prospective Predictors for Vascular Events and Cardiac Complications in Thalassemia Major Patients","keywords":"","combinedName":"doctor alessia pepe"},{"sessionId":"11780","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster III","firstName":"Sylvia Titi Titi","lastName":"Singer ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pituitary Iron: Effect on Pituitary Volume and Function in Transfusion Dependent Thalassemia","keywords":"","combinedName":"doctor sylvia titi titi singer"},{"sessionId":"11780","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster III","firstName":"Ali ","lastName":"Taher ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predicting Serum Ferritin Levels in Patients with Iron Overload Treated with the Film-Coated Tablet of Deferasirox during the Eclipse Study","keywords":"","combinedName":"doctor ali taher"},{"sessionId":"11780","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster III","firstName":"Ali ","lastName":"Amid ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Serum Ferritin Underestimates Liver Iron Concentration in Patients with Homozygous Alpha-0 Thalassemia","keywords":"","combinedName":"doctor ali amid"},{"sessionId":"11780","sessionTitle":"112. Thalassemia and Globin Gene Regulation: Poster III","firstName":"Alexandros ","lastName":"Makis ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Serum Metabolite Profiles Are Strongly Correlated with Membrane Lipid Alterations in Beta Thalassemia Patients","keywords":"","combinedName":"doctor alexandros makis"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Pablo ","lastName":"Bartolucci ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A New Tool for HbF Quantification Demonstrates That Hydroxyurea Decreases Mostly RBCs Containing Very Low Amounts of HbF","keywords":"","combinedName":"doctor pablo bartolucci"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Shin-Young ","lastName":"Park ","credentials":"Ph.D.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Arteriolar Neovasculogenesis and Sinusoidal Collapse Are Pathologic Features of the Hematopoietic Stem Cell Niche in Sickle Cell Disease (SCD) Mice","keywords":"","combinedName":"doctor shin-young park"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Saranya ","lastName":"Veluswamy ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Attention to Pain Modulates the Vasoconstriction Response to Thermal Pain in Sickle Cell Disease Subjects but Not in Controls","keywords":"","combinedName":"doctor saranya veluswamy"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Maureen ","lastName":"Mburu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cardiomyopathy Associated with Worsening Intravascular Hemolysis in Transgenic Knock-in Mouse Model of Sickle Cell Disease","keywords":"","combinedName":"doctor maureen mburu"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Juliete ","lastName":"Silva ","credentials":"Ph.D.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Treatment with Hydroxyurea and a Phosphodiesterase 9 (PDE9) Inhibitor Decreases Hepatic Damage in an Animal Model of Sickle Cell Anemia","keywords":"","combinedName":"doctor juliete silva"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Ioannis ","lastName":"Papassotiriou ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Distinct Biomarkers Reflect Pathophysiological Differences of Sickle Cell Disease Sub-Phenotypes: Viscosity-Vaso-Occlusion Vs. Hemolysis-Endothelial Dysfunction","keywords":"","combinedName":"doctor ioannis papassotiriou"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Fahim ","lastName":"Thawer ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Erythroferrone (ERFE) and Hepcidin Levels in Sickle Cell Disease with and without Transfusional Iron Overload","keywords":"","combinedName":"doctor fahim thawer"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Carsten ","lastName":"Alt ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"GBT1118 Diminishes Vaso-Occlusion in Sickle Cell Disease Mice","keywords":"","combinedName":"doctor carsten alt"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Muhammad Noman","lastName":"Hasan ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hemechip: An Automated Portable Microchip Electrophoresis Platform for Point-of-Care Sickle Cell Disease Screening","keywords":"","combinedName":"doctor muhammad noman hasan"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Kleber Yotsumoto","lastName":"Fertrin ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"LRP1 Expression in Sickle Cell Disorders: Insights into the Heterogeneity of Monocytic Response to Heme","keywords":"","combinedName":"doctor kleber yotsumoto fertrin"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Wassim ","lastName":"El Nemer ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Insights into F-Cells, F-Reticulocytes and the Role of Fetal Hemoglobin in Protecting Sickle Red Cells from Hemolysis upon Mechanical Stress","keywords":"","combinedName":"doctor wassim el nemer"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Aluya ","lastName":"Oseghale ","credentials":"BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Conjugates of Butyrate and d-Aminolevulinate Increase ?-Globin Gene Expression and Fetal Hemoglobin Synthesis in Erythroid Progenitors","keywords":"","combinedName":"doctor aluya oseghale"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Yamaja ","lastName":"Setty ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pathophysiologic Implications of Type-2 Phosphatidylserine-Positive Erythrocytes in Hemoglobin SS Disease (sickle cell anemia) and -Thalassemia","keywords":"","combinedName":"doctor yamaja setty"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Bjorn ","lastName":"Song ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pegylated Carboxyhemoglobin (SANGUINATE) Restores Blood Flow and Tissue Oxygenation in a Novel Rat Model of Acute Vaso-Occlusive Crisis","keywords":"","combinedName":"doctor bjorn song"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Qin ","lastName":"Qin ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantification of Whole-Brain Oxygenation Extraction Fraction Among People with Sickle Cell Anemia without Stroke History","keywords":"","combinedName":"doctor qin qin"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Oladele ","lastName":"Olatunya ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Red Blood Cells Microparticles Are Associated with Hemolysis Markers and Leg Ulceration in Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor oladele olatunya"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Kyle ","lastName":"Kausch ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rejuvenated RBCs Increase Oxygen Consumption in a Simulated Exchange Transfusion Model of Sickle Cell Disease Patients","keywords":"","combinedName":"doctor kyle kausch"},{"sessionId":"11781","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster III","firstName":"Kleber Yotsumoto","lastName":"Fertrin ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thromboembolic and Vascular Complications in Patients with Secondary Erythrocytosis Caused By High Oxygen Affinity Variant Hb Coimbra","keywords":"","combinedName":"doctor kleber yotsumoto fertrin"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Rafaela ","lastName":"Mendona ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Canonical Inflammasome Formation in Monocytes of Sickle Cell Anemia Patients","keywords":"","combinedName":"doctor rafaela mendona"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Craig A","lastName":"Branch ","credentials":"PhD, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cerebral Metabolic Alterations in Transgenic and Hemizygous Murine Models of Sickle Cell Disease","keywords":"","combinedName":"doctor craig a branch"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Selma ","lastName":"Unal ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chronic Hemolysis, Oxidative Stress and Inflammation Contribute to Dysfunctional HDL in Sickle Cell Disease","keywords":"","combinedName":"doctor selma unal"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Corynne ","lastName":"Adanho ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Correlations between Transcranial Doppler Velocities and Laboratory Markers of SCA Severity","keywords":"","combinedName":"doctor corynne adanho"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Om B","lastName":"Jahagirdar ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diet and Gender Influence Survival in Sickle Cell Disease","keywords":"","combinedName":"doctor om b jahagirdar"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Hasan ","lastName":"Ozpolat ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effects of N-Acetylcysteine Infusion in Patients with Sickle Cell Disease during Vaso-Occlusive Crises","keywords":"","combinedName":"doctor hasan ozpolat"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Oladele ","lastName":"Olatunya ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effects of UGT1A1 Polymorphism, Glucose-6-Phosphate Dehydrogenase Deficiency and Deletional (-3.7?b) a-Thalassemia Among Young Nigerians with Sickle Cell Anemia","keywords":"","combinedName":"doctor oladele olatunya"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Erich Vinicius","lastName":"De Paula ","credentials":"MD, PhD ","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Expression of Netosis Regulators and Correlation with Inflammatory and Coagulation Biomarkers in Sickle Cell Anemia Patients","keywords":"","combinedName":"doctor erich vinicius de paula"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Craig A","lastName":"Branch ","credentials":"PhD, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vivo Brain Redox Imaging in Transgenic-Knockout Sickle Mice","keywords":"","combinedName":"doctor craig a branch"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Ravi ","lastName":"Vats ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Neutrophil Extracellular Traps Promote Lung Arteriole Occlusion in Sickle Cell Disease","keywords":"","combinedName":"doctor ravi vats"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"John D","lastName":"Belcher ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Oral Carbon Monoxide Therapy in Murine Models of Sickle Cell Disease: Beneficial Effects on Vaso-Occlusion, Inflammation and Anemia","keywords":"","combinedName":"doctor john d belcher"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Joseph L","lastName":"Bundy ","credentials":"PhD, BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNA-Sequencing of Isolated Cell Populations Expressing Human APOL1 Risk Variants Reveals Molecular Correlates of Sickle Cell Nephropathy in Zebrafish Podocytes","keywords":"","combinedName":"doctor joseph l bundy"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Nicole Hope","lastName":"Lopez ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Salubrinal Mediated Fetal Hemoglobin Induction through the eIF2a-ATF4 Signaling Pathway","keywords":"","combinedName":"doctor nicole hope lopez"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Angela ","lastName":"Rivers ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Abnormal Presence of Mitochondria in CirculatingRed Blood Cells Cause an Increased Oxygen Consumption Rate, ROS Generation and Hemolysis in Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor angela rivers"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Sebastian ","lastName":"Vogel ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The NLRP3 Inflammasome in Platelets Is Upregulated in Sickle Cell Disease and Promotes Platelet Aggregation and in Vitro Thrombosis","keywords":"","combinedName":"doctor sebastian vogel"},{"sessionId":"11782","sessionTitle":"113. Hemoglobinopathies, Excluding ThalassemiaBasic and Translational Science: Poster II","firstName":"Amanda ","lastName":"Johnson ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Mobile Health (mHealth) Apps and Wearable Technology to Assess Changes in Pain during Treatment of Acute Pain in Sickle Cell Disease","keywords":"","combinedName":"doctor amanda johnson"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Wally ","lastName":"Smith ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Access to Care, and Emergency Department Utilization for Adults and Adolescents with Sickle Cell Disease: Ascq-Me and the SHIP-HU Study","keywords":"","combinedName":"doctor wally smith"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Amanda ","lastName":"Brandow","credentials":"DO, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cold and Mechanical Hypersensitivity Is Exacerbated during Acute Pain in Children and Adolescents with Sickle Cell Disease","keywords":"","combinedName":"doctor amanda brandow"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Wally ","lastName":"Smith ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Adult and Adolescent Quality of Ambulatory and Emergency Care in Sickle Cell Disease: Ascq-Me and the SHIP-HU Study","keywords":"","combinedName":"doctor wally smith"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Nnenna R","lastName":"Ukachi ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Impulse Oscillometry with Spirometry to Assess Lung Function inChildren with Sickle Cell Disease (SCD)","keywords":"","combinedName":"doctor nnenna r ukachi"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Jacquelyn ","lastName":"Klicka-Skeels ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Correlation between Body Mass Index and Left Ventricular Remodeling and Function in Children with Sickle Cell Disease","keywords":"","combinedName":"doctor jacquelyn klicka-skeels"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Ashley ","lastName":"Thrower ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Renin-Angiotensin-Aldosterone System Blocking Agents on Progression of Glomerulopathy in Sickle Cell Disease","keywords":"","combinedName":"doctor ashley thrower"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Bart ","lastName":"Biemond ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effects of Oral N-Acetylcysteine on Oxidative Stress in Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor bart biemond"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Alessia ","lastName":"Pepe ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gender Differences in the Development of CMR Abnormalities and Cardiac Complications: A Multicentric Prospective Study in a Cohort of Sickle Cell Disease Patients","keywords":"","combinedName":"doctor alessia pepe"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Shehu Umar","lastName":"Abdullahi ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increasedprevalence of Stroke Recurrence and Stroke Related Mortality in Children with Sickle Cell Disease inNigeria:evidencefor a Secondary Stroke Prevention Trial.","keywords":"","combinedName":"doctor shehu umar abdullahi"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Dania ","lastName":"Monagel ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lack of an Alberta Newborn Screening Program Is Associated with Delayed Diagnosis of Sickle Cell Disease","keywords":"","combinedName":"doctor dania monagel"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Eugenia Vicky","lastName":"Asare","credentials":"MBChB, BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low Body Mass Index in Pregnant Women with Sickle Cell Disease Is Associated with Premature Delivery in Sub- Saharan Africa","keywords":"","combinedName":"doctor eugenia vicky asare"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Anoosha ","lastName":"Habibi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Male Fertility in Sickle Cell Disease before and after Hydroxycarbamide","keywords":"","combinedName":"doctor anoosha habibi"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Guilherme Henrique Hencklain","lastName":"Fonseca ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NIH Bayesian Score As a Stratification Tool in Sickle Cell Disease - Results from a Single Center Cohort in Brazil","keywords":"","combinedName":"doctor guilherme henrique hencklain fonseca"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Monica L","lastName":"Hulbert ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Normalization of Cerebral Hemodynamics after Hematopoietic Stem Cell Transplant in Children with Sickle Cell Anemia","keywords":"","combinedName":"doctor monica l hulbert"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Anu ","lastName":"Marahatta ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacokinetics of Hydroxyurea Therapy in African Children with Sickle Cell Anemia: Noharm Ancillary PK Study","keywords":"","combinedName":"doctor anu marahatta"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Lewis L","lastName":"Hsu ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacokinetics, Pharmacodynamics and Safety of Ticagrelor in Children with Sickle Cell Disease: Results of a Two-Part Phase 2 Study","keywords":"","combinedName":"doctor lewis l hsu"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Jane Sandra","lastName":"Afriyie-Mensah ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pulmonary Hypertension and Associated Risk Factors in a High Burden Sickle Cell Disease Population","keywords":"","combinedName":"doctor jane sandra afriyie-mensah"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Janet ","lastName":"Kwiatkowski","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety of Deferiprone in Individuals with Sickle Cell Disease","keywords":"","combinedName":"doctor janet kwiatkowski"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Eman A","lastName":"Abdelghani ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Steady-State Cognitive Function and Pain Severity in Youth with Sickle Cell Disease","keywords":"","combinedName":"doctor eman a abdelghani"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Kirshma ","lastName":"Khemani ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use ofan Emergency Department-Based Intranasal Fentanyl Protocol for Vaso-Occlusive Episodes in Sickle Cell Disease: The Unanticipated Consequences","keywords":"","combinedName":"doctor kirshma khemani"},{"sessionId":"11783","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster II","firstName":"Norris ","lastName":"Igbineweka ","credentials":"MBBS, BSc, MRCP","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ventilation-Perfusion Scan Is Superior to CT Pulmonary Angiography in Detection of Chronic Thromboembolic Pulmonary Hypertension in SCD Adults","keywords":"","combinedName":"doctor norris igbineweka"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Kenneth ","lastName":"Bridges ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Single Center Experience of GBT440 Treatment of Severe Anemia in Sickle Cell Disease (SCD)","keywords":"","combinedName":"doctor kenneth bridges"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Patjanaporn ","lastName":"Chalacheva ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Blunted Cardiac Response to Head-up Tilt Occurs in Sickle Cell Disease but Not Healthy Controls","keywords":"","combinedName":"doctor patjanaporn chalacheva"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"James ","lastName":"Taylor ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics of a Chronic Pain Phenotype in Adults with Sickle Cell Disease","keywords":"","combinedName":"doctor james taylor"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Chau ","lastName":"Vu ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chronic Anemia Is Associated with Lower Cerebral and Peripheral Arterio-Venous Oxygen Gradients","keywords":"","combinedName":"doctor chau vu"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Srinandan ","lastName":"Guntupalli ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Contrary to Expectations: Seasonal Variation in Sickle Cell Crisis - a Nation Wide Data Analysis","keywords":"","combinedName":"doctor srinandan guntupalli"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Susanna A","lastName":"Curtis ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daily Users of Marijuana with Sickle Cell Disease Report More Severe Pain Crisis Yet Have Similar Rates of Admission to Non-Users","keywords":"","combinedName":"doctor susanna a curtis"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Omar ","lastName":"Niss ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diastolic Dysfunction Is Associated with Impaired Cardiopulmonary Exercise Performance in Sickle Cell Disease","keywords":"","combinedName":"doctor omar niss"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Dipty ","lastName":"Jain ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Frequency of Vasocclusive Crises and the Relationship of Vitamin D Deficiency to the Frequency of Pain Crises in Children with Sickle Cell Disease in an Aboriginal Tribal Region in Gadchiroli, India","keywords":"","combinedName":"doctor dipty jain"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Sherif ","lastName":"Badawy ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improved Clinical Outcomes in Adults with Sickle Cell Disease and Diabetes Treated with Metformin","keywords":"","combinedName":"doctor sherif badawy"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Frdric ","lastName":"Galactros ","credentials":"MD PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Infections in SCD Patients Treated with HU in the Framework of Escort HU","keywords":"","combinedName":"doctor frdric galactros"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Pablo ","lastName":"Bartolucci ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Renal Dysfunctions in Escort-HU Study","keywords":"","combinedName":"doctor pablo bartolucci"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Courtney ","lastName":"Johnson ","credentials":"MD, MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Moyamoya Syndrome in Children with Sickle Cell Disease: A 10-Year Single-Center Experience","keywords":"","combinedName":"doctor courtney johnson"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Yueh-Tyng ","lastName":"Chien ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multiple-Ascending-Dose Study of the Soluble Guanylate Cyclase Stimulator, IW-1701, in Healthy Subjects","keywords":"","combinedName":"doctor yueh-tyng chien"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Laurence ","lastName":"Dedeken ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"No Impact of Pharmacokinetics Profiles on the Clinical and Biological Response to Hydroxyurea in Children with Sickle Cell Disease","keywords":"","combinedName":"doctor laurence dedeken"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Pablo ","lastName":"Bartolucci ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcome of Severe Vaso Occlusive Crisis in Sickle Cell Disease Adults Admitted to Referral Centers in Africa and Europe. Preliminary Results from the Presev 2 Study","keywords":"","combinedName":"doctor pablo bartolucci"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Soumitri ","lastName":"Sil ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pediatric Pain Screening Identifies Youth at Risk for Chronic Pain in Sickle Cell Disease","keywords":"","combinedName":"doctor soumitri sil"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Foluso Joy","lastName":"Ogunsile ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Physician Prescribing Practices in Sickle Cell Disease","keywords":"","combinedName":"doctor foluso joy ogunsile"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Olivier ","lastName":"Negre ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown, ?-Globin Induction and Simultaneous Repression of -Globin for the Potential Treatment of Sickle Cell Disease","keywords":"","combinedName":"doctor olivier negre"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Rachael ","lastName":"Hall ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevalence of High Body Mass Index in Children with Sickle Cell Disease and Its Correlation of Disease Severity","keywords":"","combinedName":"doctor rachael hall"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"April E","lastName":"Slee ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Cognition in children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b paediatric cohort)","keywords":"","combinedName":"doctor april e slee"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Baba ","lastName":"Inusa ","credentials":"MD, MRCP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Pain and Quality of Life in Children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b pediatric cohort)","keywords":"","combinedName":"doctor baba inusa"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Robin E","lastName":"Miller ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantitative Sensory Testing in Children with Sickle Cell Disease","keywords":"","combinedName":"doctor robin e miller"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Santosh ","lastName":"Saraf ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduced Hemolysis and Related Complications in Females with Sickle Cell Disease","keywords":"","combinedName":"doctor santosh saraf"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Farid ","lastName":"Boulad ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy Trial of Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells (HPCs) for Globin Gene Transfer in Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor farid boulad"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Robert J","lastName":"Charnigo ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Tolerability of PF-04447943 across a Clinical Trial Program Including 277 Patients","keywords":"","combinedName":"doctor robert j charnigo"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Naresh ","lastName":"Bumma ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Scheduled Outpatient Red Blood Cell Exchange Program Reduces Admission and Complications in Sickle Cell Disease","keywords":"","combinedName":"doctor naresh bumma"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Mary ","lastName":"Cushman ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sickle Cell Trait and Cognitive Function in African Americans: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort","keywords":"","combinedName":"doctor mary cushman"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Valentine ","lastName":"Brousse ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Silent Cerebral Infarct Pathophysiology Study in Sickle Cell Anemia Children By a Multimodal Approach","keywords":"","combinedName":"doctor valentine brousse"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Allistair","lastName":"Abraham","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Similar Event-Free Survival but Higher Incidence of Mixed T Cell Chimerism after Hematopoietic Cell Transplantation for Sickle Cell Disease Using Rabbit Versus Horse: a Study from the Sickle Transplant Alliance for Research (STAR)","keywords":"","combinedName":"doctor allistair abraham"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Russell D","lastName":"Keenan ","credentials":"MBChB, PhD, FRCP, FRCPath","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Stopping Folic Acid Supplementation in Hydroxyurea Treated Children with Sickle Cell Disease","keywords":"","combinedName":"doctor russell d keenan"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Charles ","lastName":"Quinn","credentials":"MD, MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Temporal Evolution of Diffuse Myocardial Fibrosis in Sickle Cell Anemia","keywords":"","combinedName":"doctor charles quinn"},{"sessionId":"11784","sessionTitle":"114. Hemoglobinopathies, Excluding ThalassemiaClinical: Poster III","firstName":"Patrick ","lastName":"Tivnan ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ventilation-Perfusion Scintigraphy Is Comparable to CT Pulmonary Angiography for the Diagnosis of Pulmonary Embolism in Sickle Cell Disease: A 16-Year Experience","keywords":"","combinedName":"doctor patrick tivnan"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Noah ","lastName":"Federman ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 2, International, Multicenter, Prospective Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients with Solid Tumors Undergoing Chemotherapy","keywords":"","combinedName":"doctor noah federman"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Ofrat ","lastName":"Beyar Katz ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bortezomib-Activated Macrophages Contribute to Multiple Myeloma Progression Via Cancer Stem Cell Enrichment","keywords":"","combinedName":"doctor ofrat beyar katz"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Rita ","lastName":"Assi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics and Outcomes of Malignancy-Associated Hemophagocytic Lymphohistiocytosis (HLH) in Adults: A Single-Center Experience","keywords":"","combinedName":"doctor rita assi"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"David ","lastName":"Dale ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cyclic Neutropenia, Congenital and Idiopathic Neutropenia","keywords":"","combinedName":"doctor david dale"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Anne ","lastName":"Simonowski ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differential Use of the Signaling Molecules BTK and PLC-? in Mast Cells Stimulated Via the Receptors FceRI and KIT","keywords":"","combinedName":"doctor anne simonowski"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Maksim ","lastName":"Klimiankou ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effects of CSF3R mutations on Myeloid Differentiation and Proliferation of Hematopoietic Cells of Congenital Neutropenia Patients","keywords":"","combinedName":"doctor maksim klimiankou"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Francesca ","lastName":"Fioredda ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"G-CSF Vs Haematopoietic Stem Cell Transplantation in Severe Congenital Neutropenia with ELANE Mutation: Role of G-CSF Dose.a Retrospective Controlled Study on Behalf of Saawp (Severe Aplastic Anemia Working Party) of the EBMT, of the Stem Cell Transplant for Immunodeficiency Group in Europe (SCETIDE), of the Severe Chronic Neutropenia French Registry (SCNFR) and Italian Neutropenia Registry (INR)","keywords":"","combinedName":"doctor francesca fioredda"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Linglong ","lastName":"Zou ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immunogenicity Assessment of Tbo-Filgrastim in Cancer Patients Receiving Chemotherapy","keywords":"","combinedName":"doctor linglong zou"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Sagar ","lastName":"Patel ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence, Treatment Patterns, and Outcomes of Histiocytic Disorders in the United States: A Forty-Year Population Study","keywords":"","combinedName":"doctor sagar patel"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Kandace ","lastName":"Gollomp ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of Neutrophil Extracellular Trap Release through the Disruption of PAD4 Leads to Decreased Neutrophil and Platelet Accumulation at Sites of Venular Vascular Injury in a Murine Model of Heparin-Induced Thrombocytopenia","keywords":"","combinedName":"doctor kandace gollomp"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Yaping ","lastName":"Sun ","credentials":"MD, PhD, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Metabolic Reprogramming of Dendritic Cells Is Controlled By the Mir-142","keywords":"","combinedName":"doctor yaping sun"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Annalisa ","lastName":"Chiarenza ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Neutrophil to T-Lymphocyte Ratio (NLR) and Neutrophil to Monocyte Ratio (NMR) Are Promising Biomarkers in Chronic Lymphocytic Leukemia Prognostic Assessment","keywords":"","combinedName":"doctor annalisa chiarenza"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Rand ","lastName":"Abou Shaar ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Serum Ferritin Trends Are Associated with Survival in Adult Hemophagocytic Lymphohistiocytosis","keywords":"","combinedName":"doctor rand abou shaar"},{"sessionId":"11785","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster II","firstName":"Francina ","lastName":"Gonzalez ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Phosphoinositide Kinase Pikfyve Regulates Lysosomal Biogenesis in Macrophages By Modulating the Transcription Factor EB (TFEB)","keywords":"","combinedName":"doctor francina gonzalez"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Masayuki ","lastName":"Kobayashi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Mutant Wasp in X-Linked Neutropenia Partially Recapitulates Defective Neutrophil Production through Its Expression in WASP-Deficient NB4 Cells","keywords":"","combinedName":"doctor masayuki kobayashi"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Michael ","lastName":"Wang ","credentials":"Bachelor of Science","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Role for Histone Deacetylase 10 (HDAC10) in the Regulation of PD-L1 Expression and Immune Tolerance Mediated By Antigen Presenting Cells (APCs)","keywords":"","combinedName":"doctor michael wang"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Hong-Yan ","lastName":"Zhao ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Unbalanced Monocyte Macrophage Polarization in the Bone Marrow Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor hong-yan zhao"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Gaurav ","lastName":"Goyal ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Features and Treatment Approaches in Patients with Rosai-Dorfman Disease: The Mayo Clinic Experience","keywords":"","combinedName":"doctor gaurav goyal"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"C ","lastName":"Waller ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Immunogenicity between the Proposed Pegfilgrastim Biosimilar MYL-1401H and Reference Pegfilgrastim","keywords":"","combinedName":"doctor c waller"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Marcio ","lastName":"Andrade-Campos ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Correlation between Bone Disease and Genotype in Patients with Type 1 Gaucher Disease. Data from the Spanish Gaucher Disease Registry","keywords":"","combinedName":"doctor marcio andrade-campos"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Pilar ","lastName":"Giraldo ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Defective Function of KCa3.1 Channels in Lysosomal Storage Disorders","keywords":"","combinedName":"doctor pilar giraldo"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Cornelia ","lastName":"Zeidler ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HAX1AssociatedCongenital Neutropenia: A 25 Year Long-Term Analysis ofthe European Scnir Cohort","keywords":"","combinedName":"doctor cornelia zeidler"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Yoshihiro ","lastName":"Hayashi ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HIF1A Is a Critical Downstream Mediator for Hemophagocytic Lymphohistiocytosis","keywords":"","combinedName":"doctor yoshihiro hayashi"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Astrid ","lastName":"Alflen ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Idelalisib Impairs TREM-1 Mediated Neutrophil Inflammatory Responses","keywords":"","combinedName":"doctor astrid alflen"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Masao ","lastName":"Kobayashi ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Follow-up of Patients with Chronic Granulomatous Disease Receiving Bone Marrow Transplantation Using Immunosuppressive Conditioning Regimen","keywords":"","combinedName":"doctor masao kobayashi"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Yi ","lastName":"Miao ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Gene Sequencing of Adult Patients with Hemophagocytic Lymphohistiocytosis","keywords":"","combinedName":"doctor yi miao"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Kalpana ","lastName":"Gupta ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Leukocyte Derived MPO in Heart Failure","keywords":"","combinedName":"doctor kalpana gupta"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Yi ","lastName":"Lin ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcriptome Analysis of Lymphoma Edited Monocyte Phenotype","keywords":"","combinedName":"doctor yi lin"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Lyla ","lastName":"Youssef ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transfusion of Storage-Damaged Red Blood Cells Induces Ferroptosis in Splenic Macrophages","keywords":"","combinedName":"doctor lyla youssef"},{"sessionId":"11786","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: Poster III","firstName":"Giovanna ","lastName":"Lucchini ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Dilemmas in Asymptomatic Children with Primary Haemophagocytic Lymphohistiocytosis","keywords":"","combinedName":"doctor giovanna lucchini"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Ritama ","lastName":"Gupta ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Absence of TNF-a Promotes Anemia of Inflammation and Inflammatory Bowel Disease","keywords":"","combinedName":"doctor ritama gupta"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Sarbajit ","lastName":"Mukherjee ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of Outcome of Patients Treated withAnti PD-1/Pdl-1 Therapy According to the Degree of Lymphopenia","keywords":"","combinedName":"doctor sarbajit mukherjee"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Tracy Tiffany","lastName":"Wang ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Blockade of IL-2 and IL-15 Gamma Chain Receptor Signaling Decreases Leukemic Cell Viability in T-Cell Large Granular Lymphocyte Leukemia and Adult T-Cell Leukemia","keywords":"","combinedName":"doctor tracy tiffany wang"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Anthony M","lastName":"McElligott ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterisation of Naive Immunological Profile of Umbilical Cord Blood: The Role of Mucosal-Associated Invariant T Cells and Functional Defects of T Cells and Natural Killer Cells","keywords":"","combinedName":"doctor anthony m mcelligott"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Ling ","lastName":"Xu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics of CD4+ and CD8+ Memory T Cell Subsets from Peripheral and Bone Marrow in Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor ling xu"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Selena ","lastName":"Carmona ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterizing the Mechanism of NE and P3 Cross-Presentation in B Cell-Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor selena carmona"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Kseniia ","lastName":"Sychevskaia ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal T-Lymphocyte Populations in Healthy Donors","keywords":"","combinedName":"doctor kseniia sychevskaia"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Tai-Gyu ","lastName":"Kim ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Analysis of CMV pp65 Antigen-Specific CD8+ T Cell Responses According to HLA Class I Alleles and Intra-Individual Dominance","keywords":"","combinedName":"doctor tai-gyu kim"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Naohito ","lastName":"Fujishima ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Throughput Sequencing of IgG B-Cell Receptors Reveals the Frequent Usage of the Rearranged IGHV4-28//IGHJ4 Gene in Primary Immune Thrombocytopenia in Adults","keywords":"","combinedName":"doctor naohito fujishima"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Simon ","lastName":"Voelkl ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Human Double-Degative Regulatory T Cells Modulate Differentiation and Function of Conventional T Cells By Disrupting mTOR Activity","keywords":"","combinedName":"doctor simon voelkl"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Giridharan ","lastName":"Ramsingh ","credentials":"MD ","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Clearance of Senescent Cells Via Activation of Endogenous Retroviruses and the Viral Recognition Pathway","keywords":"","combinedName":"doctor giridharan ramsingh"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Betsy ","lastName":"Barnes ","credentials":"DPhil","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IRF5 Loss Impairs TLR9/BCR-Induced B Cell Activation, Proliferation and Plasmablast Differentiation through Erk1-Myc Signaling","keywords":"","combinedName":"doctor betsy barnes"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Sarah ","lastName":"Hartley ","credentials":"MBBS, MRCP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Kinetics of T-Cell Subset Reconstitution Following Bendamustine-Containing Therapy for Low-Grade Lymphoproliferative Disease; A Population Based Analysis","keywords":"","combinedName":"doctor sarah hartley"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Jeff ","lastName":"Strojny ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PDE-5 Inhibition Decreases Cancer Tumor Burden through Immunomodulation","keywords":"","combinedName":"doctor jeff strojny"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"David C","lastName":"Fajgenbaum ","credentials":"MD,MBA,MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prolonged Remission Achieved in a Relapsing Idiopathic Multicentric Castleman Disease Patient with a Novel, Targeted Treatment Approach","keywords":"","combinedName":"doctor david c fajgenbaum"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"David C","lastName":"Fajgenbaum ","credentials":"MD,MBA,MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantification of Plasma Proteins from Idiopathic Multicentric Castleman Disease Flares and Remissions Reveals Chemokine Storm and Separates Clinical Subtypes","keywords":"","combinedName":"doctor david c fajgenbaum"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Brianne ","lastName":"Dixon ","credentials":"PharmD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk of Hyponatremia and Associated Clinical Characteristics in Patients with Acute Lymphoblastic Leukemia after CD19 Targeted Chimeric Antigen Receptor (CAR) T-Cells","keywords":"","combinedName":"doctor brianne dixon"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Shannon ","lastName":"Carty","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TET2 Regulates CD4+ T Follicular Helper Differentiation","keywords":"","combinedName":"doctor shannon carty"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Sang ","lastName":"Kim ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Th1/17 Cells Are Expanded in Bronchial Alveolar Lavage (BAL) Fluid from Leukemia Patients with Checkpoint Inhibitor-Induced Pneumonitis","keywords":"","combinedName":"doctor sang kim"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Jae-Ho ","lastName":"Yoon ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"the Clinical Impact of Impaired Natural-Killer Cell Cytotoxicity for Diagnosis and Prognostication in Adult Patients with Febrile Cytopenia Including Hemophagocytic Lymphohistiocytosis and Similar Diseases: The Results of Prospective Phase II Observational Study","keywords":"","combinedName":"doctor jae-ho yoon"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Chezi ","lastName":"Ganzel ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Risk of Developing Tuberculosis in Cancer Patients Is Greatest in Lymphoma: A Large Population-Based Study","keywords":"","combinedName":"doctor chezi ganzel"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Yaya ","lastName":"Chu ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapeutic Effects of a Novel Fusion of ALT-803, an IL-15 Superagonist, with 4 Single-Chains of Anti-CD20 Antibody (2B8T2M) in Combination with Expanded Natural Killer Cells Against Rituximab Sensitive and Resistant Burkitt Lymphoma (BL)","keywords":"","combinedName":"doctor yaya chu"},{"sessionId":"11787","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III","firstName":"Christopher Sheild","lastName":"Nabel ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Virome Capture Sequencing in Castleman Disease Identifies Associations with Herpesviridae Family Members but No Novel Viruses","keywords":"","combinedName":"doctor christopher sheild nabel"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Joan ","lastName":"Ballesteros ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bispecific Antibodies on Hematological Malignancies: A Novel Mechanism of Action That May Contribute to Therapeutic Efficacy","keywords":"","combinedName":"doctor joan ballesteros"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Alison ","lastName":"Freifeld ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bloodstream Infection Survey in High-Risk Oncology Patients (BISHOP): Preliminary Report","keywords":"","combinedName":"doctor alison freifeld"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Meng ","lastName":"Song ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Analysis of Gram-Negative Bacillisepticemia-Associated Hemophagocytic Lymphohistiocytosis","keywords":"","combinedName":"doctor meng song"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Evelyn ","lastName":"Ojo ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Demonstration of a Single-Parameter, Rapid Flow Cytometry Assay in Assessing Natural Killer Cell Cytotoxic Function","keywords":"","combinedName":"doctor evelyn ojo"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Rikhia ","lastName":"Chakraborty ","credentials":"PhD, BSc, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Checkpoint Inhibitors Restore Function of Lesion Infiltrating T Lymphocytes in Langerhans Cell Histiocytosis","keywords":"","combinedName":"doctor rikhia chakraborty"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Chiara ","lastName":"Cattaneo ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Invasive Pulmonary Aspergillosis in Acute Leukemia in the Era of New Antifungal Treatment and Prophylaxis Is Still Frequent, Even in Patients with Acute Lymphoblastic Leukemia, and Adversely Affects the Overall Treatment Outcome. Results of a 5-Year Study at a Single Institution","keywords":"","combinedName":"doctor chiara cattaneo"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Mengmeng ","lastName":"Zhang ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NKG2D Negatively Regulates CD4 T Cells in Allo-Response in Mice","keywords":"","combinedName":"doctor mengmeng zhang"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Ido ","lastName":"Somekh ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Mutations in RASGRP1 Are Associated with Immune Dysregulation and Predispose to EBV-Induced Lymphoma","keywords":"","combinedName":"doctor ido somekh"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Arati ","lastName":"Khanna-Gupta ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Retrospective Next Generation DNA Sequencing Analysis in Patients with Hemophagocytic Lymphohistiocytosis (HLH) Highlights Genetic Variants Associated with Secondary/Late-Onset Disease","keywords":"","combinedName":"doctor arati khanna-gupta"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Sean ","lastName":"Mackay ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Cell Multiplex Proteomics Reveals Synergistic Impact of Antigen and Rimiducid-Dependent Stimulatory Signals on Promoting Polyfunctional GoCAR-T Cells Targeting Prostate Stem Cell Antigen (PSCA)","keywords":"","combinedName":"doctor sean mackay"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Ioannis ","lastName":"Kotsianidis ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The STAT Signaling Biosignature at the Single Cell Level Reveals Novel Insights in the Association of FOXP3+ T Regulatory Cells with Recurrent Spontaneous Abortions (RSA)","keywords":"","combinedName":"doctor ioannis kotsianidis"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Sebastian ","lastName":"Haen ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thermal Ablation of Colorectal Cancer Metastases Leads to Activation of Individual Cancer-Specific T Cell Immunity","keywords":"","combinedName":"doctor sebastian haen"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Krystalyn E","lastName":"Hudson ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tolerization of CD4+ Recent Thymic Emigrants Is Required to Prevent RBC-Specific Autoimmunity","keywords":"","combinedName":"doctor krystalyn e hudson"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Nikolaus ","lastName":"Krall ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unbiased Profiling of the Immunomodulatory Properties of Soluble Proteins","keywords":"","combinedName":"doctor nikolaus krall"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Jie ","lastName":"Jin ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Utility of Computed Tomography for the Diagnosis of Invasive Aspergillosis in Hematological Malignancy","keywords":"","combinedName":"doctor jie jin"},{"sessionId":"11788","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster II","firstName":"Albert ","lastName":"Rizvanov ","credentials":"DSc, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Zika Virus Infection Activates Proinflammatory Cytokines and Triggers Monocyte Differentiation","keywords":"","combinedName":"doctor albert rizvanov"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Mohamed ","lastName":"Samour ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cancer Cell-Derived Extracellular Vesicles Are Prothrombotic in an in-Vitro Vessel Model","keywords":"","combinedName":"doctor mohamed samour"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Moua ","lastName":"Yang ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD36 Promotes Platelet Phosphatidylserine Exposure through MAP Kinase ERK5","keywords":"","combinedName":"doctor moua yang"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Daniel A","lastName":"Keesler ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Critical Extracellular Matrix Proteins Besides Collagen Bind Von Willebrand Factor","keywords":"","combinedName":"doctor daniel a keesler"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Phong ","lastName":"Le ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Different Conformations of Fibronectin Fibrils Formed Under Cell-Free Condition in Vitro display Distinct Effects on Cell Adhesion and Spreading","keywords":"","combinedName":"doctor phong le"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Yuan ","lastName":"Kong ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dysfunction of Bone Marrow Endothelial Progenitor Cells from Subjects with Prolonged Isolated Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation Can be Improved By N-Acetyl-L-Cysteine","keywords":"","combinedName":"doctor yuan kong"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Srila ","lastName":"Gopal ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia on Signaling and Epigenetics in Endothelial Cells","keywords":"","combinedName":"doctor srila gopal"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Zhi-Jian ","lastName":"Liu ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Noval Insights into the Role of Platelet Angiogenic Growth Factors on the Regulation of Normal Vascular Development","keywords":"","combinedName":"doctor zhi-jian liu"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Elena ","lastName":"Kistanova ","credentials":"MA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimization of Clot Formation Under Blood Flow in a Tissue Engineered Blood Vessel","keywords":"","combinedName":"doctor elena kistanova"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Oluwamayokun ","lastName":"Oshinowo ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Contraction Cytometry: A Biophysical, High-Throughput Research-Enabling and Diagnostic Platform","keywords":"","combinedName":"doctor oluwamayokun oshinowo"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Diego ","lastName":"Mezzano ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Tissue Factor Activity Is Specifically Induced By GPIbActivation Pathway, Independent of GPVI,aIIb3 and Protein Disulfide Isomerase Activities","keywords":"","combinedName":"doctor diego mezzano"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Noppacharn ","lastName":"Uaprasert ","credentials":"MB, BCH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Protein Disulfide Isomerase Negatively Regulates Platelet Function through Modulation of the Thromboxane A2Receptor","keywords":"","combinedName":"doctor noppacharn uaprasert"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Aye Myat Myat ","lastName":"Thinn ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Structural and Functional Characterization of a Single Chain 3 Integrin in Solution and on the Cell Surface and the Implications on Integrin Activation and Pathogenesis of Anti-HPA-1a Alloantibodies","keywords":"","combinedName":"doctor aye myat myat thinn"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Xiangmin ","lastName":"Wang ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The C Loop of Fifth Epidermal Growth Factor-like Domain of Thrombomodulin Exerts Cytoprotective and Angiogenic Effects in Vitro and In Vivo","keywords":"","combinedName":"doctor xiangmin wang"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Hannah L","lastName":"McRae ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Effect of ABO Immune Complexes on Endothelial Cell Integrity As Measured By Electric Cell-Substrate Impedance Sensing (ECIS) and Confocal Microscopy","keywords":"","combinedName":"doctor hannah l mcrae"},{"sessionId":"11789","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster II","firstName":"Satya ","lastName":"Kunapuli ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TULA-2 Deficiency Enhances Platelet Response to CLEC-2 Agonists","keywords":"","combinedName":"doctor satya kunapuli"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Fatima Z","lastName":"Alshbool ","credentials":"PharmD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Critical Role for the IKK/Lipid Rafts Axis in Regulating Platelet Exocytosis, Via the Spatial Regulation of SNARE Proteins","keywords":"","combinedName":"doctor fatima z alshbool"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Rahma ","lastName":"Boulahya ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Brain-Derived Neurotrophic Factor Induces Platelet Aggregation","keywords":"","combinedName":"doctor rahma boulahya"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Aaron ","lastName":"Cook ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Calcium-Induced Conformational Changes in EF hands and Autoinhibitory Linker Region are Critical for Catalytic Activity of CalDAG-GEFI Towards the Small GTPase Rap1","keywords":"","combinedName":"doctor aaron cook"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Calvin ","lastName":"Harberg ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD36 Activation Enhances Hydrogen Peroxide Generation in Human Platelets","keywords":"","combinedName":"doctor calvin harberg"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Munetada ","lastName":"Haruyama ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Exogenously Added Cofilin Increases Ex Vivo Production of Functional Platelets By Stimulating Proplatelet Formation","keywords":"","combinedName":"doctor munetada haruyama"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Shauna L","lastName":"French ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improved Inhibition of Protease-Activated Receptor 4 (PAR4) with Function-Blocking Antibodies Provides Equivalent Antithrombotic Activity in the Face of the Hyper-Reactive Thr120 PAR4 Variant","keywords":"","combinedName":"doctor shauna l french"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Takahiro ","lastName":"Yoshikawa ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ischemia-Reperfusion Injury with Pringle's Maneuver Induces Increasing of Unusually Large Von Willebrand Factor Multimers after Hepatectomy","keywords":"","combinedName":"doctor takahiro yoshikawa"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Forrest D","lastName":"Nussdorfer ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"LDL and HDL Have Opposing Effects on VWF Self-Association","keywords":"","combinedName":"doctor forrest d nussdorfer"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Wei ","lastName":"Deng ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mapping the Masked Region of the A1 Domain in Full-Length VWF","keywords":"","combinedName":"doctor wei deng"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Hidekata ","lastName":"Yasuoka ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phenotype of Platelet Is Altered and Associated with Disease Activity of Rheumatoid Arthritis","keywords":"","combinedName":"doctor hidekata yasuoka"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Satya ","lastName":"Kunapuli ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phosphorylation of Y311 on Pkcd Regulates Protease Activated Receptor 4-Mediated Signaling in Platelets","keywords":"","combinedName":"doctor satya kunapuli"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Clemens ","lastName":"Hinterleitner ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Programmed Cell Death Ligand 1 (pPDL-1) Is a Prognostic Marker in Advanced Lung Cancer","keywords":"","combinedName":"doctor clemens hinterleitner"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Morgane ","lastName":"Bourcy ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role for PARS and Thrombin-Gpiba Interaction for Thrombin Induced Procoagulant Platelet Formation","keywords":"","combinedName":"doctor morgane bourcy"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Brian ","lastName":"Storrie ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Alpha-Granule Release Reaction Is Mediated By SNARE-Dependent Solubilization of the Granule Matrix","keywords":"","combinedName":"doctor brian storrie"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Jaromir ","lastName":"Gumulec ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of VWF, FVIII, ADAMTS13 and Inflammatory Response in the Outcome of Acute Ischemic Stroke Mechanical Thrombectomy Procedure","keywords":"","combinedName":"doctor jaromir gumulec"},{"sessionId":"11790","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Poster III","firstName":"Alessandro ","lastName":"Morotti ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transferrin Saturation and Its Association with Platelet Reactivity","keywords":"","combinedName":"doctor alessandro morotti"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Stephen Zachary","lastName":"Peeke ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A 2 Year of Review of HIT Evaluations at an Urban Medical Center with an Aim Towards Quality Improvement and the Development of Practical Testing Strategies","keywords":"","combinedName":"doctor stephen zachary peeke"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Si Jing ","lastName":"Chen ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Megakaryocyte-Based Screening System Identifies Compounds That Promote Megakaryocyte Maturation and Platelet Production in Vitro","keywords":"","combinedName":"doctor si jing chen"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Jennifer Minjia","lastName":"Chang ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Point-of-Care Quartz Biosensor Chip for Detection of PF4/Heparin Complexes","keywords":"","combinedName":"doctor jennifer minjia chang"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"John ","lastName":"Grainger ","credentials":"MD, MRCP, FRPATH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ASingle-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)","keywords":"","combinedName":"doctor john grainger"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Meera ","lastName":"Sridharan ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Atypical Hemolytic Uremic Syndrome-Clinical Presentation, Treatment, and Short Term Outcomes: The Mayo Clinic Experience","keywords":"","combinedName":"doctor meera sridharan"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Kundan ","lastName":"Mishra ","credentials":"MD, MBBS, MNAMS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bleeding Risk Assessment By Sonoclot in Severe Immune Thrombocytopenia","keywords":"","combinedName":"doctor kundan mishra"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Gauthami ","lastName":"Jalagadugula ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Defective Rab1b Related Megakaryocytic ER-to-Golgi Transport in RUNX1 Haplodeficiency","keywords":"","combinedName":"doctor gauthami jalagadugula"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Nora ","lastName":"Butta ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Distinctive Platelet Features and Lymphocyte Sets Distribution in Immune Thrombocytopaenia Patients Responders to Thrombopoietin Receptor Agonists","keywords":"","combinedName":"doctor nora butta"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Valery J","lastName":"Li ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies","keywords":"","combinedName":"doctor valery j li"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Hui Yin ","lastName":"Lim ","credentials":"MBBS, BMedSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Global Coagulation Assays in Normal and Thrombocytopenic Populations","keywords":"","combinedName":"doctor hui yin lim"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Charlotte A","lastName":"Bradbury ","credentials":"PhD, MD, FRCPath, FRCP, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Glucocorticoid (GC) Induced Cytokine Expression in CD4+ T Cells Is a Candidate Biomarker for Clinical Steroid Response in Patients with Immune Thrombocytopenia","keywords":"","combinedName":"doctor charlotte a bradbury"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Sandy ","lastName":"El Bitar ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Heparin-Induced Thrombocytopenia: Are We Ordering Too Much","keywords":"","combinedName":"doctor sandy el bitar"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Elizabeth ","lastName":"Van Dyne ","credentials":"MD,MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence and Outcome of Severe Thrombocytopenia Associated with Zika Virus Infection  Puerto Rico, 2016","keywords":"","combinedName":"doctor elizabeth van dyne"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Jayne ","lastName":"Peters ","credentials":"MBChB, MRCP, FRCPath","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Term Eltrombopag in Paediatric Immune Thrombocytopenia: Update on UK Patients Treated with Eltrombopag As Part of the Petit and PETIT2 Studies","keywords":"","combinedName":"doctor jayne peters"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Thomas ","lastName":"Blair ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mass Cytometry of Platelets: Simultaneous Functional and Phenotypic Analysis of Multiple Surface Markers in Healthy Subjects and Patients with Inherited Platelet Disorders Reveals Novel Platelet Sub-Populations","keywords":"","combinedName":"doctor thomas blair"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Julia M","lastName":"Cunningham ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes for Atypical Hemolytic Uremic Syndrome (aHUS) Treated with Eculizumab: A Single Center Analysis","keywords":"","combinedName":"doctor julia m cunningham"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Hugues ","lastName":"Spillemaeker ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Desialylation Is a Novel Mechanism of Thrombocytopenia during Mechanical Circulatory Assistance","keywords":"","combinedName":"doctor hugues spillemaeker"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Ian ","lastName":"Johnston ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Factor 4 Binds to Released Von Willebrand Factor Strands from Injured Endothelium and Forms a Prothrombotic HIT Antigenic Complex","keywords":"","combinedName":"doctor ian johnston"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Nora ","lastName":"Butta ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Features from Immune Thrombocytopenia Patients Refractory to Therapeutic Treatments","keywords":"","combinedName":"doctor nora butta"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Elena ","lastName":"Smolensky Koganov ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Function in Thrombocytopenic Patients with Chronic Liver Disease","keywords":"","combinedName":"doctor elena smolensky koganov"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Taylor ","lastName":"Olmsted ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Positive Direct Antiglobulin Test Predicts Development of Chronic Immune Thrombocytopenia and Treatment with Second Line Therapy in Pediatric ITP Patients","keywords":"","combinedName":"doctor taylor olmsted"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Daniel N","lastName":"Darlington ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Severe Trauma Leads to a Fall in Intracellular Triphosphates and a Rise in cAMP in Platelets","keywords":"","combinedName":"doctor daniel n darlington"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Fathima Mohiyaddin","lastName":"Ayyalil ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Successful Treatment of Alemtuzumab Induced Immune Thrombocytopenia with a Thrombopoietin Receptor Agonist","keywords":"","combinedName":"doctor fathima mohiyaddin ayyalil"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Amaris ","lastName":"Balitsky ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Anticoagulation in Patients with Immune Thrombocytopenia","keywords":"","combinedName":"doctor amaris balitsky"},{"sessionId":"11791","sessionTitle":"311. Disorders of Platelet Number or Function: Poster II","firstName":"Peipei ","lastName":"Xu ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Vincristine-Loaded Platelets Coated with Anti-CD41 MAbs: A New Proposal for the Treatment of Immune Thrombocytopenia","keywords":"","combinedName":"doctor peipei xu"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Qian ","lastName":"Qin ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acquired Thrombotic Thrombocytopenic Purpura and Acute Pancreatitis: Variable and Reciprocal Pathophysiologic Relationships","keywords":"","combinedName":"doctor qian qin"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Francesca ","lastName":"Palandri ","credentials":"PhD, MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aging Significantly Drives Decision Making and Outcome in Immune Thrombocytopenia Patients: A Monocentre Study on 508 Patients","keywords":"","combinedName":"doctor francesca palandri"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Apurva ","lastName":"Pandey ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of Patients Mislabeled with Heparin Induced Thrombocytopenia","keywords":"","combinedName":"doctor apurva pandey"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Peter A A","lastName":"Norris ","credentials":"BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Antibodies Against Macrophage CD44 Protect Platelets from Fc?R-Mediated Phagocytosis: A Potential Mechanism for CD44 Antibody Amelioration of Murine Immune Thrombocytopenia","keywords":"","combinedName":"doctor peter a a norris"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"David ","lastName":"Schmidt ","credentials":"MD, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anti-Platelet Antibodies Are Predominantly IgM in Childhood Immune Thrombocytopenia","keywords":"","combinedName":"doctor david schmidt"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Kellie","lastName":"Machlus","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aspirin Inhibits Platelets from Reprogramming Breast Tumor Cells and Promoting Metastasis","keywords":"","combinedName":"doctor kellie machlus"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Grace ","lastName":"Wegryzn ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biomarkers of Platelet Activation and Their Prognostic Value in Patients in Sepsis Associated Coagulopathy","keywords":"","combinedName":"doctor grace wegryzn"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Ferras ","lastName":"Alwan ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterizing the United Kingdom Congenital Thrombotic Thrombocytopenic Purpura Population","keywords":"","combinedName":"doctor ferras alwan"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Xinyi ","lastName":"Zuo ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Defective Early B Cell Tolerance in Primary Immune Thrombocytopenia","keywords":"","combinedName":"doctor xinyi zuo"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Naoko ","lastName":"Okamoto ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differential Expression of IL-17 Correlates with Clinical and Pathological Features of ITP","keywords":"","combinedName":"doctor naoko okamoto"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Brian ","lastName":"Curtis ","credentials":"PhD,MT(ASCP)","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Drug-Induced Immune Thrombocytopenia (DITP) Caused By Multiple Drug-Dependent Platelet-Reactive Antibodies (DDAbs) in Patients Undergoing Oxaliplatin-Containing Combination Chemotherapy for Metastatic Colon Cancer","keywords":"","combinedName":"doctor brian curtis"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Raymond SM","lastName":"Wong ","credentials":"MRCP,FRCP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Eltrombopag (EPAG) Treatment Improved Platelet Counts in Patients with Persistent or Chronic Immune Thrombocytopenia during a 2-Year, Phase IV, Open-Label Study","keywords":"","combinedName":"doctor raymond sm wong"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Anastasia ","lastName":"Ignatova ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evolution of Platelet Function and Bleeding in Children and Adults with Chronic Immune Trombocytopenia on Romiplostim Treatment","keywords":"","combinedName":"doctor anastasia ignatova"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Ang ","lastName":"Li ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"External Validation of the Plasmic Score: A Clinical Prediction Tool for Thrombotic Thrombocytopenic Purpura (TTP) Diagnosis and Treatment","keywords":"","combinedName":"doctor ang li"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Todd ","lastName":"Clover ","credentials":"MD, MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry","keywords":"","combinedName":"doctor todd clover"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Rachel ","lastName":"Leger ","credentials":"BAE","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Heparin Induced Thrombocytopenia: A Laboratory Comparison of the IgG Specific EIA Vs Polyspecific EIA","keywords":"","combinedName":"doctor rachel leger"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Akash ","lastName":"Mukherjee ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Heparin-Induced Thrombocytopenia with Very High Antibody Titer Is Associated with Slower Platelet Recovery","keywords":"","combinedName":"doctor akash mukherjee"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Jose Maria ","lastName":"Bastida ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Heterogeneous Landscape of RUNX1 Related Disorder: Four Families with Inherited Thrombocytopenias and Novel Genetic Variants in RUNX1 Associated to Relevant Clinical Complications","keywords":"","combinedName":"doctor jose maria bastida"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Parisa R","lastName":"Khalighi ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HIT Diagnosis: A Proposed New Definition for Clinical Research","keywords":"","combinedName":"doctor parisa r khalighi"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Sabina ","lastName":"Cashin ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Non-Selected Patients Treated for Influenza, Oseltamivir, a Glycosialidase Inhibitor, Demonstrates Improvement in Platelet Counts Compared to Time of Dosing, but Not over Baseline Levels","keywords":"","combinedName":"doctor sabina cashin"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Sanjay ","lastName":"Khandelwal ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vitro Complement Activation By PF4/Heparin Complexes Is Mediated By Plasma IgM","keywords":"","combinedName":"doctor sanjay khandelwal"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Jia-Min ","lastName":"Zhang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrated mRNA and miRNA Profiling Revealed Deregulation of the Cellular Stress Response in Bone Marrow Mesenchymal Stem Cells Derived from Patients with Immune Thrombocytopenia","keywords":"","combinedName":"doctor jia-min zhang"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"John ","lastName":"Grainger ","credentials":"MD, MRCP, FRPATH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Newly Diagnosed Paediatric ITP in UK","keywords":"","combinedName":"doctor john grainger"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Sang Bo ","lastName":"Oh ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Neutropenia Following Intravenous Immunoglobulin Therapy in Adult Patients with Immune Thrombocytopenic Purpura","keywords":"","combinedName":"doctor sang bo oh"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Yuzhou ","lastName":"Liu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Early Plasmapheresis Vs Late Plasmapheresis in Patients with Thrombocytopenic Thrombotic Purpura: A Nationwide Analysis from 2005-2014","keywords":"","combinedName":"doctor yuzhou liu"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Nikola ","lastName":"Ivetic ","credentials":"BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Performance Characteristics of a Novel Platelet Viability Assay for Heparin-Induced Thrombocytopenia","keywords":"","combinedName":"doctor nikola ivetic"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Yuya ","lastName":"Kitamura ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Polymorphisms of Monocyte-Activating Cytokine/Chemokine Genes Affect the Susceptibility to, and Severity of Chronic ITP","keywords":"","combinedName":"doctor yuya kitamura"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Shayna ","lastName":"Sarosiek ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recognizing the Existence of Heparin Induced Thrombocytopenia and Thrombosis in the Setting of High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Institution Case Series","keywords":"","combinedName":"doctor shayna sarosiek"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Peter ","lastName":"Barth ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Center Experience of the Utility of a Rapid ADAMTS13 Assay","keywords":"","combinedName":"doctor peter barth"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Meera ","lastName":"Sridharan ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Detectable ADAMTS13 Inhibitor on the Clinical Presentation and Outcome of Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Analysis Using the United States Thrombotic Microangiopathy (USTMA) Clinical Registry","keywords":"","combinedName":"doctor meera sridharan"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Mustafa Nuri","lastName":"Yenerel ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Whole Exome Analysis and Clinical Relevance in Patients with Atypical Hemolytic Uremic Syndrome","keywords":"","combinedName":"doctor mustafa nuri yenerel"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Saeid ","lastName":"Rezaei Jouzdani ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapy of Adults Affected By Idiopathic Thrombocytopenic Purpura with 3 Cycles Pulses of High-Dose Dexamethasone (HD-DXM): A Prospective Randomized Clinical Trial","keywords":"","combinedName":"doctor saeid rezaei jouzdani"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Yajing ","lastName":"Zhao ","credentials":"BA, MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TNF-a Blockade InhibitsPro-Inflammatory Monocytes/Macrophages in ITP","keywords":"","combinedName":"doctor yajing zhao"},{"sessionId":"11792","sessionTitle":"311. Disorders of Platelet Number or Function: Poster III","firstName":"Umesh ","lastName":"Doobaree ","credentials":"MSc, RN, BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment, Platelet Count Pattern and Comorbidities Among Primary Immune Thrombocytopenia (ITP) Patients Seen in Routine Clinical Practice: Data from the United Kingdom Immune Thrombocytopenia (UK ITP) Registry","keywords":"","combinedName":"doctor umesh doobaree"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Oladipo Jude","lastName":"Akinwale ","credentials":"MSc,BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Factor VIII Fusion with an Inactivated FIX Generates a Biologically Active Molecule with Delayed Clearance in a FVIII/VWF Knockout Mouse Model","keywords":"","combinedName":"doctor oladipo jude akinwale"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Thomas James","lastName":"Girard ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Complete TFPI Gene-Disruption Is More Severe Than TFPI Kunitz-1 Gene-Deletion in Mice","keywords":"","combinedName":"doctor thomas james girard"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Eric ","lastName":"Grabowski ","credentials":"MD, DSc ","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differentiation of Patients with Type 1 Von Willebrand Disease Vs. Low Normal Levels of the Von Willebrand Factor Using a Very High Shear Rate, Non-Citrated Blood Flow System  ","keywords":"","combinedName":"doctor eric grabowski"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Afshin ","lastName":"Ameri ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factor VII Augusta (FVII G395D/G395N):a Compound Heterozygous Deletion Insertion and Missense Variant Manifesting As Moderate Bleeding Disorder","keywords":"","combinedName":"doctor afshin ameri"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Oscar ","lastName":"Negron ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fibrin(ogen)-Pathogen Interactions Support Antimicrobial Host Defense Following Staphylococcus Aureus Peritonitis Infection","keywords":"","combinedName":"doctor oscar negron"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Sandra ","lastName":"Le Quellec ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Fusion to Factor XIII B-Subunit Improves the Pharmacokinetic Properties of Factor IX","keywords":"","combinedName":"doctor sandra le quellec"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Meenal ","lastName":"Shukla ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Molecular Weight Kininogen Alters the Tumor Microenvironment and Reduces Tumor Stem Cell Content","keywords":"","combinedName":"doctor meenal shukla"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Eduardo ","lastName":"Guillen ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of a Tolerogenic Factor V Peptide and Its Potential Role in FVIII Tolerance Induction","keywords":"","combinedName":"doctor eduardo guillen"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Rima ","lastName":"Chattopadhyay ","credentials":"Ph.D.","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of Factor IXa By Protein S: Critical Function of the Protein S SHBG-like Domain","keywords":"","combinedName":"doctor rima chattopadhyay"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Thomas James","lastName":"Girard ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low TFPI Mice in Models of Atherosclerosis and Endotoxemia","keywords":"","combinedName":"doctor thomas james girard"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Eui-Cheol ","lastName":"Jo ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Design and Characterization of a Novel, Vwf Independent Coagulation Factor VIII (LAFATE)","keywords":"","combinedName":"doctor eui-cheol jo"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Madhumouli ","lastName":"Chatterjee ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet-Based Factor VIII Activity Is Inhibited By Anti-C2 Domain Antibodies That Don't Significantly Inhibit Factor VIII Activity in a Standard Assay","keywords":"","combinedName":"doctor madhumouli chatterjee"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Katrien ","lastName":"Devreese ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Analytical Stability of Coagulation Parameters in Plasma","keywords":"","combinedName":"doctor katrien devreese"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Michael ","lastName":"Meledeo ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prolonged Prothrombin Time in DIC: Contributions of Excess Thrombin and Fibrinogen Degradation Products","keywords":"","combinedName":"doctor michael meledeo"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Teodolinda ","lastName":"Petrillo ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Protamine Sulfate Interacts with Partially Activated Forms of Factor V Which Contributes to Its Paradoxical Anticoagulant Effect","keywords":"","combinedName":"doctor teodolinda petrillo"},{"sessionId":"11793","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster II","firstName":"Michal ","lastName":"Cipok ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sensitive and Specific Functional Flow Cytometry Assay for Rapid Diagnosis of Heparin Induced Thrombocytopenia and Thrombosis (HIT)","keywords":"","combinedName":"doctor michal cipok"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Harlan N","lastName":"Bradford ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Single Cleavage Reaction in the Proteolytic Activation of Factor V to the CofactorIs Rate-Limiting in a Step That Is Selectively Dependent on Anion Binding Exosite 2 of Thrombin","keywords":"","combinedName":"doctor harlan n bradford"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Wenjing ","lastName":"Cao ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Apolipoprotein B-100 Binds Von Willebrand Factor and Accelerates Its Proteolysis By ADAMTS13 Under Fluidic Shear","keywords":"","combinedName":"doctor wenjing cao"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Xiaowu ","lastName":"Wu ","credentials":"MD, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Coagulopathy As a Dose-Limiting Toxicity in Systemic Administration of Mesenchymal Stem Cells (MSCs): Relative Safety of Bone Marrow Versus Adipose Derived MSCs ","keywords":"","combinedName":"doctor xiaowu wu"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Weidong ","lastName":"Xiao ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Glycosylation Mapping of Recombinant and Plasma-Derived Human Factor VIII Reveals Key Biological Differences","keywords":"","combinedName":"doctor weidong xiao"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Heng ","lastName":"Mei ","credentials":"PhD,MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diagnostic Performance and Prognostic Value of a Chinese Diagnostic Scoring System (CDSS) for Disseminated Intravascular Coagulation---a Multicenter Prospective Study","keywords":"","combinedName":"doctor heng mei"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Heng ","lastName":"Mei ","credentials":"PhD,MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation the Value of TAT, PIC, Tpaic, TM in Diagnosing Disseminated Intravascular Coagulation in Chinese population: a Multi-Center Prospective Observational Study","keywords":"","combinedName":"doctor heng mei"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Emily Ann","lastName":"Larson ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factor VIII Plays a Direct Role in Osteoblast Development","keywords":"","combinedName":"doctor emily ann larson"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Kirk ","lastName":"Wyatt ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Heparin Infusion for Central Line PatencyandCorrected Gestational AgeMay Affect Coagulation Studiesin the Neonatal Intensive Care Unit","keywords":"","combinedName":"doctor kirk wyatt"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Gautham ","lastName":"Sridharan ","credentials":"Ph.D.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In silico Modeling of the Impact of Antithrombin Lowering on Thrombin Generation in Rare Bleeding Disorders","keywords":"","combinedName":"doctor gautham sridharan"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Koji ","lastName":"Yada ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increasing of Ternary Complex Formation By Predominant Accumulation of Factor (F)X Accompanied By Increase of Fixa Contributes to Enhancement of Clotting Function By Apcc in Combination with Emicizumab","keywords":"","combinedName":"doctor koji yada"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Roland W","lastName":"Herzog ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Innate Immune Activation Via TLR9 May Enhance Antibody Formation Against Factors VIII and IX in Protein and Gene Therapy","keywords":"","combinedName":"doctor roland w herzog"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Janet ","lastName":"Leeds ","credentials":"Ph.D.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Physiologically Based Pharmacokinetic (PBPK) Modeling for Betrixaban and the Impact of P-Glycoprotein Inhibition on Betrixaban Pharmacokinetics","keywords":"","combinedName":"doctor janet leeds"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Prajeeda M","lastName":"Nair ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasma FXIII Mediated Crosslinking Is Necessary for Thrombin Generation and Clot Retraction","keywords":"","combinedName":"doctor prajeeda m nair"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Nicole ","lastName":"Parsons ","credentials":"B.S.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Regulation of Factor VIII By Activated Protein C: Assessment in Vitro and In Vivo","keywords":"","combinedName":"doctor nicole parsons"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Landon ","lastName":"Haslem ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rutin Increases Shear-Dependent TGF-1 Activation By Interacting with Putative PDI Binding Sites: Role of Oxidation in Shear-Dependent TGF-1 Activation","keywords":"","combinedName":"doctor landon haslem"},{"sessionId":"11794","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Poster III","firstName":"Gabriela ","lastName":"Uceda Cortez ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Von Willebrand Factor A1 Domain Binds to Clusters II and IV of Low-Density Lipoprotein Receptor-Related Protein 1","keywords":"","combinedName":"doctor gabriela uceda cortez"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Gina ","lastName":"Patel ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acquired Factor X Deficiency in Light Chain (AL) Amyloidosis Is Rare and Associated with Advanced Disease","keywords":"","combinedName":"doctor gina patel"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Guy ","lastName":"Young ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Beyond ABR: High FIX Activity Levels Translate into Clinical Benefits over Standard Prophylaxis","keywords":"","combinedName":"doctor guy young"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Vincent ","lastName":"Diego ","credentials":"Ph.D.","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of the HLA-Class-II (HLAcII)/Therapeutic Factor VIII (FVIII)-Derived Peptidome By FVIII Domain and Hlacii Isomer","keywords":"","combinedName":"doctor vincent diego"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Suman ","lastName":"Sood ","credentials":"MD, MSCE","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chronic Kidney Disease in the U.S. Hemophilia Population: A Cohort Study","keywords":"","combinedName":"doctor suman sood"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Amy ","lastName":"Shapiro ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Outcomes of Weekly Prophylaxiswith rFVIIIFc: Longitudinal Analysis of the A-LONG and ASPIRE Study Population","keywords":"","combinedName":"doctor amy shapiro"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Guido ","lastName":"Kohla ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of the Functional Characteristics and Post-Translational Modifications of Commercial Factor VIII Products","keywords":"","combinedName":"doctor guido kohla"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Joseph M","lastName":"Parker ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Computer Modeling Using Historical Data Demonstrates a Significant Reduction in Expected Extravascular Fibrinous Lesions Due to Congenital Plasminogen Deficiency While Receiving Intravenous Plasminogen (PLG) Replacement","keywords":"","combinedName":"doctor joseph m parker"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Leonora R","lastName":"Slatnick ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Disseminated Intravascular Coagulation Predicts Adverse Outcomes in Children with Suspected Sepsis in the Emergency Department","keywords":"","combinedName":"doctor leonora r slatnick"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Courtney ","lastName":"Cox ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epitope Mapping of Inhibitor Patient Plasmas during Immune Tolerance Induction","keywords":"","combinedName":"doctor courtney cox"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Alessandra N L","lastName":"Prezotti ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia ? Patients with High-Responding Inhibitors","keywords":"","combinedName":"doctor alessandra n l prezotti"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Ophira ","lastName":"Salomon ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factor XI DeficiencyIsNot Associated with Increased Risk of Pneumonia in Adults","keywords":"","combinedName":"doctor ophira salomon"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Maria Eva ","lastName":"Mingot-Castellano ","credentials":"PhD, MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Influence of Inhibitor Characteristics on Response to Hemostatic and Immunosuppressive Treaments in Acquired Hemophilia Patients: The Ciha Project","keywords":"","combinedName":"doctor maria eva mingot-castellano"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Beth Boulden","lastName":"Warren ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibitor Screening in Severe Hemophilia a: A Six-Year Single Center Experience","keywords":"","combinedName":"doctor beth boulden warren"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Elena ","lastName":"Santagostino ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Joint Replacement in Hemophilia a with Inhibitors during Emicizumab Prophylaxis","keywords":"","combinedName":"doctor elena santagostino"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Claude ","lastName":"Negrier ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Perioperative Management in Patients with Hemophilia Receiving Fitusiran, an Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia","keywords":"","combinedName":"doctor claude negrier"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Shiho ","lastName":"Nishimura ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacokinetics Using myPKFiTR for Personalized Prophylaxis in Children with Severe Hemophilia a.","keywords":"","combinedName":"doctor shiho nishimura"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Susan ","lastName":"Maroney ","credentials":"DVM, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasma Proteolytic Cascade Activation and Control during Neonatal Cardiopulmonary Bypass Surgery","keywords":"","combinedName":"doctor susan maroney"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Amy ","lastName":"Dunn ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet-Dependent Thrombin Generation Is Correlated with Phenotypic Severity in Severe Hemophilia a","keywords":"","combinedName":"doctor amy dunn"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Amit ","lastName":"Chhabra ","credentials":"MBBS, MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real-World Expenditures Associated with Treatment of Hemophilia a and B Patients with Standard and Extended Half-Life Factor Replacement Products in the US","keywords":"","combinedName":"doctor amit chhabra"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Gili ","lastName":"Kenet ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Children < 12 Years of Age with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial","keywords":"","combinedName":"doctor gili kenet"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Ivan ","lastName":"Tarandovskiy ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Supra-Physiological Concentrations of C1 Esterase Inhibitor Enhance Thrombin Generation in the Presence of Thrombomodulin","keywords":"","combinedName":"doctor ivan tarandovskiy"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Jasmine C","lastName":"Ito ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Anti-Factor VIII A1 and A3 Domain Antibodies in the ImmuneReponse to Factor VIII inPatients with Hemophilia a","keywords":"","combinedName":"doctor jasmine c ito"},{"sessionId":"11795","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster II","firstName":"Jordan ","lastName":"Spradbrow ","credentials":"BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Bleeding Assessment Tools in the Diagnosis of Von Willebrand Disease: Are We Asking the Right Questions?","keywords":"","combinedName":"doctor jordan spradbrow"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Amy ","lastName":"Dunn ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Feasibility and Usability Study of a Nursing Orchestrated, Customized 3 Dimensional Virtual Reality Environment in Children with Hemophilia Undergoing Routine Intravenous Procedures","keywords":"","combinedName":"doctor amy dunn"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Courtney","lastName":"Thornburg","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cardiometabolic Risk Assessment in Children and Young Adultswith Hemophilia","keywords":"","combinedName":"doctor courtney thornburg"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Connie H","lastName":"Miller ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Centralized Laboratory Testing for Inhibitors in the U.S. Hemophilia Treatment Centers Network: Testing Protocol and Results on 10,178 Specimens","keywords":"","combinedName":"doctor connie h miller"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Amy ","lastName":"Shapiro ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Outcomes of 14-Day Prophylaxis with rFIXFc: Longitudinal Analysis of the B-LONG and B-YOND Study","keywords":"","combinedName":"doctor amy shapiro"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Cassandra ","lastName":"Wang ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Use of Recombinant Factor VIII Fc and Recombinant Factor IX Fc in Patients with Hemophilia A and B","keywords":"","combinedName":"doctor cassandra wang"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Hermann ","lastName":"Eichler ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Concizumab (Anti-TFPI) Exposure-Response Modeling in Patients with Hemophilia a","keywords":"","combinedName":"doctor hermann eichler"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Nicola ","lastName":"Goldberg ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Does Age Affect Desmopressin Responsiveness in Patients with Von Willebrand Disease?","keywords":"","combinedName":"doctor nicola goldberg"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Andreas ","lastName":"Baumann ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Excretion and Distribution of the 60-kDa PEG Moiety Used in BAY 94-9027 in Male Wistar Rats","keywords":"","combinedName":"doctor andreas baumann"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Shawn ","lastName":"Tahata ","credentials":"BS, BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Feasibility of a Smartphone Application (App) Pictorial Blood Assessment Chart (PBAC) As an Endpoint in a Von Willebrand Disease Trial","keywords":"","combinedName":"doctor shawn tahata"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Paul ","lastName":"Moorehead ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Tolerance Induction in Hemophilia a Patients Using Wilate -a Canadian 10 Year Study (PREVAIL)","keywords":"","combinedName":"doctor paul moorehead"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Yesim ","lastName":"Dargaud ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Individually Tailored By-Passing Therapy for the Management of Breakthrough Bleeds in Hemophilia Patients with Inhibitors Receiving Prophylaxis with Emicizumab","keywords":"","combinedName":"doctor yesim dargaud"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Akihiro ","lastName":"Tamura ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Diagnosis of Hemophilia B Leyden in Japanese Brothers Reveals Spontaneous Amelioration in Early Childhood withc. -35 G&gt;A Onecut Binding Site Mutation","keywords":"","combinedName":"doctor akihiro tamura"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Bhavya S","lastName":"Doshi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Correlation between B Cell Survival Cytokines and Inhibitors in Hemophilia a","keywords":"","combinedName":"doctor bhavya s doshi"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Patrick ","lastName":"Ebbert ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Observational Study of Recombinant Factor-VIII-Fc, Eloctate, in Hemophilia Patients with and without Inhibitors","keywords":"","combinedName":"doctor patrick ebbert"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Peter ","lastName":"Turecek ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Polyethylene Glycol (PEG) Exposure in Parenteral Therapies Indicated for the Pediatric Population: History and Safety","keywords":"","combinedName":"doctor peter turecek"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Gennadii ","lastName":"Galstian ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Providing Hemostasis for Long-Term Central Venous Access Device (LTCVAD) Placement in Patients with Factor VIII (FVIII) Inhibitors","keywords":"","combinedName":"doctor gennadii galstian"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Peter ","lastName":"Cygan ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Random X-Chromosome Inactivation in Hemophilia A Carriers Does Not Fully Attenuate Bleeding Risk","keywords":"","combinedName":"doctor peter cygan"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Ulrike ","lastName":"Nowak Goettl ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reclassification of Pre-Diagnosed Von-Willebrand Disease in the Eldery: A Hospital-Based Cohort Study","keywords":"","combinedName":"doctor ulrike nowak goettl"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Ingrid","lastName":"Pabinger","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Adolescents/Adults with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial","keywords":"","combinedName":"doctor ingrid pabinger"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Joan Cox","lastName":"Gill ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recombinant Von Willebrand Factor Administration: Dosing Considerations and Rapid Stabilization of Endogenous Plasma FVIII Levels in Patients with Severe Von Willebrand Disease","keywords":"","combinedName":"doctor joan cox gill"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Runhui ","lastName":"Wu ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from a Prospective, Dose Escalating, Prophylaxis Study in Young Boys with Severe Hemophilia a in China: The China Hemophilia Individualized Prophylaxis Study (CHIPS) (NCT02999308)","keywords":"","combinedName":"doctor runhui wu"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Kiersten ","lastName":"Ricci ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Retrospective Study of Hematologic Complicationsin Vascular Malformation Patients with Localized Intravascular Coagulopathy Undergoing Surgical Intervention","keywords":"","combinedName":"doctor kiersten ricci"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Shoshan ","lastName":"Perek ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk for Major Bleeding in Patients with Severe Factor XI Deficiency Treated with Aspirin and Clopidogrel","keywords":"","combinedName":"doctor shoshan perek"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Maria Eva ","lastName":"Mingot-Castellano ","credentials":"PhD, MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Successful Treatment of Bleeding in Acquired Hemophilia a with Activated Prothrombin Complex Concentrate in Spain","keywords":"","combinedName":"doctor maria eva mingot-castellano"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Ruchika ","lastName":"Sharma ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombin Generation in Patients with Severe Hemophilia a May be Variable but Predictive of Response to Treatment","keywords":"","combinedName":"doctor ruchika sharma"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Wendy ","lastName":"Owens ","credentials":"MA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Understanding Treatment and Care Utilization &amp; Perceptions of Females with Hemophilia A or B in the Choice Project","keywords":"","combinedName":"doctor wendy owens"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Sandra ","lastName":"Mignot ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unique Inflammatory Signature in Hemophilic Arthropathy: Epigenetic Changes Due to Interaction between Blood and Fibroblast-like Synoviocytes","keywords":"","combinedName":"doctor sandra mignot"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"R. ","lastName":"Crea ","credentials":"DVM, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"United States Post-Marketing Safety (PMS) Study of Rpfviii in Patients with Acquired Hemophilia a: Preliminary Data","keywords":"","combinedName":"doctor r crea"},{"sessionId":"11796","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Poster III","firstName":"Michael ","lastName":"Callaghan","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Bypassing Agents Prior to and Post Bypassing Agent Dosing Guidance during Emicizumab Prophylaxis: Analyses from the HAVEN 1 Study","keywords":"","combinedName":"doctor michael callaghan"},{"sessionId":"11797","sessionTitle":"331. Pathophysiology of Thrombosis: Poster II","firstName":"Dewen ","lastName":"You ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Immunoblot Assay to Detect Contact Activation in Patients with Cancer","keywords":"","combinedName":"doctor dewen you"},{"sessionId":"11797","sessionTitle":"331. Pathophysiology of Thrombosis: Poster II","firstName":"Marc ","lastName":"Blondon ","credentials":"MD, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Associations of Cholecalciferol Supplementation with Thrombin Generation and Fibrin Clot Structure in Severe Vitamin D Deficiency: A Prospective Cohort Study","keywords":"","combinedName":"doctor marc blondon"},{"sessionId":"11797","sessionTitle":"331. Pathophysiology of Thrombosis: Poster II","firstName":"Rustem ","lastName":"Litvinov ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impaired Contraction (Retraction) of Blood Clots Is a Possible Pathogenic Mechanism in Venous Thromboembolism","keywords":"","combinedName":"doctor rustem litvinov"},{"sessionId":"11797","sessionTitle":"331. Pathophysiology of Thrombosis: Poster II","firstName":"Muxin ","lastName":"Yu ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phosphatidylserine on Blood Cells and Microparticles Contributes to the Hyper-Coagulable State in Diabetic Kidney Disease","keywords":"","combinedName":"doctor muxin yu"},{"sessionId":"11797","sessionTitle":"331. Pathophysiology of Thrombosis: Poster II","firstName":"Paola ","lastName":"Ranalli ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Poor Responsiveness to Low-Dose Aspirin Contributes to Persistent In Vivo Platelet Activation in Polycythemia Vera","keywords":"","combinedName":"doctor paola ranalli"},{"sessionId":"11797","sessionTitle":"331. Pathophysiology of Thrombosis: Poster II","firstName":"Raja ","lastName":"Prince ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pregnancy Outcome in Mice with Protein S Complete Deficiency","keywords":"","combinedName":"doctor raja prince"},{"sessionId":"11797","sessionTitle":"331. Pathophysiology of Thrombosis: Poster II","firstName":"Grigorios ","lastName":"Gerotziafas ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer Associated Thrombosis. the Observational Roadmap-CAT Study","keywords":"","combinedName":"doctor grigorios gerotziafas"},{"sessionId":"11797","sessionTitle":"331. Pathophysiology of Thrombosis: Poster II","firstName":"Bas ","lastName":"De Laat ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Small Angle X-Ray Scattering Reveals the Conformation of 2glycoprotein I and the Conformational Binding Epitopes of Autoantibodies ","keywords":"","combinedName":"doctor bas de laat"},{"sessionId":"11797","sessionTitle":"331. Pathophysiology of Thrombosis: Poster II","firstName":"Ravi Shankar","lastName":"Keshari ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Synthetic Pentasaccharide Fondaparinux (Arixtra) Reduces Sepsis Induced Coagulopathy and Promotes Survival in the Baboon Model of E. coli Sepsis","keywords":"","combinedName":"doctor ravi shankar keshari"},{"sessionId":"11797","sessionTitle":"331. Pathophysiology of Thrombosis: Poster II","firstName":"Victor ","lastName":"Gordeuk ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombosis and Von Willebrand Factor in Chuvash Polycythemia","keywords":"","combinedName":"doctor victor gordeuk"},{"sessionId":"11797","sessionTitle":"331. Pathophysiology of Thrombosis: Poster II","firstName":"Carrie E","lastName":"Diamond ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unprovoked Versus Provoked Venous Thromboembolism in Pediatric Patients: Comparison of Characteristics and Outcomes","keywords":"","combinedName":"doctor carrie e diamond"},{"sessionId":"11797","sessionTitle":"331. Pathophysiology of Thrombosis: Poster II","firstName":"Ambarina ","lastName":"Faiz ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Venous Thrombosis and Breast Cancer in Older Women: Racial Disparity in Risk Factors and Outcomes","keywords":"","combinedName":"doctor ambarina faiz"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Margaret ","lastName":"Kasner ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ABO Blood Type and the Risk of Cardovascular Events: An Analysis of Framingham Data and Meta-Analysis","keywords":"","combinedName":"doctor margaret kasner"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Patrick ","lastName":"Van Dreden ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Alteration of Endothelial Cell Hemostatic Equilibrium By Cancer Cell-Derived Microparticles, a New Insight in Pathogenesis of Cancer Associated Thrombosis","keywords":"","combinedName":"doctor patrick van dreden"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Raja ","lastName":"Prince ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Alternatively Spliced Tissue Factor Levels in the Plasma of Patients with Liver Fibrosis, Liver Cirrhosis, and Hepatocellular Carcinoma: A Single-Center Retrospective Study","keywords":"","combinedName":"doctor raja prince"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Livia ","lastName":"Hegerova ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation","keywords":"","combinedName":"doctor livia hegerova"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Julie ","lastName":"Jaffray ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Central Venous Catheters, a Major Culprit for Pediatric Venous Thrombosis: A Report from the Children's Hospital Acquired Thrombosis (CHAT) Project","keywords":"","combinedName":"doctor julie jaffray"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Swaroopa ","lastName":"Yerrabothala ","credentials":"MD ","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Coagulation Activation in Brain Neoplasms","keywords":"","combinedName":"doctor swaroopa yerrabothala"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Dewen ","lastName":"You ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of FXII Activation in Human Plasma By Extracellular Vesicles from Cancer Cells Versus Non-Transformed Cells","keywords":"","combinedName":"doctor dewen you"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Ana ","lastName":"Acuna-Villaorduna ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Higher Rates of Anticoagulation Among Patients with Portal Vein Thrombosis Are Not Associated with Better Outcomes","keywords":"","combinedName":"doctor ana acuna-villaorduna"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Junshik ","lastName":"Hong ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence of Venous Thromboembolism in Korea from 2009 to 2013","keywords":"","combinedName":"doctor junshik hong"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Christina ","lastName":"Berens ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pattern of Coagulation Activation in Patients with Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor christina berens"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Anna ","lastName":"Falanga ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prospective Evaluation of Thrombo-Hemorrhagic Events and Hypercoagulation Markers in Patients with Acute Promyelocytic Leukemia (APL) Receiving All-Trans Retinoic Acid (ATRA) Plus Chemotherapy","keywords":"","combinedName":"doctor anna falanga"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Sheng-Chieh ","lastName":"Chou ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Retrospective Analysis of Cancer-Associated Venous Thromboembolism in Patients with High Risk Cancer Types in Taiwan","keywords":"","combinedName":"doctor sheng-chieh chou"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Alice ","lastName":"Taylor ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Vwf-ADAMTS13 Axis in Acute Ischaemic Brain Injury:a Prospective Study","keywords":"","combinedName":"doctor alice taylor"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Ghaith ","lastName":"Abu-Zeinah ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombotic Risk Factors, Antithrombotic Therapy, and Outcomes of Asymptomatic Carriers of Antiphospholipid Antibodies and Patients with Antiphospholipid Syndrome","keywords":"","combinedName":"doctor ghaith abu-zeinah"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Carlos ","lastName":"Martinez Murillo ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tissue Factor Expression As a Prognostic Marker in Patients with B-Cell Malignant Lymphoma","keywords":"","combinedName":"doctor carlos martinez murillo"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Rachael ","lastName":"Schultz ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of the Peds Clot Clinical Decision Rule [Pcdr] in Hospital-Acquired Venous Thromboembolism","keywords":"","combinedName":"doctor rachael schultz"},{"sessionId":"11798","sessionTitle":"331. Pathophysiology of Thrombosis: Poster III","firstName":"Shiva ","lastName":"Shrotriya ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"What Predicts Venous Thromboembolism Among Cancer Inpatients: A Proposed Predictive Model","keywords":"","combinedName":"doctor shiva shrotriya"},{"sessionId":"11799","sessionTitle":"332. Antithrombotic Therapy: Poster II","firstName":"Alexander ","lastName":"Turpie","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Pooled Analysis of the Xalia and Xalia-Lea Non-Interventional Studies of Rivaroxaban Versus Standard Anticoagulation in Venous Thromboembolism","keywords":"","combinedName":"doctor alexander turpie"},{"sessionId":"11799","sessionTitle":"332. Antithrombotic Therapy: Poster II","firstName":"Huong L","lastName":"Truong ","credentials":"PharmD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adverse Events in Patients with Cancer Treated with Direct Oral Anticoagulants and Cancer Therapy","keywords":"","combinedName":"doctor huong l truong"},{"sessionId":"11799","sessionTitle":"332. Antithrombotic Therapy: Poster II","firstName":"Oliver ","lastName":"Grottke ","credentials":"MD, PhD, MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Blood Loss in Rivaroxaban Anticoagulated Pigs with Severe Polytrauma Is Significantly Reduced By Early Therapy with Prothrombin Complex Concentrate","keywords":"","combinedName":"doctor oliver grottke"},{"sessionId":"11799","sessionTitle":"332. Antithrombotic Therapy: Poster II","firstName":"Mohana ","lastName":"Roy ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Relevance of Intracranial Hemorrhage Volume in Primary and Metastatic Brain Tumors","keywords":"","combinedName":"doctor mohana roy"},{"sessionId":"11799","sessionTitle":"332. Antithrombotic Therapy: Poster II","firstName":"Craig ","lastName":"Coleman ","credentials":"PharmD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effectiveness and Safety of Rivaroxaban Vs. Warfarin in Patients with Nonvalvular Atrial Fibrillation and Moderate-to-Severe Chronic Kidney Disease","keywords":"","combinedName":"doctor craig coleman"},{"sessionId":"11799","sessionTitle":"332. Antithrombotic Therapy: Poster II","firstName":"Nicholas ","lastName":"Moore ","credentials":"MD, PhD, FRCP","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effectiveness and Safety of the 15 Mg Dose of Rivaroxaban Compared with Vitamin k Antagonists in Patients with Atrial Fibrillation: Results from a Cohort Study in the Nationwide French Claims and Hospitalization Database (SNIIRAM)","keywords":"","combinedName":"doctor nicholas moore"},{"sessionId":"11799","sessionTitle":"332. Antithrombotic Therapy: Poster II","firstName":"Kirill ","lastName":"Lobastov ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Hemostasis with the Thrombodynamics Test Improves Predictability of the Caprini Score for Postoperative DVT","keywords":"","combinedName":"doctor kirill lobastov"},{"sessionId":"11799","sessionTitle":"332. Antithrombotic Therapy: Poster II","firstName":"Lisa ","lastName":"Jennings ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of D-Dimer Assays Performed at Local Labs Vs. Central Laboratory in the Evaluation of Apex Trial Outcomes","keywords":"","combinedName":"doctor lisa jennings"},{"sessionId":"11799","sessionTitle":"332. Antithrombotic Therapy: Poster II","firstName":"Manasa ","lastName":"Nayak ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pyruvate Dehydrogenase Kinase Modulates Platelet Function and Thrombosis","keywords":"","combinedName":"doctor manasa nayak"},{"sessionId":"11799","sessionTitle":"332. Antithrombotic Therapy: Poster II","firstName":"Zachary ","lastName":"Wolfe ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants: A Traditional and Network Meta-Analysis","keywords":"","combinedName":"doctor zachary wolfe"},{"sessionId":"11799","sessionTitle":"332. Antithrombotic Therapy: Poster II","firstName":"Luai S","lastName":"Al Rabadi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thromboprophylaxis with Fixed Dose, 1mg/Kg/Day, Low Molecular Weight Heparin in Adults Undergoing Induction with Asparaginase for Acute Lymphoblastic Leukemia. Results of a Single Institution Cohort Study","keywords":"","combinedName":"doctor luai s al rabadi"},{"sessionId":"11799","sessionTitle":"332. Antithrombotic Therapy: Poster II","firstName":"Susan ","lastName":"Walborn ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Upregulation of Cortisol in Sepsis and Its Association with Markers of Hemostatic Dysregulation","keywords":"","combinedName":"doctor susan walborn"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Sydney ","lastName":"Strickland ","credentials":"PhD, BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Laboratory Assay for Monitoring Unfractionated Heparin in Patients Taking Direct Oral Anticoagulants Prior to Hospital Admission","keywords":"","combinedName":"doctor sydney strickland"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Grigorios ","lastName":"Gerotziafas ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Ex Vivo Analysis of Thrombin Generation and Thromboelastometry in Patients Undergoing Treatment with Rivaroxaban Demonstrates Sustained Anticoagulant Effect and High Inter-Individual Variability","keywords":"","combinedName":"doctor grigorios gerotziafas"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Lana A","lastName":"Castellucci ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparing Medication Adherence Tools for the Direct Oral Anticoagulants Rivaroxaban and Apixaban","keywords":"","combinedName":"doctor lana a castellucci"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"John ","lastName":"House ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Descriptive Analysis of Idarucizumab (Praxbind) Use in a National Hospital Database","keywords":"","combinedName":"doctor john house"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Christine ","lastName":"Kohn ","credentials":"BS, PharmD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effectiveness and Safety of Rivaroxaban in Patients with Cancer-Associated Venous Thromboembolism","keywords":"","combinedName":"doctor christine kohn"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Ho-Young ","lastName":"Yhim ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Rivaroxaban for the Treatment of Acute Venous Thromboembolism in Patients with Active Cancer in a Prospective Multicenter Trial: KVTE13-01","keywords":"","combinedName":"doctor ho-young yhim"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Lai Heng","lastName":"Lee ","credentials":"MBBS,FRCP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimal International Normalized Ratio Range for Asian Patients on Anticoagulation Therapy","keywords":"","combinedName":"doctor lai heng lee"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Siavash ","lastName":"Piran ","credentials":"MD, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimal Timing of Starting Thromboprophylaxis for Patients with Acute Spinal Cord Injury: A Cross-Sectional Survey of Canadian Spine Surgeons","keywords":"","combinedName":"doctor siavash piran"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Madhu ","lastName":"Chintala ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preferential Inhibition of Fibrin Mediated Thrombosis in Rodent Models By JNJ-9375, a Novel exosite1 Thrombin Inhibitor","keywords":"","combinedName":"doctor madhu chintala"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Puja ","lastName":"Arora ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Direct Oral Anticoagulants in Comparison to Low Molecular Weight Heparin in Hematological Malignancies","keywords":"","combinedName":"doctor puja arora"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Kimberley ","lastName":"Doucette ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Direct-Acting Oral Anticoagulation (DOACs) Based on BMI","keywords":"","combinedName":"doctor kimberley doucette"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Scott ","lastName":"Berkowitz ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Effects of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in the Prevention of Venous Thromboembolism after Elective Hip or Knee Replacement Surgery","keywords":"","combinedName":"doctor scott berkowitz"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Jeffrey ","lastName":"Bien ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Safety of Aspirin Vs. Direct Oral Anticoagulants: A Meta-Analysis of Currently Published Clinical Trials","keywords":"","combinedName":"doctor jeffrey bien"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Avi ","lastName":"Leader ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thrombosis and Anticoagulation in Malignant Superior Vena Cava Syndrome","keywords":"","combinedName":"doctor avi leader"},{"sessionId":"11800","sessionTitle":"332. Antithrombotic Therapy: Poster III","firstName":"Puja ","lastName":"Arora ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Direct Oral Anticoagulants in Inherited Thrombophilia","keywords":"","combinedName":"doctor puja arora"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Sergey ","lastName":"Shevkoplyas ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Portable System for Processing Donated Whole Blood into High Quality Components without Centrifugation","keywords":"","combinedName":"doctor sergey shevkoplyas"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Ghaith ","lastName":"Abu-Zeinah ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Single Institutional Experience Comparing Cryoprecipitate to Plasma in Patients with Disseminated Intravascular Coagulopathy (DIC) from Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor ghaith abu-zeinah"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Pinhas ","lastName":"Stark ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Alloimmunization and Autoimmunization in Adult Transfusion Dependent Beta Thalassemia Major Patients: Report from a Comprehensive Center in Israel","keywords":"","combinedName":"doctor pinhas stark"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Amanda ","lastName":"Mener ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Antibody-Mediated Immunosuppression Can Result from RBC Antigen Loss Independent of Fc? Receptors in Mice","keywords":"","combinedName":"doctor amanda mener"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Elizabeth ","lastName":"St Lezin ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of RBC Transfusion on Six Minute Walk Test Performance and Quality of Life in Outpatients","keywords":"","combinedName":"doctor elizabeth st lezin"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Shuntaro ","lastName":"Ikegawa ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Granulocyte Transfusions for Neutropenic Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor shuntaro ikegawa"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Anand ","lastName":"Padmanabhan ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immunoglobulin G in Normal Plasma Inhibits HIT Antibody-Mediated Platelet Activation: Implications for Therapeutic Plasma Exchange Treatment in HIT","keywords":"","combinedName":"doctor anand padmanabhan"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Jacob ","lastName":"Pendergrast ","credentials":"MD,FRCPC","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence and Risk Factors for IVIG-Mediated Hemolysis","keywords":"","combinedName":"doctor jacob pendergrast"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Patricia E","lastName":"Zerra ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Marginal Zone B Cells Facilitate RBC Alloimmunization Independent of Direct CD4+ T Cell Activation","keywords":"","combinedName":"doctor patricia e zerra"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Patrick ","lastName":"Ketter ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelets Feeding Bacteria with Lactate during Room Temperature Storage: Mitigated By Refrigeration","keywords":"","combinedName":"doctor patrick ketter"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Michaela ","lastName":"Stemberger ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Population Pharmacokinetics Profiling to Tailor Prophylaxis in Hemophilia a Patients: A Pilot Feasibility Study","keywords":"","combinedName":"doctor michaela stemberger"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Adonis ","lastName":"Stassinopoulos ","credentials":"PhD, BSc, MPhil, MA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Potential Mitigation of the Covert Risk of Bacterial Contamination of RBC: Inactivation of Propionibacterium Acnes in RBC Using Amustaline and Glutathione","keywords":"","combinedName":"doctor adonis stassinopoulos"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Deepak ","lastName":"Singhal ","credentials":"MBBS, MD, FRCPA, FRACP","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Red Cell Alloimmunisation Is Associated with Development of Autoantibodies and Increased Red Cell Transfusion Requirements in Myelodysplastic Syndromes (MDS)","keywords":"","combinedName":"doctor deepak singhal"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Suzy ","lastName":"Morton ","credentials":"FRCPath, MRCP, MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Skating on Thin Ice: National Audit of TACO Demonstrates Poor Recognition of Risk Factors","keywords":"","combinedName":"doctor suzy morton"},{"sessionId":"11801","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster II","firstName":"Jerry ","lastName":"Gottschall ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Epidemiology of Platelet Transfusions: An Analysis of Platelet Use at 12 U.S. Hospitals","keywords":"","combinedName":"doctor jerry gottschall"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"James ","lastName":"Huang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Multicenter, Retrospective Data Collection Study on the Compassionate Use of a Plasma-Derived Factor X Concentrate to Treat Patients with Hereditary Factor X Deficiency","keywords":"","combinedName":"doctor james huang"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Smith ","lastName":"Giri ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Systematic Review and Meta-Analysis of the Effect of Iron Chelation Therapy on Survival in Patients with Lower Risk Myelodysplastic Syndrome","keywords":"","combinedName":"doctor smith giri"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Samir ","lastName":"Ballas ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Systematic Review of the Effect of Iron Chelation Therapy on Survival in Patients with Sickle Cell Disease and -Thalassemia","keywords":"","combinedName":"doctor samir ballas"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Yonggang ","lastName":"Wang ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of a Complement-Mediated Hemolysis Assay for Immune Globulin Intravenous Products and Characterization of Lots Associated with Clinical Hemolysis","keywords":"","combinedName":"doctor yonggang wang"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Jonathan ","lastName":"Pan ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factors Affecting Platelet Transfusion Response Following Haploidentical Stem Cell Transplant","keywords":"","combinedName":"doctor jonathan pan"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Spiros ","lastName":"Matsagos ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Frequency of Both, Short and Long-Term Post-Transfusion Microchimerism Among the Regularly-Transfused Thalassemic Patient Population","keywords":"","combinedName":"doctor spiros matsagos"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Jose Orlando","lastName":"Bordin ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HLA and HNA Antibodies Are More Prevalent in Multiparous Women with RED Blood CELL Alloimmunization","keywords":"","combinedName":"doctor jose orlando bordin"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Henry ","lastName":"Ddungu ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How Low Can You Go: What Is the Safe Threshold for Platelet Transfusions in Patients with Hematologic Malignancy in Sub-Saharan Africa","keywords":"","combinedName":"doctor henry ddungu"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Margrt Gudrun","lastName":"Gunnarsdttir ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Iron Status of Icelandic Blood Donors and the Impact of Different Ferritin Assay Platforms on Donor Deferral Rates","keywords":"","combinedName":"doctor margrt gudrun gunnarsdttir"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Amanda ","lastName":"Hogg ","credentials":"MD, FRCPC","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Live Immunization Practices for Chronically Transfused Pediatric Patients","keywords":"","combinedName":"doctor amanda hogg"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Nicholas ","lastName":"Saadah ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"No Association between Age of Transfused Red Cells and 30-Day Mortality in Massively Transfused Patients: Results from the Australian and New Zealand Massive Transfusion Registry","keywords":"","combinedName":"doctor nicholas saadah"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Christine ","lastName":"Cahill ","credentials":"MS, BSN, RN","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient Blood Management: An Initiative Aimed at Improving Outcomes While Decreasing Red Cell Transfusions with Specialty Guidelines for Hematology Patients","keywords":"","combinedName":"doctor christine cahill"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Anno ","lastName":"Saris ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelets from Donors with Consistent Low HLA-B8, B12 or B35 Expression Do Not Undergo Antibody-Mediated Internalization","keywords":"","combinedName":"doctor anno saris"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Vivek A","lastName":"Upadhyay ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Projected Cost Savings of a Plasmic Score-Based Approach to Patients with Suspected Thrombotic Thrombocytopenic Purpura","keywords":"","combinedName":"doctor vivek a upadhyay"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Anno ","lastName":"Saris ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of Platelets in the Induction of Alloimmunization after Platelet Transfusion","keywords":"","combinedName":"doctor anno saris"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Debbie ","lastName":"Jiang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Use of Thromboelastography in Monitoring Coagulation Status for Patients Treated with Low Molecular Weight Heparin, Warfarin, Apixaban, and Rivaroxaban","keywords":"","combinedName":"doctor debbie jiang"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Yazan ","lastName":"Migdady ","credentials":"MD,MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transfusion Dependence Is Common inAdults withHemophagocytic Lymphohistiocytosis (HLH) and Is Associated with EBV Viremia","keywords":"","combinedName":"doctor yazan migdady"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Andre ","lastName":"Lebrun ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transfusion of Sickle Cell Anemia Patients in Quebec: Challenges and Opportunities","keywords":"","combinedName":"doctor andre lebrun"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Alexis J","lastName":"Perros ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Underlying Inflammation Impacts Immune Modulation Following Exposure to Platelet Concentrates and Packed Red Blood Cells","keywords":"","combinedName":"doctor alexis j perros"},{"sessionId":"11802","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Poster III","firstName":"Fei ","lastName":"Xu ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Vitamin K5 Is an Efficient Photosensitizer for Ultraviolet a Light Inactivation of Bacteria","keywords":"","combinedName":"doctor fei xu"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Paresh ","lastName":"Vyas ","credentials":"DPhil, FRCP, FRCPath, MRCP, MRCPath","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Model of Human Hemopoiesis Based on Single Cell Functional and Transcriptional Analysis of Lympho-Myeloid Progenitors","keywords":"","combinedName":"doctor paresh vyas"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Erica ","lastName":"Bresciani ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of RUNX1-Independent Hematopoiesis in Three Zebrafish runx1-KO Models","keywords":"","combinedName":"doctor erica bresciani"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Yang ","lastName":"Mei ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diaphanous-Related Formin Protein mDia2 Regulates Hematopoietic Stem and Progenitor Cell Functions through Srf-Integrins Pathway","keywords":"","combinedName":"doctor yang mei"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Jerry ","lastName":"Lee ","credentials":"MPhil, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Engineering of Induced Pluripotent Stem Cell-Derived Hemogenic Endothelium","keywords":"","combinedName":"doctor jerry lee"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Jennifer L","lastName":"Rabe ","credentials":"BS, BA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of a Hematopoietic Stem Cell Fraction That Retains Normal Function Following Chronic Inflammation","keywords":"","combinedName":"doctor jennifer l rabe"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Ryohichi ","lastName":"Sugimura ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interferon-Gamma Pathway Regulates Emergence of Engraftable Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells","keywords":"","combinedName":"doctor ryohichi sugimura"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Hal ","lastName":"Broxmeyer ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mitigating Detrimental Influences of Ambient Air Collection of Bone Marrow By Hypoxic Collection Results in Detection of Functionally Enhanced Aged Mouse Hematopoiesis: Reflecting Stem Cell Expression Levels of CXCR4, CCR5 and ROS","keywords":"","combinedName":"doctor hal broxmeyer"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Peng ","lastName":"Hua ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Insights at the Single Cell Level into the Reprogramming of Human Hematopoietic Stem Cells during Epigenetically Modified Ex Vivo Expansion","keywords":"","combinedName":"doctor peng hua"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Cuiqing ","lastName":"Fan ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"mTOR Restricts Chromatin Access and Genomic Activity to Maintain Hematopoietic Stem Cell Quiescence and Engraftment","keywords":"","combinedName":"doctor cuiqing fan"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Trent ","lastName":"Hall ","credentials":"BS, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NfixPromotes Survival of Immature Hematopoietic Cells Via Regulation of C-Mpl","keywords":"","combinedName":"doctor trent hall"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Ryan ","lastName":"Ptashkin ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Population-Scale Identification of Clonal Hematopoiesis Derived Mutations in Solid Tumor Mutation Profiling","keywords":"","combinedName":"doctor ryan ptashkin"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Yuanliang ","lastName":"Zhang ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Setd2 Is Critical for Maintaining Hematopoietic Homeostasis","keywords":"","combinedName":"doctor yuanliang zhang"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Rebecca ","lastName":"Murdaugh ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of Histone Variant H3.3 Regulation By Hira in Hematopoiesis","keywords":"","combinedName":"doctor rebecca murdaugh"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Teresa ","lastName":"Bowman","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Spliceosomal Component Sf3b1 is Essential for Hematopoietic Stem Cell Formation through the Regulation of the Jak/Stat Signaling Pathway","keywords":"","combinedName":"doctor teresa bowman"},{"sessionId":"11803","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster II","firstName":"Eliza ","lastName":"Wiercinska ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Wave-Complex-Dependent Actin Dynamics Controls Hematopoietic Stem Cell Bone Marrow Retention and Orderly Differentiation into Mature Hematopoietic Lineages","keywords":"","combinedName":"doctor eliza wiercinska"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Taylor ","lastName":"Mills ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Altered HSC Programming Drives Aberrant Blood Output Underlying RA Pathogenesis","keywords":"","combinedName":"doctor taylor mills"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Stephen ","lastName":"Chung ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD99 Regulates Normal and Malignant Stem Cell Function By Restricting Protein Translation","keywords":"","combinedName":"doctor stephen chung"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Juliana Xavier","lastName":"Xavier-Ferrucio ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Developing Live Imaging Strategies to Analyze the Influence of Cell Cycle Rate on MEP Fate Decisions at the Single Cell Level","keywords":"","combinedName":"doctor juliana xavier xavier-ferrucio"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Janina ","lastName":"Ratajczak ","credentials":"MD, PhD, DSci","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficient Ex Vivo Expansion of Human Umbilical Cord Blood-Derived SmallCD133+lin-CD45- Stem Cells Expressing Pluripotency Markers in Presence of Histone Deacethylase Inhibitors - As a New Challenging Strategy to Obtain Multipotent Cells for Regenerative Medicine","keywords":"","combinedName":"doctor janina ratajczak"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Tsin Sik ","lastName":"Wong ","credentials":"BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Engraftment and SDF-1/CXCR4 Signaling in Human CD34+ Hematopoietic Stem/Progenitor Cells Are Regulated By R4 Rgs Subfamily Proteins","keywords":"","combinedName":"doctor tsin sik wong"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Takahiro ","lastName":"Sano ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional Impairment of Hematopoietic Stem/Progenitor Cells By Loss of Uhrf2 in Mice","keywords":"","combinedName":"doctor takahiro sano"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Nadim","lastName":"Mahmud","credentials":"MBBS, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Generation of Megakaryocytes and Platelets from Valproic Acid Expanded Human Cord Blood CD34+ Cells in Culture","keywords":"","combinedName":"doctor nadim mahmud"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Zongdong ","lastName":"Li ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HEME Degradation Enzyme Biliverdin Ixb Reductase Is Required for STEM CELL Glutamine Metabolism","keywords":"","combinedName":"doctor zongdong li"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Juan ","lastName":"Haro Mora ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improved ES Cell-Derived Erythroid Cell Generation with Robust b-Globin Production through ES-Sacs","keywords":"","combinedName":"doctor juan haro mora"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Aldona A","lastName":"Karaczyn ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MiR-199b-5p Differentially Modulates Hematopoietic Stem Cell Self Renewal in Steady State and Stress Hematopoiesis","keywords":"","combinedName":"doctor aldona a karaczyn"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Theresa ","lastName":"Owuor ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MLL3 Deletion Enhances HSC Self-Renewal","keywords":"","combinedName":"doctor theresa owuor"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Helena ","lastName":"Lucente ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MTG16 Variants Provide Context to Notch Signaling to Direct Leukemic Phenotype","keywords":"","combinedName":"doctor helena lucente"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Brian ","lastName":"Wadugu ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Normal Hematopoiesis Is Dependent on the Expression of U2af1, a Spliceosome Gene Commonly Mutated in MDS","keywords":"","combinedName":"doctor brian wadugu"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Lakshmi Reddy ","lastName":"Palam ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PI3Kinase Inactivation through Combined Loss of Catalytic Subunits p110a, p110 and p110d Derails Hematopoietic Homeostasis","keywords":"","combinedName":"doctor lakshmi reddy palam"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Itziar ","lastName":"Cosso ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Replenishment of Damaged Bone Marrow Niches By Circulating Hematopoietic Stem Cells","keywords":"","combinedName":"doctor itziar cosso"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Miguel ","lastName":"Ganuza Fernandez ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Robust Autonomous Generation of Definitive Hematopoietic Stem Cells from Pre-Circulation Murine Embryos.","keywords":"","combinedName":"doctor miguel ganuza fernandez"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Jacquelyn ","lastName":"Lillis ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Cell Transcriptome Analysis of Embryonic Erythro-Myeloid Progenitor Cells Reveals Lineage Heterogeneity","keywords":"","combinedName":"doctor jacquelyn lillis"},{"sessionId":"11804","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Poster III","firstName":"Sanggu ","lastName":"Kim ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Skewed HSC Clonal Output of T-Cells in an Aged Rhesus Macaque after CD3e-Immunotoxin Treatment","keywords":"","combinedName":"doctor sanggu kim"},{"sessionId":"11805","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster II","firstName":"Amanda G","lastName":"Davis ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A CRISPR RNA-Binding Protein Screen Reveals Novel Regulators of RUNX1 Alternative Polyadenylation","keywords":"","combinedName":"doctor amanda g davis"},{"sessionId":"11805","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster II","firstName":"Erik ","lastName":"Bao ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Population-Based Genetic Fine Mapping and Single-Cell Epigenomics Provide Insights into the Regulation of Human Hematopoiesis","keywords":"","combinedName":"doctor erik bao"},{"sessionId":"11805","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster II","firstName":"Mia ","lastName":"Yabut ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Controlling Hematopoietic Stem Cell Quiescence By Ablating the TGF-Responsive, Hematopoietic-Specific Enhancer of CDKN1C (p57)","keywords":"","combinedName":"doctor mia yabut"},{"sessionId":"11805","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster II","firstName":"Weiwei ","lastName":"Yang ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gain of Function MLL1 Model Systems Distinguish Hematopoietic from Leukemogenic Pathways","keywords":"","combinedName":"doctor weiwei yang"},{"sessionId":"11805","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster II","firstName":"Hyunjun ","lastName":"Kang ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"GATA2 Is Essential for Endothelial-to-Hematopoietic Transition but Does Not Affect Formation of Hemogenic Endothelium","keywords":"","combinedName":"doctor hyunjun kang"},{"sessionId":"11805","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster II","firstName":"David ","lastName":"McClellan ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"GFI1B Splice Variants Differentially Regulate Transcription and Megakaryocyte/Erythrocyte Fate in Hematopoiesis","keywords":"","combinedName":"doctor david mcclellan"},{"sessionId":"11805","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster II","firstName":"Ruibao ","lastName":"Ren ","credentials":"M.D./Ph.D.","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Irf8 Regulates Cytokine Signaling and Proliferation of Hematopoietic Stem Cells","keywords":"","combinedName":"doctor ruibao ren"},{"sessionId":"11805","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster II","firstName":"Jess ","lastName":"Rhee ","credentials":"BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Regulation of Lipid Metabolism and Cell Cycle Progression By PU.1 in Myeloid Progenitor Cells","keywords":"","combinedName":"doctor jess rhee"},{"sessionId":"11805","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster II","firstName":"Zhengqi ","lastName":"Wang ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unique Roles for Grb2-Associated Binding (Gab) Adaptors in Hematopoietic Stem Cell Homeostasis and Repopulation","keywords":"","combinedName":"doctor zhengqi wang"},{"sessionId":"11807","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster III","firstName":"Sung Eun ","lastName":"Lim ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Hematopoietic RIPK1 Deficiency Triggers IFN?-Mediated Necroptosis and Bone Marrow Failure","keywords":"","combinedName":"doctor sung eun lim"},{"sessionId":"11807","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster III","firstName":"Eirini ","lastName":"Trompouki ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Metabolic Interplay Coordinated By Hlx Balances Hematopoietic Stem Cell Maintenance and Differentiation","keywords":"","combinedName":"doctor eirini trompouki"},{"sessionId":"11807","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster III","firstName":"Grigorios ","lastName":"Georgolopoulos ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Identification of Cis- and Trans- Elements Driving Human Hematopoiesis","keywords":"","combinedName":"doctor grigorios georgolopoulos"},{"sessionId":"11807","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster III","firstName":"Elisabeth F","lastName":"Heuston ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epigenetic and Single Cell Analyses Reveal Dual Fate Decision Points in Pre-Primed Hematopoietic Stem Cells during Erythro-Megakaryopoiesis","keywords":"","combinedName":"doctor elisabeth f heuston"},{"sessionId":"11807","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster III","firstName":"Maegan ","lastName":"Capitano ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Extracellular DEK Regulates Hematopoiesis through CXCR2-Mediated Intracellular Signaling That Does Not Require Its Translocation into the Nucleus or Binding to DNA","keywords":"","combinedName":"doctor maegan capitano"},{"sessionId":"11807","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster III","firstName":"Chaitanya R","lastName":"Badwe ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fli1 Is Essential for the Maintenance of Hematopoietic Stem Cell Homeostasis and Function","keywords":"","combinedName":"doctor chaitanya r badwe"},{"sessionId":"11807","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster III","firstName":"Yangyang ","lastName":"Zhang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gfi1-Mediated Repression of C-Fos, Egr1 and Egr2, and Inhibition of ERK1/2 Signaling Contribute to the Role of Gfi1 in Granulopoiesis","keywords":"","combinedName":"doctor yangyang zhang"},{"sessionId":"11807","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster III","firstName":"Ana ","lastName":"Espirito Santo ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HMGB1 Accelerates Regeneration of Multiple Tissues By Transitioning Stem Cells to GAlert","keywords":"","combinedName":"doctor ana espirito santo"},{"sessionId":"11807","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster III","firstName":"Samridhdi ","lastName":"Paudyal ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Roles of Separase in Hematopoiesis","keywords":"","combinedName":"doctor samridhdi paudyal"},{"sessionId":"11807","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster III","firstName":"Andrea M","lastName":"Patterson ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prostaglandin E2 Prevents Apoptosis and Promotes Homeostasis of Hematopoietic Stem Cells after Lethal Irradiation through Alteration of p53 and TNF Signaling","keywords":"","combinedName":"doctor andrea m patterson"},{"sessionId":"11807","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Poster III","firstName":"Oscar ","lastName":"Pena ","credentials":"BS, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Zebrafish gata2Orthologs Are Necessary but Not Sufficient for Developmental Hematopoiesis","keywords":"","combinedName":"doctor oscar pena"},{"sessionId":"11808","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster II","firstName":"Vinothkumar ","lastName":"Rajan ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Enhanced Zebrafish Xenograft Model to Study the Behavior of Human Hematopoietic Stem Cells and Patient Derived Leukemia In Vivo","keywords":"","combinedName":"doctor vinothkumar rajan"},{"sessionId":"11808","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster II","firstName":"Kira ","lastName":"Young ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Decreased IGF-1 Expression in the Bone Marrow Microenvironment Drives Hematopoietic Aging","keywords":"","combinedName":"doctor kira young"},{"sessionId":"11808","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster II","firstName":"Keane Jared Guillaume","lastName":"Kenswil ","credentials":"BSc, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification and Molecular Characterization of Endothelial Cells Associated with Hematopoietic Niche Formation in Humans Identifies IL-33 As an Anabolic Niche Factor","keywords":"","combinedName":"doctor keane jared guillaume kenswil"},{"sessionId":"11808","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster II","firstName":"Katja ","lastName":"Weinacht ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"iPSC-Derived Thymic Epithelial Progenitor Cells As Cell-Based Therapyto Restore Thymic Function in Hematopoietic Stem Cell Transplant Recipients","keywords":"","combinedName":"doctor katja weinacht"},{"sessionId":"11808","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster II","firstName":"Sherif ","lastName":"Abdelhamed ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Niche Regulation of Residual Hematopoietic Stem Cell Protein Synthesis By Extracellular Vesicle (EV) Trafficking in the Acute Myeloid Leukemia (AML) Microenvironment","keywords":"","combinedName":"doctor sherif abdelhamed"},{"sessionId":"11808","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster II","firstName":"Mansi ","lastName":"Shah ","credentials":"PhD, BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of SCF-Expressing Bone Marrow Populations in Hematopoietic and Leukemic Stem Cell Regulation","keywords":"","combinedName":"doctor mansi shah"},{"sessionId":"11808","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster II","firstName":"Grazia ","lastName":"Abou Ezzi ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TGF- Signaling in Mesenchymal Progenitor Cells during Development Plays an Essential Role in the Emergence of the Bone Marrow Niche","keywords":"","combinedName":"doctor grazia abou ezzi"},{"sessionId":"11808","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster II","firstName":"Rodrigo ","lastName":"Jacamo ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Up-Regulation of iNOS in AML Blasts Creates an Immunosuppressive Microenvironment, Inhibits T-Cell Proliferation and Transforms T-Cells Towards a Tumor-Tolerating Phenotype","keywords":"","combinedName":"doctor rodrigo jacamo"},{"sessionId":"11808","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster II","firstName":"Divij ","lastName":"Verma ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Warfarin Impairs the Bone Marrow Microenvironment and Hematopoiesis Via the Periostin/Integrin 3 Pathway","keywords":"","combinedName":"doctor divij verma"},{"sessionId":"11809","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster III","firstName":"Hongzhe ","lastName":"Li ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Growth Response (EGR)-1 Is a Key Regulator of Human Primary Bone Marrow Stroma Cells with a Dual Role in Proliferation and Hematopoietic Stroma Support Function","keywords":"","combinedName":"doctor hongzhe li"},{"sessionId":"11809","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster III","firstName":"Constance Tom","lastName":"Noguchi ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Erythropoietin Eliminates Increased Bone Marrow Adiposity and Alters Bone Features in Obese Mice","keywords":"","combinedName":"doctor constance tom noguchi"},{"sessionId":"11809","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster III","firstName":"Sumie ","lastName":"Fujii ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Ameliorate Graft-Versus-Host Disease-Related Manifestations","keywords":"","combinedName":"doctor sumie fujii"},{"sessionId":"11809","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster III","firstName":"Racheli ","lastName":"Ofir ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intramuscular Administration of Placenta-Derived Stromal Cells Enhances Survival of Rhesus Macaque Monkeys Exposed to Total Body Irradiation","keywords":"","combinedName":"doctor racheli ofir"},{"sessionId":"11809","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster III","firstName":"Zhiyong ","lastName":"Poon ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Manipulating Osteogenic/Adipogenic Balance in Mesenchymal Stromal Cells (MSCs) for Hematopoietic Applications","keywords":"","combinedName":"doctor zhiyong poon"},{"sessionId":"11809","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster III","firstName":"Young ","lastName":"Hsu ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Metabolic Changes in Aging Bone Marrow","keywords":"","combinedName":"doctor young hsu"},{"sessionId":"11809","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster III","firstName":"Bing Z","lastName":"Carter ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel ARC/IL1/PGE2/-Catenin/ARC Circuit Regulates Leukemia and Leukemia Microenvironment and Drug Resistance in AML","keywords":"","combinedName":"doctor bing z carter"},{"sessionId":"11809","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster III","firstName":"Christopher D","lastName":"Porada ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recreating the Hematopoietic Microenvironment in Vitro Using Microfluidic \"on-a-Chip\" Technology Enables the Study of Interactions of Normal and Malignant HSPC with Specific Bone Marrow Niches","keywords":"","combinedName":"doctor christopher d porada"},{"sessionId":"11809","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster III","firstName":"Shin ","lastName":"Hasegawa ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of GATA2 in the Maintenance of the Bone Marrow Microenvironment","keywords":"","combinedName":"doctor shin hasegawa"},{"sessionId":"11809","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Poster III","firstName":"Saravanan ","lastName":"Ganesan ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Stromal-Cells Downregulate Mir-23a-5p Levels in Myeloid Leukemic Cells to Activate Protective-Autophagy Against Chemotherapeutic Agents","keywords":"","combinedName":"doctor saravanan ganesan"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Ken ","lastName":"Ishiyama ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Moderate Increase in the WT1 mRNA Copy Number in Peripheral Blood of Patients with Long-Standing Acquired Aplastic Anemia without Apparent Signs of Myelodysplastic Syndrome","keywords":"","combinedName":"doctor ken ishiyama"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Claudia ","lastName":"Wehr ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Mutation Causing GATA2 Haploinsufficiency Activates a Cryptic Splice Site in Exon 3","keywords":"","combinedName":"doctor claudia wehr"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Carmel ","lastName":"Rice ","credentials":"FRACP, FRCPA, MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 50 Years or Older with Severe Aplastic Anaemia: Results from the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research","keywords":"","combinedName":"doctor carmel rice"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Steven ","lastName":"Holland","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Hematopoietic Stem-Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen","keywords":"","combinedName":"doctor steven holland"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Yuji ","lastName":"Yonemura ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Baseline Assessment of Patients with Newly-Diagnosed Acquired Bone Marrow Failure Enrolled in a Prospective Observational Study, Search for Unidentified Links between PNH Clone Size and the Related Clinical Manifestations By High Precision Flow Cytometry (SUPREMACY)","keywords":"","combinedName":"doctor yuji yonemura"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Hee-Ryeong ","lastName":"Jang ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Dissection of Infectious Event Following ATG Treatment for Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome Reveals Urgent Need for Anti-Aspergillus Prophylaxis","keywords":"","combinedName":"doctor hee-ryeong jang"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Hideki ","lastName":"Muramatsu ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Sequencing of 347 Children with Acquired and Inherited Bone Marrow Failure Syndromes","keywords":"","combinedName":"doctor hideki muramatsu"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Fabian ","lastName":"Beier ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Detection of Clonal Hematopoiesis Is a Rare Event in Patients with Dyskeratosis Congenita","keywords":"","combinedName":"doctor fabian beier"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Ayodele ","lastName":"Alaiya ","credentials":"MBBS,MPH,PhD,FRCPath","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of Unique Molecular Signatures for Bone Marrow Failure Syndromes","keywords":"","combinedName":"doctor ayodele alaiya"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Benedetta ","lastName":"Costantini ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional Characteristics of FAS-L Resistant and IL-2 Deprived Regulatory T Cells (Treg A) in Idiopathic Aplastic Anaemia","keywords":"","combinedName":"doctor benedetta costantini"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Katherine R","lastName":"Calvo ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Germline Mutations inCTLA4and Spectrum of Bone Marrow Features Overlapping with Aplastic Anemia and Large Granular Lymphocyte Lymphocytosis","keywords":"","combinedName":"doctor katherine r calvo"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Noriharu ","lastName":"Nakagawa ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of T Cell Receptors Specific to Antigens Presented By HLA-B5401 onIPS Cell-Derived Hematopoietic Stem Cells in a Patient with Acquired Aplastic Anemia Carrying B5401-Lacking Leukocytes","keywords":"","combinedName":"doctor noriharu nakagawa"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Katarina ","lastName":"Kapralova ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inflammatory Signature, Oxidative Stress, and DNA Damage Response in DBA Pathogenesis","keywords":"","combinedName":"doctor katarina kapralova"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Tong ","lastName":"Chen ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloid-Derived Suppressor Cells in Immune-Related Bone Marrow Failure: Novel Therapeutic Implication","keywords":"","combinedName":"doctor tong chen"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Jennifer","lastName":"Adair","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel Lineage Depletion and Manufacturing Allows for Unprecedented Preservation of Autologous Blood Stem Cells for Gene Therapy of Fanconi Anemia Complementation Group ?","keywords":"","combinedName":"doctor jennifer adair"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Supanun ","lastName":"Lauhasurayotin ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Re-Analysis of Next Generation Sequencing Gene Panel Data By Normalized Coverage Values Reveals Previously Undetected Copy Number Variations in Inherited Bone Marrow Failure Syndromes","keywords":"","combinedName":"doctor supanun lauhasurayotin"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Sicheng ","lastName":"Wen ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reversal of Aplastic Anemia By Mesenchymal Stem Cell-Derived Extracellular Vesicles","keywords":"","combinedName":"doctor sicheng wen"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Asahito ","lastName":"Hama ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk Factors for Donor-Type Aplasia after Bone Marrow Transplant in Children with Acquired Bone Marrow Failure","keywords":"","combinedName":"doctor asahito hama"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Usua ","lastName":"Oyarbide ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Starvation Stress in the Sbds-Null Zebrafish: Implications for Human Shwachman-Diamond Syndrome","keywords":"","combinedName":"doctor usua oyarbide"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Cassandra ","lastName":"Hirsch ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Surveillance of the Immune Repertoire of Aplastic Anemia Patients Using Deep Sequencing","keywords":"","combinedName":"doctor cassandra hirsch"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Emilia ","lastName":"Kozyra ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Systematic Assessment of GATA2 Genetic Variation Reveals the Presence of Novel Disease-Causing Synonymous Exonic Mutations","keywords":"","combinedName":"doctor emilia kozyra"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Zenghua ","lastName":"Lin ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T Cells Trafficking to Bone Marrow Have Different Characteristics from Those to Other Organs in an Immune-Mediated Bone Marrow Failure Mouse Model","keywords":"","combinedName":"doctor zenghua lin"},{"sessionId":"11810","sessionTitle":"508. Bone Marrow Failure: Poster II","firstName":"Aysen ","lastName":"Gunel-Ozcan ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TGF-1 Production By Bone Marrow Mesenchymal Stem Cells of FANCD2 Differs from Other Fanconi Anemia Complementation Groups","keywords":"","combinedName":"doctor aysen gunel-ozcan"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Tian ","lastName":"Zhang ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" APOC2 Is Upregulated in Acute Myeloid Leukemia and Presents a Novel Therapeutic Target","keywords":"","combinedName":"doctor tian zhang"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Yajian ","lastName":"Jiang ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AMPK Links Metabolic Regulation to Epigenome Modification in Leukemia-Initiating-Cell","keywords":"","combinedName":"doctor yajian jiang"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Paul Martin","lastName":"Ross ","credentials":"BSc, BA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Assay for Simultaneous Profiling of Gene Expression, Phospho- and Total Protein Abundance, and Somatic DNA Mutations for Hematology-Oncology Research","keywords":"","combinedName":"doctor paul martin ross"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Theresa ","lastName":"Owuor ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fetal and Neonatal Hematopoietic Progenitors Are Exquisitely Sensitive to MLL-ENL-Driven Leukemia Initiation","keywords":"","combinedName":"doctor theresa owuor"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Shella ","lastName":"Saint Fleur-Lominy ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic and Epigenetic Effects of DNA Methyltransferase Inhibition in Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor shella saint fleur-lominy"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Yuki ","lastName":"Inada ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Highly Sensitive Viral RNA-Seq Is a Powerful Tool to Analyze the Viral Transcripts in HTLV-1-Infected Individuals","keywords":"","combinedName":"doctor yuki inada"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Cristina ","lastName":"Pina ","credentials":"MD,DPhil","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Histone Acetyl-Transferase Kat2a Regulates Transcriptional Heterogeneity and Impacts Self-Renewal of Acute Myeloid Leukemia Cells in a Disease-Specific Manner","keywords":"","combinedName":"doctor cristina pina"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Pankaj ","lastName":"Acharya ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Histone Deacetylase Inhibitors Mimic BET Inhibitors and Cause RNA Polymerase Pausing at MYC, KIT, and Other Oncogenes in t(8;21) AML","keywords":"","combinedName":"doctor pankaj acharya"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Elina ","lastName":"Hirvonen ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Insights into Hematopoiesis in GATA2 Deficiency Using Single-Cell Transcriptomics","keywords":"","combinedName":"doctor elina hirvonen"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Catherine ","lastName":"Hockings ","credentials":"MBBChir, MA, FRCPath, MRCP","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Leukemogenic Second Hits in CEBPA-Mutated AML Result in Diverse Effects on Haematopoiesis","keywords":"","combinedName":"doctor catherine hockings"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Ada ","lastName":"Congrains ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Non-Coding Transcript in LEF1 Locus Is a Novel Regulatorof Cell Cycle and Apoptotic Pathways in Myeloid Leukemic Cells","keywords":"","combinedName":"doctor ada congrains"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Zachary A","lastName":"Hing ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PRMT5 Initiates an Epigenetic Program That Promotes Progression of Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor zachary a hing"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Silvia ","lastName":"Locatelli ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNA Sequencing Reveals Mechanisms Underlying Modulation of Hodgkin Lymphoma Cells and Tumor Microenvironment By the PI3K d/? Inhibitor, RP6530","keywords":"","combinedName":"doctor silvia locatelli"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Jason ","lastName":"Cheng ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNA:m5c/Methyltransferases Mediate Chromatin Organization and 5-Azacytidine Response/Resistance in Leukemia","keywords":"","combinedName":"doctor jason cheng"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Yu-Chiao ","lastName":"Chiu ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNA-Seq Revealed an Integration of Multiple Resistance Functions for Predicting Response to the 7+3 Induction Chemotherapy of De Novo Acute Myeloid Leukemia","keywords":"","combinedName":"doctor yu-chiao chiu"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Qimei ","lastName":"Han ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"SF3B1Mutation Causes Aberrant Splicing and Downregulation of PPP2R5A in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor qimei han"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Bruno K L","lastName":"Duarte ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Somatic Mutations Associated with Myeloid Transformation of RUNX1-Mutated Familial Platelet Disorders with Propensity to Myeloid Malignancies Using Targeted Next-Generation Sequencing","keywords":"","combinedName":"doctor bruno k l duarte"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Christopher Peter","lastName":"Mill ","credentials":"PhD, BA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Therapy for AML Expressing RUNX1 Mutation","keywords":"","combinedName":"doctor christopher peter mill"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Joanna ","lastName":"Pierro ","credentials":"DO","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of MMSET E1099K Mutation in Gene Dysregulation, Drug Resistance and Clonogenicity in Acute B-Lymphoblastic Leukemia","keywords":"","combinedName":"doctor joanna pierro"},{"sessionId":"11811","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster II","firstName":"Hlne ","lastName":"Jakobczyk ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Two Hematopoietic Transcription Factors, RUNX1 and FUBP1, Control the Expression of KIT Oncogene in Pre-B Lymphoblasts","keywords":"","combinedName":"doctor hlne jakobczyk"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Goichi ","lastName":"Tatsumi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aberrant Repression of GFI1 Super-Enhancer By LSD1 Plays an Important Role in Leukemia Programs in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor goichi tatsumi"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Zachary ","lastName":"Hunter ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Abnormal Splicing Patterns and Novel Intron Retentions Affect Genes Regulating Splicing, NF-Kb, ERK1/2, and TP53 in Waldenstroms Macroglobulinemia","keywords":"","combinedName":"doctor zachary hunter"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Yu ","lastName":"Fan ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Altered Transcriptome Uniquely Associated with AML Vs. Normal Hematopoiesis","keywords":"","combinedName":"doctor yu fan"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Hlne ","lastName":"Jakobczyk ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CBFA2T3 Enhances Transcriptional Activity of RUNX1: Implication in Leukemia","keywords":"","combinedName":"doctor hlne jakobczyk"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Shuchao ","lastName":"Qin ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CDK7 Inhibitor THZ1 Inhibits Glycolytic Metabolism By Suppressing HIF1a Activity in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor shuchao qin"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Daniel T","lastName":"Johnson ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of the Post-Transcriptional Regulation of AML1-ETO Expression in t(8;21) Leukemia Cells","keywords":"","combinedName":"doctor daniel t johnson"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Julien ","lastName":"Haroche ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Hematopoiesis in Erdheim-Chester Disease","keywords":"","combinedName":"doctor julien haroche"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Jessica ","lastName":"Heath ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cross Talk between Ikaros and RUNX1 in Myeloid Leukemia","keywords":"","combinedName":"doctor jessica heath"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Anna ","lastName":"Marneth ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"C-Terminal BRE Overexpression in 11q23-Rearranged and t(8;16) Acute Myeloid Leukemia Is Caused By Intragenic Transcription Initiation","keywords":"","combinedName":"doctor anna marneth"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Tomoya ","lastName":"Isobe ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epigenetic and Transcriptomic Profiling of MLL Rearranged Infant Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor tomoya isobe"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Mayukh ","lastName":"Biswas ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epigenetic Plasticity in ATP-Dependent Chromatin Remodeling Complexes in Human Acute Myeloid Leukemia","keywords":"","combinedName":"doctor mayukh biswas"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Chandrika ","lastName":"Gowda ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epigenetic Regulation of c-Kit Expression in Acute Myeloid Leukemia By Oncogenic Casein Kinase II (CK2)","keywords":"","combinedName":"doctor chandrika gowda"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Nickolas ","lastName":"Steinauer ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ETO2 Regulates Cell-Fate Genes and Controls Relapse in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor nickolas steinauer"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Mari ","lastName":"Lahnalampi ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genome-Wide Analysis of the Regulatory Landscape in Different Pre-B-ALL Subtypes","keywords":"","combinedName":"doctor mari lahnalampi"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Anindita ","lastName":"Ghosh ","credentials":"MBBS, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Bioflavonoid Exposure on DNA Damage Response and of Non-Homologous End Joining (NHEJ) Pathway Repair Proteins in Stem Cells","keywords":"","combinedName":"doctor anindita ghosh"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Paresh ","lastName":"Vyas ","credentials":"DPhil, FRCP, FRCPath, MRCP, MRCPath","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Mutant Haemopoietic Transcription Factor GATA1s on Haemopoiesis","keywords":"","combinedName":"doctor paresh vyas"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"David ","lastName":"Ma ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of microRNA 10a, an Autophagy Modulator, Increases Chemosensitivity to Ara-C in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor david ma"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Vijaya Pooja","lastName":"Vaikari ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interaction between FLT3 and CD99 in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor vijaya pooja vaikari"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Xuefei ","lastName":"Ma ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Noncoding RNA Profiling Reveals an Abundant Crnde That Inhibits Granulocytic Differentiation in APL","keywords":"","combinedName":"doctor xuefei ma"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Hiroki ","lastName":"Goto ","credentials":"M.D., Ph.D.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mechanism of Pax5 Down-Regulation and Its Function in Primary Effusion Lymphoma","keywords":"","combinedName":"doctor hiroki goto"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Swami ","lastName":"Iyer ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overexpression of BRD4 Is an Adverse Prognostic Factor in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor swami iyer"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Tineke ","lastName":"Casneuf ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Proteomic Profiling Reveals Targetable Pathways in MGUS (SLAMF6, TNFRSF8, TIMP1, TRL2) That May Contribute to Disease Progression","keywords":"","combinedName":"doctor tineke casneuf"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Katherine","lastName":"Tarlock","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recurrent Copy Number Variants Are Highly Prevalent in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor katherine tarlock"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Nandakumar ","lastName":"Packiriswamy ","credentials":"PhD, DVM","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T Cell Responses to Tumor Associated Antigens in Multiple Myeloma Patients Treated with Mv-Nis, an Oncolytic Measles Virus","keywords":"","combinedName":"doctor nandakumar packiriswamy"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Kirsten ","lastName":"Cant-Barrett ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T-ALL Oncogenes Function in the Context of Pre- and Post T-Cell Commitment Programs","keywords":"","combinedName":"doctor kirsten cant-barrett"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Sierrah Marie","lastName":"Grigsby ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The AF9-Binding Domain of DOT1L Is Critical for Its Recruitment By MLL Fusion Proteins in Leukemia and Contributes to Its Functions in Normal Hematopoiesis","keywords":"","combinedName":"doctor sierrah marie grigsby"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Mariusz Z","lastName":"Ratajczak ","credentials":"MD, PhD, DSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Effect of Bioactive Phospholipids on Normal and Malignant Hematopoiesis - Modulation of Their Effects By Downregulating the Activities of Heme Oxygenase 1 (HO-1) and Inducible Nitric Oxygenase Synthase (iNOS)","keywords":"","combinedName":"doctor mariusz z ratajczak"},{"sessionId":"11812","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster III","firstName":"Shuang ","lastName":"Liu ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impacts of Transcriptional Regulatory Mechanism and Protein Interaction Relationship between RUNX1 and KLF4 on the Biological Functions of t (8;21) Leukemia Cells","keywords":"","combinedName":"doctor shuang liu"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Matt ","lastName":"Christopher ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" Expression of the Tumor Suppressor WT1 Is Induced By PML-Rara in Acute Promyelocytic Leukemia. ","keywords":"","combinedName":"doctor matt christopher"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Francois ","lastName":"Mercier ","credentials":"M.D.","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Genome-Wide, In Vivo, Dropout CRISPR Screen in Acute Myeloid Leukemia Identifies an Essential Role for Beta-Galactosylation in Leukemic Cell Homing","keywords":"","combinedName":"doctor francois mercier"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Jie ","lastName":"Sun ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Activation of SIRT1 Deacetylase As a Therapeutic Approach for Myelodysplastic Syndromes By Restoring TET2 Function","keywords":"","combinedName":"doctor jie sun"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Xin ","lastName":"Li ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ADAR1 Is Involved in the Proliferation of Acute Myeloid Leukemia Probably Via Regulating the Wnt Pathway","keywords":"","combinedName":"doctor xin li"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Wei Zhong ","lastName":"Leong ","credentials":"BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ARID5B Activates the TAL1-Induced Core Regulatory Circuit and the MYC Oncogene in T-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor wei zhong leong"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Kohei ","lastName":"Kume ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ca2+ Oscillations and NFATC1-Activation Enable Oncogenic Signaling in Pre-B Cell Transformation and Leukemogenesis","keywords":"","combinedName":"doctor kohei kume"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Yiqian ","lastName":"Wang ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cbfb-MYH11+ Leukemia Stem Cells Are Heterogeneous and Show Dynamic Marker Expression","keywords":"","combinedName":"doctor yiqian wang"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Yusuke ","lastName":"Nakauchi ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization and Targeting TET2-Mutant HSPCs and AML","keywords":"","combinedName":"doctor yusuke nakauchi"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Mahmoud ","lastName":"Hallal ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of Kinase Activity By Phosphoproteomics in Myeloid Cell Lines for Identification of Driving Oncogenic Pathways","keywords":"","combinedName":"doctor mahmoud hallal"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Takahiro ","lastName":"Shima ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CPSF1 Regulates AML1-ETO Fusion Gene Polyadenylation and Stability in t(8;21) Acute Myelogenous Leukemia","keywords":"","combinedName":"doctor takahiro shima"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Jens ","lastName":"Schrezenmeier ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"DLBCL-Derived NF-?b Mutations Exploit Senescence and Immune Evasion Mechanisms to Promote Myc-Driven Lymphomagenesis","keywords":"","combinedName":"doctor jens schrezenmeier"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Axel ","lastName":"Hyrenius Wittsten ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FLT3N676K drives Myeloid Leukemia in a Xenograft Model of KMT2A-MLLT3 leukemogenesis","keywords":"","combinedName":"doctor axel hyrenius wittsten"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Sisi ","lastName":"Chen ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gain of Function Mutant p53 Drives Clonal Hematopoiesis and the Pathogenesis of Myelodysplastic Syndromes","keywords":"","combinedName":"doctor sisi chen"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Jiachen ","lastName":"Bu ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Global Crosstalk between Two Histone Modifications That Control Transcriptional Elongation in MLL Leukemia","keywords":"","combinedName":"doctor jiachen bu"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Archibald S","lastName":"Perkins ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Level EVI1 Perturbs Hematopoietic Function By Skewing Cells Towards Myeloid Phenotype Via Induction of PU.1/Spi1Transcription","keywords":"","combinedName":"doctor archibald s perkins"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Marisa J","lastName":"Hornbaker ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"hnRNP K: A Driver of Myeloid Malignancy","keywords":"","combinedName":"doctor marisa j hornbaker"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Ricardo ","lastName":"De Matos Simoes ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrated Functional Genomic and Pharmacological Characterization of the Kinome of Myeloma Cells","keywords":"","combinedName":"doctor ricardo de matos simoes"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Min ","lastName":"Chen ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Loss of Ahi-1 Impairs the Self-Renewal Activity of Normal and BCR-ABL+ Stem Cells in Vitro and in Vivo","keywords":"","combinedName":"doctor min chen"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Nisha ","lastName":"Narayan ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Microrna-211 - a Novel Oncogene in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor nisha narayan"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Ruben ","lastName":"Carrasco ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Modeling Lymphoplasmacytic Lymphoma/Waldenstrm Macroglobulinemia in Transgenic Mice Using Human MYD88L256P Mutated Protein","keywords":"","combinedName":"doctor ruben carrasco"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Soumya ","lastName":"Sundara Rajan ","credentials":"M.Sc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NPM1-ALK Overexpression-Driven Toxicity in ALCL Is Partner Dependent and Mediated By STAT1 Antagonism of STAT3 Survival Signaling, Revealing a Novel Therapeutic Strategy","keywords":"","combinedName":"doctor soumya sundara rajan"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Shannon M","lastName":"Buckley ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Potential Role of Ubiquitin E3 Ligase, FBXO9, As a Tumor Suppressor in AML","keywords":"","combinedName":"doctor shannon m buckley"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Goro ","lastName":"Sashida ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RUNX3 Promotes the Development of MDS/MPN Overlap Syndrome Via Enhancing Expression of Myc in the Absence of Tet2","keywords":"","combinedName":"doctor goro sashida"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Joo Agostinho","lastName":"Machado-Neto ","credentials":"BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Stathmin 1 Is Highly Expressed in Acute Promyelocytic Leukemia and Microtubule Dynamics Is a Potential Target for ATRA-Resistant APL Cells","keywords":"","combinedName":"doctor joo agostinho machado-neto"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Marco ","lastName":"De Dominici ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting CDK6 and BCL2 Exploits the \"MYB Addiction\" of Ph+ Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor marco de dominici"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Salvatore Nicola ","lastName":"Bertuccio ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The ETO2-GLIS2 Fusion Oncogene Alters Early Human Hematopoiesis in an Induced Pluripotent Stem Cells-Derived Model of Pediatric Acute Megakaryoblastic Leukemia","keywords":"","combinedName":"doctor salvatore nicola bertuccio"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Severine ","lastName":"Cathelin ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Origin and Functional Impact of Mitochondrial DNA Mutations in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor severine cathelin"},{"sessionId":"11813","sessionTitle":"603. Oncogenes and Tumor Suppressors: Poster II","firstName":"Samuel A","lastName":"Stoner ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcriptional Repression of RASSF2 Impairs Hippo Kinase-Dependent p53 Activation and Tumor Suppression in t(8;21) AML","keywords":"","combinedName":"doctor samuel a stoner"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Michael ","lastName":"Thwaites ","credentials":"PhD,BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AVID200: A Novel TGF-Beta Inhibitor for the Treatment of Anemia Associated with Myelodysplastic Syndromes","keywords":"","combinedName":"doctor michael thwaites"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Yu-Ting ","lastName":"Chang ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bone Marrow Stroma Protects FLT3 Acute Myeloid Leukemia (AML) through CYP3A4-Mediated Drug Metabolization of FLT3 Tyrosine Kinase Inhibitors (TKIs)","keywords":"","combinedName":"doctor yu-ting chang"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Hiroki ","lastName":"Akiyama ","credentials":"M.D.","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deubiquitinase Inhibitor WP1130 Blocks FLT3-ITD to Induce Apoptosis in Leukemic Cells","keywords":"","combinedName":"doctor hiroki akiyama"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Christopher B","lastName":"Ryder ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Direct-Acting Small Molecule Activators of PP2A (SMAPs) in Myeloid Malignancies: Understanding Mechanisms of Cytotoxicity to Inform Rational Combinatorial Therapeutic Strategies","keywords":"","combinedName":"doctor christopher b ryder"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Jatinder ","lastName":"Lamba ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Drug Transporter ABCB1 SNP Predicts Outcome in Patients with Acute Myeloid Leukemia Treated with Gemtuzumab Ozagamicin: A Report from Childrens Oncology Group AAML0531 Trial","keywords":"","combinedName":"doctor jatinder lamba"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Fangli ","lastName":"Chen ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of Carbonic Anhydrase-IX As a Novel Strategy to Overcome Hypoxia Mediated Drug Resistance in FLT3/ITD Mutated Acute Myeloid Leukemia.","keywords":"","combinedName":"doctor fangli chen"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Bartholomew ","lastName":"Eisfelder ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of FLT3-ITD and Melk By Small Molecule Inhibitor OTS167 in FLT3 mutant Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor bartholomew eisfelder"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Patrycja ","lastName":"Dubielecka ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Map3k8/COT1/Tpl2 Drives Resistance to Bcr-Abl1 Inhibition through Activation of MEK-ERK and NF-Kb Pathways","keywords":"","combinedName":"doctor patrycja dubielecka"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Qin ","lastName":"Lu ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PCT3, a Combination of Active Steroidal Saponins from the Paris Forrestii (Takht.) H. Li, Displays Potent Activity Against Acute Myeloid Leukemia By Suppressing the PBX1/RNF6/AKT/mTOR Signaling Pathway","keywords":"","combinedName":"doctor qin lu"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Hein ","lastName":"Than ","credentials":"MD, FRCPath, MRCP","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Persistence of Somatic Mutation Spectrum and Clonal Architecture in Chronic Myelomonocytic Leukemia Treated with Hypomethylating Agents","keywords":"","combinedName":"doctor hein than"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Huafeng ","lastName":"Wang ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PNC27 Targeting Plasma Membrane HDM2: A Potentially Novel Therapeutic Approach for Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor huafeng wang"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Zhihong ","lastName":"Zeng ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Proteomic Profiling Identifies c-KIT and 53BP1 As Resistance Factors of AML Relapse Post Allogeneic Stem Cell Transplantation with G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning","keywords":"","combinedName":"doctor zhihong zeng"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Hee-Don ","lastName":"Chae ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RSK Inhibition Induces Metaphase Arrest and Apoptosis in Acute Myeloid Leukemia Cells","keywords":"","combinedName":"doctor hee-don chae"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Paolo ","lastName":"Lunghi ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Pharmacological Blockade of Phosphodiesterase IV Potentiates the Anti-Tumor Effects of Arsenic Trioxide (ATO) in Acute Myelogenous Leukemia Cells through Multiple Signaling Pathways","keywords":"","combinedName":"doctor paolo lunghi"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Dana ","lastName":"Yehudai-Ofir ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Thymidine Dideoxynucleoside Analogue, Alovudine, Inhibits the Mitochondrial DNA Polyermase, Polg, Impairs Oxidative Phosphorylation and Promotes Monocytic Differentiation in AML","keywords":"","combinedName":"doctor dana yehudai-ofir"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Jae Yoon ","lastName":"Jeon ","credentials":"PharmD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TP-0903, a Novel Axl Inhibitor with Activity in Drug Resistant FLT3-ITD+ AML through a Mechanism That Includes FLT3 Inhibition","keywords":"","combinedName":"doctor jae yoon jeon"},{"sessionId":"11814","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster II","firstName":"Nick ","lastName":"van Gastel ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Untargeted Metabolomics Identifies Glutamine Metabolism As a Driver of Chemoresistance in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor nick van gastel"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Mark C","lastName":"Weir ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Unique N-Phenylbenzamide Inhibitor Targeting Non-Receptor Tyrosine Kinases Potently Suppresses AML Cell Growth in Vitro and In Vivo","keywords":"","combinedName":"doctor mark c weir"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Anna ","lastName":"Martner ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anti-Leukemic Properties of Histamine in Monocytic Leukemia: Role of NOX2","keywords":"","combinedName":"doctor anna martner"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Blake S","lastName":"Moses ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Artemisinins Synergize with BCL2 Inhibitors By Reducing MCL1 Protein Levels in Leukemia Cells","keywords":"","combinedName":"doctor blake s moses"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Seiichi ","lastName":"Okabe ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aurora a Kinase As a Promising Therapeutic Target in Philadelphia Chromosome Positive Leukemia Cells","keywords":"","combinedName":"doctor seiichi okabe"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Katherine A","lastName":"Minson ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bone Marrow Stromal Cell Mediated Resistance to Mertk Inhibition in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor katherine a minson"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Silvia ","lastName":"Waldeck ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CCL5 Mediates Target-Kinase Independent Resistance to FLT3 Inhibitors in FLT3-ITD-Positive AML","keywords":"","combinedName":"doctor silvia waldeck"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Jatinder ","lastName":"Lamba ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD33Single Nucleotide Polymorphism (CD33-SNP) Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: Report from Childrens Oncology Group AAML0531 Trial","keywords":"","combinedName":"doctor jatinder lamba"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Taoufik ","lastName":"Ouatas ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Concomitant Use of Midostaurin with Strong CYP3A4 Inhibitors: An Analysis from the Ratify Trial","keywords":"","combinedName":"doctor taoufik ouatas"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Mario ","lastName":"Vega ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deptor As a Target with Chemical Inhibitors; Alternative Therapy in Multiple Myeloma","keywords":"","combinedName":"doctor mario vega"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Mahroo ","lastName":"Karimpoor ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of Foam-Based 3-Dimensional Culture to Investigate Drug Sensitivity in Primary Leukaemia Cells","keywords":"","combinedName":"doctor mahroo karimpoor"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Jie ","lastName":"Zha ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Disregulation of CTCF Boundary at the HOX Locus Enhances Sensitity to Multiple Drug Treatment in Myeloid Malignancies","keywords":"","combinedName":"doctor jie zha"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Yoko ","lastName":"Tabe ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of FAO in AML Co-Cultured with BM Adipocytes: Mechanisms of Survival and Chemosensitization to Cytarabine","keywords":"","combinedName":"doctor yoko tabe"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Daniel A","lastName":"Luedtke ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of XPO1 By KPT-330 (Selinexor) Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor ABT-199 (Venetoclax) through Downregulation of Mcl-1 in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor daniel a luedtke"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Meaghan ","lastName":"Boileau ","credentials":"BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Leukemic Stem Cell Expression Signatures Identify Novel Therapeutics for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor meaghan boileau"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Yingchi ","lastName":"Zhang ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutation Profiling Reveals Novel Epigenetics and Splicing Mutations in Chemorefractory Pediatric AML","keywords":"","combinedName":"doctor yingchi zhang"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Yubin ","lastName":"Ge ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ONC213, a Novel Second Generation Analog of ONC201, Shows Promising Anti-Leukemic Activity Against AML Cells in Vitro and In Vivo","keywords":"","combinedName":"doctor yubin ge"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Pilar ","lastName":"De La Puente ","credentials":"PhD, M.Sc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasma-Derived 3D Culture for Leukemic Proliferation","keywords":"","combinedName":"doctor pilar de la puente"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Rebecca ","lastName":"Anderson ","credentials":"B.S.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pyruvate Dehydrogenase (PDH) Activity Is a Source of Resistance to Sorafenib in FLT3-ITD Expressing Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor rebecca anderson"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Heikki ","lastName":"Kuusanmki ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Cell Drug Profiling Reveals Maturation Stage-Dependent Drug Responses in AML","keywords":"","combinedName":"doctor heikki kuusanmki"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Naxin ","lastName":"Guo ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Suppression of mTOR Signaling Attenuates Apoptotic Effects Induced By the NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Acute Myeloid Leukemia Cells","keywords":"","combinedName":"doctor naxin guo"},{"sessionId":"11815","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Poster III","firstName":"Vassiliki ","lastName":"Pappa ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Association of Hif-1a Expression with Primary Resistance to Azacytidine in Patients with High Risk MDS - Preliminary Data of the Hellenic MDS Study Group","keywords":"","combinedName":"doctor vassiliki pappa"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Liang ","lastName":"Zhou ","credentials":"Ph.D","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Alvocidib Enhances Venetoclax Sensitivity in Unfavorable-Risk Multiple Myeloma Cells in Vitro and In Vivo","keywords":"","combinedName":"doctor liang zhou"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Giovanna ","lastName":"Carr ","credentials":"PhD student","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BET Inhibitors in Chronic Lymphocytic Leukemia: JQ1 Synergizes with Venetoclax in Promoting Apoptosis","keywords":"","combinedName":"doctor giovanna carr"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Jordy ","lastName":"Van Der Zwet ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Breaking IL7R Signaling-Induced Glucocorticoid Resistance By Small Molecule Inhibitors in T-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor jordy van der zwet"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Simon J","lastName":"Hogg ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical BET Inhibitor RG6146 Induces Intrinsic Apoptosis and Down-Regulates PD-L1 Expression and Induces Potent Anti-Tumor Activity in Models of Hematological Malignancy","keywords":"","combinedName":"doctor simon j hogg"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Ying ","lastName":"Li ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cullin4B Induces Autophagy Participating the Tumorigenesis of Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor ying li"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Benet ","lastName":"Pera Gresely ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of a Novel Class of Microtubule Destabilizing Agents with Selectivity Against Diffuse Large B-Cell Lymphoma (DLBCL) with B-Cell Receptor (BCR) Activation","keywords":"","combinedName":"doctor benet pera gresely"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Rosaria ","lastName":"De Filippi ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Edo-S101, a Bendamustine (BDM)/ Histone-Deacetylase Inhibitor (HDACi) Fusion Molecule, Demonstrates Potent Preclinical Activity Against T-Cell Malignancies and Overcomes BDM-Resistance","keywords":"","combinedName":"doctor rosaria de filippi"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"May ","lastName":"Garrett ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Renal and/or Hepatic Impairment on the Pharmacokinetics and Safety of Inotuzumab Ozogamicin in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor may garrett"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Owen Anthony","lastName":"O'Connor ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Elucidating Exposure-Response (Safety and Efficacy) of Adct-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Containing Antibody Drug Conjugate, for Recommended Phase 2 Dose Determination in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma","keywords":"","combinedName":"doctor owen anthony o'connor"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Samuel ","lastName":"Kitara ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of EHMT2 As a New Target in T-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor samuel kitara"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Subir ","lastName":"Roy Chowdhury ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Importance of Mitochondrial Metabolism As a Selective Therapeutic Approach in Chronic Lymphocytic Leukemia Patients","keywords":"","combinedName":"doctor subir roy chowdhury"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Ryan J","lastName":"Summers ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mertk Is a Therapeutic Target in Early T-Precursor Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor ryan j summers"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Manit ","lastName":"Munshi ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutated MYD88 Activates the BCR Component SYK and Provides a Rationale Therapeutic Target in Waldenstroms Macroglobulinemia","keywords":"","combinedName":"doctor manit munshi"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Paul ","lastName":"Takam Kamga ","credentials":"BSc, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Notch Signaling Controls Drug Response in B-Cell Acute Lymphoblastic Leukemia (B-ALL)","keywords":"","combinedName":"doctor paul takam kamga"},{"sessionId":"11816","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster II","firstName":"Ryo ","lastName":"Atsumi ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Population Pharmacokinetic and Exposure-Response Modeling for the EZH1/2 Dual Inhibitor DS-3201b in Patients with Non-Hodgkin Lymphomas","keywords":"","combinedName":"doctor ryo atsumi"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Jaewoong ","lastName":"Lee ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD25 Enables Oncogenic BCR-Signaling and Represents a Therapeutic Target in B Cell Malignancies","keywords":"","combinedName":"doctor jaewoong lee"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Daniela ","lastName":"Vorholt ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional Implication of p53-Mediated DNA Damage Response on the B-Cell Lymphoma Microenvironment Interaction in Chemoimmunotherapy","keywords":"","combinedName":"doctor daniela vorholt"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Candice ","lastName":"Jamois ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Influence of Baseline Disease Characteristics and Exposure to Obinutuzumab on Clinical Outcome in Patients with Previously Untreated Advanced Follicular Lymphoma Treated with Obinutuzumab-Based Immunochemotherapy in the GALLIUM Trial","keywords":"","combinedName":"doctor candice jamois"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Takahiro ","lastName":"Kobayashi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lenalidomide and Dexamethasone Therapy in Elderly Patients with Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide","keywords":"","combinedName":"doctor takahiro kobayashi"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Samantha ","lastName":"Goodstal ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"M7583 Isa Highly Selective and Potent Second Generation BTK Inhibitor for Treatment of B-Cell Malignancies","keywords":"","combinedName":"doctor samantha goodstal"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Sho ","lastName":"Okamoto ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preclinical Anti-Lymphoma Activity of the BCL-2 BH4 Domain Antagonist Bda-366 in Mantle Cell Lymphoma","keywords":"","combinedName":"doctor sho okamoto"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Christina ","lastName":"Wu ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Proteomic Analysis Reveals IRAK4 As a Therapeutic Target in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor christina wu"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Aneel ","lastName":"Paulus ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PSMB9 Mediates Resistance to Bortezomib in Multiple Myeloma","keywords":"","combinedName":"doctor aneel paulus"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Claudio ","lastName":"Scuoppo ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Repurposing Dasatinib for Ibrutinib-Resistant Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor claudio scuoppo"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Amit ","lastName":"Khot ","credentials":"MBBS, MD, MRCP, FRCPath, FRACP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNA Polymerase 1 Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Malignancies: Results of a Phase I First in Human Study","keywords":"","combinedName":"doctor amit khot"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Varun Vijay ","lastName":"Prabhu ","credentials":"BPharm, MS, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single Agent and Synergistic Combinatorial Efficacy of First-in-Class Small Molecule Imipridone ONC201 in Hematological Malignancies in Vitro and In Vivo through Apoptosis Via the Integrated Stress Response Pathway","keywords":"","combinedName":"doctor varun vijay prabhu"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Jan ","lastName":"Burger ","credentials":"MD, PhD ","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Clinical BET Inhibitor, GS-5829, Is Active Against Chronic Lymphocytic Leukemia As Single Agent and in Combination with B-Cell Receptor Signaling Inhibitors","keywords":"","combinedName":"doctor jan burger"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Milos ","lastName":"Miljkovic ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transient Inhibition of the JAK1/3-STAT5 Pathway By Ruxolitinib Is Insufficient to Produce Clinical Benefit in Patients with Indolent Adult T-Cell Leukemia","keywords":"","combinedName":"doctor milos miljkovic"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Nitin ","lastName":"Agarwal ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Upregulation of Alternatively Glycosylated Smoothened (SMO) Is Involved inDoxorubicin (DXR) Resistance in Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor nitin agarwal"},{"sessionId":"11817","sessionTitle":"605. Molecular Pharmacology, Drug ResistanceLymphoid and Other Diseases: Poster III","firstName":"Y. ","lastName":"Wang ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"XPO1 Inhibitor Selinexor Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma Via Nuclear Retention of I?B","keywords":"","combinedName":"doctor y wang"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Natanja ","lastName":"Oosterom ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"a Decrease in Vitamin D Levels Is Associated with Methotrexate-Induced Oral Mucositis in Children with Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor natanja oosterom"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Nicholas J","lastName":"Short ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase I/II Study of Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) for Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor nicholas j short"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Der-Shiun ","lastName":"Wang ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adjusting Dosage of Mercaptopurine By NUDT15 Polymorphisms in Childhood Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor der-shiun wang"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Andrew ","lastName":"Wei ","credentials":"MBBS, PhD, FRACP, FRCPA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Baseline Biomarkers Influencing Clinical Outcomes in Adults with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R ALL) Treated with Blinatumomab Versus Standard-of-Care Chemotherapy (SOC) from a Randomized Phase 3 Study","keywords":"","combinedName":"doctor andrew wei"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Benjamin ","lastName":"Fournier ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) with t(5;14)(q31;q32)/IL3-IGH Rearrangement and Eosinophilia: A PeculiarIGH BCP-ALL","keywords":"","combinedName":"doctor benjamin fournier"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Andrew M","lastName":"Stein ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CTL019 Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor (CAR) T Cells to Characterize the Impact of Tocilizumab on Expansion and to Identify Correlates of Cytokine Release Syndrome Severity","keywords":"","combinedName":"doctor andrew m stein"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Kara ","lastName":"Kelly ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dietary Antioxidant Micronutrient Intake and Toxicity during Remission Induction in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001","keywords":"","combinedName":"doctor kara kelly"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Jae-Ho ","lastName":"Yoon ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Durable Outcomesof a ProspectiveDouble Cord Blood Transplantation Trial inAdults with Acute Lymphoblastic Leukemia: DifferentOutcomes According to the Presence ofPhiladelphia Chromosome","keywords":"","combinedName":"doctor jae-ho yoon"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Stefan ","lastName":"Suciu ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fertility Status Among Long-Term Childhood Acute Lymphoblastic Leukemia Survivors Enrolled between 1971 and 1998 in the EORTC Children Leukemia Group Trials 58741, 58831/2 and 58881","keywords":"","combinedName":"doctor stefan suciu"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Max ","lastName":"Topp ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Health-Related Quality of Life in Adults Treated with Blinatumomab Using the Acute Lymphoblastic Leukemia Symptom Scale","keywords":"","combinedName":"doctor max topp"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Mayur ","lastName":"Sarangdhar ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Density Data Mining to Identify Unique Toxicities of Adolescent/Young Adult Cancer Treatment: A Report from the Childrens Oncology Group","keywords":"","combinedName":"doctor mayur sarangdhar"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Jae-Ho ","lastName":"Yoon ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Donor Type on Long-Term Outcomes of Hematopoietic Cell Transplantation for AdultAcute Lymphoblastic Leukemia during First Remission","keywords":"","combinedName":"doctor jae-ho yoon"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Francois Xavier ","lastName":"Gros ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improved Outcome with a Pediatric-Inspired Regimen for Philadelphia-Negative Acute Lymphoblastic Leukemia in the Elderly","keywords":"","combinedName":"doctor francois xavier gros"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Guru Subramanian ","lastName":"Guru Murthy ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence and Outcomes of T-Cell Acute Lymphoblastic Leukemia (T-ALL) in United States","keywords":"","combinedName":"doctor guru subramanian guru murthy"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Ashley ","lastName":"Perry ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased Incidence of Philadelphia Negative B-Cell Acute Lymphoblastic Leukemia Among Adults of Hispanic Ethnicity: A Population Based Study","keywords":"","combinedName":"doctor ashley perry"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Matthias ","lastName":"Stelljes ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Indirect Treatment Comparison (ITC) of Inotuzumab Ozogamicin (InO) and Blinatumomab (Blina) for Relapsed or Refractory (RR) Acute Lymphoblastic Leukemia (ALL)","keywords":"","combinedName":"doctor matthias stelljes"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Anjali ","lastName":"Advani ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inotuzumab Ozogamicin (InO) for Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) in the Global Phase 3 INO-VATE Trial: Efficacy By MLL Status","keywords":"","combinedName":"doctor anjali advani"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Hagop ","lastName":"Kantarjian","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inotuzumab Ozogamicin (InO) Vs Standard of Care (SC) in Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL): Long-Term Results of the Phase 3 INO-VATE Study","keywords":"","combinedName":"doctor hagop kantarjian"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Jessica C","lastName":"Shand ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intrinsic Activation of the NLRP3 Inflammasome in Primary Human ALL Cells Is Regulated By Endogenous HMGB1 and Bone Marrow Macrophages","keywords":"","combinedName":"doctor jessica c shand"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Alessandro ","lastName":"Rambaldi ","credentials":"MD, Prof","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Maintenance Therapy with Blinatumomab in Adults with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL): Overall Survival in Adults Enrolled in a Phase 3 Open-Label Trial","keywords":"","combinedName":"doctor alessandro rambaldi"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Clarice ","lastName":"Lee ","credentials":"PharmD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacokinetics and Pharmacodynamics of Tocilizumab for the Management of Cytokine Release Syndrome (CRS) in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Treated with CAR T-Cell Therapy, CTL019","keywords":"","combinedName":"doctor clarice lee"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Koji ","lastName":"Sasaki ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II Study of Hyper-Cmad with Liposomal Vincristine (Marqibo) for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)","keywords":"","combinedName":"doctor koji sasaki"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Sreya ","lastName":"Yalamanchili ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Second Primary Malignancies in Long Term Acute Lymphoblastic Leukemia Survivors of Three Age Groups","keywords":"","combinedName":"doctor sreya yalamanchili"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Alexander ","lastName":"Claviez ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Sex on Clinical Outcome and Toxicity in Children and Adolescents with Acute Lymphoblastic Leukemia.a Report from the BFM Study Group","keywords":"","combinedName":"doctor alexander claviez"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Ikuya ","lastName":"Usami ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Outcome of Childhood B-Cell Precursor ALL with ETV6-RUNX1 Treated with Japan Association of Childhood Leukemia Study (JACLS) ALL-02 Trial","keywords":"","combinedName":"doctor ikuya usami"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Giridharan ","lastName":"Ramsingh ","credentials":"MD ","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Presence of Philadelphia Chromosome Does Not Confer Poor Prognosis in Adult Pre-B Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era  a Surveillance, Epidemiology, and End Results Database Analysis","keywords":"","combinedName":"doctor giridharan ramsingh"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Huafang ","lastName":"Wang ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role and Mechanism of PTPN21 Isoforms in Acute Lymphoblastic Leukemia Escaping NK Cell Killing","keywords":"","combinedName":"doctor huafang wang"},{"sessionId":"11818","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster II","firstName":"Cecilie ","lastName":"Rank ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thromboembolism in ALL Patients 1-45 Years Treated According to the NOPHO-ALL 2008 Protocol","keywords":"","combinedName":"doctor cecilie rank"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Jian ","lastName":"Li ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Multicenter Nonrandom Clinical Study of Induction Regimen of FLAG-ID and Dae in the Treatment of Childhood De Novo Acute Myeloid Leukemia in South of China:the Early Report of Efficacy and Safety","keywords":"","combinedName":"doctor jian li"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Neil ","lastName":"Palmisiano ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Trial of Sirolimus with Standard Induction Chemotherapy in Patients with De Novo Acute Myeloid Leukemia","keywords":"","combinedName":"doctor neil palmisiano"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Yazhini ","lastName":"Vallatharasu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Myeloid Leukemia and Myelodysplasia Related Changes: Trends in Survival between 2000 and 2013","keywords":"","combinedName":"doctor yazhini vallatharasu"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Michael ","lastName":"Dennis ","credentials":"MD,MRCP,FRCPath","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Evaluation of 17 Years of Low Dose Cytarabine As Therapy for AML Patients Not Fit for Intensive Treatment, Including Patients with Adverse Cytogenetics, Shows Improving Survival, Potential Underutilisation and Highlights the Need for New Therapy","keywords":"","combinedName":"doctor michael dennis"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Yuqi ","lastName":"Wang ","credentials":"MD,FRCPC","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics of Venous Thromboembolism in Patients with Acute Leukemia","keywords":"","combinedName":"doctor yuqi wang"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Oussama ","lastName":"Abla ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Characteristics and Treatment Outcome of Acute Myeloid Leukemia with APL-like Morphology and Uncommon Rara Fusion Variants","keywords":"","combinedName":"doctor oussama abla"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Anthony ","lastName":"Sung ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Outcomes of Microtransplantation for Older Adults with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor anthony sung"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Garret MK","lastName":"Leung ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combination of Omacetaxine Mepesuccinate (homoharringtonine) and Sorafenib As an Effective Regimen for Acute Myeloid Leukemia (AML) Carrying FLT3-ITD","keywords":"","combinedName":"doctor garret mk leung"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Ing Soo S","lastName":"Tiong ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Frontline Induction Therapy Using Idarubicin in Combination with High-Dose (HDAC3) Versus Intermediate-Dose Cytarabine (IDAC3) in Adult Acute Myeloid Leukemia","keywords":"","combinedName":"doctor ing soo s tiong"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Anna B","lastName":"Halpern ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Developing Models to Predict Intensive Care Unit Admission and Mortality for Adults with Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor anna b halpern"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Oren ","lastName":"Pasvolsky ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Anthracycline Dose on Acute Anthracycline Induced Cardiotoxicity in Patients with Acute Myeloid Leukemia Undergoing Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor oren pasvolsky"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"NIRA ","lastName":"Arad-Cohen ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epidemiology, Cytogenetic and Molecular Abnormalities and Outcome of Childhood Acute Myeloid Leukemia- an Israeli Retrospective Multicenter Study","keywords":"","combinedName":"doctor nira arad-cohen"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Sangmin ","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factors Affecting Transfusion Utilization in Acute Myeloid Leukemia (AML) Patients Undergoing Initial Therapy","keywords":"","combinedName":"doctor sangmin lee"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Omer ","lastName":"Jamy ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Favorable Outcomes with Fludarabine, High Dose Cytarabine and Granulocyte Colony Stimulating Factor (FLAG) As Re-Induction for Residual Acute Myeloid Leukemia on Day 14 Bone Marrow","keywords":"","combinedName":"doctor omer jamy"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Michael Richard","lastName":"Grunwald ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor michael richard grunwald"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Ana ","lastName":"Alfonso Pierola ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Next-Generation Sequencing on Treatment Choices for Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor ana alfonso pierola"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Frederic ","lastName":"Baron ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of the Type of Anthracycline and of Allogeneic Stem Cell Transplantation in the Treatment of Younger Acute Myeloid Leukemia Patients: Long-Term Follow-up of the EORTC-Gimema AML-10 Trial","keywords":"","combinedName":"doctor frederic baron"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Walentyna ","lastName":"Balwierz ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improvement of the Treatment Results in Childhood Acute Myeloid Leukemia in Poland from 1983 to 2017","keywords":"","combinedName":"doctor walentyna balwierz"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Kenneth ","lastName":"Jacobs ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lead-in Dose Optimization to Mitigate Cytokine Release Syndrome in AML and MDS Patients Treated with Flotetuzumab, a CD123 x CD3 Dart Molecule for T-Cell Redirected Therapy","keywords":"","combinedName":"doctor kenneth jacobs"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Naveen ","lastName":"Pemmaraju ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)","keywords":"","combinedName":"doctor naveen pemmaraju"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Kelly D","lastName":"Getz ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Occurrence of Cardiotoxicity and the Impact on Outcomes Among Children Treated on the AAML0531 Clinical Trial: A Report from the Childrens Oncology Group","keywords":"","combinedName":"doctor kelly d getz"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Matthew ","lastName":"Kutny ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes Based on CNS Disease Status in Pediatric Acute Myeloid Leukemia and the Role of Peripheral Blood Contamination in Diagnostic Lumbar Punctures; A Report from the Children's Oncology Group Studies AAML0531 and AAML1031","keywords":"","combinedName":"doctor matthew kutny"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Frances Linzee","lastName":"Mabrey ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outpatient Intensive Induction Chemotherapy for Acute Myeloid Leukemia and Advanced Myelodysplastic Syndrome","keywords":"","combinedName":"doctor frances linzee mabrey"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Pak Ling ","lastName":"Lui ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasma HCK Level As a Biomarker Predicting Poor Outcome in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor pak ling lui"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Hagop ","lastName":"Kantarjian","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predictors of Response and Survival in 206 AML Patients Treated with Guadecitabine ina Phase 2 Study","keywords":"","combinedName":"doctor hagop kantarjian"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Marcos ","lastName":"Lemos ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Value of Day 14 Bone Marrow Biopsy (d14BM) in Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor marcos lemos"},{"sessionId":"11820","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster III","firstName":"Matthew ","lastName":"Tenold ","credentials":"MD, BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Retrospective Analysis of Adult Relapsed and Refractory Acute Leukemia Patients Treated with FLAG at a Comprehensive Cancer Center","keywords":"","combinedName":"doctor matthew tenold"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Nicholas J","lastName":"Short ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Randomized Phase II Trial of 5-Day Versus 10-Day Schedules of Decitabine for Older Patients with Previously Untreated Acute Myeloid Leukemia","keywords":"","combinedName":"doctor nicholas j short"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Sonia ","lastName":"Christian ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Single Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) for Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia","keywords":"","combinedName":"doctor sonia christian"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Osman ","lastName":"Radhwi ","credentials":"M.D.","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Strategy of Day 14 Bone Marrows and Early Intervention Is Associated with Similar Outcomes Compared to a Strategy of No Day 14 Bone Marrows and Delayed Intervention in Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor osman radhwi"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Maria Pilar ","lastName":"Gallego Hernanz ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Addition of Lomustine in the Treatment of Elderly Patients with Acute Myeloblastic Leukemia Improves Survival with Acceptably Increased Infectious Toxicity. a Filo Study","keywords":"","combinedName":"doctor maria pilar gallego hernanz"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Megan ","lastName":"Melody ","credentials":"BA, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Defining Acute Myeloid Leukemia Ontogeny in Older Patients","keywords":"","combinedName":"doctor megan melody"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Daiichiro ","lastName":"Hasegawa ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effectiveness of Supportive Care Measurements to Reduce Infections during Induction for Children with Acute Myeloid Leukemia: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)","keywords":"","combinedName":"doctor daiichiro hasegawa"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Melanie ","lastName":"Rebechi ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FLT3 ITD AML Outcomes Are Impacted By Exposure to One Cycle of Cytarabine Based Consolidation, Pre- and Post-Transplant TKI Therapy, and Presence of Minimal Residual Disease (MRD) Prior to Allogeneic Blood or Marrow Transplant","keywords":"","combinedName":"doctor melanie rebechi"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Lane ","lastName":"Miller ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence and Predictors of Adverse Respiratory Events during Induction Therapy in Children with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor lane miller"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Simon ","lastName":"Kavanagh ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patients Who Are Refractory to Ida-FLAG As Initial Induction Chemotherapy for AML Have Persistence of the Dominant Genetic Mutations and a Poor Clinical Outcome","keywords":"","combinedName":"doctor simon kavanagh"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Michael ","lastName":"Byrne ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Results from an Ongoing Phase 1/2 Study of INCB053914, a Pan-Proviral Integration Sites for Moloney Virus (PIM) Kinase Inhibitor, in Patients with Advanced Hematologic Malignancies","keywords":"","combinedName":"doctor michael byrne"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Cheng-Hong ","lastName":"Tsai ","credentials":"M.D., M.Sc.","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Impacts and Dynamic Changes of Cohesin Complex Gene Mutations in De Novo Acute Myeloid Leukemia","keywords":"","combinedName":"doctor cheng-hong tsai"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Jorne Lionel","lastName":"Biccler ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Promyelocytic Leukemia Patients Surviving the Critical Initial Phase Have Survival Equivalent to That of the Calendar Year-, Sex-, and Age-Matched General Population","keywords":"","combinedName":"doctor jorne lionel biccler"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"James ","lastName":"Foran","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prospective Study of Acute Myeloid Leukemia (AML) Clinical Epidemiology and Cytogenetic Risk Group in Older Adults in the ECOG-ACRIN E2906 Clinical Trial: The Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) Study","keywords":"","combinedName":"doctor james foran"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Mary ","lastName":"Nauffal ","credentials":"PharmD,MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rate of Differentiation Syndrome in Patients Based on Timing of Initial All-Trans Retinoic Acid Administration","keywords":"","combinedName":"doctor mary nauffal"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Guru Subramanian ","lastName":"Guru Murthy ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recent Trends in the Incidence and Outcomes of Acute Promyelocytic Leukemia in United States","keywords":"","combinedName":"doctor guru subramanian guru murthy"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Jimmy ","lastName":"He ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Relationship between Complete Remission and Overall Survival in Acute Myeloid Leukemia: A Report from Daco-016 and Daco-017","keywords":"","combinedName":"doctor jimmy he"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Andrew ","lastName":"Lane","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from Ongoing Phase 1/2 Trial of SL-401 As Consolidation Therapy in Patients with Acute Myeloid Leukemia (AML) in Remission with Minimal Residual Disease (MRD)","keywords":"","combinedName":"doctor andrew lane"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Charles ","lastName":"Craddock ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Clinical Activity of Combined Romidepsin and Azacitidine Therapy in High Risk Acute Myeloid Leukemia: Preliminary Results of the Romaza Trial","keywords":"","combinedName":"doctor charles craddock"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Richard ","lastName":"Stone","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Addition of Midostaurin to Standard Chemotherapy Decreases Cumulative Incidence of Relapse (CIR) in the International Prospective Randomized, Placebo-Controlled, Double-Blind Trial (CALGB 10603 / RATIFY [Alliance]) for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with FLT3 Mutations","keywords":"","combinedName":"doctor richard stone"},{"sessionId":"11821","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Poster II","firstName":"Marla ","lastName":"Jalbut ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Antimicrobial Prophylaxis during Induction Chemotherapy for Acute Myeloid Leukemia in the Current Era","keywords":"","combinedName":"doctor marla jalbut"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Heng ","lastName":"Mei ","credentials":"PhD,MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Abnormal Coagulation Function in CD19-Targeted CAR-T Therapy","keywords":"","combinedName":"doctor heng mei"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Kimberly ","lastName":"Payne ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biologicfor the TreatmentofPh-like B-Cell AcuteLymphoblasticLeukemia with Overexpression of CRLF2","keywords":"","combinedName":"doctor kimberly payne"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Hye Na ","lastName":"Kim ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CAR T Cell Relapse CD19 Negative ALL Cells Express Integrins and Integrin Blockade Can Prolong Survival In Vivo","keywords":"","combinedName":"doctor hye na kim"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Benjamin ","lastName":"Frisch ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CCL3 Signaling Is Essential for Leukemia Progression but Dispensable for Hematopoietic Stem Cell Maintenance","keywords":"","combinedName":"doctor benjamin frisch"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"A. ","lastName":"Rijneveld ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clofarabin Added to Standard Treatment in Adult Patients with Newly Diagnosed ALL: First Results of the Randomized Phase III HOVON-100 Study","keywords":"","combinedName":"doctor a rijneveld"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Chelsea ","lastName":"Dieck ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Evolution Mechanisms and Collateral Sensitivity to Impdh Inhibitor Therapy in Relapsed Lymphoblastic Leukemia","keywords":"","combinedName":"doctor chelsea dieck"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Gabriele ","lastName":"Escherich ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daunorubicin during Delayed Intensification Considerably Lowers the Incidence of Infectious Complications but Might Result in Decreased Disease-Free Survival Compared to Adriamycin in Children with Acute Lymphoblastic Leukemia  a Randomized Comparison in Trial Coall 08-09.","keywords":"","combinedName":"doctor gabriele escherich"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Yashodhara ","lastName":"Dasgupta ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Drugging DNA Repair to Target T-ALL Cells","keywords":"","combinedName":"doctor yashodhara dasgupta"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Sarah K","lastName":"Tasian","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enhanced Efficacy of the SYK Inhibitor Entospletinib and Chemotherapy in Infant Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor sarah k tasian"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Christina ","lastName":"Halsey ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional SCD1 Is Critical for Acute Lymphoblastic Leukaemia Maintenance in the Central Nervous System","keywords":"","combinedName":"doctor christina halsey"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Rita ","lastName":"Assi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Blinatumomab in Combination with a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-Positive Leukemia","keywords":"","combinedName":"doctor rita assi"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Jishi ","lastName":"Wang ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Crucial Role of ROS-HO-1 Dependent Apoptosis Induced By Pan-HDACi in T-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor jishi wang"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Sergey ","lastName":"Bondarenko ","credentials":"PhD,MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Efficacy and Toxicity of Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Russian Multicenter Experience","keywords":"","combinedName":"doctor sergey bondarenko"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Etan ","lastName":"Orgel ","credentials":"MD, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapy for Children and Adults withEGIL- or WHO2008-DefinedMixed Phenotype Acute Leukemia: A Systematic Review and Meta-Analysis","keywords":"","combinedName":"doctor etan orgel"},{"sessionId":"11822","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II","firstName":"Rita ","lastName":"Assi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Updated Results of the Phase II Trial of Inotuzumab Ozogamicin (INO) Combined with Mini-Hyper-CVD As Salvage Therapy for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL)","keywords":"","combinedName":"doctor rita assi"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Eduardo ","lastName":"Laborda ","credentials":"DVM, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Switchable CAR-T Platform for Acute Lymphoblastic Leukemia Treatment","keywords":"","combinedName":"doctor eduardo laborda"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Amber ","lastName":"King ","credentials":"PharmD, BCOP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biomarkers for Predicting Toxicity and Response in Adult Acute Lymphoblastic Leukemia (ALL) Patients Treated with Blinatumomab","keywords":"","combinedName":"doctor amber king"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Andrey ","lastName":"Sokolov ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Blinatumomab + Tyrosine Kinase Inhibitorswith No Chemotherapyin BCR-ABL-Positive orIKZF1-Deleted or FLT3-ITD-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia Patients:High Molecular Remission Rate and Toxicity Profile","keywords":"","combinedName":"doctor andrey sokolov"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Anna ","lastName":"Richter ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Casein Kinase II Inhibition By CX-4945 and Epigenetic Modulation By Decitabine Demonstrate Significant Antiproliferative Activity As Single Agents As Well As in Combination in Acute B-Lymphoblastic Leukemia Cells","keywords":"","combinedName":"doctor anna richter"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Christian Omar ","lastName":"Ramos Penafiel ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Metformin in Patients with ALL Who Express High Levels of the ABCB1 Gene and Its Impact on Survival","keywords":"","combinedName":"doctor christian omar ramos penafiel"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Takaya ","lastName":"Moriyama ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Nudt15-Guided Thiopurine Dose Individualization In Vivo Using CRISPR/Cas9-Edited Mouse Model","keywords":"","combinedName":"doctor takaya moriyama"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Abhishek ","lastName":"Maiti ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hyper-CVAD Plus Ofatumumab As Frontline Therapy in CD20+ Acute Lymphoblastic Leukemia: Updated Results of a Phase II Trial","keywords":"","combinedName":"doctor abhishek maiti"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Eun Ji","lastName":"Gang ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrin alpha6Deletion Induces Apoptosis and Src Signaling Changes in Acute Lymphoblastic Leukemia Cells","keywords":"","combinedName":"doctor eun ji gang"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Haneen ","lastName":"Shalabi ","credentials":"DO","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intensification of Lymphodepletion Optimizes CAR Re-Treatment Efficacy","keywords":"","combinedName":"doctor haneen shalabi"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Paraskevi ","lastName":"Diamanti ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Investigating the Efficacy of Anti-CD200 Immunotherapy in MRD Low and Risk B Cell Precursor ALL","keywords":"","combinedName":"doctor paraskevi diamanti"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Patricia ","lastName":"Garrido Castro ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Irinotecan Induces Complete Remission in MLL-Rearranged Acute Lymphoblastic Leukemia Xenografts","keywords":"","combinedName":"doctor patricia garrido castro"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Jessica ","lastName":"Hochberg ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mitoxantrone in Combination with Clofarabine (MITCL) in Children, Adolescents and Young Adults with Refractory/Relapsed Acute Leukemia","keywords":"","combinedName":"doctor jessica hochberg"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Sneha ","lastName":"Ramakrishna ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Modulation of CD22 Antigen Density Improves Efficacy of CD22 Chimeric Antigen Receptor (CAR) T Cells Against CD22lo B-Lineage Leukemia and Lymphoma","keywords":"","combinedName":"doctor sneha ramakrishna"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Annika ","lastName":"Goss ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Oncolytic Measles Virus MV-NIS Controls Relapsed ALL Patient-Derived Xenografts","keywords":"","combinedName":"doctor annika goss"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Michael ","lastName":"Farrar ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overcoming Leukemia-Induced Immune Suppression in BCR-ABL+ Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor michael farrar"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"S. ","lastName":"Chu ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting the DNA Damage Response Pathway in MLL-rearranged B-Acute Lymphoblastic Leukemias","keywords":"","combinedName":"doctor s chu"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Karen ","lastName":"Bride ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targetting CD38 in T Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor karen bride"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Katharine E","lastName":"Bailey ","credentials":"MBBS, FRCPath, MA, MRCP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Relevance of CD20 Targeting of Oncolytic Measles Virus in the Treatment of Adult Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor katharine e bailey"},{"sessionId":"11823","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III","firstName":"Stephen Yang","lastName":"Liang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Outcome of Dasatinib in Combination with Less-Intensive Induction, Homobarringtonie, Cytarabine, G-SCF in Newly Diagnosed Patients with Ph+ALL","keywords":"","combinedName":"doctor stephen yang liang"},{"sessionId":"11824","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster II","firstName":"Rose Ann ","lastName":"Padua ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BCL-2 Inhibition with ABT-199 Shows Efficacy in AML Cell Lines with Synergistic Effects upon Addition of the MEK Inhibitor GDC-0973 and Prolongs Survival in an NAS/BCL-2-Mediated Mouse Model of AML Post-MDS","keywords":"","combinedName":"doctor rose ann padua"},{"sessionId":"11824","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster II","firstName":"Nainong ","lastName":"LI ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Outcomes of Different Regimens in Patients Newly Diagnosed with Acute Promyelocytic Leukemia","keywords":"","combinedName":"doctor nainong li"},{"sessionId":"11824","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster II","firstName":"Pankit ","lastName":"Vachhani ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intensive Chemotherapy Vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience","keywords":"","combinedName":"doctor pankit vachhani"},{"sessionId":"11824","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster II","firstName":"Almudena ","lastName":"Cabero Martnez ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Results and Cost-Effectiveness of the Flagida-Lite Regimen in Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome","keywords":"","combinedName":"doctor almudena cabero martnez"},{"sessionId":"11824","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster II","firstName":"Gabriele ","lastName":"Greve ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preferential in Vitro and In Vivo Induction of Endogenous Retrovirus Transcription from a Monoallelic Chromosome 7q in Decitabine (DAC) Treated AML Blasts","keywords":"","combinedName":"doctor gabriele greve"},{"sessionId":"11824","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster II","firstName":"Allison ","lastName":"Kaeding ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prolonged Azacitidine Exposure Alters Immunophenotype in Myeloid Leukemia Cell Lines","keywords":"","combinedName":"doctor allison kaeding"},{"sessionId":"11824","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster II","firstName":"Uwe ","lastName":"Platzbecker ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real Life Experience with ATRA-Arsenic Trioxide Based Regimen in Acute Promyelocytic Leukemia  Updated Results of the Prospective German Intergroup Napoleon Registry","keywords":"","combinedName":"doctor uwe platzbecker"},{"sessionId":"11824","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster II","firstName":"Takenobu ","lastName":"Nii ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Novel Imipridone ONC212 Induces Pronounced Anti-Leukemia Effects in Vitro and In Vivo and Is Highly Synergistic with the BCL-2 Inhibitor ABT-199","keywords":"","combinedName":"doctor takenobu nii"},{"sessionId":"11824","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster II","firstName":"Clemence ","lastName":"Marcault ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Topotecan Plus Cytarabine Is an Effective and Safe Regimen for Newly Diagnosed and Adverse ELN-Risk Acute Myeloid Leukemia Subset in Patients with Cardiac Comorbidities","keywords":"","combinedName":"doctor clemence marcault"},{"sessionId":"11825","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster III","firstName":"Michael Richard","lastName":"Grunwald ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AcDVP16 Induction Therapy for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor michael richard grunwald"},{"sessionId":"11825","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster III","firstName":"Alexandra McLean","lastName":"Stevens ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Atovaquone Demonstrates Single Agent Activity and an Additive Effect in Combination with Cytotoxic Chemotherapy (Cytarabine and Daunorubicin) in AML ","keywords":"","combinedName":"doctor alexandra mclean stevens"},{"sessionId":"11825","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster III","firstName":"LaQuita M","lastName":"Jones ","credentials":"DO","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Exceptional Responses to Epigenetic Based Therapy in Pediatric and Young Adult Monosomy 7 MDS/AML Patients with and without TP53 Mutations","keywords":"","combinedName":"doctor laquita m jones"},{"sessionId":"11825","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster III","firstName":"Antoine N","lastName":"Saliba ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Final Results of Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib in Acute Myeloid Leukemia with FLT3-ITD Mutation or Poor-Risk Cytogenetics","keywords":"","combinedName":"doctor antoine n saliba"},{"sessionId":"11825","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster III","firstName":"Stefan D ","lastName":"Dendorfer ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Induction Therapy for AML with 90 Mg/m Daunorubicin Results in Higher Troponin T Serum Levels in Comparison to Treatment with 60 Mg/m Daunorubicin","keywords":"","combinedName":"doctor stefan d dendorfer"},{"sessionId":"11825","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster III","firstName":"Sarah ","lastName":"Bertoli ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Is Hydroxyurea Deleterious in Patients with ELN Favorable AML and WBC Inferior to 50.109/L?","keywords":"","combinedName":"doctor sarah bertoli"},{"sessionId":"11825","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster III","firstName":"Salem ","lastName":"Bahashwan ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcome after Midam Regimen and Impact of Post-Remission Strategy in Patients with Relapsing or Refractory Acute Myeloid Leukemia","keywords":"","combinedName":"doctor salem bahashwan"},{"sessionId":"11825","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster III","firstName":"Prajwal ","lastName":"Boddu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes By Treatment Setting and Genomic Profile in Patients with AML on Cladribine, Idarubicin, and Cytarabine","keywords":"","combinedName":"doctor prajwal boddu"},{"sessionId":"11825","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Poster III","firstName":"Christoph","lastName":"Rollig","credentials":"MD, MSC","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real World Data on Decitabine Treatment in 296 Patients with Acute Myeloid Leukemia: Outcome and Impact of TP53 Mutations","keywords":"","combinedName":"doctor christoph rollig"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Derek NJ","lastName":"Hart ","credentials":"PhD, FRCPA, FRACP, MB","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Blood Dendritic Cell Vaccine for Acute Myeloid Leukemia Expands Anti-Tumour T Cell Responses at Remission","keywords":"","combinedName":"doctor derek nj hart"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Matthew ","lastName":"Foster ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Dose-Finding Study of Lenalidomide As Post-Remission Therapy for Older Adults with Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor matthew foster"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Keith","lastName":"Pratz","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase (ph) 1b/2 Study of TAK-659, an Investigational Dual FLT-3 and SYK Inhibitor, in Patients (Pts) with Relapsed or Refractory Acute Myelogenous Leukemia (R/R AML)","keywords":"","combinedName":"doctor keith pratz"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Laura ","lastName":"Finn ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 2 Study of Actinium-225 (225Ac)-Lintuzumab in Older Patients with Previously Untreated Acute Myeloid Leukemia (AML) Unfit for Intensive Chemotherapy","keywords":"","combinedName":"doctor laura finn"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Usama ","lastName":"Gergis ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adoptive Immunotherapy with Cord Blood (CB) Grafts Targeting Shared Inherited Paternal Antigens (IPA) and/or Non-Inherited Maternal Antigens (NIMA) during Induction Treatment for High Risk Myeloid Malignancies: Safety and Preliminary Results","keywords":"","combinedName":"doctor usama gergis"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Colin ","lastName":"Godwin ","credentials":"MD, MPhil","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bispecific Anti-CD123 x Anti-CD3 Adaptir Molecules APVO436 and APVO437 Have Broad Activity Against Primary Human AML Cells In Vitro","keywords":"","combinedName":"doctor colin godwin"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Carsten ","lastName":"Riether ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Blocking CD70/CD27 Signaling in Combination with Hypomethylating Agents Eradicates Human CD34+ AML Stem and Progenitor Cells in Vitro and In Vivo","keywords":"","combinedName":"doctor carsten riether"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Katherine","lastName":"Tarlock","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD33 DE2 Transcript Variant Encoded By Splicing Polymorphism Is Devoid of Antibody Binding Site and Lacks Response to CD33 Directed Antibody Drug Conjugates","keywords":"","combinedName":"doctor katherine tarlock"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Maksim ","lastName":"Mamonkin ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chimeric Antigen Receptor (CAR) T Cell Therapy for CD7-Positive Acute Myeloid Leukemia","keywords":"","combinedName":"doctor maksim mamonkin"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Xiangmeng ","lastName":"Wang ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 in AML","keywords":"","combinedName":"doctor xiangmeng wang"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Kristopher ","lastName":"Clark ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CT7001, a Novel Orally Bio-Available CDK7 Inhibitor, Is Highly Active in in-Vitro and in-Vivo Models of AML","keywords":"","combinedName":"doctor kristopher clark"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Alexander ","lastName":"Lewis ","credentials":"BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dual Sphingosine Kinase and Bcl-2 Inhibition Exhibits Synergistic Cell Death in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor alexander lewis"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Joseph ","lastName":"Jurcic ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Results from a Biomarker-Directed Phase 2 Trial of Sy-1425 in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Demonstrate DHRS3 Induction and Myeloid Differentiation Following Sy-1425 Treatment","keywords":"","combinedName":"doctor joseph jurcic"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Jeffrey ","lastName":"Lancet","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of CPX-351 Versus 7+3 in Older Adults with Secondary Acute Myeloid Leukemia: Combined Subgroup Analysis of Phase 2 and Phase 3 Studies","keywords":"","combinedName":"doctor jeffrey lancet"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Saisai ","lastName":"Li ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incorporation of 4-1BB Endowed the Potent CD33 Specific Chimeric Antigen Receptor T Cells with Anti-Exhaustion Capacity and Increased Central Memory Compartment","keywords":"","combinedName":"doctor saisai li"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Jo ","lastName":"Ishizawa ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of Translation Initiation and Heat Shock Factor 1 (HSF1): A Novel Strategy Targeting FLT3 Double Mutant and Non-FLT3 Mutant AML Progenitor/Stem Cells","keywords":"","combinedName":"doctor jo ishizawa"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Timothy S","lastName":"Pardee ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim Analysis of a Single Arm Phase II Study of Cpi-613 in Combination with High Dose Cytarabine and Mitoxantrone for Patients with Relapsed or Refractory AML","keywords":"","combinedName":"doctor timothy s pardee"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Allison ","lastName":"Kaeding ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mesothelin Is a Novel Disease Marker and Potential Therapeutic Target in Pediatric Acute Myeloid Leukemia","keywords":"","combinedName":"doctor allison kaeding"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Bettina ","lastName":"Lindl ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Midostaurin Reduces Bite Mediated Cytotoxicity Against Acute Myeloid Leukemia","keywords":"","combinedName":"doctor bettina lindl"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Lucas ","lastName":"Gutierrez ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Midostaurin Reduces Regulatory T Cell Population in Healthy and Acute Myeloid Leukemia Cells","keywords":"","combinedName":"doctor lucas gutierrez"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Geoffrey ","lastName":"Uy ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multivariate Efficacy Analysis of a Randomized, Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Treatment-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes","keywords":"","combinedName":"doctor geoffrey uy"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Sarah ","lastName":"Cooley ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Neurological Consequences of Cytokine Release Syndrome Following Subcutaneous Recombinant IL-15 and Haploidentical Donor Natural Killer Cell Therapy for Advanced Acute Myeloid Leukemia","keywords":"","combinedName":"doctor sarah cooley"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Justin ","lastName":"Boucher ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Next Generation Sequencing of Immunized Mouse Splenocytes to Develop an Anti-TIM3 Chimeric Antigen Receptor for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor justin boucher"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Tae Kon ","lastName":"Kim ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PD-1H (VISTA) Induces Immune Evasion in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor tae kon kim"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Raoul ","lastName":"Tibes ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition with Sonidegib (LDE225) in Myeloid Malignancies","keywords":"","combinedName":"doctor raoul tibes"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Jessica ","lastName":"Liegel ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I/Ib Trial of the MUC1 Inhibitor GO-203-2C Alone and in Combination with Decitabine for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor jessica liegel"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Naval","lastName":"Daver","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase IB/II Study of Lirilumab with Azacytidine (AZA) in Relapsed AML","keywords":"","combinedName":"doctor naval daver"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Stephen ","lastName":"Strickland","credentials":"MD, MSCI","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II Trial of Vosaroxin and Infusional Cytarabine for Frontline Treatment of Acute Myeloid Leukemia (VITAL) Patients Eligible for Intensive Chemotherapy: A Planned Interim Analysis","keywords":"","combinedName":"doctor stephen strickland"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Tomas ","lastName":"Jelinek ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Clinical Efficacy of the Anti-CD38 Monoclonal Antibody (mAb) Isatuximab in Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor tomas jelinek"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Gabriela ","lastName":"Hobbs","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preclinical Rationale for the Use of Regorafenib in Myeloid Malignancies","keywords":"","combinedName":"doctor gabriela hobbs"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Tianyu ","lastName":"Cai ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Clinical Studies of Allogeneic Anti-CD123 CAR T-Cells for the Therapy of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)","keywords":"","combinedName":"doctor tianyu cai"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Mohamad","lastName":"Mohty","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transplantation (auto-FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment (ODYSSEE study): First Results of a Prospective Multicenter Trial","keywords":"","combinedName":"doctor mohamad mohty"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Justin M","lastName":"Watts","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from a Phase 1b (OX1222) Dose-Ranging Study of OXi4503 Combined with Cytarabine in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome","keywords":"","combinedName":"doctor justin m watts"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Aaron D","lastName":"Goldberg","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from an Ongoing Phase 1 Study Indicate Adct-301 (Camidanlumab Tesirine) Is Well-Tolerated in Patients with Relapsed or Refractory CD25-Positive Acute Leukemia","keywords":"","combinedName":"doctor aaron d goldberg"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Graeme ","lastName":"Hodgson ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sy-1365, a Potent and Selective CDK7 Inhibitor, Exhibits Anti-Tumor Activity in Preclinical Models of Hematologic Malignancies, and Demonstrates Interactions with the BCL-XL/BCL2 Mitochondrial Apoptosis Signaling Pathway in Leukemia","keywords":"","combinedName":"doctor graeme hodgson"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Hairui ","lastName":"Su ","credentials":"BS, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting PRMT1 As a Novel Curative Therapy for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor hairui su"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Lina ","lastName":"Han ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Residual Chemotherapy-Resistant Acute Myeloid Leukemia Cells By a Novel Oxphos Inhibitor IACS010759","keywords":"","combinedName":"doctor lina han"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Xiaojia ","lastName":"Niu ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting the GAS6/AXL Pathway with a Newly Developed AXL-Selective Inhibitor SLC-0211 for the Treatment of Acute Myeloid Leukemia","keywords":"","combinedName":"doctor xiaojia niu"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Timothy ","lastName":"Ferng ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Novel, Irreversible FLT3 Inhibitor FF-10101 Demonstrates Broad in Vitro Activity Against FLT3 Inhibitor Resistance Mutations","keywords":"","combinedName":"doctor timothy ferng"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Metis ","lastName":"Hasipek ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapeutic Targeting of GLI1 in Acute Myeloid Leukemia ","keywords":"","combinedName":"doctor metis hasipek"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Silvia ","lastName":"Maifrede ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tyrosine Kinase Inhibitor-Induced Defects in DNA Repair Sensitize FLT3(ITD)-Positive Acute Myeloid Leukemia Quiescent and Proliferative Cells to PARP Inhibitors","keywords":"","combinedName":"doctor silvia maifrede"},{"sessionId":"11826","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II","firstName":"Courtney ","lastName":"DiNardo","credentials":"MD, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Updated Safety and Efficacy of Venetoclax with Decitabine or Azacitidine in Treatment-Naive, Elderly Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor courtney dinardo"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Diana ","lastName":"Hanekamp ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Dynamic Epigenetic Landscape in Genetic and Immunophenotypic Stable Pediatric AML","keywords":"","combinedName":"doctor diana hanekamp"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Leylah ","lastName":"Drusbosky ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Genomic Signature Predicting Venetoclax Treatment Response in Acute Myeloid Leukemia (AML) Identified By Protein Network Mapping and Validated By Ex Vivo Ddrug Sensitivity Testing","keywords":"","combinedName":"doctor leylah drusbosky"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Durga Prasad ","lastName":"Dash ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A New Highly Sensitive Realtime PCR Assay with Faster Turnaround Time for Detecting IDH1 and IDH2 mutations in Acute Myeloid Leukemia (AML) Patients","keywords":"","combinedName":"doctor durga prasad dash"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Linda ","lastName":"Fogelstrand ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Accurate and Sensitive Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Deep Sequencing of Single Nucleotide Variations","keywords":"","combinedName":"doctor linda fogelstrand"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Bhavana ","lastName":"Bhatnagar ","credentials":"DO","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Myeloid Leukemia (AML) Patients with an Isolated Trisomy Display Increased Frequency of Spliceosome Mutations","keywords":"","combinedName":"doctor bhavana bhatnagar"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Anna Amanda","lastName":"Schnherz ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Myeloid Leukemia Classification System That Associates Normal Myeloid-Cell Subset Gene Signatures with Prognosis","keywords":"","combinedName":"doctor anna amanda schnherz"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Ashwin ","lastName":"Sridharan ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AML-Associated Somatic Mutations Can be Detected in Stem and Progenitor Populations in Patients with Antecedent Multiple Myeloma Years before Onset of Therapy-Related Transformation","keywords":"","combinedName":"doctor ashwin sridharan"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Virginia Mara","lastName":"De Deus Wagatsuma ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Association between Nuclear SET Domain (NSD) Protein Lysine Methyltransferases (KMT) Expression and Poor Prognosis in Acute Promyelocytic Leukemia (APL) Patients Treated with ATRA and Anthracycline Protocol","keywords":"","combinedName":"doctor virginia mara de deus wagatsuma"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Kim ","lastName":"Klein ","credentials":"MD, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics and Outcomes of Pediatric Patients with t(16;16)-AML: Results of a Case Series By the International BFM Study Group","keywords":"","combinedName":"doctor kim klein"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Yazeed ","lastName":"Sawalha ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics, Mutation Profiles andOutcomes of Patients with Acute Myeloid Leukemia and a History of Autoimmune Disease","keywords":"","combinedName":"doctor yazeed sawalha"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Mridul ","lastName":"Agrawal ","credentials":"MD,MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Relevance of Alternatively Spliced Isoform AML1-ETO9a in Adult Patients with t(8;21)(q22;q22.1) Acute Myeloid Leukemia (AML): A Study of the German-Austrian AML Study Group (AMLSG)","keywords":"","combinedName":"doctor mridul agrawal"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Patrizia ","lastName":"Vitullo ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Treatment with JQ1 and Curcumin Synergically Modulates Apoptosis, Cell Cycle Features, Micrornas and Gene Expression in High-Risk Pediatric Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor patrizia vitullo"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Antonio ","lastName":"Lucena-Araujo ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combining Gene Mutation with Gene Expression Data Improves Outcomes Prediction in Acute Promyelocytic Leukemia","keywords":"","combinedName":"doctor antonio lucena-araujo"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Hong ","lastName":"Mu ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Induction Chemotherapy in NSG and NOD-Rag1nullIL2rgnullMouse Models of FLT3 Mutant AML","keywords":"","combinedName":"doctor hong mu"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Hongxing ","lastName":"Liu ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CSF3R Mutation in Acute Leukemia and MDS Patients","keywords":"","combinedName":"doctor hongxing liu"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Matt ","lastName":"Christopher ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Downregulation of MHC Class II in Relapsed AML Cells after Allogeneic Transplantation","keywords":"","combinedName":"doctor matt christopher"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Chetasi ","lastName":"Talati ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of NPM1 Mutation on Prognosis and Therapeutic Efficacy in Patients Aged =70 Years with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor chetasi talati"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Chi Young ","lastName":"Ok ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Endleukemia Assay v1: Enabling NGS-Based Comprehensive Routine Molecular Profiling of Leukemias in Routine Clinical Care","keywords":"","combinedName":"doctor chi young ok"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Wing Hing ","lastName":"Wong ","credentials":"BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Error-Corrected Sequencing of Cord Bloods Identifies Pediatric AML-Associated Clonal Hematopoiesis","keywords":"","combinedName":"doctor wing hing wong"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Mark ","lastName":"Levis","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of the Impact of Minimal Residual Disease, FLT3 Allelic Ratio, and FLT3 Mutation Status on Overall Survival in FLT3 Mutation-Positive Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) in the Chrysalis Phase 1/2 Study","keywords":"","combinedName":"doctor mark levis"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Maher ","lastName":"Albitar ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FLT3 Mutation in Acute Myeloid Leukemia: Primary or Secondary Mutation?","keywords":"","combinedName":"doctor maher albitar"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Katherine","lastName":"Tarlock","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional Evaluation and Clinical Implications of FLT3 Juxtamembrane Domain Short Variants in Pediatric AML","keywords":"","combinedName":"doctor katherine tarlock"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Irene ","lastName":"Locher ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fusion Transcripts without Corresponding Cytogenetic Abnormalities in Acute Myeloid Leukemia: Implications for AML Pathogenesis","keywords":"","combinedName":"doctor irene locher"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Nikolaus ","lastName":"Jahn ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Heterogeneity of t(8;21)(q22;q22.1) Acute Myeloid Leukemia Revealed By High-Throughput Targeted Sequencing","keywords":"","combinedName":"doctor nikolaus jahn"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Richard ","lastName":"Stone","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Profiling and Deep IDH1 Mutation Clearance to =0.04% in Ivosidenib (AG-120)-Treated Patients with Mutant IDH1 Relapsed or Refractory and Untreated AML","keywords":"","combinedName":"doctor richard stone"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Sarah ","lastName":"Zhao ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Long Non-Coding RNA Genes Important for Normal Hematopoiesis and Leukemogenesis Using Bioinformatics Tools","keywords":"","combinedName":"doctor sarah zhao"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Giuseppe ","lastName":"Rossi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Relapse Risk Using a Multiparameter Flow Cytometry-Based Detection of Minimal Residual Disease in Adult Patients with Acute Myeloid Leukemia at ELN Intermediate-Risk","keywords":"","combinedName":"doctor giuseppe rossi"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Manja ","lastName":"Meggendorfer ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IDH1R132, IDH2R140 and IDH2R172 in AML: Different Genetic Landscapes Correlate with Outcome and May Influence Targeted Treatment Strategies","keywords":"","combinedName":"doctor manja meggendorfer"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Aaron D","lastName":"Goldberg","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Profiling in Extramedullary Acute Myeloid Leukemia Reveals Distinct Subgroups Defined By Mutations in KIT and RUNX1","keywords":"","combinedName":"doctor aaron d goldberg"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Terrence J","lastName":"Bradley ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutational Frequency in Hispanic and Non-Hispanic Patients with Acute Myeloid Leukemia (AML): Updated Analysis of 227 Patients","keywords":"","combinedName":"doctor terrence j bradley"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Caner ","lastName":"Saygin ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutations in DNMT3A, U2AF1, and EZH2 Identify Intermediate-Risk Acute Myeloid Leukemia Patients with Poor Outcome after CR1","keywords":"","combinedName":"doctor caner saygin"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Diego Antonio","lastName":"Pereira-Martins ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overexpression of KMT2E Is Associated with Higher Granulocytic Differentiation Rate in Response to ATRA-Based Treatment in Acute Promyelocytic Leukemia Cell Lines","keywords":"","combinedName":"doctor diego antonio pereira-martins"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Jun Hyung ","lastName":"Lee ","credentials":"MD, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overexpression of Phospholipase C Beta 2 Is Associated with Favorable Prognosis in Normal Karyotype Acute Myeloid Leukemia","keywords":"","combinedName":"doctor jun hyung lee"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Kiyomi ","lastName":"Morita ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Persistent Somatic Mutation at Remission Is Associated with Poor Survival and Higher Risk of Relapse in Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor kiyomi morita"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Liliana H","lastName":"Mochmann ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phosphoproteomic Profiling Reveals Metabolic Factors Facilitating Leukemia-Stroma Crosstalk in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor liliana h mochmann"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Shaun ","lastName":"Fleming ","credentials":"MBBS(Hons) FRACP FRCPA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Post-Allogeneic Stem Cell Transplant Surveillance of CD34+ Sorted Peripheral Blood to Quantify Emergent DNMT3A, IDH and NPM1 clones and Correlation with Clinical Outcome","keywords":"","combinedName":"doctor shaun fleming"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Mihong ","lastName":"Choi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Receptor Tyrosine Kinase-RAS Pathway Mutation Is Enriched in Myeloid Sarcoma","keywords":"","combinedName":"doctor mihong choi"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Abdelrahman ","lastName":"Elsayed ","credentials":"BSc, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk Score Generated from Ara-C Metabolic Pathway Predicts Leukemic Cell Intracellular Ara-CTP Levels in AML-97 Pediatric Patients","keywords":"","combinedName":"doctor abdelrahman elsayed"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Anna ","lastName":"Stengel ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RUNX1 Mutations in MDS, s-AML and De Novo AML: Differences in Accompanying Cytogenetic and Molecular Genetic Alterations, Clonal Architecture and Outcome","keywords":"","combinedName":"doctor anna stengel"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Alexandra McLean","lastName":"Stevens ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Select Peripheral Blood Cytokine Levels Are Associated with Survival in Pediatric Acute Myeloid Leukemia","keywords":"","combinedName":"doctor alexandra mclean stevens"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Yi ","lastName":"Zhou ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Significance of Peri-Transplant Measurable Residual Disease Detected By Multiparameter Flow Cytometry and Next-Generation Sequencing in Adults with NPM1-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor yi zhou"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Zohar ","lastName":"Sachs ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Cell Transcriptional Profiling of Acute Myeloid Leukemia Identifies Prognostic Transcriptional Profiles at Diagnosis","keywords":"","combinedName":"doctor zohar sachs"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Fanny ","lastName":"Gonzales ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Aberrant Expression of CD81 Impacts Cell Adhesion and Migration, Drug Resistance and Prognosis of Acute Myeloid Leukemia","keywords":"","combinedName":"doctor fanny gonzales"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Johannes ","lastName":"Schetelig ","credentials":"MD ","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of the ELN 2017 Classification for AML with Intermediate Risk Cytogenetics with or without NPM1-Mutations and High or Low Ratio FLT3-ITDs","keywords":"","combinedName":"doctor johannes schetelig"},{"sessionId":"11827","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Claudia ","lastName":"Haferlach ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whole Genome Sequencing in Combination with Transcriptome Sequencing Unravels the Pathogenetic Impact of Rare Balanced Rearrangements in Myeloid Malignancies and May Lead to Novel Personalized Therapeutic Strategies","keywords":"","combinedName":"doctor claudia haferlach"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Akash ","lastName":"Mukherjee ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Integer Weighted Genomic Mutation Score (GMS) Using Next Generation Sequencing Is Predictive of Prognosis in Intermediate Risk AML Patients","keywords":"","combinedName":"doctor akash mukherjee"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Valentina ","lastName":"Salvestrini ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bitter Taste Receptors Are Expressed on Acute Myeloid Leukemia Cells and Their Activation Results in Quiescence Induction and Prevention of Migration","keywords":"","combinedName":"doctor valentina salvestrini"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Bei ","lastName":"Jia ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bone Marrow CD8 T Cells Express High Frequency of PD-1 and Exhibit Reduced Anti-Leukemia Response in AML Patients","keywords":"","combinedName":"doctor bei jia"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Giorgia ","lastName":"Simonetti ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bromodomain Inhibition Is Effective Against Acute Myeloid Leukemia Cells Under Hypoxia and Induces Genome-Dependent Metabolic Perturbations","keywords":"","combinedName":"doctor giorgia simonetti"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Teppei ","lastName":"Sakoda ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Canonical Wnt Pathway Is Activated in Myeloid Leukemia Stem Cells Via Hematopoietic Cell Kinase That Is Phosphorylated By an Autocrine TIM-3/Galectin-9 Signaling","keywords":"","combinedName":"doctor teppei sakoda"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Sabine","lastName":"Kayser","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics and Outcome of Patients with Acute Myeloid Leukemia and t(6;9)(p22;q34)","keywords":"","combinedName":"doctor sabine kayser"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Alan ","lastName":"Miller ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of Acute Myeloid Leukaemia (AML) Patients with Elevated Peripheral Blood Plasma D-2-Hydroxyglutarate (D-2HG) and/or Isocitrate Dehydrogenase (IDH) Mutational Status","keywords":"","combinedName":"doctor alan miller"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Sarvenaz ","lastName":"Taghavi ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of Cooperating Mutations in Murine Acute Leukemias: Towards Establishing Leukemia Models with Genetic Lesions in Defined Cellular Pathways","keywords":"","combinedName":"doctor sarvenaz taghavi"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Taehyung ","lastName":"Kim ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical and Genetic Relevance of Somatic Mutations in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Patients Using Serial Sequencing","keywords":"","combinedName":"doctor taehyung kim"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Lisa ","lastName":"Brodersen ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Implications of Detection and Clearance of Post-Induction Residual Disease in 2119 Children and Young Adults with AML: Childrens Oncology Group Studies AAML0531 and AAML1031","keywords":"","combinedName":"doctor lisa brodersen"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Chetasi ","lastName":"Talati ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Survival Outcomes in Elderly Acute Myeloid Leukemia Patients (Age = 70) When Treated with Azacitidine or Decitabine As an Initial Treatment Modality","keywords":"","combinedName":"doctor chetasi talati"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Anthony ","lastName":"Colombo ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Characterization of Transposable Elements in the Acute Myeloid Leukemia Transcriptome","keywords":"","combinedName":"doctor anthony colombo"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Genki ","lastName":"Yamato ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Methylation Analysis in Pediatric Patients with Acute Myeloid Leukemia the Jccg Study, JPLSG AML-05","keywords":"","combinedName":"doctor genki yamato"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Julia ","lastName":"Maxson ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CSF3R Mutations Synergize with CEBPA and SETBP1 Mutations in Acute Myeloid Leukemia and Chronic Neutrophilic Leukemia","keywords":"","combinedName":"doctor julia maxson"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Miguel ","lastName":"Torres Martin ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differentiation Response to Quizartinib, a Potent 2nd Generation FLT3 Inhibitor, in Relapsed FLT3-Mutant AML Patients Correlates with Specific DNA Methylation Signature Prior to Therapy","keywords":"","combinedName":"doctor miguel torres martin"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Leylah ","lastName":"Drusbosky ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Digital Drug Screening and Computational Modeling Identifies Treatment Opportunities Despite Lack of Directly Actionable Mutations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)","keywords":"","combinedName":"doctor leylah drusbosky"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Renata Scopim","lastName":"Ribeiro ","credentials":"BSc, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"DNMT3A Is Highly Expressed in Bone Marrow Cells from Acute Myeloid Leukemia Patients","keywords":"","combinedName":"doctor renata scopim ribeiro"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Bowen ","lastName":"Yan ","credentials":"Ph. D","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Epigenetic Drugs Selectively Target a Population of AML Cells Which Are Positive for CD123 Cell Surface Marker and Are Chemoresistant","keywords":"","combinedName":"doctor bowen yan"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Oscar ","lastName":"Brck ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Extensive Immunosuppression in the Acute Myeloid Leukemia (AML) Bone Marrow and Discovery of NK Cells As Biomarker of Superior Survival","keywords":"","combinedName":"doctor oscar brck"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Zhenyi ","lastName":"Jin ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Higher Proportion of a Novel PD-1+ Foxp3+ ?d Regulatory T Cell Subset in De Novo and Recurrent AML","keywords":"","combinedName":"doctor zhenyi jin"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Dennis ","lastName":"Eastburn ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Throughput Single-Cell DNA Sequencing of AML Tumors with Droplet Microfluidics","keywords":"","combinedName":"doctor dennis eastburn"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Chetasi ","lastName":"Talati ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hypomethylating Agents Versus Intensive Chemotherapy in Elderly Patients (Age = 70) with Acute Myeloid Leukemia with High White Blood Cell Count","keywords":"","combinedName":"doctor chetasi talati"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Thomas","lastName":"Koehnke","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Novel Targets for Antibody or Chimeric Antigen Receptor (CAR) Based Immunotherapy in AML: Characterizing the Surfaceome from Primary Patient Samples","keywords":"","combinedName":"doctor thomas koehnke"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Juan Luiz","lastName":"Coelho-Silva ","credentials":"BSc, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IGF Signaling Predicts Outcomes and Is a Promising Target Therapy for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor juan luiz coelho-silva"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Sergio ","lastName":"Rutella ","credentials":"MD,PhD,FRCPath","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Gene Expression Profiling in Children and Adults with Acute Myeloid Leukemia Identifies Distinct Phenotypic Patterns","keywords":"","combinedName":"doctor sergio rutella"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Bettina ","lastName":"Balk ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of 9q Deletions on the Classification in AML","keywords":"","combinedName":"doctor bettina balk"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Ivn ","lastName":"Martn ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Gene mutations and Dynamics Methylation of CDKN2B and DLC-1 Promoters on Treatment Response with Azacitidine","keywords":"","combinedName":"doctor ivn martn"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Rod ","lastName":"Docking ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improved Clinical Assessment of Myeloid Malignancies By Transcriptome Profiling","keywords":"","combinedName":"doctor rod docking"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Koichi ","lastName":"Takahashi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrative Genomic Analysis of Adult Mixed Phenotype Acute Leukemia (MPAL)","keywords":"","combinedName":"doctor koichi takahashi"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Jayakumar ","lastName":"Vadakekolathu ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interferon-? Induces Distinct mRNA and Protein Profiles in Acute and Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor jayakumar vadakekolathu"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Valeria ","lastName":"Bisio ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Non Coding RNA BALR2-CDK6 Axis Influences Cell Differentiation and Metabolic Status of Acute Myeloid Leukemia","keywords":"","combinedName":"doctor valeria bisio"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Tiziana ","lastName":"Ottone ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Longitudinal Detection of DNMT3AR882H Transcripts in Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor tiziana ottone"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Etienne ","lastName":"De Clara ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Longitudinal Transcriptome Analysis of Myelodysplatic Syndrome Progression to Acute Myeloid Leukemia: Implications for Prognosis","keywords":"","combinedName":"doctor etienne de clara"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"George ","lastName":"Rassidakis ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low-Level SAMHD1 Expression in Acute Myeloid Leukemia Blasts Correlates with Favorable Outcome in Patients with Diploid Cytogenetics Treated with Cytarabine-Based Chemotherapy Regimens","keywords":"","combinedName":"doctor george rassidakis"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Joseph David","lastName":"Khoury ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MAPKAP1 (Sin1), a Key Component of the MTORC2 Complex, Confers Resistance to Sorafenib and Correlates with Adverse Clinical Outcomes in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor joseph david khoury"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Giovanni ","lastName":"Marconi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration","keywords":"","combinedName":"doctor giovanni marconi"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Jens-Uwe ","lastName":"Hartmann ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MiR-143 Targets ERK5 in Granulopoiesis and Predicts Outcome of Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor jens-uwe hartmann"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Francesca ","lastName":"Schieppati ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Monitoring of NPM1 Is a Useful Tool for Detecting Early-Stage Relapse and to Guide Pre-Emptive Treatment Approaches in Patients with NPM1-Mutated Acute Myeloid Leukemia","keywords":"","combinedName":"doctor francesca schieppati"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Louise ","lastName":"Pettersson ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Monitoring Leukemic Mutations Using UltrasensitiveIbsafe Digital Droplet Analysis Predicts Relapse of Acute Myeloid Leukemia","keywords":"","combinedName":"doctor louise pettersson"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Marius ","lastName":"Bill ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutational Landscape and Clinical Outcome Associated with Different Rearrangements Involving 11q23/MLL in De Novo Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor marius bill"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Sara ","lastName":"Mastaglio ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Natural Killer Receptor Ligand Expression By AML Blasts Determines Survival and Relapse Following Induction Chemotherapy","keywords":"","combinedName":"doctor sara mastaglio"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Ryan J","lastName":"Stubbins ","credentials":"MD,MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"N-Myristoyltransferase 2 (NMT2) Protein Levels Predict Survival in Acute Myeloid Leukemia (AML): A Novel Prognostic Biomarker","keywords":"","combinedName":"doctor ryan j stubbins"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Sanne ","lastName":"Noort ","credentials":"MD, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NUP98-KDM5A Fusion Gene Is Not Exclusive to Acute Megakaryoblastic Leukemia and Is an Independent Predictor of Poor Prognosis","keywords":"","combinedName":"doctor sanne noort"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Syed Khizer ","lastName":"Hasan ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Over-Expression of ERG Predicts Poor Outcome in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor syed khizer hasan"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Robin ","lastName":"Lesley ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Peripheral Blood As a Substitute for Bone Marrow for Assessing the Immune Profile in AML","keywords":"","combinedName":"doctor robin lesley"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Christopher ","lastName":"Marlein ","credentials":"BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PGC1a Driven Mitochondrial Biogenesis within the Bone Marrow Stromal Cells of the Acute Myeloid Leukemia Micro-Environment Is a Pre-Requisite for Mitochondrial Transfer to Leukemic Blasts","keywords":"","combinedName":"doctor christopher marlein"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Michael ","lastName":"Boyiadzis ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasma-Derived Exosomes Carrying Leukemia-Associated Antigens Associate with Leukemia Relapse in AML Patients after Chemotherapy","keywords":"","combinedName":"doctor michael boyiadzis"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Mariko ","lastName":"Minami ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PML-RARa of the Short but Not the Long/Variant Isoform Initiate from CD34+TIM-3+  LSCs with Hierarchical Leukemic Organization","keywords":"","combinedName":"doctor mariko minami"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Leylah ","lastName":"Drusbosky ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predicting Response to BET Inhibitors Using a Computational Model and Its Validation: A Beat AML Project Study","keywords":"","combinedName":"doctor leylah drusbosky"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Leylah ","lastName":"Drusbosky ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predicting Response to CDK4/6 Inhibitors and Combinations Using a Computational Biology Model and Its Validation: A Beat AML Project Study","keywords":"","combinedName":"doctor leylah drusbosky"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Leylah ","lastName":"Drusbosky ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predicting Response to IDH1/IDH2 Inhibitors Beyond IDH Mutations Using a Computational Model and Its Validation: A Beat AML Project Study","keywords":"","combinedName":"doctor leylah drusbosky"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Mariam ","lastName":"Ibaez ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preexisting Mutations in Hematopoietic Stem Cells in Patients with Therapy-Related Myeloid Neoplasms","keywords":"","combinedName":"doctor mariam ibaez"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"James ","lastName":"England ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognosis and Application of Day 14 Bone Marrow Results in Acute Myeloid Leukemia Induction","keywords":"","combinedName":"doctor james england"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Ya ","lastName":"Zhang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Importance of DOCK1 Transcript Levels, and Biologic Insights from DOCK1-Associated Gene and Microrna Expression Signatures in De Novo acute Myeloid Leukemia","keywords":"","combinedName":"doctor ya zhang"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Jun Hyung ","lastName":"Lee ","credentials":"MD, MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prohibitin Expression Level As a Companion Diagnostic Marker in Cytogenetically Normal Acute Myeloid Leukemia","keywords":"","combinedName":"doctor jun hyung lee"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Hendrik ","lastName":"Folkerts ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Putative Autophagy Protein VMP1 Amplifies Protective Autophagy Under Stress Conditions in AML Cells","keywords":"","combinedName":"doctor hendrik folkerts"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Bora E","lastName":"Baysal ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNA Editing By APOBEC3A Confers Dynamic Mutational Load in Monocytic Leukemias","keywords":"","combinedName":"doctor bora e baysal"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Shelley ","lastName":"Herbrich ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Robust Bioinformatics Approach for Identifying Novel AML LSC Targets: Putative Role of Galectin-1 in the Immune-Microenvironment","keywords":"","combinedName":"doctor shelley herbrich"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Emily ","lastName":"Silgard ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Robust Parsing and Automated ELN Risk Classification for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor emily silgard"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Zdenka ","lastName":"Kosarova ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Simulation of AML Clonality in Patient-Derived Xenografts","keywords":"","combinedName":"doctor zdenka kosarova"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Lisa ","lastName":"Wei ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single Cell Transcriptome Analysis Reveals Changing Levels and Distributions of Stemness across Disease States in Pediatric AML","keywords":"","combinedName":"doctor lisa wei"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Laurent ","lastName":"Mauvieux ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Mutation Analysis of Acute Myeloid Leukemia at Diagnosis and Relapse Shows Different Clonal Evolution Patterns Involving Different Functional Classes of Genes","keywords":"","combinedName":"doctor laurent mauvieux"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Antonio ","lastName":"Gualberto ","credentials":"PhD, MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The CXCL12/CXCR4 Pathway As a Potential Target of Tipifarnib in Acute Myeloid Leukemia and Myelodysplastic Syndromes","keywords":"","combinedName":"doctor antonio gualberto"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Shlomo ","lastName":"Elias ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Oncogenic Fusion Protein CBFB-SMMHC Downregulates CD48 to Evade NK Cell Recognition","keywords":"","combinedName":"doctor shlomo elias"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Samantha L","lastName":"Savage ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapeutically Targetable Activating c-ABL1 Mutations in Philadelphia Chromosome-Negative Leukemias","keywords":"","combinedName":"doctor samantha l savage"},{"sessionId":"11828","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Mohammad ","lastName":"Refaei ","credentials":"MD, BSc, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Utility of Leukemic Stem Cells Markers in Determining Minimal Residual Disease in Patients with AML","keywords":"","combinedName":"doctor mohammad refaei"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Anna ","lastName":"Ferrari ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adult Triple Negative ACUTE Lymphoblastic Leukemia Genome Wide Characterization","keywords":"","combinedName":"doctor anna ferrari"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Mattias ","lastName":"Pilheden ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessing the Subclonal Genetic Landscape of KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia By Single-Cell Genomics","keywords":"","combinedName":"doctor mattias pilheden"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Evgeniya ","lastName":"Angelova ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD123 Expression Patterns and Potential of IMGN632, a CD123-Targeted Antibody Drug Conjugate, in Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor evgeniya angelova"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Hiroaki ","lastName":"Shimizu ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Significance of Additional Cytogenetic Abnormalities (ACA) Acquired at the First Relapse in Adult Patients with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL)","keywords":"","combinedName":"doctor hiroaki shimizu"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Wolfgang ","lastName":"Kern ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Analysis of Mixed Phenotype Acute Leukemia (MPAL) By Whole Genome Sequencing","keywords":"","combinedName":"doctor wolfgang kern"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Jia-Min ","lastName":"Zhang ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dehydropeptidase 1 Promoted Survival and Cell Cycle Progression through Regulation of CREB and P53 Pathways in B-Cell ALL","keywords":"","combinedName":"doctor jia-min zhang"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Annette ","lastName":"Fasan ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Feasibility of Targeted RNA Sequencing for Routine Diagnostics of B-Cell Precursor ALL","keywords":"","combinedName":"doctor annette fasan"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Lorenz ","lastName":"Bastian ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Homocygous PAX5 Sequence Mutations Define a Novel Subtype of B Cell Precursor Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor lorenz bastian"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Bing ","lastName":"Chen ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Novel Fusion Genes and Characterization of Transcriptome Features in T-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor bing chen"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Marketa ","lastName":"Zaliova ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Limited Therapeutical Impact of Extensive Genomic Profiling in Relapsed Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia: Population-Based Four-Year Consecutive Cohort","keywords":"","combinedName":"doctor marketa zaliova"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Martin ","lastName":"Neumann ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multi-Omics of Adult T Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor martin neumann"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Caroline ","lastName":"Von Knebel Doeberitz ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PDX Models Recapitulate Genetics and Epigenetics of Pediatric T-Cell Leukemia","keywords":"","combinedName":"doctor caroline von knebel doeberitz"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Olga ","lastName":"Gavrilina ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Persistence of the Minimal Residual Disease at the End of Induction Is Not a Factor of Poor Prognosis If Imatinib Was Changed to the Dasatinib By Ph+ RALL Protocol in Ph-Positive Acute Lymphoblastic Leukemia Patients","keywords":"","combinedName":"doctor olga gavrilina"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Leylah ","lastName":"Drusbosky ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predictive Simulation Modeling of Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) Patient Genomics Identifies Targeted Combination Treatment Options","keywords":"","combinedName":"doctor leylah drusbosky"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Udo ","lastName":"Zur Stadt ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rapid Capture NGS Identifies Genomic Rearrangements in BCP-ALL for MRD Diagnostics","keywords":"","combinedName":"doctor udo zur stadt"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Yingxi ","lastName":"Xu ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Regulatory T Cells Promote the Stemness of Acute Myeloid Leukemia Cells through IL10 Cytokine Related Signaling Pathway","keywords":"","combinedName":"doctor yingxi xu"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Paulina ","lastName":"Richter-Pechanska ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Relapsing Pediatric T-Cell Acute Lymphoblastic Leukemia Downregulates T-Cell Properties and Upregulates Cell Adhesion","keywords":"","combinedName":"doctor paulina richter-pechanska"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Ricardo ","lastName":"Sanchez ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted RNA-Seq Identify a Subset of Adolescent and Adult Patients with Acute Lymphoblastic Leukemia with BCR-ABL1-like Characteristics","keywords":"","combinedName":"doctor ricardo sanchez"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Gayle ","lastName":"Pouliot ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Fanconi Pathway in Pediatric T-Cell Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor gayle pouliot"},{"sessionId":"11829","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster II","firstName":"Musa ","lastName":"Yilmaz ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Prognostic Significance of Translocation (1;19) in Adult Patients (Pts) with B-Cell Acute Lymphoblastic Leukemia (ALL)","keywords":"","combinedName":"doctor musa yilmaz"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Chunhua ","lastName":"Song ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aberrant ARID5B Expression and Its Association with Ikaros Dysfunction in Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor chunhua song"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Yu-Fen ","lastName":"Wang ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Artificial Intelligence Approach for B Lymphoblastic Leukemia Minimal Residual Disease Detection and Clinical Prognosis Prediction Using Flow Cytometry Data","keywords":"","combinedName":"doctor yu-fen wang"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Alexander ","lastName":"Popov ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Applicability and Prognostic Significance of Flow Cytometric Cerebrospinal Fluid Investigation in Children with Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor alexander popov"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Olga ","lastName":"Illarionova ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Changes inLeukemic BlastsCD19 Expression in Children with Relapsed/Refractory B-Cell Precursor ALL Treated with Blinatumomab","keywords":"","combinedName":"doctor olga illarionova"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Thayana da Conceio","lastName":"Barbosa ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization ofRB1in PediatricTCF3-PBX1+ acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor thayana da conceio barbosa"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Caner ","lastName":"Saygin ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical and Molecular Characteristics of Therapy-Related Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor caner saygin"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Hiroo ","lastName":"Ueno ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Effect of Genetic Alterations in Pediatric Patients with B-Progenitor Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor hiroo ueno"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Claire","lastName":"Schwab","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Constitutional Ring Chromosome 21 Predisposes to Acute Lymphoblastic Leukaemia (ALL) with iAMP21","keywords":"","combinedName":"doctor claire schwab"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Matthew ","lastName":"Nix ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Defining the Cell Surface Proteome of MLL Rearranged Leukemia","keywords":"","combinedName":"doctor matthew nix"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Constance Regina","lastName":"Baer ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Detection of ABL1 kinase Domain Mutations in Therapy Naive BCR-ABL1 Positive ALL","keywords":"","combinedName":"doctor constance regina baer"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Marketa ","lastName":"Zaliova ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dissecting Childhood B-Other Acute Lymphoblastic Leukemia: Lower Frequency of Druggable Gene Fusions in European Population?","keywords":"","combinedName":"doctor marketa zaliova"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Laura ","lastName":"Hinze ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genome-Wide Association Study (GWAS) of High-Risk Minimal Residual Disease and Relapse in B-Cell Acute Lymphoblastic Leukemia on Trial AIEOP-BFM ALL 2000","keywords":"","combinedName":"doctor laura hinze"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Jillian ","lastName":"Fry ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Analysis and Pathway Characterization of Genes with Somatic Variants in Infant Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor jillian fry"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Helena ","lastName":"Hohtari ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Amount of PD1+TIM3+ T Helper Cells May Predict Poor Outcome in Adult Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor helena hohtari"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Maria ","lastName":"Jeppesen ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Expression of Legumain in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia Is Associated with Central Nervous System Involvement","keywords":"","combinedName":"doctor maria jeppesen"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Hirano ","lastName":"Daiki ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Expression of MEF2D-Fusion Protein Is Caused By Escaping from the Suppression By miRNA and Leads to Suppress Transcriptional Activity of PAX5","keywords":"","combinedName":"doctor hirano daiki"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Tanja ","lastName":"Hartmann ","credentials":"Ph.D.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased Palmitoylation Modulates Cytoskeletal Regulators to Enhance CXCR4-Mediated Motility of Malignant B Cells","keywords":"","combinedName":"doctor tanja hartmann"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Yasuo ","lastName":"Kubota ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrated Genetic/Epigenetic Analysis Revealed High Heterogeneity of Acute Lymphoblastic Leukemia in Down Syndrome","keywords":"","combinedName":"doctor yasuo kubota"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Kadriye Nehir Nehir","lastName":"Cosgun ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lgr5 Functions As Negative Regulator of Wnt Signaling in B Cells and Is Critical for Self-Renewal of Normal and Transformed B Cells","keywords":"","combinedName":"doctor kadriye nehir nehir cosgun"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Mark ","lastName":"Murakami ","credentials":"MD,MA,MMSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Linking Biophysical and Transcriptional Profiles of In Vivo-Treated Human Leukemias on a Single-Cell Level Uniquely Resolves Subpopulations of Response","keywords":"","combinedName":"doctor mark murakami"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Li-Xin ","lastName":"Wu ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutation Topology of Adult B-Cell Acute Lymphoblastic Leukaemia","keywords":"","combinedName":"doctor li-xin wu"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Alexander ","lastName":"Popov ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Peg-Asparaginase Administration on Day 3 of Remission Induction Accelerates MRD Response in Children with B-Cell Precursor Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor alexander popov"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Antony ","lastName":"Cousins ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Upregulated Cholesterol Biosynthesis Is a Biomarker for Isolated Central Nervous System Relapse in Acute Lymphoblastic Leukaemia","keywords":"","combinedName":"doctor antony cousins"},{"sessionId":"11830","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III","firstName":"Michaela ","lastName":"Novakova ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"When Standard Markers Are Not Sufficient for Monitoring Minimal Residual Disease or Targeted Treatment: New Transcriptome Derived Flow Cytometry Markers for Switching B Cell Precursor Leukemias","keywords":"","combinedName":"doctor michaela novakova"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Luigi ","lastName":"Scotto ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Azacytidine and Decitabine Exhibit Differential Effects on Cytotoxicity and Methylation and Exhibit Class Synergy with Hdaci in Models of Ptcl","keywords":"","combinedName":"doctor luigi scotto"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Michael ","lastName":"Jin ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Impact of Somatic Copy Number Alterations in Circulating Tumor DNA from Diverse Lymphoma Subtypes","keywords":"","combinedName":"doctor michael jin"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Ayako ","lastName":"Nakamura ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Detection of MYD88 L265P Mutation By Next Generation Deep Sequencing in Peripheral Blood Mononuclear Cells of Waldenstrom Macroguloblinemia and IgM Monoclonal Gammopathy of Undetermined Significance","keywords":"","combinedName":"doctor ayako nakamura"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Anna S","lastName":"Nam ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Exploring the Tumor Clonal Dynamics between Diffuse Large B-Cell Lymphomas and Bone Marrow Involvement By Deep Immunoglobulin Heavy Chain VDJ Sequencing","keywords":"","combinedName":"doctor anna s nam"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Mary L","lastName":"McMaster ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genome-Wide Association Study for Waldenstrm Macroglobulinemia Identifies Novel Susceptibility Loci","keywords":"","combinedName":"doctor mary l mcmaster"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Shamzah ","lastName":"Araf ","credentials":"MRCP, MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Profiling Reveals Spatial Intra-Tumor Heterogeneity in Follicular Lymphoma","keywords":"","combinedName":"doctor shamzah araf"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Shamzah ","lastName":"Araf ","credentials":"MRCP, MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Longitudinal Analyses of the Genomic, Transcriptomic, and T Cell Repertoire in Diffuse Large B Cell Lymphoma Demonstrates Changes in Signaling and Immune Recognition at Relapse","keywords":"","combinedName":"doctor shamzah araf"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Sara ","lastName":"Elkashef ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mitochondrial Metabolism and RNA Methylation in DLBCL","keywords":"","combinedName":"doctor sara elkashef"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Liang ","lastName":"Zhang ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Pathways Associated with Ibrutinib Resistance in Mantle Cell Lymphoma","keywords":"","combinedName":"doctor liang zhang"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Joo ","lastName":"Song ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutations in the Phosphoinositide 3-Kinase Pathway (PI3K) Are Associated with Poor Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP","keywords":"","combinedName":"doctor joo song"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Christopher ","lastName":"Melani ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Next-Generation Sequencing Based Monitoring of Circulating-Tumor DNA in Untreated Peripheral T-Cell Lymphoma","keywords":"","combinedName":"doctor christopher melani"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Zhu ","lastName":"Mengyuan ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NSE Promotes Macrophage Towards to M2 Polarization in Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor zhu mengyuan"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Alice ","lastName":"McDonald ","credentials":"BA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Response to the EZH2 Inhibitor Tazemetostat Is Independent of Cell of Origin Determined Via Hans Imunohistochemistry or Nanostring Lymphoma Subtyping Test in EZH2 Wild-Type DLBCL Patients","keywords":"","combinedName":"doctor alice mcdonald"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Dina ","lastName":"Istasi ","credentials":"MD, Masters","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"SOX11 and CD43 Biomarkers in Mantle Cell Lymphoma","keywords":"","combinedName":"doctor dina istasi"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Christopher ","lastName":"Bolen ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Systematic Analysis of the Prognostic Impact of Somatic Mutations in Diffuse Large B-Cell Lymphoma (DLBCL) with Evaluation of Cell-of-Origin Dependence: Results from the Phase 3 GOYA Trial in Previously Untreated DLBCL","keywords":"","combinedName":"doctor christopher bolen"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Elisa ","lastName":"Genuardi ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Locus Amplification (TLA): A Novel Next Generation Sequencing (NGS) Technology to Detect New Molecular Markers and Monitoring Minimal Residual Disease (MRD) in Mantle Cell and Follicular Lymphoma","keywords":"","combinedName":"doctor elisa genuardi"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Maher K","lastName":"Gandhi ","credentials":"MB, FRACP, FRCPath, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of EBV upon the Tumor Microenvironment and Mutational Profile of Primary CNS Lymphoma in PTLD","keywords":"","combinedName":"doctor maher k gandhi"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Julieta ","lastName":"Sepulveda ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Mutation Landscape of Follicular Lymphoma and Chronic Lymphocytic Leukemia Reveals a Distinctive Frequency and Composition of Aid-Related Mutation Signatures","keywords":"","combinedName":"doctor julieta sepulveda"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Johannes ","lastName":"Hellmuth ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Mutational Landscape and Immune Microenvironment of Primary Intestinal Follicular Lymphoma (PIFL)","keywords":"","combinedName":"doctor johannes hellmuth"},{"sessionId":"11831","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster II","firstName":"Felicia ","lastName":"Gomez ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ultra Deep Whole Exome Sequencing of Classical Hodgkin Lymphoma (cHL) Reveals Novel Recurrent Somatic Mutations","keywords":"","combinedName":"doctor felicia gomez"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Francesco ","lastName":"Maura ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Compendium of Transcriptional and Mutational Data to Improve the Stratification of Peripheral T-Cell Lymphoma Subtypes","keywords":"","combinedName":"doctor francesco maura"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Annalisa ","lastName":"Chiappella ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ABC Subtype, TP53 Mutation and BCL2 Overexpression Are Associated with a Worse Outcome in Untreated Poor-Risk Young Diffuse Large B-Cell Lymphoma: Results from the Frontline Phase III BIO-DLBCL04 Study of the Fondazione Italiana Linfomi","keywords":"","combinedName":"doctor annalisa chiappella"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Thomas Yssing","lastName":"Michaelsen ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"B-Cell Differentiation Dependent Classification of Diffuse Large B-Cell Lymphoma By the Nanostring Technology","keywords":"","combinedName":"doctor thomas yssing michaelsen"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Csaba ","lastName":"Bdr ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cell of Origin and Genomic Profile of Primary Central Nervous System Lymphoma Determined Using the Nanostring Lst Assay and Ultra Deep Targeted Next Generation Sequencing","keywords":"","combinedName":"doctor csaba bdr"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Kristiina ","lastName":"Karihtala ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of Immunological Profiles with Clinical Significance in Patients with Classical Hodgkin Lymphoma","keywords":"","combinedName":"doctor kristiina karihtala"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Afshin ","lastName":"Beheshti ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Circulating Micrornas (miRNA) As a Novel Liquid Biopsy and Therapeutic Platform in MYC and Non-MYC Diffuse Large B-Cell Lymphoma (DLBCL)","keywords":"","combinedName":"doctor afshin beheshti"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Eric A","lastName":"Severson ","credentials":"MD, PhD, MMSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Genomic Profiling Demonstrates Differences in Primary CNS Lymphoma and Systemic Diffuse Large B Cell Lymphoma and Reveals Biomarkers Indicating Potential Benefit from Immune Checkpoint Inhibitors","keywords":"","combinedName":"doctor eric a severson"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Chantana ","lastName":"Polprasert ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Sequencing Analysis in Subcutaneous Panniculitis-like T-Cell Lymphoma","keywords":"","combinedName":"doctor chantana polprasert"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Brett ","lastName":"Collinge ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deciphering Discordance between MYC mRNA and MYC IHC in DLBCL: The Role of MYC Exon 2 Mutations and N11S Polymorphism","keywords":"","combinedName":"doctor brett collinge"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Scott ","lastName":"Daigle ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Discovery of Candidate Predictors of Response to Tazemetostat in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma Using NGS Technology on ctDNA Samples Collected Pre-Treatment","keywords":"","combinedName":"doctor scott daigle"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Josep ","lastName":"Muncunill ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers","keywords":"","combinedName":"doctor josep muncunill"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Wei ","lastName":"Zhang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Defects Affecting LymphocyteCytotoxicity in Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases","keywords":"","combinedName":"doctor wei zhang"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Anna ","lastName":"Stengel ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Depict a High Complexity on the Cytogenetic, but Not on the Molecular Genetic Level and Show MYC Mutations As Prognostic Marker","keywords":"","combinedName":"doctor anna stengel"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Sebastiaan ","lastName":"Somers ","credentials":"MD, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Prevalence of Oncogenic MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma: Implication for Therapy with Brutons Kinase Inhibitors?","keywords":"","combinedName":"doctor sebastiaan somers"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Lauren ","lastName":"Chong ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Resolution Architecture and Partner Genes of MYC Rearrangements in Lymphoma with DLBCL Morphology","keywords":"","combinedName":"doctor lauren chong"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Juan Carlos ","lastName":"Ramos ","credentials":"MD, BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Histone Deacetylase Inhibitors Abolish HBZ Protein Expression and Induce Cell Death in HTLV-1 Related Adult T-Cell Leukemia-Lymphoma","keywords":"","combinedName":"doctor juan carlos ramos"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Rebecca J","lastName":"Leeman-Neill ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Characterization of Post-Transplant Plasmablastic Lymphomas Implicates RAS, TP53, and NOTCH Mutations and MYC Deregulation in Disease Pathogenesis","keywords":"","combinedName":"doctor rebecca j leeman-neill"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Federica ","lastName":"Melle ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Definition of Activated B Cell-like (ABC) DLBCL Identifies Patients Who May Benefit from Front-Line Intensive R-HDS Chemotherapy with ASCT","keywords":"","combinedName":"doctor federica melle"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Steven P","lastName":"Treon ","credentials":"MD,PhD,FRCP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MYD88 Mutation Status Impacts Overall Survival and Risk of Histological Transformation in Waldenstroms Macroglobulinemia","keywords":"","combinedName":"doctor steven p treon"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Alexandra ","lastName":"Nagy ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Next Generation Sequencing of Castleman Disease and Follicular Dendritic Cell Sarcomas Associated with Castleman Disease","keywords":"","combinedName":"doctor alexandra nagy"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Sirpa ","lastName":"Leppa ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Th1/2 Immune Response Signature Predicts Outcome after Dose-Dense Immunochemotherapy in Patients with High Risk Diffuse Large B-Cell Lymphoma  Results from Nordic Lymphoma Group Trials","keywords":"","combinedName":"doctor sirpa leppa"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Zachary ","lastName":"Hunter ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Genomic Landscape of MYD88 Wild-Type WaldenstrMs Macroglobulinemia Ischaracterized By Somatic Mutations in TBL1XR1, the CBM Complex, and NFKB2","keywords":"","combinedName":"doctor zachary hunter"},{"sessionId":"11832","sessionTitle":"621. LymphomaGenetic/Epigenetic Biology: Poster III","firstName":"Torsten","lastName":"Haferlach","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whole Genome Sequencing in Hairy Cell Leukemia-Variant (HCL-v) and Splenic Marginal Zone Lymphoma (SMZL)","keywords":"","combinedName":"doctor torsten haferlach"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Tanaya ","lastName":"Shree ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Altered Peripheral Immune Phenotypes in Mantle Cell Lymphoma Survivors","keywords":"","combinedName":"doctor tanaya shree"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Pallavi ","lastName":"Khattar ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"B- Cell Maturation Antigen Is Exclusively Expressed in a Wide Range of B-Cell and Plasma Cell Neoplasm and in a Potential Therapeutic Target for Bcma Directed Therapies","keywords":"","combinedName":"doctor pallavi khattar"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Ramesh ","lastName":"Balusu ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CDC37 As a Novel Target for the Treatment of NPM1-ALK Expressing Anaplastic Large Cell Lymphomas","keywords":"","combinedName":"doctor ramesh balusu"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Joanne ","lastName":"Soo ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Circulating Tumor DNA Recovery from Plasma and Serum","keywords":"","combinedName":"doctor joanne soo"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Jennifer ","lastName":"Crombie ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dynamic BH3 Profiling Reveals Novel Therapeutic Strategies for the Treatment of Double-Hit Lymphoma","keywords":"","combinedName":"doctor jennifer crombie"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Bethany L","lastName":"Mundy-Bosse ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enhanced Spontaneous Anti-Tumor Cytotoxicity of Natural Killer Cells in Cutaneous T-Cell Lymphoma Patients","keywords":"","combinedName":"doctor bethany l mundy-bosse"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Karin ","lastName":"Tarte ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Follicular Lymphoma Regulatory T Cell Function and Origin","keywords":"","combinedName":"doctor karin tarte"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Robert ","lastName":"Kridel ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FOXP1 Expression Is a Prognostic Biomarker in Follicular Lymphoma Treated with Immunochemotherapy and Is Associated with Distinct Molecular Features","keywords":"","combinedName":"doctor robert kridel"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Marjukka ","lastName":"Pollari ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Amount of PD-L1+ Tumor Associated Macrophages Is Associated with Better Survival in Patients with Primary Testicular Lymphoma","keywords":"","combinedName":"doctor marjukka pollari"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Mohan ","lastName":"Singh ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Highly Multiplexed Imaging Mass Cytometry Allows Visualization of Tumor and Immune Cell Interactions of the Tumor Microenvironment in FFPE Tissue Sections","keywords":"","combinedName":"doctor mohan singh"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"John Simon","lastName":"Van Arnam ","credentials":"MD, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integrated Phosphoproteomic and N-Glycoproteomic Landscape of Cutaneous T-Cell Lymphoma Reveals Distinctive Pathogenetic Insights and Therapeutic Vulnerabilities","keywords":"","combinedName":"doctor john simon van arnam"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Yasuhisa ","lastName":"Sando ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Loss of the GVL Effect By Distinct Expression of Migration Markers As a Mechanism of Immune Escape in Adult T Cell Leukemia/Lymphoma (ATLL), a Malignant Counterpart of Regulatory T Cells","keywords":"","combinedName":"doctor yasuhisa sando"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Weige ","lastName":"Wang ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RAC2 Links B-Cell Receptor Signaling and Cell Adhesion in Mantle Cell Lymphoma","keywords":"","combinedName":"doctor weige wang"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Shengjian ","lastName":"Huang ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Resistance Mechanisms Underlying Venetoclax Resistance in Mantle Cell Lymphoma","keywords":"","combinedName":"doctor shengjian huang"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Duncan ","lastName":"Murray ","credentials":"FRCPath, MRCP, MA, BMBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T Cell Versus T Cell; A Study of the Immune Checkpoint Landscape in Cutaneous T Cell Lymphoma","keywords":"","combinedName":"doctor duncan murray"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Anke ","lastName":"Maes ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Anaphase Promoting Complex/Cyclosome: A New Promising Target in Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma","keywords":"","combinedName":"doctor anke maes"},{"sessionId":"11833","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster II","firstName":"Ravi ","lastName":"Dashnamoorthy ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Immune Checkpoint Receptors PD-1, PD-L1, TIM-3 and LAG-3 in Lymphoma: Tumor Cell and Tumor Infiltrating Lymphocyte (TIL)Expression, Patient Prognostication, and Identification of Rational Therapeutic Targets","keywords":"","combinedName":"doctor ravi dashnamoorthy"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Kei ","lastName":"Nakajima ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aberrant Activation of NF-Kb and Hypoxia Enhances Glycolytic Enzyme Hexokinase II Expression in B- Cell Lymphoma through Activation of HIF-1","keywords":"","combinedName":"doctor kei nakajima"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Olga ","lastName":"Pozdnyakova ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessment of CD52 Expression in \"Double-Hit\" and \"Double-Expressor\" Lymphomas: Implications for Clinical Trial Eligibility","keywords":"","combinedName":"doctor olga pozdnyakova"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"David ","lastName":"Foureau ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Correlation of Myeloid Derived Suppressor Cells and Response to Standard Chemoimmunotherapy in Diffuse Large B Cell Lymphoma","keywords":"","combinedName":"doctor david foureau"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Joseph G","lastName":"Schroers-Martin ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Determinants of Circulating Tumor DNA Levels across Lymphoma Histologic Subtypes","keywords":"","combinedName":"doctor joseph g schroers-martin"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Marshall ","lastName":"Kadin ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evidence That Some Breast Implant Associated Anaplastic Large Cell Lymphomas Arise in the Context of Allergic Inflammation","keywords":"","combinedName":"doctor marshall kadin"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Lixin ","lastName":"Rui ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gene Regulation and Suppression of Type I Interferon Signaling By STAT3 in Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor lixin rui"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Michihide ","lastName":"Tokuhira ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of the Duration of Methotrexate Administration and the Specific HLA Alleles on the Regressive Methotrexate-Induced Lymphoproliferative Disorders","keywords":"","combinedName":"doctor michihide tokuhira"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Suvi-Katri ","lastName":"Leivonen ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low Expression of T/NK-Cell Signature Predicts Poor Survival in Patients with Primary Testicular and Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor suvi-katri leivonen"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Richard ","lastName":"Lemal ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mast Cell Density and Its Clinical Relevance in Waldenstroms Macroglobulinemia","keywords":"","combinedName":"doctor richard lemal"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Man ","lastName":"Nie ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Neutrophils Extracellular Traps Induced By Lymphoma -Derived IL-8 Could Promote Diffuse Large B Cell Lymphoma Progression","keywords":"","combinedName":"doctor man nie"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Maria ","lastName":"Arcila ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Next Generation Sequencing (NGS) Based IGH and TCR Clonality Assays Provide Excellent Specificity and Sensitivity for Routine Clonal Characterization and Monitoring of Lymphoproliferative Disorders","keywords":"","combinedName":"doctor maria arcila"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Jithma Prasad","lastName":"Abeykoon ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predictors of Hyperviscosity Syndrome (HVS) in Waldenstrm Macroglobulinemia (WM)","keywords":"","combinedName":"doctor jithma prasad abeykoon"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Eric ","lastName":"Hsi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Utility of Serum TARC, MDC, IL10, and Soluble CD163 Levels with Positron Emission Tomography (PET) Response-Adapted Therapy for Advanced-Stage Hodgkin Lymphoma (HL): a SWOG S0816 US Intergroup Correlative Study","keywords":"","combinedName":"doctor eric hsi"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Mamta ","lastName":"Gupta ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Selective Inhibition of HDAC1 and HDAC3 Inhibits Survival of Diffuse Large Cell Lymphoma Via Epigenetic Modulation of Death Associated Protein (DAPK)","keywords":"","combinedName":"doctor mamta gupta"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Clare","lastName":"Sun","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Serum B-Cell Maturation Antigen As a Biomarker for Chronic Lymphocytic Leukemia Treated with Ibrutinib","keywords":"","combinedName":"doctor clare sun"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Shahrzad ","lastName":"Jalali ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Soluble PD-1 Ligands Regulate T-Cell Function in Waldenstroms Macroglobulinemia","keywords":"","combinedName":"doctor shahrzad jalali"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Angelo ","lastName":"Fama ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T-Cell Subsets and Macrophages in the Tumor Microenvironment Are Associated with Early Outcome in Follicular Lymphoma","keywords":"","combinedName":"doctor angelo fama"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Akiho ","lastName":"Tsuzura ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tumor Cells from EBV-Positive T- or NK-Cell Neoplasms Induce Differentiation and Activation of Macrophages By Secreting Humoral Factors","keywords":"","combinedName":"doctor akiho tsuzura"},{"sessionId":"11834","sessionTitle":"622. Lymphoma BiologyNon-Genetic Studies: Poster III","firstName":"Jian ","lastName":"Yu ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Wnt5a Can Induce Activation of Rac1 and Proliferation in Mantle Cell Lymphoma Via a ROR1-Dependent, but BTK-Independent, Signaling Pathway","keywords":"","combinedName":"doctor jian yu"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Arne ","lastName":"Kolstad ","credentials":"MD, Ph.D","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"177 Lu-Lilotomab Satetraxetan, a Novel CD37-Targeted Antibody-Radionuclide Conjugate in RelapsedNon-Hodgkins Lymphoma (NHL): Updated Results of an Ongoing Phase I/II Study (LYMRIT 37-01)","keywords":"","combinedName":"doctor arne kolstad"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Pam ","lastName":"Skrabek ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bendamustine and Rituximab As Initial Therapy in Indolent Non-Hodgkins Lymphoma and Mantle Cell Lymphoma in a Canadian Population; Highly Effective with Frequent Infections","keywords":"","combinedName":"doctor pam skrabek"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Gregory ","lastName":"Coffey ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B Cell Malignancies: Results from a Phase I Dose Escalation Study","keywords":"","combinedName":"doctor gregory coffey"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Gilles ","lastName":"Salles ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Effectiveness of Single-Agent Ibrutinib in the Ray Trial Versus Real-World Treatment in the Lyon-Sud Database in Patients with Relapsed or Refractory Mantle Cell Lymphoma","keywords":"","combinedName":"doctor gilles salles"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Suchitra ","lastName":"Sundaram ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Cardiovascular Toxicity with Treatment of Follicular Lymphoma Is Associated with Shorter Overall Survival","keywords":"","combinedName":"doctor suchitra sundaram"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Suchitra ","lastName":"Sundaram ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Histologic Grade on Clinical Outcomes of Follicular Lymphoma: Prolonged Progression Free Survival of Grade 3 Follicular Lymphoma in the Rituximab Era","keywords":"","combinedName":"doctor suchitra sundaram"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Dario ","lastName":"Marino ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of Radiation Treatement in Ocular Adnexa Mucosa-Associated Lymphoid Tissue Lymphoma: A Retrospective Evaluation in a Single Center Experience","keywords":"","combinedName":"doctor dario marino"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Wojciech ","lastName":"Jurczak ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"First in Human, Phase I/II Trial of the Brutons Tyrosine Kinase Inhibitor (BTKi) M7583 in Patients with B Cell Malignancies: Study Design and Initial Outcomes","keywords":"","combinedName":"doctor wojciech jurczak"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Charlotte ","lastName":"Wilding ","credentials":"BSc, MBChB","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Focal Splenic Lesions May Identify Patients Who Benefit from Anthracycline Based Therapy and Are Significantly Associated with High Grade Transformation in Follicular Lymphoma","keywords":"","combinedName":"doctor charlotte wilding"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Angelo ","lastName":"Fama ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Human Pegivirus (HPgV) Infection and Lymphoma Risk and Prognosis: A Study from North America","keywords":"","combinedName":"doctor angelo fama"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Steven P","lastName":"Treon ","credentials":"MD,PhD,FRCP","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ibrutinib Is Highly Active As First Line Therapy in Symptomatic Waldenstroms Macroglobulinemia","keywords":"","combinedName":"doctor steven p treon"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Christopher ","lastName":"Flowers ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intratumoral G100 Induces Systemic Immunity and Abscopal Tumor Regression in Patients with Follicular Lymphoma: Results of a Phase 1/ 2 Study Examining G100 Alone and in Combination with Pembrolizumab","keywords":"","combinedName":"doctor christopher flowers"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Kirsten ","lastName":"Meid ","credentials":"MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Follow-up of a Prospective Clinical Trial of Carfilzomib, Rituximab and Dexamethasone (CaRD) in Waldenstroms Macroglobulinemia","keywords":"","combinedName":"doctor kirsten meid"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Sandra ","lastName":"Lockmer ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Follow-up of Patients with Indolent Lymphoma after First Line Therapy with Rituximab As Single Agent or in Combination with Interferon-a2a","keywords":"","combinedName":"doctor sandra lockmer"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Steven P","lastName":"Treon ","credentials":"MD,PhD,FRCP","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Follow-up of Previously Treated Patients Who Received Ibrutinib for Symptomatic Waldenstroms Macroglobulinemia: Update of Pivotal Clinical Trial","keywords":"","combinedName":"doctor steven p treon"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Brian ","lastName":"Hill ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Maintenance Rituximab or Observation after Frontline Treatment with Bendamustine-Rituximab (BR) for Follicular Lymphoma: A Real World Analysis Across 13 US Cancer Centers","keywords":"","combinedName":"doctor brian hill"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Robert J","lastName":"Kreitman ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Negative Minimal Residual Disease Associated with Extended Response to Moxetumomab Pasudotox in Patients with Relapsed/Refractory Hairy Cell Leukemia: Long-Term Follow-up of Bone Marrow Immunohistochemistry Analyses from a Phase 1 Study","keywords":"","combinedName":"doctor robert j kreitman"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Rima Panchal","lastName":"Panchal ","credentials":"Intern","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase Ib-II Study of Brutons Tyrosine Kinase (BTK) Inhibitor Ibrutinib, w/ Lenalidomide and Rituximab in Relapsed / Refractory Mantle Cell Lymphoma","keywords":"","combinedName":"doctor rima panchal panchal"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Anna ","lastName":"Nishihara ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rituximab Combined Therapy and Maintenance Eliminate the Follicular Lymphoma with MYC Translocation","keywords":"","combinedName":"doctor anna nishihara"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Neerav ","lastName":"Monga ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Systematic Literature Review of the Clinical Efficacy and Safety of Treatments in the Relapsed/Refractory Setting for Patients with Follicular Lymphoma or Marginal Zone Lymphoma","keywords":"","combinedName":"doctor neerav monga"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Martin","lastName":"Dreyling","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Updated Safety and Efficacy from the Copanlisib CHRONOS-1 Trial in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma: Low Incidence of Late-Onset Severe Toxicities","keywords":"","combinedName":"doctor martin dreyling"},{"sessionId":"11836","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster II","firstName":"Meenal ","lastName":"Kheterpal ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Utility of Systemic Staging in Low Grade B-Cell Lymphomas Presenting in the Skin","keywords":"","combinedName":"doctor meenal kheterpal"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Michinori ","lastName":"Ogura ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Study ofTHP-COP (pirarubicin, cyclophosphamide, vincristine and prednisolone) in Patients with Newly Diagnosed Advanced Peripheral T-Cell Lymphoma: THP-3 Study of Japan Hematopoietic Malignancy Clinical Study Group (HMCSG)","keywords":"","combinedName":"doctor michinori ogura"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Christin ","lastName":"Destefano ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Population-Based Study of Race & UV Exposure on Incidence & Survivalin Mycosis Fungoides","keywords":"","combinedName":"doctor christin destefano"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Peter D","lastName":"Cole ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Changes in Serum TARC Predict PET Response Among Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma Treated with Brentuximab Vedotin and Gemcitabine: A Report from the Children's Oncology Group","keywords":"","combinedName":"doctor peter d cole"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Hua ","lastName":"Wang ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chemotherapy of GEP Regimen(Gemcitabine,etoposide and Pegaspargase) for the Patients with Newly Diagnosed Extranodal Natural Killer/T Cell Lymphoma:a Phase II Clinical Trial","keywords":"","combinedName":"doctor hua wang"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Hui-qiang ","lastName":"Huang ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chidamide ,Oral Subtype-Selective Histone Deacetylase Inhibitor (HDACI) Monotherapy Was Effective on the Patients with Relapsed or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma","keywords":"","combinedName":"doctor hui-qiang huang"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Bastian ","lastName":"von Tresckow ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Outcomes of Patients with 3rd or Higher Relapsed Classical Hodgkin Lymphoma: Results from the German Hodgkin Study Group","keywords":"","combinedName":"doctor bastian von tresckow"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Liang ","lastName":"Huang ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Subtypes, Molecular Features and Treatment Strategies of Aggressive NK-Cell Leukemia: A Multicenter Analysis of 113 Patients","keywords":"","combinedName":"doctor liang huang"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Alice ","lastName":"Skorov ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Elderly Hodgkin Lymphoma  Multicenter Retrospective Data Analysis from the Czech Hodgkin Lymphoma Registry","keywords":"","combinedName":"doctor alice skorov"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Moussab ","lastName":"Damlaj ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma  a Real World Analysis","keywords":"","combinedName":"doctor moussab damlaj"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Fredrik","lastName":"Ellin","credentials":"MD, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of the NCCN-IPI As a Prognostic Tool in PTCLs","keywords":"","combinedName":"doctor fredrik ellin"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Michelle ","lastName":"Fanale","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Five-Year Survival Results: Frontline Brentuximab Vedotin in Combination with CHP in Patients with CD30-Expressing Peripheral T-Cell Lymphomas","keywords":"","combinedName":"doctor michelle fanale"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Claudio ","lastName":"Cerichione ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Dose BendamustinePlus Brentuximab Combination Is Effective and Has a Favourable Toxicity Profile in the Treatment of Refractory and Relapsed Hodgkin Lymphoma","keywords":"","combinedName":"doctor claudio cerichione"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Zhiyuan ","lastName":"Zhou ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of PTX3 and S100A9 As Serum Diagnostic and Therapeutic Response Biomarkers of NK/T Cell Lymphoma Patients","keywords":"","combinedName":"doctor zhiyuan zhou"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Saad ","lastName":"Akhtar ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): Clinical Features, Treatment, and Outcome. a Single Institution Result of 145 Patients from the Middle East","keywords":"","combinedName":"doctor saad akhtar"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Mukhija ","lastName":"Dhruvika ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes in Patients with Enteropathy-Associated T-Cell Lymphoma (EATL) and Hepatosplenic T-Cell Lymphoma (HSTCL): A Population Based Analysis Using the SEER Data","keywords":"","combinedName":"doctor mukhija dhruvika"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Sanjay ","lastName":"de Mel ","credentials":"BSc( Hons) BM (Hons) MRCP(UK) FRCPath","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantitative Analysis of MultiplexedImmunofluorescence in T-Cell Lymphoma","keywords":"","combinedName":"doctor sanjay de mel"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Ryan ","lastName":"Cassaday ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Radiographic and High-Throughput Sequencing (HTS)-Based Response Assessment after Brentuximab Vedotin (BV) Plus Ifosfamide, Carboplatin, and Etoposide (ICE) for Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (cHL): Updated Results of a Phase I/II Trial","keywords":"","combinedName":"doctor ryan cassaday"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Yasuhiro","lastName":"Oki","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Anti-Tumour Activity of RP6530, Dual PI3K d/? Inhibitor, in Relapsed/Refractory T-Cell Lymphoma: Updated Results from the Dose Expansion Cohort of an on-Going Phase I/Ib Study","keywords":"","combinedName":"doctor yasuhiro oki"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Byeong Seok ","lastName":"Sohn ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Absolute Lymphocyte Count Is Associated with the Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified","keywords":"","combinedName":"doctor byeong seok sohn"},{"sessionId":"11837","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster II","firstName":"Thomas E","lastName":"Witzig ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The CXCL12/CXCR4 Pathway As a Potential Target of Tipifarnib: Preliminary Results from an Open-Label, Phase II Study in Relapsed or Refractory Peripheral T-Cell Lymphoma","keywords":"","combinedName":"doctor thomas e witzig"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Paolo ","lastName":"Strati ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 1 Trial of Alisertib and Romidepsin for Relapsed/Refractory Aggressive B-Cell and T-Cell Lymphomas","keywords":"","combinedName":"doctor paolo strati"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Joseph ","lastName":"Tuscano ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"a Phase I California Cancer Consortium Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory CD20+ B-Cell Lymphoma; Efficacy, Safety and Immune Correlative Analysis","keywords":"","combinedName":"doctor joseph tuscano"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Florencia ","lastName":"Negri Aranguren ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Retrospective Multicenter Analysis of the Safety and Efficacy of Brentuximab Vedotin (BV) As Monotherapy or in Combination with Bendamustine (BV-B) in Relapsed Refractory Classic Hodgkin Lymphoma (cHL) in Argentina","keywords":"","combinedName":"doctor florencia negri aranguren"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Christiane ","lastName":"Querfeld ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Single Direct Intratumoral Injection of TTI-621 (SIRPaFc) Induces Antitumor Activity in Patients with Relapsed/Refractory Mycosis Fungoides and Szary Syndrome: Preliminary Findings Employing an Immune Checkpoint Inhibitor Blocking the CD47 Do Not Eat Signal","keywords":"","combinedName":"doctor christiane querfeld"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Silvia ","lastName":"Park ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"APhase II Study of Brentuximab Vedotin for Relapsed or Refractory CD30-Positive Non-Hodgkin Lymphomas Other Than Anaplastic Large Cell Lymphoma","keywords":"","combinedName":"doctor silvia park"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"David M","lastName":"Burns ","credentials":"BSc,MBBS,MRCP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An ABVD-Based Approach Confers Superior Outcomes for Adolescent and Young Adult Patients Compared to Other Adults with Advanced Classical Hodgkin Lymphoma","keywords":"","combinedName":"doctor david m burns"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Won Seog ","lastName":"Kim ","credentials":"M.D., Ph. D.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autologous EBV-Specific T Cells (CMD-003): Early Results from a Multicenter, Multinational Phase 2 Trial for Treatment of EBV-Associated NK/T-Cell Lymphoma","keywords":"","combinedName":"doctor won seog kim"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Ewa ","lastName":"Paszkiewicz-Kozik ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bendamustine, Gemcitabine and Dexamethasone Chemotherapy Is Effective Salvage and Stem-Cell Mobilization Regimen in Patients with Relapsed or Refractory Hodgkin Lymphoma  Early Results of the Polish Lymphoma Research Group Study","keywords":"","combinedName":"doctor ewa paszkiewicz-kozik"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Luciana ","lastName":"Vinti ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Brentuximab Vedotinin Combination with Bendamustine in Relapsed or Refractory Hodgkin Lymphoma: A Retrospective Analysis on 23 Paediatric Patients or Young Adults","keywords":"","combinedName":"doctor luciana vinti"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Amy ","lastName":"Steele ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Changes in Second Primary Malignancies (SPM)after Hodgkin Lymphoma over Time in the United States","keywords":"","combinedName":"doctor amy steele"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Atsushi ","lastName":"Satake ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Impact of Mogamulizumab Against Aggressive ATL: A Single-Center Retrospective Analysis","keywords":"","combinedName":"doctor atsushi satake"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Andrei ","lastName":"Shustov ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Negative (ALCL, ALK-): Analysis of 203 Patients Prospectively Registered in the International T-Cell Project","keywords":"","combinedName":"doctor andrei shustov"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Andrei ","lastName":"Shustov ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Positive (ALCL, ALK+): Data from 119 Patients Prospectively Registered in the International T-Cell Project","keywords":"","combinedName":"doctor andrei shustov"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Laura N","lastName":"Rodriguez-Romo ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Outcomes By Age of Patients with Limited Stage Hodgkin Lymphoma Treated with ABVD Alone; A Secondary Analysis of the Canadian Cancer Trial Group HD.6 Trial","keywords":"","combinedName":"doctor laura n rodriguez-romo"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Domenico ","lastName":"Galati ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dendritic Cells Subsets Profiles in Classical Hodgkin Lymphoma at Diagnosis and upon Treatment Completion: Analysis on 54 Patients","keywords":"","combinedName":"doctor domenico galati"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Wendy","lastName":"Cozen","credentials":"DO, MPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differences in Fecal Microbiota in Long-TermAdolscent/Young AdultHodgkin Lymphoma Survivors and Their Unaffected Twins.","keywords":"","combinedName":"doctor wendy cozen"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Esteban ","lastName":"Ciliberti ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of a Short Course of Chemotherapy with ABVD for Elderly Patients with Hodgkin Lymphoma for All Disease Stages","keywords":"","combinedName":"doctor esteban ciliberti"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Dai ","lastName":"Maruyama ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"First-in-Human Study of the EZH1/2 Dual Inhibitor DS-3201b in Patients with Relapsed or Refractory Non-Hodgkin Lymphomas  Preliminary Results","keywords":"","combinedName":"doctor dai maruyama"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Johanne Marie ","lastName":"Holst ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Intratumoral Galectin-1 Is Associated with Adverse Outcome in ALK-Negative, CD30-Positive Peripheral T-Cell Lymphomas","keywords":"","combinedName":"doctor johanne marie holst"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Kelly E","lastName":"Faulk ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased Rate of Pulmonary Toxicity in Pediatric Patients with Relapsed Hodgkin Lymphoma Receiving Brentuximab Vedotin","keywords":"","combinedName":"doctor kelly e faulk"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Steven ","lastName":"Bair ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes, Toxicities, and Patterns of Use of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Multicenter Retrospective Study","keywords":"","combinedName":"doctor steven bair"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Paul ","lastName":"Broeckelmann ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient and Physician Preferences for Front-Line Treatment of Advanced Stage Hodgkin Lymphoma in Germany, France and the United Kingdom","keywords":"","combinedName":"doctor paul broeckelmann"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Craig ","lastName":"Moskowitz","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pembrolizumab Antitumor Activity in Relapsed/Refractory Classical Hodgkin Lymphoma in Keynote-087: Revised Response Criteria for Malignant Lymphoma 2007 Criteria Versus Lugano 2014 Classification","keywords":"","combinedName":"doctor craig moskowitz"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Nikita ","lastName":"Kondapalli ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk of Second Malignancies in Long Term Hodgkin Lymphoma Survivors of Two Age Cohorts","keywords":"","combinedName":"doctor nikita kondapalli"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Vittorio ","lastName":"Stefoni ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Bbv Regimen: A Phase II Study with Bendamustine Plus Brentuximab Vedotin in Hodgkin Lymphoma and CD30+ Peripheral T-Cell Lymphoma in First Salvage Setting","keywords":"","combinedName":"doctor vittorio stefoni"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Hui-qiang ","lastName":"Huang ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Therapeutic Response of Chidamide Was Associated with Elevated H3 Acetylation Level in Patients with Refractory/Relapsed Non-Hodgkin Lymphoma (R/R-NHL)","keywords":"","combinedName":"doctor hui-qiang huang"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Dong-Yeop ","lastName":"Shin ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unmet Needs for a Better Treatment in Patients with Peripheral T Cell Lymphoma: Data from a Nationwide, Multi-Center Prospective Registry Study (CISL 1404)","keywords":"","combinedName":"doctor dong-yeop shin"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Hirohiko ","lastName":"Shibayama ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Updated Report of a Phase I/II Multicenter Study of Forodesine, a Purine Nucleoside Phosphorylase Inhibitor, in Japanese Patients with Relapsed Peripheral T-Cell Lymphoma","keywords":"","combinedName":"doctor hirohiko shibayama"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Jessica ","lastName":"Hochberg ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Upfront Brentuximab Vedotin and Rituximab with Reduced Toxicity Chemotherapy in Children, Adolescents and Young Adults with Newly Diagnosed Hodgkin Lymphoma","keywords":"","combinedName":"doctor jessica hochberg"},{"sessionId":"11838","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell LymphomaClinical Studies: Poster III","firstName":"Xingyue ","lastName":"Huang ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of Extracorporeal Photopheresis (ECP) in the Treatment of Patients with Cutaneous T-Cell Lymphoma (CTCL), 2010-2015","keywords":"","combinedName":"doctor xingyue huang"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Stephen Kenneth","lastName":"Tahir ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Abbv-621 Is a Novel and Potent TRAIL Receptor Agonist Fusion Protein That Induces Apoptosis Alone and in Combination with Navitoclax and Venetoclax in Hematological Tumors","keywords":"","combinedName":"doctor stephen kenneth tahir"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Ali ","lastName":"Bazarbachi ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Arsenic Trioxide and Lenalidomide: A Promising Combination Therapy for Primary Effusion Lymphoma","keywords":"","combinedName":"doctor ali bazarbachi"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Simon ","lastName":"Heine ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cyclin D1 Driven CDK4 Activity Is Responsible for Hypersensitivity to NOXA Inducing Combination Treatment in Mantle Cell Lymphoma (MCL) Cells","keywords":"","combinedName":"doctor simon heine"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Wee Joo ","lastName":"Chng ","credentials":"MB ChB, MRCP, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab Efficiently Targets NK/T Cell Lymphoma with High CD38 Expression","keywords":"","combinedName":"doctor wee joo chng"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Tara ","lastName":"Chapman-Arvedson ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Generation of a Half-Life Extended Anti-CD19 BiTE Antibody Construct Compatible with Once-Weekly Dosing for Treatment of CD19-Positive Malignancies","keywords":"","combinedName":"doctor tara chapman-arvedson"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Patricia ","lastName":"Prez-Galn ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Idelalisib Interferes with the Crosstalk of Follicular Lymphoma and Its Immune Microenvironment and Potentiates the Activity of ABT-199","keywords":"","combinedName":"doctor patricia prez-galn"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Zhen ","lastName":"Zhou ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Knockout Tumor Microenvironment HO-1 Enhances the Therapeutic Effect of Histone Deacetylase Inhibitor (RGFP966) on B Cell Lymphoma","keywords":"","combinedName":"doctor zhen zhou"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Ramakrishnan ","lastName":"Gopalakrishnan ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Narciclasine Display Preferential Pre-Clinical Activity Against KSHV-Associated Primary Effusion Lymphoma By Targeting MYC Via NF-?b","keywords":"","combinedName":"doctor ramakrishnan gopalakrishnan"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Julie ","lastName":"Bruneau ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NKp46 Is a Useful Diagnostic Biomarker in Gastrointestinal T-Cell Lymphoproliferative Diseases and Constitutes a Therapeutic Target. a Celac Network Study","keywords":"","combinedName":"doctor julie bruneau"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Molly M","lastName":"Gallogly ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Small Molecule Activators of Protein Phosphatase 2A (SMAPs) Cause c-Myc Degradation and Tumor Growth Suppression in Preclinical Models of Lymphoid Malignancies","keywords":"","combinedName":"doctor molly m gallogly"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Antonio ","lastName":"Sacco ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Lymphoplasmacytic Lymphoma through a Novel Anti-FGF-Based Therapeutical Strategy","keywords":"","combinedName":"doctor antonio sacco"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Francesco ","lastName":"Bertoni ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The ETS Inhibitors Yk-4-279 and TK-216 Interfere with Spib and Synergize with Lenalidomide in Diffuse Large B Cell Lymphoma of the Activated B Cell-like Type (ABC DLBCL)","keywords":"","combinedName":"doctor francesco bertoni"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Ipsita ","lastName":"Pal ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Umbralisib/TGR-1202 As a Novel Dual PI3K/CK1 Inhibitor Has a Unique Therapeutic Role in Silencing Oncogenes in Aggressive Lymphomas","keywords":"","combinedName":"doctor ipsita pal"},{"sessionId":"11839","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster II","firstName":"Marta ","lastName":"Crespo ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Xpo-1 Inhibition Synergizes with BCR Inhibition, Blocks Tumor Growth and Tumor-Associated Macrophages Infiltration and Prolongs Survival in a Bioluminescent Animal Model of Primary Central Nervous System Lymphoma","keywords":"","combinedName":"doctor marta crespo"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Hahn-Sun ","lastName":"Jung ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combination of BR101801 and Venetoclax Demonstrates Synergistic Activity in DLBCL Cell Lines Harboring Double Hit and Double Expressor Alterations","keywords":"","combinedName":"doctor hahn-sun jung"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Wolfram ","lastName":"Brugger ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Inhibition of mTOR and BTK Signalling Is Required for Optimal Long Term Growth Inhibition in DLBCL Models","keywords":"","combinedName":"doctor wolfram brugger"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Michal ","lastName":"Dranitzki Elhalel ","credentials":"MD, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CTLA4-FasL, the Hexameric Targeted FasL Fusion Protein, As Potential Novel Treatment for DLBCL","keywords":"","combinedName":"doctor michal dranitzki elhalel"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Steven I","lastName":"Park ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dual Inhibition of Aurora Kinase and BRD4 Leads to Improved Anti-Tumor Activity in Myc-Overexpressing Lymphoma Cells","keywords":"","combinedName":"doctor steven i park"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Linda ","lastName":"Hammerich ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Situ Vaccination Improves Efficacy of PD-1 Blockade in Unresponsive Lymphoma Tumors through Induction of a Highly Efficient Cross-Presenting Dendritic Cell Subset Expressing TLR3","keywords":"","combinedName":"doctor linda hammerich"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Adrienne ","lastName":"Sallets ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In-Situ Vaccination Using Sting Agonists Combined with Immune-Modulating Antibodies to Treat Lymphoma","keywords":"","combinedName":"doctor adrienne sallets"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Rebecca L","lastName":"Allchin ","credentials":"MRCP, MBBS, BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Clinical Study of Ibrutinib for the Treatment of T-Cell Lymphoma Using Magnetic Resonance Imaging (MRI) Assessment","keywords":"","combinedName":"doctor rebecca l allchin"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Carole ","lastName":"Soussain ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Primary CNS Lymphomas (PCNSL) Patient-Derived Xenograft (PDX) Models Capture the Biological and Molecular Characteristics of the Disease","keywords":"","combinedName":"doctor carole soussain"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Yu Ri ","lastName":"Kim ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Silencing Oncogene Translation Using Pateamine a Analogues As a Novel Therapeutic Strategy for c-Myc Driven Lymphoma","keywords":"","combinedName":"doctor yu ri kim"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Hiromi ","lastName":"Muraoka ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TAS4464, a Novel, Highly Potent NEDD8-Activating Enzyme Inhibitor Shows Antitumor Activity in Ibrutinib-Insensitive Mantle Cell Lymphoma Via Inactivation of the NF-?B Pathway","keywords":"","combinedName":"doctor hiromi muraoka"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Gael ","lastName":"Roue ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The BET Inhibitor GS-626510 Converges with Idelalisib through the Inhibition of Tumor-Macrophage Crosstalk and Cytokine Production in Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor gael roue"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Tara ","lastName":"Peters ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Marine Natural Compound Elatol Is a Novel Protein Translation Inhibitor with Potent Activity Against Aggressive Non-Hodgkin Lymphomas","keywords":"","combinedName":"doctor tara peters"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Silvia ","lastName":"Locatelli ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Novel Calcium Release-Activated Calcium(CRAC) Channel Inhibitor RP4010 Exerts Potent Antitumor Effects in NOD/SCID/IL2Rg-/- Mice with Diffuse Large B Cell Lymphoma (DLBCL) Cell Line Xenografts","keywords":"","combinedName":"doctor silvia locatelli"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Anjali ","lastName":"Mishra ","credentials":"PhD ","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapeutic Targeting of Microrna-214 in Cutaneous T-Cell Lymphoma","keywords":"","combinedName":"doctor anjali mishra"},{"sessionId":"11840","sessionTitle":"625. Lymphoma: Pre-ClinicalChemotherapy and Biologic Agents: Poster III","firstName":"Ann ","lastName":"Maclaren ","credentials":"PhD, BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Trph-222, a Novel Anti-CD22 Antibody Drug Conjugate (ADC), Has Signficant Anti-Tumor Activity in NHL Xenografts and Is Well Tolerated in Non-Human Primates","keywords":"","combinedName":"doctor ann maclaren"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Pallawi ","lastName":"Torka ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 1/2 Study of Carfilzomib Combined with Rituximab, Ifosfamide, Carboplatin and Etoposide (C-RICE) in Patients with Transplant-Eligible, Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)","keywords":"","combinedName":"doctor pallawi torka"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Christine ","lastName":"Schmitz ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ANew Dynamic PET-Based Scoring System Improves Outcome Prediction in Patients with Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor christine schmitz"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Laurie ","lastName":"Sehn","credentials":"MD, MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Addition of Polatuzumab Vedotin to Bendamustine and Rituximab (BR) Improves Outcomes in Transplant-Ineligible Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Versus BR Alone: Results from a Randomized Phase 2 Study","keywords":"","combinedName":"doctor laurie sehn"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Laurence ","lastName":"Brugires ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Crizotinib in Advanced ALK+ Anaplastic Large Cell Lymphoma in Children and Adults: Results of the Acs Phase II Trial","keywords":"","combinedName":"doctor laurence brugires"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Alberto ","lastName":"Risueo ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Discovery of an Immune-Driven Gene Expression Signature That Predicts for Clinical Benefit to CC-122 in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)","keywords":"","combinedName":"doctor alberto risueo"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Pier Luigi","lastName":"Zinzani","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (rrPMBCL): Updated Analysis of the Keynote-170 Phase 2 Trial","keywords":"","combinedName":"doctor pier luigi zinzani"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Mathias J","lastName":"Rummel ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Subcutaneous or Intravenous Administration of Rituximab in Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Final Results of the Randomized, Open-Label, Crossover, PrefMab Study","keywords":"","combinedName":"doctor mathias j rummel"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Shigeru ","lastName":"Kusumoto ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Managing the Risk of Hepatitis B Virus Reactivation in Patients with B-Cell Lymphomas Treated with Obinutuzumab or Rituximab Immunochemotherapy","keywords":"","combinedName":"doctor shigeru kusumoto"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Brian ","lastName":"Hill ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Marked Re-Expansion of Chimeric Antigen Receptor (CAR) T Cells and Tumor Regression Following Nivolumab Treatment in a Patient Treated with Axicabtagene Ciloleucel (axi-cel; KTE-C19) for Refractory Diffuse Large B Cell Lymphoma (DLBCL)","keywords":"","combinedName":"doctor brian hill"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Zhongjun ","lastName":"Xia ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Old Drugs with New Tricks: Rituximab in Combination with Albumin-Bound paclitaxel and Pegylated Liposomal Doxorubicin in the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma","keywords":"","combinedName":"doctor zhongjun xia"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Matthew A","lastName":"Care ","credentials":"PhD, MSc, BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Parsimonious Gene Correlation Network Analysis in DLBCL Allows Refined Linkage to Mutation State and Treatment Response","keywords":"","combinedName":"doctor matthew a care"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Claire L","lastName":"Sutherland ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacokinetic, Pharmacodynamic and Blood Analytes Associated with Clinical Response and Safety in Relapsed/Refractory Aggressive B-NHL Patients Treated with JCAR017","keywords":"","combinedName":"doctor claire l sutherland"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Frederick ","lastName":"Locke","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 1 Results from ZUMA-6: Axicabtagene Ciloleucel (axi-cel; KTE-C19) in Combination with Atezolizumab for the Treatment of Patients with Refractory Diffuse Large B Cell Lymphoma (DLBCL)","keywords":"","combinedName":"doctor frederick locke"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Andrea ","lastName":"Kuhnl ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"R-GEM-Lenalidomide Versus R-GEM-P As Second-Line Treatment of Diffuse Large B-Cell Lymphoma: Results from the UK NCRI Phase II Randomized Legend Trial","keywords":"","combinedName":"doctor andrea kuhnl"},{"sessionId":"11842","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster II","firstName":"Andrs J M","lastName":"Ferreri ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Activity of a Dose-Dense Short-Term Chemoimmunotherapy in HIV-Positive Patients with Burkitt Lymphoma (HIV-BL pts): Final Results of the Carmen Phase II Trial","keywords":"","combinedName":"doctor andrs j m ferreri"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Cecilia ","lastName":"Carpio ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Gene Expression Classifier Enriches for Single Agent Clinical Activity of CC-122, a Cereblon Modulator, Administered Orally to Relapsed or Refractory Diffuse Large B-Cell Lymphoma Subjects: Results from the Phase I CC-122-ST-001 Study","keywords":"","combinedName":"doctor cecilia carpio"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Alex ","lastName":"Herrera","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase I Study of the Anti-CD79b THIOMABTM-Drug Conjugate DCDS0780A in Patients (pts) with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)","keywords":"","combinedName":"doctor alex herrera"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Pengpeng ","lastName":"Xu ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Study of Chidamide Plus R-CHOP in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: An Interim Analysis","keywords":"","combinedName":"doctor pengpeng xu"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Deborah ","lastName":"Stephens ","credentials":"DO","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics and Outcomes of Patients with Double-Protein Expression in Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of SWOG Study S1001 (NCT01359592)","keywords":"","combinedName":"doctor deborah stephens"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Matthew J","lastName":"Maurer ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diagnosis-to-Treatment Interval (DTI) Remains Associated with Adverse Clinical Characteristics and Outcome in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma Treated on Clinical Trials","keywords":"","combinedName":"doctor matthew j maurer"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Stephen ","lastName":"Smith ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pembrolizumab (MK-3475) in Combination with Standard RCHOP Therapy for Previously Untreated Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor stephen smith"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Wael A","lastName":"Harb ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 1 Clinical Safety, Pharmacokinetics (PK), and Activity of Apilimod Dimesylate (LAM-002A), a First-in-Class Inhibitor of Phosphatidylinositol-3-Phosphate 5-Kinase (PIKfyve), in Patients with Relapsed or Refractory B-Cell Malignancies","keywords":"","combinedName":"doctor wael a harb"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Elise ","lastName":"Chong ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I/II Study of Pembrolizumab for Progressive Diffuse Large B Cell Lymphoma after Anti-CD19 Directed Chimeric Antigen Receptor Modified T Cell Therapy","keywords":"","combinedName":"doctor elise chong"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Andres ","lastName":"Forero-Torres ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Polatuzumab Vedotin Combined with Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone (G-CHP) for Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Updated Results of a Phase Ib/II Study","keywords":"","combinedName":"doctor andres forero-torres"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Yoshitoyo ","lastName":"Kagami ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)","keywords":"","combinedName":"doctor yoshitoyo kagami"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"G A Amos","lastName":"Burke ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results of Inter-B-NHL Ritux 2010  Phase II Study of DA-EPOCH-R for Children and Adolescents with Primary Mediastinal Large B-Cell Lymphoma (PMLBL) on Behalf of European Intergroup for Childhood Non Hodgkin's Lymphoma (EICNHL) and Children's Oncology Group (COG)","keywords":"","combinedName":"doctor g a amos burke"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Carlo","lastName":"Gambacorti-Passerini","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Crizotinib in ALK-Positive Lymphomas: A Phase 1b Open-Label Study","keywords":"","combinedName":"doctor carlo gambacorti-passerini"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Gilles ","lastName":"Salles ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind","keywords":"","combinedName":"doctor gilles salles"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Alon ","lastName":"Rozental ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of Maintenance Therapy in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis","keywords":"","combinedName":"doctor alon rozental"},{"sessionId":"11843","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Prospective Clinical Trials: Poster III","firstName":"Stephen ","lastName":"Ansell","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TTI-621 (SIRPaFc), an Immune Checkpoint Inhibitor Blocking the CD47 \"Do Not Eat\" Signal, Induces Objective Responses in Patients with Advanced, Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)","keywords":"","combinedName":"doctor stephen ansell"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Chia-Jen ","lastName":"Liu ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A New Prognostic Scoring System to Predict Disease Progression and Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma","keywords":"","combinedName":"doctor chia-jen liu"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Eri ","lastName":"Ishikawa ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Prognostic Model for Primary Gastric Diffuse Large B-Cell Lymphoma in the Rituximab Era, Integrating EBV Harboring on Tumor Cells","keywords":"","combinedName":"doctor eri ishikawa"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Jeong ","lastName":"Seong Hyun ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients with Diffuse Large B-Cell Lymphoma (CISL 1403)","keywords":"","combinedName":"doctor jeong seong hyun"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Hanne ","lastName":"Due ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Beneficial Effect of Microrna-155 in Vincristine Response and Clinical Outcome in Especially GCB Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor hanne due"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Sabarish ","lastName":"Ayyappan ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Central Nervous System Relapse in Diffuse Large B Cell Lymphoma - Predictors at Diagnosis","keywords":"","combinedName":"doctor sabarish ayyappan"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Preetesh ","lastName":"Jain ","credentials":"MBBS,MD,DM,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics, Treatments, and Outcomes of Patients with Lymphomatoid Granulomatosis - MD Anderson Cancer Center Experience","keywords":"","combinedName":"doctor preetesh jain"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Erin ","lastName":"Mulvey ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CNS Prophylaxis in DLBCL: A Ten Year Single-Center Review in the Rituximab Era","keywords":"","combinedName":"doctor erin mulvey"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Giulia ","lastName":"Bartalucci ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of the Efficacy and Feasibility of R-CODOX-M/IVAC-R Versus Conventional R-CHOP As First Line Regimen for High Risk Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor giulia bartalucci"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Yolla ","lastName":"EL Dakdouki ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dose-Adjusted Rituximab Mini-CYVE (CYtarabine bolus, VEpeside and dexamethasone) for Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Not Eligible for High Dose Therapy","keywords":"","combinedName":"doctor yolla el dakdouki"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Christopher ","lastName":"Melani ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"End-of-Treatment CT and Serial FDG-PET Imaging to Assess Residual Disease in Primary Mediastinal B-Cell Lymphoma","keywords":"","combinedName":"doctor christopher melani"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Nobuyuki ","lastName":"Kabasawa ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Dose Ara-C, Carboplatin, Etoposide, and Steroids (ACES) Is Effective in Relapse and Refractory Non-Hodgkin Lymphoma ","keywords":"","combinedName":"doctor nobuyuki kabasawa"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Tomotaka ","lastName":"Suzuki ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of the Double Expression of MYC and BCL2 on Outcomes of Primary Refractory Diffuse Large B-Cell Lymphoma Following R-CHOP Chemoimmunotherapy","keywords":"","combinedName":"doctor tomotaka suzuki"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Magali ","lastName":"Le Garff-Tavernier ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Keep an Eye on CXCL-13: A Promising Biomarker to Help IL-10 and IL-6 for the Diagnosis of Intraocular Lymphomas","keywords":"","combinedName":"doctor magali le garff-tavernier"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Konstantinos ","lastName":"Lontos ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Location Matters in Nodal Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor konstantinos lontos"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Rui ","lastName":"Gao ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low Serum Cholesterol Levels Predict Inferior Prognosis in Diffuse Large B Cell Lymphoma","keywords":"","combinedName":"doctor rui gao"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Joachim ","lastName":"Baech ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lymphoma Patients Treated without Anthracyclines Have Negligible Risk of Cardiotoxicity: A Nationwide Cohort Study","keywords":"","combinedName":"doctor joachim baech"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Alessandro ","lastName":"Broccoli ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PET/CT Guided Biopsy for the Diagnosis of Lymphoma","keywords":"","combinedName":"doctor alessandro broccoli"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Dong ","lastName":"Sheng ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PET-CT Invisible Diffuse Large B-Cell Lymphoma Features a Silent B-Cell Receptor Signaling","keywords":"","combinedName":"doctor dong sheng"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Ji Hyun ","lastName":"Lee ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pretreatment Nutritional Status and Cardiovascular Risk Factors Affect Survival of Diffuse Large B-Cell Lymphoma Patients Treated with Immunochemotherapy","keywords":"","combinedName":"doctor ji hyun lee"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"David ","lastName":"Kasouha ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Impact of Extranodal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma","keywords":"","combinedName":"doctor david kasouha"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Qunling ","lastName":"Zhang ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Protein Kinase C Delta in Diffuse Large B-Cell Lymphoma Post-Rituximab Era: Potential Prognostic Marker in Germinal Center B-Cell Lymphoma","keywords":"","combinedName":"doctor qunling zhang"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Anna ","lastName":"Dodero ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rituximab Dose Adjusted EPOCH Improves Progression-Free Survival of Patients Affected By Diffuse Large Cell Lymphomas with Double Expression of MYC and BCL2 Proteins","keywords":"","combinedName":"doctor anna dodero"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Choquet ","lastName":"Sylvain ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Temozolomide in Relapse/Refractory Primary Vitreo-Retinal Lymphoma (R/R PVRL): A New Effective, Well-Tolerated and Cheap Reference. Result of a Study on Behalf of the LOC Network","keywords":"","combinedName":"doctor choquet sylvain"},{"sessionId":"11844","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster II","firstName":"Rui ","lastName":"Gao ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Type 2 Diabetes Mellitus Strongly Impacts Survival in Patients with Diffuse Large B Cell Lymphoma","keywords":"","combinedName":"doctor rui gao"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Michael D","lastName":"Ashby ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Multicenter Retrospective Review of Outcomes of Diffuse Large B Cell Lymphoma (DLBCL) in the Elderly Treated with RCHOP in Australia","keywords":"","combinedName":"doctor michael d ashby"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Jaewon ","lastName":"Hyung ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adding Beta-2 Microglobulin for Better Prognostication of Primary Central Nervous System Lymphoma","keywords":"","combinedName":"doctor jaewon hyung"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Anna S","lastName":"Nam ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessing the Utility of Immunoglobulin and T Cell Receptor Gene Rearrangement Studies for Cerebrospinal Fluid Specimens","keywords":"","combinedName":"doctor anna s nam"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Sakshi ","lastName":"Jasra ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Barriers and Opportunities in Accrual of HIV-Positive Minority Underserved Patients with Non-Hodgkin Lymphoma, into AIDS Malignancy Consortium (AMC) Clinical Trials: A Retrospective 12- Year Single Institution Experience","keywords":"","combinedName":"doctor sakshi jasra"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Daisuke ","lastName":"Kurita ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinicopathological Study of Methotrexate-Associated Lymphoproliferative Disorders in Rheumatoid Arthritis Patients:Histological Classification and Predictive Factors for Disease Progression","keywords":"","combinedName":"doctor daisuke kurita"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Dai ","lastName":"Chihara ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Difference in Survival Outcome of Primary Central Nervous System Lymphoma By Histologic Types","keywords":"","combinedName":"doctor dai chihara"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Taeyun ","lastName":"Kim ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect on Clinical Outcomes of Anemia and Serum Level of Ferritin in Diffuse Large B Cell Lymphoma Treated with Rituximab Combined Chemotherapy","keywords":"","combinedName":"doctor taeyun kim"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Talha ","lastName":"Badar ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of Salvage Chemotherapy in Diffuse Large B Cell Lymphoma with Primary Treatment Failure According to Putative Cell of Origin","keywords":"","combinedName":"doctor talha badar"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Julie Bondgaard","lastName":"Mortensen ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Elevated Pre-Therapeutic Serum Levels of Soluble Programmed Death 1 Protein (sPD-1) Identify DLBCL Patients with Adverse Prognostic Features","keywords":"","combinedName":"doctor julie bondgaard mortensen"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Kentaro ","lastName":"Narita ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Risk Factors and Survival Effect of Delayed Excretion of High-Dose Methotrexate in Patients with Leukemia and Lymphoma","keywords":"","combinedName":"doctor kentaro narita"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Martine ","lastName":"Chamuleau ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"First Report on a Successful Screening Program for MYC Rearrangements and a Prospective Clinical Trial Based on MYC Rearrangement in Newly Diagnosed DLBCL Patients in the Netherlands","keywords":"","combinedName":"doctor martine chamuleau"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Mara Victoria","lastName":"Irigon ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Absolute Monocyte Count at Diagnosis Predicts Adverse Outcome Among Very Good and Good R-IPI Diffuse Large B Cell Lymphoma","keywords":"","combinedName":"doctor mara victoria irigon"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Li-Wen ","lastName":"Huang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Prevalence and Incidence of Fractures in Patients Treated for Aggressive B-Cell Non-Hodgkin Lymphomas","keywords":"","combinedName":"doctor li-wen huang"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Luis E","lastName":"Malpica Castillo ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of IRF4/MUM1 Expression on Adult T-Cell Leukemia/Lymphoma and Treatment Outcome","keywords":"","combinedName":"doctor luis e malpica castillo"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Yang ","lastName":"Fu ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improved Outcome of Newly Diagnosed Childhood Mature B-Cell Lymphoma/Leukemia with High Tumor Burden Treated with BFM95-Based Protocol Combining Rituximab: A Report from Shanghai, China","keywords":"","combinedName":"doctor yang fu"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Tarsheen ","lastName":"Sethi ","credentials":"MD, MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence of Central Nervous System (CNS) Relapse in MYC Rearranged Diffuse Large B-Cell Lymphoma: Does CNS Prophylaxis Improve Outcome?","keywords":"","combinedName":"doctor tarsheen sethi"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Masako ","lastName":"Iwanaga ","credentials":"MD, PhD, MPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence Patterns of Patients with Two or More Lymphoid Malignancies in a Patient with a Prior History of Lymphoid Malignancy: A Population-Based Cancer Registry Study in Nagasaki, Japan","keywords":"","combinedName":"doctor masako iwanaga"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Daniel ","lastName":"Landsburg ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim PET-CT Result Is Not Predictive of Survival in Patients with MYC-Rearranged Non-Burkitt Aggressive B Cell Lymphoma","keywords":"","combinedName":"doctor daniel landsburg"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Kevin ","lastName":"Hall ","credentials":"PharmD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intrathecal Central Nervous System Prophylaxis in Patients with Diffuse Large B-Cell Lymphoma at an Academic Healthcare System","keywords":"","combinedName":"doctor kevin hall"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Daniel J","lastName":"Enriquez ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Prognostic Classification for Adult T Cell Lymphoma/Leukemia Based on Hypercalcemia and Neutrophil-to-Lymphocyte Ratio","keywords":"","combinedName":"doctor daniel j enriquez"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Andrew ","lastName":"Ritter ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overall Survival Disparities in Metro/Urban/Rural Diffuse Large B-Cell Lymphoma (DLBCL) Patients","keywords":"","combinedName":"doctor andrew ritter"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Prioty ","lastName":"Islam ","credentials":"MD, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PET-Derived Tumor Metrics Predict DLBCL Response and Progression-Free Survival","keywords":"","combinedName":"doctor prioty islam"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Yuko ","lastName":"Mishima ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Poor Prognosis of CD5 Positive with Non Germinal Center Type of Diffuse Large B Cell Lymphoma Especially Having the Aberration of 19q13","keywords":"","combinedName":"doctor yuko mishima"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Zachary ","lastName":"Quinn ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Primary Dural Diffuse Large B-Cell Lymphoma Is Associated with Good Prognosis and Is Effectively Treated with CHOP-R Alone","keywords":"","combinedName":"doctor zachary quinn"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Rudy ","lastName":"Birsen ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Value of Early 18F-FDG PET/CT Scanner Evaluation in Immunocompetent Primary CNS Lymphoma Patients","keywords":"","combinedName":"doctor rudy birsen"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Betty ","lastName":"Gration ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"R-GCVP As Second Line Treatment in Elderly Patients with DLBCL Who Fail R-CHOP and Are Not Candidates for Intensive Therapy","keywords":"","combinedName":"doctor betty gration"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Alessandra ","lastName":"Tucci ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rituximab with Dose-Adjusted EPOCH (R-DA-EPOCH) As First-Line Treatment in Patients with Double-Hit Lymphoma: Preliminary Results in 35 Consecutive Patients from Two Institutions","keywords":"","combinedName":"doctor alessandra tucci"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Silvia ","lastName":"Park ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Routine Prophylaxis of Pneumocystis Pneumonia from the Fourth Cycle of R-CHOP Regimen in DLBCL Patients ","keywords":"","combinedName":"doctor silvia park"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Guillaume ","lastName":"Aussedat ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sequential Lymphoma between Classical Hodgkin Lymphoma and Diffuse Large B Cell Lymphoma: Clinicopathological Characteristics and Outcome of 18 Patients from Lysa Center","keywords":"","combinedName":"doctor guillaume aussedat"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Theresa ","lastName":"Keegan ","credentials":"PhD, MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Survival after Diffuse Large B-Cell Lymphoma Among Children, Adolescents and Young Adults in the Era of Immunotherapy: A Population-Based Study","keywords":"","combinedName":"doctor theresa keegan"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"George A","lastName":"Follows ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Cambridge University Hospitals and Anglia Regional Experience of Using PEP-C As Palliative Chemotherapy in Lymphoma","keywords":"","combinedName":"doctor george a follows"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Kartiga ","lastName":"Thiyagarajah ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Efficacy of PET-CT in Detecting Bone Marrow Involvement in Patients with Newly Diagnosed Lymphoma: A Retrospective Study","keywords":"","combinedName":"doctor kartiga thiyagarajah"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Kyoungmin ","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Efficacy of Systemic High Dose Methotrexate As Central Nervous System Prophylaxis in Patients with High Risk Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis","keywords":"","combinedName":"doctor kyoungmin lee"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Hideaki ","lastName":"Nitta ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Presence of Pleural Effusion at Diagnosis Predicts Poor Outcomes in Diffuse Large B-Cell Lymphoma Patients with MYC-Rearrangement or Double Protein Expression","keywords":"","combinedName":"doctor hideaki nitta"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Ji Hyun ","lastName":"Lee ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"the Prognostic Implication of Inflammatory Factor-Based Scoring System in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era","keywords":"","combinedName":"doctor ji hyun lee"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Dai ","lastName":"Chihara ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of Radiation Therapy and Risk of Developing Secondary Gastric Cancer in Patients Presenting with Early Stage Gastric Lymphoma","keywords":"","combinedName":"doctor dai chihara"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Lori ","lastName":"Leslie ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment of High Risk DLBCL with DA-R-EPOCH in Those Unable to Tolerate Intensive Chemotherapy: Well-Tolerated and Effective, but Inadequate in Double/Triple Hit or Expressing DLBCL","keywords":"","combinedName":"doctor lori leslie"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Rohan ","lastName":"Kehar ","credentials":"MD,MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Outcomes in the Management of Lymphoblastic Lymphoma (LBL) in Adults: An Institutional Review","keywords":"","combinedName":"doctor rohan kehar"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Jordan ","lastName":"Goldstein ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Utilizing Digital Pathology Informatics Algorithms for Diffuse Large B-Cell Lymphoma Subtyping","keywords":"","combinedName":"doctor jordan goldstein"},{"sessionId":"11845","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)Results from Retrospective/Observational Studies: Poster III","firstName":"Maria Queralt ","lastName":"Salas Gay ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of the NCCN-IPI and the Geltamo-IPI in a Large Cohort of Patients Diagnosed of Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP/R-CHOP-like in a Single Institution","keywords":"","combinedName":"doctor maria queralt salas gay"},{"sessionId":"11846","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Federica ","lastName":"SORA ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Association between 9p21 Chromosome Polymorphisms rs1333040 and rs7865618 and Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor federica sora"},{"sessionId":"11846","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Mirle ","lastName":"Schemionek ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bcr-Abl1 Kinase-Independent Upregulation of Fc?RIIb Mediates Malignant Signaling That Is Critical for Leukemogenesis","keywords":"","combinedName":"doctor mirle schemionek"},{"sessionId":"11846","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Sukjoong ","lastName":"Oh ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterization of ABL Compound Mutation Using Sanger and Subcloning Sequencing in Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor sukjoong oh"},{"sessionId":"11846","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Bandana Ajay","lastName":"Vishwakarma ","credentials":"BSc, MSc, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hoxa9 and Hoxa10 Induce CML Myeloid Blast Crisis Development through Activation of Myb Expression","keywords":"","combinedName":"doctor bandana ajay vishwakarma"},{"sessionId":"11846","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Asumi ","lastName":"Yokota ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IFN-a Upregulates the Expression of C/EBP and Induces Myeloid Differentiation and Exhaustion of CD34+ CML Stem Cells","keywords":"","combinedName":"doctor asumi yokota"},{"sessionId":"11846","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Elias D","lastName":"Bhrer ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Splenic Red Pulp Macrophages Provide a Secondary Stem Cell Niche for Chronic Myeloid Leukemia Stem Cells","keywords":"","combinedName":"doctor elias d bhrer"},{"sessionId":"11846","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Carmen ","lastName":"Fava ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Standardization of Two Dpcr Platforms for Detection of BCR/ABL1 - Minimal Residual Disease (MRD) in Ph+ Chronic Myeloid Leukemia (CML)","keywords":"","combinedName":"doctor carmen fava"},{"sessionId":"11846","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Wenxue ","lastName":"Ma ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Telomerase Inhibition Impairs Self-Renewal of -Catenin Activated Myeloproliferative Neoplasm Progenitors","keywords":"","combinedName":"doctor wenxue ma"},{"sessionId":"11847","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Bing Z","lastName":"Carter ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Activation of p53 Enhances Antileukemia Activity of Bcr-Abl Tyrosine Kinase Inhibitors in a Murine Model of CML","keywords":"","combinedName":"doctor bing z carter"},{"sessionId":"11847","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Filomena ","lastName":"Daraio ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease","keywords":"","combinedName":"doctor filomena daraio"},{"sessionId":"11847","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Min Young ","lastName":"Lee ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Expression Levels of PD-1 on CD8+ T Cells in Chronic Myeloid Leukemia with and without BCR-ABL1 kinase Mutation","keywords":"","combinedName":"doctor min young lee"},{"sessionId":"11847","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Anna ","lastName":"Eiring","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Loss of G0S2 in Kinase-Independent TKI Resistance and Blastic Transformation of CML","keywords":"","combinedName":"doctor anna eiring"},{"sessionId":"11847","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Seung Hun ","lastName":"Han ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mir-424 and Mir-503 Regulates Cobll1 Expression during the CML Progression","keywords":"","combinedName":"doctor seung hun han"},{"sessionId":"11847","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Dehuan ","lastName":"Ji ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Oncogenic Heterogeneous Nuclear Ribonucleoprotein D-like Promotes the Growth of Chronic Myeloid Leukemia Cellsthrough Post-Transcriptional Regulation of Pre-B-Cell Leukemia Homeobox 1","keywords":"","combinedName":"doctor dehuan ji"},{"sessionId":"11847","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Preetesh ","lastName":"Jain ","credentials":"MBBS,MD,DM,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pattern of Mutational Changes in Patients with Chronic Phase CML Who Are Treated with Frontline TKI and Transform to Blast Phase CML","keywords":"","combinedName":"doctor preetesh jain"},{"sessionId":"11847","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Olatundun ","lastName":"Williams ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tumor Suppressor, NORE1A (RASSF5), Is an Icsbp-Dependent Inhibitor of Aberrant Stress Granulopoiesis","keywords":"","combinedName":"doctor olatundun williams"},{"sessionId":"11847","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Chun Shik ","lastName":"Park ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Vitamin K3 (menadione) Induces Cytotoxicity in Chronic Myeloid Leukemia Stem Cells By Upregulating DYRK2 through the Inhibition of SIAH2 Ubiquitin Ligase","keywords":"","combinedName":"doctor chun shik park"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Silvia ","lastName":"Mori ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" Imatinib Suspension and Validation Study: Results from the Isav Study at 62 Months","keywords":"","combinedName":"doctor silvia mori"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Luigia ","lastName":"Luciano ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Real Life Evaluation of Efficacy and Safety of Ponatinib Therapy in CML Patients","keywords":"","combinedName":"doctor luigia luciano"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Jorge ","lastName":"Cortes","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Arterial Occlusive Events (AOEs) in the Phase 2 Ponatinib PACE Trial: 5-Year Update in Heavily Treated Patients (Pts) with Chronic-Phase Chronic Myeloid Leukemia (CP-CML)","keywords":"","combinedName":"doctor jorge cortes"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Ya-Zhen ","lastName":"Qin ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessment of Standardization and International Scale (IS) Alignment Efforts of BCR-ABL1 Testing By the Chinese CML Alliance in an International External Quality Assessment Program","keywords":"","combinedName":"doctor ya-zhen qin"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Olivia ","lastName":"Copelan ","credentials":"BA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Association of Tyrosine Kinase Inhibitors with Vascular Adverse Events: A Cohort Study Using Pooled Electronic Health Record","keywords":"","combinedName":"doctor olivia copelan"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Remco J","lastName":"Molenaar ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Atherosclerotic Arterial Disease-Related Mortalityin Chronic Myeloid Patients Treated with Tyrosine Kinase Inhibitors","keywords":"","combinedName":"doctor remco j molenaar"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Jorge ","lastName":"Cortes","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: 12-Month Patient-Reported Outcomes from the BFORE Trial","keywords":"","combinedName":"doctor jorge cortes"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Fumihito ","lastName":"Tajima ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Both CD4+CD25+Foxp3+ Regulatory T Cells and CD3-CD56+ NK Cells Affect the Response of Newly Diagnosed Chronic Myeloid Leukemia Patients to Treatment with a Tyrosine Kinase Inhibitor","keywords":"","combinedName":"doctor fumihito tajima"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Juan Manuel ","lastName":"Alonso Dominguez ","credentials":"MD, PhD, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparation of Digital PCR and Quantitative Pcr for Molecular Monitorization of Chronic Myeloid Leukemia Patients","keywords":"","combinedName":"doctor juan manuel alonso dominguez"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Ahmad ","lastName":"Ghorab ","credentials":"MD,MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Risk Assessment of Imatinib, Nilotinib and Dasatinib in Randomized Controlled Trials: A Meta-Analysis","keywords":"","combinedName":"doctor ahmad ghorab"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Qian ","lastName":"Jiang ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of the Outcome between Newly Diagnosed Patients in the Accelerated Phase and Chronic Phase with Chronic Myeloid Leukemia Treated with Frontline Tyrosine Kinase Inhibitors","keywords":"","combinedName":"doctor qian jiang"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Joanna ","lastName":"Gora Tybor ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Concomitant Medications and Comorbidities Affect Early Response in CML Patients Treated with Imatinib: A Retrospective Analysis of 340 Patients from the Polish Adult Leukemia Group (PALG) Registry","keywords":"","combinedName":"doctor joanna gora tybor"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Jorge ","lastName":"Cortes","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cytogenetic and Molecular Responses after 2 Years of Tyrosine Kinase Inhibitor (TKI) Treatment in Simplicity, an Observational Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (Pts) in Routine Clinical Practice","keywords":"","combinedName":"doctor jorge cortes"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Ali ","lastName":"Alahmari ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dasatinib Induced Reversible Nephrotic Range Proteinuria Occurs More Frequently Compared to Other Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor ali alahmari"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Anna ","lastName":"Martner ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Delayed Expansion of Murine BCR-ABL1+ Leukemia By Genetic and Pharmacological Inhibition of NOX2","keywords":"","combinedName":"doctor anna martner"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Psmh ","lastName":"Pakistan Society For Molecular and Clinical Hematology ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Disovery of Novel Mutations Exclusively Shared ByAccelerated and Blast Crisis Phase CML Patients Using Whole Exome Sequencing:Implication in Hunt for Common Biomarker /Drug Target of CML Progression","keywords":"","combinedName":"doctor psmh pakistan society for molecular and clinical hematology"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Jorge ","lastName":"Cortes","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Echocardiographic Findings in Patients (pts) Receiving Tyrosine Kinase Inhibitors (TKIs) for the Treatment of Chronic Myeloid Leukemia (CML)","keywords":"","combinedName":"doctor jorge cortes"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Iman ","lastName":"Aboudalle ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Generic Imatinib after Switching from Innovator Imatinib in Patients Treated for Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor iman aboudalle"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Nurgul ","lastName":"Ozgur Yurttas ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors:Preliminary Results of a Single-Center Cross-Sectional Study","keywords":"","combinedName":"doctor nurgul ozgur yurttas"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Franck Emmanuel","lastName":"Nicolini ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Body Mass Index on Outcome in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Imatinib in First-Line","keywords":"","combinedName":"doctor franck emmanuel nicolini"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Ralf ","lastName":"Knoefler ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Tyrosine-Kinase Inhibitors (TKIs) on Primary Hemostasis  Evaluation of Effects In Vitro","keywords":"","combinedName":"doctor ralf knoefler"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Ahmad ","lastName":"Ghorab ","credentials":"MD,MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Isolated Extramedullary (EMD) Blastic Transformation of Chronic Myeloid Leukemia (CML-BP) in the TKI Era: Characteristics, Treatments and Outcomes","keywords":"","combinedName":"doctor ahmad ghorab"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Rita ","lastName":"Assi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Chronic Myeloid Leukemia (CML) during Pregnancy Among Patients (pts) Treated with a Tyrosine Kinase Inhibitor (TKI): A Single-Center Experience","keywords":"","combinedName":"doctor rita assi"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Hsi-Che ","lastName":"Liu ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Responses and Outcomes of Pediatric CML Treated with Front-Line Imatinib and a Comparison between Pediatric and Adult Cohorts","keywords":"","combinedName":"doctor hsi-che liu"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"David ","lastName":"Yeung ","credentials":"PhD,BSc,FRACP,FRCPA,MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nilotinib in Combination with Pegylated Interferon Alfa-2b for CP-CML Leads to High Molecular Response Rates: Interim Results of the Pinnacle Study","keywords":"","combinedName":"doctor david yeung"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Lilian ","lastName":"Iglesias ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"No Excess Risk of Second Malignancies in Chronic Myeloid Leukemia (CML) Patients Treated with Tyrosine Kinase Inhibitors (TKIs)","keywords":"","combinedName":"doctor lilian iglesias"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Alexis ","lastName":"Genthon ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"No Influence of BCR-ABL1 Transcript Types e13a2 and e14a2 on MR4.5 in Patients with Chronic Myeloid Leukemia Treated with Nilotinib Frontline","keywords":"","combinedName":"doctor alexis genthon"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"May ","lastName":"Garrett ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimizing Dose of Bosutinib to Minimize Adverse Events While Maintaining Efficacy in Patients with Newly Diagnosed Chronic Myelogenous Leukemia","keywords":"","combinedName":"doctor may garrett"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Ester ","lastName":"Pungolino ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Experience of Imatinib after Nilotinib in the First Line Treatment of Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor ester pungolino"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Maliha ","lastName":"Khan ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Response and Outcomes of Third-Line Tyrosine Kinase Inhibitor Therapy on Patients with Chronic Phase Chronic Myeloid Leukemia","keywords":"","combinedName":"doctor maliha khan"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Franck Emmanuel","lastName":"Nicolini ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Response to Ponatinib Is Not Related to the Drug Plasma Levels in Chronic Phase CML","keywords":"","combinedName":"doctor franck emmanuel nicolini"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Ellen K","lastName":"Ritchie ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib","keywords":"","combinedName":"doctor ellen k ritchie"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Ehab ","lastName":"Atallah ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from the U.S. Life after Stopping TKIs (Last) Study","keywords":"","combinedName":"doctor ehab atallah"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Laura ","lastName":"Cesini ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Erythropoietin in the Late Anemia of Patients with Chronic Myeloid Leukemia Treated Frontline with Imatinib","keywords":"","combinedName":"doctor laura cesini"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Martin ","lastName":"Mller ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sample Exchange to Standardize Molecular Monitoring for CML: The EUTOS Experience","keywords":"","combinedName":"doctor martin mller"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Sung-Eun ","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Early Molecular Response at 3 Months on Long-Term Survival Was Enhanced in the CP CML Patients Treated with Second-Generation Tyrosine Kinase Inhibitors","keywords":"","combinedName":"doctor sung-eun lee"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Ka-Won ","lastName":"Kang ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Potential of Exosomes Derived from Chronic Myelogenous Leukemia Cells As Biomarker Based on the BCR-ABL mRNA Transcript","keywords":"","combinedName":"doctor ka-won kang"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Adam J","lastName":"Mead","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Target UK Study: Real-World Evidence of Molecular Response to Tyrosine Kinase Inhibitors Supports European Leukemianet 2013 Recommendations for the Management of Chronic Myeloid Leukaemia","keywords":"","combinedName":"doctor adam j mead"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Jorge ","lastName":"Cortes","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Characteristics and Deep Molecular Response in Chronic Phase  Chronic Myeloid Leukemia Patients Treated with Second-Line Nilotinib or Dasatinib: A Multi-Country Retrospective Chart Review Study","keywords":"","combinedName":"doctor jorge cortes"},{"sessionId":"11848","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Poster II","firstName":"Timothy ","lastName":"Hughes ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment-Free Remission (TFR) Among Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Not Initially Eligible for Treatment Discontinuation Due to Unstable Deep Molecular Response (DMR): Enestfreedom and Enestop","keywords":"","combinedName":"doctor timothy hughes"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Ayalew","lastName":"Tefferi","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Blast Phase Myeloproliferative Neoplasm: A Mayo Agimm Study of 419 Consecutive Cases","keywords":"","combinedName":"doctor ayalew tefferi"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Daniel ","lastName":"Zinn ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BRAF-V600E in Peripheral Mononuclear Cells and Microglia-like Brain Cells Suggest Hematopoietic Origin of Langerhans Cell Histiocytosis-Associated Neurodegeneration","keywords":"","combinedName":"doctor daniel zinn"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Merav ","lastName":"Barzilai ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics and Outcome of Philadelphia(Ph) Negative Myeloproliferative Neoplasms(MPN) in Patients Younger Than 45 Years  a Multicenter Retrospective Study","keywords":"","combinedName":"doctor merav barzilai"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Maximilian ","lastName":"Christopeit ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Evolution of Myelofibrosis Patients in Relapse after Allogeneic Stem Cell Transplantation Revealed By Whole Exome Sequencing","keywords":"","combinedName":"doctor maximilian christopeit"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Gregor ","lastName":"Hoermann ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Digital Droplet PCR: Next Generation KIT D816V Testing As Advanced Tool for Diagnosis and Prognostication in Mastocytosis","keywords":"","combinedName":"doctor gregor hoermann"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Mythri ","lastName":"Mudireddy ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Thrombotic Events Following Splenectomy for Myelofibrosis: Incidence, Risk Factors and Effect of Pre-Emptive Anticoagulant Therapy","keywords":"","combinedName":"doctor mythri mudireddy"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Hans Michael ","lastName":"Kvasnicka ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Heterogeneity of Bone Marrow Morphology in Patients with Polycythemia Vera Resistant to First and Second Line Therapies  Impact of Hydroxyurea Dosage on MDS-like Progression","keywords":"","combinedName":"doctor hans michael kvasnicka"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Zimu ","lastName":"Gong ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of I(17q) in Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor zimu gong"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Andrew ","lastName":"Brunner","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Transfusion Dependence on Outcomes of Patients with Acute Myeloid Leukemia (AML) Evolving from Myeloproliferative Neoplasms (MPNs)","keywords":"","combinedName":"doctor andrew brunner"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Spencer ","lastName":"Krichevsky ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence of Infections and Second Cancers in Philadelphia Chromosome-Negative Patients with Myeloproliferative Neoplasms Treated with Ruxolitinib","keywords":"","combinedName":"doctor spencer krichevsky"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Hubert ","lastName":"Tsui ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Niche-Targeted Clinical Grade Immunohistochemistry Reveals Heterogeneous Bone Marrow Neuropathy and Novel Stromal Patterns in Primary Myelofibrosis Patients","keywords":"","combinedName":"doctor hubert tsui"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Michael Richard","lastName":"Grunwald ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient-Reported Symptom Burden and Peripheral Blood Counts Among Patients with Polycythemia Vera: An Analysis from the Reveal Study","keywords":"","combinedName":"doctor michael richard grunwald"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"John ","lastName":"Baird ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 2 Study of Brentuximab Vedotin in Patients with Advanced Systemic Mastocytosis","keywords":"","combinedName":"doctor john baird"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Alexander ","lastName":"Coltoff ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real-World Outcomes of Ruxolitinib for Polycythemia Vera","keywords":"","combinedName":"doctor alexander coltoff"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Mrinal ","lastName":"Patnaik ","credentials":"MD,MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results from Ongoing Phase 1/2 Trial of SL-401 in Patients with Myeloproliferative Neoplasms Including Chronic Myelomonocytic Leukemia and Primary Myelofibrosis","keywords":"","combinedName":"doctor mrinal patnaik"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Timothy ","lastName":"Devos ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Ruxolitinib (rux) in an Open-Label, Multicenter, Expanded Treatment Protocol in Patients (Pts) with Polycythemia Vera (PV) Who Are Hydroxyurea (HU) Resistant or Intolerant and for Whom No Alternative Treatments Are Available","keywords":"","combinedName":"doctor timothy devos"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Sravanthi ","lastName":"Lavu ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Splanchnic Vein Thrombosis in Overt Myeloproliferative Neoplasms: The Mayo Clinic Experience with 107 Unselected Consecutive Cases","keywords":"","combinedName":"doctor sravanthi lavu"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Elizabeth A","lastName":"Morgan ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Systematic KIT Sequencing Identifies Unsuspected Systemic Mastocytosis with Associated Hematological Neoplasm","keywords":"","combinedName":"doctor elizabeth a morgan"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Mohamad ","lastName":"Jawhar ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Systemic Mastocytosis with Associated Acute Myeloid Leukemia (SM-AML): a Poor-Risk Multi-Mutated Disease That Follows a Distinct Diagnostic Algorithm and Requires High-Dose Stem Cell-Targeting Therapy","keywords":"","combinedName":"doctor mohamad jawhar"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Bianca F","lastName":"Goemans ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Deep Sequencing ofGATA1 more Sensitively Identifies Transient Myeloproliferative Disorder in Neonates with Down Syndrome","keywords":"","combinedName":"doctor bianca f goemans"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Benjamin ","lastName":"Garmezy ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Relationship between Cause of Death in Myelofibrosis and the Dynamic International Prognostic Scoring System","keywords":"","combinedName":"doctor benjamin garmezy"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Ja Min ","lastName":"Byun ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Understanding the Secondary Transformation of JAK2 Myeloproliferative Neoplasms: Genomic Analysis","keywords":"","combinedName":"doctor ja min byun"},{"sessionId":"11849","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster II","firstName":"Mythri ","lastName":"Mudireddy ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of the Who-Defined 20% Circulating Blasts Threshold for Diagnosis of Acute Leukemia in Myelofibrosis: A Single Center Study of 144 Patients with Blast or Chronic Phase Disease with Excess Blasts","keywords":"","combinedName":"doctor mythri mudireddy"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Lawrence J","lastName":"Druhan ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" Aberrant Trafficking and Signal Propagation By the T618I CSF3R Mutant in Patients with Chronic Neutrophilic Leukemia","keywords":"","combinedName":"doctor lawrence j druhan"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Carlos ","lastName":"Besses Raebel ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acquisition of Non-Driver Mutations during Follow-up in Patients with Polycythemia Vera and Essential Thrombocythemia","keywords":"","combinedName":"doctor carlos besses raebel"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Fabio P S","lastName":"Santos ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of Patterns of Co-Occurrence and Mutual Exclusivity of Gene Mutations in Philadelphia-Negative Myeloproliferative (Ph-negative MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)","keywords":"","combinedName":"doctor fabio p s santos"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Yoko ","lastName":"Ushijima ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Analysis of Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor yoko ushijima"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Niccol ","lastName":"Bartalucci ","credentials":"PhD,BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deletion of Calr By CRISPR/Cas9 Genome-Editing Mimics Abnormalities of Megakaryocytopoiesis Induced By Calr Del52 Mutation","keywords":"","combinedName":"doctor niccol bartalucci"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Andrew ","lastName":"Kuykendall ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gaining a Better \"Sense\" for ASXL1Mutations in Myelofibrosis: Assessing the Variable Impact of Frameshift, Nonsense, and Missense Mutations","keywords":"","combinedName":"doctor andrew kuykendall"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Jeffrey ","lastName":"Patterson-Fortin ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mechanism of Escape from LNK Negative Regulation: Constitutively Active JAK2V617F Retains Lysine63-Ubiquitin","keywords":"","combinedName":"doctor jeffrey patterson-fortin"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Xiaoli ","lastName":"Wang ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloproliferative Neoplasm (MPN) Blastic Transformation Occurs at the Level of Both Short and Long Term Hematopoietic Stem Cells","keywords":"","combinedName":"doctor xiaoli wang"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Sun ","lastName":"Ting ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Neuropathy in the Altered Bone Marrow Microenvironment of Patients with Essential Thrombocythemia and the Effects of Interferona-2b on Them","keywords":"","combinedName":"doctor sun ting"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Margaret ","lastName":"Nieborowska-Skorska ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ruxolitinib-Induced Defects in DNA Repair Cause Sensitivity to PARP Inhibitors in Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor margaret nieborowska-skorska"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Manuela ","lastName":"Mancini ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications","keywords":"","combinedName":"doctor manuela mancini"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Gary ","lastName":"Reuther ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Insulin-like Growth Factor/Insulin Receptor Signaling to Overcome JAK2 Inhibitor Persistence in Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor gary reuther"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Yu ","lastName":"Zhang ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The JAK2V617F-Bearing Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion through the Thrombopoietin/MPL Signaling","keywords":"","combinedName":"doctor yu zhang"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Tianxiang ","lastName":"Hu ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Mir-17/92 Cluster Is Involved in the Molecular Etiology of the SCLL Syndrome Driven By the BCR-FGFR1 Chimeric Kinase","keywords":"","combinedName":"doctor tianxiang hu"},{"sessionId":"11850","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster II","firstName":"Nicolas ","lastName":"Martinez-Calle ","credentials":"MD, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ZFP36L1, a Novel Potential Tumor Supressor Gene in Myelofibrosis, Epigenetically Deregulated By Methylation of the Enhancer Region","keywords":"","combinedName":"doctor nicolas martinez-calle"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Orly ","lastName":"Leiva ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Lysyl Oxidase Inhibitor Attenuates Bone Marrow Fibrosis and Decreases Spleen Size in a Mouse Model of Primary Myelofibrosis","keywords":"","combinedName":"doctor orly leiva"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Ami ","lastName":"Patel","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ANovel JAK2 Mutation Confers Cytokine-Independence in the Absence of a Type I Dimeric Cytokine Receptor","keywords":"","combinedName":"doctor ami patel"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Patrycja ","lastName":"Dubielecka ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Beyond JAK-STAT: Contribution of Abi-1, STAT3, and NF-?b Signaling to Pathogenesis of Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor patrycja dubielecka"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Dorian ","lastName":"Forte ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Circulating Platelet Vs Megakaryocyte-Derived Microparticles Identify Myelofibrosis Patients with JAK2V617F Mutation, High Disease Burden and Ruxolitinib Response","keywords":"","combinedName":"doctor dorian forte"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Haijiao ","lastName":"Zhang ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Coexisting Oncogenic Signaling Pathway Mutations in Cnl/Acml/CMML/MPN-U","keywords":"","combinedName":"doctor haijiao zhang"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Min ","lastName":"Lu ","credentials":"PhD,MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combination Treatment with an MDM2 Antagonist and a BET Inhibitor Targets Both Myelofibrosis Hematopoietic Stem/ Progenitor Cells and Their Tumor Promoting Microenvironment","keywords":"","combinedName":"doctor min lu"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Fabio P S","lastName":"Santos ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Analysis of Whole Exome Sequencing Data in Philadelphia-Negative Myeloproliferative (Ph-negative MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs) Reveals Novel Recurrently Mutated Genes","keywords":"","combinedName":"doctor fabio p s santos"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Constance Regina","lastName":"Baer ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Genetic Characterization of 63 Myeloid/Lymphoid Neoplasms Associated with Eosinophilia and Rearrangement of PDGFR-Alpha, PDGFR-Beta, FGFR1 or PCM1-JAK2","keywords":"","combinedName":"doctor constance regina baer"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Nicolas ","lastName":"Chatain ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Critical Interferon-Response Genes Are Induced By JAK2V617F but Repressed By BCR-ABL, and They Are Responsible for the Differential Effects of Interferon in PV Vs. CML","keywords":"","combinedName":"doctor nicolas chatain"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Manja ","lastName":"Meggendorfer ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deep Learning Algorithms Support Distinction of PV, PMF, and ET Based on Clinical and Genetic Markers","keywords":"","combinedName":"doctor manja meggendorfer"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Lorena Lobo","lastName":"Figueiredo-Pontes","credentials":"MD, PhD ","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Imbalance between Tolerant and Cytotoxic Functional Subsets of NK Cells in a JAK2V617F Myeloproliferative Neoplasm Model","keywords":"","combinedName":"doctor lorena lobo figueiredo-pontes"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Brianna ","lastName":"Craver ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"JAK2V617F Hematopoietic Stem Cells Exhibit a Blunted Response to Acute Inflammation","keywords":"","combinedName":"doctor brianna craver"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Cdric ","lastName":"Cleyrat ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Leukemic Transformation of Post-Essential Thrombocythemia Myelofibrosis: A Unique Case Presenting with Double MPL and Calr Mutations","keywords":"","combinedName":"doctor cdric cleyrat"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Stephen ","lastName":"Oh ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mass Cytometry Analysis Reveals Cellular Loci of Cytokine Overproduction in Myelofibrosis with Differential Sensitivity to Ruxolitinib","keywords":"","combinedName":"doctor stephen oh"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Joo Agostinho","lastName":"Machado-Neto ","credentials":"BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Metformin Reduces Tumor Burden and Splenomegaly in JAK2V617F Murine Models","keywords":"","combinedName":"doctor joo agostinho machado-neto"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Parvesh ","lastName":"Chaudhry ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Modulating Hedgehog Signaling Reduces MAPK, TGF-, and Marrow Fibrosis in a Transgenic Mouse Model of JAK2V617F Associated Myeloproliferative Disease","keywords":"","combinedName":"doctor parvesh chaudhry"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Chi Hua Sarah ","lastName":"Lin ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The JAK2V617F-Bearing Vascular Niche Regulates Hematopoietic Stem/Progenitor Cell Regeneration Following Radiation Injury","keywords":"","combinedName":"doctor chi hua sarah lin"},{"sessionId":"11851","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Poster III","firstName":"Karen Phaik Har ","lastName":"Lim ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcriptional Profiles, Lineage Tracing with BRAF-V600E and HLA-DQB2 Expression Support a Model of Blood CD1c+ Cells As Precursors to LCH Lesion CD207+ Cells","keywords":"","combinedName":"doctor karen phaik har lim"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Erin ","lastName":"Peckham-Gregory ","credentials":"PhD, MPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Evaluation of Parental and Perinatal Characteristics and Risk of Langerhans Cell Histiocytosis in Texas Identifies Risk Disparities By Racial/Ethnic Group","keywords":"","combinedName":"doctor erin peckham-gregory"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Andrew ","lastName":"Kuykendall ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Between a Rux and a Hard Place: Investigating Causes of Ruxolitinib Discontinuation, Salvage Treatment and Outcome in Myelofibrosis","keywords":"","combinedName":"doctor andrew kuykendall"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Catriona ","lastName":"Jamieson ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Case Series of Potential Wernickes Encephalopathy in Patients Treated with Fedratinib","keywords":"","combinedName":"doctor catriona jamieson"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Paola ","lastName":"Guglielmelli ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Changing Patterns, and Clinical Correlates, of Mutations in Patients with Myelofibrosis over Treatment with Ruxolitinib or Hydroxyurea","keywords":"","combinedName":"doctor paola guglielmelli"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Nimesh A","lastName":"Jayasuriya ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cigarette Smoking, Complete Blood Count, and Myeloproliferative Neoplasms  a Meta-Analysis","keywords":"","combinedName":"doctor nimesh a jayasuriya"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Spencer ","lastName":"Krichevsky ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Critical Evaluation of Who 2016 Criteria for the Diagnosis of Polycythemia Vera: Distinction from JAK2V617+ Essential Thrombocythemia","keywords":"","combinedName":"doctor spencer krichevsky"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Massimiliano ","lastName":"Bonifacio ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Distinct Diagnostic and Clinical Features of Bone Marrow Mastocytosis: A Study of the Registry of the European Competence Network on Mastocytosis (ECNM)","keywords":"","combinedName":"doctor massimiliano bonifacio"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Matteo ","lastName":"Molica ","credentials":"M.D.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Does Bone Marrow Fibrosis Play a Role in the Prognostication of Newly Diagnosed Polycythemia Vera Patients?","keywords":"","combinedName":"doctor matteo molica"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Heinz ","lastName":"Gisslinger ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Essential Thrombocythemia Versus Pre-Fibrotic/Early Primary Myelofibrosis: Discrimination By Laboratory and Clinical Data","keywords":"","combinedName":"doctor heinz gisslinger"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Julia ","lastName":"Czech ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Higher Rates of Molecular Response to Peg-IFNa in JAK2V617F Vs. Calr Mutant MPN Patients Are Due to JAK1-Mediated STAT1 Activation and Autoregulation","keywords":"","combinedName":"doctor julia czech"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Carlos ","lastName":"Besses Raebel ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hydroxyurea Mucocutaneous Toxicity: A Prospective Cohort Study of 110 ET and PV Patients from a Single Institution","keywords":"","combinedName":"doctor carlos besses raebel"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Ayalew","lastName":"Tefferi","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"JAK2 Exon 12 Mutated Polycythemia Vera: The Mayo Clinic-University of Florence Experience with 33 Consecutive Cases and Comparison with JAK2V617F Mutated Disease","keywords":"","combinedName":"doctor ayalew tefferi"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Yasuhito ","lastName":"Nannya ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Signatures That Predict Response to Azacitidine Treatment for Myelodysplastic Syndromes","keywords":"","combinedName":"doctor yasuhito nannya"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Lorenzo ","lastName":"Falchi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myelofibrosis (MF) Leukemic Transformation (LT) in the Era of Ruxolitinib and Genomics: Characteristics and Outcomes","keywords":"","combinedName":"doctor lorenzo falchi"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Linda ","lastName":"Resar ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloproliferative Neoplasms in Pediatrics and Young Adults: Genetic Lesions, Diagnostic Features, and Clinical Outcomes","keywords":"","combinedName":"doctor linda resar"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Prajwal ","lastName":"Boddu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Non-Driver Mutations and Gene Sequence Variants Identified By Targeted Deep Sequencing in Polycythemia Vera and Essential Thrombocythemia","keywords":"","combinedName":"doctor prajwal boddu"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Stephen ","lastName":"Couban ","credentials":"MD,BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 1b Results of a Study to Assess the Efficacy and Safety of Vismodegib in Combination with Ruxolitinib in Patients with Intermediate- or High-Risk Myelofibrosis","keywords":"","combinedName":"doctor stephen couban"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Piyapong ","lastName":"Kanya ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet Function Tests and Inflammatory Markers for the Differentiation of Primary Thrombocytosis and Secondary Thrombocytosis","keywords":"","combinedName":"doctor piyapong kanya"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Haifa Kathrin","lastName":"Al-Ali ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Primary Analysis of JUMP, a Phase 3b, Expanded-Access Study Evaluating the Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis (N = 2233)","keywords":"","combinedName":"doctor haifa kathrin al-ali"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Ihosvany ","lastName":"Fernandez-Bello ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Procoagulant Mechanisms in Patients with Myelodysplastic Syndrome","keywords":"","combinedName":"doctor ihosvany fernandez-bello"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Jingbo ","lastName":"Yu ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real-World Patterns of First-Line Hydroxyurea Treatment Among Patients with Essential Thrombocythemia in US Community Oncology Practices","keywords":"","combinedName":"doctor jingbo yu"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Ayalew","lastName":"Tefferi","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Revised DIPSS-Plus: A Composite Clinical, Cytogenetic and Molecular Prognostic System for Primary Myelofibrosis","keywords":"","combinedName":"doctor ayalew tefferi"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Anders B ","lastName":"Dohlman ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Shared and Tissue-Specific Genetic Features of Primary Myelofibrosis, Hepatic Fibrosis, Idiopathic Pulmonary Fibrosis and Kidney Fibrosis","keywords":"","combinedName":"doctor anders b dohlman"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Amylou ","lastName":"Dueck ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single-Arm Phase II Trial of Pegylated Interferon Alpha 2a in Patients with High-Risk Essential Thrombocythemia or Polycythemia Vera Resistant or Intolerant to Hydroxyurea: MPN Symptom Impact & Quality of Life Results of the Myeloproliferative Disorders-Research Consortium (MPD-RC) Protocol 111 Global Phase II Trial","keywords":"","combinedName":"doctor amylou dueck"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Krisstina ","lastName":"Gowin ","credentials":"DO","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sleep and Psychiatric Disturbance in Chronic Philadelphia Negative Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor krisstina gowin"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Ayalew","lastName":"Tefferi","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Deep Sequencing in Blast Phase Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor ayalew tefferi"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Silvia ","lastName":"Betti ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"the Anatomy of Recurrent Thrombosis and Its Risk Factors in Myeloproliferative Neoplasms","keywords":"","combinedName":"doctor silvia betti"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Hui Yin ","lastName":"Lim ","credentials":"MBBS, BMedSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Utility of Global Coagulation Assays in Myeloproliferative Neoplasm: Thromboelastography, Thrombin Generation and Overall Haemostatic Potential","keywords":"","combinedName":"doctor hui yin lim"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Lucia ","lastName":"Masarova ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of the Myelofibrosis Secondary to PV and ET-Prognostic Model in Patients with Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis: MD Anderson Cancer Center","keywords":"","combinedName":"doctor lucia masarova"},{"sessionId":"11852","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Poster III","firstName":"Monia ","lastName":"Marchetti ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Younger JAK2V617F+ Individuals with Myeloproliferative Neoplasms Are at Higher Risk of Developing Lymphoproliferative Disorders: A Scoping Review of 214 Patients","keywords":"","combinedName":"doctor monia marchetti"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Ioanna ","lastName":"Mosialou ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Activation Levels of b-Catenin Signaling in Osteoblasts Define a Threshold for the Development of Myeloid Neoplasia of Variable Severity","keywords":"","combinedName":"doctor ioanna mosialou"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Marianna ","lastName":"Rossi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Implications of TP53 Mutations and p53 Dysfunction in Patients with Myelodysplastic Syndrome (MDS). a Study from the Italian MDS Clinical Network","keywords":"","combinedName":"doctor marianna rossi"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Luise ","lastName":"Hartmann ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comprehensive Molecular Characterization of Myeloid Malignancies with 9q Deletion","keywords":"","combinedName":"doctor luise hartmann"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Leylah ","lastName":"Drusbosky ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Computational Biology Approach to Predict Hypomethylating Agent (HMA) Response Using Genomic and Clinical Characteristics in Myelodsyplastic Syndromes (MDS)","keywords":"","combinedName":"doctor leylah drusbosky"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Manja ","lastName":"Meggendorfer ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deep Learning Algorithms Depict New Subgroups of AML and MDS Based on Genetics Only and Allow Distinction of Both Entities with High Accuracy of 90%","keywords":"","combinedName":"doctor manja meggendorfer"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Jack ","lastName":"Khouri ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Distinct Clinical Phenotypes of Patients with Myeloid Neoplasms Carrying SF3B1 Hotspot Mutations","keywords":"","combinedName":"doctor jack khouri"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Tanzir ","lastName":"Ahmed ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Haploinsufficiency of Multiple Genes on Del(5q) Cooperate to Induce B Cell Abnormalities in Mice","keywords":"","combinedName":"doctor tanzir ahmed"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Abhinav ","lastName":"Goyal ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How Somatic Mutations Carve Morphologic Imprint in MDS?","keywords":"","combinedName":"doctor abhinav goyal"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Claudia ","lastName":"Haferlach ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutational Pattern and Clonal Hierarchy in MDS with Monosomy 7","keywords":"","combinedName":"doctor claudia haferlach"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Thomas ","lastName":"Coats ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Neoantigens in MDS Are Associated with Two Novel CD4+ T Cell Subsets and Improved Overall Survival","keywords":"","combinedName":"doctor thomas coats"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Olivier ","lastName":"Herault ","credentials":"MD-PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Oxidative Stress in Stem / Progenitor Cells and Specific Antioxidant Response in Bone Marrow from Myelodysplastic Syndrome Patients","keywords":"","combinedName":"doctor olivier herault"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Pragya ","lastName":"Srivastava ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patients with MDS Demonstrate Reduced Numbers and Impaired Differentiation of CD141Hi Conventional Dendritic Cells","keywords":"","combinedName":"doctor pragya srivastava"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Britta ","lastName":"Will ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Clinical Modeling of Concomitant Therapy with Azacytidine and Eltrombopag in MDS/AML","keywords":"","combinedName":"doctor britta will"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Peipei ","lastName":"Lin ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The High NRF2 Expression Confers Chemotherapy Resistance through Upregulated DUSP1 in Myelodysplastic Syndromes","keywords":"","combinedName":"doctor peipei lin"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Madeline ","lastName":"Niederkorn ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tifab Deficiency Protects Against Stress-Induced Bone Marrow Failure at the Expense of Pre-Leukemic Selection","keywords":"","combinedName":"doctor madeline niederkorn"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"David ","lastName":"Muench ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Understanding Early Stage Myelodysplastic Syndrome Pathobiology","keywords":"","combinedName":"doctor david muench"},{"sessionId":"11853","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster II","firstName":"Abdullah Mahmood","lastName":"Ali ","credentials":"PhD ","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unique Gene Expressional Profile Associated with Lack of Quantifiable Terminal Erythroid Differentiation in Myelodysplastic Syndrome Patients","keywords":"","combinedName":"doctor abdullah mahmood ali"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Valeria ","lastName":"Visconte ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Activation of Autophagy in Models of SF3B1 Mutant MDS","keywords":"","combinedName":"doctor valeria visconte"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Andreas Due","lastName":"rskov ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Activation of T Cells Specific to Endogenous Retroviral Peptides: Possible Association with Clinical Response to Azacitidine in Myeloid Malignancies","keywords":"","combinedName":"doctor andreas due rskov"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Cassandra ","lastName":"Hirsch ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Architecture of TET2 Mutations Influences the Clinical Phenotype of Patients with Myeloid Neoplasms","keywords":"","combinedName":"doctor cassandra hirsch"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Yazan ","lastName":"Madanat ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Distinct Genomic Associations to Predict Acute Myeloid Leukemia (AML) Progression from Myelodysplastic Syndromes (MDS)","keywords":"","combinedName":"doctor yazan madanat"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Lewis R","lastName":"Silverman ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effects of Rigosertib (RIGO) Alone or in Combination with Azacitidine or Vorinostat on Epigenetic Reprogramming of CD34+ Cells in the Myelodysplastic Syndrome","keywords":"","combinedName":"doctor lewis r silverman"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Abdullah Mahmood","lastName":"Ali ","credentials":"PhD ","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Emergence of a Novel Clinical Entity within Myelodysplastic Syndromes Marked By Absence of Quantifiable Terminal Erythroid Differentiation, More Profound Anemia and Significantly Worse Survival across All Prognostic Risk Categories","keywords":"","combinedName":"doctor abdullah mahmood ali"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Cherie ","lastName":"Green ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evidence of Targetable Immune Dysfunction in the Bone Marrow of Patients with Intermediate/High-Risk Myelodysplastic Syndrome Refractory to Hypomethylating Agents","keywords":"","combinedName":"doctor cherie green"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Kensuke ","lastName":"Takaoka ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Human Germline HLTF E259K Mutation Identified in Familial MDS Patients Accumulates DNA Damage through Impaired PCNA Polyubiquitination","keywords":"","combinedName":"doctor kensuke takaoka"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Margot ","lastName":"Van Spronsen ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immunophenotypically Aberrant Stem Cells in Myelodysplastic Syndromes: A Biomarker for Leukemic Progression","keywords":"","combinedName":"doctor margot van spronsen"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Tea ","lastName":"Pemovska ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integration of Functional Ex Vivo Drug Testing and Molecular Profiling Reveals Novel Vulnerabilities in CMML","keywords":"","combinedName":"doctor tea pemovska"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Kathleen ","lastName":"McGrath ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Modeling Defective Erythropoiesis in Myelodysplastic Syndrome (MDS)","keywords":"","combinedName":"doctor kathleen mcgrath"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Reem ","lastName":"Elagooz ","credentials":"MS, MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PPM1D Mutations and up Modulation Phenocopy TP53 Lesions in Myeloid Neoplasms","keywords":"","combinedName":"doctor reem elagooz"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Deepak ","lastName":"Singhal ","credentials":"MBBS, MD, FRCPA, FRACP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Presence of Rare Germline Variants in Fanconi Anaemia Pathway Genes Confers a Poor Prognosis Comparable to TP53 Mutations in Therapy-Related Myeloid Neoplasms","keywords":"","combinedName":"doctor deepak singhal"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Jing ","lastName":"Zou ","credentials":"PhD, MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Programmed Necrosis Correlates with Development and Progression of Myelodysplastic Syndromes","keywords":"","combinedName":"doctor jing zou"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Arnold ","lastName":"Kloos ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Serially Transplantable Patient-Derived Xenograft Model of Chronic Myelomonocytic Leukemia (CMML)","keywords":"","combinedName":"doctor arnold kloos"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Meagan ","lastName":"Jacoby ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Subclonal Evolution Characterizes MDS Disease Progression Following Allogeneic Stem Cell Transplant","keywords":"","combinedName":"doctor meagan jacoby"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Helen ","lastName":"Papadaki ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Effect of 5-Azacitidine Treatment on the Biologic Characteristics of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes","keywords":"","combinedName":"doctor helen papadaki"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Natacha ","lastName":"Mauz ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tumor Microenvironment and Clonal Monocytes of Chronic Myelomonocytic Leukemia Induce a Procoagulant Climate within the Tumor Niche","keywords":"","combinedName":"doctor natacha mauz"},{"sessionId":"11854","sessionTitle":"636. Myelodysplastic SyndromesBasic and Translational Studies: Poster III","firstName":"Serine ","lastName":"Avagyan ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Visualizing Clonal Hematopoiesis Associated with gata2 Deficiency in Zebrafish Using Color-Barcoding","keywords":"","combinedName":"doctor serine avagyan"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Brian A","lastName":"Jonas ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 1 Trial of the Combination of Ibrutinib and Azacitidine for the Treatment of Higher Risk Myelodysplastic Syndromes: University of California Hematologic Malignancies Consortium (UCHMC) Study 1503","keywords":"","combinedName":"doctor brian a jonas"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Ravi ","lastName":"Vij ","credentials":"MD MBA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Study to Predict Response to Azacitidine or Lenalidomide/Azacitidine Combination Therapy in MDS and AML Patients Using a Computational Biological Modeling (CBM) Approach","keywords":"","combinedName":"doctor ravi vij"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Howard ","lastName":"Oster ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Can We Diagnose MDS without Bone Marrow Examination? a Proposed EUMDS-Based Non-Invasive Diagnostic Model","keywords":"","combinedName":"doctor howard oster"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Xia ","lastName":"Xiao ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chromosome Aberrations Detected By SNP Array Technique Indicating a High Risk of MDS Transformationin Patients with Icus and Poor Prognosis of Patients with MDS","keywords":"","combinedName":"doctor xia xiao"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Candace ","lastName":"Haddox ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Correlates and Outcomes of Bone Marrow Failure and Myeloid Clonal Evolution in Patients with Germline GATA2 Haploinsufficiency","keywords":"","combinedName":"doctor candace haddox"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Wolfgang ","lastName":"Kern ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Correlation of Myelodysplasia-Related Flow Cytometric Findings with Mutations in Patients Undergoing Diagnostics for Suspected Myelodysplastic Syndrome","keywords":"","combinedName":"doctor wolfgang kern"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Norbert","lastName":"Gattermann","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Deferasirox Combined with Erythropoietin Versus Erythropoietin Alone on Erythroid Response in Patients with Low- and Int-1-Risk Myelodysplastic Syndromes: Results of the Phase II Kallisto Trial","keywords":"","combinedName":"doctor norbert gattermann"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Jing ","lastName":"Liu ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in MDS-EB and AML-MRC","keywords":"","combinedName":"doctor jing liu"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Heather ","lastName":"Leitch ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Iron Overload in Lower International Prognostic Scoring System Risk Myelodysplastic Syndromes Patients Receiving Red Blood Cell Transfusions: Relation to Infection and Possible Benefit of Iron Chelation Therapy","keywords":"","combinedName":"doctor heather leitch"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Olivier ","lastName":"Kosmider ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lenalidomide-Mediated Erythroid Improvement in Non-Del(5q) Myelodysplastic Syndromes Is Associated with Bone Marrow Immuno-Remodeling","keywords":"","combinedName":"doctor olivier kosmider"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Karam ","lastName":"Al-Issa ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Model Heterogeneity in Predicting Outcomes of Patients with Myelodysplastic Syndromes (MDS)","keywords":"","combinedName":"doctor karam al-issa"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Uwe ","lastName":"Platzbecker ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutational Profile and Analysis of Lower-Risk Myelodysplastic Syndromes (MDS) Patients Treated with Luspatercept: Phase 2 PACE-MDS Study","keywords":"","combinedName":"doctor uwe platzbecker"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Panagiotis Theodorou","lastName":"Diamantopoulos ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myelodysplastic Syndromes/Myeloproliferative Neoplasms Treated with 5-Azacytidine. Results from the Hellenic 5-Azacytidine Registry","keywords":"","combinedName":"doctor panagiotis theodorou diamantopoulos"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Panagiotis ","lastName":"Tsirigotis ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Natural Killer Cell Cytotoxicity Is a Predictor of Outcome for Patients with High Risk Myelodysplastic Syndrome and Oligoblastic Acute Myeloid Leukemia Treated with Azacytidine","keywords":"","combinedName":"doctor panagiotis tsirigotis"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Nicholas J","lastName":"Short ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Omacetaxine Mepesuccinate for Patients with Higher-Risk MDS and CMML after Failure of Hypomethylating Agents: A Phase II Trial","keywords":"","combinedName":"doctor nicholas j short"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Sangmin ","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II Clinical Study of the Clinical Efficacy and Safety of Tosedostat in Patients with Myelodysplastic Syndromes (MDS) after Failure of Hypomethylating Agent-Based Therapy","keywords":"","combinedName":"doctor sangmin lee"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Sangmin ","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prediction of Clinically Relevant Mutations in (MDS): A Report on Behalf of the MDS Clinical Research Consortium (CRC)","keywords":"","combinedName":"doctor sangmin lee"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Mrinal ","lastName":"Patnaik ","credentials":"MD,MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Results from an Open-Label, Phase 2 Study of Tipifarnib in Chronic Myelomonocytic Leukemia (CMML)","keywords":"","combinedName":"doctor mrinal patnaik"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Athanasios ","lastName":"Galanopoulos ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognosis of Lower Risk Patients with Myelodysplastic Syndromes without Isolated Del(5q) after Failure of Erythropoiesis-Stimulating Agents. a Multicenter Study By the Hellenic MDS Study Group","keywords":"","combinedName":"doctor athanasios galanopoulos"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Mrinal ","lastName":"Patnaik ","credentials":"MD,MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Factors and Survival Outcomes in Blast Transformed Chronic Myelomonocytic Leukemia: A Mayo Clinic-MD Anderson Cancer Center Study of 171 Cases","keywords":"","combinedName":"doctor mrinal patnaik"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Abhishek ","lastName":"Mangaonkar ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Impact of ASXL1 Mutations and Extent of Bone Marrow Dysplasia in Patients with Who-defined Myelodysplastic Syndrome with Ring Sideroblasts","keywords":"","combinedName":"doctor abhishek mangaonkar"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Yoshiaki ","lastName":"Abe ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Implication of Bone Marrow Abnormality of Appendicular Skeletons Detected By Low-Dose Multidetector Computed Tomography in Patients with Myelodysplastic Syndrome","keywords":"","combinedName":"doctor yoshiaki abe"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Montserrat ","lastName":"Arnan Sangerman ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic VALUE of EARLY Drop in the Platelet Counts in Patients with VERY Low, Low and Intermediate Risk IPSS-R Myelodysplastic Syndromes. Results from a Single Center Analysis","keywords":"","combinedName":"doctor montserrat arnan sangerman"},{"sessionId":"11855","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster II","firstName":"Marta ","lastName":"Riva ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Refining Hellstrm-Lindberg Score: Which Patients Could Benefit from Standard Dose EPO?","keywords":"","combinedName":"doctor marta riva"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Guillermo","lastName":"Garcia-Manero","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 2 Dose-Confirmation Study of Oral ASTX727, a Combination of Oral Decitabine with a Cytidine Deaminase Inhibitor (CDAi) Cedazuridine (E7727), in Subjects with Myelodysplastic Syndromes (MDS)","keywords":"","combinedName":"doctor guillermo garcia-manero"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Neil ","lastName":"Palmisiano ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Study of Azacitidine and Sirolimus for the Treatment of Acute Myeloid Leukemia (AML) Refractory to or Not Eligible for Intensive Chemotherapy or High Risk Myelodysplastic Syndrome (MDS)","keywords":"","combinedName":"doctor neil palmisiano"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Raphael ","lastName":"Itzykson ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Trial of Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Thrombocytopenia","keywords":"","combinedName":"doctor raphael itzykson"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Christina ","lastName":"Ganster ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acquisition Patterns and Interaction of Molecular, Obvious and Cryptic Cytogenetic Abnormalities in Myelodysplastic Syndromes","keywords":"","combinedName":"doctor christina ganster"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Judith ","lastName":"Neukirchen ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Additional Prognostic Impact of the Percentage of Erythroid Cells in the Bone Marrow of MDS Patients","keywords":"","combinedName":"doctor judith neukirchen"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Uwe ","lastName":"Platzbecker ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Integrated Analysis of Darbepoetin Alfa (DAR) in the Treatment of Anemia in Patients with Low- or Intermediate-1 (int-1) Risk Myelodysplastic Syndrome (MDS)","keywords":"","combinedName":"doctor uwe platzbecker"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Ioannis ","lastName":"Kotsianidis ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Azacytidine Failure Revisited: An Appraisal Based on Real Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS)","keywords":"","combinedName":"doctor ioannis kotsianidis"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Yasushi ","lastName":"Miyazaki ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chromosomal Analysis of Myelodysplastic Syndromes Among Atomic Bomb Survivors in Nagasaki","keywords":"","combinedName":"doctor yasushi miyazaki"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Uma ","lastName":"Borate ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Trial Inclusion of Therapy-Related Myelodysplastic Syndromes (MDS) over the Past 20 Years","keywords":"","combinedName":"doctor uma borate"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Maher ","lastName":"Albitar ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Hematopoiesis in Normal Individuals Is Not Random and Likely Reflects Early MDS","keywords":"","combinedName":"doctor maher albitar"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Kiran ","lastName":"Naqvi ","credentials":"MD,MPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Hematopoiesis of Indeterminate Potential - Associated Mutations and Risk of Comorbidities in Patients with Myelodysplastic Syndrome","keywords":"","combinedName":"doctor kiran naqvi"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Pierre ","lastName":"Fenaux ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Imetelstat in RBC Transfusion-Dependent (TD) IPSS Low/Int-1 MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agents (ESA) (IMerge)","keywords":"","combinedName":"doctor pierre fenaux"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Katherine ","lastName":"Hoversten ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Extramedullary Manifestations in World Health Organization-Defined Chronic Myelomonocytic Leukemia: Clinical, Molecular and Prognostic Correlates","keywords":"","combinedName":"doctor katherine hoversten"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Ryotaro ","lastName":"Nakamura ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Favorable Impact of Allogeneic Stem Cell Transplantation in Patients with Therapy-Related Myelodysplasia Regardless of TP53 Mutational Status","keywords":"","combinedName":"doctor ryotaro nakamura"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Julia ","lastName":"Stomper ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fetal Hemoglobin (HbF) Induction during Initial Decitabine (DAC) Treatment of Elderly High-Risk MDS and AML Patients: A Potential Dynamic Biomarker for Outcome","keywords":"","combinedName":"doctor julia stomper"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Rami ","lastName":"Komrokji","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fluorescence in Situ Hybridization (FISH) Frequently Upstages Risk Estimates for MDS Patients with Normal Metaphase Karyotype","keywords":"","combinedName":"doctor rami komrokji"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Leylah ","lastName":"Drusbosky ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Icare 1: A Prospective Clinical Trial to Predict Treatment Response Based on Mutanome-Informed Computational Biology in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)","keywords":"","combinedName":"doctor leylah drusbosky"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Roberto ","lastName":"Latagliata ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Is Deferasirox Safe and Effective in Very Elderly Patients (> 75 Years) with Myelodysplastic Syndromes and Transfusional Iron Overload?","keywords":"","combinedName":"doctor roberto latagliata"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Maher ","lastName":"Albitar ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Liquid Biopsy As a Diagnostic Test for Myelodysplastic Syndrome and Other Acute and Chronic Myeloid Neoplasms","keywords":"","combinedName":"doctor maher albitar"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Maher ","lastName":"Albitar ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MDS Diagnosis Using Cfrna Profiling By Targeted Enrichment Next Generation Sequencing","keywords":"","combinedName":"doctor maher albitar"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Aziz","lastName":"Nazha","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Model Heterogeneity in Predicting Outcomes in Patients with Chronic Myelomonocytic Leukemia (CMML): An Overestimation of Survival in Lower-Risk Group ","keywords":"","combinedName":"doctor aziz nazha"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Orianne ","lastName":"Wagner Ballon ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multicentric Validation of the Monocyte Assay for Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry","keywords":"","combinedName":"doctor orianne wagner ballon"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Rami ","lastName":"Komrokji","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Myelodysplastic Syndromes (MDS) Patients with Chromosome 17 Abnormalities: A Report on Behalf of the MDS Clinical Research Consortium (MDSCRC)","keywords":"","combinedName":"doctor rami komrokji"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Victoria ","lastName":"Panagiota ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PPM1D Mutations in MDS Patients with Deletion of Chromosome 5q","keywords":"","combinedName":"doctor victoria panagiota"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Danielle ","lastName":"Blunt ","credentials":"BMBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predictive Factors of Overall Survival and the Completion of Four Cycles of Azacitidine: An MDS-CAN Study","keywords":"","combinedName":"doctor danielle blunt"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Jungmin ","lastName":"Jo ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party","keywords":"","combinedName":"doctor jungmin jo"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Roberto ","lastName":"Latagliata ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Response to Erythropoietin in Different Karyotipic Subsets of Myelodysplastic Syndromes (MDS) and MDS with Sideroblasts: Multicentric Real-Life Experience from the Grom-L Cooperative Group","keywords":"","combinedName":"doctor roberto latagliata"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Christopher B","lastName":"Benton ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sequential Stratification Prognostic Score for Patients with Intermediate-Risk Myelodysplastic Syndrome","keywords":"","combinedName":"doctor christopher b benton"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Marlise ","lastName":"Luskin","credentials":"MD, MSCE","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Spliceosome Mutations Are Associated with Frailty in Older Patients with Myeloid Malignancies","keywords":"","combinedName":"doctor marlise luskin"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Argiris ","lastName":"Symeonidis ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Diabetes Mellitus As Comorbid Condition, in Patients with Lower-Risk Myelodysplastic Syndromes (MDS). a Study of the European Leukemianet-Based MDS (EUMDS) Registry","keywords":"","combinedName":"doctor argiris symeonidis"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Ming-En ","lastName":"Lin ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Implications of Endoplasmic Reticulum Stress Response in the Prognosis and Pathogenesis of Myelodysplastic Syndrome","keywords":"","combinedName":"doctor ming-en lin"},{"sessionId":"11856","sessionTitle":"637. Myelodysplastic SyndromesClinical Studies: Poster III","firstName":"Sotirios ","lastName":"Papageorgiou ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Prognostic Value of Monosomal Karyotype (MK) in High-Risk Patients with Myelodysplastic Syndromes Treated with 5-Azacitidine","keywords":"","combinedName":"doctor sotirios papageorgiou"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Dana ","lastName":"Ghergus ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Percentage of Normal B Cells from CLL Patients Express ZAP-70, Which Is Associated with Autoimmunity and Could be Responsible for Arising of Malignant Clone","keywords":"","combinedName":"doctor dana ghergus"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Preetesh ","lastName":"Jain ","credentials":"MBBS,MD,DM,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Absolute Percent Deviation of IGHV Mutation As a Continuum Is Prognostically Relevant in Patients with CLL","keywords":"","combinedName":"doctor preetesh jain"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Marwan ","lastName":"Kwok ","credentials":"MBBS,MRCP","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BCR Unresponsiveness and 13q14 Duplication Underpin Spontaneous Disease Regression in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor marwan kwok"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Pau ","lastName":"Abrisqueta ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Outcome and Prognostic Factors of Patients with Richters Syndrome: Retrospective Multicenter Study of the Spanish Chronic Lymphocytic Leukemia (CLL) Study Group (GELLC)","keywords":"","combinedName":"doctor pau abrisqueta"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Simon ","lastName":"Bouzy ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clonal Evolution in CLL","keywords":"","combinedName":"doctor simon bouzy"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Loic ","lastName":"Ysebaert ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Computational Integration to Model Tumor Dynamics in CLL Patients Treated with the Btk Inhibitor Ibrutinib (CompuTreatCLL): First Results of an Integrative Systems Biology Approach","keywords":"","combinedName":"doctor loic ysebaert"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Mariela ","lastName":"Sivina ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CXCL13 (BCA-1) Plasma Levels Are a Useful Biological Marker for Disease Progression in Chronic Lymphocytic Leukemia (CLL) Patients","keywords":"","combinedName":"doctor mariela sivina"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Theodoros ","lastName":"Moysiadis ","credentials":"PhD, BSc, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Different Time-Dependent Risk for Disease Evolution in Chronic Lymphocytic Leukemia with Distinct IGHV Gene Somatic Hypermutation Status","keywords":"","combinedName":"doctor theodoros moysiadis"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Anna ","lastName":"Vardi ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differential Impact of Signaling Inhibitor Treatment Versus Standard Chemoimmunotherapy on Chronic Lymphocytic Leukemia T Cells: Clinical Implications","keywords":"","combinedName":"doctor anna vardi"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Lenka ","lastName":"Kruzova ","credentials":"MA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gender, Age and TP53 Aberrations in Context of Complex Karyotypes in Chronic Lymphocytic Leukemia Patients in the Era of Chemo +/- Immunotherapy","keywords":"","combinedName":"doctor lenka kruzova"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Lili ","lastName":"Wang ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic and Transcriptomic Characterization of Marrow Progenitor Cells in Patients with Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor lili wang"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Benjamin H","lastName":"Durham ","credentials":"MD, BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Analysis of Hairy Cell Leukemia Identifies Novel Recurrent Genetic Alterations","keywords":"","combinedName":"doctor benjamin h durham"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Jennifer ","lastName":"Edelmann ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Resolution SNP-Array Profiling of Ultra-High Risk CLL Cases Reveals New Recurrent Genomic Alterations","keywords":"","combinedName":"doctor jennifer edelmann"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Ramona ","lastName":"Cassin ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hypogammaglobulinemia in Chronic Lymphocytic Leukemia: A Predictor of Outcome?","keywords":"","combinedName":"doctor ramona cassin"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Sabine ","lastName":"Jeromin ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Infrequently Mutated Genes on Prognosis in 531 Untreated CLL Patients","keywords":"","combinedName":"doctor sabine jeromin"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Alexander ","lastName":"Fuchs ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lck Is a Crucial Anergy Regulator in CLL","keywords":"","combinedName":"doctor alexander fuchs"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Julio ","lastName":"Delgado ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Linear and Branching Progression of Chronic Lymphocytic Leukemia (CLL) Under PI3K Inhibition (PI3Ki)","keywords":"","combinedName":"doctor julio delgado"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Yun ","lastName":"Chen ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nurse-like Cells Express High-Levels of Wnt5a, Which Induces ROR1-Dependent Signaling That Promotes Migration and Survival of Neoplastic Cells in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor yun chen"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Annika ","lastName":"Scheffold ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PI3K-d Inhibition Influences T-Cell Populations and Anti-Tumoral Immune Function in Preclinical Models","keywords":"","combinedName":"doctor annika scheffold"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Joana ","lastName":"Dos Santos ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Primary Chronic Lymphocytic Leukemia Cells Can be Maintained Long-Termin Serum-Free, Cytokine-Free 3D Culture","keywords":"","combinedName":"doctor joana dos santos"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Gilad ","lastName":"Itchaki ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rare Germline Variant in NFATC4 Associated with Familial Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor gilad itchaki"},{"sessionId":"11857","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Jennifer ","lastName":"Edelmann ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rituximab Activates NOTCH1 Signaling in CLL Cells and Induces Changes in the Cytokine Repertoire Favoring a Tumor-Protective Microenvironment","keywords":"","combinedName":"doctor jennifer edelmann"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Jacob ","lastName":"Soumerai ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AValidated Risk Model for Overall Survival in Relapsed/Refractory Chronic Lymphocytic Leukemia Applicable to Patients Treated with Novel Therapies and Standard of Care","keywords":"","combinedName":"doctor jacob soumerai"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Kyle R","lastName":"Crassini ","credentials":"MBBS,BE,BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of mRNA Expression in Peripheral, Bone Marrow and Lymph Node Dervied CLL Cells Using the Nanosting Ncounter Platform","keywords":"","combinedName":"doctor kyle r crassini"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Eric ","lastName":"Eldering ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cross-Talk between Cytokine and NF-?B Signaling in the CLL Microenvironment Can Affect Sensitivity for Venetoclax","keywords":"","combinedName":"doctor eric eldering"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Rebecca ","lastName":"Valentin ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dynamic BH3 Profiling to Assess the Effects of Novel Agents on Anti-Apoptotic Protein Dependence of CLL Cells","keywords":"","combinedName":"doctor rebecca valentin"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Laura ","lastName":"Bounaix ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dynamic of Telomeric Parameters in Relapsing or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL), an Analysis of the Filo ICLL001 Bomp Trial","keywords":"","combinedName":"doctor laura bounaix"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Muharrem ","lastName":"Muftuoglu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of T Cell Compartment By Mass Cytometry Reveals Distinct Patterns of Expression of Exhaustion Markers in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor muharrem muftuoglu"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Philipp M","lastName":"Rner ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Exhausted PD-1hi T-Cells Are Enriched in Secondary Lymphoid Organs of CLL Patients","keywords":"","combinedName":"doctor philipp m rner"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Elisavet ","lastName":"Chartomatsidou ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"External Stimuli Modulate EZH2 Expression in Chronic Lymphocytic Leukemia. Rationale and Evidence for Synergistic Anti-Tumor Effects of B Cell Signaling and EZH2 Inhibitors","keywords":"","combinedName":"doctor elisavet chartomatsidou"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Tiziana ","lastName":"Vaisitti ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic and Molecular Characterization of Novel Richter Syndrome Patient-Derived Xenograft Models","keywords":"","combinedName":"doctor tiziana vaisitti"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Alexander ","lastName":"Leeksma ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Complexity in Chronic Lymphocytic Leukemia Defined By Array-Based Analysis: Definitions, Associations with Other Biomarkers and Clinical Impact","keywords":"","combinedName":"doctor alexander leeksma"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Yi ","lastName":"Miao ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genomic Landscape of Chronic Lymphocytic Leukemia in China By Targeted Gene Sequencing","keywords":"","combinedName":"doctor yi miao"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Andreas ","lastName":"Agathangelidis ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Throughput Immunoprofiling of Low Count B Lymphocytosis Reveals a Distinct T Cell Receptor Repertoire from Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor andreas agathangelidis"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Inhye ","lastName":"Ahn ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improving Depth of Response with Continued Ibrutinib Therapy in CLL Patients","keywords":"","combinedName":"doctor inhye ahn"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Henning ","lastName":"Popp ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increase of DNA Damage and Alteration of the DNA Damage Response in Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor henning popp"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Faith ","lastName":"Norster ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased Levels of Soluble RAGE in CLL Patient Plasma Has a Protective Effect on CLL Disease Progression","keywords":"","combinedName":"doctor faith norster"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Stefania ","lastName":"Fiorcari ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interferon Regulatory Factor 4 (IRF4) Is a Master Regulator in the Pathogenesis of Chronic Lymphocytic Leukemia Patients Harboring Trisomy 12","keywords":"","combinedName":"doctor stefania fiorcari"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Alberto ","lastName":"Orfao ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low-Count Monoclonal B-Cell Lymphocytosis Persists after 7 Years of Follow-up and Confers a Higher Risk of Death","keywords":"","combinedName":"doctor alberto orfao"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Gerardo ","lastName":"Ferrer ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Myeloid-Derived Suppressor Cell Subtypes Are Responsible for the Th2 Phenotype of T Cells in CLL","keywords":"","combinedName":"doctor gerardo ferrer"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Xiao ","lastName":"Yan ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Over-Expression of Activation-Induced Cytidine Deaminase in TCL1 Mice Leads to the Development of IGHV-Mutated CLL Clones That Associate with More Aggressive Disease","keywords":"","combinedName":"doctor xiao yan"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Uri ","lastName":"Rozovski ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overexpression of CD36, Driven By STAT3, Mediates Free Fatty Acid Uptake in CLL Cells","keywords":"","combinedName":"doctor uri rozovski"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Rong ","lastName":"He ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PD-1 Expression in Chronic Lymphocytic Leukemia and Large B-Cell Richter Transformation (DLBCL-RT): A Distinguishing Feature for DLBCL-RT andPromising Surrogate Marker for Clonal Relatedness","keywords":"","combinedName":"doctor rong he"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Matthew D","lastName":"Blunt ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PI3Kd/AKT Inhibition Augments 2-Phenylethynesulfonamide Induced Apoptosis Via the Unfolded Protein Response in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor matthew d blunt"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Daphne ","lastName":"Friedman ","credentials":"MD ","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PI3K-Delta Inhibitors Induce Primary Monocyte Cytotoxicity but Do Not Alter Monocyte Differentiation","keywords":"","combinedName":"doctor daphne friedman"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Leylah ","lastName":"Drusbosky ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predicting Mechanisms of Ibrutinib-Resistance in Chronic Lymphocytic Leukemia (CLL) Using Computational-Based Modeling for Personalized Therapy with Clinical Validation","keywords":"","combinedName":"doctor leylah drusbosky"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Eric ","lastName":"Sturgill ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reactive Oxygen Species and Metabolic Gene Expression Profiling Further Differentiate CXCR4/CD5 Fractions in Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor eric sturgill"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Boyu ","lastName":"Hu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Standardized Targeted Sequencing of 29 Genes with Recurrent Mutations in Chronic Lymphocytic Leukemia (CLL) Helps to Better Define Clinical Correlates and Genomic Hotspots","keywords":"","combinedName":"doctor boyu hu"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Esteban ","lastName":"Braggio ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Deep Sequencing in Untreated Progressive CLL Helps to Better Dissect the Genomic Landscape and Shows Novel Associations between Mutations, Prognostic and Clinical Parameters: Data from E1912, a Randomized Phase III Study of the ECOG-ACRIN Cancer Research Group","keywords":"","combinedName":"doctor esteban braggio"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Fortunato ","lastName":"Morabito ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tumor Microenvironment (TME) Regulation of Programmed Death-1 (PD1) Receptor and Its Ligands PDL1 and PDL2 in Chronic Lymphocytic Leukemia (CLL)","keywords":"","combinedName":"doctor fortunato morabito"},{"sessionId":"11858","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Yun ","lastName":"Chen ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Wnt5a Induces Interleukin-6 Via a ROR1-Dependent Pathway in Chronic Lymphocytic Leukemia, Leading to Leukemia-Cell Activation of STAT3","keywords":"","combinedName":"doctor yun chen"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Anthony ","lastName":"Mato","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase I/II Study of Reduced Dose FCR (FCR-lite) in Combination with Lenalidomide Followed By Lenalidomide Maintenance (FCR2) for Initial Therapyof CLL: Final Results and Long-Term Follow-up","keywords":"","combinedName":"doctor anthony mato"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Paul ","lastName":"Hampel ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Center","keywords":"","combinedName":"doctor paul hampel"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Inhye ","lastName":"Ahn ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combination of Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients with CLL: A Pilot Phase II Study","keywords":"","combinedName":"doctor inhye ahn"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Erik ","lastName":"Slinger ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combinatorial Treatment of Chronic Lymphocytic Leukemia with Ibrutinib and Venetoclax Is Superior to Treatment with Single Agents in the TCL1 Mouse Model","keywords":"","combinedName":"doctor erik slinger"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Alak ","lastName":"Manna ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab Mitigates B-Cell Receptor Signaling and Enhances Antitumor Activity of Ibrutinib in Chronic Lymphocytic Leukemia (CLL) Cells","keywords":"","combinedName":"doctor alak manna"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Kamira ","lastName":"Maharaj ","credentials":"PhD Candidate","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differential Regulation of T Cells By PI3K Delta Inhibitors in a CLL Murine Model","keywords":"","combinedName":"doctor kamira maharaj"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Eileen ","lastName":"Hu ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of ROR1 Targeted Antibody Drug Conjugates in Acute and Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma","keywords":"","combinedName":"doctor eileen hu"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Anthony ","lastName":"Mato","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Front-Line Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) in the Real World: Responses, Toxicity, Outcomes and Subsequent Therapies","keywords":"","combinedName":"doctor anthony mato"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Robert ","lastName":"Chen ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ibrutinib Therapy in Patients with Relapsed/Refractory Marginal Zone Lymphoma: Analysis By Prior Rituximab Treatment and Baseline Mutations","keywords":"","combinedName":"doctor robert chen"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Shlomo ","lastName":"Elias ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Obinutuzumab Activates CD64 More Potently Than Other Anti-CD20 Antibodies in Chronic Lymphocytic Leukemia (CLL)","keywords":"","combinedName":"doctor shlomo elias"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Talha ","lastName":"Munir ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Obinutuzumab As Consolidation after Chemo-Immunotherapy Is Highly Effective in Achieving MRD Clearance from Bone Marrow and Peripheral Blood- Initial Results of UK NCRI Phase II/III Galactic Trial","keywords":"","combinedName":"doctor talha munir"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Anthony ","lastName":"Mato","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I/II Study of Pembrolizumab in Combination with Ublituximab (TG-1101) and Umbralisib (TGR-1202) in Patients with Relapsed/Refractory CLL","keywords":"","combinedName":"doctor anthony mato"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Nadine ","lastName":"Kutsch ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Impact of Immunohistochemistry and MRD Results in Bone Marrow after Frontline Chemoimmunotherapy of Chronic Lymphocytic Leukemia (CLL): Results of Central Laboratory Analyses of the CLL10 Trial of the German CLL Study Group (GCLLSG)","keywords":"","combinedName":"doctor nadine kutsch"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Jennifer ","lastName":"Brown","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk Factors for Grade 3/4 Transaminase Elevation in Patients with Chronic Lymphocytic Leukemia Treated with Idelalisib","keywords":"","combinedName":"doctor jennifer brown"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Veronique ","lastName":"Leblond ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the GREEN Study","keywords":"","combinedName":"doctor veronique leblond"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Paolo ","lastName":"Strati ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sustained Long-Lasting Responses after Lenalidomide Discontinuation in Patients with Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor paolo strati"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"Talha ","lastName":"Munir ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Bloodwise TAP Calibre Feasibility Study to Assess the Mechanism of Action of Idelalisib in B-Cell Receptor Pathway (BCR) Inhibition in Chronic Lymphocytic Leukaemia (CLL)","keywords":"","combinedName":"doctor talha munir"},{"sessionId":"11859","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster II","firstName":"William G","lastName":"Wierda ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Venetoclax (VEN) Is Active in Chronic Lymphocytic Leukemia (CLL) Relapsed or Refractory to More Than One B-Cell Receptor Pathway Inhibitor (BCRi)","keywords":"","combinedName":"doctor william g wierda"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Sarit","lastName":"Assouline","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Clinical Trial of the Pan PI3K Inhibitor, Buparlisib, for the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia: Canadian Cancer Trials Group IND.216","keywords":"","combinedName":"doctor sarit assouline"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Prithviraj ","lastName":"Bose ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Pilot Study of Lower Doses of Ibrutinib in Patients (pts) with Chronic Lymphocytic Leukemia (CLL)","keywords":"","combinedName":"doctor prithviraj bose"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Satyen ","lastName":"Gohil ","credentials":"BSc, MBBS, MRCP, FRCPath","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A ROR1 Bispecific T Cell Engager for the Treatment of Chronic Lymphocytic Leukaemia Demonstrates Enhanced Function Following Ibrutinib Treatment","keywords":"","combinedName":"doctor satyen gohil"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Caroline ","lastName":"Algrin ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"B-Cell Prolymphocytic Leukemia, a Rare Lymphoproliferative Disorder: Analysis of 35 Cases, a Study on Behalf of the French Innovative Leukemia Organization (FILO)","keywords":"","combinedName":"doctor caroline algrin"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Mazyar ","lastName":"Shadman ","credentials":"MD,MPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Outcomes of Chronic Lymphocytic Leukemia (CLL) Patientswith Richters Transformation (RT)to Aggressive Non-Hodgkin Lymphoma (aNHL): a Single-Institution Experience","keywords":"","combinedName":"doctor mazyar shadman"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Anthony ","lastName":"Mato","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Disease and Patient Characteristics, Patterns of Care, Toxicities, and Outcomes of Chronic Lymphocytic Leukemia (CLL) Patients Treated with Venetoclax: A Multicenter Study of 204 Patients","keywords":"","combinedName":"doctor anthony mato"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Antonio ","lastName":"Cuneo ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Bendamustine and Rituximab As First Salvage Treatment in Chronic Lymphocytic Leukemia: Results of the Gimema-Eric LLC1315 Study","keywords":"","combinedName":"doctor antonio cuneo"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Arnon ","lastName":"Kater ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of First-Line Therapy with Chlorambucil, Rituximab and Individualized Dose Lenalidomide in FCR-Unfit Patients with Advanced Chronic Lymphocytic Leukemia (CLL): A Phase I/II HOVON Trial","keywords":"","combinedName":"doctor arnon kater"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Mohammad ","lastName":"Hojjat-Farsangi ","credentials":"MSc, PhD, Assist. Prof.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia Cells","keywords":"","combinedName":"doctor mohammad hojjat-farsangi"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Rosa ","lastName":"Ruchlemer ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ibrutinib: A Risk Factor for Invasive Fungal Infections?","keywords":"","combinedName":"doctor rosa ruchlemer"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"William G","lastName":"Wierda ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Number of Prior Therapies and Bulk of Disease on Outcomes with Venetoclax (VEN) Monotherapy for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)","keywords":"","combinedName":"doctor william g wierda"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Matthew ","lastName":"Davids","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Initial Results of a Phase Ib Study of Ibrutinib in Combination with Obinutuzumab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor matthew davids"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Narjust ","lastName":"Duma ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Invasive Aspergillosis in Chronic Lymphocytic Leukemia:Therapy and Outcomes","keywords":"","combinedName":"doctor narjust duma"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Anthony ","lastName":"Mato","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"KI Intolerance Study: A Phase 2 Study to Assess the Safety and Efficacy of Umbralisib (TGR-1202) in Patients with Chronic Lymphocytic Leukemia (CLL) Who Are Intolerant to Prior BTK or PI3K-d Inhibitor Therapy","keywords":"","combinedName":"doctor anthony mato"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Marzia ","lastName":"Palma ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Treatment with Ibrutinib in Chronic Lymphocytic Leukemia Patients Normalizes CD3+ and CD8+ TCells and Immune Checkpoints Expression but Gradually Leads to CD4+ T-Cell Depletion","keywords":"","combinedName":"doctor marzia palma"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Fie Juhl","lastName":"Vojdeman ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial","keywords":"","combinedName":"doctor fie juhl vojdeman"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Chaitra ","lastName":"Ujjani ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 1 Study of Lenalidomide and Ibrutinib in Combination with Rituximab in Relapsed and Refractory CLL and SLL","keywords":"","combinedName":"doctor chaitra ujjani"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Jose ","lastName":"Garcia-Marco ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)","keywords":"","combinedName":"doctor jose garcia-marco"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"John ","lastName":"Byrd ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pooled Analysis of Safety Data from Clinical Trials Evaluating Acalabrutinib Monotherapy in Hematologic Malignancies","keywords":"","combinedName":"doctor john byrd"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Erin ","lastName":"Bange ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real-World Evidence for Durable Treatment Responses after Toxicity Related Discontinuation of Idelalisib","keywords":"","combinedName":"doctor erin bange"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Veronika ","lastName":"Opatrna ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recurrent Gene Mutations and Clinical Outcome in the Context of Lenalidomide Treatment of Relapsed/Refractory CLL  Results from Multicenter Phase II Trial CLL-009","keywords":"","combinedName":"doctor veronika opatrna"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Stephan ","lastName":"Stilgenbauer ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety of Obinutuzumab Alone or Combined with Chemotherapy in Previously Untreated (Fit or Unfit) or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients: Results from the Primary Analysis of the Phase 3b GREEN Study","keywords":"","combinedName":"doctor stephan stilgenbauer"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Kevin ","lastName":"Freise ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sustained Minimal Residual Disease Negativity Predicted in Chronic Lymphocytic Leukemia Patients Treated with Venetoclax Combination Therapy for 2 Years:an Integrated Mechanistic Analysis of Multiple Phase I and II Studies","keywords":"","combinedName":"doctor kevin freise"},{"sessionId":"11860","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Poster III","firstName":"Joanna ","lastName":"Rhodes ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Front-Line Ibrutinib Dose Reduction and Interruption on Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients","keywords":"","combinedName":"doctor joanna rhodes"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Jules ","lastName":"Zhang-Yin ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"18f-Fluorocholine Versus 18f-Fluorodeoxyglucose for PET/CT Imaging in Staging, Follow up or Suspected Relapse of Multiple Myeloma","keywords":"","combinedName":"doctor jules zhang-yin"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Emma ","lastName":"Scott ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Comparison between 3 Staging Systems in Multiple Myeloma Using the Center for International Blood and Marrow Transplant Research (CIBMTR) Database","keywords":"","combinedName":"doctor emma scott"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Yu-Tzu ","lastName":"Tai ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Proliferation Inducing Ligand (APRIL) Directly Impacts Immune Regulatory Subsets to Regulate Suppressive Multiple Myeloma Bone Marrow Microenvironment","keywords":"","combinedName":"doctor yu-tzu tai"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Wendy","lastName":"Cozen","credentials":"DO, MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AMeta-Analysis of Genome-Wide Association Studies of Multiple Myeloma in Persons of African Ancestry (African-American Multiple Myeloma Study (AAMMS)) IdentifiesSuggestive Risk Variants","keywords":"","combinedName":"doctor wendy cozen"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Marc ","lastName":"Braunstein ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of the IgA Heavy Chain Repertoire in Multiple Myeloma: Implications for Host-Microbiome Influences","keywords":"","combinedName":"doctor marc braunstein"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Jesus ","lastName":"Delgado-Calle ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aplidin (Plitidepsin) Regulates Viability and Function of Myeloma Cells and Bone Cells in Combination with Other Anti-MM Drugs","keywords":"","combinedName":"doctor jesus delgado-calle"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Alessandra ","lastName":"Romano ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Arginine Deprivation and Autophagy Sustain Bioenergetics in Multiple Myeloma","keywords":"","combinedName":"doctor alessandra romano"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Ilaria ","lastName":"Chicca ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessment of Anti-Bacterial Antibodies in Multiple Myeloma Patients at Disease Presentation and in Response to Therapy: Implication for Patient Management","keywords":"","combinedName":"doctor ilaria chicca"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Anglique ","lastName":"Bruyer ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction","keywords":"","combinedName":"doctor anglique bruyer"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Peter ","lastName":"Forsberg ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cellular Proliferation By Multiplex Immunohistochemistry Identifies Aggressive Disease Behavior in Relapsed Multiple Myeloma","keywords":"","combinedName":"doctor peter forsberg"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Jeffery ","lastName":"Sawyer ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chromosome 1q12 Instability Drives Both 1q21 Amplification and Arm-Length Deletions in Multiple Myeloma","keywords":"","combinedName":"doctor jeffery sawyer"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Carolina ","lastName":"Schinke ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical and Molecular Characterization of Primary Plasma Cell Leukemia","keywords":"","combinedName":"doctor carolina schinke"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Surbhi ","lastName":"Sidana ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Composite Organ and Hematologic Response Model Risk Stratifies Patients with Light Chain Amyloidosis","keywords":"","combinedName":"doctor surbhi sidana"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Jing ","lastName":"Yang ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"C-Reactive Protein Promotes Bone Destruction in Human Myeloma By Stimulating Myeloma Cell Production of Osteolytic Cytokines Via the CD32/Fc?RII-p38MAPK-Twist Axis","keywords":"","combinedName":"doctor jing yang"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Rebecca ","lastName":"Ye ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Defining aBone Marrow Immune Signature Associated with Immunoglobulin Isotype Switchingafter Autologous Stem Cell Transplant","keywords":"","combinedName":"doctor rebecca ye"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Carolina ","lastName":"Terragna ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Definition of a Prognostic Risk-Classifier Based on SNPs Array Analysis of Copy Number Alterations in Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients","keywords":"","combinedName":"doctor carolina terragna"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Paola ","lastName":"Storti ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Continuous Lenalidomide Treatment on Copy Number Alteration and Cytogenetic Abnormalities in Multiple Myeloma Cells","keywords":"","combinedName":"doctor paola storti"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Charlotte","lastName":"Pawlyn","credentials":"BA,PhD,MBBChir,MRCP,FRCPath","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Factors Predicting Poor Outcomes for Myeloma Patients at Different Ages: Results from 3894 Patients in the Myeloma XI Trial","keywords":"","combinedName":"doctor charlotte pawlyn"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Brooks ","lastName":"Benard ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FGFR3 Mutations Are an Adverse Prognostic Factor in Patients with t(4;14)(p16;q32) Multiple Myeloma: An Mmrf Commpass Analysis","keywords":"","combinedName":"doctor brooks benard"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Miguel ","lastName":"Gonzalez Velez ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gene Expression Profiling (GEP) As a Prognostic Indicator of Multiple Myeloma, Irrespective of Disease Stage, Prior Treatment and Prior Transplant - a Single Center Experience","keywords":"","combinedName":"doctor miguel gonzalez velez"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Ruth ","lastName":"Wester ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Higher Expression of Nuclear Cereblon in Bone Marrow Biopsies of Patients with Multiple Myeloma Included in the HOVON-87/Nmsg-18 Trial May be Associated with Longer PFS and OS","keywords":"","combinedName":"doctor ruth wester"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Sho ","lastName":"Ikeda ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hypoxia-Inducible KDM3A Addiction in Multiple Myeloma","keywords":"","combinedName":"doctor sho ikeda"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Caleb K","lastName":"Stein ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identifying High-Risk Phenotypes Using Three-Way Feature Interactions in Multiple Myeloma: An Analysis of Publically Available Mmrf Commpass Study","keywords":"","combinedName":"doctor caleb k stein"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Subodh ","lastName":"Kumar ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identifying Novel Genes Involved in Dysregulation of Homologous Recombination and Genomic Integrity in Myeloma","keywords":"","combinedName":"doctor subodh kumar"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Jinsong ","lastName":"Hu ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interleukin-6 Drives Multiple Myeloma Progression through Upregulating of CD147/Emmprin Expression and Its Sialylation","keywords":"","combinedName":"doctor jinsong hu"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Sara ","lastName":"Gandolfi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Interactions with Bone Marrow Stromal Cells Alter the Molecular Dependencies of Myeloma Cells: Insights from Genomewide CRISPR-Based Functional Genomic Screens","keywords":"","combinedName":"doctor sara gandolfi"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Leon ","lastName":"Furchtgott ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multiple Myeloma Drivers of High Risk and Response to Stem Cell Transplantation Identified By Causal Machine Learning: Out-of-Cohort and Experimental Validation","keywords":"","combinedName":"doctor leon furchtgott"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Nidhi ","lastName":"Tandon ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes with Early Response to First Line Treatment in Patients with Newly Diagnosed Multiple Myeloma","keywords":"","combinedName":"doctor nidhi tandon"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Manisha ","lastName":"Bhutani ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Peripheral Cellular Immunome Reveals Heterogeneity Spanning Myeloma Spectrum Diseases","keywords":"","combinedName":"doctor manisha bhutani"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Rao ","lastName":"Prabhala ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Perturbation in B Cell-Subsets Can Explain the Observed Suppression of Uninvolved Immunoglobulins and Their Impact on T Tell-Subsets As Well As Patients Outcome in Myeloma","keywords":"","combinedName":"doctor rao prabhala"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Noa ","lastName":"Holtzman ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plasma Cell Leukemia (PCL): Clinical Characteristics, Outcomes, and the Impact of Circulating Plasma Cells (CPC) Percentage - A SingleCenter Experience","keywords":"","combinedName":"doctor noa holtzman"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Shannon ","lastName":"Matulis ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predicting Venetoclax Sensitivity in Multiple Myeloma Using Biologic Activity Assays","keywords":"","combinedName":"doctor shannon matulis"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Nidhi ","lastName":"Tandon ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Impact of Complete Response after First Line Therapy on Outcomes Following Initial Relapse in Newly Diagnosed Multiple Myeloma","keywords":"","combinedName":"doctor nidhi tandon"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Sylvie ","lastName":"Hermouet ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pro-Inflammatory State of MGUS and Myeloma Patients Presenting with a Monoclonal Immunoglobulin Specific for an Infectious Pathogen","keywords":"","combinedName":"doctor sylvie hermouet"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Yoshiaki ","lastName":"Abe ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Serum Free Light Chain Assay Measurement at Disease Relapse for Prognostication in Patients with Multiple Myeloma in the Novel Agent Era","keywords":"","combinedName":"doctor yoshiaki abe"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Nicola","lastName":"Giuliani","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Soluble CX3CL1/Fractalkine Is a New Player in the Pro-Inflammatory Microenvironment of Multiple Myeloma Patients Related to Bone Marrow Plasma Cell Infiltration and Neo-Vascularization","keywords":"","combinedName":"doctor nicola giuliani"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Signy ","lastName":"Chow ","credentials":"MD, FRCP(C)","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted-Capture Sequencing Approach to V(D)J Rearrangement, Immunoglobulin (Ig) Translocation and Mutation Detection in Multiple Myeloma (MM): Potential Applications in Minimal Residual Disease (MRD) Analysis and Comparison to Multiparameter Flow Cytometry (MFC) in the Myeloma Canada Research Network (MCRN) 001 Study with Intravenous Busulfan and Melphalan (BuMel) Conditioning Followed By Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma (NDMM)","keywords":"","combinedName":"doctor signy chow"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Gordon ","lastName":"Cook ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Leeds Risk Profile Predicts Outcome for Older Myeloma Patients: A Prognostic Score Using Frailty Biomarkers Derived and Tested Using 2371 Clinical Trial Patients","keywords":"","combinedName":"doctor gordon cook"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Mariko ","lastName":"Ishibashi ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The New Immunoreceptor SLAMF3 Promotes Aggressive Biological and Clinical Characteristics in Multiple Myeloma","keywords":"","combinedName":"doctor mariko ishibashi"},{"sessionId":"11861","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II","firstName":"Cody Cody","lastName":"Ashby ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whole Genome Sequencing Reveals the Extent of Structural Variants in Multiple Myeloma and Identifies Recurrent Mutational Hotspots within the Non-Coding Regions","keywords":"","combinedName":"doctor cody cody ashby"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Noriyoshi ","lastName":"Kurihara ","credentials":"DDS, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" a Novel Ex-Vivo Model of Prolonged Osteoblast Suppression in Multiple Myeloma  ","keywords":"","combinedName":"doctor noriyoshi kurihara"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Brian ","lastName":"Chiu ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"5-Hydroxymethylcytosine of Circulating Cell-Free DNA in Plasma: A Novel Non-Invasive Marker for Progression and Prognosis in Multiple Myeloma","keywords":"","combinedName":"doctor brian chiu"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Emily ","lastName":"Martin ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Method to Identify Patients with Multiple Myeloma Who Are at Risk of Developing Concomitant Amyloidosis","keywords":"","combinedName":"doctor emily martin"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Martin ","lastName":"Schreder ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Whole Blood Gene Expression Signature Accurately Diagnoses Multiple Myeloma and Differentiates Patients in Remission from Those with Active and Progressive Disease","keywords":"","combinedName":"doctor martin schreder"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Joaquin ","lastName":"Martinez-Lopez ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Abnormalities in Mitochondrial DNA Copy Number Have Pathogenetic and Prognostic Implications in Multiple Myeloma","keywords":"","combinedName":"doctor joaquin martinez-lopez"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Gudbjorg ","lastName":"Jonsdottir ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors","keywords":"","combinedName":"doctor gudbjorg jonsdottir"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Sonia ","lastName":"Jaramillo ","credentials":"MD, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Age Related Distribution of Cytogenetic Abnormalities in Multiple Myeloma","keywords":"","combinedName":"doctor sonia jaramillo"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Sarah K","lastName":"Johnson ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Analysis of the Metabolic State of Residual Multiple Myeloma Plasma Cells Reveals a Proliferative Subset with Glycolytic Gene Expression","keywords":"","combinedName":"doctor sarah k johnson"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Srikanth ","lastName":"Talluri ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Apobec Family of Proteins Mediate Genomic Changes in Multiple Myeloma By Inducing DNA Damage and C>T Mutations","keywords":"","combinedName":"doctor srikanth talluri"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Yuki ","lastName":"Nishida ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Automatic Digital Quantification of Bone Marrow Myeloma Volume in Appendicular Skeletons  Clinical Implications and Prognostic Significance","keywords":"","combinedName":"doctor yuki nishida"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Sharon A","lastName":"Secola ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BCMA Versus CD138 for Identifying Multiple Myeloma on Flow Cytometry","keywords":"","combinedName":"doctor sharon a secola"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Tommaso ","lastName":"Perini ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bone Marrow Microenvironment Induces Genomic Instability and Enables Clonal Evolution in Multiple Myeloma","keywords":"","combinedName":"doctor tommaso perini"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Sean ","lastName":"Bujarski ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Changes in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Multiple Myeloma Patients Undergoing New Treatments","keywords":"","combinedName":"doctor sean bujarski"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Stefanie ","lastName":"Huhn ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Circulating Tumor Cells As a Surrogate Marker for Bone Marrow Minimal Residual Disease and an Adverse Prognostic Factor for Patients with Multiple Myelom","keywords":"","combinedName":"doctor stefanie huhn"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Peter ","lastName":"Mollee ","credentials":"FRACP, FRCPA, MBBS, MMSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Comparison of a New Serum Free Light Chain (FLC) Assay Based on the Seralite Monoclonal Anti-FLC Antibodies with the Freelite and N-Latex FLC Assays in the Diagnosis of AL Amyloidosis","keywords":"","combinedName":"doctor peter mollee"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Sarakshi ","lastName":"Mahajan ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Significance of Plasma Cell Tetrasomy in Multiple Myeloma","keywords":"","combinedName":"doctor sarakshi mahajan"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Maurizio ","lastName":"Zangari ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumamab in High Risk Relapse/Refractory Myeloma Patients Effect of 1q21 Gain and GEP70 Status","keywords":"","combinedName":"doctor maurizio zangari"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Steven P","lastName":"Treon ","credentials":"MD,PhD,FRCP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differential Diagnosis of Suspected MYD88 Wild-Type Waldenstroms Macroglobulinemia Includes Other Malignant and Non-Malignant IgM Secreting Entities, Including Frequent Cases of IgM Myeloma","keywords":"","combinedName":"doctor steven p treon"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Vassilis ","lastName":"Koutoulidis ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diffuse Medullary Hyperdensities of the Femora and Humeri on Whole-Body Low-Dose Computed Tomography Identify Diffuse MRI Pattern of Involvement and Correlate with Advanced Disease Stage in Patients with Multiple Myeloma","keywords":"","combinedName":"doctor vassilis koutoulidis"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Jithendra ","lastName":"Kini Bailur ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Enrichment and Subsequent Dysfunction of Marrow ILC Subsets in Monoclonal Gammopathy: Target for IMiD Therapy","keywords":"","combinedName":"doctor jithendra kini bailur"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Binder ","lastName":"Moritz ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Paraprotein Kinetics and Response to Treatment in Multiple Myeloma","keywords":"","combinedName":"doctor binder moritz"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Marie-France ","lastName":"Gagnon ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients at the CHUM (Centre Hospitalier de lUniversit de Montral)  a Single-Institution Retrospective Study","keywords":"","combinedName":"doctor marie-france gagnon"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Hongxia ","lastName":"Xu ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Exosome-Mediated Transfer of lncRUNX2-AS1 from Multiple Myeloma Cells to Mesenchymal Stem Cells Contributes to Osteogenic Differentiation","keywords":"","combinedName":"doctor hongxia xu"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Vishal ","lastName":"Bhatnagar ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FDA Analysis of Racial Demographics in Multiple Myeloma Trials","keywords":"","combinedName":"doctor vishal bhatnagar"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Catherine ","lastName":"Claussen ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gene Expression Profiling Is a Strong Predictor of Clinical Outcomes in Newly Diagnosed Multiple Myeloma","keywords":"","combinedName":"doctor catherine claussen"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Amit Kumar","lastName":"Mitra ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gene Expression Profiling of Kinetic Response to Proteasome Inhibitors in Innate and Acquired Resistant Multiple Myeloma","keywords":"","combinedName":"doctor amit kumar mitra"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Jiaxiong ","lastName":"Tan ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High PD-1 and Tim-3 Expression Concurrent with Exhausted CD4+ and CD8+ T Cells in Bone Marrow Compared with Peripheral Blood from Patients with Multiple Myeloma","keywords":"","combinedName":"doctor jiaxiong tan"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Eva ","lastName":"De Smedt ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Histone Methyltransferases G9a and Glp; Identification and Validation of Novel Therapeutic Targets for Multiple Myeloma Treatment","keywords":"","combinedName":"doctor eva de smedt"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Sophia ","lastName":"Adamia ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification Cause of Aberrant Splicing and Novel Drug Targets in Patients with Multiple Myeloma","keywords":"","combinedName":"doctor sophia adamia"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Min Young ","lastName":"Lee ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma","keywords":"","combinedName":"doctor min young lee"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Srikanth ","lastName":"Talluri ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Microenvironment Contributes to Dysregulation of Aid/Apobec Expression and Genomic Instability in Multiple Myeloma","keywords":"","combinedName":"doctor srikanth talluri"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Yoon Seok ","lastName":"Choi ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immunologic Characterization of Tumor Antigen-Specific T Cells in Multiple Myeloma: Implication in Immune Checkpoint Blockade","keywords":"","combinedName":"doctor yoon seok choi"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Gaurav ","lastName":"Goyal ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma","keywords":"","combinedName":"doctor gaurav goyal"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Bertrand ","lastName":"Arnulf ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Implication of the Long Non-Coding RNA Crnde in Multiple Myeloma","keywords":"","combinedName":"doctor bertrand arnulf"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Florentin ","lastName":"Spth ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intra-Individual Changes in Immune Marker Concentrations and Multiple Myeloma Risk: A Longitudinal Prospective Study Using Repeated Pre-Diagnostic Plasma Samples","keywords":"","combinedName":"doctor florentin spth"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Yuan Xiao ","lastName":"Zhu ","credentials":"Ph.D.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lenalidomide, Pomalidomide and CC-220 Resistant Multiple Myeloma: Confirmation of Role of CRBN/IRF4 Axis and Identification of Multiple Disruption Mechanisms","keywords":"","combinedName":"doctor yuan xiao zhu"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Kazuki ","lastName":"Homma ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Noncoding RNA PVT1 and MYC Are Co-Regulated By Bromodomain Protein BRD4 in Multiple Myeloma and Associated with Disease Progression","keywords":"","combinedName":"doctor kazuki homma"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Valeriy V","lastName":"Lyzogubov ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MAF and NF-?b Signaling Pathways Regulate Expression of APOBEC3B in Multiple Myeloma","keywords":"","combinedName":"doctor valeriy v lyzogubov"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Ya-Wei ","lastName":"Qiang ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mafa Expression Promotes Proliferation of Myeloma Cells and Its Protein Stability Is Regulated By Proteasome Inhibitors","keywords":"","combinedName":"doctor ya-wei qiang"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Hearn Jay","lastName":"Cho ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MAGE-a Inhibits Apoptosis in Multiple Myeloma through Regulation of Bim and PUMA","keywords":"","combinedName":"doctor hearn jay cho"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Francesco ","lastName":"Di Raimondo ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mesenchymal Stromal Cells (MSC) As Key Players in the Tumor Microenvironment Transformation from MGUS to Myeloma","keywords":"","combinedName":"doctor francesco di raimondo"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Carlos ","lastName":"Fernandez de Larrea ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Micrornas in Bone Marrow Mesenchymal Stromal Cells Are Differentially Expressed According to Response in Multiple Myeloma","keywords":"","combinedName":"doctor carlos fernandez de larrea"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Jihane ","lastName":"Khalife ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MiR-16 Regulates Crosstalk in NF-?b Inflammatory Signaling between Myeloma Cells and Bone Marrow Macrophages","keywords":"","combinedName":"doctor jihane khalife"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Erik H","lastName":"Van Beers ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mmprofiler with SKY92 Combined with ISS Identifies High and Low Risk Multiple Myeloma in the VTD Arm of Gimema-MMY-3006","keywords":"","combinedName":"doctor erik h van beers"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Vallari ","lastName":"Shah ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Characterisation of TP53 Aberrations in 1,777 Myeloma Trial Patients","keywords":"","combinedName":"doctor vallari shah"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Anwar ","lastName":"Rjoop ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Molecular Subtypes of Plasma Cell Neoplasms with Circulating Neoplastic Plasma Cells","keywords":"","combinedName":"doctor anwar rjoop"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Paolo ","lastName":"Milani ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"N-Terminal Fragment of the Type-B Natriuretic Peptide (NT-proBNP) Is an Independent Prognostic Factor for Overall Survival in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)","keywords":"","combinedName":"doctor paolo milani"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Mark ","lastName":"Schroeder","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overexpression of EZH2 in Multiple Myeloma Is Associated with Poor Prognosis Regardless of Treatment with Novel Agents or High-Dose Chemotherapy","keywords":"","combinedName":"doctor mark schroeder"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Smundur ","lastName":"Rgnvaldsson ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Peripheral Neuropathy Is an Under-Recognized Feature of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 18,668 MGUS Patients and Their 97,641 Matched Controls","keywords":"","combinedName":"doctor smundur rgnvaldsson"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Giovanni ","lastName":"Palladini ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Persisting Cardiac Dysfunction and Quality of Response Predict Survival in Patients with AL Amyloidosis Who Respond to Upfront Therapy","keywords":"","combinedName":"doctor giovanni palladini"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Kenneth ","lastName":"Carson ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Post-MGUS Diagnosis Serum M-Protein Velocity and the Risk of Progression of MGUS to Multiple Myeloma","keywords":"","combinedName":"doctor kenneth carson"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Yoshiaki ","lastName":"Abe ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Relevance of Clonal Circulating Plasma Cells Detected By Multiparameter Flow Cytometry in Patients with Newly Diagnosed Multiple Myeloma Treated with Novel Agents: Comparative Investigation with the Revised International Staging System","keywords":"","combinedName":"doctor yoshiaki abe"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Myra M","lastName":"Robinson ","credentials":"MSPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Significance of Ki67 Expression By Immunohistochemistry (IHC) on Bone Marrow Biopsy in Newly Diagnosed Multiple Myeloma","keywords":"","combinedName":"doctor myra m robinson"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Sabrina ","lastName":"Manni ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Protein Kinase CSNK1A Regulates the Multiple Myeloma Plasma Cell-Microenvironment Interplay","keywords":"","combinedName":"doctor sabrina manni"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Christian ","lastName":"Gocke ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Protein Synthesis Rates Regulate Tumor-Initiating Potential and Chemoresistance in Multiple Myeloma","keywords":"","combinedName":"doctor christian gocke"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Giampaolo ","lastName":"Merlini ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Proteotoxicity in Cardiac Amyloidosis: Amyloidogenic Light Chains Affect the Levels of Iintracellular Proteins in Human Heart Cells","keywords":"","combinedName":"doctor giampaolo merlini"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Baptiste ","lastName":"Lamarthe ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantitative and Functional Alterations of 6-Sulfo Lacnac Dendritic Cells in Multiple Myeloma","keywords":"","combinedName":"doctor baptiste lamarthe"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Marcel ","lastName":"Seibold ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ral Mediates Multiple Myeloma Cell Survival Independently of Oncogenic RAS","keywords":"","combinedName":"doctor marcel seibold"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Chunkang ","lastName":"Chang ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduction of Dicer1 By Multiple Myeloma Cells in Mesenchymal Stem Cells Promotes Cellular Senescence and Tumor-Supporting Effect and Decreases the Differentiation","keywords":"","combinedName":"doctor chunkang chang"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Arjun ","lastName":"Lakshman ","credentials":"MD, MRCP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk Stratification of Smoldering Multiple Myeloma in the Light of the Revised IMWG Diagnostic Criteria","keywords":"","combinedName":"doctor arjun lakshman"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Alboukadel ","lastName":"Kassambara ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RNA Sequencing Data-Driven Dissection of Human Plasma Cell Differentiation Reveals New Potential Transcription Regulators","keywords":"","combinedName":"doctor alboukadel kassambara"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Santiago ","lastName":"Barrio Garcia ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of MAX As a Tumor Suppressor Driver Gene in Multiple Myeloma","keywords":"","combinedName":"doctor santiago barrio garcia"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Cristina ","lastName":"Panaroni ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Sclerostin in Multiple Myeloma Progression","keywords":"","combinedName":"doctor cristina panaroni"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Niels ","lastName":"Weinhold ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Spatial Genomic Heterogeneity in Multiple Myeloma: Surrogate Markers and Its Significance for Understanding the Evolutionary Processes Leading to Relapse","keywords":"","combinedName":"doctor niels weinhold"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Meirong ","lastName":"Zang ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Suppression of Cdc37 Induces BTZ Resistance through XBP1s Mediated Plasma Cell Immaturation in Multiple Myeloma","keywords":"","combinedName":"doctor meirong zang"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"David ","lastName":"Coffey ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeted Next Generation Sequencing of Circulating Tumor DNA in Multiple Myeloma","keywords":"","combinedName":"doctor david coffey"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Subodh ","lastName":"Kumar ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Homologous Recombination Increases Cytotoxicity While Reducing Genomic Instability Induced By Melphalan in Myeloma","keywords":"","combinedName":"doctor subodh kumar"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Nasrin ","lastName":"Rastgoo ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting of Marcks By MiR-34a Overcomes Drug Resistance in Multiple Myeloma","keywords":"","combinedName":"doctor nasrin rastgoo"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Gilberto ","lastName":"Gastelum ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting of the Hypoxia-Induced Acid Microenvironment of Multiple Myeloma Cells Increases Hypoxia-Mediated Apoptosis","keywords":"","combinedName":"doctor gilberto gastelum"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Marco ","lastName":"Rossi ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Th17 Cells Targeting By MiR-21 Inhibitor Impairs Multiple Myeloma Related Bone Disease","keywords":"","combinedName":"doctor marco rossi"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Megan Murray","lastName":"Dupuis ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Gamma Gap: A Point-of-Care Test That Correlates with Disease Burden and Treatment Response in Multiple Myeloma","keywords":"","combinedName":"doctor megan murray dupuis"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Davine ","lastName":"Hofste Op Bruinink ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Level of Circulating Myeloma Cells at Diagnosis Correlates with a Plasma Cell Leukemia-like Phenotype of the Corresponding Myeloma Cells in Bone Marrow","keywords":"","combinedName":"doctor davine hofste op bruinink"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Rumi ","lastName":"Ino ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role and Therapeutic Target of Base Excision Repair Genes in Multiple Myeloma (MM)","keywords":"","combinedName":"doctor rumi ino"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Martine ","lastName":"Amiot ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Use of a BH3 Mimetic Toolkit Reveals a Switch of Myeloma Patients Dependency from BCL2 at Diagnosis to MCL1 at Relapse","keywords":"","combinedName":"doctor martine amiot"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Dimitra ","lastName":"Zacharaki ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcriptome Alterations of Prospectively Isolated Bone Marrow Stromal Cells Provide Potential Cues to MGUS and Multiple Myeloma Pathobiology","keywords":"","combinedName":"doctor dimitra zacharaki"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Eli ","lastName":"Muchtar ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"What Does AL Amyloidosis Look like in the Era of Mass Spectrometry Typing?","keywords":"","combinedName":"doctor eli muchtar"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Zuzana ","lastName":"Kufova ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whole Exome Sequencing of Plasma Cells Precancerosis MGUS and Malignant AL Amyloidosis Reveals Small Number of Shared Mutated Genes","keywords":"","combinedName":"doctor zuzana kufova"},{"sessionId":"11862","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster III","firstName":"Laura ","lastName":"Schmalbrock ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Whole Exome Sequencing Reveals High Genetic Diversity in Relapsed Multiple Myeloma","keywords":"","combinedName":"doctor laura schmalbrock"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Nathalie ","lastName":"Meurice ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Direct to Drug Screening As a Route to Individualized Therapy in Multiple Myeloma","keywords":"","combinedName":"doctor nathalie meurice"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Vikas ","lastName":"Gupta ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A B-Cell like Phenotype Is Associated with Sensitivity to Venetoclax in Multiple Myeloma","keywords":"","combinedName":"doctor vikas gupta"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Thorsten ","lastName":"Gantke ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AFM26  Targeting B Cell Maturation Antigen (BCMA) for NK Cell-Mediated Immunotherapy of Multiple Myeloma","keywords":"","combinedName":"doctor thorsten gantke"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Rohit ","lastName":"Mathur ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"B-Cell Maturation Antigen (BCMA)-Specific, CentyrinTM-Based, PiggyBacTM-Transposed CAR-T Memory Stem Cells Are Effective Against p53-/- and Patient-Derived Multiple Myeloma Tumors","keywords":"","combinedName":"doctor rohit mathur"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Yu-Tzu ","lastName":"Tai ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD8+ Anti-Bcma mRNA CAR T-Cells Effectively Kill Human Multiple Myeloma Cells in Vitro and In Vivo","keywords":"","combinedName":"doctor yu-tzu tai"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Nathalie ","lastName":"Meurice ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Charting Venetoclax Sensitivity and Synergism Ex Vivo in Multiple Myeloma","keywords":"","combinedName":"doctor nathalie meurice"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Xiao-Yue ","lastName":"Wan ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CircPVT1 Inhibit Apoptosis and Enhance Drug Resistance in Multiple Myeloma","keywords":"","combinedName":"doctor xiao-yue wan"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Evangelos ","lastName":"Terpos ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Proteasome Inhibitors-Induced Cardiotoxicity (carfilzomib vs. bortezomib): Insights into the Molecular Mechanisms","keywords":"","combinedName":"doctor evangelos terpos"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Flavia ","lastName":"Pichiorri ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Copper-64-Labeled Daratumumab As a PET Imaging Tracer for Multiple Myeloma: Potential Use for Minimal Residual Disease Detection","keywords":"","combinedName":"doctor flavia pichiorri"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Dilan ","lastName":"Serdar ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Generation of a Lenalidomide-Sensitive Mouse Model for Multiple Myeloma By Expression of the CrbnI391V Mutant in Mopc-315.BM Cells","keywords":"","combinedName":"doctor dilan serdar"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Changyong ","lastName":"Wei ","credentials":"PhD, BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Glutamine Catabolism Maintains MCL-1 Expression in Glucose-Deprived Multiple Myeloma","keywords":"","combinedName":"doctor changyong wei"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Lisa J","lastName":"Crawford ","credentials":"BSc, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HUWE1 Inhibition As a Therapeutic Strategy to Target MYC in MM","keywords":"","combinedName":"doctor lisa j crawford"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Sarah M","lastName":"Larson ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of PI3K Alpha and PI3K Delta with Copanlisib Shows Preclinical Activity As a Single Agent and in Combination in Multiple Myeloma","keywords":"","combinedName":"doctor sarah m larson"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Andrej ","lastName":"Besse ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nelfinavir Blocks Export of Newly Synthesized Protein from the ER and Interacts with ER-Resident and Mitochondrial Proteins in an Activity-Dependent Fashion","keywords":"","combinedName":"doctor andrej besse"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Jonathan ","lastName":"Ko ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preclinical Evaluation of Hdp-101, a Novel Anti-Bcma Antibody-Drug Conjugate, in Multiple Myeloma","keywords":"","combinedName":"doctor jonathan ko"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Yan ","lastName":"Song ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Proteasome- Associated Ubiquitin Receptor PSMD4/Rpn10 in Multiple Myeloma","keywords":"","combinedName":"doctor yan song"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Qingxiao ","lastName":"Chen ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Mechanisms of PIM Kinase Inhibitor, SGI-1776 Free Base, in Treating Myeloma-Associated Bone Disease","keywords":"","combinedName":"doctor qingxiao chen"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Karen ","lastName":"Menezes ","credentials":"PhD, BSc, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Novel Protein HSF1 Stress Pathway Inhibitor Bisamide CCT361814 Demonstrates Pre-Clinical Anti-Tumor Activity in Myeloma","keywords":"","combinedName":"doctor karen menezes"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Tianyuan ","lastName":"Zhou ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Therapeutic Targeting of Interferon Regulatory Factor 4 with Next Generation Antisense Oligonucleotides Produces Robust In Vivo Antitumor Activity in Preclinical Models of Multiple Myeloma","keywords":"","combinedName":"doctor tianyuan zhou"},{"sessionId":"11863","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster II","firstName":"Hector H","lastName":"Huang ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unbiased Phosphoproteomics Reveals a Therapeutically Relevant Connection between Pre-mRNA Splicing and Proteasome Inhibition in Multiple Myeloma","keywords":"","combinedName":"doctor hector h huang"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Jianhong ","lastName":"Lin ","credentials":"MD, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Single Gene-Mediated Perturbation of the Human Genome Leads to Malignant Transformation in a Murine Transgenic Model","keywords":"","combinedName":"doctor jianhong lin"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Mark ","lastName":"Berger ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Actinium Labeled Daratumumab Demonstrates Enhanced Killing of Multiple Myeloma Cells over Naked Daratumumab","keywords":"","combinedName":"doctor mark berger"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Matthew ","lastName":"Ho ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Blocking HDAC3 in Bone Marrow Stromal Cells Has Direct Anti-Multiple Myeloma Effect and Modulates T Cell Function","keywords":"","combinedName":"doctor matthew ho"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Jesus ","lastName":"Delgado-Calle ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bone-Targeted Pharmacological Inhibition of Notch Signaling As a Novel Approach to Inhibit Myeloma Growth and Bone Destruction","keywords":"","combinedName":"doctor jesus delgado-calle"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Arturo ","lastName":"Molina ","credentials":"MD,MS, FACP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD74 Is Expressed in Relapsed and Refractory Multiple Myeloma and Can be Targeted with a Novel Anti-CD74 Antibody Drug Conjugate, S?RO-001","keywords":"","combinedName":"doctor arturo molina"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Alexandre ","lastName":"Detappe ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of an Antibody-Targeted Nanoparticle for Early Detection of Minimal Residual Disease in Multiple Myeloma","keywords":"","combinedName":"doctor alexandre detappe"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"James ","lastName":"Driscoll ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Eosinophils Upregulate PD-L1 and PD-L2 Expression to Enhance the Immunosuppressive Microenvironment in Multiple Myeloma","keywords":"","combinedName":"doctor james driscoll"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Taxiarchis","lastName":"Kourelis","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluating Pembrolizumab Interference with Monoclonal Protein Detection By Immunofixation and By MALDI-TOF Mass Spectrometry (MASS-FIX)","keywords":"","combinedName":"doctor taxiarchis kourelis"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Mara N","lastName":"Zeissig ","credentials":"BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HIF-2a Upregulates CCR1 to Promote Dissemination of Plasma Cells in Multiple Myeloma","keywords":"","combinedName":"doctor mara n zeissig"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Hiroko ","lastName":"Nishida ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Humanized Anti-CD26 Monoclonal Antibody Has Anti-Myeloma Efficacy for the Treatment of High-Risk Multiple Myeloma","keywords":"","combinedName":"doctor hiroko nishida"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Mark ","lastName":"Meads ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Target Pathways of Acquired IMiD and Proteasome Inhibitor Resistance in Multiple Myeloma","keywords":"","combinedName":"doctor mark meads"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Greg D","lastName":"Whitehill ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immunomodulatory Effects of HDACi in Combination with Checkpoint Blockade and Lenalidomide in the Immunosuppressive Multiple Myeloma Bone Marrow Microenvironment","keywords":"","combinedName":"doctor greg d whitehill"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Ryosuke ","lastName":"Shirasaki ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vivo Validation of Essential Genes for Myeloma Cells By CRISPR/Cas9 Studies in a Scaffold-Based System Engineered to Establish a \"Humanized\" Bone Marrow-like Microenvironment","keywords":"","combinedName":"doctor ryosuke shirasaki"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Silvia ","lastName":"Marino ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inhibition of p62-ZZ Domain-Mediated Signaling Overcomes Bortezomib Resistance in Multiple Myeloma Cells Independent of Their p53 Status","keywords":"","combinedName":"doctor silvia marino"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Ralf ","lastName":"Buettner ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Leflunomide Inhibits c-Myc Signaling and Impairs Myeloma Cell Growth","keywords":"","combinedName":"doctor ralf buettner"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Roy ","lastName":"Heusschen ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Inhibits Osteoclast Activity and Restores Osteoblast Activity in a Murine Model of Multiple Myeloma Bone Disease","keywords":"","combinedName":"doctor roy heusschen"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Muntasir M","lastName":"Majumder ","credentials":"MSc, BPharm","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Midostaurin Shows Efficacy in Refractory Multiple Myeloma with TP53 Mutation and Elevated Expression of NTRK1, NTRK3 and AURKA","keywords":"","combinedName":"doctor muntasir m majumder"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Cecilia ","lastName":"Bonolo De Campos ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pikfyve Inhibitors for the Treatment of Multiple Myeloma","keywords":"","combinedName":"doctor cecilia bonolo de campos"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Jianxuan ","lastName":"Zou ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Protein Homeostatic Modulators, a Novel Class of Cereblon-Targeting Small Molecules As Potential Clinical Candidates in Multiple Myeloma","keywords":"","combinedName":"doctor jianxuan zou"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Haiming ","lastName":"Chen ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Serum Bcma May Interfere with Anti-Bcma-CAR-Transduced T Cells or Other Anti-Bcma Antibody-Based Immunotherapy in Multiple Myeloma","keywords":"","combinedName":"doctor haiming chen"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Richa ","lastName":"Bajpai ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Succinate Ubiquinone Reductase Activity Predicts Multiple Myeloma Sensitivity to Venetoclax","keywords":"","combinedName":"doctor richa bajpai"},{"sessionId":"11864","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III","firstName":"Andrew ","lastName":"Stefka ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment with the Novel TOPK Inhibitor OTS514 Exhibits Potent Anti-Myeloma Activity in Pre-Clinical Models","keywords":"","combinedName":"doctor andrew stefka"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Evangelos ","lastName":"Terpos ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real World Data on the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Combined Study from the Greek, Czech and UK Databases","keywords":"","combinedName":"doctor evangelos terpos"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Amanda ","lastName":"Jeske ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"3D-Tissue Engineered Bone Marrow (3DTEBM) Culture Predicts Clinical Efficacy of Drugs Better Than Regular Culture Systems in Multiple Myeloma","keywords":"","combinedName":"doctor amanda jeske"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Mark ","lastName":"Fiala ","credentials":"MSW","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Cost-Benefit Analysis of Bortezomib, Lenalidomide, and Bortezomib/Lenalidomide Combination Therapy for Newly Diagnosed Multiple Myeloma","keywords":"","combinedName":"doctor mark fiala"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Cristina ","lastName":"Gasparetto ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 1b Study to Assess the Combination of Selinexor and Daratumumab in Patients with Relapsed / Refractory Multiple Myeloma Previously Exposed to Proteasome Inhibitors (PI) and Immunomodulatory Drugs (IMiDs)","keywords":"","combinedName":"doctor cristina gasparetto"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Hartmut ","lastName":"Goldschmidt ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab (Anti IL-6 Monoclonal Antibody) in Patients with High-Risk Smoldering Multiple Myeloma","keywords":"","combinedName":"doctor hartmut goldschmidt"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Elisabet ","lastName":"Manasanch","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase I/II Study of Pomalidomide and Dexamethasone with Growth Factor Support in Patients with Relapsed/Refractory Multiple Myeloma","keywords":"","combinedName":"doctor elisabet manasanch"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Enrique ","lastName":"Ocio ","credentials":"MD PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase Ib Study of Isatuximab in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone (VCDI) in Patients with Newly Diagnosed Multiple Myeloma Non-Eligible for Transplantation","keywords":"","combinedName":"doctor enrique ocio"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Henrik ","lastName":"Gregersen ","credentials":"M.D.","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma","keywords":"","combinedName":"doctor henrik gregersen"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Hirofumi ","lastName":"Yamauchi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Acquired Chromosomal Abnormalities t(14;16), Del(17p) or Del(13q) after Receiving Chemotherapies Predict the Poor Prognosis of Multiple Myeloma","keywords":"","combinedName":"doctor hirofumi yamauchi"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Sarah ","lastName":"Pogue ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Attenuated Interferon-a Targeted to CD38 Expressing Multiple Myeloma Tumor Cells Induces Robust and Durable Anti-Tumor Responses through Direct Anti-Proliferative Activity in Addition to Indirect Recruitment and Activation of M1 Macrophages","keywords":"","combinedName":"doctor sarah pogue"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Mohit ","lastName":"Narang ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Baseline Disease Characteristics and Diagnostic Patterns for NDMM of the Connect MM Registry: Observations over Time in Cohort 1 (2009-2011) and Cohort 2 (2012-2016)","keywords":"","combinedName":"doctor mohit narang"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Angelo ","lastName":"Belotti ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bortezomib-Based Induction Regimen Followed By Autologous Stem Cell Transplantation (ASCT) after Conditioning with MEL200 Is Highly Effective and Well Tolerated in Elderly Multiple Myeloma (MM) Patients up to the Age of 75 Years","keywords":"","combinedName":"doctor angelo belotti"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Roberto ","lastName":"Mina ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bortezomib-Dexamethasone Re-Treatment at Biochemical Relapse Vs Observation in Relapsed/Refractory Multiple Myeloma Patients: Results of a Phase II Multi-Center, Randomized Study","keywords":"","combinedName":"doctor roberto mina"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Victor ","lastName":"Jimenez-Zepeda ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bortezomib-Maintenance for Patients with AL Amyloidosis: A Single Center Experience","keywords":"","combinedName":"doctor victor jimenez-zepeda"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Ruth ","lastName":"Wester ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Carfilzomib Combined with Thalidomide and Low-Dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma: The Carthadex Trial","keywords":"","combinedName":"doctor ruth wester"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Maria-Victoria ","lastName":"Mateos ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Carfilzomib in Relapsed or Refractory Multiple Myeloma Patients with Early or Late Relapse Following Prior Therapy: A Subgroup Analysis of the Randomized Phase 3 Aspire and Endeavor Trials","keywords":"","combinedName":"doctor maria-victoria mateos"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Benjamin ","lastName":"Diamond ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Carfilzomib Is Safe and Effective in Newly Diagnosed Patients with Multiple Myeloma with Renal Involvement","keywords":"","combinedName":"doctor benjamin diamond"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Sabarinath ","lastName":"Venniyil Radhakrishnan ","credentials":"MBBS, MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chimeric Antigen Receptor (CAR) T Cells Specific for CD229: A Potentially Curative Approach for Multiple Myeloma","keywords":"","combinedName":"doctor sabarinath venniyil radhakrishnan"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Ajay","lastName":"Nooka","credentials":"MD,MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Overall Survival Associated with Lenalidomide+Dexamethasone and Bortezomib+Dexamethasone Among Relapsed/Refractory Multiple Myeloma Patients: A Matched Analysis of Real World and Clinical Trial Populations","keywords":"","combinedName":"doctor ajay nooka"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Heinz","lastName":"Ludwig","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Proteasome Inhibition Activity between Carfilzomib and Bortezomib in the Phase 3 Endeavor Study","keywords":"","combinedName":"doctor heinz ludwig"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Cinnie Yentia","lastName":"Soekojo ","credentials":"MD, MRCP","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Conventional Karyotyping Is Still an Important Prognostic Marker for Myeloma in the Era of R-ISS Staging","keywords":"","combinedName":"doctor cinnie yentia soekojo"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Max ","lastName":"Qian ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Correlative Analyses of Cereblon (CRBN), cMYC, IRF4, BLIMP1, and XBP1 with Clinical Outcomes in Stratus (MM-010), a Phase 3b Study of Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)","keywords":"","combinedName":"doctor max qian"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Ajai ","lastName":"Chari ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab (DARA) in Combination with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) in Patients with Newly Diagnosed Multiple Myeloma (MMY1001): Updated Results from an Open-Label, Phase 1b Study","keywords":"","combinedName":"doctor ajai chari"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Lisa Xingguang","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab Activity Is Agnostic to Fc Gamma Receptor 3A (Fc?R3A) 158 Genotype in Patients with Primary Refractory or Relapsed Systemic AL Amyloidosis","keywords":"","combinedName":"doctor lisa xingguang lee"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Niels WCJ","lastName":"Van De Donk ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab in Combination with Lenalidomide Plus Dexamethasone Results in Persistent Natural Killer (NK) Cells with a Distinct Phenotype and Expansion of Effector Memory T-Cells in Pollux, a Phase 3 Randomized Study","keywords":"","combinedName":"doctor niels wcj van de donk"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Andrew ","lastName":"Spencer ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Daratumumab, Bortezomib, and Dexamethasone (DVd) Versus Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (RRMM): Updated Efficacy and Safety Analysis of Castor","keywords":"","combinedName":"doctor andrew spencer"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Eli ","lastName":"Muchtar ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Depth of Organ Response in Newly Diagnosed AL Amyloidosis Is Associated with Improved Survival: Improved Outcome Discrimination with Graded Organ Response","keywords":"","combinedName":"doctor eli muchtar"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Sundar ","lastName":"Jagannath ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of a Predictive Model of Multiple Myeloma (MM) Patient (pt) Outcomes Based on Treatment Class Transitions Using the Connect MMpatient Registry","keywords":"","combinedName":"doctor sundar jagannath"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Cristina ","lastName":"Gasparetto ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differential Effect of t(11;14) Abnormality on Survival and Depth of Response in African American (AA) and Non-AA (NAA) Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) in the Connect MM Registry","keywords":"","combinedName":"doctor cristina gasparetto"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Efstathios ","lastName":"Kastritis ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Relapse Post Autologous Transplantation Is Associated with Very Poor Survival and Identifies an Ultra High Risk Group of Myeloma Patients","keywords":"","combinedName":"doctor efstathios kastritis"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Monica ","lastName":"Galli ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Proteasome Inhibitors and/or Immunomodulatory Drugs on the Risk of Early Death of 991 Newly Diagnosed Symptomatic Multiple Myeloma Patients: A Single Centre Retrospective Analysis","keywords":"","combinedName":"doctor monica galli"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Jian-Qing ","lastName":"Mi ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By Bcma-Specific Chimeric Antigen Receptor-Modified T Cells","keywords":"","combinedName":"doctor jian-qing mi"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"James R","lastName":"Berenson ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of Pomalidomide As a Replacement Therapy for Lenalidomide for Relapsed/Refractory Multiple Myeloma Patients Refractory to a Lenalidomide-Containing Combination Regimen","keywords":"","combinedName":"doctor james r berenson"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Sung Won ","lastName":"Lim ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of Bortezomib-Based Regimens for Patients with Newly Diagnosed AL Amyloidosis Not Receiving ASCT Compared with Alkylators and Dexamethasone-Based Regimens","keywords":"","combinedName":"doctor sung won lim"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Efstathios ","lastName":"Kastritis ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of Lenalidomide As Salvage Therapy for Patients with AL Amyloidosis","keywords":"","combinedName":"doctor efstathios kastritis"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Arjun ","lastName":"Lakshman ","credentials":"MD, MRCP","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of VDT PACE-like Regimens in Treatment of Relapsed/Refractory Multiple Myeloma- a Single Center Experience","keywords":"","combinedName":"doctor arjun lakshman"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Robert Frank","lastName":"Cornell ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Eltanexor (KPT-8602), a Second-Generation Selective Inhibitor of Nuclear Export (SINE) Compound, in Patients with Refractory Multiple Myeloma","keywords":"","combinedName":"doctor robert frank cornell"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Ajay","lastName":"Nooka","credentials":"MD,MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Efficacy Outcomes Among Relapsed/Refractory Multiple Myeloma Treated Patients in a Real-World Setting","keywords":"","combinedName":"doctor ajay nooka"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Elizabeth ","lastName":"O'Donnell ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Final Results of a Phase 2 Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVD lite) in Transplant-Ineligible Multiple Myeloma","keywords":"","combinedName":"doctor elizabeth o'donnell"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Paul G","lastName":"Richardson ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"First Report on Overall Survival (OS) and Improved Progression Free Survival (PFS) in a Completed Phase 2a Study of Melflufen in Advanced Relapsed Refractory Multiple Myeloma (RRMM)","keywords":"","combinedName":"doctor paul g richardson"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Claudia ","lastName":"Stege ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group","keywords":"","combinedName":"doctor claudia stege"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"David J","lastName":"Kuter ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Healthcare Resource Utilization and Costs Associated with Different Treatment Modalities of Relapsed/Refractory Multiple Myeloma Patients in the US: Findings from Preamble","keywords":"","combinedName":"doctor david j kuter"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Raquel ","lastName":"Jimnez ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incidence and Outcome of Soft-Tissue Plasmacytomas in Patients with Multiple Myeloma before and after the Introduction of Novel Drugs","keywords":"","combinedName":"doctor raquel jimnez"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Andrew ","lastName":"Johnsrud ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Infectious Complications of Daratumumab-Containing Therapy for Multiple Myeloma","keywords":"","combinedName":"doctor andrew johnsrud"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Ajai ","lastName":"Chari ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma","keywords":"","combinedName":"doctor ajai chari"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Elisabet ","lastName":"Manasanch","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim Results from the Phase 1a/1b Dose-Finding Study of CWP232291 (CWP291) in Relapsed or Refractory Myeloma (RRMM) Alone or in Combination with Lenalidomide and Dexamethasone","keywords":"","combinedName":"doctor elisabet manasanch"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Nisha ","lastName":"Joseph ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lenalidomide, Bortezomib, and Dexamethasone (RVD) As Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)","keywords":"","combinedName":"doctor nisha joseph"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Rafael Alonso","lastName":"Fernndez ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Maintenance Treatment with Lenalidomide for Multiple Myeloma Increases the Proportion of MRD Negative (Flow-/PET-CT-) Patients","keywords":"","combinedName":"doctor rafael alonso fernndez"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Bita ","lastName":"Fakhri ","credentials":"MD,MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Measuring Cardiopulmonary Complications of Carfilzomib Treatment and Associated Risk Factors Using the SEER-Medicare Database","keywords":"","combinedName":"doctor bita fakhri"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Aaron Seth","lastName":"Rosenberg ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Morbid Progression Is Common Among Patients with Multiple Myeloma and Is Associated with Shortened Overall Survival: Validation of the Progression-Free Survival Endpoint","keywords":"","combinedName":"doctor aaron seth rosenberg"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Neha ","lastName":"Korde ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MRD Response-Driven Phase I/II Study forNewly Diagnosed Multiple MyelomaPatients Using HigherDoses of Twice-Weekly Carfilzomib(45 and 56 mg/m2) in Combination with Lenalidomideand Dexamethasone","keywords":"","combinedName":"doctor neha korde"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Laura ","lastName":"Gengenbach ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Navigating the Changing Multiple Myeloma (MM) Treatment Landscape: Real-World Data on Clinical Practice Patterns in 287 MM Patients Treated in and Outside German DSMM (Deutsche Studiengruppe Multiples Myelom) Study Group Trials","keywords":"","combinedName":"doctor laura gengenbach"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Evangelos ","lastName":"Terpos ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Next Generation Flow (NGF) Cytometry for Minimal Residual Disease (MRD) Evaluation in Multiple Myeloma (MM) Patients with Sustained Complete Response (CR) after Frontline Therapy: Results of a Prospective Single-Center Analysis","keywords":"","combinedName":"doctor evangelos terpos"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Yael C","lastName":"Cohen ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Novel CT-Based Bone Strength Assessment By Finite Element Analysis for Monitoring Bone Involvement in Myeloma: a Proof of Concept Study","keywords":"","combinedName":"doctor yael c cohen"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Steffan ","lastName":"Nawrocki ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Oncolytic Reovirus Sensitizes Multiple Myeloma Cells to Anti-PD-L1 Therapy","keywords":"","combinedName":"doctor steffan nawrocki"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Ashley ","lastName":"Paquin ","credentials":"BA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overall Survival of Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma: Comparative Effectiveness Analysis of Modern Induction Regimens on Outcome","keywords":"","combinedName":"doctor ashley paquin"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Jonathan ","lastName":"Kaufman ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 1 Study of Venetoclax in Combination with Dexamethasone As Targeted Therapy for t(11;14) Relapsed/Refractory Multiple Myeloma","keywords":"","combinedName":"doctor jonathan kaufman"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Jeffrey A","lastName":"Zonder ","credentials":"MD ","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I Trial of Pomalidomide, Bortezomib, and Dexamethasone As Frontline Treatment of AL Amyloidosis","keywords":"","combinedName":"doctor jeffrey a zonder"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Rachid","lastName":"Baz","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I/II Study of Liposomal Doxorubicin (DOX) in Combination with Selinexor (SEL) and Dexamethasone (Dex) for Relapsed and Refractory Multiple Myeloma (RRMM)","keywords":"","combinedName":"doctor rachid baz"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Tomonori ","lastName":"Nakazato ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II Clinical Trial of Personalized-VCD-VTD Sequential Therapy Using VES-13 for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma","keywords":"","combinedName":"doctor tomonori nakazato"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Tadao ","lastName":"Ishida ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II Study of the Bortezomib-Melphalan-Prednisolone Induction Therapy Followed By Lenalidomide-Plus-Dexamethasone Consolidation and Lenalidomide Maintenance in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma (CANDLE trial)","keywords":"","combinedName":"doctor tadao ishida"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Elisabet ","lastName":"Manasanch","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pilot Study of Pembrolizumab for Immunoprevention in Smoldering Multiple Myeloma","keywords":"","combinedName":"doctor elisabet manasanch"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Krista ","lastName":"Kinneer ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preclinical Evaluation of MEDI2228, a BCMA-Targeting Pyrrolobenzodiazepine-Linked Antibody Drug Conjugate for the Treatment of Multiple Myeloma","keywords":"","combinedName":"doctor krista kinneer"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Shi Hui Clarice ","lastName":"Choong ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real World Management of Multiple Myeloma in Asia: Treatment Pattern and Cost","keywords":"","combinedName":"doctor shi hui clarice choong"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Paul G","lastName":"Richardson ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real-World and Clinical Trial Data in Relapsed/Refractory Multiple Myeloma (RRMM): Evaluating Treatment Duration and Comparing Effectiveness and Efficacy","keywords":"","combinedName":"doctor paul g richardson"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Michael ","lastName":"Rosenzweig ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Repurposing Leflunomide for Relapsed/Refractory Multiple Myeloma: A Phase 1 Trial","keywords":"","combinedName":"doctor michael rosenzweig"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Saad Z","lastName":"Usmani","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed and Refractory Multiple Myeloma: Final Results from GEN501 and Sirius","keywords":"","combinedName":"doctor saad z usmani"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Christine I","lastName":"Chen ","credentials":"MD, FRCP(C)","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Selinexor in Combination with Pomalidomide and Low Dose Dexamethasone in a Relapsed / Refractory Multiple Myeloma Patient Population with Prior Proteasome Inhibitor and Lenalidomide Exposure","keywords":"","combinedName":"doctor christine i chen"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Nizar ","lastName":"Bahlis ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Selinexor in Combination with Weekly Low Dose Bortezomib and Dexamethasone (SVd) Induces a High Response Rate with Durable Responses in Patients with Refractory Multiple Myeloma (MM)","keywords":"","combinedName":"doctor nizar bahlis"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Sandra ","lastName":"Sauer ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Systemic Versus Local Treatment in Patients with Multiple Myeloma and a Single Lesion in Whole Body Imaging","keywords":"","combinedName":"doctor sandra sauer"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Barbara ","lastName":"Muz ","credentials":"PhD,MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting CD47 As a Novel TherapeuticStrategy in Multiple Myeloma","keywords":"","combinedName":"doctor barbara muz"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Ho Sup ","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"the Clinical Outcomes of Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma : A Nationwide Registry Study of the Korean Multiple Myeloma Working Party (KMMWP) ","keywords":"","combinedName":"doctor ho sup lee"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Andrey ","lastName":"Garifullin ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Significance of Flow Cytometry and Positron Emission Tomography and Computed Tomography (PET-CT) in the Assessment of the Minimum Residual Disease in Patients with Multiple Myeloma","keywords":"","combinedName":"doctor andrey garifullin"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Hannah ","lastName":"Cherniawsky ","credentials":"BSc, MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Survival Impact of Lenalidomide Maintenance Chemotherapy in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplant and Bortezomib-Based Induction; An Analysis of Real World Data","keywords":"","combinedName":"doctor hannah cherniawsky"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Ravi ","lastName":"Vij ","credentials":"MD, MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Patterns and Associated Outcomes in Patients with Relapsed or Refractory Multiple Myeloma in the US and Non-US Countries: Findings from Preamble","keywords":"","combinedName":"doctor ravi vij"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Clara ","lastName":"Chen ","credentials":"PhD, BS, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Sequencing Patterns Observed in Patients Treated Initially with Lenalidomide/Dexamethasone Combination As Frontline Multiple Myeloma Therapy","keywords":"","combinedName":"doctor clara chen"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Maria ","lastName":"Gavriatopoulou ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Vulnerability Variables Among Octogenarians Myeloma Patients: A Single-Center Analysis in 110 Patients","keywords":"","combinedName":"doctor maria gavriatopoulou"},{"sessionId":"11865","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Poster II","firstName":"Michael ","lastName":"O'Dwyer ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Weekly Cybord-Dara Is a Safe and Effective Upfront Treatment for Newly Diagnosed Multiple Myeloma. Preliminary Results of the Early Phase 16-Bcni-001/Ctrial-IE (ICORG) 16-02 Study","keywords":"","combinedName":"doctor michael o'dwyer"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Paul G","lastName":"Richardson ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adults Receiving Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Stem Cell Transplantation (HSCT): Final Results from the Expanded-Access Program","keywords":"","combinedName":"doctor paul g richardson"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Michaela ","lastName":"Dring ","credentials":"Dr. med.","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Antiemetic Prophylaxis with Granisetron and Fosaprepitant during Moderate and High Emetogenic Chemotherapy in Pediatric Patients","keywords":"","combinedName":"doctor michaela dring"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Jai N","lastName":"Patel ","credentials":"PharmD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Busulfan Pharmacogenetics and Drug Exposure in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor jai n patel"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Nerea ","lastName":"Arratibel ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CCR6, IL7R, FAS and Madcam-1 Single Nucleotide Polymorphisms Are Associated with Higher Incidence of Infections in Allogeneic Stem-Cell Transplant from a Related Donor after a Reduced Intensity Conditioning Regimen: A Multicenter Experience","keywords":"","combinedName":"doctor nerea arratibel"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Amandine ","lastName":"Le Bourgeois ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CMV Status Predicts Survival in Refractory/Relapsed Myeloid Patients after a Clofarabine-Based Sequential Regimen: A Retrospective Study on Behalf of the SFGM-TC","keywords":"","combinedName":"doctor amandine le bourgeois"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Thomas ","lastName":"Heinicke ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Outcome after Allogeneic Stem Cell Transplantation in AML Patients in First or Second Complete Remission Following Either Fludarabin/Busulfan, Flamsa-TBI or Flamsa-Bu Conditioning","keywords":"","combinedName":"doctor thomas heinicke"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Anke ","lastName":"Verlinden ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of the Power of Procalcitonin and C-Reactive Protein to Differentiate between Different Etiologies of Febrile Neutropenia in Patients with Prolonged Profound Neutropenia","keywords":"","combinedName":"doctor anke verlinden"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Rajiv ","lastName":"Kumar ","credentials":"MBBS, MD, DM","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cyclophosphamide Followed By Intravenous Busulfan (Cy-Bu) As Myeloablative Conditioning: Impact on Venoocclusive Disease and Transplant Outcomes, Real World Experience","keywords":"","combinedName":"doctor rajiv kumar"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Roni ","lastName":"Shouval ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Determinants for Oral Mucositis in Allogeneic Hematopoietic Stem Cell Transplantation: Prospective Evaluation and Risk Analysis","keywords":"","combinedName":"doctor roni shouval"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Su-Peng ","lastName":"Yeh ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differential Impact of Conditioning Intensity on Post-Transplant Outcome of FLT3-Mutated and FLT3 Wild Type AML in First Remission, a Report from Taiwan Bone Marrow Transplant Registry (TBMTR)","keywords":"","combinedName":"doctor su-peng yeh"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Yuko ","lastName":"Shimosato-Wada ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effectiveness of Acyclovir Prophylaxis Against Varicella Zoster Virus Infection after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis","keywords":"","combinedName":"doctor yuko shimosato-wada"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Armin ","lastName":"Rashidi ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Favorable Outcome in Patients with Pre-Transplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci","keywords":"","combinedName":"doctor armin rashidi"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Paul G","lastName":"Richardson ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Final Analysis of Day +100 Survival By Prior Hematopoietic Stem Cell Transplant Type from an Expanded Access Study of Defibrotide for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome","keywords":"","combinedName":"doctor paul g richardson"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Yoshimitsu ","lastName":"Shimomura ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fluid Overload Early after Allogeneic Hematopoietic Stem Cell Transplantation Was Associated with Poor Survival","keywords":"","combinedName":"doctor yoshimitsu shimomura"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Christoph ","lastName":"Groth ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Dose Melphalan-Based Sequential Conditioning Chemotherapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor christoph groth"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Chunfu ","lastName":"Li ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hypomethylation of Decitabine Improved Outcomes of Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia","keywords":"","combinedName":"doctor chunfu li"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Stephen Yang","lastName":"Liang ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improved Outcome of Haploidentical Peripheral Blood Stem Cell Transplant Treating Severe Aplastic Anemia","keywords":"","combinedName":"doctor stephen yang liang"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Byung Sik ","lastName":"Cho ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improved Survival Outcomes By Iron Chelating Therapy with Deferasirox after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor byung sik cho"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Sun-Hye ","lastName":"Ko ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor sun-hye ko"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Mauricette ","lastName":"Michallet ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Liver Complications after Allogeneic Hematopoietic Stem Cell Transplantation: Descriptive Longitudinal Study Using Liver Parameters Monitoring and Their Impact on Transplantation Outcomes Using a Prediction Score","keywords":"","combinedName":"doctor mauricette michallet"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Ioanna ","lastName":"Sakellari ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Outcomes of Total Body Irradiation Plus Cyclophosphamide Versus Busulfan Plus Cyclophosphamide As Conditioning Regimen for Acute Lymphoblastic Leukemia: A Comparative Study","keywords":"","combinedName":"doctor ioanna sakellari"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Jenna ","lastName":"Sopfe ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Malyglycemia Is Associated with Increased Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients","keywords":"","combinedName":"doctor jenna sopfe"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Katie S","lastName":"Gatwood ","credentials":"PharmD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of a Novel Rituximab-Based Non-Ablative Conditioning Regimen for Hematopoietic Cell Transplantation in Severe Aplastic Anemia","keywords":"","combinedName":"doctor katie s gatwood"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Pavan Kumar ","lastName":"Bhamidipati ","credentials":"MBBS, MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Patients with Baseline Marrow Fibrosis at Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor pavan kumar bhamidipati"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Varun ","lastName":"Mehra ","credentials":"MRCP, FRCPath","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Patients with Pre-Existing Invasive Fungal Disease Undergoing Allogeneic Haematopoietic Stem Cell Transplantation - 5 Years Single Centre Experience","keywords":"","combinedName":"doctor varun mehra"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Alok ","lastName":"Srivastava ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacokinetics of Treosulfan in Patients with Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation  a Comparison of Two Formulations and Correlation with Clinical Outcomes","keywords":"","combinedName":"doctor alok srivastava"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Betul","lastName":"Oran","credentials":"MD,MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Post-Transplant Cyclophosphamide Improves Progression Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients with Prior CTLA-4 or PD-1 Blockade","keywords":"","combinedName":"doctor betul oran"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Bin ","lastName":"Fu ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Post-Transplantation Cyclophosphamide and Short-Term Methotrexate for Tolerance Induction in HLA-Haploidentical Transplantation for Severe Aplastic Anemia","keywords":"","combinedName":"doctor bin fu"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Kazuya ","lastName":"Ishiwata ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prospective Study of High Dose Foscarnet Prophylaxis for HHV-6 Related CNS Diseases in Cord Blood Transplantation for Adult Patients","keywords":"","combinedName":"doctor kazuya ishiwata"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Vladan ","lastName":"Vucinic ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduction of Immunosuppression after Disease-Specific Donor Cell Chimerism Decrease Can Prevent Hematological Relapse Following Allogeneic Stem Cell Transplantation after Non-Myeloablative (NMA) Conditioning - Results of a Prospective Phase II Study. Eudract #: 2007-002420-15","keywords":"","combinedName":"doctor vladan vucinic"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Shinichi ","lastName":"Kako ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis","keywords":"","combinedName":"doctor shinichi kako"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Semjon ","lastName":"Willier ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Single-Dose Intravenous Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients with Hematooncological Malignancies after Moderate and High Emetogenic Chemotherapy","keywords":"","combinedName":"doctor semjon willier"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Issa ","lastName":"Khouri ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety of Addition of Inotuzumab Ozogamicin (CMC 544) to Bendamustine, Fludarabine, and Rituximab (BFR) Allogeneic Conditioning for Lymphoid Malignancies","keywords":"","combinedName":"doctor issa khouri"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Sung-Eun ","lastName":"Lee ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Role of Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells in Allogeneic Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor sung-eun lee"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Ramzi ","lastName":"Abboud ","credentials":"MD, BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tocilizumab Is Safe after T-Cell Replete Peripheral Blood Haploidentical Donor Transplantation","keywords":"","combinedName":"doctor ramzi abboud"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"John L","lastName":"Vaughn ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Toxigenic Clostridium Difficile Colonization in Patients with Hematologic Malignancies Admitted to the Hospital for Chemotherapy or Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor john l vaughn"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Monzr ","lastName":"Al Malki ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transfusion- Related Iron Overload (TRIO) Is Associated with Delayed Engraftment and Increased Non Relapse Mortality (NRM) in Patients Undergoing Umbilical Cord Blood (UCB) Hematopoietic Cell Transplantation (HCT)","keywords":"","combinedName":"doctor monzr al malki"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Adolfo E","lastName":"Diaz ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Evolution for Multiple Myeloma before Autologous Stem Cell Transplant and Its Relation with Engraftment Syndrome: 15 Years of Experience","keywords":"","combinedName":"doctor adolfo e diaz"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Patrizia ","lastName":"Chiusolo ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen","keywords":"","combinedName":"doctor patrizia chiusolo"},{"sessionId":"11867","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II","firstName":"Daniel ","lastName":"Rivera ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Usefulness of Thrombopoietin Receptor Agonists for Thrombocytopenia after Allogeneic Stem Cell Transplantation. An Eight-Year Single Center Experience","keywords":"","combinedName":"doctor daniel rivera"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Ryan ","lastName":"Eckert ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Pilot Study of Online Yoga to Improve Fatigue and Quality of Life in Myeloproliferative Neoplasm Patients","keywords":"","combinedName":"doctor ryan eckert"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Robert M","lastName":"Rifkin ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Real-World Comparative Analysis of Carfilzomib and Other Systemic Multiple Myeloma Chemotherapies in the US Community Oncology Setting","keywords":"","combinedName":"doctor robert m rifkin"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Shahed ","lastName":"Iqbal ","credentials":"PhD MBBS MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Retrospective Real-World Study of Incident Comorbidities and Complications Among Acute Myeloid Leukemia Patients and Non-Cancer Comparison Patients in the US","keywords":"","combinedName":"doctor shahed iqbal"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Gary ","lastName":"Lyman ","credentials":"MD, MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Systematic Literature Review of Overall Survival and Delivered Dose Intensity in Cancer Patients Receiving Chemotherapy and G-CSF in Randomized Control Trials","keywords":"","combinedName":"doctor gary lyman"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Tanya ","lastName":"Wildes ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adherence to Lenalidomide in Older Patients with Multiple Myeloma (MM): A SEER-Medicare Analysis","keywords":"","combinedName":"doctor tanya wildes"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Sudeep ","lastName":"Karve ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adverse Events, Resource Use, and Economic Burden in Patients with Mantle Cell Lymphoma in the United States","keywords":"","combinedName":"doctor sudeep karve"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Michael Asger","lastName":"Andersen ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bacterial Infectionsin Patients with Chronic LymphocyticLeukemia: A LongitudinalNation-Wide Study","keywords":"","combinedName":"doctor michael asger andersen"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Robert M","lastName":"Rifkin ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Carfilzomib Dosing Patterns and Time to Next Treatment Among Adult Patients with Multiple Myeloma Treated in the US Community Oncology Setting","keywords":"","combinedName":"doctor robert m rifkin"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Thuy Thi","lastName":"Koll ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cognitive Function in Older Adults with Hematological Malignancies","keywords":"","combinedName":"doctor thuy thi koll"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Estherina ","lastName":"Trachtenbrg ","credentials":"MSc, BA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cognitive Impairment in Hodgkin Lymphoma Survivors","keywords":"","combinedName":"doctor estherina trachtenbrg"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Samantha J","lastName":"Mayo ","credentials":"RN PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cognitive Outcomes Among Patients with Hematological Cancer with Access to Computerized Cognitive Training: Results from a Feasibility Study","keywords":"","combinedName":"doctor samantha j mayo"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Sikander ","lastName":"Ailawadhi ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Analysis of Clinical Trial Outcomes between African American and White Patients Treated with Lenalidomide and Dexamethasone for Multiple Myeloma (MM)","keywords":"","combinedName":"doctor sikander ailawadhi"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Gwendolyn ","lastName":"Ho ","credentials":"MD, MAS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Complications and Early Mortality in Patients with Acute Promyelocytic Leukemia Treated in California","keywords":"","combinedName":"doctor gwendolyn ho"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Jessica ","lastName":"ElAsmar ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Conditional Long-Term Survival Among Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Autologous Hematopoietic Cell Transplantation (AHCT) ","keywords":"","combinedName":"doctor jessica elasmar"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Candice ","lastName":"Yong ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Costs Associated with Productivity Loss Among U.S. Patients Newly Diagnosed with Multiple Myeloma Receiving Oral Versus Injectable Chemotherapy","keywords":"","combinedName":"doctor candice yong"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Gian Maria","lastName":"Zaccaria ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Delphi, a Data Warehouse to Discover Associations between Variables in Clinical Trials: Application to the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial","keywords":"","combinedName":"doctor gian maria zaccaria"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Tobias ","lastName":"Boch ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diagnostics of Pulmonary Aspergillosis in Critically Ill Hematological and Non-Hematological Patients in the Intensive Care Unit By Combined Use of Galactomannan, 1-3-Beta-D-Glucan, Aspergillus Specific PCR and Conventional Culture in Concurrent Blood and Bronchoalveolar Lavage Samples  Results of a Multicenter Prospective Pilot Study","keywords":"","combinedName":"doctor tobias boch"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Sikander ","lastName":"Ailawadhi ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Economic Burden of Stem Cell Transplant Among Patients with Multiple Myeloma","keywords":"","combinedName":"doctor sikander ailawadhi"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Andreas","lastName":"Engert","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effect of Nivolumab on Patient-Reported Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma after Autologous Transplantation: Results from the Multicohort Phase 2 Checkmate 205 Study","keywords":"","combinedName":"doctor andreas engert"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Jill A","lastName":"Bell ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enhancing the Content of the EORTC QLQ-C30 to Maximize the Detection of Treatment Benefit in Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Low-Blast Acute Myeloid Leukemia Using the EORTC Item Bank","keywords":"","combinedName":"doctor jill a bell"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Sophia ","lastName":"Scheubeck ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional Assessment (FA) in Multiple Myeloma (MM) Patients Predicts Survival: Use of Most Valuable Comorbidity Scores and Functional Tests in a German Study Group (Deutsche Studiengruppe Multiples Myelom [DSMM]) Incentive","keywords":"","combinedName":"doctor sophia scheubeck"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Huang ","lastName":"Jian ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gender and Marital Status Influence Survival of Myelodysplastic Syndrome and Risk of Secondary Acute Myeloid Leukemia: A Population-Based Study of Patients in the Surveillance, Epidemiology, and End Results (SEER) Database","keywords":"","combinedName":"doctor huang jian"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Himalee ","lastName":"Sabnis ","credentials":"MD,MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Growth Disturbances in Pediatric Patients Receiving Long-Term Tyrosine Kinase Inhibitor Therapy","keywords":"","combinedName":"doctor himalee sabnis"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Jill A","lastName":"Bell ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Healthcare Costs in Elderly Patients with Acute Myeloid Leukemia (AML) in Routine Clinical Care in the United States (US)","keywords":"","combinedName":"doctor jill a bell"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Fabio ","lastName":"Efficace ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Health-Related Quality of Life and Symptom Burden in Chronic Myeloid Leukemia Patients Treated with First Line with Imatinib Versus Those Treated with Dasatinib: First Results of the Leonidas Study","keywords":"","combinedName":"doctor fabio efficace"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Emily ","lastName":"Johnston ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Intensity End-of-Life Care of Allogeneic Hematopoietic Cell Transplantation Recipients (HCT)  a Population-Based Study","keywords":"","combinedName":"doctor emily johnston"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Karen E","lastName":"Effinger ","credentials":"MD, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes within Five Years from Diagnosis in Pediatric Hodgkin Lymphoma Patients Following Contemporary Therapy","keywords":"","combinedName":"doctor karen e effinger"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Jill A","lastName":"Bell ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient Perspectives on Symptom Experience and Impact on Health-Related Quality of Life in Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Low-Blast Acute Myeloid Leukemia","keywords":"","combinedName":"doctor jill a bell"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Anita ","lastName":"D'Souza ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults","keywords":"","combinedName":"doctor anita d'souza"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Dianne ","lastName":"Pulte ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Population Level Survival for Patients with Multiple Myeloma By Insurance Type and Early Indications of Changes with Adoption of the Medicaid Expansion of the Affordable Care Act","keywords":"","combinedName":"doctor dianne pulte"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Richard J","lastName":"Lin ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Potentially Inappropriate Medication Use in Elderly Patients with Diffuse Large B-Cell Lymphoma Predicts Inferior Survival and Treatment-Related Toxicities","keywords":"","combinedName":"doctor richard j lin"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Matthew James","lastName":"Butler ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Factors and Survival Outcomes in Phase I Patients with Hematologic Malignancies","keywords":"","combinedName":"doctor matthew james butler"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Blake ","lastName":"Langlais ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quality of Life and Symptom Burden Among Patients with Myeloproliferative Neoplasms: Do Symptoms Impact Quality of Life?","keywords":"","combinedName":"doctor blake langlais"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Sikander ","lastName":"Ailawadhi ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Racial Disparities in Treatment Patterns and Outcomes Among Patients with Multiple Myeloma: A SEER-Medicare Analysis","keywords":"","combinedName":"doctor sikander ailawadhi"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Rafael","lastName":"Fonseca","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real-World Outcomes for Maintenance Treatment Sequencing after Receiving Lenalidomide, Bortezomib, and Dexamethasone Induction in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Followed By Autologous Stem Cell Transplant (ASCT)","keywords":"","combinedName":"doctor rafael fonseca"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Paula ","lastName":"Aristizabal ","credentials":"MD, MAS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Role of Health Literacy, Acculturation and Socio-Demographics on Perception of Voluntariness during Informed Consent for Pediatric Leukemia Clinical Trials","keywords":"","combinedName":"doctor paula aristizabal"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Deepa ","lastName":"Gotur ","credentials":"MD, MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rothman Index As a Real-Time Predictor of Intensive Care Unit Admissions and Mortality in Acute Myeloid Leukemia Patients Undergoing Induction Chemotherapy","keywords":"","combinedName":"doctor deepa gotur"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Alix ","lastName":"Seif ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Severe Sepsis As Immune Stimulation and Protection from Relapse of Childhood Acute Lymphoblastic Leukemia (ALL): Results from a Pilot Study and Validation of Events in a National Administrative Dataset","keywords":"","combinedName":"doctor alix seif"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Jayadev ","lastName":"Manikkam Umakanthan ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Socioeconomic Factors Associated with Overall Survival (OS) in Adults with Acute Lymphoblastic Leukemia (ALL)","keywords":"","combinedName":"doctor jayadev manikkam umakanthan"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Benjamin ","lastName":"Tillman ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Systematic Review of Infectious Events in Prospective Trials of Ibrutinib","keywords":"","combinedName":"doctor benjamin tillman"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Qian ","lastName":"Wang ","credentials":"MD, MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Hospital Mortality, Cost and Length of Stay Among Hodgkins Lymphoma and Venous Thromboembolism Patients: An Analysis from National Inpatient Sample","keywords":"","combinedName":"doctor qian wang"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Jessica ","lastName":"Chung ","credentials":"PhD, MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Depression and Use of Anti-Depressants on Healthcare Resource Utilization (HCRU) in Multiple Myeloma (MM) Patients","keywords":"","combinedName":"doctor jessica chung"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Chloe ","lastName":"Yang ","credentials":"MD, BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tolerability and Efficacy of Post Transplant Lenalidomide Maintenance Therapy in Multiple Myeloma: A Real World Single Centre Experience","keywords":"","combinedName":"doctor chloe yang"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Sam ","lastName":"Grigg ","credentials":"BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Urine Cultures at the Onset of Febrile Neutropenia (FN) in Patients with Haematological Malignancies Rarely Impact Antibiotic Management in the Absence of Urinary Symptoms","keywords":"","combinedName":"doctor sam grigg"},{"sessionId":"11868","sessionTitle":"904. Outcomes ResearchMalignant Conditions: Poster II","firstName":"Najla H","lastName":"El Jurdi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Use of a Fitness Tracking Device to Monitor Physical Activity and Sleep Patterns during Hospitalization for Hematopoietic Stem Cell Transplant. Results of a Prospective Observational Study","keywords":"","combinedName":"doctor najla h el jurdi"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Heather","lastName":"Stefanski","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Process for the Expansion of Functional Human ILC2 Cells for Gvhd Prevention","keywords":"","combinedName":"doctor heather stefanski"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Yiwen ","lastName":"Li ","credentials":"BS, MMSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Absence of Vasoactive Intestinal Peptide Synthesis in Recipients in Allogeneic Bone Marrow Transplant Increases Graft Versus Host Diseases","keywords":"","combinedName":"doctor yiwen li"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Yasuyuki ","lastName":"Arai ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enhanced Expression of CXCR4 Facilitates the Trafficking of Anti-c-Kit Chimeric Antigen Receptor (CAR) T Cells to Bone Marrow and Achieves Effective Donor Stem Cell Engraftment","keywords":"","combinedName":"doctor yasuyuki arai"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Miki ","lastName":"Iwamoto ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Essential Role of Regulatory T Cells on Early B Cell Reconstitution after Haploidentical BMT with Posttransplant Cyclophosphamide","keywords":"","combinedName":"doctor miki iwamoto"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Xie-Na ","lastName":"Cao ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impaired Bone Marrow Endothelial Progenitor Cells May Contribute to Acute Graft-Versus-Host Disease after Allotransplant","keywords":"","combinedName":"doctor xie-na cao"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Kate A","lastName":"Markey ","credentials":"MBBS, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vivo Expansion of Recipient DC Leads to Deletion of Donor Alloreactive CD8+ T Cells and Is an Alternative to Post-Transplant Cyclophosphamide for the Prevention of Graft-Versus-Host Disease after BMT","keywords":"","combinedName":"doctor kate a markey"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Amy ","lastName":"Tang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Iron Overload Decreases Engraftment of Mice Receiving Allogeneicor Syngeneic Bone Marrow Transplant","keywords":"","combinedName":"doctor amy tang"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Warren D","lastName":"Shlomchik ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Memory T Cells from Minor Histocompatibility Antigen-Vaccinated Donors Improve Engraftment with Low Intensity Conditioning","keywords":"","combinedName":"doctor warren d shlomchik"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Yuan ","lastName":"Kong ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"N-Acetyl-L-Cysteine Improves Mesenchymal Stem Cell Function in Prolonged Isolated Thrombocytopenia Post-Allotransplant","keywords":"","combinedName":"doctor yuan kong"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Shoba ","lastName":"Amarnath ","credentials":"BSc, MSc, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PD-1 through Asparaginyl Endopeptidase Regulates Foxp3 Stability in Induced Regulatory T Cells","keywords":"","combinedName":"doctor shoba amarnath"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Yosuke ","lastName":"Makuuchi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Post-Transplant Cyclophosphamide Contributes to ImpairedGraft-Versus-Leukemia Effects and Regulates Graft-Versus-Host Disease in the Murine Stem Cell Transplant Model","keywords":"","combinedName":"doctor yosuke makuuchi"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Lucas ","lastName":"Wachsmuth ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Post-Transplantation Cyclophosphamide Induces Alloreactive T-Cell Functional Impairment and Depends on Foxp3+ Regulatory T Cells Not Selective Elimination or Intrathymic Clonal Deletion of Alloreactive T Cells","keywords":"","combinedName":"doctor lucas wachsmuth"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Yasufumi ","lastName":"Kawasaki ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recipient Hematopoietic, but Not Non-Hematopoietic, Antigen-Presenting Cells Are Indispensable for CD4+ T-Cell-Mediated Xenogeneic Graft-Versus-Host Disease","keywords":"","combinedName":"doctor yasufumi kawasaki"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Mojibade ","lastName":"Hassan ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduced GvHD in Recipients of BM Derived Versus G-CSF Mobilized Plasmacytoid Dendritic Cells: Role of Inducible IL-12","keywords":"","combinedName":"doctor mojibade hassan"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Sabrina ","lastName":"Copsel ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Regulatory T Cells Expanded Via TL1A-Ig Fusion Protein and Low Dose IL-2 Demonstrate Potent Suppression of Graft-Versus-Host Disease","keywords":"","combinedName":"doctor sabrina copsel"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"John S","lastName":"Riley ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Regulatory T Cells Prevent Donor Cell Rejection in a Mouse Model of Delayed Gestational Age in Utero Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor john s riley"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Jerry ","lastName":"Stein ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results of a Non-Interventional Clinical Trial of Apograft - a Novel Technology for GvHD Prevention","keywords":"","combinedName":"doctor jerry stein"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Wei ","lastName":"Huang ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Syngeneic Fecal Microbiota Transplant Effectively Attenuated Graft-Versus-Host Disease after Bone Marrow Transplantation in Mice","keywords":"","combinedName":"doctor wei huang"},{"sessionId":"11869","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster III","firstName":"Edouard ","lastName":"Forcade ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"T Follicular Regulatory (TFR) Cell Deficiency during Chronic Graft-Versus-Host Disease Is Improved By Low-Dose IL-2 Therapy","keywords":"","combinedName":"doctor edouard forcade"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"Elizabeth ","lastName":"Kang ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogenic C57B/6->B6D2F1 Transplantation As a Model for Graft Versus Host Disease in the Brain","keywords":"","combinedName":"doctor elizabeth kang"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"Antonia ","lastName":"Mueller ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characterizing Graft-Vs-Host Disease of the Bone Marrow Post Allogeneic Hematopoietic Cell Transplantation in Mice","keywords":"","combinedName":"doctor antonia mueller"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"Eiko ","lastName":"Hayase ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gastric Stem Cells Are Targeted in Upper Gastrointestinal Gvhd","keywords":"","combinedName":"doctor eiko hayase"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"Ezhilarasi ","lastName":"Chendamarai ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Generation and Characterization of Murine Allogeneic T Cell Resistant APL Cells","keywords":"","combinedName":"doctor ezhilarasi chendamarai"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"Hanspeter ","lastName":"Waldner ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetically Engineered Regulatory T Cells for Treatment of Graft-Versus-Host-Disease","keywords":"","combinedName":"doctor hanspeter waldner"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"Grigory ","lastName":"Efimov ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Highly Variable Frequencies of Donor Antigen-Specific Naive Cells May Dictate the Immunogenicity of Minor Histocompatibility Antigens after Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor grigory efimov"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"KO ","lastName":"Ebata ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intestinal Microbiota Play a Critical Role in Neutrophil Engraftment Posttransplant and Recovery after Chemotherapy By Stimulating T Cell Production of IL-17A","keywords":"","combinedName":"doctor ko ebata"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"Yongxia ","lastName":"Wu ","credentials":"PhD, MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Microrna-31 Promotes T-Cell Pathogenicity in Chronic Graft-Versus-Host Disease","keywords":"","combinedName":"doctor yongxia wu"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"Vikram ","lastName":"Gota ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Modulation of Donor Graft By the Steroidal Lactone Withaferin A Alleviates Post-Transplant Acute GVHD Via Nrf-2 Independent T-Reg Induction","keywords":"","combinedName":"doctor vikram gota"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"Mohammed Hanief","lastName":"Sofi ","credentials":"PhD, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Oxidative Stress Regulates T Cell Pathogenicity in Gvhd","keywords":"","combinedName":"doctor mohammed hanief sofi"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"David","lastName":"Ritchie","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacological Control of Recipient NK Cell Function By Venetoclax Promotes Engraftment and LimitsGvhd Following Reduced Intensity Conditioning without Impacting the Graft Versus AML Effect","keywords":"","combinedName":"doctor david ritchie"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"Jerry ","lastName":"Stein ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TAT-MYC Recombinant Fusion Protein Enhances Hematopoietic Stem Cell Graft Performance and Immune Cell Reconstitution after Transplantation","keywords":"","combinedName":"doctor jerry stein"},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"James ","lastName":"Coghill Jr.","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Anti-Viral Compound Cosalane Attenuates Acute Graft-Versus-Host Disease in Murine Hematopoietic Stem Cell Transplant Models","keywords":"","combinedName":"doctor james coghill jr "},{"sessionId":"11871","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Poster II","firstName":"Senthilnathan ","lastName":"Palaniyandi ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"TNFAIP8 (TIPE) Deficiency Exacerbates Acute Graft Versus-Host Disease in Murine Model","keywords":"","combinedName":"doctor senthilnathan palaniyandi"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Simon ","lastName":"Thomas ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Dominant Negative SHP-2 Which Abrogates PD-1 Signalling Pathways and Restores Function of Cytotoxic CAR T Cells","keywords":"","combinedName":"doctor simon thomas"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Taylor ","lastName":"Hickman ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adaptability of Antibody-Coupled T Cell Receptor (ACTR) Engineered Autologous T Cells in Combination with Daratumumab over CAR-Based Approaches","keywords":"","combinedName":"doctor taylor hickman"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Hong ","lastName":"Qin ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CAR-T Cells Targeting BAFF-Receptor for B-Cell Malignancies: A Potential Alternative to CD19","keywords":"","combinedName":"doctor hong qin"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"In-Young ","lastName":"Jung ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CRISPR/Cas9-Mediated Diacylglycerol Kinase Knockout Potentiates Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T-Cells","keywords":"","combinedName":"doctor in-young jung"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"J. ","lastName":"Bayle ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dual-Switch CAR-T Cells: Orthogonal Molecular Switches to Control Activation and Elimination of CAR-T Cells to Target CD123+Cancer","keywords":"","combinedName":"doctor j bayle"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Yusuke ","lastName":"Meguri ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Early Administration of Low-Dose IL-2 Intensify Graft-Versus-Leukemia Effect without Worsening Gvhd through Sequential Enhancement of Effector T Cell and CD62L+ Regulatory T Cell Subset","keywords":"","combinedName":"doctor yusuke meguri"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Gloria ","lastName":"Castellano Gonzalez ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Generation of Fungus-Specific T Lymphocytes for Use in HSCT Patients with Invasive Fungal Disease","keywords":"","combinedName":"doctor gloria castellano gonzalez"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Ron S","lastName":"Gejman ","credentials":"BA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Cross-Reactive Targets of TCR-Based Therapeutic Agents within the Human Proteome","keywords":"","combinedName":"doctor ron s gejman"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"J. ","lastName":"Melenhorst ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor j melenhorst"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Stefan ","lastName":"Ciurea ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim Results of a Phase 2 Clinical Trial Using Mb-IL21 Ex Vivo Expanded NK Cells to Enhance Graft Versus Leukemia Effect for Patients with Myeloid Malignancies after Haploidentical Transplantation","keywords":"","combinedName":"doctor stefan ciurea"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Ryan ","lastName":"Bjordahl ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Multi-Functional Genetic Engineering of Pluripotent Cell Lines for Universal Off-the-Shelf Natural Killer Cell Cancer Immunotherapy","keywords":"","combinedName":"doctor ryan bjordahl"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Akhilesh ","lastName":"Kumar ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NOTCH Activation at the Definitive Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells","keywords":"","combinedName":"doctor akhilesh kumar"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Sophia ","lastName":"Stock ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PI3K Inhibition with Idelalisib for Optimized Production of Chimeric Antigen Receptor T Cells","keywords":"","combinedName":"doctor sophia stock"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Muzaffar ","lastName":"Qazilbash","credentials":"MD ","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Randomized Phase II Trial of Combination Idiotype Vaccine and Adoptive Cell Transfer of Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation","keywords":"","combinedName":"doctor muzaffar qazilbash"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Esther ","lastName":"Drent ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Combination of 41BB and CD28 Costimulatory Signals Endows Lower Affinity CAR T Cells with the Most Optimal Properties for Selective Targeting of the Tumor Associated Antigen CD38","keywords":"","combinedName":"doctor esther drent"},{"sessionId":"11872","sessionTitle":"703. Adoptive Immunotherapy: Poster II","firstName":"Jeong-Su ","lastName":"Do ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treg in Gvhd Prophylaxis: Unique Transcription Factor Regulation of Foxp3 Expression in Itreg Derived from Human Umbilical Cord Blood (UCB) Vs Adult (AB) Naive CD4 T Cells","keywords":"","combinedName":"doctor jeong-su do"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Marco ","lastName":"Ruella ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Cellular Antidote to Specifically Deplete Anti-CD19 Chimeric Antigen Receptor (CAR19) Positive Cells","keywords":"","combinedName":"doctor marco ruella"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Mark Eric","lastName":"Kohler ","credentials":"M.D., Ph.D.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Direct Comparison of the In Vivo Efficacy and in Vitro Signaling of Chimeric Antigen Receptors and Endogenous T Cell Receptors","keywords":"","combinedName":"doctor mark eric kohler"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Mirko ","lastName":"Farina ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AProspective, Non-Randomized, Multicenter, Phase II Study to Assess Safety and Efficacy of the Infusion of Peripheral Blood Stem Cells Obtained from HLA-Haploidentical Familial Donors (mHaploSCI) after Standard Chemotherapy in Elderly Patients with Acute Myeloid Leukemia at Intermediate or Adverse Risk","keywords":"","combinedName":"doctor mirko farina"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Alejandra ","lastName":"Leivas ","credentials":"PhD, BS, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Activated and Expanded Natural Killer Cells Expressing an NKG2D-CAR Efficiently Target Multiple Myeloma Cells","keywords":"","combinedName":"doctor alejandra leivas"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Paul ","lastName":"Rennert ","credentials":"Ph.D","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CAR19 T Cells Redirected to Novel Antigens Mediate Robust Cytotoxicity Against Diverse Malignancies","keywords":"","combinedName":"doctor paul rennert"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Andreas T","lastName":"Bjrklund ","credentials":"MD, PhD, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CompleteRemission and Signs of Immunoediting Following Haploidentical NK Cell Therapy in Refractory High-Risk MDS and AML Ell Therapy in Refractory High-Risk MDS and AML","keywords":"","combinedName":"doctor andreas t bjrklund"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Lucila Nassif","lastName":"Kerbauy ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cord Blood NK Cells Engineered to Express a Humanized CD123-Targeted Chimeric Antigen Receptor (CAR) and IL-15 As Off-the-Shelf Therapy for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor lucila nassif kerbauy"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Li ","lastName":"Li ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CS1-Specific Chimeric Antigen Receptor Drives Cord Blood NK Cell Maturation and Expansion In Vivo","keywords":"","combinedName":"doctor li li"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Sarita Rani","lastName":"Jaiswal ","credentials":"MD, BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CTLA4Ig Primed Donor Lymphocyte Infusions (DLI): A Novel Approach to Natural Killer Cell Immunotherapy Following Haploidentical PBSC Transplantation for Advanced Hematological Malignancies","keywords":"","combinedName":"doctor sarita rani jaiswal"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Muharrem ","lastName":"Muftuoglu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Exploring the Cord Blood T Cell Compartment with Mass Cytometry Reveals the Existence of Memory CD4, CD8 and Regulatory T Cell Pools in the Fetal Period","keywords":"","combinedName":"doctor muharrem muftuoglu"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Huang ","lastName":"Zhu ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetically Engineered Pluripotent Cell-Derived Natural Killer Cell Therapy Provides Enhanced Antibody Dependent Cellular Cytotoxicity Against Hematologic Malignancies and Solid Tumors in Combination with Monoclonal Antibody Therapy","keywords":"","combinedName":"doctor huang zhu"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Eran ","lastName":"Tallis ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identification of Myeloperoxidase As a Leukemia-Associated Antigen and Therapeutic Target for Acute Myeloid Leukemia","keywords":"","combinedName":"doctor eran tallis"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Meng ","lastName":"Zhou ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mechanisms of GVL-Resistance: T Cell Exhaustion and a Failure of Antigen Cross-Presentation","keywords":"","combinedName":"doctor meng zhou"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Bartosz ","lastName":"Grzywacz ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NK Cell Homing and Persistence in Bone Marrow after Adoptive Immunotherapy Correlates with Therapy Response","keywords":"","combinedName":"doctor bartosz grzywacz"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"James B","lastName":"Rottman ","credentials":"DVM, PhD, DACVP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ROR1-Directed Chimeric Antigen Receptor T Cell Recognition of Self-Antigen Is Associated with Acute Toxicity, T Cell Dysfunction, and Poor Tumor Control. ","keywords":"","combinedName":"doctor james b rottman"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Jeffrey ","lastName":"Miller ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Second-Generation Camelid Trike Induces Improved NK Cell Mediated Targeting of AML in Pre-Clinical Models","keywords":"","combinedName":"doctor jeffrey miller"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Zachariah ","lastName":"McIver ","credentials":"DO, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting T Cell Bioenergetics By Modulating P-Glycoprotein Selectively Depletes Alloreactive T Cells to Prevent Graft-Versus-Host Disease While Maintaining Antitumor Immunity","keywords":"","combinedName":"doctor zachariah mciver"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Sunil S","lastName":"Raikar ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting T-Cell Malignancies with Chimeric Antigen Receptors Using Two Structurally Different Antigen Binding Domains Against CD5","keywords":"","combinedName":"doctor sunil s raikar"},{"sessionId":"11873","sessionTitle":"703. Adoptive Immunotherapy: Poster III","firstName":"Shan ","lastName":"He ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Phosphorylation State of Ezh2 Determines Its Capacity to Maintain CD8+ Memory T Cells for Antitumor Immunity","keywords":"","combinedName":"doctor shan he"},{"sessionId":"11874","sessionTitle":"711. Cell Collection and Processing: Poster II","firstName":"Jia ","lastName":"Wu ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" Multi-Phase Ex Vivo Generation of Platelet-like Particles from CD34+ Cord Blood Cell-Derived Megakaryocytes","keywords":"","combinedName":"doctor jia wu"},{"sessionId":"11874","sessionTitle":"711. Cell Collection and Processing: Poster II","firstName":"Dolores ","lastName":"Grosso ","credentials":"DNP, CRNP","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Differences in Allogeneic Product T-Cell Subsets According to Donor Age: Associations with Immune Reconstitution and Acute Graft Versus Host Disease (aGVHD) in Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)","keywords":"","combinedName":"doctor dolores grosso"},{"sessionId":"11874","sessionTitle":"711. Cell Collection and Processing: Poster II","firstName":"Moses ","lastName":"Evbuomwan ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Generation and Characterization of Novel VLA-4 Inhibitors for Stem Cell Mobilization in Combination with a CXCR2 Agonist","keywords":"","combinedName":"doctor moses evbuomwan"},{"sessionId":"11874","sessionTitle":"711. Cell Collection and Processing: Poster II","firstName":"Melissa ","lastName":"Mavers ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IL-2 Plus IL-15 Leads to Enhanced Ex Vivo Expansion of Human Invariant Natural Killer T Cells","keywords":"","combinedName":"doctor melissa mavers"},{"sessionId":"11874","sessionTitle":"711. Cell Collection and Processing: Poster II","firstName":"April ","lastName":"Depombo ","credentials":"DO","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Large-Scale, Bioreactor-Generated Expansion of Umbilical Cord Blood Tissue-Derived Mesenchymal Stromal Cells for Clinical Use","keywords":"","combinedName":"doctor april depombo"},{"sessionId":"11874","sessionTitle":"711. Cell Collection and Processing: Poster II","firstName":"Carsten ","lastName":"Alt ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Acting, Oxidation-Resistant IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Wild-Type IL-33, G-CSF or AMD3100","keywords":"","combinedName":"doctor carsten alt"},{"sessionId":"11874","sessionTitle":"711. Cell Collection and Processing: Poster II","firstName":"Edmund ","lastName":"Waller ","credentials":"MD ","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimization ofEx VivoActivation and Expansion of T Cells for Therapy of Lymphoma Via Antagonism of PI3K d and Vasoactive Intestinal Peptide Signaling","keywords":"","combinedName":"doctor edmund waller"},{"sessionId":"11874","sessionTitle":"711. Cell Collection and Processing: Poster II","firstName":"Caroline M","lastName":"Bateman ","credentials":"MD,PhD,FRCPath","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Results of Using Automated Clinimacs Prodigy for CD34 Selection from Mobilized Peripheral Blood Stem Cell Products","keywords":"","combinedName":"doctor caroline m bateman"},{"sessionId":"11874","sessionTitle":"711. Cell Collection and Processing: Poster II","firstName":"Hamza ","lastName":"Hashmi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"VRD-CEP: An Effective and Tolerable Chemo-Mobilization and Debulking Regimen for Multiple Myeloma","keywords":"","combinedName":"doctor hamza hashmi"},{"sessionId":"11875","sessionTitle":"711. Cell Collection and Processing: Poster III","firstName":"Jia ","lastName":"Wu ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" Gaussian Mixture Models and Machine Learning Predict Megakaryocytic Growth and Differentiation Potential Ex Vivo ","keywords":"","combinedName":"doctor jia wu"},{"sessionId":"11875","sessionTitle":"711. Cell Collection and Processing: Poster III","firstName":"Patrick ","lastName":"Hanley ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Use of CMV-Specific T Cells Derived from CMV-Naive Donors","keywords":"","combinedName":"doctor patrick hanley"},{"sessionId":"11875","sessionTitle":"711. Cell Collection and Processing: Poster III","firstName":"Hideki ","lastName":"Goto ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Feasibility and Kinetics of CD34+ Hematopoietic Cells Mobilization By Low-Dose Pegfilgrastim in Lymphoma Patients","keywords":"","combinedName":"doctor hideki goto"},{"sessionId":"11875","sessionTitle":"711. Cell Collection and Processing: Poster III","firstName":"Reema ","lastName":"Panjwani ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"IFN-? Induces Distinct Single Cell Transcriptomes in Clinical-Grade Mesenchymal Stromal Cells","keywords":"","combinedName":"doctor reema panjwani"},{"sessionId":"11875","sessionTitle":"711. Cell Collection and Processing: Poster III","firstName":"Christopher ","lastName":"Ramsborg ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"JCAR017 Is a Defined Composition CAR T Cell Product with Product and Process Controls That Deliver Precise Doses of CD4 and CD8 CAR T Cell to Patients with NHL","keywords":"","combinedName":"doctor christopher ramsborg"},{"sessionId":"11875","sessionTitle":"711. Cell Collection and Processing: Poster III","firstName":"Alessandra ","lastName":"Pompa ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outpatient Stem Cell Mobilization with Low and Intermediate Dose Cyclophosphamide Is a Safe andEffective Procedure in Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplantation","keywords":"","combinedName":"doctor alessandra pompa"},{"sessionId":"11875","sessionTitle":"711. Cell Collection and Processing: Poster III","firstName":"Mariusz Z","lastName":"Ratajczak ","credentials":"MD, PhD, DSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sphingosine Kinase 2 (Sphk2) Deficiency Does Not Lower but Instead Surprisingly Increases the Level of Sphingosine-1-Phosphate (S1P) in Peripheral Blood, Providing a Novel Strategy for Stimulating Hematopoietic Stem Cell Mobilization By Inhibiting Sphk2 Activity","keywords":"","combinedName":"doctor mariusz z ratajczak"},{"sessionId":"11875","sessionTitle":"711. Cell Collection and Processing: Poster III","firstName":"Lan ","lastName":"Wang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Studies for Stability of Ex Vivo Produced Megakaryocytes and Their Distribution in Transplanted Mice","keywords":"","combinedName":"doctor lan wang"},{"sessionId":"11875","sessionTitle":"711. Cell Collection and Processing: Poster III","firstName":"Sarita Rani","lastName":"Jaiswal ","credentials":"MD, BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Single Dose Plerixaforas an Adjunct to G-CSF Based Peripheral Blood Stem Cell Mobilisation on the Graft Composition and Outcome for T Replete Haploidentical Pbsc Transplantation with Post Transplantation Cyclophosphamide : A Pilot Study","keywords":"","combinedName":"doctor sarita rani jaiswal"},{"sessionId":"11875","sessionTitle":"711. Cell Collection and Processing: Poster III","firstName":"Nasha ","lastName":"Elavia ","credentials":"MD, MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Post-Thaw Recovery of Cryopreserved Chimeric Antigen Receptor (CAR) T-Cells during Manufacture Is Better Than That of Cryopreserved Peripheral Blood CD3+ Cells","keywords":"","combinedName":"doctor nasha elavia"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Ivetta ","lastName":"Danylesko ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anti a47 Integrin Monoclonal Antibody (Vedolizumab) for the Treatment of Steroid-Resistant Severe Intestinal Acute Graft Versus Host Disease","keywords":"","combinedName":"doctor ivetta danylesko"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Ming ","lastName":"Ni ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Biomarkers for Clinical Response of Extracorporeal Photopheresis","keywords":"","combinedName":"doctor ming ni"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Avichai ","lastName":"Shimoni ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Carfilzomib in Addition to Standard Cyclosporine/ Methotrexate Combination Effectively Prevents Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation from Unrelated Donors","keywords":"","combinedName":"doctor avichai shimoni"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Joshua ","lastName":"Kellner ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cord Blood Regulatory T Cells for Prevention of Graft Versus Host Disease","keywords":"","combinedName":"doctor joshua kellner"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Xiangyu ","lastName":"Zhao ","credentials":"M.D., PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Donor and Recipient HLA Class I Molecule Are Required for Maximum NK Cells Cytotoxicity Reconstitution Post Haploidentical Hematopoietic Stem Cells Transplantation","keywords":"","combinedName":"doctor xiangyu zhao"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Shahinaz M","lastName":"Gadalla ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Donor Lymphocyte Cell-Specific Telomere Length and Causes of Death after Unrelated Hematopoietic Cell Transplant in Patients with Marrow Failure","keywords":"","combinedName":"doctor shahinaz m gadalla"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Peter ","lastName":"Lang ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effects of Various ATG Doses on Rejection Rate and Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation","keywords":"","combinedName":"doctor peter lang"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Andrew ","lastName":"Lin ","credentials":"PharmD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Omitting Post-Transplant Mini-Methotrexate Doses in Allogeneic Hematopoietic Cell Transplantation: A Single-Center Retrospective Study","keywords":"","combinedName":"doctor andrew lin"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Maria V","lastName":"Soares ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased Naive, Stem Cell Memory and Terminally Differentiated CD8+ T Cells in Chronic Graft Versus Host Disease","keywords":"","combinedName":"doctor maria v soares"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Jennifer ","lastName":"Whangbo ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Individual Patient Dose-Escalated Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease in Children and Adults: Safety, Efficacy and Immune Correlates","keywords":"","combinedName":"doctor jennifer whangbo"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Estrella ","lastName":"Carrillo-Cruz ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Influence of VDR Polymorphisms on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) within the Alovita Trial. ","keywords":"","combinedName":"doctor estrella carrillo-cruz"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Aleksandr","lastName":"Lazaryan","credentials":"MD, PhD, MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Initial Results of KD025-208: A Phase 2a Open Label Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease","keywords":"","combinedName":"doctor aleksandr lazaryan"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Kareem ","lastName":"Jamani ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intermediate Post-HCT Exposure to Thymoglobulin Minimizes Mortality and High Exposure Minimizes the Composite of Death, Relapse or Chronic Graft-Versus-Host Disease","keywords":"","combinedName":"doctor kareem jamani"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Jiangying ","lastName":"Liu ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inverse Correlation of Vd2-T-Cell Recovery with EBV Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor jiangying liu"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Thomas ","lastName":"Luft ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mortality after Allogeneic Stem Cell Transplantation Associates with Gene Polymorphisms in CD40L and Thrombomodulin in the Absence of Statins","keywords":"","combinedName":"doctor thomas luft"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Christelle ","lastName":"Retiere ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NK-Cell Alloreactivity Is Associated with Acute Gvhd and Decreased Relapse Incidence after T-Replete Haplo-Identical Allotransplant with High-Dose Post-Transplant Cyclophosphamide","keywords":"","combinedName":"doctor christelle retiere"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Natasha ","lastName":"Kekre ","credentials":"MD,FRCPC","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II Trial of Natalizumab (Tysabri) with Corticosteroids As Initial Treatment of Gastrointestinal Acute Graft Versus Host Disease","keywords":"","combinedName":"doctor natasha kekre"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Silvy ","lastName":"Lachance ","credentials":"MD,FRCPC","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prediction of Severe Acute Graft-Versus-Host Disease (aGVHD) Based on Whole Transcriptome Sequencing of Donor CD4 T Cells","keywords":"","combinedName":"doctor silvy lachance"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Luciana Ribeiro","lastName":"Jarduli ","credentials":"BPharm, MMSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recovery of Thymic Function after Allogeneic Hematopoietic Stem Cell Transplantation in with Sickle Cell Anemia Patients","keywords":"","combinedName":"doctor luciana ribeiro jarduli"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Erik ","lastName":"Boberg ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thymic Function Predicts Response to Mesenchymal Stromal Cell Treatment in Chronic GvHD: A Phase II Clinical Study","keywords":"","combinedName":"doctor erik boberg"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Swati ","lastName":"Naik ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Towards Functional Immune Monitoring in Allogeneic Hematopoietic Stem Cell Transpant Recipients","keywords":"","combinedName":"doctor swati naik"},{"sessionId":"11876","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster II","firstName":"Laura ","lastName":"Newell ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcriptomal Evidence for Dysregulation of Angiogenic Factors and Inflammatory Markers after Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor laura newell"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Lia ","lastName":"Perez ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Trial Evaluating the Use of the Histone Deacetylase Inhibitor Panobinostat for Graft-Versus-Host Disease (GVHD) Prevention","keywords":"","combinedName":"doctor lia perez"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Madan ","lastName":"Jagasia ","credentials":"MD, MBBS, MS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ARandomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy with UVADEX (Methoxsalen) for National Institutes of Health (NIH)-Graded Moderate to Severe Chronic Graft-Vs-Host Disease (cGVHD)","keywords":"","combinedName":"doctor madan jagasia"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Theodoros ","lastName":"Karantanos ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessment of a Multi-Cytokine Profile By a Novel Biochip-Based Assay Reveals Unique Correlation Patterns with Immune Reconstitution after Cord Blood Transplantation in Adults","keywords":"","combinedName":"doctor theodoros karantanos"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Charlotte McIlwaine","lastName":"Story ","credentials":"BS, MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Class I HLA Peptide Epitope Binding Efficiency Has No Impact on Graft Vs. Host Disease Incidence Following AllogeneicHematopoietic CellTransplantation","keywords":"","combinedName":"doctor charlotte mcilwaine story"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Edmund ","lastName":"Waller ","credentials":"MD ","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of Early Post-Transplant Vaccination Using a Prime and Boost Strategy Is Independent of a Prior History of GvHD: Results from BMT CTN 0201","keywords":"","combinedName":"doctor edmund waller"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Yannouck F","lastName":"van Lier ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fecal Microbiota Transplantation As Safe and Successful Therapy for Intestinal Graft-Versus-Host Disease","keywords":"","combinedName":"doctor yannouck f van lier"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Mikhail ","lastName":"Drokov ","credentials":"MD, PhD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Granzyme B Expression in Conventional CD4+ T-Cells Is Strongly Associated with Increased Relapse Rate during First 6 Months after Allo-HSCT","keywords":"","combinedName":"doctor mikhail drokov"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Angela ","lastName":"Granata ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)","keywords":"","combinedName":"doctor angela granata"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Pascal ","lastName":"Wlfinger ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"How to Identify Patients for Treg DLI - Treg Subsets in Gvhd As Biomarker for SuccessfulTreg DLI","keywords":"","combinedName":"doctor pascal wlfinger"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Melhem M","lastName":"Solh ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identifying Risk Factors for Acute and Chronic Graft-Versus-Host Disease in T-Replete HLA-Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide","keywords":"","combinedName":"doctor melhem m solh"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Hua ","lastName":"Jin ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients Is an Important Risk Factor Not Only for Acute Graft-Versus-Host Disease but Also for Chronic Graft-Versus-Host Disease","keywords":"","combinedName":"doctor hua jin"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Saurabh ","lastName":"Chhabra ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study","keywords":"","combinedName":"doctor saurabh chhabra"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Alvaro ","lastName":"Veiga ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mesenchymal Stromal Cells for Refractory Acute Graft-Versus-Host Disease By Compassionate Use Provide Comparable Results to Those of Phase II Clinical Trials","keywords":"","combinedName":"doctor alvaro veiga"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Li ","lastName":"Li ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"NK Cell Diversity Influences Outcomes after Cord Blood Transplantation","keywords":"","combinedName":"doctor li li"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Ching Chan ","lastName":"Lin ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Post Transplant Cyclophosphamide (PTCy) with Anti-Thymocyte Globulin (ATG) AsGvhd Prophylaxis Is Effectivein Haploidentical Peripheral Stem Cell Transplantation andwithout Increasing Risk of Relapse","keywords":"","combinedName":"doctor ching chan lin"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Wilson ","lastName":"Lam ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Transplant Pulmonary Function Test Parameters of FEF50% (Forced expiratory flow at 50% of forced vital capacity) and RV (residual volume) in Combination Can Predict the Risk for Development of Lung Gvhd after Allogeneic Transplantation","keywords":"","combinedName":"doctor wilson lam"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Daisuke ","lastName":"Koyama ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quantitative Assessment of TCR Repertoire and Allo-Reactivity of Human Acute Gvhd Tissue-Infiltrating T Cells","keywords":"","combinedName":"doctor daisuke koyama"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Badri ","lastName":"Modi ","credentials":"MD","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ruxolinitib As Salvage Therapy for Chronic Graft-Versus-Host Disease","keywords":"","combinedName":"doctor badri modi"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Virginia ","lastName":"Escamilla Gomez ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study","keywords":"","combinedName":"doctor virginia escamilla gomez"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Karina A","lastName":"Mendoza ","credentials":"BS","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Similar Outcomes of Early Failure Steroid Dependent Acute GvHD and Upfront Steroid Refractory Acute GvHD: Implications on Clinical Trials","keywords":"","combinedName":"doctor karina a mendoza"},{"sessionId":"11877","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I","firstName":"Sebastian ","lastName":"Giebel ","credentials":"","sessionStartTime":"2017-12-09T17:30:00Z","sessionEndTime":"2017-12-09T19:30:00Z","startTime":"17:30:00","endTime":"19:30:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Use of Anti-Thymocyte Globulin Is Associated with Decreased Risk of Chronic Graft-Versus-Host Disease without Impact on Survival after Allogeneic Peripheral Blood Stem Cell Transplantation for Adults with Philadelphia-Positive Acute Lymphoblastic Leukemia: An Analysis By the Acute Leukemia Working Party of the EBMT","keywords":"","combinedName":"doctor sebastian giebel"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Elizabeth ","lastName":"Stenger ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of a Multi-Center Cohort to Evaluate Long-Term Outcomes and Late Effects Following Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Initiative","keywords":"","combinedName":"doctor elizabeth stenger"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Sung-Soo ","lastName":"Park ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of Prognostic Prediction Model for Decision of Secondary Allogeneic Stem Cell Transplantation for Relapsed Acute Myeloid Leukemia after First Stem Cell Transplantation","keywords":"","combinedName":"doctor sung-soo park"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Adam ","lastName":"Bryant ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of Donor Lymphocyte Infusion in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplant for Myeloid and Lymphoid Malignancies: A Single Center Experience","keywords":"","combinedName":"doctor adam bryant"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Lohith ","lastName":"Gowda ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Graft Failure Post Allogeneic Stem Cell Transplant: Conditioning Regimen Improves Engraftment and Survival","keywords":"","combinedName":"doctor lohith gowda"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Kalyan ","lastName":"Nadiminti ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoietic Cell Transplant-Comorbidity Index (HCT-CI) Score Predicts Non-Relapse Mortality (NRM) and Overall Survival (OS) in Multiple Myeloma Patients Undergoing Intensive Preparative Regimen with Autologous Stem Cell Transplantation (ASCT) Followed By Maintenance Therapy Using Novel Agents","keywords":"","combinedName":"doctor kalyan nadiminti"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Louise ","lastName":"Bouard ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Early Post-Transplant 5-Point Deauville Scale (18)F-FDG-PET Status on Survival Outcomes after Allogeneic Transplantation for Lymphoma","keywords":"","combinedName":"doctor louise bouard"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Kasey J","lastName":"Leger ","credentials":"MD, MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lifestyle Factors and Subsequent Ischemic Heart Disease Risk after Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor kasey j leger"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Aziz","lastName":"Nazha","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mutational Burden before and after Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Acute Myeloid Leukemia (AML)","keywords":"","combinedName":"doctor aziz nazha"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Sousuke ","lastName":"Nakamura ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Personalized Circulating Tumor DNA Predicts Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome","keywords":"","combinedName":"doctor sousuke nakamura"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Andrew ","lastName":"Brunner","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I Study of Bortezomib Combined with Lenalidomide for Relapsed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Following Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor andrew brunner"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Raphal ","lastName":"Cauchois ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prophylactic Donor Lymphocyte Infusions after Haploidentical Hematopoietic Stem Cell Transplantation for High Risk Hematological Malignancies: A Retrospective Bicentric Analysis of Serial Infusions of Increasing Doses of CD3+ Cells","keywords":"","combinedName":"doctor raphal cauchois"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Peter","lastName":"Dreger","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties","keywords":"","combinedName":"doctor peter dreger"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Alessia ","lastName":"Pepe ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Secondary Solid Cancer Following Hematopoietic Cell Transplantation in Patients with Thalassemia Major","keywords":"","combinedName":"doctor alessia pepe"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Zinaida ","lastName":"Peric ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Severe Ocular Graft-Versus-Host Disease Successfully Treated with Amniotic Membrane Transplantation  Case Series","keywords":"","combinedName":"doctor zinaida peric"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Xi ","lastName":"Yang ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"This Is a Title inHbi-8000, a Novel HDAC Inhibitor, Is Effective for Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation and Results in Th1 Polarization in AML Patients with AML1-ETO","keywords":"","combinedName":"doctor xi yang"},{"sessionId":"11878","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster II","firstName":"Dipenkumar ","lastName":"Modi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transaminase Elevation As a Marker of Liver Gvhd Is Associated with Poor Survival Among Allogeneic Stem Cell Transplant Recipients","keywords":"","combinedName":"doctor dipenkumar modi"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Sean ","lastName":"Dougherty ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Accelerated T Cell Senescence after Allogeneic Hematopoeitic Stem Cell Transplantation","keywords":"","combinedName":"doctor sean dougherty"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Ting-An ","lastName":"Lin ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cerebrovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, Risk and Clinical Outcome","keywords":"","combinedName":"doctor ting-an lin"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Kirsten ","lastName":"Williams","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Complete Remissions Post Infusion of Multiple Tumor Antigen Specific T Cells for the Treatment of High Risk Leukemia and Lymphoma Patients after HCT","keywords":"","combinedName":"doctor kirsten williams"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Susan ","lastName":"Prockop ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder","keywords":"","combinedName":"doctor susan prockop"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Angelo ","lastName":"Andreini ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience","keywords":"","combinedName":"doctor angelo andreini"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Marcos ","lastName":"de Lima ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Final Analysis of the Phase I/II Study of CC-486 (Oral Azacitidine) Maintenance Therapy after Allogeneic Stem Cell Transplantation (Allo-SCT) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)","keywords":"","combinedName":"doctor marcos de lima"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Guo-Pan ","lastName":"Yu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Front-Line Treatment with Second-Generation Tyrosine Kinase Inhibitors Following By Allo-Transplantation Benefits Patients with Better Survival Inph-Positive Acute Lymphoblastic Leukemia","keywords":"","combinedName":"doctor guo-pan yu"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Leo ","lastName":"Rasche ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Functional Imaging Detects Residual Disease in MRD-Negative Multiple Myeloma Patients Who Subsequently Relapse","keywords":"","combinedName":"doctor leo rasche"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Monica","lastName":"Thakar","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Haploidentical Hematopoietic Cell Transplantation Followed By Donor Natural Killer Cell Infusion and Sirolimus Maintenance Can Successfully Treat Patients with High-Risk Ewing Sarcoma","keywords":"","combinedName":"doctor monica thakar"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Kirill ","lastName":"Kirgizov ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoietic Stem Cell Transplantation for Children with Neurological Diseases Improves the Outcomes and Not Leads to Significant Late Effects  Report from Russian Group","keywords":"","combinedName":"doctor kirill kirgizov"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Nicolas ","lastName":"Stocker ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Pre-Emptive Rituximab Treatment for Epstein-Barr Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Longitudinal Study of 110 Patients","keywords":"","combinedName":"doctor nicolas stocker"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Zachariah ","lastName":"Defilipp ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Longitudinal Changes in Body Composition Following Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor zachariah defilipp"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Felicitas ","lastName":"Thol ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Next-Generation Sequencing-Based Measurable Residual Disease (MRD) Monitoring Is Highly Predictive for Outcome after Allogeneic Stem Cell Transplantation","keywords":"","combinedName":"doctor felicitas thol"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Michael ","lastName":"Scordo ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-Conditioned Autologous Stem Cell Transplantation Are at a Higher Risk for DNA Virus Infections Than Patients with Systemic Non-Hodgkin Lymphoma Receiving Traditional Conditioning","keywords":"","combinedName":"doctor michael scordo"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Prachi ","lastName":"Jain ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PD-1 Is Not a Reliable Marker of Impending Relapse after Allogeneic Stem Cell Transplantation","keywords":"","combinedName":"doctor prachi jain"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Robert ","lastName":"Chen","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase II Trial of Bortezomib Plus Rituximab As Maintenance Therapy Post ASCT for Patients with Mantle Cell Lymphoma","keywords":"","combinedName":"doctor robert chen"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Forat ","lastName":"Lutfi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Poor Graft Function Following Autologous Stem Cell Transplant (ASCT): A Retrospective Analysis over Two Decades at a Transplant Center","keywords":"","combinedName":"doctor forat lutfi"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Satoshi ","lastName":"Kaito ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Post-Transplant Maintenance Therapy with Azacitidine and Gemtuzumab Ozogamicin for High-Risk Hematologic Malignancies","keywords":"","combinedName":"doctor satoshi kaito"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Beihui ","lastName":"Huang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Scoring System for Predicting Risk of Relapse in Patients with Multiple Myeloma within Two Years after Stem Cell Transplantation","keywords":"","combinedName":"doctor beihui huang"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Yuki ","lastName":"Asano-Mori ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Secondary Solid Cancers after Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience of 1374 Patients Including 812 Cord Blood Transplant Recipients","keywords":"","combinedName":"doctor yuki asano-mori"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Syed Osman Ali","lastName":"Ahmed ","credentials":"BSc, FRCPath, MBBS, MRCP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Single Center Study of Outcomes of Patients Admitted to ICU Following Allogeneic Hematopoietic Cell Transplantation: Patients Who Have Experienced Post Transplant Relapse Prior to ICU Admission Have the Worst Outcomes","keywords":"","combinedName":"doctor syed osman ali ahmed"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Thomas ","lastName":"Schroeder ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment of Relapse of MDS, AML and CMML after Allogeneic Blood Stem Cell Transplantation with Azacitidine, Lenalidomide and Donor Lymphocyte Infusions  Results from the First Interim Analysis of the Azalena-Trial (NCT02472691)","keywords":"","combinedName":"doctor thomas schroeder"},{"sessionId":"11879","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III","firstName":"Piyanuch ","lastName":"Kongtim ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of a Predictive Model for Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome Receiving Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor piyanuch kongtim"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Mita ","lastName":"Manna ","credentials":"MD, FRCPC","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autologous Transplantation Improves Survival Rates for Follicular Lymphoma Patients Who Relapse within 2-Years of Chemoimmunotherapy: A Multi-Centre Retrospective Analysis of Consecutively Treated Patients in the Real World","keywords":"","combinedName":"doctor mita manna"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Diego ","lastName":"Adrianzen Herrera ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autologous Transplantation Is Associated with Better Outcomes Compared to Chemotherapy Alone in a Minority-Rich Non-High-Risk Acute Myeloid Leukemia Cohort","keywords":"","combinedName":"doctor diego adrianzen herrera"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Jie ","lastName":"Ji ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chidamide, a HDAC Inhibitor, Combined with Cladribine,High Dose Gemcitabine and Busulfan with Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory and Poor-Risk Lymphoma","keywords":"","combinedName":"doctor jie ji"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Diego ","lastName":"Villa ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Effectiveness of High-Dose Bendamustine-EAM Versus BEAM in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation","keywords":"","combinedName":"doctor diego villa"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Michele ","lastName":"Donato ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cyclophosphamide Based Regimens Comparedto Plerixafor-Based Regimens for Stem Cell Mobilization in Patients with Multiple Myeloma Result in Higher CD34+ Cell Yield, Lower Cost and Similar Outcome Post Autologous Transplantation","keywords":"","combinedName":"doctor michele donato"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Robert ","lastName":"Pytlik ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Destiny of Elderly Patients with Lymphoma Indicated for Autologous Stem Cell Transplantation (ASCT)","keywords":"","combinedName":"doctor robert pytlik"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Stephen ","lastName":"Robinson ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In the Era of Chemoimmunotherapy, Relapse Post Autologous Stem Cell Transplantation for Follicular Lymphoma Is Associated with Prolonged Overall Survival. an Analysis By the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)","keywords":"","combinedName":"doctor stephen robinson"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Guido ","lastName":"Ghilardi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Melphalan Dose in Myeloma Patients over 65 Years of Age Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation","keywords":"","combinedName":"doctor guido ghilardi"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Guillermo Jose","lastName":"Ruiz-Argelles Sr.","credentials":"MD FRCP. (GLASG) MACP","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Modifications to the Classical Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective","keywords":"","combinedName":"doctor guillermo jose ruiz-argelles sr "},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Gunjan ","lastName":"Shah ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacokinetics and Toxicities after Evomela (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis","keywords":"","combinedName":"doctor gunjan shah"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Keren ","lastName":"Osman ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 1 Study of Elotuzumab and Peripheral Blood Mononuclear Cell Reconstitution in Combination with Autologous Stem Cell Transplantation and Lenalidomide Maintenance for Multiple Myeloma","keywords":"","combinedName":"doctor keren osman"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Joanna ","lastName":"Blocka ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Impact of Tandem Autologous Stem Cell Transplantation (ASCT) in Different Response Subgroups after 1st ASCT","keywords":"","combinedName":"doctor joanna blocka"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Michele ","lastName":"Donato ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk of Engraftment Syndrome after Autologous Stem Cell Transplantation for Multiple Myeloma Increases with Age and Lower Dose of CD34+ Cells, but Is Not Impacted By Immunomodulatory Chemotherapy","keywords":"","combinedName":"doctor michele donato"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Muhamed ","lastName":"Baljevic ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Association between CD34+ Dose, Platelet Recovery and Incidence of Relapse after Autologous Stem Cell Transplant in Multiple Myeloma","keywords":"","combinedName":"doctor muhamed baljevic"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Maxim ","lastName":"Solovev ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Duration of MRD-Negative Status in Multiple Myeloma (MM) Patients after Auto-HSCT Is a Criterion for Prolonged Remission without Maintenance Therapy","keywords":"","combinedName":"doctor maxim solovev"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Claudio G","lastName":"Brunstein ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Transplantation","keywords":"","combinedName":"doctor claudio g brunstein"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Jaewon ","lastName":"Hyung ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma","keywords":"","combinedName":"doctor jaewon hyung"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Srinivas ","lastName":"Devarakonda ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transplant Still Relevant Even in the Era of Novel Treatments for Multiple Myeloma  National Cancer Database Analysis","keywords":"","combinedName":"doctor srinivas devarakonda"},{"sessionId":"11880","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster II","firstName":"Xin ","lastName":"Liu ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Which Patients with Ph+ Acute Lymphoblastic Leukemia Should Undergo Autologous Hematopoietic Stem Cell Transplantation in TKI Era?","keywords":"","combinedName":"doctor xin liu"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Alexandra ","lastName":"Gomez-Arteaga ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Study of a Novel Conditioning Regimen of Bendamustine and Melphalan Followed By Autologous Stem Cell Transplant for Patients with Multiple Myeloma","keywords":"","combinedName":"doctor alexandra gomez-arteaga"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Francesca Maria ","lastName":"Gay ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Randomized Study of Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Cyclophosphamide-Dexamethasone Induction in Newly Diagnosed Myeloma Patients Eligible for Transplant: High Efficacy in High- and Standard-Risk Patients","keywords":"","combinedName":"doctor francesca maria gay"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Kalyan ","lastName":"Nadiminti ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy Is Safe in Older Recently Diagnosed Multiple Myeloma (MM) Patients. Preliminary Results from the Prospective Phase II Trial (NCT01849783)","keywords":"","combinedName":"doctor kalyan nadiminti"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"David ","lastName":"Ma ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Advanced, Treatment Refractory Multiple Sclerosis (MS) - a Phase II Clinical Trial","keywords":"","combinedName":"doctor david ma"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Carlton ","lastName":"Scharman ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autologous Stem Cell Transplant in the Era of Bortezomib-Based Induction for AL Amyloidosis Results in Improved Hematologic Response Rates:a Single Institution 11 Year Experience","keywords":"","combinedName":"doctor carlton scharman"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Priyanka ","lastName":"Pophali ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in the Elderly (=65 Years Of Age): The Mayo Clinic Experience","keywords":"","combinedName":"doctor priyanka pophali"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Theodora ","lastName":"Anagnostou ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Baseline Immune Dysregulation in Autologous Stem Cell Transplant Recipients Is Associated with a Graft Versus Host-like Syndrome and Results in Poor Outcomes","keywords":"","combinedName":"doctor theodora anagnostou"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Meletios ","lastName":"Dimopoulos","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bortezomib-Based Therapy Overcomes the Adverse Impact of Renal Impairment in Transplant Eligible Patients : An Analysis of the Prospective Randomized EMN02/HO95 Study","keywords":"","combinedName":"doctor meletios dimopoulos"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Varun ","lastName":"Mehra ","credentials":"MRCP, FRCPath","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"EBV Reactivation Incidence and Severity in Multiple Sclerosis Patients Treated with Autologous Haematopoietic Stem Cell Transplant and Comparing with Aplastic Anaemia Treated with ATG- Single Site Experience","keywords":"","combinedName":"doctor varun mehra"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Andrzej ","lastName":"Jakubowiak ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Rate of Sustained Minimal Residual Disease Negativity Predicts Prolonged Survival for the Overall Patient Population in the Phase 2 KRd Plus Autologous Stem Cell Transplantation MMRC Trial","keywords":"","combinedName":"doctor andrzej jakubowiak"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Praful ","lastName":"Ravi ","credentials":"MA, MBBChir, MRCP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inability to Complete the Second of Planned Tandem Autologous Stem Cell Transplantations for Metastatic Germ Cell Tumors: Reasons, Toxicity and Impact on Outcomes","keywords":"","combinedName":"doctor praful ravi"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Bernd ","lastName":"Metzner ","credentials":"M.D., Ph.D.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Clinical and Molecular Remissions in Patients with Follicular Lymphoma (FL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)","keywords":"","combinedName":"doctor bernd metzner"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Mauricette ","lastName":"Michallet ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Survival of Patients with Chronic Phase Chronic Myeloid Leukemia Who Received Autologous Stem Cell Transplantation and Further Exposed to Tyrosine Kinase Inhibitors. a Study on Behalf of the French Society of Blood and Marrow Transplantation and the French Group of CML","keywords":"","combinedName":"doctor mauricette michallet"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Wasithep ","lastName":"Limvorapitak ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Intermediate Risk Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared to Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-Score Adjusted Analysis","keywords":"","combinedName":"doctor wasithep limvorapitak"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Michele ","lastName":"Donato ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patients Responding to Any First Line Therapy for Multiple Myeloma Should Proceed to Autologous Stem Cell Transplantation Instead of Receiving Second Line Therapy to Deepen Response","keywords":"","combinedName":"doctor michele donato"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Marta ","lastName":"Davidson ","credentials":"MD PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I/II Study of Infusional Gemcitabine and High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation for Patients with Relapsed/Refractory Lymphoma: Interim Safety Analysis","keywords":"","combinedName":"doctor marta davidson"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Beihui ","lastName":"Huang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Positive Minimal Residual Disease By Multiparameter Flow Cytometry in 9 Months after Autologous Stem Cell Transplantation and High-Risk Cytogenetics Predict Poor Outcome in Multiple Myeloma","keywords":"","combinedName":"doctor beihui huang"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Louis ","lastName":"Williams ","credentials":"MD, MBA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Effect of Decline in Pulmonary Function Testing after Autologous Stem Cell Transplantation","keywords":"","combinedName":"doctor louis williams"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Kiyoshi ","lastName":"Okazuka ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Retrospective Analysis of High-Dose Melphalan and Autologous Stem Cell Transplantation for Systemic Light-Chain Amyloidosis: A Single Center 63 Cases","keywords":"","combinedName":"doctor kiyoshi okazuka"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Louise ","lastName":"Man ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Impact of Maintenance Therapy in the Treatment of Multiple Myeloma with a Subset Analysis on Patients Who Achieve a Complete Response (CR) or Better: A Retrospective Analysis","keywords":"","combinedName":"doctor louise man"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Amanda ","lastName":"Li ","credentials":"MD, BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Toxicity and Outcomes of Autologous Stem Cell Transplant in Multiple Myeloma Patients with Renal Insufficiency: An Institutional Comparison between Two Eras","keywords":"","combinedName":"doctor amanda li"},{"sessionId":"11881","sessionTitle":"731. Clinical Autologous Transplantation: Results: Poster III","firstName":"Stephan ","lastName":"Grupp","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Post-Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Neuroblastoma: Final Data from the Defibrotide Expanded-Access Program","keywords":"","combinedName":"doctor stephan grupp"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Ehsan ","lastName":"Shabbir ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"a New Risk Assessment Tool for Allogeneic Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor ehsan shabbir"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Raynier ","lastName":"Devillier ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Hematopoietic Stem Cell Transplantation Improves Outcome of Patients > 60 Years with Acute Myeloid Leukemia in First Complete Remission: A 10-Year Single Center Transplantation Program Analysis","keywords":"","combinedName":"doctor raynier devillier"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Hirotoshi ","lastName":"Sakaguchi ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Significance of Natural Killer Cell-Mediated Alloreactivity in Unrelated Cord Blood Transplantation for Children with Acute Leukemia: A Japanese National Registry Study","keywords":"","combinedName":"doctor hirotoshi sakaguchi"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Roni","lastName":"Tamari","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CMV Reactivation Post CD34+ Selected Allo-HCT Has Adverse Outcomes on Blood Counts Recovery ","keywords":"","combinedName":"doctor roni tamari"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Youngil ","lastName":"Koh ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Discovery of Donor Genotype Associated with Long-Term Survival of Patients with Hematopoietic Stem Cell Transplantation in Refractory Acute Myeloid Leukemia","keywords":"","combinedName":"doctor youngil koh"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Harald ","lastName":"Schulze ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Distinct HLA-DPB1 Matching of Unrelated Donors for Malignant and Non-Malignant Indications Is Critical in Pediatric Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor harald schulze"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Simona ","lastName":"Pagliuca ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Novel Endpoints As Treatment Outcome in Allogeneic Hematopoietic Stem Cell Transplantation: A Comparison of Classical and Refined Definition of Graft-Versus Host Disease Free and Relapse Free Survival for Registry-Based Studies","keywords":"","combinedName":"doctor simona pagliuca"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Koen ","lastName":"Van Besien ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fludarabine Melphalan Conditioning Followed By T-Replete Haplo Identical (Haplo) Transplantation or Haplo Cord (HC) Transplantation","keywords":"","combinedName":"doctor koen van besien"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Farah ","lastName":"O'Boyle ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Related Transplantation in b Thalassaemia Major Leads to Early and Sustained Engraftment with Low Incidence of VOD and GvHD but a High Rate of Long-Term Mixed Chimerism","keywords":"","combinedName":"doctor farah o'boyle"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Christopher ","lastName":"Gibson ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Genetic Ontogeny Defines Distinct Prognostic Subgroups in AML Patients Age 60 and Older Following Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor christopher gibson"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Chunfu ","lastName":"Li ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoietic Stem Cell Transplantation from Full Matched Alternative Donor Has Same Results As Those from Matched Sibling for Patients with Beta-Thalassemia Major -a Large-Cohort Multicenter Study from China","keywords":"","combinedName":"doctor chunfu li"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Shahrzad ","lastName":"Bakhtiar ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoietic Stem Cell Transplantation in 65 Patients with Leukocyte Adhesion Deficiency Type I and Type III - A Retrospective Multi-Center Study","keywords":"","combinedName":"doctor shahrzad bakhtiar"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Maximilian ","lastName":"Stahl ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hypomethylating Agents (HMAs) in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML) Transplant Outcomes Post HMA Therapy in a Large International Patient Cohort","keywords":"","combinedName":"doctor maximilian stahl"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Nicoletta ","lastName":"Cieri ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intention-to-Treat Analysis of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Peripheral T-Cell Non-Hodgkin Lymphomas: A Large Italian Single-Center Experience","keywords":"","combinedName":"doctor nicoletta cieri"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Avichai ","lastName":"Shimoni ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"KIR- Ligand Mismatching Is Associated with Inferior Survival in Patients with Acute Leukemia Following T-Cell Replete Peripheral-Blood Stem Cell Haplo-Identical Transplantation with Post-Transplant Cyclophosphamide. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). ","keywords":"","combinedName":"doctor avichai shimoni"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Marie ","lastName":"Robin ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Life Expectancy in Long-Term Survivors Transplanted for Myelofibrosis: A Registry Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation","keywords":"","combinedName":"doctor marie robin"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Hany ","lastName":"Elmariah ","credentials":"MD,MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Nonmyeloablative (NMA), HLA-Haploidentical (Haplo) Blood or Marrow Transplantation (BMT) from Non-First-Degree Related Donors Has Similar Outcomes to First-Degree Related BMT","keywords":"","combinedName":"doctor hany elmariah"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Nico ","lastName":"Gagelmann ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimized EBMT Transplant-Specific Risk Score of Patients with Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation","keywords":"","combinedName":"doctor nico gagelmann"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Annalisa ","lastName":"Paviglianiti ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Cord Blood Transplantation for Adult Patients with Hodgkin Lymphoma, a Eurocord and EBMT Lymphoma Working Party Study","keywords":"","combinedName":"doctor annalisa paviglianiti"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Fabio ","lastName":"Guolo ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Transplant Minimal Residual Disease Evaluation Performed By Molecular WT1-Based or Multicolor Flow Cytometry Assessment Overcomes the Prognostic Value of Cytogenetic and Molecular Risk Factors at Diagnosis in Advanced Acute Myeloid Leukemia Patients","keywords":"","combinedName":"doctor fabio guolo"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Mark ","lastName":"Cook ","credentials":"MBChB,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduced Intensity Stem Cell Transplantation Followed By Adjunctive Lenalidomide Is Tolerable and Safe and Improves Complete Response Rate in Multiple Myeloma:a UK NCRI Phase 2 Feasibility Study (LenaRIC)","keywords":"","combinedName":"doctor mark cook"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Luca ","lastName":"Castagna ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduced Relapse and Improved Survival in Chemosensitive Hodgkin Lymphoma Patients Undergoing Haploidentical Related Donor Compared to HLA-Identical Donor Transplantation","keywords":"","combinedName":"doctor luca castagna"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Shreya ","lastName":"Agarwal ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Reduced-Intensity Conditioning Is Successful in Matched Sibling Bone Marrow Transplantation As a Cure for Sickle Cell Disease","keywords":"","combinedName":"doctor shreya agarwal"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Barbara ","lastName":"Cappelli ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk Factors and Outcomes According to Age at Transplant with an HLA Identical Sibling for Sickle Cell Disease","keywords":"","combinedName":"doctor barbara cappelli"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Hongtao ","lastName":"Liu ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Selinexor Maintenance Is Feasible and Tolerable after Allogeneic Stem Cell Transplant (allo-SCT) for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)","keywords":"","combinedName":"doctor hongtao liu"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Laura ","lastName":"Soln ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"ST2 As a Biomarker of Non-Relapse Mortality after HLA-Haploidentical SCT with High-Dose Post-Transplantation Cyclophosphamide","keywords":"","combinedName":"doctor laura soln"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Madan ","lastName":"Jagasia ","credentials":"MD, MBBS, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: An Analysis By the EBMT Complications and Quality of Life WP","keywords":"","combinedName":"doctor madan jagasia"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Sabrina ","lastName":"Giammarco ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transplant Outcome for Patients with Acquired Aplastic Anemia over the Age of 40: Mortality HAS NOT Been Reduced in 2015","keywords":"","combinedName":"doctor sabrina giammarco"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Bipin ","lastName":"Savani ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transplant Outcome for Secondary Acute Myeloid Leukemia Based on Prior Hematological Disease or Solid Malignancy - on Behalf of the ALWP of the EBMT","keywords":"","combinedName":"doctor bipin savani"},{"sessionId":"11882","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster II","firstName":"Monia ","lastName":"Marchetti ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Which Patients with Myelofibrosis Should Receive Allogeneic Stem Cell Transplantation? a Decision Analysis Based on the Systematic Review of 4,341 Patients","keywords":"","combinedName":"doctor monia marchetti"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Shukaib ","lastName":"Arslan ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" Outcomes and Risks of Allogeneic Hematopoietic Stem Cell Transplant for Hematological Malignancies in Patients with HIV Infection","keywords":"","combinedName":"doctor shukaib arslan"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Simona ","lastName":"Pagliuca ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" Outcomes of Hematopoietic Stem Cell Transplantation after Chronic Graft Versus Host Disease and Evaluation of Revised Failure Free Survival in a Retrospective Analysis from Two Referral Centers. ","keywords":"","combinedName":"doctor simona pagliuca"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Anthony ","lastName":"Stein ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase II Study of Total Marrow and Lymphoid Irradiation (TMLI) in Combination with Cyclophosphamide and Etoposide in Patients with Relapsed/Refractory Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor anthony stein"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Dania ","lastName":"Monagel ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Alemtuzumab/Low Dose TBI Conditioning Facilitates Stable Long-Term Donor Hematopoietic Cell Engraftment from Sibling Donors in Children with Sickle Cell Disease","keywords":"","combinedName":"doctor dania monagel"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Sajad ","lastName":"Khazal ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Blood and Marrow Transplantation for Pediatric Patients with Sickle Cell Anemia: An Institutional Experience","keywords":"","combinedName":"doctor sajad khazal"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Giulia ","lastName":"Prunotto ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Allogeneic Stem Cell Transplantation for the Treatment of Lymphoproliferative Disorders in Patients Affected By Primary Immunodeficiencies: The UK Experience","keywords":"","combinedName":"doctor giulia prunotto"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Michael ","lastName":"Maschan ","credentials":"MD,MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Alpha/Beta T Cell Depleted Haploidentical Transplantation Results in High Survival in Pediatric Patients with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor michael maschan"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Kavita ","lastName":"Raj ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An EBMT Analysis of Matched Sibling, Mismatched Family or Matched Unrelated Donors for Allogeneic Stem Cell Transplants in MDS","keywords":"","combinedName":"doctor kavita raj"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Richard ","lastName":"LeBlanc ","credentials":"MD,FRCPC","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bortezomib Consolidation after NonmyeloablativeAllogeneic Transplant Is Safe and Leads to a High Incidence of Immunophenotypic Complete Response in High-Risk or Young Myeloma Patients","keywords":"","combinedName":"doctor richard leblanc"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Alberto ","lastName":"Mussetti ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD3 Lymphocyte Graft Content and Not Hematopoietic Stem Cell Source Is Associated to Higher Chronic Gvhd after Haploidentical Transplantation with Post-Transplant Cyclophosphamide","keywords":"","combinedName":"doctor alberto mussetti"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Pavan Kumar ","lastName":"Bhamidipati ","credentials":"MBBS, MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Characteristics of Isolated CNS Relapse after Allogeneic Transplantation for AML  Poor Outcomes Despite Longer Time to Relapse","keywords":"","combinedName":"doctor pavan kumar bhamidipati"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Selim ","lastName":"Corbacioglu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparable Outcome of CD3+-/CD19+ Depleted Haploidentical with Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Advanced Stage Sickle Cell Disease: Result of a Pilot Study","keywords":"","combinedName":"doctor selim corbacioglu"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Jia ","lastName":"Chen ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Autologous Stem Cell Transplantation Versus Haplo-Identical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission","keywords":"","combinedName":"doctor jia chen"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Mohammad Junaid","lastName":"Hussain ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Biologically Assigned HLA-Identical Versus Haploidentical Related Donor Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor mohammad junaid hussain"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Asad ","lastName":"Bashey ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Outcomes Following Allogeneic HCT for Adverse Cytogenetic/Molecular Risk AML Using T-Replete Haploidentical Donors to Optimally Matched Related and Unrelated Donors","keywords":"","combinedName":"doctor asad bashey"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Thomas L","lastName":"Kiss ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Outcomes of Elderly Patients with Acute Myeloid Leukemia (AML) in CR1 Receiving Reduced Intensity Allogeneic Stem Cell Transplantation (RICT) from Matched Sibling (MSD) or Unrelated Donors (URD)","keywords":"","combinedName":"doctor thomas l kiss"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Salvatore ","lastName":"Fiorenza ","credentials":"MBBS PhD MPH BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Determinants of Long-Term Survival Following Allogeneic Stem Cell Transplantation for Multiple Myeloma: A Multi-Centre Analysis across the United Kingdom and Australia","keywords":"","combinedName":"doctor salvatore fiorenza"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Kothari ","lastName":"Shawn ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Dose Escalation Prophylactic Donor Lymphocyte Infusion (pDLI) after T-Cell Depleted (TCD) Matched Related Donor (MRD) Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Is Feasible and Results in Higher Donor Chimerism, Faster Immune Re-Constitution and Prolonged PFS","keywords":"","combinedName":"doctor kothari shawn"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Florent ","lastName":"Malard ","credentials":"MD,PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Ex Vivo T Cell-Depleted and In Vivo T Cell-Depleted Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission Resulted in Similar Overall Survival Survival: On Behalf of the ALWP of the EBMT and the MSKCC","keywords":"","combinedName":"doctor florent malard"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Johannes ","lastName":"Schetelig ","credentials":"MD ","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Favorable Long-Term Outcomes after Allogeneic Transplantation for Elderly Patients with Myelodysplastic Syndromes: A Report from the Chronic Malignancies Working Party of EBMT","keywords":"","combinedName":"doctor johannes schetelig"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Pavan Kumar ","lastName":"Bhamidipati ","credentials":"MBBS, MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"FLT3 Positivity Is a Predictor of Early Relapse Post-Transplantation  Allo-HCT Is an Ineffective Salvage Strategy in Active AML","keywords":"","combinedName":"doctor pavan kumar bhamidipati"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Pierre-Edouard ","lastName":"Debureaux ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fractionated Gemtuzumab Ozogamicin in Association with High Dose Chemotherapy: A Bridge to Allogeneic Stem Cell Transplantation in Refractory and Relapsed Acute Myeloid Leukemia?","keywords":"","combinedName":"doctor pierre-edouard debureaux"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Yasuhiko ","lastName":"Shibasaki ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Further Prognostic Factors for Stratification of Patients in the High-Risk HCT-CI Group Undergoing Allogeneic HCT","keywords":"","combinedName":"doctor yasuhiko shibasaki"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Jonathan ","lastName":"Canaani ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Haploidentical Stem Cell Transplantation Attenuates the Prognostic Impact of FLT3-ITD in Acute Myeloid Leukemia","keywords":"","combinedName":"doctor jonathan canaani"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Michael ","lastName":"Slade ","credentials":"MD,MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematopoietic Cell Transplant for Adults Age =65: Does Donor Type Matter?","keywords":"","combinedName":"doctor michael slade"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Aleksandar ","lastName":"Radujkovic ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Progression-Free Survival after Reduced Intensity Total Body Irradiation-Based Conditioning in Patients Allografted for Chronic Myelomonocytic Leukemia (CMML)","keywords":"","combinedName":"doctor aleksandar radujkovic"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Nicole ","lastName":"Foley ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Demographic and Socioeconomic Factors on Outcomes Following Allogeneic Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor nicole foley"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Yu ","lastName":"Wang ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Intensified Conditioning and DLI for Relapsed/Refractory Acute Leukemia: Real-World Data from China Registry","keywords":"","combinedName":"doctor yu wang"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Angela Maria","lastName":"Trujillo ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Term Follow up of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Children and Teenagers < 18 Years Old with High-Risk Acute Leukemia. Very Good Results in CR1 and CR2 Patients but Unexpected High Incidence of Severe Acute Graft Versus Host Disease in Children < 10 Years","keywords":"","combinedName":"doctor angela maria trujillo"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Musa ","lastName":"Waiswa ","credentials":"MBChB","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long Term Followup of Sickle Cell Disease Post Hematopoietic Stem Cell Transplant from Uganda","keywords":"","combinedName":"doctor musa waiswa"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Frederick ","lastName":"Fasslrinner ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Efficacy of Reduced-Intensity Conditioning Compared to Standard Myeloablative Conditioning before Allogeneic Hemopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission: 10-Year Follow-up of a Prospective, Open-Label Randomized Phase III Trial","keywords":"","combinedName":"doctor frederick fasslrinner"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Camille ","lastName":"Puronen ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Follow up of 90y-Ibritumomab Tiuxetan, Fluadarabine and TBI Based Non-Myeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B-Cell Lymphoma","keywords":"","combinedName":"doctor camille puronen"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Ioannis ","lastName":"Politikos ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Long-Term Follow-up of Adult Double Unit Cord Blood (CB) Transplantation (dCBT) Recipients Reveals High Rates of Progression-Free Survival after a Novel Cy/ Flu/ Thio/ TBI 400 Intermediate Intensity Conditioning Regimen","keywords":"","combinedName":"doctor ioannis politikos"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Andrea ","lastName":"Velardi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Low-Toxicity/High-Efficacy HLA Haploidentical Transplantation for Elderly/Unfit Patients with Acute Leukemia","keywords":"","combinedName":"doctor andrea velardi"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Kaito ","lastName":"Harada ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Melphalan Dose in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation with Reduced-Intensity Fludarabine and Melphalan","keywords":"","combinedName":"doctor kaito harada"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Bei ","lastName":"Hu ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Optimal Timing of Allogeneic Stem Cell Transplantation (Allo-SCT) for Chronic Myeloid Leukemia (CML) Patients in the Tyrosine Kinase Inhibitor (TKI) Era","keywords":"","combinedName":"doctor bei hu"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Alice ","lastName":"Bertaina ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcome of Children with Acute Leukemia Given Allogeneic HSCT Either from an Unrelated Donor or from an HLA-Partially Matched Relative after a-T Cell/B-Cell Depletion: A Multicenter, Retrospective, Comparative Analysis of the AIEOP Network","keywords":"","combinedName":"doctor alice bertaina"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Miao ","lastName":"Miao ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes of Combination of HLA-Haploidentical Hematopoietic SCT with an Unrelated Cord Blood Unit for 127 Patients with Acquired Severe Aplastic Anemia","keywords":"","combinedName":"doctor miao miao"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Jie ","lastName":"Ji ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pilot Study of Safety and Efficacy of Chidamide in Allogenic Peripheral Hematopoietic Stem Cell Transplantation: Better Disease Control and Positively Lower Graft Versus Host Disease","keywords":"","combinedName":"doctor jie ji"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Jeanne ","lastName":"Palmer ","credentials":"Md","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pre-Transplantation Predictors of Survival in Patients Undergoing Allogeneic Stem Cell Transplant for Myelofibrosis","keywords":"","combinedName":"doctor jeanne palmer"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Julie-An ","lastName":"Talano ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Promising Results at 1 Year Follow-up Following Familial Haploidentical (FHI) T-Cell Depleted (TCD) with CD34 Enrichment and T-Cell (CD3) Addback Allogeneic Stem Cell Transplantation in Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359)","keywords":"","combinedName":"doctor julie-an talano"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Johannes ","lastName":"Schetelig ","credentials":"MD ","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party","keywords":"","combinedName":"doctor johannes schetelig"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Olivier ","lastName":"Tournilhac ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"RIC Allogeneic Stem Cell Transplantation for High Risk CLL Followed By Preemptive MRD-Based Immunointervention  Final Results from the Phase II ICLL03 Ricac-Pmm Trial (FILO  SFGM-TC French intergroup)","keywords":"","combinedName":"doctor olivier tournilhac"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Lucia ","lastName":"Brunello ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sequential High-Dose Chemotherapy Reinduction Followed By Haploidentical Transplantation in Acute Leukemias","keywords":"","combinedName":"doctor lucia brunello"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Ron ","lastName":"Ram ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sequential Therapy for Patients with Primary Refractory AML  a Retrospective Analysis of the German and Israeli Experience","keywords":"","combinedName":"doctor ron ram"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Santosh ","lastName":"Saraf ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Stable Engraftment with Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor santosh saraf"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Maurizio ","lastName":"Miano ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Stem Cell Transplantation for Congenital Dyserythropoietic Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)","keywords":"","combinedName":"doctor maurizio miano"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Neha ","lastName":"Mehta-Shah ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Successful Treatment of Mature T-Cell Lymphoma with Allogeneic Stem Cell Transplantation: The Largest Multicenter Retrospective Analysis","keywords":"","combinedName":"doctor neha mehta-shah"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Joseph ","lastName":"Rimando ","credentials":"BS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Relationship between HLA Disparity and Clinical Outcomes in Peripheral Blood T Cell Replete Haploidentical Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor joseph rimando"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Francesco ","lastName":"Saraceni ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thiotepa-Busulfan-Fludarabine in Comparison to Busulfan-Cyclophosphamide As Myeloablative Conditioning Regimen Pre Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)","keywords":"","combinedName":"doctor francesco saraceni"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Tania ","lastName":"Jain ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transfusion Dependence at Day +100 Predicts Poorer Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation for Myelofibrosis","keywords":"","combinedName":"doctor tania jain"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Yue ","lastName":"Lu ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Unmanipulated Haploidentical Transplant for Acquired Severe Aplastic Anemia Achieved Comparable Outcomes with Unrelated Donor Transplant in Adult and Children Patients","keywords":"","combinedName":"doctor yue lu"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Michael ","lastName":"Leukam ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of Pre-Transplant Biomarker Measurement and Risk Score for Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant (HCT)","keywords":"","combinedName":"doctor michael leukam"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Taiki ","lastName":"Ando ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Value of Computed Tomography-Defined Sarcopenia: A Prognostic Predictor of Non-Relapse Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome","keywords":"","combinedName":"doctor taiki ando"},{"sessionId":"11883","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Poster III","firstName":"Melhem M","lastName":"Solh ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA- Haploidenitcal Relative or an Older Fully HLA-Matched Sibling or Unrelated Volunteer?","keywords":"","combinedName":"doctor melhem m solh"},{"sessionId":"11884","sessionTitle":"801. Gene Therapy and Transfer: Poster II","firstName":"Steven","lastName":"Pipe","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"101HEMB01 Is a Phase 1/2 Open-Label, Single Ascending Dose-Finding Trial of DTX101 (AAVrh10FIX) in Patients with Moderate/Severe Hemophilia B That Demonstrated Meaningful but Transient Expression of Human Factor IX (hFIX)","keywords":"","combinedName":"doctor steven pipe"},{"sessionId":"11884","sessionTitle":"801. Gene Therapy and Transfer: Poster II","firstName":"Stefan ","lastName":"Radtke ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Novel Highly Conserved Hematopoietic Stem/Progenitor Cell Population for Stem Cell Transplantation and Gene Therapy","keywords":"","combinedName":"doctor stefan radtke"},{"sessionId":"11884","sessionTitle":"801. Gene Therapy and Transfer: Poster II","firstName":"Megan ","lastName":"Hoban ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aryl Hydrocarbon Receptor Antagonists Expand Adult Hematopoietic Stem Cells from Mobilized Peripheral Blood and Bone Marrow and Increase the Dose of CRISPR/Cas9 Gene-Edited NSG-Repopulating Cells","keywords":"","combinedName":"doctor megan hoban"},{"sessionId":"11884","sessionTitle":"801. Gene Therapy and Transfer: Poster II","firstName":"Lung-Ji ","lastName":"Chang ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chimeric Antigen Receptor 4SCAR-GD2-Modified T Cells Targeting High-Risk and Recurrent Neuroblastoma: A Phase II Multi-Center Trial in China","keywords":"","combinedName":"doctor lung-ji chang"},{"sessionId":"11884","sessionTitle":"801. Gene Therapy and Transfer: Poster II","firstName":"Nobuhiro ","lastName":"Nishio ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Durable Remission after Salvage Chemotherapy with Combining Bortezomib and Vorinostat Followed By CD19 CAR-T Therapy in a Patient with MLL-Rearranged ALL after Early Relapse Post Allogeneic Hematopoietic Stem Cell Transplantation","keywords":"","combinedName":"doctor nobuhiro nishio"},{"sessionId":"11884","sessionTitle":"801. Gene Therapy and Transfer: Poster II","firstName":"Roberto ","lastName":"Calcedo ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Immune Responses in 101HEMB01, a Phase 1/2 Open-Label, Single Ascending Dose-Finding Trial of DTX101 (AAVrh10FIX) in Patients with Severe Hemophilia B","keywords":"","combinedName":"doctor roberto calcedo"},{"sessionId":"11884","sessionTitle":"801. Gene Therapy and Transfer: Poster II","firstName":"Brian ","lastName":"Long ","credentials":"PhD, MS, BSMedTech","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Pre-Existing Immunogenicity to AAV on Vector Transduction By Bmn 270, an AAV5-Based Gene Therapy Treatment for Hemophilia a","keywords":"","combinedName":"doctor brian long"},{"sessionId":"11884","sessionTitle":"801. Gene Therapy and Transfer: Poster II","firstName":"Aaron ","lastName":"Foster ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inducible MyD88/CD40 (iMC) Costimulation Enhances Polyclonal Epstein-Barr Virus-Specific Cytotoxic T Lymphocyte (EBV-CTL) Proliferation and Anti-Tumor Activity","keywords":"","combinedName":"doctor aaron foster"},{"sessionId":"11884","sessionTitle":"801. Gene Therapy and Transfer: Poster II","firstName":"Joab ","lastName":"Camarena ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Priming Human Hematopoietic Stem and Progenitor Cells for Cas9/Sgrna and rAAV6-Mediated Homologous Recombination","keywords":"","combinedName":"doctor joab camarena"},{"sessionId":"11884","sessionTitle":"801. Gene Therapy and Transfer: Poster II","firstName":"Naoya ","lastName":"Uchida ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Selective Proliferation of Gene-Modified Human Erythroid Cells with Truncated Erythropoietin Receptors","keywords":"","combinedName":"doctor naoya uchida"},{"sessionId":"11884","sessionTitle":"801. Gene Therapy and Transfer: Poster II","firstName":"Christopher ","lastName":"Lux ","credentials":"MD,PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Talen Mediated Therapeutic Gene Editing Strategy for -Hemoglobinopathies","keywords":"","combinedName":"doctor christopher lux"},{"sessionId":"11884","sessionTitle":"801. Gene Therapy and Transfer: Poster II","firstName":"Trudy ","lastName":"Straetemans ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Towards the Next Generation CAR T Cells with TEGs: In Vivo Efficacy  Toxicity Profile in Xenografts of Primary Human AML Disease and Healthy Bone Marrow","keywords":"","combinedName":"doctor trudy straetemans"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Sandra ","lastName":"Le Quellec ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Adeno-Associated Virus Mediated Gene Transfer with Hyperfunctional FIX-E410H Variant Improves Mean Factor IX Activity Levels in Hemophilia B Mice","keywords":"","combinedName":"doctor sandra le quellec"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Emmanuelle ","lastName":"Six ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diverse and Distinct Human Hematopoietic Differentiation Programs Generate By Bone Marrow and G-CSF Mobilized Hematopoietic Stem and Progenitors Cells","keywords":"","combinedName":"doctor emmanuelle six"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Jennifer L","lastName":"Gori","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Expanding CRISPR Genome Editing Strategies in Hematopoietic Stem and Progenitor Cells for the Treatment of Hematologic Diseases","keywords":"","combinedName":"doctor jennifer l gori"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Selami ","lastName":"Demirci ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fetal Hemoglobin Induction with Forced Chromatin Looping in Gene-Modified Erythroid Cells Differentiated from Rhesus Hematopoietic Progenitor Cells","keywords":"","combinedName":"doctor selami demirci"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Andre ","lastName":"Lieber ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Vivo HSC Transduction and Selection Results in Long-Term, High-Level Expression of Human Gamma Globin in Peripheral Blood Erythrocytes of Mice","keywords":"","combinedName":"doctor andre lieber"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Brian ","lastName":"Long ","credentials":"PhD, MS, BSMedTech","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Interim Analysis of Immunogenicity to the Vector Capsid and Transgene-Expressed Human FVIII in a Phase-1/2 Clinical Study of Bmn 270, an AAV5-Mediated Gene Therapy for Hemophilia a","keywords":"","combinedName":"doctor brian long"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Antonia ","lastName":"Rotolo ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Invariant NKT Are a More Effective and Versatile Platform Than T Cells for CAR Immunotherapy of CD1d-Expressing B Lineage Malignancies: Cellular and Molecular Mechanisms","keywords":"","combinedName":"doctor antonia rotolo"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Marina","lastName":"Cavazzana","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Longer Term Follow-up on the First Patients with Severe Hemoglobinopathies Treated with Lentiglobin Gene Therapy","keywords":"","combinedName":"doctor marina cavazzana"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Aaron ","lastName":"Foster ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MyD88/CD40 Enhanced CD19-Specific CAR-T Cells Maintain Therapeutic Efficacy Following Resolution of Cytokine-Related Toxicity Using Inducible Caspase-9","keywords":"","combinedName":"doctor aaron foster"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Jing ","lastName":"Li ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Platelet-Targeted Gene Transfer Induces Immune Tolerance in a Primed Model","keywords":"","combinedName":"doctor jing li"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Daniel ","lastName":"Dever ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preclinical Development of HBBGene Correction in Autologous Hematopoietic Stem and Progenitor Cells to Treat Severe Sickle Cell Disease","keywords":"","combinedName":"doctor daniel dever"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Kristen ","lastName":"Fousek ","credentials":"BS, MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Targeting Primary Pre-B Cell Acute Lymphoblastic Leukemia and CD19-Negative Relapses Using Trivalent CAR T Cells","keywords":"","combinedName":"doctor kristen fousek"},{"sessionId":"11885","sessionTitle":"801. Gene Therapy and Transfer: Poster III","firstName":"Michael Kyle","lastName":"Cromer ","credentials":"BS, MPhil, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transcriptional Response to Genome Editing Machinery in CD34+ HSPCs","keywords":"","combinedName":"doctor michael kyle cromer"},{"sessionId":"11886","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster II","firstName":"Valgardur ","lastName":"Sigurdsson ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Transient Induction of Blood-Circulating Bile Acid Is a Therapeutic Marker and Target of Chemotherapy-Oriented Myelosuppression","keywords":"","combinedName":"doctor valgardur sigurdsson"},{"sessionId":"11886","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster II","firstName":"Sonal S","lastName":"Tonapi ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aptamer C10.36 Reveals a Ribonucleoprotein Complex on the Surface of Non-Hodgkin Lymphoma Cells Providing Candidates for Multi-Target Therapeutics","keywords":"","combinedName":"doctor sonal s tonapi"},{"sessionId":"11886","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster II","firstName":"Misbah ","lastName":"Sabir ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of Novel Highly Specific FLT3 Targeted Inhibitors for Combination or Sequential Therapy of Acute Myeloid Leukemia","keywords":"","combinedName":"doctor misbah sabir"},{"sessionId":"11886","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster II","firstName":"Aksinija A","lastName":"Kogan ","credentials":"BS, MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"DNA Demethylating Agents Generate a Brcaness Effect in Multiple Sporadic Tumor Types: Prediction for Sensitivity to PARP Inhibitors in AML","keywords":"","combinedName":"doctor aksinija a kogan"},{"sessionId":"11886","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster II","firstName":"Sarah ","lastName":"Holstein ","credentials":"MD, PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Structure-Function Relationships of Novel Benzimidazole-Based Inhibitors of the Isoprenoid Biosynthetic Pathway in Myeloma Cells","keywords":"","combinedName":"doctor sarah holstein"},{"sessionId":"11886","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster II","firstName":"Ryosuke ","lastName":"Shirasaki ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Systematic Characterization of the \"Resistome\" of Tumor Cells Against Panels of Small Molecule Inhibitors - Application in the Context of Inhibitors of Transcriptional Cyclin-Dependent Kinases (tCDKs) and Implications for Future \"Individualized\" Clinical Applications","keywords":"","combinedName":"doctor ryosuke shirasaki"},{"sessionId":"11886","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster II","firstName":"Charlie ","lastName":"Ly ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Pan-FLT3/BTK Multi-Kinase Inhibitor CG 806 Induces AML Killing in FLT-Mutant and Wild Type Cells, and Exerts Synergistic Pro-Apoptotic Effects with Concomitant Targeting of Anti-Apoptotic Bcl-2 and/or Mcl-1","keywords":"","combinedName":"doctor charlie ly"},{"sessionId":"11887","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster III","firstName":"Ajay ","lastName":"Gopal ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 1-2 Dose-Escalation and Cohort- Expansion Study of eFT508, a Selective, Orally Bioavailable Inhibitor of MNK1and MNK2,inPatientswith Hematological Malignancies","keywords":"","combinedName":"doctor ajay gopal"},{"sessionId":"11887","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster III","firstName":"Kevin ","lastName":"Mills ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Small Molecule RAD51 Inhibitor Preferentially Affects Cells Expressing High Cytidine Deaminase Activity","keywords":"","combinedName":"doctor kevin mills"},{"sessionId":"11887","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster III","firstName":"Evandro D","lastName":"Bezerra ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Barriers to Successful Implementation of Precision Medicine to the Treatment of Refractory AML: Lessons Learned","keywords":"","combinedName":"doctor evandro d bezerra"},{"sessionId":"11887","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster III","firstName":"Stephen E","lastName":"Kurtz ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CG 806, a First-in-Class Pan-FLT3/BTK Inhibitor, Exhibits Potent Growth Inhibition As a Single Agent and in Combination with a BET Bromodomain Inhibitor or a Bcl2 Inhibitor on Primary AML and CLL Patient Samples","keywords":"","combinedName":"doctor stephen e kurtz"},{"sessionId":"11887","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster III","firstName":"Guopan ","lastName":"Yu ","credentials":"MD., PhD.","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CG 806, a Novel Pan-FLT3/BTK Multi-Kinase Inhibitor, Induces Cell Cycle Arrest, Apoptosis or Autophagy in AML Cells Depending on FLT3 Mutation Status","keywords":"","combinedName":"doctor guopan yu"},{"sessionId":"11887","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster III","firstName":"John Dimos","lastName":"Stratigis ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Utero Injections of Nanoparticle Encapsulated Myelin Oligodendrocyte Glycoprotein Peptides Prevent Experimental Autoimmune Encephalopathy Via Central Tolerance","keywords":"","combinedName":"doctor john dimos stratigis"},{"sessionId":"11887","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster III","firstName":"Staci ","lastName":"Haney ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preclinical Investigation of a Potent Geranylgeranyl Diphosphate Synthase Inhibitor","keywords":"","combinedName":"doctor staci haney"},{"sessionId":"11887","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster III","firstName":"Katherine ","lastName":"Sullivan ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Leukemia Cells","keywords":"","combinedName":"doctor katherine sullivan"},{"sessionId":"11887","sessionTitle":"802. Chemical Biology and Experimental Therapeutics: Poster III","firstName":"Kevin ","lastName":"Mills ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Synthetic Lethality Targeting the Aid/RAD51 Axis for Treatment of AICDA-Expressing Lymphoma","keywords":"","combinedName":"doctor kevin mills"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Elena ","lastName":"Pera ","credentials":"PhD,MSc,MPhil","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Cost-Effective Implementation of Pre-Operative Protocol with Sucrosomial Iron Supplementation","keywords":"","combinedName":"doctor elena pera"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Matthew ","lastName":"Sears ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Prospective Multi-Centered Registry Is Feasible in Sickle Cell Disease: Globin Regional Network for Data and Discovery (GRNDaD)","keywords":"","combinedName":"doctor matthew sears"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Earleisha ","lastName":"Felder ","credentials":"PA-C","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessment of Referral Patterns of Adult Patients to a Sickle Cell Disease Specialty Clinic within a Statewide Sickle Cell Network","keywords":"","combinedName":"doctor earleisha felder"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Craig C","lastName":"Hofmeister ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"B-Cell Lymphoma Patients Have a 10% Risk of Shingles, 7% in Cutaneous T-Cell Lymphoma","keywords":"","combinedName":"doctor craig c hofmeister"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Anjelica C","lastName":"Saulsberry ","credentials":"BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Caregiver Perceptions of Adolescent Self-Management Skills Predicts Higher Disease Knowledge Among Adolescents with SCD","keywords":"","combinedName":"doctor anjelica c saulsberry"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Linda ","lastName":"Hoang ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Use of Direct Oral Anticoagulants and Warfarin in the Treatment of Atrial Fibrillation and Venous Thromboembolism and Prophylaxis: A Retrospective Single Center Utilization Study","keywords":"","combinedName":"doctor linda hoang"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Susan T","lastName":"Paulukonis ","credentials":"MA, MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"County Level Surveillance of Sickle Cell Disease Population, Healthcare Utilization, and Fragmentation to Support Improvements in Access to Care","keywords":"","combinedName":"doctor susan t paulukonis"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Ariela ","lastName":"Marshall ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Determinants of Hematology-Oncology Trainees Post-Fellowship Career Pathways with a Focus on Non-Malignant Hematology","keywords":"","combinedName":"doctor ariela marshall"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Natalie ","lastName":"Duncan ","credentials":"MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development and Validation of a Patient/Caregiver-Report Hydroxyurea Treatment Adherence Scale","keywords":"","combinedName":"doctor natalie duncan"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Emanuele ","lastName":"Angelucci ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Direct Medical Care Costs Associated with -Thalassemia Care in Italy","keywords":"","combinedName":"doctor emanuele angelucci"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Irbaz Bin ","lastName":"Riaz ","credentials":"MD,MMSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Gender Differences in Faculty Rank, Departmental Leadership, and Research OutputAmongst Hematology/OncologyFacultyin United States","keywords":"","combinedName":"doctor irbaz bin riaz"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Wilma ","lastName":"Barcellini ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Healthcare Resource Utilization in Autoimmune Hemolytic Anemia Patients: Analysis of 190 Cases from a Single Center","keywords":"","combinedName":"doctor wilma barcellini"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Ikuyo Ota","lastName":"Tsutsumi ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Oral Voriconazole As Prophylaxis during Intensive Chemotherapy for Adult Patients with Acute Myeloid Leukemia: A Retrospective Cohort Study Using Japanese Administrative Database","keywords":"","combinedName":"doctor ikuyo ota tsutsumi"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Girish ","lastName":"Kunapareddy ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience","keywords":"","combinedName":"doctor girish kunapareddy"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Natasha ","lastName":"Archer ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improving the Diagnosis and Early Follow-up of Children with Sickle Cell Disease Born in Mirebalais Haiti","keywords":"","combinedName":"doctor natasha archer"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Jessica ","lastName":"Cohen ","credentials":"BS, BA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inflammatory Bowel Disease and Thrombosis: A National Inpatient Sample (NIS) Study","keywords":"","combinedName":"doctor jessica cohen"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Pierre ","lastName":"Toulon ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lack of Inter-Laboratory Agreement in the Monitoring of Unfractionated Heparin Using the Anti-Factor Xa Activity and the Anti-Factor Xa-Correlated Activated Partial Thromboplastin Time","keywords":"","combinedName":"doctor pierre toulon"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Varun ","lastName":"Mittal ","credentials":"M.B.B.S","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Obstetric and Bleeding Complications in Pregnancy with Von Willebrand Disease: Results from Nationwide Inpatient Sample Database 2003-2011","keywords":"","combinedName":"doctor varun mittal"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Madan ","lastName":"Aryal ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recent Trends in Incidence and Financial Impact of Peripherally Inserted Central Catheter (PICC)-Associated Upper Extremity Deep Vein Thrombosis (DVT): Data from National Inpatient Sample","keywords":"","combinedName":"doctor madan aryal"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Eric ","lastName":"Lau ","credentials":"DO","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Resource Utilization Associated with the Management of Adults with Hemophagocytic Lymphohistiocytosis (HLH): A Benchmark Analysis for Improving Inpatient Care at a Quaternary Hospital ","keywords":"","combinedName":"doctor eric lau"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Uttara ","lastName":"Nag ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Risk Factors for Thrombosis in the Neonatal Intensive Care Unit: Analysis of a Large National Database","keywords":"","combinedName":"doctor uttara nag"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Lianna ","lastName":"Marks ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Stroke in Pediatric Sickle Cell Disease in Sub-Saharan Africa: Systematic Review and Estimated Prevalence","keywords":"","combinedName":"doctor lianna marks"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Carlton ","lastName":"Scharman ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Off-Label Use of Four-Factor Prothrombin Complex Concentrate: A Single Institution Retrospective Study","keywords":"","combinedName":"doctor carlton scharman"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Tomi ","lastName":"Jun ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Using Electronic Best Practice Alerts to Improve Thrombophilia Testing Based on ASH Choosing Wisely Guidelines","keywords":"","combinedName":"doctor tomi jun"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Grant ","lastName":"Jester ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Utilizing the EMR to Curb Inappropriate Inpatient Thrombophilia Testing","keywords":"","combinedName":"doctor grant jester"},{"sessionId":"11888","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster II","firstName":"Heather ","lastName":"Wright ","credentials":"DO","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Venous Thromboembolism (VTE) Increases the Healthcare Burden in Patients with Malignant Glioma (MG)","keywords":"","combinedName":"doctor heather wright"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Faizan ","lastName":"Khan ","credentials":"BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Decision Model to Estimate Risk Thresholds for Guiding Duration of Anticaogulation in Unprovoked Venous Thromboembolism","keywords":"","combinedName":"doctor faizan khan"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Bruno K L","lastName":"Duarte ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Simple Bundle to Control an Outbreak of Carbapenem-Resistant Enterobacteriacae in an Onco-Hematological Inpatient Unit: Report from a Single Center","keywords":"","combinedName":"doctor bruno k l duarte"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Grammati ","lastName":"Sarri ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Systematic Literature Review of Patient-Reported Outcome Instruments Used in Sickle Cell Disease","keywords":"","combinedName":"doctor grammati sarri"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Carlton ","lastName":"Dampier ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Access to Care for Medicaid and Commercially-Insured United States Patients with Sickle Cell Disease","keywords":"","combinedName":"doctor carlton dampier"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Deepa","lastName":"Manwani","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Intensive Transition Navigator Intervention Improves Transition Readiness to Adult Care in Youth with Sickle Cell Disease","keywords":"","combinedName":"doctor deepa manwani"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Larissa ","lastName":"Liontos ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BleedingRiskUsingINR/aPTT Pre-Surgery:SystematicReview (BRUISR)","keywords":"","combinedName":"doctor larissa liontos"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Erika ","lastName":"Szabo ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Budget Impact Analysis of Switching Chemotherapy Patients Using Granulocyte Colony-Stimulating Factors (G-CSFs) from Pegfilgrastim to Short-Acting G-CSFs in the United States","keywords":"","combinedName":"doctor erika szabo"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Chebli ","lastName":"Mrad ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cerebrovascular Accidents Among African American Adults with Sickle Cell Disease: A Nationwide Outcomes and Trend Analysis over Two Decades","keywords":"","combinedName":"doctor chebli mrad"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Erika ","lastName":"Szabo ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Cost-Efficiency Analysis of Granulocyte Colony-Stimulating Factors for Use in Chemotherapy Patients in the United States","keywords":"","combinedName":"doctor erika szabo"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Pallavi ","lastName":"Kopparthy ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Diagnosis and Management of Heparin Induced Thrombocytopenia - Are We Choosing Wisely?","keywords":"","combinedName":"doctor pallavi kopparthy"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Abiola ","lastName":"Oladapo ","credentials":"PhD, BPharm","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Estimating the Cost Savings and Cost Effectiveness of Low Dose Immune Tolerance Induction (ITI) Therapy with Bypassing Agent Prophylaxis Compared to High Dose ITI and Low Dose ITI","keywords":"","combinedName":"doctor abiola oladapo"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Melissa N","lastName":"Yan ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Clinical and Radiological Factors Associated with Thrombosis Recurrence in Cancer Associated Subsegmental Pulmonary Embolism","keywords":"","combinedName":"doctor melissa n yan"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Sonia ","lastName":"Anand ","credentials":"MPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Health Disparity in Hematopoietic Cell Transplantation for Sickle Cell Disease: Analyzing the Association of Insurance and Socioeconomic Status Among Children Undergoing Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor sonia anand"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Michael ","lastName":"Streiff ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Healthcare Costs Associated with Venous Thromboembolism in Cancer Patients Treated with Anticoagulants","keywords":"","combinedName":"doctor michael streiff"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Tiffany ","lastName":"Quock ","credentials":"PhD, MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Healthcare Utilization and Costs in Commercially Insured Patients with AL Amyloidosis","keywords":"","combinedName":"doctor tiffany quock"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Zaid ","lastName":"Abdel-Rahman ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematology Referrals for Mild Thrombocytopenia in a Tertiary Center in Detroit: A Step Towards a Standardized Approach for Referrals and Testing","keywords":"","combinedName":"doctor zaid abdel-rahman"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Siriporn ","lastName":"Jutiamornlerd ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Incidence of True Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia Antibody Development in Critically Ill Medical Patients","keywords":"","combinedName":"doctor siriporn jutiamornlerd"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Jason ","lastName":"Payne ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Early Analgesia on Hospitalization for Sickle Cell Pain Crisis","keywords":"","combinedName":"doctor jason payne"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Erika ","lastName":"Correa ","credentials":"MD, MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Iron Deficiency Anemia on Inpatient Mortality, Hospital Cost, and Length of Stay in Patients with Luminal Gastrointestinal Cancers: Data from the Healthcare Cost and Utilization Project from 1999-2014","keywords":"","combinedName":"doctor erika correa"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Ming Yeong","lastName":"Lim ","credentials":"MBBChir","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Systems-Based Hematologists in Maintaining a HIT Program Using Continuous Clinical Audit and Education in an Academic Medical Center","keywords":"","combinedName":"doctor ming yeong lim"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Susan ","lastName":"Claster ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Improving Access to Care for Adults with Sickle Cell Disease in Los Angeles County","keywords":"","combinedName":"doctor susan claster"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Gabriela ","lastName":"Sanchez Petitto ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Modified Khorana Models for Prediction of Cancer-Associated Venous Thromboembolism: An Exploratory Study","keywords":"","combinedName":"doctor gabriela sanchez petitto"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Andrea ","lastName":"Charron ","credentials":"MSc, MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pharmacy Hydroxyurea Education Materials for Patients with Sickle Cell Disease: An Environmental Scan and Assessment of Accuracy","keywords":"","combinedName":"doctor andrea charron"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Mak ","lastName":"Djulbegovic ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Predictive Tool to Support Decision-Making about Management of Conflicts of Interest for Guideline Development: Derivation and Validation","keywords":"","combinedName":"doctor mak djulbegovic"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"David C","lastName":"Fajgenbaum ","credentials":"MD,MBA,MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Results from Accelerate, an International, Web-Based, Natural History Registry of Castleman Disease","keywords":"","combinedName":"doctor david c fajgenbaum"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Vera ","lastName":"Troitskaya ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Impact of Pregnancy on Long-Term Outcome in Acute Leukemias Patients","keywords":"","combinedName":"doctor vera troitskaya"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Jin ","lastName":"Han ","credentials":"PharmD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Program Expansion of a Day Hospital Dedicated to Manage Sickle Cell Pain","keywords":"","combinedName":"doctor jin han"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Craig C","lastName":"Hofmeister ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Shingles Occurs in Only 0.5% of Myeloma Patients on Any Dose of Antiviral Prophylaxis","keywords":"","combinedName":"doctor craig c hofmeister"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Dongyoun Deborah","lastName":"Park ","credentials":"MD, BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sickle Cell Disease and the Adherence to Guidelines for Use of Blood Transfusions","keywords":"","combinedName":"doctor dongyoun deborah park"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Dhauna ","lastName":"Karam ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Spectrum of Hematological Disorders in Young Navy Recruits","keywords":"","combinedName":"doctor dhauna karam"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Velu ","lastName":"Nair ","credentials":"MBBS, MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Splenic Infarct As an Harbinger for Sickle Cell Traits in High Altitude","keywords":"","combinedName":"doctor velu nair"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Meredith ","lastName":"Schaffner ","credentials":"DO","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Striving to HIT the Bullseye When Diagnosing Heparin-Induced Thrombocytopenia","keywords":"","combinedName":"doctor meredith schaffner"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Janine Claudia Khadija","lastName":"Harewood ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Anticoagulation Champion Efficacy of Warfarin Anticoagulation in a Resident Based Primary Care Clinic","keywords":"","combinedName":"doctor janine claudia khadija harewood"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Sudeep K","lastName":"Siddappa Malleshappa ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Thirty Day Readmissions Due to Venous Thromboembolism in Patients Discharged with Syncope","keywords":"","combinedName":"doctor sudeep k siddappa malleshappa"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Miriam ","lastName":"Kwarteng-Siaw ","credentials":"BA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Transition Readiness Assessment of Adolescents with Sickle Cell Disease and Their Caretakers at the Sickle Cell Clinic in Kumasi, Ghana","keywords":"","combinedName":"doctor miriam kwarteng-siaw"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Shafia ","lastName":"Rahman ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience","keywords":"","combinedName":"doctor shafia rahman"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Varun ","lastName":"Mittal ","credentials":"M.B.B.S","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Trends and Outcomes of Venous Thromboembolism in Hospitalized Patients with Ovarian Cancer: Results from Nationwide Inpatient Sample Database 2003 -2011","keywords":"","combinedName":"doctor varun mittal"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Rochelle ","lastName":"Maxwell ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Utilization of a Pediatric Sickle Cell Day Hospital By Patients with Sickle Cell Disease and Pain Events Is Associated with a Lower Rate of Inpatient Hospital Admission Compared to Utilization of the Pediatric Emergency Department","keywords":"","combinedName":"doctor rochelle maxwell"},{"sessionId":"11889","sessionTitle":"901. Health Services ResearchNon-Malignant Conditions: Poster III","firstName":"Alok ","lastName":"Khorana","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"VTE Recurrence and Safety of Anticoagulants Among Patients with Cancer Treated for Venous Thromboembolism","keywords":"","combinedName":"doctor alok khorana"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Alina ","lastName":"Basnet ","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":" Low Enrollment of Adult Patients in Clinical Trials: Is Communication Still a Problem?","keywords":"","combinedName":"doctor alina basnet"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Ricardo ","lastName":"Parrondo ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Antibiotic Overload: Antibiotic Stewardship in Febrile Patients with Hematologic Malignancies","keywords":"","combinedName":"doctor ricardo parrondo"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Stephanie ","lastName":"Debragga ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comorbid Conditions in Newly Diagnosed Patients with Acute Promyelocytic Leukemia (APL)in \"Real World\" Patients; Decreased Induction Mortality Despite a High Comorbid Index","keywords":"","combinedName":"doctor stephanie debragga"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Karen ","lastName":"Seiter ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparison of Healthcare Resource Utilization and Costs Related to Infections between Patients Newly Diagnosed with Chronic Myeloid Leukemia Treated with Dasatinib and Nilotinib As First-Line Therapy in the United States","keywords":"","combinedName":"doctor karen seiter"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Eric M","lastName":"Maiese ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cost-Effectiveness of Daratumumab Plus Bortezomib and Dexamethasone Versus Bortezomib Plus Dexamethasone for Treatment of Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy: An Analysis of the Castor Trial","keywords":"","combinedName":"doctor eric m maiese"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Mara M","lastName":"Epstein ","credentials":"ScD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Detecting Cases of Monoclonal Gammopathy of Undetermined Significance in Electronic Health Data","keywords":"","combinedName":"doctor mara m epstein"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Xinke ","lastName":"Zhang ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Economic Burden of Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Acute Lymphoblastic Leukemia (ALL) in the US","keywords":"","combinedName":"doctor xinke zhang"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Abdalla ","lastName":"Aly ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Economic Burden of Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) in the US","keywords":"","combinedName":"doctor abdalla aly"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Elias ","lastName":"Jabbour","credentials":"MD ","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Economic Modeling of the Potential Impact of Chronic Myeloid Leukemia (CML) Monitoring on Healthcare Costs","keywords":"","combinedName":"doctor elias jabbour"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Jonathan ","lastName":"Wang ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Estimating the Need for Complex Malignant Hematologists in Ontario Using Monte Carlo Simulation","keywords":"","combinedName":"doctor jonathan wang"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Raakhee ","lastName":"Shah ","credentials":"MPharm","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of the Safety and Tolerability of Rapid Infusion of Biosimilar Rituximab Truxima - the University College London Hospitals (UCLH) Experience","keywords":"","combinedName":"doctor raakhee shah"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Kristen M","lastName":"Rosenthal ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evolving Treatment Patterns of Healthcare Providers (HCPs) and Multiple Myeloma (MM) Experts from 2013-2017: Analysis of an Annually Updated Online Treatment Decision Tool","keywords":"","combinedName":"doctor kristen m rosenthal"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Sanjeev ","lastName":"Balu ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Expanded Access to Obinutuzumab from Cost-Savings Generated By Biosimilar Filgrastim-Sndz in the Prophylaxis of Chemotherapy-Induced (Febrile) Neutropenia: US Simulation Study","keywords":"","combinedName":"doctor sanjeev balu"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Shannon ","lastName":"Cope ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Expert Elicitation of Long-Term Survival for Pediatric Acute Lymphoblastic Leukemia Patients Receiving CTL019 in Eliana Phase II Study","keywords":"","combinedName":"doctor shannon cope"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Nitya ","lastName":"Nathwani ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of a Brief Touchscreen Based Modified Geriatric Assessment on the Care of Older Adults with Multiple Myeloma","keywords":"","combinedName":"doctor nitya nathwani"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Binod","lastName":"Dhakal","credentials":"MBBS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Incremental Financial and Health-RelatedBurdenof Novel Drugs Used in the Treatment of Relapsed and/or Refractory Multiple Myeloma (RRMM): A Meta-Analysis of Phase III Randomized Controlled Trials (RCTs)","keywords":"","combinedName":"doctor binod dhakal"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Faye A","lastName":"Sharpley ","credentials":"MBBChir, MA, MRCP, MSc BA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inferior Clinical Outcomes with Fixed Duration Therapy for Transplant Ineligible Myeloma Patients: UK Real-World Data in Comparison with First Trial (MM-020)","keywords":"","combinedName":"doctor faye a sharpley"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Sujith ","lastName":"Dhanasiri ","credentials":"MSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lenalidomide Maintenance Therapy Post-Autologous Stem Cell Transplant: A Healthcare Cost-Impact Analysis in Europe","keywords":"","combinedName":"doctor sujith dhanasiri"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Laura Anne ","lastName":"Habib ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Management of Polycythemia Vera: a Survey of Canadian Physician Practice Plans","keywords":"","combinedName":"doctor laura anne habib"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Dietger ","lastName":"Niederwieser ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Narrowing the Gap for Hematopoietic Cell Transplantation in the East-Mediterranean/African Region: Comparison with Global HSCT Indications and Trends. a Report on Behalf of the East Mediterranean (EMBMT), African Blood and Marrow Transplantation Group (AfBMT) and Worldwide Network for Blood and Marrow Transplantation (WBMT)","keywords":"","combinedName":"doctor dietger niederwieser"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Christine ","lastName":"Sam ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase 1 Clinical Trial Methodology in Hematological Malignancies from 2005 - 2015: A Systematic Review","keywords":"","combinedName":"doctor christine sam"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Miha ","lastName":"Orazem ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Protecting Minor Donors of Hematopoietic Stem Cells: A Survey in EBMT Transplant Centers","keywords":"","combinedName":"doctor miha orazem"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Jan ","lastName":"Styczynski ","credentials":"MD PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Protective Environment for Hematopoietic Cell Transplant (HSCT) Recipients: The Infectious Diseases Working Party EBMT Analysis of Global Recommendations on Health-Care Facilities","keywords":"","combinedName":"doctor jan styczynski"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Erlene ","lastName":"Seymour ","credentials":"MD,BS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real-World Testing and Treatment Patterns in Chronic Lymphocytic Leukemia (CLL) in the United States during the Modern Era: A SEER Patterns of Care Analysis","keywords":"","combinedName":"doctor erlene seymour"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Ranjan ","lastName":"Pathak ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Recent Trends in the Incidence and Outcomes of Tumor Lysis Syndrome in Hematological Malignancies: Data from 2010-2014 National Inpatient Sample","keywords":"","combinedName":"doctor ranjan pathak"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Aniket ","lastName":"Bankar ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Resource Utilization Using Micro-Costing Method and Cost Effectiveness Analysis of Treatment of Acute Promyelocytic Leukemia with Generic Arsenic-Trioxide","keywords":"","combinedName":"doctor aniket bankar"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Ellen K","lastName":"Ritchie ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Patterns in Patients with Chronic Myeloid Leukemia in Chronic Phase in US Clinical Practice, with a Focus on Tyrosine Kinase Inhibitor Therapy Discontinuation","keywords":"","combinedName":"doctor ellen k ritchie"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Sikander ","lastName":"Ailawadhi ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Utilization of Radiation Therapy in Multiple Myeloma: Trends and Changes in Practice","keywords":"","combinedName":"doctor sikander ailawadhi"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Michelle ","lastName":"Deveaux ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Validation of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) Score for Hypomethylating Agents (HMAs) Use in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)","keywords":"","combinedName":"doctor michelle deveaux"},{"sessionId":"11891","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster II","firstName":"Areej ","lastName":"El-Jawahri ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"What Do Transplant Physicians Think about Palliative Care?a National Survey Study","keywords":"","combinedName":"doctor areej el-jawahri"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"lvaro ","lastName":"Cabrera-Garca ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Multicenter Retrospective Experience of Hematologic Neoplasms in Pregnancy","keywords":"","combinedName":"doctor lvaro cabrera-garca"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Srinivasa Reddy ","lastName":"Sanikommu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Value-Based Approach to Optimizing Peripheral Blood Progenitor Cell (PBPC) Mobilization and Collection for Autologus Hematopoietc Cell Transplantation (AHCT)","keywords":"","combinedName":"doctor srinivasa reddy sanikommu"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Ana Carolina","lastName":"Oliver ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Apache II and Sofa Scores Predict Mortality in Hematologic Malignancies Patients at Intensive Care Unit Admission","keywords":"","combinedName":"doctor ana carolina oliver"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Sujith ","lastName":"Dhanasiri ","credentials":"MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Assessing Outcomes, Healthcare Resource Utilisation and Costs across Europe in Newly Diagnosed Multiple Myeloma (NDMM) Patients Post Autologous Stem Cell Transplant (ASCT)","keywords":"","combinedName":"doctor sujith dhanasiri"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Emily ","lastName":"Huschart ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"AssessingSafe Discharge Criteria for Pediatric Oncology Patients Admitted for Febrile Neutropenia","keywords":"","combinedName":"doctor emily huschart"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Luciano ","lastName":"Costa ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Autologous Hematopoietic Progenitor Cells Mobilization with Combination of Pegfilgrastim and Plerixafor: Efficacy and Cost Assessment","keywords":"","combinedName":"doctor luciano costa"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Claudio ","lastName":"Cerichione ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Combined Oral Administration of Analgesia and Anxiolysis for Pain Associated with Bone Marrow Aspiration and Biopsy","keywords":"","combinedName":"doctor claudio cerichione"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Damion ","lastName":"Nero ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Comparative Study of Cardiovascular Co-Morbidities between Ibrutinib and Non-Ibrutinib-Treated Chronic Lymphocytic Leukemia (CLL) Patients","keywords":"","combinedName":"doctor damion nero"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Anuraag ","lastName":"Kansal ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cost-Effectiveness of CPX-351 Versus 7+3 Regimen in the Treatment of Treatment-Related Acute Myeloid Leukemia (tAML) or AML with Myelodysplasia-Related Changes (MRC)","keywords":"","combinedName":"doctor anuraag kansal"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Eric M","lastName":"Maiese ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cost-Effectiveness of Daratumumab Plus Lenalidomide Plus Dexamethasone Versus Lenalidomide Plus Dexamethasone for Treatment of Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy: An Analysis of the Pollux Trial","keywords":"","combinedName":"doctor eric m maiese"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Eytan ","lastName":"Stein ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Cost-Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States","keywords":"","combinedName":"doctor eytan stein"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Jacob ","lastName":"Orme ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Disparities in Outcomes of Patients with Multiple Myeloma Based on Geographic Distance from NCI-Designated Cancer Centers: A SEER Based Analysis","keywords":"","combinedName":"doctor jacob orme"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Anthony ","lastName":"Mato","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Drivers of Treatment Patterns in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with B-Cell Receptor Inhibitors (BCRis)  a Medical Chart Review Study","keywords":"","combinedName":"doctor anthony mato"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Navneet ","lastName":"Majhail","credentials":"MD, MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Easy-to-Read Informed Consent (ETRIC) Form for Hematopoietic Cell Transplantation (HCT) Clinical Trials: Results from Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1205 Study","keywords":"","combinedName":"doctor navneet majhail"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Xinke ","lastName":"Zhang ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Economic Burden Associated with Adverse Events of Special Interest (AESI) in Patients with Relapsed Acute Lymphoblastic Leukemia (ALL) in the US","keywords":"","combinedName":"doctor xinke zhang"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Clara ","lastName":"Chen ","credentials":"PhD, BS, MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Economic Burden in US Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Brentuximab Vedotin or Chemotherapy after Failure of Autologous Hematopoietic Cell Transplantation","keywords":"","combinedName":"doctor clara chen"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Bruno C","lastName":"Medeiros ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Economic Burden of Treatment Episodes in Acute Myeloid Leukemia (AML) Patients in the US: A Retrospective Analysis of a Commercial Payer Database","keywords":"","combinedName":"doctor bruno c medeiros"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Ivo ","lastName":"Abraham ","credentials":"PhD, RN","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Economic Evaluation for the US of Ibrutinib Versus Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia with 17p Deletion","keywords":"","combinedName":"doctor ivo abraham"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Ivo ","lastName":"Abraham ","credentials":"PhD, RN","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Economic Evaluation for the US of Venetoclax Versus Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia with 17p Deletion","keywords":"","combinedName":"doctor ivo abraham"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Ivar S","lastName":"Jensen ","credentials":"MBA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Economic Model Shows That Guideline Recommended Testing of Patients with Early Symptoms of Myeloma Results in Improved Patient Outcomes and Decreased Hospital Costs","keywords":"","combinedName":"doctor ivar s jensen"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Anca ","lastName":"Prica ","credentials":"MD, FRCP(C)","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial","keywords":"","combinedName":"doctor anca prica"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Erika Barbara","lastName":"Brulc ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Frailty Evaluation in a Cohort of Onco -Hematology Patients","keywords":"","combinedName":"doctor erika barbara brulc"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Marjorie E","lastName":"Zettler ","credentials":"PhD, MPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Fulfillment of Postmarketing Commitments for Novel Malignant Hematology Products Granted Accelerated Approval By the FDA between 2011-2016","keywords":"","combinedName":"doctor marjorie e zettler"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Zachary ","lastName":"Liederman ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"HBV Care Map for Patients Receiving Anti-CD20 Therapy","keywords":"","combinedName":"doctor zachary liederman"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Lih-Wen ","lastName":"Mau ","credentials":"PhD, MPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Healthcare Reimbursement and Service Utilization for One Year of Post-Allogeneic Hematopoietic Cell Transplantation (alloHCT) Care for Medicare Beneficiaries Ages 65 and Older with Acute Myeloid Leukemia","keywords":"","combinedName":"doctor lih-wen mau"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"James ","lastName":"Baumgardner ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hematologic Cancers More Costly and Have Fewer Savings Options Than Solid Tumors Under the OCM","keywords":"","combinedName":"doctor james baumgardner"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Eric ","lastName":"Kim ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High-Intensity Healthcare Utilization and Costs Among Older 10+y Survivors of Allogeneic Blood or Marrow Transplantation (BMT): A Report from the BMT Survivor Study-2 (BMTSS-2)","keywords":"","combinedName":"doctor eric kim"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Alice ","lastName":"Wolfromm ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Home Administration of Subcutaneous Rituximab Is Safe and Associated with Significant Cost Saving: A Single Center Experience","keywords":"","combinedName":"doctor alice wolfromm"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Emily S","lastName":"Van Laar ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Identifying Clinical Gaps in the Diagnosis, Monitoring, and Management of Immunoglobulin Light Chain (AL) Amyloidosis Among Hematologist/Oncologists","keywords":"","combinedName":"doctor emily s van laar"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Urshila ","lastName":"Durani ","credentials":"MD, MPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In-Hospital Mortality and Cost of Allogeneic Hematopoietic Cell Transplant (HCT) in Adult Acute Myeloid Leukemia: National Inpatient Sample (NIS) Years 2002-2013","keywords":"","combinedName":"doctor urshila durani"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Andrea ","lastName":"Sitlinger ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Insurance Design and out-of-Pocket (OOP) Costs:a Comparison of Oral and Intravenous (IV) Treatment Plans for Chronic Lymphocytic Leukemia (CLL) in the Era of the Affordable Care Act (ACA)","keywords":"","combinedName":"doctor andrea sitlinger"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Murali ","lastName":"Sundaram ","credentials":"MBA, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Managing Acute Myeloid Leukemia in Older Patients: Are We Making Progress? an Analysis of Treatment Patterns and Healthcare Resource Utilization","keywords":"","combinedName":"doctor murali sundaram"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Jeffrey ","lastName":"Sharman ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"MCL Treatment Patterns and Outcomes: A Community Oncology Practice Experience","keywords":"","combinedName":"doctor jeffrey sharman"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Marita ","lastName":"Zimmermann ","credentials":"PhD, MPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Measurable Residual Disease (MRD) Testing in Multiple Myeloma Using an Improved Testing Technology: Population Impact","keywords":"","combinedName":"doctor marita zimmermann"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Karla Nohemi","lastName":"Guerrero Gmez ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Primary Caregivers Knowledge Related to Cancer: Opportune Detection and Prevention of Treatment Complications in a Pediatric Hematology-Oncology Unit","keywords":"","combinedName":"doctor karla nohemi guerrero gmez"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Erika ","lastName":"Szabo ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real-World Characteristics of CLL Patients Receiving Front-Line Therapy, Using the Flatiron Health Database","keywords":"","combinedName":"doctor erika szabo"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Scott","lastName":"Huntington","credentials":"MD,MPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real-World Patterns of Care for Patients with Follicular Lymphoma Treated with Lenalidomide and Rituximab (R2) in the US Medicare Population","keywords":"","combinedName":"doctor scott huntington"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Dipesh ","lastName":"Uprety ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Survival Trends Among Patients with Acute Myeloid Leukemia with Favorable Cytogenetics in the United States","keywords":"","combinedName":"doctor dipesh uprety"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Joanne ","lastName":"Buzaglo ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Symptom Burden, Palliative Care Needs, and Patient-Provider Communication Among Chronic Myeloid Leukemia Survivors","keywords":"","combinedName":"doctor joanne buzaglo"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Abhishek ","lastName":"Maiti ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Clinical Benefit of Event-Free Survival (EFS) in Acute Myeloid Leukemia (AML): A Surrogate of Overall Survival (OS) or Meritorious on Its Own Right?","keywords":"","combinedName":"doctor abhishek maiti"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Salvatore ","lastName":"Salamone ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Cost-Effectiveness of Therapeutic Drug Monitoring (TDM) of Generic Imatinib for the Treatment of Chronic Myelogenous Leukemia","keywords":"","combinedName":"doctor salvatore salamone"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Dina ","lastName":"Khalaf ","credentials":"MD, BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Utility of Early Broncholaveolar Lavage in Prolonged Neutropenic Patients with Pulmonary Nodules","keywords":"","combinedName":"doctor dina khalaf"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Dahlia ","lastName":"Sano ","credentials":"MBBCH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Utility of End of Treatment PET- CT in Patients with Diffuse Large B-Cell Lymphoma and Documented Complete Remission By Interim PET","keywords":"","combinedName":"doctor dahlia sano"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Ragisha ","lastName":"Gopalakrishnan ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Widow Maker: A National Inpatient Sample Study of Health Care Utilization Costs for Cardiovascular Complications Patients Diagnosed with Non-Hodgkins Lymphoma from 2000-2014","keywords":"","combinedName":"doctor ragisha gopalakrishnan"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Giulia ","lastName":"Graziani ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Time from First Symptom Onset to the Final Diagnosis of Multiple Myeloma - Possible Risks and Future Solutions: Large Retrospective and Confirmatory Prospective Deutsche Studiengruppe Multiples Myelom (DSMM) Analysis","keywords":"","combinedName":"doctor giulia graziani"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Erika ","lastName":"Correa ","credentials":"MD, MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Trends in Hospital Cost, Length of Stay, Complication Rates, and Mortality in Patients with Acute Lymphoblastic Leukemia in Teaching Versus Nonteaching Institutions: Data from the Nationwide Inpatient Sample from 1999-2014","keywords":"","combinedName":"doctor erika correa"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"Yuzhou ","lastName":"Liu ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"US Regional Difference in Hospitalization Cost for Autologous Stem Cell Transplantation in Multiple Myeloma Patients: A Nationwide 10-Year Analysis from 2005 to 2014","keywords":"","combinedName":"doctor yuzhou liu"},{"sessionId":"11892","sessionTitle":"902. Health Services ResearchMalignant Conditions: Poster III","firstName":"James ","lastName":"Signorovitch ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Who Is Receiving Novel Therapies for Relapsed/Refractory Follicular Lymphoma? a Retrospective Chart Review of Recent Real-World Practice","keywords":"","combinedName":"doctor james signorovitch"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Anuja ","lastName":"Roy ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Canadian Cost-Effectiveness Analysis for the Treatment of Immune Thrombocytopenia: Assessing the Relative Value of with Eltrombopag Versus Romiplostim","keywords":"","combinedName":"doctor anuja roy"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Kristen ","lastName":"Sanfilippo ","credentials":"MD ","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Aspirin May be Inadequate Thromboprophylaxis in Multiple Myeloma","keywords":"","combinedName":"doctor kristen sanfilippo"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Anuja ","lastName":"Roy ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Benefit-Risk Comparison in Patients with Immune Thrombocytopenia (ITP) Receiving Eltrombopag or Romiplostim: Real World Evidence (RWE) from 26 Hospital Institutions","keywords":"","combinedName":"doctor anuja roy"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Mark ","lastName":"Skinner ","credentials":"","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study","keywords":"","combinedName":"doctor mark skinner"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Marilyn J","lastName":"Manco-Johnson ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Characteristics of Males with Hemophilia in the United States Hemophilia Treatment Center Network (USHTCN) with New-Onset Elevated Inhibitor Titers, December 15, 2013  December 31, 2016","keywords":"","combinedName":"doctor marilyn j manco-johnson"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Susanna A","lastName":"Curtis ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Chronic Red Blood Cell Exchange Transfusion Therapy Does Not Impact Hospital Utilization or Ascq-Me Pain Domains in Adults Living with Sickle Cell Disease","keywords":"","combinedName":"doctor susanna a curtis"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Andreas M","lastName":"Pleil ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Defining Vaso-Occlusive Crises in Sickle Cell Disease from the Perspective of the Patient: Development of a New Toolbox to Measure Treatment Outcomes","keywords":"","combinedName":"doctor andreas m pleil"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Alpesh ","lastName":"Amin ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Did Patients with Renal Disease Receive Sufficient Prophylaxis for Venous Thromboembolism in the Real-World Settings?: A Study Among Hospitalized Acutely Medically Ill Patients","keywords":"","combinedName":"doctor alpesh amin"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Daniel ","lastName":"Sop Mouaffo ","credentials":"MS","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Enhancing Adherence to Prescribed Opioids Using a Mobile-Based App: A Feasibility Study in Non-Cancer Pain","keywords":"","combinedName":"doctor daniel sop mouaffo"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Kristen ","lastName":"McCausland ","credentials":"PhD, MPH","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Health Utility Analyses in AL Amyloidosis  Existing Mapping Algorithms May be Inadequate","keywords":"","combinedName":"doctor kristen mccausland"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Lise ","lastName":"Estcourt ","credentials":"DPhil, FRCPath, MBBChir, MRCP, MSc, MA","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Intracranial Hemorrhage in Patients with Haematological Malignancy, a Nested Case-Control Study","keywords":"","combinedName":"doctor lise estcourt"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Michael ","lastName":"White ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Outcomes and Risk Factors Associated with Thrombosis Recurrence and Post-Thrombotic Syndrome in Children and Adolescents with May-Thurner Syndrome","keywords":"","combinedName":"doctor michael white"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Nancy ","lastName":"Green ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Potential Association between Sickle Trait and MRI-Defined Cerebrovascular Outcomes in Two Multi-Ethnic Elderly Populations","keywords":"","combinedName":"doctor nancy green"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Natalya E","lastName":"O'Neill ","credentials":"BSc","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Quality Improvement in the Care of Patients with Asplenia: Focus on Diminishing Risk of Infection","keywords":"","combinedName":"doctor natalya e o'neill"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Amanda ","lastName":"Grimes ","credentials":"MD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Re-Presentation to Medical Care Due to Adverse Effects of Intravenous ImmunoglobulinTherapy in Pediatric Immune ThrombocytopeniaPatients","keywords":"","combinedName":"doctor amanda grimes"},{"sessionId":"11893","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster II","firstName":"Cynthia ","lastName":"Sinha ","credentials":"PhD","sessionStartTime":"2017-12-10T18:00:00Z","sessionEndTime":"2017-12-10T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Influence of the Age of Adults with Sickle Cell Disease on the Uptake, Utilization and Efficacy of Hydroxyurea","keywords":"","combinedName":"doctor cynthia sinha"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Nicole M","lastName":"Alberts ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Developmental Examination of Pain Among Youth with Sickle Cell Disease","keywords":"","combinedName":"doctor nicole m alberts"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Ana Z","lastName":"Kerep ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Large Cohort Comparison of 2005 National Institutes of Health Chronic Graft-Versus-Host Disease Staging Criteria to 2014 National Institutes of Health Chronic Graft-Versus-Host Disease Staging Criteria","keywords":"","combinedName":"doctor ana z kerep"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Dana ","lastName":"Angelini ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Anticoagulant Prescription Patterns for Cancer Associated Thrombosis: New Insights into the Use of Direct Oral Anticoagulants","keywords":"","combinedName":"doctor dana angelini"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Kristen ","lastName":"McCausland ","credentials":"PhD, MPH","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Associations between Socioeconomic Status and Health-Related Quality of Life in Patients with AL Amyloidosis","keywords":"","combinedName":"doctor kristen mccausland"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Peter ","lastName":"Mollee ","credentials":"FRACP, FRCPA, MBBS, MMSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Catheter-Associated Bloodstream Infections (CA-BSI) in Adults with Cancer: A Prospective Randomized Controlled Trial","keywords":"","combinedName":"doctor peter mollee"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Tyler ","lastName":"Buckner ","credentials":"MD, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Correlations between Patient-Reported Outcomes and Self-Reported Characteristics in Adults with Hemophilia B and Caregivers of Children with Hemophilia B: Analysis of the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) Study","keywords":"","combinedName":"doctor tyler buckner"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Kristin ","lastName":"Richards ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Deferasirox Adherence and Persistence Among Texas Medicaid Patients Taking Dispersible Tablets and Film-Coated Tablets","keywords":"","combinedName":"doctor kristin richards"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Jessica ","lastName":"Markowitz ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Development of a Concept-Driven Disease Impact Instrument from Patients with Hemophilia (Pediatric and Adult) and Caregivers","keywords":"","combinedName":"doctor jessica markowitz"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Mia ","lastName":"Djulbegovic ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Direct Oral Anticoagulants for the Prevention of Recurrent Venous Thromboembolism: A Systematic Review & Network Meta-Analysis","keywords":"","combinedName":"doctor mia djulbegovic"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Michael ","lastName":"Nichol ","credentials":"PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Health-Related Quality of Life and Health Insurance Coverage Among Persons with Hemophilia a Inhibitors","keywords":"","combinedName":"doctor michael nichol"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Damon ","lastName":"Houghton ","credentials":"MD, MSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hemoglobin Levels, Sex, Race and Coronary Heart Disease Risk in the Reasons for Geographic and Racial Differences in Stroke Study","keywords":"","combinedName":"doctor damon houghton"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Alexander ","lastName":"Trussler ","credentials":"MD, MSc, BSc","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Inferior Vena Cava Filter Utilization at Kingston Health Sciences Centre: A Comparison of Practice with Guidelines","keywords":"","combinedName":"doctor alexander trussler"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Edison ","lastName":"Tsui ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Integration of a Heparin-Induced Thrombocytopenia Order-Set (HITOS): A Retrospective Study","keywords":"","combinedName":"doctor edison tsui"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Sabrina ","lastName":"Mueller ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient Preferences Regarding Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients - a Discrete Choice Experiment","keywords":"","combinedName":"doctor sabrina mueller"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Antonis ","lastName":"Kattamis ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Physical Activities in Patients with -Thalassemia As Measured By Fitbit in Association with Patient-Reported Outcomes","keywords":"","combinedName":"doctor antonis kattamis"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Kartiga ","lastName":"Thiyagarajah ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Post-Thrombotic Syndrome and Recurrent Thromboembolism in Patients with Upper Extremity Deep Vein Thrombosis: A Systematic Review and Meta-Analysis of Proportions","keywords":"","combinedName":"doctor kartiga thiyagarajah"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Sabrina ","lastName":"Mueller ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Real-World Adherence to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation: Results of an International Survey","keywords":"","combinedName":"doctor sabrina mueller"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Lei ","lastName":"Gao ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Sirolimus Is Effective in Refractory Immune Thrombocytopenia: Results of an Open-Label Prospective Multicenter Trial in China","keywords":"","combinedName":"doctor lei gao"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Alpesh ","lastName":"Amin ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Frequency of Venous Thromboembolism (VTE) Prophylaxis Among Patients Hospitalized for Cancer in the US","keywords":"","combinedName":"doctor alpesh amin"},{"sessionId":"11894","sessionTitle":"903. Outcomes ResearchNon-Malignant Conditions: Poster III","firstName":"Uttara ","lastName":"Nag ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Vascular Thrombosis Leading to Graft Failure Following Pediatric Liver Transplantation","keywords":"","combinedName":"doctor uttara nag"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Julian R","lastName":"Davis ","credentials":"MD, MA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"A Phase 1 Study of Everolimus and Bendamustine in Patients with Relapsed or Refractory Lymphoid Malignancies and Myeloma","keywords":"","combinedName":"doctor julian r davis"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Matthew ","lastName":"Davids","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An Integrated Safety Analysis of the Next Generation PI3Kd Inhibitor Umbralisib (TGR-1202) in Patients with Relapsed/Refractory Lymphoid Malignancies","keywords":"","combinedName":"doctor matthew davids"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Zi Yun ","lastName":"Ng ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"An International Multicenter Retrospective Comparison of Induction Chemoimmunotherapy Regimens on Outcomes in Patients with Transplant-Eligible Mantle Cell Lymphoma","keywords":"","combinedName":"doctor zi yun ng"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Catherine ","lastName":"Thieblemont ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"BendamustineinCombination with Rituximab As First-Line Treatmentof Splenic Marginal Zone Lymphoma (BRISMA). Results of theIELSG-36 Phase II Study","keywords":"","combinedName":"doctor catherine thieblemont"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Arshia ","lastName":"Soleimani ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CD5-Negative Mantle Cell Lymphoma Defines a Distinct Disease Entity Characterized By an Indolent Clinical Course Irrespective of Known Prognostic Markers","keywords":"","combinedName":"doctor arshia soleimani"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Aqsa ","lastName":"Nasir ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Significance of Low Grade Follicular Lymphoma with High Proliferative Index","keywords":"","combinedName":"doctor aqsa nasir"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Vaibhav ","lastName":"Agrawal ","credentials":"MD, MBA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of 90Y-Ibritumomab Tiuxetan in the Older Population with Non-Hodgkin Lymphoma Pre-Treated with Rituximab-Based Regimens: A Single-Institution Experience","keywords":"","combinedName":"doctor vaibhav agrawal"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Martin","lastName":"Dreyling","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1 Trial","keywords":"","combinedName":"doctor martin dreyling"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Harumi ","lastName":"Kato ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evaluation of Tumor Burden for Predicting Survival in Patients with Follicular Lymphoma Receiving First-Line R-CHOP Treatment: Comparison of Different Definition of GELF Criteria","keywords":"","combinedName":"doctor harumi kato"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Toby ","lastName":"Eyre ","credentials":"MBBChir, MRCP","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Idelalisib-Rituximab Results in Considerable Toxicity but Induces Durable Clinical Remissions in Patients with TP53 Disrupted B Cell Prolymphocytic Leukemia","keywords":"","combinedName":"doctor toby eyre"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Joshua ","lastName":"Gustine ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Impact of Ibrutinib Dose Intensity on Patient Outcomes in Previously Treated Waldenstrm Macroglobulinemia","keywords":"","combinedName":"doctor joshua gustine"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Yukiko ","lastName":"Kawaguchi ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased C-Reactive Protein Level Is Associated with Poor Prognosis in Patients with Follicular Lymphoma Treated with Rituximab-Containing Regimens","keywords":"","combinedName":"doctor yukiko kawaguchi"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Annalynn ","lastName":"Williams ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Increased Risk of Toxicity with Novel PI3K Delta Inhibitor Combinations Compared with Standard Use in Non-Hodgkin Lymphoma Patients","keywords":"","combinedName":"doctor annalynn williams"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Marzia ","lastName":"Varettoni ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Lymphoplasmacytic Lymphoma Not Associated with an IgM Monoclonal Paraprotein Has Distinctive Clinical and Biological Features and a Similar Outcome As Compared with Waldenstroms Macroglobulinemia: Multicentric Study of the Rete Ematologica Lombarda","keywords":"","combinedName":"doctor marzia varettoni"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Sara ","lastName":"Rattotti ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Mantle Cell Lymphoma Mimicking Mucosa-Associated Lymphoid Tissue (MALT) Lymphomas: A Pathological Characterization (on behalf of the Fondazione Italiana Linfomi (FIL) - Postgraduate Master Course)","keywords":"","combinedName":"doctor sara rattotti"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Thais ","lastName":"Fischer ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Natural History of Hypogammaglobulinemia in Patients with Follicular Lymphoma and the Impact of Anti-CD20-Based Therapy","keywords":"","combinedName":"doctor thais fischer"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Danielle ","lastName":"Canioni ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"P53 and P16 Protein Expression Have Prognostic Value in Mantle Cell Lymphomas in the Lyma Trial in the Lysa Group","keywords":"","combinedName":"doctor danielle canioni"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Jorge ","lastName":"Castillo ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Patient-Reported Symptoms during Ibrutinib Holds: A Withdrawal Syndrome","keywords":"","combinedName":"doctor jorge castillo"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Wei ","lastName":"Ding ","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"PD-1 Blockade with Pembrolizumab in Relapsed Low Grade Non-Hodgkin Lymphoma","keywords":"","combinedName":"doctor wei ding"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Avyakta ","lastName":"Kallam ","credentials":"MBBS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Phase I/II Trial of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkins Lymphoma (NHL)","keywords":"","combinedName":"doctor avyakta kallam"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Pier Luigi","lastName":"Zinzani","credentials":"MD, PhD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Pooled Safety Analysis from Phase I and II Studies for Patients with Relapsed Indolent Non-Hodgkins Lymphoma Treated with Intravenous Copanlisib","keywords":"","combinedName":"doctor pier luigi zinzani"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Andres ","lastName":"Forero-Torres ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Preliminary Results from an Ongoing Phase 1/2 Study of INCB057643, a Bromodomain and Extraterminal (BET) Protein Inhibitor, in Patients (pts) with Advanced Malignancies","keywords":"","combinedName":"doctor andres forero-torres"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Jin-Hua ","lastName":"Liang ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prognostic Value of Baseline and Interim Total Metabolic Tumour Volume and Total Lesion Glycolysis Measured on 18f-FDG PET/CT in Patients with Follicular Lymphoma","keywords":"","combinedName":"doctor jin-hua liang"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Liam ","lastName":"Smyth ","credentials":"MD, FRCPath","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon a","keywords":"","combinedName":"doctor liam smyth"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Claudie ","lastName":"Roy ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Rituximab Maintenance for Two Years in Previously Untreated Follicular Lymphoma: No Difference in Outcome between Patients Receiving Treatment at Two Month Versus Three Month Interval","keywords":"","combinedName":"doctor claudie roy"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Melody R","lastName":"Becnel ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Activity of Lenalidomide and Rituximab in Previously Untreated Marginal Zone Lymphoma: Subgroup Analysis and Long-Term Follow-up of an Open-Label Phase II Trial","keywords":"","combinedName":"doctor melody r becnel"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Gavin ","lastName":"Cull ","credentials":"MB, BS, FRACP, FRCPA","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Combination with the PD-1 Inhibitor BGB-A317 in Patients with B-Cell Lymphoid Malignancies","keywords":"","combinedName":"doctor gavin cull"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Gwynivere ","lastName":"Davies ","credentials":"MD,FRCPC","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Significant Adverse Consequences of Initial Watchful Waiting for Follicular Lymphoma Patients: A Retrospective Analysis of Patients Diagnosed in Alberta from 1994-2011","keywords":"","combinedName":"doctor gwynivere davies"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Yuqin ","lastName":"Song ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Simultaneous Global Phase I Studies of a Differentiated BTK Inhibitor, Dtrmwxhs-12, in Relapsed/Refractory Patients with Chronic Lymphocytic Leukemia and B-Cell Lymphomas","keywords":"","combinedName":"doctor yuqin song"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Amaara ","lastName":"Babwah ","credentials":"MS","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Survival Rates and Clinical Characteristics of Young Patients with Waldenstrm Macroglobulinemia","keywords":"","combinedName":"doctor amaara babwah"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Kamel ","lastName":"Laribi ","credentials":"","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Bendamustine Plus Rituximab Regimen Is Active and Safe in Previously Untreated Patients with Waldenstrm Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)","keywords":"","combinedName":"doctor kamel laribi"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Aaron ","lastName":"Galaznik ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Treatment Patterns in Newly Treated and Relapse/Refractory Patients with Follicular Lymphoma in Routine Clinical Care  a United States Electronic Medical Record Database Study","keywords":"","combinedName":"doctor aaron galaznik"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Jeffrey ","lastName":"Sharman ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Understanding Ibrutinib Treatment Discontinuation Patterns for Chronic Lymphocytic Leukemia","keywords":"","combinedName":"doctor jeffrey sharman"},{"sessionId":"11895","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell LymphomaClinical Studies: Poster III","firstName":"Stephen ","lastName":"Smith ","credentials":"MD","sessionStartTime":"2017-12-11T18:00:00Z","sessionEndTime":"2017-12-11T20:00:00Z","startTime":"18:00:00","endTime":"20:00:00","sessionLocation":"Bldg A- Lvl 1- Hall A2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"VR-CAP Alternating with Rituximab and High-Dose Cytarabine: An Effective First-Line Mantle Cell Lymphoma Regimen Prior to Autologous Stem Cell Transplant","keywords":"","combinedName":"doctor stephen smith"},{"sessionId":"12024","sessionTitle":"Hemoglobin Thresholds and Population Health ","firstName":"Robert ","lastName":"Means Jr.","credentials":"MD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:55:00Z","startTime":"13:15:00","endTime":"13:35:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Current Hemoglobin Cutoffs: How Did We Get Here?","keywords":"","combinedName":"doctor robert means jr "},{"sessionId":"12024","sessionTitle":"Hemoglobin Thresholds and Population Health ","firstName":"Max ","lastName":"Gassmann ","credentials":"DVM","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:55:00Z","startTime":"14:35:00","endTime":"14:55:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effects of Hypoxia, Altitude and Smoking on Hemoglobin Concentrations","keywords":"","combinedName":"doctor max gassmann"},{"sessionId":"12024","sessionTitle":"Hemoglobin Thresholds and Population Health ","firstName":"Elizabeta","lastName":"Nemeth","credentials":"PhD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:55:00Z","startTime":"13:35:00","endTime":"13:55:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Effects of Inflammation on Hemoglobin Concentrations - Mechanisms and Clinical Effects","keywords":"","combinedName":"doctor elizabeta nemeth"},{"sessionId":"12024","sessionTitle":"Hemoglobin Thresholds and Population Health ","firstName":"Melissa ","lastName":"Young ","credentials":"","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:55:00Z","startTime":"13:55:00","endTime":"14:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Evidence for Hemoglobin Thresholds and Functional Outcomes in Young Children and in Pregnancy","keywords":"","combinedName":"doctor melissa young"},{"sessionId":"12024","sessionTitle":"Hemoglobin Thresholds and Population Health ","firstName":"Sant-Rayn","lastName":"Pasricha","credentials":"MD, PhD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:55:00Z","startTime":"13:05:00","endTime":"13:15:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Overview of the World Health Organization Hemoglobin Thresholds Project","keywords":"","combinedName":"doctor sant-rayn pasricha"},{"sessionId":"12024","sessionTitle":"Hemoglobin Thresholds and Population Health ","firstName":"Parmi ","lastName":"Suchdev ","credentials":"MD, MPH","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:55:00Z","startTime":"14:15:00","endTime":"14:35:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"The Epidemiology and Determinants of Anemia in Low Income Countries","keywords":"","combinedName":"doctor parmi suchdev"},{"sessionId":"12025","sessionTitle":"New Immune Monitoring Methods","firstName":"Michael","lastName":"Angelo","credentials":"MD, PhD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:05:00Z","startTime":"13:35:00","endTime":"14:05:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"In Situ Methods of Analysis of Tumor Microenvironment ","keywords":"","combinedName":"doctor michael angelo"},{"sessionId":"12025","sessionTitle":"New Immune Monitoring Methods","firstName":"Hanlee","lastName":"Ji","credentials":"MD","sessionStartTime":"2017-12-08T13:05:00Z","sessionEndTime":"2017-12-08T14:05:00Z","startTime":"13:05:00","endTime":"13:35:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Methods and Results from Single Cell Analysis of Tumor Microenvironment ","keywords":"","combinedName":"doctor hanlee ji"},{"sessionId":"12028","sessionTitle":"Novel Targets and Delivery Systems","firstName":"Paul","lastName":"Sondel","credentials":"MD, PhD","sessionStartTime":"2017-12-08T14:35:00Z","sessionEndTime":"2017-12-08T15:35:00Z","startTime":"14:35:00","endTime":"15:05:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"New Methods of Tumor Vaccination ","keywords":"","combinedName":"doctor paul sondel"},{"sessionId":"12028","sessionTitle":"Novel Targets and Delivery Systems","firstName":"June Helen","lastName":"Myklebust","credentials":"PhD","sessionStartTime":"2017-12-08T14:35:00Z","sessionEndTime":"2017-12-08T15:35:00Z","startTime":"15:05:00","endTime":"15:35:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Tigit, a New Target in the Tumor Microenvironment","keywords":"","combinedName":"doctor june helen myklebust"},{"sessionId":"12029","sessionTitle":"Bispecific Antibodies and CAR T cells","firstName":"Rajat","lastName":"Bannerji","credentials":"MD, PhD","sessionStartTime":"2017-12-08T16:05:00Z","sessionEndTime":"2017-12-08T17:05:00Z","startTime":"16:05:00","endTime":"16:35:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Bispecifics Targeting CD20","keywords":"","combinedName":"doctor rajat bannerji"},{"sessionId":"12029","sessionTitle":"Bispecific Antibodies and CAR T cells","firstName":"Renier ","lastName":"Brentjens","credentials":"MD, PhD","sessionStartTime":"2017-12-08T16:05:00Z","sessionEndTime":"2017-12-08T17:05:00Z","startTime":"16:35:00","endTime":"17:05:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"CAR-T Cells: Beyond CD19 (BCMA/CD30/armored CARs)","keywords":"","combinedName":"doctor renier brentjens"},{"sessionId":"12040","sessionTitle":"Hemoglobin Thresholds and Clinical Medicine","firstName":"Stefano ","lastName":"Rivella ","credentials":"PhD","sessionStartTime":"2017-12-08T15:10:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"15:55:00","endTime":"16:10:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Erythroid Genetics and Hemoglobin Concentrations","keywords":"","combinedName":"doctor stefano rivella"},{"sessionId":"12040","sessionTitle":"Hemoglobin Thresholds and Clinical Medicine","firstName":"Erica ","lastName":"Wood ","credentials":"","sessionStartTime":"2017-12-08T15:10:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"15:25:00","endTime":"15:40:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hemoglobin Concentrations and Transfusion Thresholds","keywords":"","combinedName":"doctor erica wood"},{"sessionId":"12040","sessionTitle":"Hemoglobin Thresholds and Clinical Medicine","firstName":"Domenico ","lastName":"Girelli ","credentials":"MD, PhD","sessionStartTime":"2017-12-08T15:10:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"15:10:00","endTime":"15:25:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Hemoglobin Thresholds in the Elderly","keywords":"","combinedName":"doctor domenico girelli"},{"sessionId":"12040","sessionTitle":"Hemoglobin Thresholds and Clinical Medicine","firstName":"Dorine ","lastName":"Swinkels","credentials":"MD, PhD","sessionStartTime":"2017-12-08T15:10:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"15:40:00","endTime":"15:55:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Laboratory Measurement of Hemoglobin in Clinical Laboratory Practice and the Field","keywords":"","combinedName":"doctor dorine swinkels"},{"sessionId":"12043","sessionTitle":"Plenary Scientific Session","firstName":"Joseph M","lastName":"Connors ","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"15:45:00","endTime":"16:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Brentuximab Vedotin Plus Doxorubicin, Vinblastine, Dacarbazine (A+AVD) As Frontline Therapy Demonstrates Superior Modified Progression-Free Survival Versus ABVD in Patients with Previously Untreated Stage III or IV Hodgkin Lymphoma (HL): The Phase 3 Echelon-1 Study","keywords":"","combinedName":"doctor joseph m connors"},{"sessionId":"12043","sessionTitle":"Plenary Scientific Session","firstName":"Daniel ","lastName":"DeAngelo","credentials":"MD, PhD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"14:25:00","endTime":"14:40:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (AdvSM)","keywords":"","combinedName":"doctor daniel deangelo"},{"sessionId":"12043","sessionTitle":"Plenary Scientific Session","firstName":"Stella T","lastName":"Chou","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"14:45:00","endTime":"15:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Customized Induced Pluripotent Stem Cell-Derived Red Cell Reagents","keywords":"","combinedName":"doctor stella t chou"},{"sessionId":"12043","sessionTitle":"Plenary Scientific Session","firstName":"Luigi ","lastName":"Alvarado ","credentials":"PhD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"15:05:00","endTime":"15:20:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Heterodimerization of TPO and IFN Impairs Human Hematopoietic Stem/Progenitor Cell Signaling and Survival in Chronic Inflammation","keywords":"","combinedName":"doctor luigi alvarado"},{"sessionId":"12043","sessionTitle":"Plenary Scientific Session","firstName":"Claire ","lastName":"Lentaigne ","credentials":"BSc, MB, MRCP","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"15:25:00","endTime":"15:40:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"High Throughput Sequencing in 3449 Patients with Bleeding and Platelet Disorders: Novel Gene Discovery and Robust Diagnosis","keywords":"","combinedName":"doctor claire lentaigne"},{"sessionId":"12043","sessionTitle":"Plenary Scientific Session","firstName":"Raghav ","lastName":"Ramabadran ","credentials":"BS","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"14:05:00","endTime":"14:20:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Loss of De Novo DNAMethyltransferase DNMT3A Impacts Alternative Splicing in Hematopoietic Stem Cells","keywords":"","combinedName":"doctor raghav ramabadran"},{"sessionId":"12043","sessionTitle":"Plenary Scientific Session","firstName":"Omar","lastName":"Abdel-Wahab","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"14:00:00","endTime":"14:05:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plenary Introducer","keywords":"","combinedName":"doctor omar abdel-wahab"},{"sessionId":"12043","sessionTitle":"Plenary Scientific Session","firstName":"Neil","lastName":"Shah","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"14:20:00","endTime":"14:25:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plenary Introducer","keywords":"","combinedName":"doctor neil shah"},{"sessionId":"12043","sessionTitle":"Plenary Scientific Session","firstName":"Naomi ","lastName":"Luban","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"14:40:00","endTime":"14:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plenary Introducer","keywords":"","combinedName":"doctor naomi luban"},{"sessionId":"12043","sessionTitle":"Plenary Scientific Session","firstName":"Janis ","lastName":"Abkowitz","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"15:00:00","endTime":"15:05:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plenary Introducer","keywords":"","combinedName":"doctor janis abkowitz"},{"sessionId":"12043","sessionTitle":"Plenary Scientific Session","firstName":"Jorge","lastName":"Di Paola","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"15:20:00","endTime":"15:25:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plenary Introducer","keywords":"","combinedName":"doctor jorge di paola"},{"sessionId":"12043","sessionTitle":"Plenary Scientific Session","firstName":"George ","lastName":"Canellos","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"15:40:00","endTime":"15:45:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"Plenary Introducer","keywords":"","combinedName":"doctor george canellos"},{"sessionId":"11082","sessionTitle":"ASH Grassroots Network Lunch","firstName":"Alan","lastName":"Wurtzel","credentials":"Special Advisor","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Int'l Blrm- No. Twr- M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor alan wurtzel"},{"sessionId":"11217","sessionTitle":"Networking Reception for Female Hematologists","firstName":"Christine","lastName":"Chomienne","credentials":"MD, PhD","sessionStartTime":"2017-12-11T19:30:00Z","sessionEndTime":"2017-12-11T21:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Int'l Blrm. E-F No. Twr. M2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor christine chomienne"},{"sessionId":"11217","sessionTitle":"Networking Reception for Female Hematologists","firstName":"Linda ","lastName":"Burns","credentials":"MD","sessionStartTime":"2017-12-11T19:30:00Z","sessionEndTime":"2017-12-11T21:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Int'l Blrm. E-F No. Twr. M2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor linda burns"},{"sessionId":"11220","sessionTitle":"Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal","firstName":"Benjamin ","lastName":"Ebert","credentials":"MD, PhD","sessionStartTime":"2017-12-12T09:30:00Z","sessionEndTime":"2017-12-12T09:45:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/12/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor benjamin ebert"},{"sessionId":"11220","sessionTitle":"Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal","firstName":"Josef ","lastName":"Prchal","credentials":"MD","sessionStartTime":"2017-12-12T09:30:00Z","sessionEndTime":"2017-12-12T09:45:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/12/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor josef prchal"},{"sessionId":"11220","sessionTitle":"Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal","firstName":"Sherrill ","lastName":"Slichter","credentials":"MD","sessionStartTime":"2017-12-12T09:30:00Z","sessionEndTime":"2017-12-12T09:45:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/12/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor sherrill slichter"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","firstName":"Betty ","lastName":"Pace","credentials":"MD","sessionStartTime":"2017-12-10T13:30:00Z","sessionEndTime":"2017-12-10T14:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor betty pace"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","firstName":"Marshall ","lastName":"Lichtman","credentials":"MD","sessionStartTime":"2017-12-10T13:30:00Z","sessionEndTime":"2017-12-10T14:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor marshall lichtman"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","firstName":"Oliver ","lastName":"Press","credentials":"MD, PhD","sessionStartTime":"2017-12-10T13:30:00Z","sessionEndTime":"2017-12-10T14:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor oliver press"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","firstName":"Ronald","lastName":"Hoffman","credentials":"MD","sessionStartTime":"2017-12-10T13:30:00Z","sessionEndTime":"2017-12-10T14:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor ronald hoffman"},{"sessionId":"11235","sessionTitle":"A Brave New World: The Clinical Management of Bone Marrow Failure and Myeloid Malignancy in a Time of Personalized Therapy","firstName":"Corey ","lastName":"Cutler","credentials":"MD, MPH","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"A703-A704","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor corey cutler"},{"sessionId":"11235","sessionTitle":"A Brave New World: The Clinical Management of Bone Marrow Failure and Myeloid Malignancy in a Time of Personalized Therapy","firstName":"Gerard","lastName":"Socie","credentials":"MD, PhD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"A703-A704","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor gerard socie"},{"sessionId":"11235","sessionTitle":"A Brave New World: The Clinical Management of Bone Marrow Failure and Myeloid Malignancy in a Time of Personalized Therapy","firstName":"Guillermo","lastName":"Garcia-Manero","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"A703-A704","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor guillermo garcia-manero"},{"sessionId":"11235","sessionTitle":"A Brave New World: The Clinical Management of Bone Marrow Failure and Myeloid Malignancy in a Time of Personalized Therapy","firstName":"Laura ","lastName":"Michaelis","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"A703-A704","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor laura michaelis"},{"sessionId":"11235","sessionTitle":"A Brave New World: The Clinical Management of Bone Marrow Failure and Myeloid Malignancy in a Time of Personalized Therapy","firstName":"Mark ","lastName":"Levis","credentials":"MD, PhD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"A703-A704","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor mark levis"},{"sessionId":"11235","sessionTitle":"A Brave New World: The Clinical Management of Bone Marrow Failure and Myeloid Malignancy in a Time of Personalized Therapy","firstName":"Valeria","lastName":"Santini","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"A703-A704","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor valeria santini"},{"sessionId":"11237","sessionTitle":"Addressing Current Questions and Controversies in the Management of Lymphoma and Chronic Lymphocytic Leukemia (Part 1 of 2)","firstName":"Craig ","lastName":"Moskowitz","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis C-D","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor craig moskowitz"},{"sessionId":"11237","sessionTitle":"Addressing Current Questions and Controversies in the Management of Lymphoma and Chronic Lymphocytic Leukemia (Part 1 of 2)","firstName":"Jonathan ","lastName":"Friedberg","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis C-D","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor jonathan friedberg"},{"sessionId":"11237","sessionTitle":"Addressing Current Questions and Controversies in the Management of Lymphoma and Chronic Lymphocytic Leukemia (Part 1 of 2)","firstName":"Laurie ","lastName":"Sehn","credentials":"MD, MPH","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis C-D","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor laurie sehn"},{"sessionId":"11237","sessionTitle":"Addressing Current Questions and Controversies in the Management of Lymphoma and Chronic Lymphocytic Leukemia (Part 1 of 2)","firstName":"Martin","lastName":"Dreyling","credentials":"MD, PhD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis C-D","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor martin dreyling"},{"sessionId":"11237","sessionTitle":"Addressing Current Questions and Controversies in the Management of Lymphoma and Chronic Lymphocytic Leukemia (Part 1 of 2)","firstName":"Owen ","lastName":"OConnor","credentials":"MD, PhD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis C-D","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor owen oconnor"},{"sessionId":"11245","sessionTitle":"Meet the Blood Editors","firstName":"David ","lastName":"Bodine","credentials":"PhD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B408","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor david bodine"},{"sessionId":"11245","sessionTitle":"Meet the Blood Editors","firstName":"Thomas ","lastName":"Ortel","credentials":"MD, PhD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B408","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor thomas ortel"},{"sessionId":"11246","sessionTitle":"Meet the Blood Editors","firstName":"Jose ","lastName":"Lopez","credentials":"MD","sessionStartTime":"2017-12-11T12:15:00Z","sessionEndTime":"2017-12-11T13:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B408","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor jose lopez"},{"sessionId":"11246","sessionTitle":"Meet the Blood Editors","firstName":"Nancy","lastName":"Berliner","credentials":"MD","sessionStartTime":"2017-12-11T12:15:00Z","sessionEndTime":"2017-12-11T13:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B408","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor nancy berliner"},{"sessionId":"11275","sessionTitle":"Integrating Therapeutic Advances to Improve Current Practices in Myeloma Patient Care","firstName":"Jesus ","lastName":"Berdeja","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor jesus berdeja"},{"sessionId":"11275","sessionTitle":"Integrating Therapeutic Advances to Improve Current Practices in Myeloma Patient Care","firstName":"Katja","lastName":"Weisel","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor katja weisel"},{"sessionId":"11275","sessionTitle":"Integrating Therapeutic Advances to Improve Current Practices in Myeloma Patient Care","firstName":"Nina","lastName":"Shah","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor nina shah"},{"sessionId":"11275","sessionTitle":"Integrating Therapeutic Advances to Improve Current Practices in Myeloma Patient Care","firstName":"Peter ","lastName":"Voorhees","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor peter voorhees"},{"sessionId":"11286","sessionTitle":"Precision and Emerging Medicine for Hematological Diseases","firstName":"Anas","lastName":"Younes","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor anas younes"},{"sessionId":"11286","sessionTitle":"Precision and Emerging Medicine for Hematological Diseases","firstName":"Cheryl ","lastName":"Willman","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor cheryl willman"},{"sessionId":"11286","sessionTitle":"Precision and Emerging Medicine for Hematological Diseases","firstName":"John","lastName":"Chan","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor john chan"},{"sessionId":"11286","sessionTitle":"Precision and Emerging Medicine for Hematological Diseases","firstName":"Jonathan ","lastName":"Keats","credentials":"PhD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor jonathan keats"},{"sessionId":"11286","sessionTitle":"Precision and Emerging Medicine for Hematological Diseases","firstName":"Karen ","lastName":"Kaul","credentials":"MD, PhD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor karen kaul"},{"sessionId":"11286","sessionTitle":"Precision and Emerging Medicine for Hematological Diseases","firstName":"Sandeep","lastName":"Dave","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor sandeep dave"},{"sessionId":"11288","sessionTitle":"Individualizing Therapeutic Strategies for Patients With MDS","firstName":"John","lastName":"Koreth","credentials":"MBBS, DPhil","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor john koreth"},{"sessionId":"11288","sessionTitle":"Individualizing Therapeutic Strategies for Patients With MDS","firstName":"Jude","lastName":"Fitzgibbon","credentials":"PhD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor jude fitzgibbon"},{"sessionId":"11288","sessionTitle":"Individualizing Therapeutic Strategies for Patients With MDS","firstName":"Luca","lastName":"Malcovati","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor luca malcovati"},{"sessionId":"11288","sessionTitle":"Individualizing Therapeutic Strategies for Patients With MDS","firstName":"Rami ","lastName":"Komrokji","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor rami komrokji"},{"sessionId":"11288","sessionTitle":"Individualizing Therapeutic Strategies for Patients With MDS","firstName":"Shahram","lastName":"Kordasti","credentials":"MD, PhD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor shahram kordasti"},{"sessionId":"11301","sessionTitle":"Polycythemia Vera and Myelofibrosis: Expert Perspectives on Challenging Cases, Clinical Issues, Practice Patterns, and Emerging Treatment Options","firstName":"Brady ","lastName":"Stein","credentials":"MD, MHS","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Imperial A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor brady stein"},{"sessionId":"11301","sessionTitle":"Polycythemia Vera and Myelofibrosis: Expert Perspectives on Challenging Cases, Clinical Issues, Practice Patterns, and Emerging Treatment Options","firstName":"John","lastName":"Mascarenhas","credentials":"","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Imperial A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor john mascarenhas"},{"sessionId":"11301","sessionTitle":"Polycythemia Vera and Myelofibrosis: Expert Perspectives on Challenging Cases, Clinical Issues, Practice Patterns, and Emerging Treatment Options","firstName":"Raajit ","lastName":"Rampal","credentials":"MD, PhD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Imperial A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor raajit rampal"},{"sessionId":"11314","sessionTitle":"Advancing Standards in the Management of Hemophilia A: Contemporary Strategies and Innovations","firstName":"Cindy ","lastName":"Leissinger","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Int'l Ballroom North","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor cindy leissinger"},{"sessionId":"11314","sessionTitle":"Advancing Standards in the Management of Hemophilia A: Contemporary Strategies and Innovations","firstName":"Erik","lastName":"Berntorp","credentials":"MD, PhD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Int'l Ballroom North","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor erik berntorp"},{"sessionId":"11317","sessionTitle":"Advances in the Management of Chronic Lymphocytic Leukemia and Other B-Cell Lymphomas","firstName":"Anthony ","lastName":"Mato","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"A703-A704","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor anthony mato"},{"sessionId":"11317","sessionTitle":"Advances in the Management of Chronic Lymphocytic Leukemia and Other B-Cell Lymphomas","firstName":"Barbara ","lastName":"Rogers","credentials":"CRNP, MN, AOCN, ANP-BC","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"A703-A704","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor barbara rogers"},{"sessionId":"11317","sessionTitle":"Advances in the Management of Chronic Lymphocytic Leukemia and Other B-Cell Lymphomas","firstName":"Matthew ","lastName":"Matasar","credentials":"MD, MS","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"A703-A704","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor matthew matasar"},{"sessionId":"11317","sessionTitle":"Advances in the Management of Chronic Lymphocytic Leukemia and Other B-Cell Lymphomas","firstName":"Val ","lastName":"Adams","credentials":"PharmD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"A703-A704","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor val adams"},{"sessionId":"11319","sessionTitle":"Hemophilia 2018: Current and Emerging Therapies","firstName":"K. ","lastName":"Pasi","credentials":"","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor k pasi"},{"sessionId":"11319","sessionTitle":"Hemophilia 2018: Current and Emerging Therapies","firstName":"Michael ","lastName":"Callaghan","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor michael callaghan"},{"sessionId":"11319","sessionTitle":"Hemophilia 2018: Current and Emerging Therapies","firstName":"Stacy ","lastName":"Croteau","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 2- C202-C204","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor stacy croteau"},{"sessionId":"11322","sessionTitle":"Incorporating New Therapeutic Strategies in the Treatment of Hodgkin Lymphoma","firstName":"Andrew ","lastName":"Evens","credentials":"DO, MSc","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Imperial A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor andrew evens"},{"sessionId":"11322","sessionTitle":"Incorporating New Therapeutic Strategies in the Treatment of Hodgkin Lymphoma","firstName":"Pier Luigi","lastName":"Zinzani","credentials":"MD, PhD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Imperial A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor pier luigi zinzani"},{"sessionId":"11322","sessionTitle":"Incorporating New Therapeutic Strategies in the Treatment of Hodgkin Lymphoma","firstName":"Ranjana ","lastName":"Advani","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Imperial A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor ranjana advani"},{"sessionId":"11322","sessionTitle":"Incorporating New Therapeutic Strategies in the Treatment of Hodgkin Lymphoma","firstName":"Robert ","lastName":"Chen","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Imperial A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor robert chen"},{"sessionId":"11326","sessionTitle":"Exploring New Strategies in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","firstName":"Elias","lastName":"Jabbour","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Centennial I","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor elias jabbour"},{"sessionId":"11326","sessionTitle":"Exploring New Strategies in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","firstName":"Giovanni","lastName":"Martinelli","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Centennial I","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor giovanni martinelli"},{"sessionId":"11326","sessionTitle":"Exploring New Strategies in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","firstName":"Jerald ","lastName":"Radich","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Centennial I","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor jerald radich"},{"sessionId":"11326","sessionTitle":"Exploring New Strategies in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","firstName":"Sergio ","lastName":"Giralt","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Centennial I","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor sergio giralt"},{"sessionId":"11328","sessionTitle":"Stories from the MPN Casebook: Expert Perspectives on Challenging Treatment Decisions in Polycythemia Vera and Myelofibrosis","firstName":"Francesco","lastName":"Passamonti","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Regency VI","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor francesco passamonti"},{"sessionId":"11328","sessionTitle":"Stories from the MPN Casebook: Expert Perspectives on Challenging Treatment Decisions in Polycythemia Vera and Myelofibrosis","firstName":"Nicolaus","lastName":"Krger","credentials":"","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Regency VI","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor nicolaus krger"},{"sessionId":"11328","sessionTitle":"Stories from the MPN Casebook: Expert Perspectives on Challenging Treatment Decisions in Polycythemia Vera and Myelofibrosis","firstName":"Robyn ","lastName":"Scherber","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Regency VI","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor robyn scherber"},{"sessionId":"11338","sessionTitle":"Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development","firstName":"Anjana","lastName":"Rao","credentials":"PhD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C104","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor anjana rao"},{"sessionId":"11338","sessionTitle":"Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development","firstName":"Frank","lastName":"Lyko","credentials":"PhD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C104","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor frank lyko"},{"sessionId":"11338","sessionTitle":"Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development","firstName":"Maria ","lastName":"Figueroa","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C104","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor maria figueroa"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","firstName":"Anna ","lastName":"Brown","credentials":"PhD","sessionStartTime":"2017-12-09T11:45:00Z","sessionEndTime":"2017-12-09T12:45:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C103","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor anna brown"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","firstName":"Christina","lastName":"Curtis","credentials":"PhD","sessionStartTime":"2017-12-09T11:45:00Z","sessionEndTime":"2017-12-09T12:45:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C103","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor christina curtis"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","firstName":"Daniel ","lastName":"Link","credentials":"MD","sessionStartTime":"2017-12-09T11:45:00Z","sessionEndTime":"2017-12-09T12:45:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C103","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor daniel link"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","firstName":"Timothy ","lastName":"Ley","credentials":"MD","sessionStartTime":"2017-12-09T11:45:00Z","sessionEndTime":"2017-12-09T12:45:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C103","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor timothy ley"},{"sessionId":"11340","sessionTitle":"Shining a Light on Benign Hematology Conditions: Focus on New Insights and Emerging Therapies","firstName":"James ","lastName":"Bussel","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor james bussel"},{"sessionId":"11340","sessionTitle":"Shining a Light on Benign Hematology Conditions: Focus on New Insights and Emerging Therapies","firstName":"Janet ","lastName":"Kwiatkowski","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 2- C208-C210","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor janet kwiatkowski"},{"sessionId":"11341","sessionTitle":"Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies","firstName":"Cameron ","lastName":"Turtle","credentials":"MBBS, PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C104","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor cameron turtle"},{"sessionId":"11341","sessionTitle":"Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies","firstName":"Crystal ","lastName":"Mackall","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C104","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor crystal mackall"},{"sessionId":"11341","sessionTitle":"Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies","firstName":"Gianpietro","lastName":"Dotti","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C104","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor gianpietro dotti"},{"sessionId":"11344","sessionTitle":"Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis","firstName":"Anil","lastName":"Sood","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C103","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor anil sood"},{"sessionId":"11344","sessionTitle":"Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis","firstName":"Elisabeth ","lastName":"Battinelli","credentials":"MD, PhD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C103","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor elisabeth battinelli"},{"sessionId":"11344","sessionTitle":"Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis","firstName":"Tatiana ","lastName":"Byzova","credentials":"PhD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C103","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor tatiana byzova"},{"sessionId":"11345","sessionTitle":"Evidence- and Value-Based Approaches to Pathology and Laboratory Diagnosis and Prognosis of Common Hematologic Neoplasms: A Case-Based Illustration","firstName":"David ","lastName":"Viswanatha","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor david viswanatha"},{"sessionId":"11345","sessionTitle":"Evidence- and Value-Based Approaches to Pathology and Laboratory Diagnosis and Prognosis of Common Hematologic Neoplasms: A Case-Based Illustration","firstName":"Dragan","lastName":"Jevremovic","credentials":"MD, PhD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor dragan jevremovic"},{"sessionId":"11345","sessionTitle":"Evidence- and Value-Based Approaches to Pathology and Laboratory Diagnosis and Prognosis of Common Hematologic Neoplasms: A Case-Based Illustration","firstName":"Ellen ","lastName":"McPhail","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor ellen mcphail"},{"sessionId":"11345","sessionTitle":"Evidence- and Value-Based Approaches to Pathology and Laboratory Diagnosis and Prognosis of Common Hematologic Neoplasms: A Case-Based Illustration","firstName":"Francis ","lastName":"Buadi","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor francis buadi"},{"sessionId":"11345","sessionTitle":"Evidence- and Value-Based Approaches to Pathology and Laboratory Diagnosis and Prognosis of Common Hematologic Neoplasms: A Case-Based Illustration","firstName":"Kaaren ","lastName":"Reichard","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor kaaren reichard"},{"sessionId":"11345","sessionTitle":"Evidence- and Value-Based Approaches to Pathology and Laboratory Diagnosis and Prognosis of Common Hematologic Neoplasms: A Case-Based Illustration","firstName":"Mrinal ","lastName":"Patnaik","credentials":"MBBS","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor mrinal patnaik"},{"sessionId":"11346","sessionTitle":"Plasma Cells and Myeloma","firstName":"Lawrence ","lastName":"Boise","credentials":"PhD ","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Cypress- No. Twr- M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor lawrence boise"},{"sessionId":"11347","sessionTitle":"Platelet Clearance","firstName":"Karin ","lastName":"Hoffmeister","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Magnolia- No. Twr- M2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor karin hoffmeister"},{"sessionId":"11349","sessionTitle":"Contact Pathways in Health and Disease","firstName":"James ","lastName":"Morrissey","credentials":"PhD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Juniper- No. Twr- M2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor james morrissey"},{"sessionId":"11350","sessionTitle":"Getting Clear Answers to Complex Treatment Challenges in Multiple Myeloma: Case Discussions","firstName":"Bruno","lastName":"Paiva","credentials":"PhD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor bruno paiva"},{"sessionId":"11350","sessionTitle":"Getting Clear Answers to Complex Treatment Challenges in Multiple Myeloma: Case Discussions","firstName":"Jess ","lastName":"San-Miguel","credentials":"","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor jess san-miguel"},{"sessionId":"11350","sessionTitle":"Getting Clear Answers to Complex Treatment Challenges in Multiple Myeloma: Case Discussions","firstName":"Philippe","lastName":"Moreau","credentials":"","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor philippe moreau"},{"sessionId":"11350","sessionTitle":"Getting Clear Answers to Complex Treatment Challenges in Multiple Myeloma: Case Discussions","firstName":"S. ","lastName":"Rajkumar","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor s rajkumar"},{"sessionId":"11351","sessionTitle":"Next Generation Sequencing as a Diagnostic Tool for Precision Medicine","firstName":"Torsten","lastName":"Haferlach","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Spruce- So. Twr- Atrium Ter","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor torsten haferlach"},{"sessionId":"11352","sessionTitle":"Optimizing Management of Acute Lymphoblastic Leukemia: From Adolescents to Adults","firstName":"Ching-Hon","lastName":"Pui","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Int'l Ballroom North","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor ching-hon pui"},{"sessionId":"11352","sessionTitle":"Optimizing Management of Acute Lymphoblastic Leukemia: From Adolescents to Adults","firstName":"Eunice ","lastName":"Wang","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Int'l Ballroom North","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor eunice wang"},{"sessionId":"11352","sessionTitle":"Optimizing Management of Acute Lymphoblastic Leukemia: From Adolescents to Adults","firstName":"Nicola","lastName":"Goekbuget","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Int'l Ballroom North","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor nicola goekbuget"},{"sessionId":"11352","sessionTitle":"Optimizing Management of Acute Lymphoblastic Leukemia: From Adolescents to Adults","firstName":"Stephen ","lastName":"Sallan","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Int'l Ballroom North","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor stephen sallan"},{"sessionId":"11353","sessionTitle":"Hematologic Malignancies in the Era of Immunotherapy: Clinician and Patient Perspectives","firstName":"Andreas","lastName":"Engert","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Centennial I","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor andreas engert"},{"sessionId":"11353","sessionTitle":"Hematologic Malignancies in the Era of Immunotherapy: Clinician and Patient Perspectives","firstName":"Donna","lastName":"Reece","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Centennial I","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor donna reece"},{"sessionId":"11353","sessionTitle":"Hematologic Malignancies in the Era of Immunotherapy: Clinician and Patient Perspectives","firstName":"Jorge ","lastName":"Cortes","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Centennial I","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor jorge cortes"},{"sessionId":"11353","sessionTitle":"Hematologic Malignancies in the Era of Immunotherapy: Clinician and Patient Perspectives","firstName":"Michael ","lastName":"Mauro","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Centennial I","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor michael mauro"},{"sessionId":"11354","sessionTitle":"The Role of Genetic Pathways in Bone Marrow Failure","firstName":"Steven ","lastName":"Holland","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Maple C- So. Twr- Atrium Ter","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor steven holland"},{"sessionId":"11355","sessionTitle":"How Long to Anticoagulate My Patient With VTE","firstName":"Marc","lastName":"Carrier","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Pine- So. Twr- Atrium Ter","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor marc carrier"},{"sessionId":"11357","sessionTitle":"Immune Thrombocytopenia","firstName":"Douglas ","lastName":"Cines","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Hickory- No. Twr- M3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor douglas cines"},{"sessionId":"11358","sessionTitle":"Thrombotic Thrombocytopenic Purpura","firstName":"Marie","lastName":"Scully","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Birch- So. Twr- Atrium Ter","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor marie scully"},{"sessionId":"11359","sessionTitle":"Aplastic Anemia","firstName":"Rodrigo ","lastName":"Calado","credentials":"MD, PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Maple B- So. Twr- Atrium Ter","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor rodrigo calado"},{"sessionId":"11360","sessionTitle":"ALL in Adolescents and Young Adults","firstName":"Wendy","lastName":"Stock","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Redwood- No. Twr- M1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor wendy stock"},{"sessionId":"11361","sessionTitle":"Individualized Therapy in Patients With AML","firstName":"Selina ","lastName":"Luger","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Cypress- No. Twr- M2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor selina luger"},{"sessionId":"11362","sessionTitle":"Treating and Monitoring Patients With CML","firstName":"Francois-Xavier","lastName":"Mahon","credentials":"MD, PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Magnolia- No. Twr- M2","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor francois-xavier mahon"},{"sessionId":"11363","sessionTitle":"Novel Therapy Combinations in Multiple Myeloma","firstName":"Shaji ","lastName":"Kumar","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Cottonwood- No. Twr- M1","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor shaji kumar"},{"sessionId":"11364","sessionTitle":"Relapsed/Refractory Diffuse Large B-Cell Lymphoma","firstName":"Laurie ","lastName":"Sehn","credentials":"MD, MPH","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Redwood- No. Twr- M1","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor laurie sehn"},{"sessionId":"11366","sessionTitle":"Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients With GvHD","firstName":"John ","lastName":"DiPersio","credentials":"MD, PhD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg A- Lvl 4- A402-A403","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor john dipersio"},{"sessionId":"11366","sessionTitle":"Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients With GvHD","firstName":"Karl","lastName":"Peggs","credentials":"MBBChir","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg A- Lvl 4- A402-A403","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor karl peggs"},{"sessionId":"11366","sessionTitle":"Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients With GvHD","firstName":"Kenneth","lastName":"Cooke","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg A- Lvl 4- A402-A403","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor kenneth cooke"},{"sessionId":"11368","sessionTitle":"Targeting With FLT3 Tyrosine Kinase Inhibitors in Acute Myeloid Leukemia","firstName":"Hartmut","lastName":"Dohner","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor hartmut dohner"},{"sessionId":"11368","sessionTitle":"Targeting With FLT3 Tyrosine Kinase Inhibitors in Acute Myeloid Leukemia","firstName":"Jacob ","lastName":"Rowe","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor jacob rowe"},{"sessionId":"11368","sessionTitle":"Targeting With FLT3 Tyrosine Kinase Inhibitors in Acute Myeloid Leukemia","firstName":"Keith ","lastName":"Pratz","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor keith pratz"},{"sessionId":"11368","sessionTitle":"Targeting With FLT3 Tyrosine Kinase Inhibitors in Acute Myeloid Leukemia","firstName":"Marlise ","lastName":"Luskin","credentials":"MD, MSCE","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B401-B402","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor marlise luskin"},{"sessionId":"11369","sessionTitle":"A Master-Class on Building Better Therapy for AML: Making the Most of an Increasing Number of Innovative Options","firstName":"Amir ","lastName":"Fathi","credentials":"MD, MD, BS","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor amir fathi"},{"sessionId":"11369","sessionTitle":"A Master-Class on Building Better Therapy for AML: Making the Most of an Increasing Number of Innovative Options","firstName":"Michael ","lastName":"Savona","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor michael savona"},{"sessionId":"11369","sessionTitle":"A Master-Class on Building Better Therapy for AML: Making the Most of an Increasing Number of Innovative Options","firstName":"Naval","lastName":"Daver","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor naval daver"},{"sessionId":"11369","sessionTitle":"A Master-Class on Building Better Therapy for AML: Making the Most of an Increasing Number of Innovative Options","firstName":"Stephen ","lastName":"Strickland","credentials":"MD, MSCI","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor stephen strickland"},{"sessionId":"11374","sessionTitle":"Current Status and the Future Potential of CAR T-Cell Therapy for Lymphoid Malignancies: The Experts Weigh-In on Recent Data and Clinical Experience","firstName":"James ","lastName":"Kochenderfer","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor james kochenderfer"},{"sessionId":"11374","sessionTitle":"Current Status and the Future Potential of CAR T-Cell Therapy for Lymphoid Malignancies: The Experts Weigh-In on Recent Data and Clinical Experience","firstName":"Jeremy ","lastName":"Abramson","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor jeremy abramson"},{"sessionId":"11374","sessionTitle":"Current Status and the Future Potential of CAR T-Cell Therapy for Lymphoid Malignancies: The Experts Weigh-In on Recent Data and Clinical Experience","firstName":"Stephen ","lastName":"Schuster","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B308-B309","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor stephen schuster"},{"sessionId":"11376","sessionTitle":"Test Driving CARs: Optimizing Outcomes","firstName":"Rebecca","lastName":"Gardner","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor rebecca gardner"},{"sessionId":"11376","sessionTitle":"Test Driving CARs: Optimizing Outcomes","firstName":"Sattva ","lastName":"Neelapu","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- C108-C109","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor sattva neelapu"},{"sessionId":"11378","sessionTitle":"Heparin-Induced Thrombocytopenia: HITs and Misses","firstName":"Lawrence","lastName":"Rice","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Sycamore- No. Twr- M2","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor lawrence rice"},{"sessionId":"11379","sessionTitle":"Tailored Therapy for Patients With Hodgkin Lymphoma","firstName":"Stephen ","lastName":"Ansell","credentials":"MD, PhD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Cottonwood- No. Twr- M1","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor stephen ansell"},{"sessionId":"11380","sessionTitle":"Progress in Acute Myeloid Leukemia: Adapting Treatment to Individual Patients","firstName":"B. ","lastName":"Smith","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor b smith"},{"sessionId":"11380","sessionTitle":"Progress in Acute Myeloid Leukemia: Adapting Treatment to Individual Patients","firstName":"Gail ","lastName":"Roboz","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor gail roboz"},{"sessionId":"11380","sessionTitle":"Progress in Acute Myeloid Leukemia: Adapting Treatment to Individual Patients","firstName":"Roland ","lastName":"Walter","credentials":"MD, PhD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Atrium A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor roland walter"},{"sessionId":"11382","sessionTitle":"Evaluating the Emerging Role of Biosimilar Agents for the Treatment of Hematologic Malignancies","firstName":"Andrew ","lastName":"Zelenetz","credentials":"MD, PhD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg A- Lvl 4- A402-A403","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor andrew zelenetz"},{"sessionId":"11382","sessionTitle":"Evaluating the Emerging Role of Biosimilar Agents for the Treatment of Hematologic Malignancies","firstName":"Bertrand","lastName":"Coiffier","credentials":"MD, PhD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg A- Lvl 4- A402-A403","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor bertrand coiffier"},{"sessionId":"11382","sessionTitle":"Evaluating the Emerging Role of Biosimilar Agents for the Treatment of Hematologic Malignancies","firstName":"Pamela ","lastName":"Becker","credentials":"MD, PhD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg A- Lvl 4- A402-A403","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor pamela becker"},{"sessionId":"11383","sessionTitle":"Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Waldenstrm Macroglobulinemia, and Amyloidosis (Part 2 of 2)","firstName":"Meletios ","lastName":"Dimopoulos","credentials":"","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis C-D","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor meletios dimopoulos"},{"sessionId":"11383","sessionTitle":"Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Waldenstrm Macroglobulinemia, and Amyloidosis (Part 2 of 2)","firstName":"Nikhil ","lastName":"Munshi","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis C-D","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor nikhil munshi"},{"sessionId":"11383","sessionTitle":"Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Waldenstrm Macroglobulinemia, and Amyloidosis (Part 2 of 2)","firstName":"Noopur","lastName":"Raje","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis C-D","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor noopur raje"},{"sessionId":"11383","sessionTitle":"Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Waldenstrm Macroglobulinemia, and Amyloidosis (Part 2 of 2)","firstName":"Robert ","lastName":"Orlowski","credentials":"MD, PhD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis C-D","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor robert orlowski"},{"sessionId":"11383","sessionTitle":"Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Waldenstrm Macroglobulinemia, and Amyloidosis (Part 2 of 2)","firstName":"Sagar","lastName":"Lonial","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis C-D","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor sagar lonial"},{"sessionId":"11384","sessionTitle":"Improving MDS Outcomes From Diagnosis to Treatment: A Multidisciplinary Approach","firstName":"Dita","lastName":"Gratzinger","credentials":"MD, PhD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg A- Lvl 4- A402-A403","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor dita gratzinger"},{"sessionId":"11384","sessionTitle":"Improving MDS Outcomes From Diagnosis to Treatment: A Multidisciplinary Approach","firstName":"Marilyn ","lastName":"Slovak","credentials":"PhD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg A- Lvl 4- A402-A403","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor marilyn slovak"},{"sessionId":"11384","sessionTitle":"Improving MDS Outcomes From Diagnosis to Treatment: A Multidisciplinary Approach","firstName":"Steven ","lastName":"Gore","credentials":"MD","sessionStartTime":"2017-12-08T07:00:00Z","sessionEndTime":"2017-12-08T11:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg A- Lvl 4- A402-A403","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor steven gore"},{"sessionId":"11385","sessionTitle":"Redefining Patient Care in Acute Lymphoblastic Leukemia: The Impact of Novel Antibody and Immune Technologies on Clinical Outcomes","firstName":"Charles ","lastName":"Mullighan","credentials":"MBBS (Hons), MSc, MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Centennial IV","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor charles mullighan"},{"sessionId":"11385","sessionTitle":"Redefining Patient Care in Acute Lymphoblastic Leukemia: The Impact of Novel Antibody and Immune Technologies on Clinical Outcomes","firstName":"Mark ","lastName":"Litzow","credentials":"MD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Centennial IV","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor mark litzow"},{"sessionId":"11385","sessionTitle":"Redefining Patient Care in Acute Lymphoblastic Leukemia: The Impact of Novel Antibody and Immune Technologies on Clinical Outcomes","firstName":"Stephan ","lastName":"Grupp","credentials":"MD, PhD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Centennial IV","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor stephan grupp"},{"sessionId":"11392","sessionTitle":"Anticoagulation: Applying Innovation in Clinical Practice","firstName":"A. ","lastName":"Camm","credentials":"QHP, MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor a camm"},{"sessionId":"11392","sessionTitle":"Anticoagulation: Applying Innovation in Clinical Practice","firstName":"Ajay ","lastName":"Kakkar","credentials":"MB, PhD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor ajay kakkar"},{"sessionId":"11392","sessionTitle":"Anticoagulation: Applying Innovation in Clinical Practice","firstName":"Alexander ","lastName":"Turpie","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor alexander turpie"},{"sessionId":"11392","sessionTitle":"Anticoagulation: Applying Innovation in Clinical Practice","firstName":"Howard ","lastName":"Liebman","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor howard liebman"},{"sessionId":"11392","sessionTitle":"Anticoagulation: Applying Innovation in Clinical Practice","firstName":"Jeffrey ","lastName":"Weitz","credentials":"MD","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor jeffrey weitz"},{"sessionId":"11392","sessionTitle":"Anticoagulation: Applying Innovation in Clinical Practice","firstName":"Keith ","lastName":"Fox","credentials":"MBBS","sessionStartTime":"2017-12-08T12:30:00Z","sessionEndTime":"2017-12-08T16:30:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Marquis A","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Marriot Marquis Atlanta","papertitle":"","keywords":"","combinedName":"doctor keith fox"},{"sessionId":"11394","sessionTitle":"Platelet Regulation of Tumor Growth and Metastasis","firstName":"Anil","lastName":"Sood","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Walnut- No. Twr- M3","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor anil sood"},{"sessionId":"11395","sessionTitle":"Reversal of Anticoagulants","firstName":"Mark","lastName":"Crowther","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Pine- So. Twr- Atrium Ter","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor mark crowther"},{"sessionId":"11397","sessionTitle":"Hematopoietic Stem Cell Generation, Reprogramming, and Expansion","firstName":"Kateri ","lastName":"Moore","credentials":"DVM","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Maple A- So. Twr- Atrium Ter","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor kateri moore"},{"sessionId":"11400","sessionTitle":"Genome Sequencing in the Newborn: Diagnostic Challenges and Emerging Opportunities","firstName":"Jennifer","lastName":"Puck","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Maple B- So. Twr- Atrium Ter","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor jennifer puck"},{"sessionId":"11401","sessionTitle":"Understanding Microbial Immune System Interactions","firstName":"Mark","lastName":"Davis","credentials":"PhD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Birch- So. Twr- Atrium Ter","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor mark davis"},{"sessionId":"11405","sessionTitle":"Scholarly Work in Quality Improvement","firstName":"Lisa ","lastName":"Hicks","credentials":"MD, MSc","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Maple A- So. Twr- Atrium Ter","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor lisa hicks"},{"sessionId":"11405","sessionTitle":"Scholarly Work in Quality Improvement","firstName":"Vishal","lastName":"Kukreti","credentials":"MD","sessionStartTime":"2017-12-09T11:15:00Z","sessionEndTime":"2017-12-09T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Maple A- So. Twr- Atrium Ter","key_AorB":"A","sessiondate":"12/9/2017 12:00:00 AM","property":"Omni Hotel at CNN Center","papertitle":"","keywords":"","combinedName":"doctor vishal kukreti"},{"sessionId":"11407","sessionTitle":"Illuminating the Role of Shared Decision-Making as the Hemophilia A Management Landscape Continues to Evolve: Progress in Practice","firstName":"Johannes","lastName":"Oldenburg","credentials":"MD, PhD","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Regency VI","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor johannes oldenburg"},{"sessionId":"11407","sessionTitle":"Illuminating the Role of Shared Decision-Making as the Hemophilia A Management Landscape Continues to Evolve: Progress in Practice","firstName":"Rebecca","lastName":"Kruse-Jarres","credentials":"","sessionStartTime":"2017-12-08T18:00:00Z","sessionEndTime":"2017-12-08T22:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Regency VI","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Hyatt Regency Atlanta","papertitle":"","keywords":"","combinedName":"doctor rebecca kruse-jarres"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","firstName":"Jonathan M","lastName":"Marron","credentials":"MD, MPH","sessionStartTime":"2017-12-08T17:10:00Z","sessionEndTime":"2017-12-08T17:55:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor jonathan m marron"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","firstName":"Kayla","lastName":"Hamilton","credentials":"MS, CGC","sessionStartTime":"2017-12-08T17:10:00Z","sessionEndTime":"2017-12-08T17:55:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor kayla hamilton"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","firstName":"Luke","lastName":"Maese","credentials":"DO","sessionStartTime":"2017-12-08T17:10:00Z","sessionEndTime":"2017-12-08T17:55:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor luke maese"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","firstName":"Michael ","lastName":"Pulsipher","credentials":"MD","sessionStartTime":"2017-12-08T17:10:00Z","sessionEndTime":"2017-12-08T17:55:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B211-B212","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor michael pulsipher"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","firstName":"George ","lastName":"Canellos","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor george canellos"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","firstName":"Janis ","lastName":"Abkowitz","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor janis abkowitz"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","firstName":"Jorge","lastName":"Di Paola","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor jorge di paola"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","firstName":"Naomi ","lastName":"Luban","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor naomi luban"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","firstName":"Neil","lastName":"Shah","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor neil shah"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","firstName":"Omar","lastName":"Abdel-Wahab","credentials":"MD","sessionStartTime":"2017-12-10T14:00:00Z","sessionEndTime":"2017-12-10T16:00:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg C- Lvl 1- Hall C2-C3","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor omar abdel-wahab"},{"sessionId":"11942","sessionTitle":"Featured Topic Discussion: Hemophilia Revolution","firstName":"Barbara","lastName":"Konkle","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor barbara konkle"},{"sessionId":"11942","sessionTitle":"Featured Topic Discussion: Hemophilia Revolution","firstName":"David","lastName":"Lillicrap","credentials":"MD","sessionStartTime":"2017-12-10T11:15:00Z","sessionEndTime":"2017-12-10T12:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B405-B407","key_AorB":"A","sessiondate":"12/10/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor david lillicrap"},{"sessionId":"11943","sessionTitle":"Featured Topic Discussion: Combination Therapies: How Are We Deciding What to Utilize?","firstName":"Donna","lastName":"Przepiorka","credentials":"MD, PhD","sessionStartTime":"2017-12-11T12:15:00Z","sessionEndTime":"2017-12-11T13:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor donna przepiorka"},{"sessionId":"11943","sessionTitle":"Featured Topic Discussion: Combination Therapies: How Are We Deciding What to Utilize?","firstName":"Steven","lastName":"Grant","credentials":"MD","sessionStartTime":"2017-12-11T12:15:00Z","sessionEndTime":"2017-12-11T13:15:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 5- Murphy BR 1-2","key_AorB":"A","sessiondate":"12/11/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor steven grant"},{"sessionId":"12020","sessionTitle":"Panel Discussion/Questions","firstName":"Cynthia ","lastName":"Dunbar","credentials":"MD","sessionStartTime":"2017-12-08T14:05:00Z","sessionEndTime":"2017-12-08T14:20:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor cynthia dunbar"},{"sessionId":"12020","sessionTitle":"Panel Discussion/Questions","firstName":"Gerald","lastName":"De Haan","credentials":"PhD","sessionStartTime":"2017-12-08T14:05:00Z","sessionEndTime":"2017-12-08T14:20:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor gerald de haan"},{"sessionId":"12020","sessionTitle":"Panel Discussion/Questions","firstName":"Laura ","lastName":"Calvi","credentials":"MD","sessionStartTime":"2017-12-08T14:05:00Z","sessionEndTime":"2017-12-08T14:20:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor laura calvi"},{"sessionId":"12020","sessionTitle":"Panel Discussion/Questions","firstName":"Michael Gustave","lastName":"Poulos","credentials":"PhD","sessionStartTime":"2017-12-08T14:05:00Z","sessionEndTime":"2017-12-08T14:20:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor michael gustave poulos"},{"sessionId":"12021","sessionTitle":"Panel Discussion/Questions","firstName":"Bindu","lastName":"Kanapuru","credentials":"MD","sessionStartTime":"2017-12-08T15:05:00Z","sessionEndTime":"2017-12-08T15:20:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor bindu kanapuru"},{"sessionId":"12021","sessionTitle":"Panel Discussion/Questions","firstName":"Fabienne","lastName":"Lucas","credentials":"MD PhD","sessionStartTime":"2017-12-08T15:05:00Z","sessionEndTime":"2017-12-08T15:20:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor fabienne lucas"},{"sessionId":"12021","sessionTitle":"Panel Discussion/Questions","firstName":"Hartmut","lastName":"Geiger","credentials":"PhD","sessionStartTime":"2017-12-08T15:05:00Z","sessionEndTime":"2017-12-08T15:20:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor hartmut geiger"},{"sessionId":"12022","sessionTitle":"Panel Discussion/Questions","firstName":"Alisa ","lastName":"Wolberg","credentials":"PhD","sessionStartTime":"2017-12-08T16:20:00Z","sessionEndTime":"2017-12-08T16:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor alisa wolberg"},{"sessionId":"12022","sessionTitle":"Panel Discussion/Questions","firstName":"Matthew ","lastName":"Rondina","credentials":"MD","sessionStartTime":"2017-12-08T16:20:00Z","sessionEndTime":"2017-12-08T16:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor matthew rondina"},{"sessionId":"12022","sessionTitle":"Panel Discussion/Questions","firstName":"Pavel","lastName":"Davizon-Castillo","credentials":"MD","sessionStartTime":"2017-12-08T16:20:00Z","sessionEndTime":"2017-12-08T16:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor pavel davizon-castillo"},{"sessionId":"12026","sessionTitle":"Panel Discussion/Questions","firstName":"Marlise ","lastName":"Luskin","credentials":"MD, MSCE","sessionStartTime":"2017-12-08T17:20:00Z","sessionEndTime":"2017-12-08T17:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor marlise luskin"},{"sessionId":"12026","sessionTitle":"Panel Discussion/Questions","firstName":"Paul ","lastName":"Hamlin","credentials":"MD","sessionStartTime":"2017-12-08T17:20:00Z","sessionEndTime":"2017-12-08T17:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor paul hamlin"},{"sessionId":"12026","sessionTitle":"Panel Discussion/Questions","firstName":"Raul","lastName":"Cordoba","credentials":"MD, PhD","sessionStartTime":"2017-12-08T17:20:00Z","sessionEndTime":"2017-12-08T17:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B216-B217","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor raul cordoba"},{"sessionId":"12032","sessionTitle":"Panel Discussion","firstName":"Hanlee","lastName":"Ji","credentials":"MD","sessionStartTime":"2017-12-08T14:05:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor hanlee ji"},{"sessionId":"12032","sessionTitle":"Panel Discussion","firstName":"Michael","lastName":"Angelo","credentials":"MD, PhD","sessionStartTime":"2017-12-08T14:05:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor michael angelo"},{"sessionId":"12033","sessionTitle":"Panel Discussion","firstName":"June Helen","lastName":"Myklebust","credentials":"PhD","sessionStartTime":"2017-12-08T15:35:00Z","sessionEndTime":"2017-12-08T16:05:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor june helen myklebust"},{"sessionId":"12033","sessionTitle":"Panel Discussion","firstName":"Paul","lastName":"Sondel","credentials":"MD, PhD","sessionStartTime":"2017-12-08T15:35:00Z","sessionEndTime":"2017-12-08T16:05:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor paul sondel"},{"sessionId":"12034","sessionTitle":"Panel Discussion","firstName":"Rajat","lastName":"Bannerji","credentials":"MD, PhD","sessionStartTime":"2017-12-08T17:05:00Z","sessionEndTime":"2017-12-08T17:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor rajat bannerji"},{"sessionId":"12034","sessionTitle":"Panel Discussion","firstName":"Renier ","lastName":"Brentjens","credentials":"MD, PhD","sessionStartTime":"2017-12-08T17:05:00Z","sessionEndTime":"2017-12-08T17:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 3- B312-B314","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor renier brentjens"},{"sessionId":"12041","sessionTitle":"Conclusions and Study Needs","firstName":"Andrea","lastName":"Sharma","credentials":"PhD, MPH","sessionStartTime":"2017-12-08T16:30:00Z","sessionEndTime":"2017-12-08T16:40:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor andrea sharma"},{"sessionId":"12041","sessionTitle":"Conclusions and Study Needs","firstName":"Maria Nieves","lastName":"Garcia-Casal","credentials":"","sessionStartTime":"2017-12-08T16:30:00Z","sessionEndTime":"2017-12-08T16:40:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 2- B213-B214","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor maria nieves garcia-casal"},{"sessionId":"12065","sessionTitle":"Next Steps for Myeloid Neoplasm Clinical & Molecular Epidemiology: Towards Translation","firstName":"James ","lastName":"Foran","credentials":"MD","sessionStartTime":"2017-12-08T15:35:00Z","sessionEndTime":"2017-12-08T15:45:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor james foran"},{"sessionId":"12065","sessionTitle":"Next Steps for Myeloid Neoplasm Clinical & Molecular Epidemiology: Towards Translation","firstName":"Lindsay ","lastName":"Morton","credentials":"PhD","sessionStartTime":"2017-12-08T15:35:00Z","sessionEndTime":"2017-12-08T15:45:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor lindsay morton"},{"sessionId":"12066","sessionTitle":"How to Build an Epidemiological Research Community in T-cell Lymphoma/leukemia","firstName":"Amanda","lastName":"Termuhlen","credentials":"","sessionStartTime":"2017-12-08T17:45:00Z","sessionEndTime":"2017-12-08T17:55:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor amanda termuhlen"},{"sessionId":"12066","sessionTitle":"How to Build an Epidemiological Research Community in T-cell Lymphoma/leukemia","firstName":"Fredrik","lastName":"Ellin","credentials":"MD, MSc","sessionStartTime":"2017-12-08T17:45:00Z","sessionEndTime":"2017-12-08T17:55:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor fredrik ellin"},{"sessionId":"12066","sessionTitle":"How to Build an Epidemiological Research Community in T-cell Lymphoma/leukemia","firstName":"Sophia ","lastName":"Wang","credentials":"PhD","sessionStartTime":"2017-12-08T17:45:00Z","sessionEndTime":"2017-12-08T17:55:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor sophia wang"},{"sessionId":"12071","sessionTitle":"Next Steps for B-cell Neoplasms Epidemiology: Towards Translation","firstName":"James ","lastName":"Cerhan","credentials":"MD, PhD","sessionStartTime":"2017-12-08T14:25:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor james cerhan"},{"sessionId":"12071","sessionTitle":"Next Steps for B-cell Neoplasms Epidemiology: Towards Translation","firstName":"Jeffrey ","lastName":"Switchenko","credentials":"PhD, MS","sessionStartTime":"2017-12-08T14:25:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor jeffrey switchenko"},{"sessionId":"12071","sessionTitle":"Next Steps for B-cell Neoplasms Epidemiology: Towards Translation","firstName":"Maria ","lastName":"Oliveira","credentials":"","sessionStartTime":"2017-12-08T14:25:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor maria oliveira"},{"sessionId":"12071","sessionTitle":"Next Steps for B-cell Neoplasms Epidemiology: Towards Translation","firstName":"Marta","lastName":"Epeldegui","credentials":"PhD","sessionStartTime":"2017-12-08T14:25:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor marta epeldegui"},{"sessionId":"12071","sessionTitle":"Next Steps for B-cell Neoplasms Epidemiology: Towards Translation","firstName":"Smita","lastName":"Bhatia","credentials":"MD, MPH","sessionStartTime":"2017-12-08T14:25:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor smita bhatia"},{"sessionId":"12071","sessionTitle":"Next Steps for B-cell Neoplasms Epidemiology: Towards Translation","firstName":"Susan ","lastName":"Slager","credentials":"PhD","sessionStartTime":"2017-12-08T14:25:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor susan slager"},{"sessionId":"12071","sessionTitle":"Next Steps for B-cell Neoplasms Epidemiology: Towards Translation","firstName":"Wendy","lastName":"Cozen","credentials":"DO, MPH","sessionStartTime":"2017-12-08T14:25:00Z","sessionEndTime":"2017-12-08T14:35:00Z","startTime":"00:00:00","endTime":"00:00:00","sessionLocation":"Bldg B- Lvl 4- B404","key_AorB":"A","sessiondate":"12/8/2017 12:00:00 AM","property":"Georgia World Congress Center","papertitle":"","keywords":"","combinedName":"doctor wendy cozen"}]
